Citrus Sinensis ID: 037297
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 366 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.909 | 0.445 | 0.577 | 1e-112 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.893 | 0.412 | 0.587 | 1e-110 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.915 | 0.440 | 0.571 | 1e-109 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.833 | 0.406 | 0.599 | 1e-108 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.923 | 0.428 | 0.579 | 1e-106 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.825 | 0.413 | 0.587 | 1e-104 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.896 | 0.449 | 0.568 | 1e-103 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.860 | 0.412 | 0.568 | 1e-103 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.890 | 0.445 | 0.560 | 1e-103 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.896 | 0.426 | 0.563 | 1e-103 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 206/357 (57%), Positives = 278/357 (77%), Gaps = 24/357 (6%)
Query: 3 STLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFS 62
S LL+F F + G L + ++K+R I+++ +FF++NGG+LL+Q L + +V + ++FS
Sbjct: 350 SALLLFAFGIFG--LYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLARKEGNV-EMSRIFS 405
Query: 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
S EL+KAT++FN NR+LGQGGQGTVYKGML DGRI+AVK+ K AVD++ ++EEFINE+
Sbjct: 406 SHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AVDED---RVEEFINEV 461
Query: 123 VILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIA 170
V+L+QINHRN+VKLLGCCLETEVP+L LHD ++++ +TWE+RL IA
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDE--SDDYTMTWEVRLHIA 519
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
E+AGALSYLHSAAS PIYHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ G
Sbjct: 520 IEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAG 579
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
TFGY++PEY QSS+ T+KSDVYSFGVVLVELLTG+KP S+ S+EN LAA FV +++
Sbjct: 580 TFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVK 637
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347
+N + DI+DD++ +Q+M+ ANLA RCL+ GKKRP M EV++EL IR S++
Sbjct: 638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHY 694
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-110, Method: Compositional matrix adjust.
Identities = 204/347 (58%), Positives = 264/347 (76%), Gaps = 20/347 (5%)
Query: 9 LFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDK 68
L V+G LL KK+ + K++FFK+NGGLLLQQ L S ++++ +FSS+EL+K
Sbjct: 384 LIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLIS-TVGMVEKTIVFSSRELEK 442
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
AT +F+ NRILGQGGQGTVYKGML DGRI+AVKK K+ +D KLEEFINE+VILSQI
Sbjct: 443 ATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFINEVVILSQI 498
Query: 129 NHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
NHRN+VKLLGCCLET+VP+L HLHD +E TW IRLRIA ++AGA
Sbjct: 499 NHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAIDIAGA 557
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LSYLHS+ASSPIYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT GY++
Sbjct: 558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMD 617
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PEY QSSQ TDKSDVYSFGVVLVEL+TG+K I + SQEN +LA +F+ +M++N ++D
Sbjct: 618 PEYFQSSQFTDKSDVYSFGVVLVELITGEKSI--SFLRSQENRTLATYFILAMKENKLFD 675
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
I+D ++ +Q+ A A +A +CL+L G+KRP+M EV+MEL+ IR
Sbjct: 676 IIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-109, Method: Compositional matrix adjust.
Identities = 203/355 (57%), Positives = 272/355 (76%), Gaps = 20/355 (5%)
Query: 3 STLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFS 62
S LL+F F + G L + I+K+R +++ FF++NGG+LL+Q L + +V + K+FS
Sbjct: 358 SALLLFAFGIFG--LYKFIKKQRRSSRMR-VFFRRNGGMLLKQQLARKEGNV-EMSKIFS 413
Query: 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
S EL+KAT++FN NR+LGQGGQGTVYKGML DGRI+AVK+ K A+D++ K+EEFINE+
Sbjct: 414 SNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AMDED---KVEEFINEV 469
Query: 123 VILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNE--EFPLTWEIRLRIATE 172
V+L+QINHRN+VKLLGCCLETEVP+L L R+E ++ +TWE+RL IA E
Sbjct: 470 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIE 529
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+AGALSYLHSAAS PIYHRDIK+TNILLDE+Y+ KV+DFGTS+ + +DQTH+TT++ GTF
Sbjct: 530 IAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTF 589
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
GY++PEY QSS+ TDKSDVYSFGVVLVEL+TGK P S+ S+EN AA FV ++++N
Sbjct: 590 GYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNP--SSRVQSEENRGFAAHFVAAVKEN 647
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347
DI+D+++ +Q+MA A LA+RCL+ GKKRP M EV++EL IR S++
Sbjct: 648 RFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSY 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1002), Expect = e-108, Method: Compositional matrix adjust.
Identities = 193/322 (59%), Positives = 253/322 (78%), Gaps = 17/322 (5%)
Query: 34 FFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE 93
FFK+NGGLLL+Q L + +V K+FSSKEL+KAT++FN+NR+LGQGGQGTVYKGML
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLV 441
Query: 94 DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL---HL 150
DGRI+AVK+ K+ +D K+EEFINE+ +LSQINHRN+VKL+GCCLETEVP+L H+
Sbjct: 442 DGRIVAVKRSKVLDED----KVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHI 497
Query: 151 HD-------HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203
+ HH ++++ +TW++RLRI+ E+AGAL+YLHSAAS+P+YHRD+K+TNILLDE+
Sbjct: 498 PNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEK 557
Query: 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
YRAKV+DFGTS+ I +DQTH+TT + GTFGYL+PEY Q+SQ TDKSDVYSFGVVLVEL+T
Sbjct: 558 YRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELIT 617
Query: 264 GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLD 323
G+KP FS +EN L + F +M++N + DI+D ++ + Q++A A LA RCL
Sbjct: 618 GEKP-FSV-MRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLS 675
Query: 324 LNGKKRPTMEEVTMELNGIRGS 345
L GKKRP M EV++EL IR S
Sbjct: 676 LKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 383 bits (984), Expect = e-106, Method: Compositional matrix adjust.
Identities = 205/354 (57%), Positives = 258/354 (72%), Gaps = 16/354 (4%)
Query: 2 ISTLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLF 61
+ + L V+G LR KKR K K +FFK+NGGLLLQQ LN+ +V ++ ++F
Sbjct: 381 VGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNV-EKTRIF 439
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINE 121
SS+EL+KAT++F+ +RILGQGGQGTVYKGML DGR +AVKK K+ +D KLEEFINE
Sbjct: 440 SSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDED----KLEEFINE 495
Query: 122 IVILSQINHRNVVKLLGCCLETEVPLL----------HLHDHHRNEEFPLTWEIRLRIAT 171
+VILSQINHR+VVKLLGCCLETEVP L H H ++++ TW +RLRIA
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAV 555
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
++AGALSYLHSAASSPIYHRDIKSTNILLDE+YR KV+DFGTS+ + +D TH TT I GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291
GY++PEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ + N SQE LA F +M++
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVAMKE 674
Query: 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
N ++I+D ++ K Q+MA ANLA RCL+ GKKRP M +V +L I S
Sbjct: 675 NRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 191/325 (58%), Positives = 250/325 (76%), Gaps = 23/325 (7%)
Query: 33 RFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGML 92
+FFK+NGGLLL+Q L + D SV + K+FSS+EL+KAT++F+++R+LGQGGQGTVYK ML
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSV-EMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRML 447
Query: 93 EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL---- 148
DG I+AVK+ K+ +D K+EEFINEIV+LSQINHRN+VKLLGCCLETEVP+L
Sbjct: 448 VDGSIVAVKRSKVVDED----KMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEY 503
Query: 149 --------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL 200
LHD + +++ +TWE+RLRIA E+AGALSY+HSAAS PI+HRDIK+TNILL
Sbjct: 504 IPNGDLFKRLHDEY--DDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILL 561
Query: 201 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVE 260
DE+YRAK++DFGTS+ +A DQTH+TT + GTFGY++PEY SSQ T KSDVYSFGVVLVE
Sbjct: 562 DEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVE 621
Query: 261 LLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAER 320
L+TG+KP+ S+E + LA +F+ +M++N DI+D ++ K Q+MA A LA R
Sbjct: 622 LITGEKPMSRV--RSEEGIGLATYFLEAMKENRAVDIIDIRIKDESK--QVMAVAKLARR 677
Query: 321 CLDLNGKKRPTMEEVTMELNGIRGS 345
CL+ G KRP M EV+++L IR S
Sbjct: 678 CLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 200/352 (56%), Positives = 262/352 (74%), Gaps = 24/352 (6%)
Query: 6 LVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKE 65
LVF +G L + KKR +I ++FFK+NGGLLL+Q L + D +V + K+FSSKE
Sbjct: 366 LVFF---VGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKIFSSKE 421
Query: 66 LDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVIL 125
L KAT++F+++R+LGQGGQGTVYKGML DG I+AVK+ K+ +D K+EEFINEIV+L
Sbjct: 422 LRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDED----KMEEFINEIVLL 477
Query: 126 SQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEV 173
SQINHRN+VKLLGCCLETEVP+L LHD ++++ +TWE+RLRIA E+
Sbjct: 478 SQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDE--SDDYTMTWEVRLRIAIEI 535
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
AGAL+Y+HSAAS PI+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GTFG
Sbjct: 536 AGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFG 595
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
Y++PEY SSQ T KSDVYSFGVVLVEL+TG+KP+ S+E LA F+ +M++N
Sbjct: 596 YMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENR 653
Query: 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
+ DI+D ++ K Q+MA A LA +CL+ GK RP M+EV+ EL IR S
Sbjct: 654 VIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (965), Expect = e-103, Method: Compositional matrix adjust.
Identities = 191/336 (56%), Positives = 251/336 (74%), Gaps = 21/336 (6%)
Query: 19 RIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRI 78
+++RK+RM + K +FFK+NGGLLLQQ LN+ V ++ KLFSS+EL+KAT++FN NR+
Sbjct: 402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+GQGGQGTVYKGML DGR +AVKK + +D KL+EFINE++ILSQINHR+VVKLLG
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNVVDED----KLQEFINEVIILSQINHRHVVKLLG 515
Query: 139 CCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
CCLETEVP+L HLH+ +++ W +R+RIA +++GA SYLH+AA S
Sbjct: 516 CCLETEVPILVYEFIPNGNLFQHLHEEF--DDYTALWGVRMRIAVDISGAFSYLHTAACS 573
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
PIYHRDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT GY++PEY+ SS T
Sbjct: 574 PIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFT 633
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
+KSDVYSFGVVLVEL+TG+KP+ + T QE LA +F +MR+N +++I+D ++
Sbjct: 634 EKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDC 692
Query: 307 KKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
K Q++A ANLA RCL GK RP M EV+ L I
Sbjct: 693 KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 194/346 (56%), Positives = 258/346 (74%), Gaps = 20/346 (5%)
Query: 12 VIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATN 71
V+G + L I KKR I +FFK+NGGLLL+Q L + +D +D +LFSS+EL KAT+
Sbjct: 371 VVGTLGLIIFIKKRRRIISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATD 430
Query: 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+F+V R+LG+G QGTVYKGM+ DG+I+AVK+ K+ +D KLE+FINEI++LSQINHR
Sbjct: 431 NFSVKRVLGKGSQGTVYKGMMVDGKIIAVKRSKVVDED----KLEKFINEIILLSQINHR 486
Query: 132 NVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
N+VKL+GCCLETEVP+L LHD ++++ +TWE+RLRIA E+AGAL+Y
Sbjct: 487 NIVKLIGCCLETEVPILVYEYIPNGDMFKRLHDE--SDDYAMTWEVRLRIAIEIAGALTY 544
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+HSAAS PIYHRDIK+TNILLDE+Y AKV+DFGTS+ + +DQTH+TT + GTFGY++PEY
Sbjct: 545 MHSAASFPIYHRDIKTTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEY 604
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
SSQ TDKSDVYSFGVVLVEL+TG+KP+ S+E LA F+ +M++N + DI+D
Sbjct: 605 FLSSQYTDKSDVYSFGVVLVELITGEKPLSRI--RSEEGRGLATHFLEAMKENRVIDIID 662
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
++ + K +Q+MA A LA +CL G KRP M E ++EL IR S
Sbjct: 663 IRIKEESKLDQLMAVAKLARKCLSRKGIKRPNMREASLELERIRSS 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 199/353 (56%), Positives = 269/353 (76%), Gaps = 25/353 (7%)
Query: 4 TLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSS 63
+ LVF+ + L + IR++R + K++FFK+NGGLLLQQ L + + +V D ++F+S
Sbjct: 368 STLVFIGGIY--WLYKFIRRQRR-LNQKKKFFKRNGGLLLQQQLTTTEGNV-DSTRVFNS 423
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIV 123
+EL+KAT +F++ RILG+GGQGTVYKGML DGRI+AVKK K+ +D KLEEFINE+V
Sbjct: 424 RELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFINEVV 479
Query: 124 ILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLT-WEIRLRIA 170
ILSQINHRN+VKLLGCCLET+VP+L HLHD ++++ +T WE+RLRIA
Sbjct: 480 ILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDD--SDDYTMTTWEVRLRIA 537
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
++AGALSYLHSAASSPIYHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT + G
Sbjct: 538 VDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSG 597
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
T GY++PEY QSSQ TDKSDVYSFGVVL EL+TG+K + + SQE +LA +F +M+
Sbjct: 598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSV--SFLRSQEYRTLATYFTLAMK 655
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+N + DI+D ++ K NQ+ A A +A +CL++ G+KRP+M +V+MEL IR
Sbjct: 656 ENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 366 | ||||||
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.915 | 0.386 | 0.657 | 1e-126 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.882 | 0.782 | 0.665 | 1e-123 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.879 | 0.391 | 0.664 | 1e-123 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.915 | 0.493 | 0.640 | 1e-121 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.912 | 0.481 | 0.636 | 1e-121 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.871 | 0.438 | 0.640 | 1e-118 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.868 | 0.442 | 0.653 | 1e-118 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.879 | 0.441 | 0.645 | 1e-117 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.868 | 0.309 | 0.653 | 1e-117 | |
| 359475624 | 376 | PREDICTED: wall-associated receptor kina | 0.825 | 0.803 | 0.680 | 1e-117 |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1173), Expect = e-126, Method: Compositional matrix adjust.
Identities = 232/353 (65%), Positives = 278/353 (78%), Gaps = 18/353 (5%)
Query: 1 TISTLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKL 60
TI L L V+ L I+ K+R IK KE+ F +NGGLLL+Q L+S + + ID+ KL
Sbjct: 303 TIGALGTLLL-VLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGN-IDKTKL 360
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
F+SKEL+KAT+ +N NR++GQGG+GTVYKGML DGRI+AVKK K+ D KLE+FIN
Sbjct: 361 FTSKELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDS----KLEQFIN 416
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLL----------HLHDHHRNEEFPLTWEIRLRIA 170
E+VIL QINHRNVVKLLGCCLETEVPLL H H +NEEFP+TWEIRLRIA
Sbjct: 417 EVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIA 476
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
TEVAGALSYLHSAAS PIYHRDIKSTNILLD++YRAKVADFG SKF+A+DQTH+TT++QG
Sbjct: 477 TEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQG 536
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
TFGYL+PEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI ST S+E SLA++F+ SM
Sbjct: 537 TFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMN 594
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
++ + D+LD QVVK +K +I A A LA RC++LNGKKRPTM EV MEL IR
Sbjct: 595 EDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIR 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-123, Method: Compositional matrix adjust.
Identities = 229/344 (66%), Positives = 278/344 (80%), Gaps = 21/344 (6%)
Query: 12 VIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATN 71
VI LL + K+R IK KE+ FK+NGGLLL+Q L+S + +V D+ KLF+SKEL+KAT+
Sbjct: 23 VICAWLLYRVLKRRRKIKHKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEKATD 81
Query: 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+N NR++GQGGQGTVYKGML DGRI+AVKK K+ D KLE+FINE+VILSQINHR
Sbjct: 82 RYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KLEQFINEVVILSQINHR 137
Query: 132 NVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
NVVKLLGCCLE EVPLL H+HD +NEEFP+TW++RL+IATEVAGALSY
Sbjct: 138 NVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIHD--QNEEFPITWKMRLQIATEVAGALSY 195
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
LHSAAS PIYHRDIKSTNILLD++YRAKVADFGTSK +A+DQTH+TTK+QGTFGYL+PEY
Sbjct: 196 LHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEY 255
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
QSSQ T+KSDVYSFG+VL+ELLTGKKPI S G S E SLA++F+ SM+++ + D+LD
Sbjct: 256 FQSSQFTEKSDVYSFGIVLIELLTGKKPILSIG--SGEGKSLASYFIMSMKEDRLSDLLD 313
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+VVK +K +I A A LA+RC++LNGKKRPTM EV MEL IR
Sbjct: 314 ARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIR 357
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-123, Method: Compositional matrix adjust.
Identities = 228/343 (66%), Positives = 274/343 (79%), Gaps = 21/343 (6%)
Query: 9 LFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDK 68
L VI L + K+R IK KE+ FK+NGGLLL+Q L+S + +V D+ KLF+SKEL+K
Sbjct: 466 LLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEK 524
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
AT+ +N NR++GQGGQGTVYKGML DGRI+AVKK K+ D K+E+FINE+VILSQI
Sbjct: 525 ATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KVEQFINEVVILSQI 580
Query: 129 NHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
NHRNVVKLLGCCLET VPLL H+HD +NEEFP+TWE+RLRIA EVAGA
Sbjct: 581 NHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHD--QNEEFPITWEMRLRIAIEVAGA 638
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LSYLHSAAS PIYHRDIKSTNILLD++YRAKVADFGTSK +A+DQTH+TT++QGTFGYL+
Sbjct: 639 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLD 698
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI ST S+E SLA++F+ SM ++ + D
Sbjct: 699 PEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMNEDRLSD 756
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+LD QVVK KK +I A A LA RC++LNGKKRPTM EV MEL
Sbjct: 757 LLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 226/353 (64%), Positives = 273/353 (77%), Gaps = 18/353 (5%)
Query: 1 TISTLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKL 60
TI +L L V+ L I K+R IK KE+ F +NGGLLL+Q L+S + + ID+ KL
Sbjct: 288 TIGSLGTLLL-VLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGN-IDKTKL 345
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
F+SKEL+KAT+ +N NR++GQG QGT YKGML DGRI+AVKK K+ D KLE+FIN
Sbjct: 346 FTSKELEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDS----KLEQFIN 401
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLL----------HLHDHHRNEEFPLTWEIRLRIA 170
E+VIL QINHRNVVKLLGCCLETEVPLL H H +NEEFP+TWE+RLRIA
Sbjct: 402 EVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIA 461
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
TEV GALSYLHS AS PIYHRDIKSTNILLB++YRAKVADFG SKF+A+DQTH+TT++QG
Sbjct: 462 TEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQG 521
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
TFGYL+PEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI S S+E SLA++F+ SM
Sbjct: 522 TFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIA--SEEGKSLASYFILSMN 579
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
++ + D+LD QVVK +K +I A A LA RC++LNGKKRPTM EV MEL IR
Sbjct: 580 EDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIR 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-121, Method: Compositional matrix adjust.
Identities = 224/352 (63%), Positives = 283/352 (80%), Gaps = 18/352 (5%)
Query: 8 FLFQVIGRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELD 67
FL +IG L I K+R +KLK+ FFK+NGGLLL+Q L+S ++ V ++ K+F+SKEL+
Sbjct: 336 FLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYV-EQTKVFTSKELE 394
Query: 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
KAT+ ++ NRILGQGGQGTVYKGML DGR++A+KK K+ +D KL++FINE+VILSQ
Sbjct: 395 KATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDED----KLDQFINEVVILSQ 450
Query: 128 INHRNVVKLLGCCLETEVPLL----------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
INHRNVVKL+GCCLETEVPLL + + H+ NEEFP+TWE+RLRIATEVAGAL
Sbjct: 451 INHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGAL 510
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+YLH+AAS PIYHRDIKS+NILLDE+YRAKVADFGTSK I++DQTHVTT++QGTFGYL+P
Sbjct: 511 AYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDP 570
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
EY QSSQ T+KSDVYSFGVVLVELLTG+KPI S S E SLA +F+ +M ++ +++I
Sbjct: 571 EYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSY--RSVEERSLATYFLMTMEESRLFEI 628
Query: 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGH 349
LD +V+K + +I+A A LAE+CL+LNGKKRP M+ V +EL GIR S GH
Sbjct: 629 LDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQ-GH 679
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1106), Expect = e-118, Method: Compositional matrix adjust.
Identities = 216/337 (64%), Positives = 275/337 (81%), Gaps = 18/337 (5%)
Query: 19 RIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRI 78
+II+++R KLK++FFK+NGGLLL+Q L+S +S +++ K+F+SKEL+KAT++++ +RI
Sbjct: 343 KIIKRRRA-TKLKQKFFKRNGGLLLEQQLSS-TESHVEQTKVFTSKELEKATDNYHTSRI 400
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LGQGGQGTVYKGML DGR++A+KK KL +D KL++FINE+VILSQINHRNVVKL G
Sbjct: 401 LGQGGQGTVYKGMLTDGRVVAIKKSKLVDED----KLDQFINEVVILSQINHRNVVKLTG 456
Query: 139 CCLETEVPLL----------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
CCLETEVPLL + + N+EFP+TWE+RLRIATEVAGAL+YLHSAAS PI
Sbjct: 457 CCLETEVPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPI 516
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
YHRDIKS+NILLDE+YRAKVADFGTSK IA++QTHVTT +QGTFGYL+PEY QSSQ T+K
Sbjct: 517 YHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEK 576
Query: 249 SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308
SDVYSFGVVLVELLTG+KPI S S E SLA +F+ +M +N +++ILD +V+K +
Sbjct: 577 SDVYSFGVVLVELLTGQKPISSL--RSVEERSLATYFLMTMEENRLFEILDARVLKEGGR 634
Query: 309 NQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
+I+A A +AE+CL+LNGKKRP M+ V +EL GIR S
Sbjct: 635 EEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSS 671
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1106), Expect = e-118, Method: Compositional matrix adjust.
Identities = 219/335 (65%), Positives = 271/335 (80%), Gaps = 17/335 (5%)
Query: 21 IRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILG 80
+ +K++DI++K+RFFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 336 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 394
Query: 81 QGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140
QGGQGTVYKGML DGRI+AVKK K+ VD+ +L E FINEIVILSQINHRNVV +LGCC
Sbjct: 395 QGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGILGCC 450
Query: 141 LETEVPLLHLH----------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190
LETEVPLL H +N EFPL+WE+RLRIA EV+GALSYLHSA S PIYH
Sbjct: 451 LETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYH 510
Query: 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSD 250
RDIKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYL+PEY QSSQ T+KSD
Sbjct: 511 RDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSD 570
Query: 251 VYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310
VYSFGVVLVELLTG+KPI ST S E SLA F+ S++++ ++DILD +VVK +K
Sbjct: 571 VYSFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKEGRKED 628
Query: 311 IMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
IM FA LA RCL+LNG+KRPTM+EVT E++ IR S
Sbjct: 629 IMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1103), Expect = e-117, Method: Compositional matrix adjust.
Identities = 220/341 (64%), Positives = 270/341 (79%), Gaps = 19/341 (5%)
Query: 14 GRMLLRIIRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHF 73
G L + KKR +I+LK +FFK+NGGLLLQQ L+S SV + K+F+SKEL+ AT+ F
Sbjct: 336 GISWLYKLAKKRKNIELKRKFFKRNGGLLLQQQLSSNHGSV-QKTKIFTSKELETATDRF 394
Query: 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
N NRILGQGGQGTVYKGMLEDGRI+AVK+ + ++ KLEEFINE+VILSQINHRNV
Sbjct: 395 NENRILGQGGQGTVYKGMLEDGRIVAVKRSTIVGEE----KLEEFINEVVILSQINHRNV 450
Query: 134 VKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
VKL GCCLETEVPLL +LH+ ++NE+F L+WE+RL+IA EVAGALSYLH
Sbjct: 451 VKLFGCCLETEVPLLVYEFISNGNLFQYLHNFYQNEDFILSWEMRLQIAIEVAGALSYLH 510
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
SAAS PIYHRDIKS NILLD++YRAKV+DFG+S+ +A+DQTH+TT +QGTFGYL+PEY Q
Sbjct: 511 SAASIPIYHRDIKSANILLDDKYRAKVSDFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQ 570
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301
SSQ TDKSDVYSFGVVLVELL+GKKPI S+ TSQE SLA F+ M +N ++DILD Q
Sbjct: 571 SSQFTDKSDVYSFGVVLVELLSGKKPIISS--TSQETRSLATHFIVLMEENRLFDILDVQ 628
Query: 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
V + + +IMA ANLA+RCL+++ K RPTM+EV+ EL I
Sbjct: 629 VKEDCLEEEIMAVANLAKRCLNVSRKHRPTMKEVSAELERI 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 219/335 (65%), Positives = 271/335 (80%), Gaps = 17/335 (5%)
Query: 21 IRKKRMDIKLKERFFKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILG 80
+ +K++DI++K+RFFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 216 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 274
Query: 81 QGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140
QGGQGTVYKGML DGRI+AVKK K+ VD+ +L E FINEIVILSQINHRNVV +LGCC
Sbjct: 275 QGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGILGCC 330
Query: 141 LETEVPLLHLH----------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190
LETEVPLL H +N EFPL+WE+RLRIA EV+GALSYLHSA S PIYH
Sbjct: 331 LETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYH 390
Query: 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSD 250
RDIKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYL+PEY QSSQ T+KSD
Sbjct: 391 RDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSD 450
Query: 251 VYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310
VYSFGVVLVELLTG+KPI ST S E SLA F+ S++++ ++DILD +VVK +K
Sbjct: 451 VYSFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKEGRKED 508
Query: 311 IMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
IM FA LA RCL+LNG+KRPTM+EVT E++ IR S
Sbjct: 509 IMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475624|ref|XP_002267548.2| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 217/319 (68%), Positives = 256/319 (80%), Gaps = 17/319 (5%)
Query: 35 FKQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLED 94
F +NGGLLL+Q L+S +V D+ KLF+SKEL+KAT+ +N NR++GQGGQGTVYKGML D
Sbjct: 40 FNRNGGLLLEQQLSSSKGNV-DKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMD 98
Query: 95 GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL------ 148
GRI+AVKK K+ D KLE+FINE+VIL QINHRNVVKLLGCCLETEVPLL
Sbjct: 99 GRIVAVKKLKIMSDS----KLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIP 154
Query: 149 ----HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204
H H +NEEFP+TWE+RL+IATEVA ALSYLHSAAS PIYHRDIKSTNILLD++Y
Sbjct: 155 NGTLSEHIHGQNEEFPITWEMRLQIATEVAKALSYLHSAASIPIYHRDIKSTNILLDDKY 214
Query: 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTG 264
RAKVADFGTSKF ++DQTH+TT++QGTFGYL+PEY QSSQ T+KSDVYSFGVVL+ELLTG
Sbjct: 215 RAKVADFGTSKFFSIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLIELLTG 274
Query: 265 KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDL 324
KKPI ST S+E SLA +F SM+++H+ D+LD +VVK K I A LA RC++L
Sbjct: 275 KKPILST--RSEERKSLALYFKISMKEDHLSDLLDARVVKEGMKEDINEIAFLARRCINL 332
Query: 325 NGKKRPTMEEVTMELNGIR 343
NGKKRPTM EV MEL IR
Sbjct: 333 NGKKRPTMMEVAMELERIR 351
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 366 | ||||||
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.909 | 0.445 | 0.557 | 1.2e-97 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.898 | 0.438 | 0.560 | 2.2e-96 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.893 | 0.412 | 0.564 | 1.4e-94 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.877 | 0.439 | 0.551 | 1.5e-92 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.904 | 0.420 | 0.567 | 1.9e-92 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.901 | 0.429 | 0.542 | 2.4e-92 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.926 | 0.470 | 0.533 | 1.9e-90 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.871 | 0.405 | 0.557 | 3.1e-90 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.893 | 0.412 | 0.543 | 1.1e-89 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.866 | 0.414 | 0.544 | 2.5e-88 |
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 199/357 (55%), Positives = 268/357 (75%)
Query: 3 STLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFS 62
S LL+F F + G L + ++K+R I+++ +FF+ + +V + ++FS
Sbjct: 350 SALLLFAFGIFG--LYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLARKEGNV-EMSRIFS 405
Query: 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
S EL+KAT++FN NR+LGQGGQGTVYKGML DGRI+AVK+ K AVD++ ++EEFINE+
Sbjct: 406 SHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AVDED---RVEEFINEV 461
Query: 123 VILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIA 170
V+L+QINHRN+VKLLGCCLETEVP+L LHD ++++ +TWE+RL IA
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDE--SDDYTMTWEVRLHIA 519
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
E+AGALSYLHSAAS PIYHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ G
Sbjct: 520 IEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAG 579
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
TFGY++PEY QSS+ T+KSDVYSFGVVLVELLTG+KP S+ S+EN LAA FV +++
Sbjct: 580 TFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVK 637
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347
+N + DI+DD++ +Q+M+ ANLA RCL+ GKKRP M EV++EL IR S++
Sbjct: 638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHY 694
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
Identities = 195/348 (56%), Positives = 260/348 (74%)
Query: 9 LFQVIGRM-LLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELD 67
LF V+G L++ ++K+R I+ K FFK + +V K+FSSKEL+
Sbjct: 358 LFLVLGIWGLIKFVKKRRKIIR-KRMFFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELE 415
Query: 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
KAT++FN+NR+LGQGGQGTVYKGML DGRI+AVK+ K+ DE+ K+EEFINE+ +LSQ
Sbjct: 416 KATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVL--DED--KVEEFINEVGVLSQ 471
Query: 128 INHRNVVKLLGCCLETEVPLL---HLHD-------HHRNEEFPLTWEIRLRIATEVAGAL 177
INHRN+VKL+GCCLETEVP+L H+ + HH ++++ +TW++RLRI+ E+AGAL
Sbjct: 472 INHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGAL 531
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+YLHSAAS+P+YHRD+K+TNILLDE+YRAKV+DFGTS+ I +DQTH+TT + GTFGYL+P
Sbjct: 532 AYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDP 591
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
EY Q+SQ TDKSDVYSFGVVLVEL+TG+KP FS +EN L + F +M++N + DI
Sbjct: 592 EYFQTSQFTDKSDVYSFGVVLVELITGEKP-FSVMRP-EENRGLVSHFNEAMKQNRVLDI 649
Query: 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
+D ++ + Q++A A LA RCL L GKKRP M EV++EL IR S
Sbjct: 650 VDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 1.4e-94, P = 1.4e-94
Identities = 196/347 (56%), Positives = 255/347 (73%)
Query: 9 LFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDK 68
L V+G LL KK+ + K++FFK S ++++ +FSS+EL+K
Sbjct: 384 LIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLIS-TVGMVEKTIVFSSRELEK 442
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
AT +F+ NRILGQGGQGTVYKGML DGRI+AVKK K+ VD++ KLEEFINE+VILSQI
Sbjct: 443 ATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFINEVVILSQI 498
Query: 129 NHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
NHRN+VKLLGCCLET+VP+L HLHD +E TW IRLRIA ++AGA
Sbjct: 499 NHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAIDIAGA 557
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LSYLHS+ASSPIYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT GY++
Sbjct: 558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMD 617
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PEY QSSQ TDKSDVYSFGVVLVEL+TG+K I SQEN +LA +F+ +M++N ++D
Sbjct: 618 PEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFL--RSQENRTLATYFILAMKENKLFD 675
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
I+D ++ +Q+ A A +A +CL+L G+KRP+M EV+MEL+ IR
Sbjct: 676 IIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 187/339 (55%), Positives = 253/339 (74%)
Query: 17 LLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDKATNHFNVN 76
L ++I+K+R +I ++FFK + D +V + K+FSSKEL KAT++F+++
Sbjct: 375 LFKLIKKRR-NINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKIFSSKELRKATDNFSID 432
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
R+LGQGGQGTVYKGML DG I+AVK+ K+ VD++ K+EEFINEIV+LSQINHRN+VKL
Sbjct: 433 RVLGQGGQGTVYKGMLVDGSIVAVKRSKV-VDED---KMEEFINEIVLLSQINHRNIVKL 488
Query: 137 LGCCLETEVPLL---HLHD-------HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
LGCCLETEVP+L ++ + H ++++ +TWE+RLRIA E+AGAL+Y+HSAAS
Sbjct: 489 LGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASF 548
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
PI+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GTFGY++PEY SSQ T
Sbjct: 549 PIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYT 608
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
KSDVYSFGVVLVEL+TG+KP+ S+E LA F+ +M++N + DI+D ++
Sbjct: 609 HKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENRVIDIIDIRIKDES 666
Query: 307 KKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
K Q+MA A LA +CL+ GK RP M+EV+ EL IR S
Sbjct: 667 KLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
Identities = 197/347 (56%), Positives = 249/347 (71%)
Query: 9 LFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDK 68
L V+G LR KKR K K +FFK + +V ++ ++FSS+EL+K
Sbjct: 388 LVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNV-EKTRIFSSRELEK 446
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
AT++F+ +RILGQGGQGTVYKGML DGR +AVKK K+ VD++ KLEEFINE+VILSQI
Sbjct: 447 ATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKV-VDED---KLEEFINEVVILSQI 502
Query: 129 NHRNVVKLLGCCLETEVPLL--------HL--HDHHRNEEFPLTWEIRLRIATEVAGALS 178
NHR+VVKLLGCCLETEVP L +L H H ++++ TW +RLRIA ++AGALS
Sbjct: 503 NHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALS 562
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
YLHSAASSPIYHRDIKSTNILLDE+YR KV+DFGTS+ + +D TH TT I GT GY++PE
Sbjct: 563 YLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPE 622
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
Y+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ + N SQE LA F +M++N ++I+
Sbjct: 623 YYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVAMKENRFFEIM 681
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
D ++ K Q+MA ANLA RCL+ GKKRP M +V +L I S
Sbjct: 682 DARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 920 (328.9 bits), Expect = 2.4e-92, P = 2.4e-92
Identities = 193/356 (54%), Positives = 262/356 (73%)
Query: 1 TISTLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKL 60
+ STL VF+ + L + IR++R + K++FFK + + +V D ++
Sbjct: 366 SFSTL-VFIGGIY--WLYKFIRRQRR-LNQKKKFFKRNGGLLLQQQLTTTEGNV-DSTRV 420
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
F+S+EL+KAT +F++ RILG+GGQGTVYKGML DGRI+AVKK K+ VD++ KLEEFIN
Sbjct: 421 FNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFIN 476
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLT-WEIRL 167
E+VILSQINHRN+VKLLGCCLET+VP+L HLHD ++++ +T WE+RL
Sbjct: 477 EVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDD--SDDYTMTTWEVRL 534
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
RIA ++AGALSYLHSAASSPIYHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT
Sbjct: 535 RIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTV 594
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
+ GT GY++PEY QSSQ TDKSDVYSFGVVL EL+TG+K + SQE +LA +F
Sbjct: 595 VSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL--RSQEYRTLATYFTL 652
Query: 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+M++N + DI+D ++ K NQ+ A A +A +CL++ G+KRP+M +V+MEL IR
Sbjct: 653 AMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 191/358 (53%), Positives = 252/358 (70%)
Query: 1 TISTLLVFLFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKL 60
T+S+ L+ L + G LL +KR K K +FF+ SV +R K+
Sbjct: 321 TLSSGLLLL--IFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSV-NRTKV 377
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
FSS +L+ AT+ FN +RILGQGGQGTVYKGMLEDG I+AVKK K A+ +E L EEFIN
Sbjct: 378 FSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSK-ALKEENL---EEFIN 433
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRN--EEFPLTWEIRLRIA 170
EI++LSQINHRNVVK+LGCCLETEVP+L +L DH N E+FP++WE+RL IA
Sbjct: 434 EIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIA 493
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
EVA ALSYLHSA S PIYHRD+KSTNILLDE++RAKV+DFG S+ +A+D TH+TT +QG
Sbjct: 494 CEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQG 553
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
T GY++PEY QS+ T KSDVYSFGV+L+ELLTG+KP+ QE L A+F+ +MR
Sbjct: 554 TIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRR--QEVRMLGAYFLEAMR 611
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348
+ +++ILD ++ + + +++A A LA RCL LN + RPTM +V +EL+ ++ G
Sbjct: 612 NDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKG 669
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
Identities = 188/337 (55%), Positives = 244/337 (72%)
Query: 17 LLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDKATNHFNVN 76
L + + K+RM K K++FFK + V+++ ++F+SKEL+KAT +F+ N
Sbjct: 390 LRKFLVKRRM-AKRKKKFFKRNGGLLLQQELNTRQ-GVVEKARIFTSKELEKATENFSEN 447
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
R+LG GGQGTVYKGML DGR +AVKK K+ +D++ KL+EFINE+VILSQINHR+VVKL
Sbjct: 448 RVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQEFINEVVILSQINHRHVVKL 503
Query: 137 LGCCLETEVPLL--------HLHDH-HRNE--EFPLTWEIRLRIATEVAGALSYLHSAAS 185
LGCCLETEVP+L +L H H E ++ + W +RLRIA ++AGALSYLHSAAS
Sbjct: 504 LGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAAS 563
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
SPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT GY++PEY++SSQ
Sbjct: 564 SPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQY 623
Query: 246 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305
T+KSDVYSFGV+L EL+TG KP+ NT QE ++LA F +M++ + DI+D ++
Sbjct: 624 TEKSDVYSFGVILAELITGDKPVIMVQNT-QEIIALAEHFRVAMKERRLSDIMDARIRDD 682
Query: 306 VKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
K Q+MA ANLA +CL G+ RP M EV EL I
Sbjct: 683 SKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 895 (320.1 bits), Expect = 1.1e-89, P = 1.1e-89
Identities = 188/346 (54%), Positives = 245/346 (70%)
Query: 9 LFQVIGRMLLRIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDK 68
L V G LR KR K K++FFK + + +++ ++F+S+EL+K
Sbjct: 390 LVLVGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTRE-GYVEKTRVFNSRELEK 448
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
AT +F+ NR+LG GGQGTVYKGML DGR +AVKK K+ +D++ KL+EFINE+VILSQI
Sbjct: 449 ATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQEFINEVVILSQI 504
Query: 129 NHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
NHR+VVKLLGCCLETEVP+L H+H+ ++++ + W +RLRIA ++AGA
Sbjct: 505 NHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEE-SDDYTMLWGMRLRIAVDIAGA 563
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LSYLHS+ASSPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT GY++
Sbjct: 564 LSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVD 623
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PEY+QSSQ T+KSDVYSFGV+L EL+TG KP+ NT QE V+LA F +M++ + D
Sbjct: 624 PEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIVALAEHFRVAMKEKRLTD 682
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
I+D ++ K Q+MA A +A +CL GKKRP M EV EL I
Sbjct: 683 IIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
Identities = 182/334 (54%), Positives = 242/334 (72%)
Query: 19 RIIRKKRMDIKLKERFFKXXXXXXXXXXXXSYDDSVIDRCKLFSSKELDKATNHFNVNRI 78
+++RK+RM + K +FFK + V ++ KLFSS+EL+KAT++FN NR+
Sbjct: 402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+GQGGQGTVYKGML DGR +AVKK + VD++ KL+EFINE++ILSQINHR+VVKLLG
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNV-VDED---KLQEFINEVIILSQINHRHVVKLLG 515
Query: 139 CCLETEVPLL--------HL--HDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
CCLETEVP+L +L H H +++ W +R+RIA +++GA SYLH+AA SPI
Sbjct: 516 CCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPI 575
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
YHRDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT GY++PEY+ SS T+K
Sbjct: 576 YHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEK 635
Query: 249 SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308
SDVYSFGVVLVEL+TG+KP+ + T QE LA +F +MR+N +++I+D ++ K
Sbjct: 636 SDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDCKL 694
Query: 309 NQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
Q++A ANLA RCL GK RP M EV+ L I
Sbjct: 695 EQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 366 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-48
Identities = 85/273 (31%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ + R LG G GTVYK G+I+AVK K + + K + EI IL +++H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHP 58
Query: 132 NVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
N+V+L+ + + L L D+ PL+ + +IA ++ L YLHS
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
I HRD+K NILLDE K+ADFG +K + + +TT GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGG 173
Query: 244 QL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
K DV+S GV+L ELLTGK P Q + +D
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-----QLIRRILGPPLEFDEPKWSS 228
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+L ++CL+ + KRPT EE+
Sbjct: 229 GSE-------EAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-45
Identities = 71/194 (36%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG+GG GTVY + G+ +A+K K ++ LEE + EI IL ++NH N+VKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK---EDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 138 GCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
G + L L D + E L+ + LRI ++ L YLH S+ I
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 190 HRDIKSTNILLDER-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTD 247
HRD+K NILLD + K+ADFG SK + + I GT Y+ PE ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 248 KSDVYSFGVVLVEL 261
KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 75/273 (27%), Positives = 112/273 (41%), Gaps = 35/273 (12%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ + LG+G G VY + G+++A+K K + E + EI IL ++ H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK---DRERILREIKILKKLKHP 57
Query: 132 NVVKLLGCCLETE--------VPLLHLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
N+V+L + + L D + E R ++ AL YLHS
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEAR-FYLRQILSALEYLHS 115
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I HRD+K NILLDE K+ADFG ++ +D T GT Y+ PE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
D++S GV+L ELLTG KP F + L F + + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTG-KPPFPGDDQ------LLELFKKIGKPKPPFPPPEWDI 223
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
K +L + L + +KR T EE
Sbjct: 224 SPEAK--------DLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 54/282 (19%)
Query: 76 NRILGQGGQGTVYKGMLE----DGRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG+G G VYKG L+ ++ AVK K ++++ EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60
Query: 131 RNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
NVVKLLG C E E + L + R L+ L A ++A + YL S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
HRD+ + N L+ E K++DFG S+ + D + + ++ PE +
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 243 SQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301
+ T KSDV+SFGV+L E+ T G++P + +++
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP--------------------------YPGMSNEE 211
Query: 302 VVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEV 335
V++ +K + +L +C + + RPT E+
Sbjct: 212 VLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 55/283 (19%)
Query: 76 NRILGQGGQGTVYKGMLEDGRIM-----AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG+G G VYKG L+ AVK K ++++ EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60
Query: 131 RNVVKLLGCCLETEVPLL--------HLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VKLLG C E E ++ L D+ +N L+ L A ++A + YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
S HRD+ + N L+ E K++DFG S+ + D + + ++ PE +
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
+ T KSDV+SFGV+L E+ T G++P + +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP--------------------------YPGMSNA 211
Query: 301 QVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEV 335
+V++ +KK + L +C + + RPT E+
Sbjct: 212 EVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-42
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 36/271 (13%)
Query: 77 RILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+LG+G G+VY + +D G +MAVK +L+ D EE +LE EI ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVR 63
Query: 136 LLGCCLETEVPLLH----------LHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
G + E L+ L + + P IR + ++ L+YLHS
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLHSNG 121
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLEPEYHQSS 243
I HRDIK NIL+D K+ADFG +K + ++ T ++GT ++ PE +
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 244 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303
+ +D++S G ++E+ TGK P GN +Y I
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----------------LYKIGSSGEP 222
Query: 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ ++ + +CL + KKRPT +E
Sbjct: 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 77/295 (26%), Positives = 122/295 (41%), Gaps = 66/295 (22%)
Query: 77 RILGQGGQGTVYKGMLEDG----RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
+ LG+G G VYKG L+ +AVK K +EE ++F+ E ++ ++ H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57
Query: 133 VVKLLGCCLETEVPLL------------HLHDHHRNEEFP----LTWEIRLRIATEVAGA 176
VV+LLG C E E L +L P L+ + L A ++A
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GY 234
+ YL S HRD+ + N L+ E K++DFG S+ + D + G +
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRW 173
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
+ PE + T KSDV+SFGV+L E+ T G P
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP-------------------------- 207
Query: 294 MY-DILDDQVVKLVKKNQIMAF--------ANLAERCLDLNGKKRPTMEEVTMEL 339
Y + +++V++ ++K + L C L+ + RPT E+ L
Sbjct: 208 -YPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 57/288 (19%)
Query: 76 NRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG+G G VYKG L +AVK K +EE EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER---EEFLEEASIMKKLSH 60
Query: 131 RNVVKLLGCCLETEVPLL------H--LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
N+V+LLG C + E + L D R LT + L++A ++A + YL S
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLEPEY 239
HRD+ + N L+ E K++DFG S+ I D + G ++ PE
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPES 175
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ + T KSDV+SFGV+L E IF+ G +S
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWE-------IFTLGEQPYPGMSNE----------------- 211
Query: 300 DQVVKLVKKNQIMAF--------ANLAERCLDLNGKKRPTMEEVTMEL 339
+V++L++ + L +C + + RPT E+ +L
Sbjct: 212 -EVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 79/271 (29%), Positives = 115/271 (42%), Gaps = 46/271 (16%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+GG G VYK G+ +A+K + E K E+ INEI IL + H N+VK
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 138 GCCLE-TEV-------PLLHLHD--HHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAA 184
G L+ E+ L D N+ + IA E+ L YLHS
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG 118
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
I HRDIK+ NILL K+ DFG S ++ T + GT ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKP 173
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304
K+D++S G+ +EL GK P E + A ++ I +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYS-------ELPPMKA----------LFKIATNGPPG 216
Query: 305 LVKKNQIMA-FANLAERCLDLNGKKRPTMEE 334
L + F + ++CL N +KRPT E+
Sbjct: 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 82/279 (29%), Positives = 117/279 (41%), Gaps = 42/279 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ ++LGQG G VYK G+I A+KK + D+E +L E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 130 HRNVVKLLGC-CLETEVPLL-------HLHD-HHRNEEFPLTWEIRL-RIATEVAGALSY 179
VVK G E E+ ++ L D + + P E L IA ++ L Y
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP---EPVLAYIARQILKGLDY 114
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI----AMDQTHVTTKIQGTFGYL 235
LH+ I HRDIK +N+L++ + K+ADFG SK + T V GT Y+
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYM 167
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295
PE Q + +D++S G+ L+E GK P G S FF M
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--------FF------ELMQ 213
Query: 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
I D L + F + CL + KKRP+ E
Sbjct: 214 AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
++ + ++G+G G VYKG+ LE G +A+K+ L EE L+ + EI +L + H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE--ALKSIMQEIDLLKNLKH 58
Query: 131 RNVVKLLGCCLETEVPLL---------HLHD-HHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+VK +G +ET L L + FP + + + + +V L+YL
Sbjct: 59 PNIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPES-LVAVYVY-QVLQGLAYL 115
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
H + HRDIK+ NIL + K+ADFG + + D + + GT ++ PE
Sbjct: 116 HE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVI 171
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ S + SD++S G ++ELLTG P +
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYY 200
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G G G VY + L+ G +MAVK+ + + D + ++E +E+ +L + H N+VK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKE--IRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 138 GCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIAT-EVAGALSYLHSAAS 185
G + E L L +H R + E +R+ T ++ L+YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG- 119
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLEPEYHQS 242
I HRDIK NI LD K+ DFG + + + T + ++Q G Y+ PE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 243 SQLTDK---SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ +D++S G V++E+ TGK+P +S +N F V + K + D
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP-WS----ELDNEFQIMFHVGAGHKPPIPD--S 230
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337
Q+ K + +RCL+ + KKRPT E+
Sbjct: 231 LQLSPEGK--------DFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 76/271 (28%), Positives = 117/271 (43%), Gaps = 36/271 (13%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+ +G+G G VY DG++ +K+ L+ E+ + E+ +NE+ IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63
Query: 136 LLGCCLE----------TEVPLLHLHDHHRNEEF-PLTWEIRLRIATEVAGALSYLHSAA 184
E + L + +E P E L ++ AL YLHS
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
I HRDIK NI L K+ DFG SK ++ T + GT YL PE Q+
Sbjct: 124 ---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKP 179
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304
KSD++S G VL EL T K P F G +L + ++ Y + Q
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP-F-EGE------NLLELALKILKGQ--YPPIPSQYSS 229
Query: 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
NL L + ++RP++ ++
Sbjct: 230 --------ELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (266), Expect = 5e-26
Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 32/283 (11%)
Query: 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH- 130
+ + R LG+G G VY D +++A+K ++ + +E F+ EI IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKE-VERFLREIQILASLNHP 57
Query: 131 RNVVKLLGCC----------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+VKL + L + PL+ L I ++ AL YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 181 HSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHV-----TTKIQGTFGY 234
HS I HRDIK NILLD K+ DFG +K + + + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 235 LEPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291
+ PE L + SD++S G+ L ELLTG P N+S + +L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP--- 231
Query: 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
L + + A ++L ++ L + K R +
Sbjct: 232 ---TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 43/275 (15%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F++ LG+G G+VYK + E G+++A+K + D +E++K EI IL Q +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK------EISILKQCDSP 58
Query: 132 NVVKLLGCCL-ETEVPLLHLH-------DHHRNEEFPLTWEIRLRIATEVAGA---LSYL 180
+VK G T++ ++ + D + LT E IA + L YL
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE---EIAAILYQTLKGLEYL 115
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS + HRDIK+ NILL+E +AK+ADFG S + T I GT ++ PE
Sbjct: 116 HS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
Q +K+D++S G+ +E+ GK P +H MR ++ I +
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSD---------------IHPMRA--IFMIPNK 214
Query: 301 QVVKLVK-KNQIMAFANLAERCLDLNGKKRPTMEE 334
L + F + ++CL + ++RP+ +
Sbjct: 215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 36/275 (13%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +G+G G VYK G+ +A+KK +L ++EL+ INEI+I+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI-----INEILIMKDC 72
Query: 129 NHRNVVKLLGCCL-ETEVPLLH-------LHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
H N+V L E+ ++ L D + + EV L YL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS + HRDIKS NILL + K+ADFG + + +++ + + GT ++ PE
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVI 188
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
+ K D++S G++ +E+ G+ P +R ++ I
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLR---------------EPPLRA--LFLITTK 231
Query: 301 QVVKLVKKNQIMA-FANLAERCLDLNGKKRPTMEE 334
+ L + F + +CL + +KRP+ EE
Sbjct: 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-24
Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 34/268 (12%)
Query: 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F + +G+G G V+K + + D R+ A+K+ L+ + + EE I+E +L++++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR--REREEAIDEARVLAKLDSS 59
Query: 132 NVVKLLGCCLETE--------VPLLHLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+++ L+ LH PL + R ++ L++LHS
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I HRDIKS N+ LD K+ D G +K ++ D T+ I GT YL PE +
Sbjct: 120 ---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCED 175
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+KSDV++ GVVL E TGK P F N A + +R V
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHP-FDANNQ-------GALILKIIRG----------V 217
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRP 330
V + A L ++CL + ++RP
Sbjct: 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-24
Identities = 66/233 (28%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R LG+G G V+ G D ++AVK K ++ ++F E +L+ H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND---ARKDFEREAELLTNFQH 67
Query: 131 RNVVKLLGCCLETEVPL--------------LHLHDHH-------RNEEFPLTWEIRLRI 169
N+VK G C E + P+ L H + LT L+I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--- 226
A ++A + YL AS HRD+ + N L+ K+ DFG S+ + TT
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYY 178
Query: 227 KIQGT----FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274
++ G ++ PE + T +SDV+SFGVVL E+ T GK+P + N
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 52/294 (17%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHR 131
+G+G G VYK + G ++A+KK ++ ++E+ E F I EI +L ++ H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEK----EGFPITAIREIKLLQKLRHP 58
Query: 132 NVVKLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+V+L +++ HD +F + +I+ ++ L YL
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQYL 116
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-Y 239
HS I HRDIK +NIL++ K+ADFG ++ + T T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE------------------NVSL 281
+++ + D++S G +L EL G KPIF G+T E VS
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPIF-QGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+F + K L + L+ + +L ++ L L+ KKR + ++
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDP----SALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK-----LEEFINEIVILSQINHR 131
++G G G+VY GM G +MAVK+ +L L+ EI +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 132 NVVKLLGCCLETE--------VP---LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+V+ LG L+ + VP + L +++ E L +R + + G L+YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQILKG-LNYL 122
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGYL 235
H+ I HRDIK NIL+D + K++DFG SK + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE + + T K+D++S G ++VE+LTGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 40/272 (14%)
Query: 77 RILGQG--GQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
R+LG+G G+ T+Y+ ED ++ K+ L E+ + +NEIVILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQHPNII 62
Query: 135 KLLGCCLETEVPLLHLH-----------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
++ L+ + + + F E+ L ++ A+SY+H A
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHKA 120
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
I HRDIK+ NI L + K+ DFG SK + + + T + GT Y+ PE Q
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGV 176
Query: 244 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303
+ KSD+++ G VL ELLT K+ F N V ++ N+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKR-TFDATN-------PLNLVVKIVQGNY---------- 218
Query: 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
V +L L + +KRPT +EV
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-23
Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 77 RILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
R++G+G G VY G L DG+ + AVK D EE+ E+F+ E +I+ +H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57
Query: 133 VVKLLGCCLETE-VPLL------H--LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
V+ LLG CL +E PL+ H L + R+E T + + +VA + YL
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--- 114
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGTFGYLEPEYH 240
AS HRD+ + N +LDE + KVADFG ++ I H T + ++ E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKP 267
Q+ + T KSDV+SFGV+L EL+T P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 79 LGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
LG G G V K +L G+IMAVK +L +++ ++ + E+ IL + N +V
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQI---LRELDILHKCNSPYIVGF 64
Query: 137 LGCCL-ETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
G ++ + L + + + I +IA V L+YLH I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRD+K +NIL++ R + K+ DFG S + ++ +T V GT Y+ PE Q + +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYS 177
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
KSD++S G+ L+EL TG+ P + L + I+++ +L
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL------------LQYIVNEPPPRLP 225
Query: 307 KKNQIMAFANLAERCLDLNGKKRPTMEEVT 336
F + CL + ++RP+ +E+
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 73 FNVNRILGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F V + LG+G G+VYK L D + A+K+ L ++ + E+ +NEI IL+ +NH
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNHP 59
Query: 132 NVVK-----LLGC--CLETE-VPLLHLHDHHRNEEF---PLTWEIRLRIATEVAGALSYL 180
N++ L G C+ E P L + + + RI ++ L L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
H I HRD+KS NILL K+ D G SK + + T+I GT Y+ PE
Sbjct: 120 HEQK---ILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAPEVW 173
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ + KSD++S G +L E+ T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 76 NRILGQGGQGTVYKGM---LEDGRI-MAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
R +G+G G VY+G+ E+ +I +AVK K E+F+ E I+ Q +H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS---VREKFLQEAYIMRQFDHP 67
Query: 132 NVVKLLGCCLETEV-------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
++VKL+G E V PL L + + ++ L + + +++ AL+YL S
Sbjct: 68 HIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
HRDI + N+L+ K+ DFG S+++ + + +K + ++ PE +
Sbjct: 128 ---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 245 LTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
T SDV+ FGV + E+L G KP N
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-22
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 18/195 (9%)
Query: 79 LGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG G G VY+G+ + +AVK K E+ +++EEF+ E ++ +I H N+V+LL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 138 GCC-------LETE-VPLLHLHDHHR-NEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
G C + TE + +L D+ R + + L +AT+++ A+ YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
HRD+ + N L+ E + KVADFG S+ + D + + PE ++ + K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 249 SDVYSFGVVLVELLT 263
SDV++FGV+L E+ T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 48/295 (16%)
Query: 73 FNVNRILGQGGQGTVYKGML--EDGRI--MAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +ILG+G G+V +G L +DG +AVK KL + ++EEF++E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDF 58
Query: 129 NHRNVVKLLGCCLETE-----------VPLLHLHDHH------RNEEFP--LTWEIRLRI 169
+H NV+KL+G C E +P + D H R P L + L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI- 228
++A + YL ++ HRD+ + N +L E VADFG SK I + +I
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287
+ ++ E T KSDV++FGV + E+ T G+ P N + + H
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-----YLRH 230
Query: 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
R D LD + +M C + K RPT ++ L I
Sbjct: 231 GNRLKQPEDCLD-------ELYDLMYS------CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-22
Identities = 71/206 (34%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 79 LGQGGQGTVYKGMLED-GRIMAVK---KFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
LG+G G V +D G++ A+K K K+ E E + E ILS+INH +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEV----EHTLTERNILSRINHPFIV 56
Query: 135 KLLGCCLETEVPLL---------HLHDHHRNEE-FPLTWEIRLRIATEVAGALSYLHSAA 184
KL +TE L L H E F R A E+ AL YLHS
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLHSLG 113
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
I +RD+K NILLD K+ DFG +K ++ + + T GT YL PE
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFS 270
D +S GV+L E+LTGK P ++
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-22
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
F + R LG G G V++G+ ++ +A+K K ++LLK ++F E+ L ++ H++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK----SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 133 VVKLLGCCLETEVPLL---------HLHDHHRN-EEFPLTWEIRLRIATEVAGALSYLHS 182
++ L C E P+ L R+ E L + +A +VA ++YL
Sbjct: 64 LISLFAVCSVGE-PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLEPEYHQ 241
HRD+ + NIL+ E KVADFG ++ I D KI + + PE
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAAS 177
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 277
+ KSDV+SFG++L E+ T G+ P G + E
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPY--PGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 57/290 (19%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ +G+G G V G G+ +AVK K ++ + F+ E +++ + H
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRH 59
Query: 131 RNVVKLLGCCLETEVPLL---------HLHDHHRNEEFP-LTWEIRLRIATEVAGALSYL 180
N+V+LLG L+ PL L D+ R+ +T +L A +V + YL
Sbjct: 60 PNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HRD+ + N+L+ E AKV+DFG +K + Q ++ T PE
Sbjct: 119 EE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEAL 171
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
+ + + KSDV+SFG++L E I+S G + L
Sbjct: 172 REKKFSTKSDVWSFGILLWE-------IYSFGRVPYPRIPL------------------K 206
Query: 301 QVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
VV V+K M + + C +L+ KRPT +++ +L I
Sbjct: 207 DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-21
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 78 ILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD-----EELLKLEEFINEIVILSQINHRN 132
+LG+G GTVY G+ G+++AVK+ +L + +E KL+E E+ +L + H N
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHVN 63
Query: 133 VVKLLGCCLETEVPLLHLH-------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+V+ LG CL+ + + N PL + + ++ ++YLH+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--- 120
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-----TKIQGTFGYLEPEYH 240
+ + HRDIK N++L K+ DFG ++ +A H T + GT ++ PE
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
S KSD++S G + E+ TGK P+ S
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G G G V+ G + R +A+K + E + E+FI E ++ +++H +V+L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 139 CCLE-TEVPLLH-------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190
C E + + L+ L D+ R + + E L + +V ++YL S+ + H
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSD 250
RD+ + N L+ E KV+DFG ++F+ DQ +T + + PE S+ + KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 251 VYSFGVVLVELLTGKKPIFSTGNTSQENVS 280
V+SFGV++ E +FS G T EN S
Sbjct: 184 VWSFGVLMWE-------VFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+G+G G VYKG+L+ +AVK + LK +F+ E IL Q +H N+VKL
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLK-RKFLQEAEILKQYDHPNIVKL 57
Query: 137 LGCCLETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
+G C++ + VP L R ++ LT + L+++ + A + YL S
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLEPEYHQSSQLTD 247
HRD+ + N L+ E K++DFG S+ V+ + Q + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 248 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280
+SDV+S+G++L E FS G+T +S
Sbjct: 175 ESDVWSYGILLWE-------TFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK------LEEFINEIVILSQIN 129
++LG G GTVYKG+ + +G K K+ V + L + +E ++E +++ ++
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGE-----KVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 130 HRNVVKLLGCCLETE-------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H +VV+LLG CL ++ +PL L D+ RN + + + L ++A +SYL
Sbjct: 68 HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT-FGYLEPEYHQ 241
+ HRD+ + N+L+ K+ DFG +K + +D+ + ++ E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKP 267
T KSDV+S+GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
LG+G G VYK + G I+A+KK +L ++E + + EI +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS--TALREISLLKELKHPNIVKL 63
Query: 137 LGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
L + L+L D R I+ I ++ L+Y HS
Sbjct: 64 L--DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPN-LIK-SIMYQLLRGLAYCHSHR- 118
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
I HRD+K NIL++ K+ADFG ++ + T ++ T Y PE S+
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 246 TDKS-DVYSFGVVLVELLTGKKPIF 269
+ D++S G + E++TG KP+F
Sbjct: 176 YSTAVDIWSVGCIFAEMITG-KPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 76/250 (30%), Positives = 108/250 (43%), Gaps = 42/250 (16%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIV 123
E + + +LG+G G VY L +A+K+ D + L E EI
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHE---EIA 57
Query: 124 ILSQINHRNVVKLLGCCLET--------EVPLLHLHDHHRNEEFPLTW-EIRLRIAT-EV 173
+ S + HRN+V+ LG E +VP L R++ PL E + T ++
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGT 231
L YLH + I HRDIK N+L++ Y K++DFGTSK +A T GT
Sbjct: 118 LEGLKYLH---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCTETFTGT 172
Query: 232 FGYLEPEYHQSSQLTDK--------SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283
Y+ PE + DK +D++S G +VE+ TGK P G AA
Sbjct: 173 LQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AA 220
Query: 284 FFVHSMRKNH 293
F M K H
Sbjct: 221 MFKVGMFKIH 230
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 77/272 (28%), Positives = 114/272 (41%), Gaps = 35/272 (12%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK-LEEFINEIVILSQINHRNVV 134
++LGQG G VY ++ GR +AVK+ D E K + EI +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 135 KLLGCCLETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
+ GC + E +P + D + LT + + ++ + YLHS +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS---N 123
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
I HRDIK NIL D K+ DFG SK I T + + + GT ++ PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGE 182
Query: 244 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303
K+DV+S G +VE+LT K P E ++AA F + +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPW-------AEFEAMAAIF-KIATQPTNPQLPSHVSP 234
Query: 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
N R N KKRP+ EE+
Sbjct: 235 DAR---------NFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 8e-21
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + + ++G G VY + L + +A+K+ L + +E E+ +SQ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCN 57
Query: 130 HRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIAT---EVAG 175
H NVVK + + LL + +P IAT EV
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKS----SYPRGGLDEAIIATVLKEVLK 113
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MDQTHVTTK-IQGTF 232
L YLHS HRDIK+ NILL E K+ADFG S +A D+T K GT
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 233 GYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
++ PE Q K+D++SFG+ +EL TG P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 37/273 (13%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+G+G GTV K DG+I+ K+ E+ + ++ ++E+ IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EKQQLVSEVNILRELKHPNIVRY 64
Query: 137 LGCCLETEVPLLHLH-------------DHHRNEEFPLTWEIRLRIATEVAGALSYLH-- 181
++ L++ + E + E RI T++ AL H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
S + + HRD+K NI LD K+ DFG +K + D + T + GT Y+ PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301
+KSD++S G ++ EL P F+ N + LA S K + + +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP-FTARN----QLQLA-----SKIKEGKFRRIPYR 233
Query: 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ N+++ L+++ KRP+ EE
Sbjct: 234 YSSEL--NEVIKS------MLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 75 VNRILGQGGQGTVYKGML-EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ + LG+G G+V +G L +D I+ AVK K+A+ ++E+F++E V + + +H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHP 60
Query: 132 NVVKLLGCCLETE-----------VPLLHLHDHH------RNEEFP--LTWEIRLRIATE 172
NV++L+G CL+T +P + D H R + P L ++ ++ T+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGT 231
+A + YL +S HRD+ + N +L+E VADFG SK I + +I +
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMR 290
++ E T KSDV+SFGV + E+ T G+ P EN + + R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNR 232
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
D LD +L C LN K RP+ E + EL
Sbjct: 233 LKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 77 RILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ LG+G G V + G +AVK E +F EI IL ++H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHE 66
Query: 132 NVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VK G C + +P L D+ + + + L ++++ + YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLEPE 238
S HRD+ + NIL++ K++DFG +K + D+ + K G F Y PE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLT 263
++S+ + SDV+SFGV L EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 54/281 (19%)
Query: 79 LGQGGQGTVYKG-MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G G G VYK + G ++A+K KL D+ E EI +L + H N+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD----FEIIQQEISMLKECRHPNIVAYF 66
Query: 138 GC---------CLE-----TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
G +E + + + +E +I + E L+YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAY-VCRETLKGLAYLHE- 119
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ---GTFGYLEPEYH 240
+ HRDIK NILL E K+ADFG S + T K + GT ++ PE
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVA 173
Query: 241 QSSQLTD---KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
+ K D+++ G+ +EL + P+F +H MR +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFD---------------LHPMRALFLISK 218
Query: 298 LDDQVVKLVKKNQ-IMAFANLAERCLDLNGKKRPTMEEVTM 337
+ KL K + F + ++CL + KKRPT ++
Sbjct: 219 SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 85/276 (30%), Positives = 127/276 (46%), Gaps = 48/276 (17%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQINHR 131
+LG G G+VY+G+ L+DG AVK+ LA D E + +LE+ EI +LS++ H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---EIALLSKLQHP 62
Query: 132 NVVKLLGCCLETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATE-VAGALSYLHS 182
N+V+ LG E + VP L + ++ E +R+ T + L YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLEPEY-H 240
HRDIK NIL+D K+ADFG +K + K +G+ ++ PE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH--MYDIL 298
Q +D++S G ++E+ TGK P +S E V AA F K + D L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP-WS----QLEGV--AAVFKIGRSKELPPIPDHL 227
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
D+ K+ I+ +CL + RPT E
Sbjct: 228 SDEA-----KDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 77/286 (26%), Positives = 119/286 (41%), Gaps = 53/286 (18%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAV-----DDEELLKLEEFIN-EIVILSQINH 130
++G+G G VY + + G +MAVK+ +L D + + + EI L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 131 RNVVKLLGCCLETEVPLLH--------------LHDHHRNEEFPLTWEIRLRIATEVAGA 176
N+V+ LG ET L L + R EE L +V
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLV----RFFTEQVLEG 120
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTHVTTKIQGTF 232
L+YLHS I HRD+K+ N+L+D K++DFG SK DQ +QG+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQGSV 174
Query: 233 GYLEPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
++ PE S + K D++S G V++E+ G++P S E A F + + R
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------WSDEEAIAAMFKLGNKR 228
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336
I D + L + C +N RPT E+
Sbjct: 229 SAP--PIPPDVSMNLSP-----VALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 61/283 (21%)
Query: 79 LGQGGQGTVYKG--MLEDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
LG G G+V KG +++ G+ + AVK K + +EF+ E +++Q++H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 135 KLLGCCLETE-------VPLLHLHDHHR-NEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
+L+G C PL L + + E P++ +++ +A +VA ++YL S
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVS-DLKE-LAHQVAMGMAYLES---K 114
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPE---YHQ 241
HRD+ + N+LL R++AK++DFG S+ + + G + + PE Y +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN-------H 293
S KSDV+S+GV L E + G KP E + A R
Sbjct: 175 FSS---KSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVI---AMLESGERLPRPEECPQE 226
Query: 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336
+Y I+ C + RPT E+
Sbjct: 227 IYSIM--------------------LSCWKYRPEDRPTFSELE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G V+ G +A+K + E + ++FI E ++ +++H N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 139 CCLE-------TEVPLLH--LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
C + TE + + L ++ R + L E L + ++V A+ YL S
Sbjct: 67 VCTKQRPIFIVTEY-MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKS 249
HRD+ + N L+ E KV+DFG ++++ DQ + + + PE S+ + KS
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 250 DVYSFGVVLVELLTGKKPIFSTGNTSQ 276
DV+SFGV++ E+ + K + + S+
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
HF + R++G+G G V D + M K+ E + +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 132 NVVKLLGCCLETE-----VPLL-------HL-HDHHRNEEFPLTWEIRLRIATEVAGALS 178
+V L + E V LL HL +EE +++ I E+ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWIC-EIVLALE 114
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
YLHS I HRDIK NILLDE+ + DF + + D +TT GT GY+ PE
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ D +S GV E L GK+P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 49/239 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELL----KLEEFINEIVIL 125
+ F +I+G+G TV E + A+K + D+ L K++ E +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK-----ILDKRQLIKEKKVKYVKIEKEVL 55
Query: 126 SQIN-HRNVVKLLGC---------CLE--TEVPLLHLHDHHRNEEFPLTWEIRLRIATEV 173
+++N H ++KL LE LL + + + T R A E+
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RF-YAAEI 111
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ---- 229
AL YLHS I HRD+K NILLD+ K+ DFGT+K + + + + K
Sbjct: 112 LLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 230 ---------------GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273
GT Y+ PE SD+++ G ++ ++LTGK P F N
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP-FRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-19
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQI 128
+ + LG G + Y+ ++ G +MAVK + E+ +E EI +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 129 NHRNVVKLLGCCLET-------------EVPLLHLHDHHRNEEFPLTWEIRLRIATEVAG 175
NH +++++LG E V L L + +E + + ++
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKE-----AVIINYTEQLLR 114
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQT---HVTTKIQGT 231
LSYLH + I HRD+K N+L+D R ++ADFG + +A T ++ GT
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
++ PE + Q DV+S G V++E+ T K P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 75 VNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ +++G G G V +G L + +A+K K D++ L +F+ E I+ Q +H
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTEASIMGQFDH 64
Query: 131 RNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+++L G ++ P++ L R + T + + +A + YL
Sbjct: 65 PNIIRLEGVVTKSR-PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL- 122
Query: 182 SAASSPIY-HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGYL 235
S Y HRD+ + NIL++ KV+DFG S+ + + TTK I+ T
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
PE + T SDV+SFG+V+ E+++ G++P + N
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 72 HFNVNRILGQGGQGTVYK---GMLED--GRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
H + LG+G G+V L+D G ++AVKK + + + L +F EI IL
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH----LRDFEREIEILK 60
Query: 127 QINHRNVVKLLGCC---------LETE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGA 176
+ H N+VK G C L E +P L D+ + L L A+++
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 233
+ YL S HRD+ + NIL++ R K+ DFG +K + D+ + + G F
Sbjct: 121 MEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
Y PE S+ + SDV+SFGVVL EL T S ++ S A F+ M +
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMMGNDK 226
Query: 294 MYDILDDQVVKLVKKNQ--------IMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
++ +++L+K N + + C + + +RP+ E+ +++ IR
Sbjct: 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH---RNV 133
++G+G G VY+G + GR++A+K L D+++ + E+ +LSQ+ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLRQSQPPNI 64
Query: 134 VKLLGCCLE-TEVPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
K G L+ + ++ + + + P+ + I EV AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---G 121
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
+ HRDIK+ NIL+ K+ DFG + + + + +T + GT ++ PE + D
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 248 -KSDVYSFGVVLVELLTGKKP 267
K+D++S G+ + E+ TG P
Sbjct: 181 TKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 7e-19
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
++ +G +G YKG + V K ++D + +EI + ++ H N+VK
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVK---EINDVNSIPS----SEIADMGKLQHPNIVK 747
Query: 136 LLGCCLETEVPLLHLHDHHRNEEFP-----LTWEIRLRIATEVAGALSYLHSAASSPIYH 190
L+G C + L +H++ + L+WE R +IA +A AL +LH S +
Sbjct: 748 LIGLCRSEKGAYL-IHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSD 250
++ I++D + + + D + Y+ PE ++ +T+KSD
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSD 860
Query: 251 VYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK---LVK 307
+Y FG++L+ELLTGK P + S+ + + H+ D+ D ++ V
Sbjct: 861 IYGFGLILIELLTGKSP---ADAEFGVHGSIVEWARYCYSDCHL-DMWIDPSIRGDVSVN 916
Query: 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+N+I+ NLA C + RP +V L
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 41/214 (19%)
Query: 75 VNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
VNRI G G GTVYK + GR+ A+K +D + EI IL +NH NV
Sbjct: 79 VNRI-GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT---VRRQICREIEILRDVNHPNV 134
Query: 134 VKLLGCCL-------ETEVPLLH-----LHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
VK C E +V L L H +E L +A ++ ++YLH
Sbjct: 135 VK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLH 185
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MDQTHVTTKIQGTFGYLEPEY 239
I HRDIK +N+L++ K+ADFG S+ +A MD + + GT Y+ PE
Sbjct: 186 R---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPE- 238
Query: 240 HQSSQLTD------KSDVYSFGVVLVELLTGKKP 267
++ L D++S GV ++E G+ P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ R LG G G V+ G +AVK K + E F+ E I+ ++ H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRH 60
Query: 131 RNVVKLLGCCLETEVPLL---------HLHDHHRNEE-FPLTWEIRLRIATEVAGALSYL 180
+V+L C E E P+ L D ++ E L + +A ++A ++YL
Sbjct: 61 DKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLE 236
S HRD+ + NIL+ E K+ADFG ++ I D+ K I+ T
Sbjct: 120 ESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----A 172
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + T KSDV+SFG++L E++T G+ P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 79/296 (26%), Positives = 118/296 (39%), Gaps = 60/296 (20%)
Query: 60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKF----KLAVDDEELLK 114
LFS + +K F R +G G G VY + ++A+KK K + + K
Sbjct: 7 LFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-----K 58
Query: 115 LEEFINEIVILSQINHRNVVKLLGC-------------CLETEVPLLHLHDHHRNEEFPL 161
++ I E+ L Q+ H N ++ GC CL + +L +H E
Sbjct: 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE---- 114
Query: 162 TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221
+ IA GAL L S HRDIK+ NILL E K+ADFG++ ++
Sbjct: 115 -----VEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169
Query: 222 THVTTKIQGTFGYLEPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
+ V GT ++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 170 SFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-- 222
Query: 279 VSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+Y I + L + F N + CL + RP+ EE
Sbjct: 223 ---------------LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
R LG G G V++G+ + +AVK K D + +F+ E I+ ++ H +++L
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-----DFLAEAQIMKKLRHPKLIQL 66
Query: 137 LGCCLETEVPLL---------HLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
C E P+ L ++ L + +A +VA ++YL +
Sbjct: 67 YAVCTLEE-PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-- 123
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRD+ + N+L+ E KVADFG ++ I D + + PE ++ +
Sbjct: 124 -YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 247 DKSDVYSFGVVLVELLT-GKKP 267
KSDV+SFG++L E++T G+ P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 31/288 (10%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N + V ++G+G G V K G I+A+KKFK + DDE++ K + E+ +L Q+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLR 58
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHHRN-----EEFP--LTWEIRLRIATEVAGALSYLHS 182
H N+V L L R E P L + ++ A++Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I HRDIK NIL+ E K+ DFG ++ + T T Y PE
Sbjct: 119 ---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 243 SQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301
K DV++ G ++ ELL G +P+F G++ + + L + + +H +
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG-EPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233
Query: 302 V---VKLVKKNQIMAFA------------NLAERCLDLNGKKRPTMEE 334
V + +Q + + + CL ++ K+R T +E
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 79 LGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEELLKL-EEFINEIVILSQINHRNVVK 135
LG+G G VYKG + R+ A + + K+ +EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 136 LLGCCLETEVPL-----------LH----LHDHHRNEEF---------PLTWEIRLRIAT 171
LLG C + E P LH + H + L L IA
Sbjct: 73 LLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQG 230
++A + YL +S HRD+ + N L+ E K++DFG S+ I + D V +K
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
++ PE + T +SD++SFGVVL E+ + G +P + N
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 79 LGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
LG+G G V+ +D ++AVK K A + +F E +L+ + H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ----DFQREAELLTVLQHQH 68
Query: 133 VVKLLGCCLETEVPLLHLHDHHRNEEF-----------------------PLTWEIRLRI 169
+V+ G C E PLL + ++ R+ + LT L I
Sbjct: 69 IVRFYGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 228
A+++A + YL AS HRD+ + N L+ + K+ DFG S+ I + D V +
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274
++ PE + T +SD++SFGVVL E+ T GK+P + NT
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 79 LGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFI-----NEIVILSQINHRN 132
+G+G G V+K E G +A+KK L +LE I EI L H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALR-------RLEGGIPNQALREIKALQACQHPY 60
Query: 133 VVKLL-------GCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
VVKLL G L E L + R+EE PL + ++Y+H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG- 119
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
I HRD+K N+L+ K+ADFG ++ + ++ + + T Y PE ++
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 246 TDKS-DVYSFGVVLVELLTGKKPIFS 270
D D+++ G + ELL G P+F
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 79 LGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG G G+V K + G +MA KK + K + + E+ I+ + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRK--QILRELQIMHECRSPYIVSFY 69
Query: 138 GCCL-ETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
G L E + + L D + P+ EI +IA V L+YL++ I
Sbjct: 70 GAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
HRDIK +NIL++ R + K+ DFG S + ++ T V GT Y+ PE Q + T
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181
Query: 248 KSDVYSFGVVLVELLTGKKP 267
KSDV+S G+ ++EL GK P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 53/274 (19%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYK + +++A+K L ++E+ E+ EI LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRSPYITKYY 65
Query: 138 GCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
G L+ L L + L I EV L YLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGK- 119
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRDIK+ NILL E K+ADFG S + + T + GT ++ PE + S
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR------KNHMYDILDD 300
+K+D++S G+ +EL G+ P+ +H MR KN+ + +
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSD---------------LHPMRVLFLIPKNNPPSLEGN 221
Query: 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ K K + CL+ + K+RP+ +E
Sbjct: 222 KFSKPFK--------DFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYK G I+A+KK KL + E + K + EI +L ++NH N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKLL 64
Query: 138 GC----------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
+ L L + L + ++ L++ HS
Sbjct: 65 DVFRHKGDLYLVFEFMDTDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLT 246
I HRD+K N+L++ K+ADFG ++ T + T Y PE +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 247 DKSDVYSFGVVLVELLTGKKPIF 269
D++S G + ELL+ +P+F
Sbjct: 178 TPVDIWSVGCIFAELLSR-RPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 77/278 (27%), Positives = 113/278 (40%), Gaps = 53/278 (19%)
Query: 77 RILGQGGQGTVYKGMLEDGR---IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
R +G G G VY D R ++A+KK + + K ++ I E+ L +I H N
Sbjct: 31 REIGHGSFGAVY--FARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNS 87
Query: 134 VKLLGC-------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
++ GC CL + LL +H E + IA GAL L
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---------VEIAAITHGALQGL 138
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY- 239
S + HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 240 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
Q K DV+S G+ +EL K P+F+ S +Y I
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHI 236
Query: 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ L F N + CL + RPT EE+
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 43/215 (20%)
Query: 79 LGQGGQGTVYKGML--EDGRIMAVKKFKLAVDDEE----LLKLEEFINEIVILSQINHRN 132
+G+G GTV K ML G IMAVK+ + VD++E L+ L+ V++ +
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD------VVMRSSDCPY 64
Query: 133 VVKLLG-------C--CLE---TEVPLLHLHDH-HRNEEFPLTWEIRLRIATEVAGALSY 179
+VK G C C+E + + + + P EI +IA AL+Y
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNY 122
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF----IAMDQTHVTTKIQGTFGYL 235
L I HRD+K +NILLD K+ DFG S IA T+ G Y+
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPYM 174
Query: 236 EPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKP 267
PE S +SDV+S G+ L E+ TGK P
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 78 ILGQGGQGTVY----KGMLEDG--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
LG+G G V+ KG+ E+G ++ VK + DE L EF E+ + +++H+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQ--SEFRRELDMFRKLSHK 68
Query: 132 NVVKLLGCCLETEVPLLHLHDH-----------------HRNEEFPLTWEIRLRIATEVA 174
NVV+LLG C E E P + ++ + + PL+ + ++ + T++A
Sbjct: 69 NVVRLLGLCREAE-PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
+ +L +++ HRD+ + N L+ + KV+ SK + + + +
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294
L PE Q + KSDV+SFGV++ E +F+ G +S
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWE-------VFTQGELPFYGLSDEEVLNRLQAGKLE 237
Query: 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ + +L K +M RC +N K RP+ E+ L
Sbjct: 238 LPVPEGCPSRLYK---LMT------RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 73/293 (24%), Positives = 118/293 (40%), Gaps = 67/293 (22%)
Query: 77 RILGQGGQGTVYKGML-------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
R LGQG G VY+G+ + R+ A+K ++ + + EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTV---NENASMRERIEFLNEASVMKEFN 67
Query: 130 HRNVVKLLGCCLETEVPLL------------HLHDHHRNEEF-----PLTWEIRLRIATE 172
+VV+LLG + L+ +L E P T + +++A E
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGT 231
+A ++YL A+ HRD+ + N ++ E K+ DFG ++ I D K
Sbjct: 128 IADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMR 290
++ PE + T KSDV+SFGVVL E+ T ++P N
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----------------- 227
Query: 291 KNHMYDILDDQVVKLVKKNQIMA--------FANLAERCLDLNGKKRPTMEEV 335
++V+K V + L C N K RPT E+
Sbjct: 228 ---------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 35/272 (12%)
Query: 78 ILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+LG+G G V+KG L+D +AVK K + E LK++ F++E IL Q +H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIK-FLSEARILKQYDHPNIVKLI 58
Query: 138 GCCLETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
G C + + VP R ++ L + ++ A + A ++YL S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC---I 115
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLEPEYHQSSQLTDK 248
HRD+ + N L+ E K++DFG S+ D + ++ + Q + PE + + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 249 SDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307
SDV+S+G++L E + G P G T+Q+ A V + D V K++
Sbjct: 175 SDVWSYGILLWETFSLGVCPY--PGMTNQQ----AREQVEKGYRMSCPQKCPDDVYKVM- 227
Query: 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+RC D + RP E+ EL
Sbjct: 228 -----------QRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 31/264 (11%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+GQG GTVY + + G+ +A+K+ L ++ K E INEI+++ + H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL----QQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 138 GCCL---ETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIYHR 191
L E V + +L + T +IA E AL +LH S+ + HR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIKS NILL K+ DFG I +Q+ +T + GT ++ PE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 252 YSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQI 311
+S G++ +E++ G+ P + EN A + + + + + +
Sbjct: 199 WSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPELQN----------PEKLS 242
Query: 312 MAFANLAERCLDLNGKKRPTMEEV 335
F + RCL+++ +KR + +E+
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 79 LGQGGQGTVYKGMLED--GRIM--AVKKFKLAVDDEELLK-LEEFINEIVILSQINHRNV 133
LG G G V +G G+++ AVK K ++L +++F+ E I+ ++H N+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 134 VKLLGCCLE------TEV-PLLHLHDHHRNE---EFPLTWEIRLRIATEVAGALSYLHSA 183
++L G L TE+ PL L D R + F ++ A ++A + YL S
Sbjct: 59 IRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLES- 115
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT--FGYLEPEYHQ 241
HRD+ + NILL + K+ DFG + + ++ H + F + PE +
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKP 267
+ + SDV+ FGV L E+ T G++P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 77 RILGQGGQGTVYKG----MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
R LG G G VY+G D + V L E +F+ E +I+S+ NH+N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIMSKFNHQN 70
Query: 133 VVKLLGCCLETEVP---------------LLHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
+V+L+G E +P L + LT + L A +VA
Sbjct: 71 IVRLIGVSFER-LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 178 SYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTSKFI-AMDQTHVTTKIQGTFG 233
YL HRDI + N LL + AK+ADFG ++ I +
Sbjct: 130 KYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 277
++ PE T K+DV+SFGV+L E+ + G P G T+QE
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY--PGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 37/228 (16%)
Query: 75 VNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ R LG+G G V+ +D ++AVK K A D+ ++F E +L+ +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNL 64
Query: 129 NHRNVVKLLGCCLETEVPLLHLHDHHR---------------------NEEFPLTWEIRL 167
H ++VK G C+E + PL+ + ++ + N LT L
Sbjct: 65 QHEHIVKFYGVCVEGD-PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTT 226
IA ++A + YL AS HRD+ + N L+ E K+ DFG S+ + + D V
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
++ PE + T +SDV+S GVVL E+ T GK+P + N
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 38/215 (17%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK-LEEFINEIVILSQINHRNVV 134
++LGQG G VY ++ GR +A K+ + + E K + EI +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 135 KLLGCCLETEVPLLHLHDHHRN------EEFP-------------LTWEIRLRIATEVAG 175
+ GC L D E P LT + + ++
Sbjct: 68 QYYGC----------LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTF 232
+SYLHS + I HRDIK NIL D K+ DFG SK I M T + + + GT
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTP 173
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
++ PE K+DV+S G +VE+LT K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 73 FNVNRILGQGGQGTVYKGML--EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
F + R+LG+G G+V + L EDG V L D +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 131 RNVVKLLGCCLETE-----------VPLLHLHDHHR--------NEEFPLTWEIRLRIAT 171
NV+KL+G L + +P + D H E F L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
++A + YL +S HRD+ + N +L+E VADFG SK I + QG
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----QGC 173
Query: 232 FGYLEPEYHQSSQLTD-----KSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFF 285
L ++ L D SDV++FGV + E++T G+ P EN + +
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYL 228
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+ R D L+D L +C K RP+ + + +L I
Sbjct: 229 IKGNRLKQPPDCLED-------------VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 72/276 (26%), Positives = 112/276 (40%), Gaps = 44/276 (15%)
Query: 77 RILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
LG+G G+V K L G I A K + +L K + + E+ I +VK
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFA-LKTITTDPNPDLQK--QILRELEINKSCKSPYIVK 63
Query: 136 LLGCCL---ETEVPLLH---------------LHDHHRNEEFPLTWEIRLRIATEVAGAL 177
G L + + + R E L +IA V L
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVLKGL 118
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVTTKIQGTFGYL 235
SYLHS I HRDIK +NILL + + K+ DFG S + + ++ T GT Y+
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYM 170
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295
PE Q + SDV+S G+ L+E+ + P G + L ++ V +M +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELK 229
Query: 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331
D + + F + ++CL+ + +RPT
Sbjct: 230 DEPGNGI------KWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 70/305 (22%), Positives = 125/305 (40%), Gaps = 79/305 (25%)
Query: 77 RILGQGGQGTVYK----GML--EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R +GQG G V++ G+L E ++AVK K ++ +F E ++++ +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDH 67
Query: 131 RNVVKLLGCCLETEVPLLHLHDH-----------HRN-------------------EEFP 160
N+VKLLG C + P+ L ++ HR+ P
Sbjct: 68 PNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 161 LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AM 219
L+ +L IA +VA ++YL + HRD+ + N L+ E K+ADFG S+ I +
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQEN 278
D + ++ PE ++ T +SDV+++GVVL E+ + G +P + +
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----- 238
Query: 279 VSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA--------FANLAERCLDLNGKKRP 330
++V+ V+ +++ NL C RP
Sbjct: 239 ---------------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 331 TMEEV 335
+ +
Sbjct: 278 SFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 44/214 (20%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE----LLKLEEFINEIVILSQINHRNV 133
+G G G VYK + G +MAVK+ + + EE L+ L+ V+L + +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD------VVLKSHDCPYI 76
Query: 134 VKLLGC----------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
VK G CL+ LL P+ +I ++ + AL
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDK---LLKRIQG------PIPEDILGKMTVAIVKAL 127
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
YL + HRD+K +NILLD K+ DFG S + + T+ G Y+ P
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAP 183
Query: 238 EYHQSSQLTDK----SDVYSFGVVLVELLTGKKP 267
E K +DV+S G+ LVEL TG+ P
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 79/295 (26%), Positives = 131/295 (44%), Gaps = 63/295 (21%)
Query: 71 NHFNVNRILGQGGQGTVYK----GMLEDGRIM--AVKKFKLAVDDEELLKLEEFINEIVI 124
N+ + + LG G G V + G+ + +M AVK K E E ++E+ I
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKI 91
Query: 125 LSQI-NHRNVVKLLGCCLETEVPLLHLHDH----------HRNEEFPLTWEIRLRIATEV 173
+S + NH N+V LLG C P+L + ++ R E LT E L + +V
Sbjct: 92 MSHLGNHENIVNLLGACTIGG-PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT-- 231
A +++L AS HRD+ + N+LL K+ DFG ++ I D +V ++G
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNAR 204
Query: 232 --FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289
++ PE + T +SDV+S+G++L E IFS G+ +
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWE-------IFSLGSNPYPGM---------- 247
Query: 290 RKNHMYDILDDQVVKLVKKNQIMA---FA-----NLAERCLDLNGKKRPTMEEVT 336
+D + KL+K+ MA A ++ + C D + KRPT +++
Sbjct: 248 -------PVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 75/221 (33%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 77 RILGQGGQGTVY---KGMLED-GRIMAVKKFK---LAVDDEELLKLEEFINEIVILSQIN 129
++LGQG G V+ K D G++ A+K K L V D K+E IL+++N
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER-----DILAEVN 56
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHHR--------NEEFPLTWE-IRLRIATEVAGALSYL 180
H +VKL +TE L + D R ++E T E ++ +A E+A AL +L
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 114
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS I +RD+K NILLDE K+ DFG SK ++D GT Y+ PE
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
T +D +SFGV++ E+LTG P G +E +++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPF--QGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 73 FNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKL---EEFINEIVIL 125
F + LG G G V ML G+ A+K + +++KL E +NE IL
Sbjct: 3 FEFIKTLGTGSFGRV---MLVRHKGSGKYYALK----ILSKAKIVKLKQVEHVLNEKRIL 55
Query: 126 SQINHRNVVKLLGC---------CLETEVPLLHLHDHHRNE-EFPLTWEIRLRIATEVAG 175
I H +V L G +E VP L H R FP R A +V
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEY-VPGGELFSHLRKSGRFPEPV-ARFYAA-QVVL 112
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
AL YLHS I +RD+K N+LLD K+ DFG +K + +T+ + GT YL
Sbjct: 113 ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEYL 165
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
PE S D ++ G+++ E+L G P F
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 73/316 (23%), Positives = 123/316 (38%), Gaps = 63/316 (19%)
Query: 67 DKATNHFNVNRILGQGGQGTVY------------KGMLEDG-----RIMAVKKFKLAVDD 109
+ N LG+G G V+ K E+ ++AVK + D
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 110 EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP--LLHLHDHHRNEEF-------- 159
E+F+ E+ ILS+++ N+ +LLG C ++ ++ +F
Sbjct: 61 NAR---EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 160 --------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211
L++ L +AT++A + YL S HRD+ + N L+ + Y K+ADF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADF 174
Query: 212 GTSKFIAMDQTHVTTKIQGT----FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKK 266
G S+ + + ++QG ++ E + T KSDV++FGV L E+LT ++
Sbjct: 175 GMSRNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 267 PIFSTGNTSQ--ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDL 324
+ Q EN H R + L N L C
Sbjct: 232 QPYEHLTDQQVIENAG------HFFRDDGRQIYLPR------PPNCPKDIYELMLECWRR 279
Query: 325 NGKKRPTMEEVTMELN 340
+ + RPT E+ + L
Sbjct: 280 DEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 80/293 (27%), Positives = 119/293 (40%), Gaps = 49/293 (16%)
Query: 66 LDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
L T F + ++G+G G VYK + G+++A+K + D+EE +K E N +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE--YNILRK 58
Query: 125 LSQINHRNVVKLLGCCLETEVPLLH-----------------LHDHHRNEEFPLTWEIRL 167
S NH N+ G ++ P L R + L E
Sbjct: 59 YS--NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
I E L+YLH + + HRDIK NILL + K+ DFG S + T
Sbjct: 117 YILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 228 IQGTFGYLEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282
I GT ++ PE + D +SDV+S G+ +EL GK P+
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD------------ 220
Query: 283 AFFVHSMRKNHMYDILDDQVVKLV-KKNQIMAFANLAERCLDLNGKKRPTMEE 334
+H MR ++ I + L +N F + CL N ++RP MEE
Sbjct: 221 ---MHPMRA--LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 72 HFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLK-LEEFINEIVILSQIN 129
++ + ++LG+G G VY D GR +AVK+ D +E K + EI +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 130 HRNVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
H +V+ GC + E +P + D + LT + R ++ +SY
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSY 121
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLE 236
LHS + I HRDIK NIL D K+ DFG SK I M T + + + GT ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMS 177
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE K+DV+S +VE+LT K P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 73 FNVNRILGQGGQGTVYKGML----EDGRI-MAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
F ++LG G GTVYKG+ E +I +A+K+ + A + +E ++E +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK---ANKEILDEAYVMAS 65
Query: 128 INHRNVVKLLGCCLETEVPLLH-------LHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
+++ +V +LLG CL + V L+ L D+ R + + + L ++A ++YL
Sbjct: 66 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLEP 237
+ HRD+ + N+L+ K+ DFG +K + D+ K+ + LE
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
H+ T +SDV+S+GV + EL+T G KP
Sbjct: 183 ILHRI--YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 72 HFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLK-LEEFINEIVILSQIN 129
++ + ++LGQG G VY D GR +AVK+ + + E K + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHHR---------NEEFPLTWEIRLRIATEVAGALSYL 180
H +V+ GC + L + H LT + + ++ +SYL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLEP 237
HS + I HRDIK NIL D K+ DFG SK I + T + + + GT ++ P
Sbjct: 123 HS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
E K+D++S G +VE+LT K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 70/219 (31%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 77 RILGQGGQGTVYKGMLED------GRI-MAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
LG G G VY+G D G I +AVK + D+E +EF+ E ++S N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK---KEFLKEAHLMSNFN 57
Query: 130 HRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFP---LTWEIRLRIATEVAG 175
H N+VKLLG CL E LL R E F LT + L I +VA
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFI-AMDQTHVTTKIQ 229
YL HRD+ + N L+ E K+ DFG ++ I D +
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
++ PE + T +SDV+SFGV++ E+LT G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 75/265 (28%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+GQG GTVY M + G+ +A+++ L ++ K E INEI+++ + + N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 138 GCCL---ETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIYHR 191
L E V + +L + T +IA E AL +LHS + + HR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIKS NILL K+ DFG I +Q+ + + GT ++ PE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 252 YSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQI 311
+S G++ +E++ G+ P + EN A +Y I + +L ++
Sbjct: 200 WSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPELQNPEKL 242
Query: 312 MA-FANLAERCLDLNGKKRPTMEEV 335
A F + RCLD++ +KR + +E+
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 76/311 (24%), Positives = 129/311 (41%), Gaps = 63/311 (20%)
Query: 75 VNRILGQGGQGTVYKGMLED--GR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + LG+G G V K GR +AVK K EL L ++E +L Q+
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL---LSEFNLLKQV 60
Query: 129 NHRNVVKLLGCCLETEVPLLHLH------------------------DHHRN-------E 157
NH +V+KL G C + LL + D +RN +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 158 EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217
E LT + A +++ + YL A + HRD+ + N+L+ E + K++DFG S+ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 218 AMDQTHVT-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS 275
+ ++V +K + ++ E T +SDV+SFGV+L E++T G P G
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIAP 235
Query: 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ +L ++ + + + N NL C KRPT ++
Sbjct: 236 ERLFNL-------LKTGYRMERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADI 279
Query: 336 TMELNGIRGSN 346
+ EL + +
Sbjct: 280 SKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 75 VNRILGQGGQGTVYKGM------LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ R LG+G G V+ +D ++AVK K D L ++F E +L+ +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNL 64
Query: 129 NHRNVVKLLGCCLETEVPLLHLHDHHRNEEF------------------------PLTWE 164
H ++VK G C + + PL+ + ++ ++ + L
Sbjct: 65 QHEHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 223
L IA+++A + YL AS HRD+ + N L+ K+ DFG S+ + + D
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274
V ++ PE + T +SDV+SFGV+L E+ T GK+P F NT
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 76/275 (27%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 77 RILGQGGQGTV----YKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
R+LG+G G V Y + G ++AVK K + + EI IL + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK---RECGQQNTSGWKKEINILKTLYHE 66
Query: 132 NVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VK GCC E VPL L D+ + L L A ++ ++YLH
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQICEGMAYLH 124
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLEPE 238
S HRD+ + N+LLD K+ DFG +K + + + G F Y E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
+ ++ + SDV+SFGV L ELLT S +E + + +R + ++L
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR---LIELL 237
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTME 333
+ + KN L + C + K RPT
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ I+G+G G V +G G+ +AVK K V + F+ E ++++++H+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV------TAQAFLEETAVMTKLHHK 59
Query: 132 NVVKLLGCCLETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSA 183
N+V+LLG L + ++ N ++ L+ + +VA + YL S
Sbjct: 60 NLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQGTFGYLEPEYHQ 241
+ HRD+ + NIL+ E AKV+DFG ++ + +D + + K + PE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKP 267
+ + KSDV+S+GV+L E+ + G+ P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVK-KFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
++LG G GTVYKG+ + DG + + K+ ++ +E ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 135 KLLGCCLETEVPLLH-------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
+LLG CL + V L+ L D+ R + + + L ++A +SYL
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLEPEYHQSSQ 244
+ HRD+ + N+L+ K+ DFG ++ + +D+T K+ + LE H+ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR--R 187
Query: 245 LTDKSDVYSFGVVLVELLT-GKKP 267
T +SDV+S+GV + EL+T G KP
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+F + + +G+G VYK + L DGR++A+KK ++ + + ++ + EI +L Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI-FEMMDAKARQDCLKEIDLLKQL 59
Query: 129 NHRNVVKLLGCCLE-------TEVP----LLHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
+H NV+K L +E E+ L + H + ++ + + ++ AL
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
++HS I HRDIK N+ + K+ D G +F + T + + GT Y+ P
Sbjct: 120 EHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
E + KSD++S G +L E+ + P +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 40/268 (14%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G+G G V+KG+ D R V K+ +E ++E+ EI +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 139 CCLE-TEVPLLHLH-------DHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSP 187
L+ T++ ++ + D R F +IAT E+ L YLHS
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFD-----EFQIATMLKEILKGLDYLHSEKK-- 122
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
HRDIK+ N+LL E+ K+ADFG + + Q T + GT ++ PE Q S
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 248 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307
K+D++S G+ +EL G+ P N+ +H MR ++ I + L
Sbjct: 181 KADIWSLGITAIELAKGEPP-----NSD----------MHPMRV--LFLIPKNNPPTLTG 223
Query: 308 KNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ F + CL+ + RPT +E+
Sbjct: 224 EFS-KPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V+ G L D +AVK + + + LK +F+ E IL Q +H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LK-AKFLQEARILKQYSHPNIVRLI 59
Query: 138 GCCLETE-----VPLLHLHDHH---RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
G C + + + L+ D R E L + +++ A + YL S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---I 116
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLEPEYHQSSQLTD 247
HRD+ + N L+ E+ K++DFG S+ D + +T Q + PE + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 248 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307
+SDV+SFG++L E FS G N+S + ++ V
Sbjct: 176 ESDVWSFGILLWE-------AFSLGAVPYANLS----------NQQTREAIEQGVRLPCP 218
Query: 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ A L ERC + + +RP+ V EL
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 79 LGQGGQGTVYKG---MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
LG G GTV KG M + + +AVK K +D L +E + E ++ Q+++ +V+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVR 60
Query: 136 LLGCCLETEVPLL------------------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
++G C E E +L H+ + + E + +V+ +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE-----------LVHQVSMGM 108
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 235
YL + HRD+ + N+LL ++ AK++DFG SK + D+ + K G + +
Sbjct: 109 KYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY 165
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + + KSDV+SFGV++ E + G+KP
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLE-EFINEIVILSQINHRNVV 134
++LG G GTVYKG+ + +G + + +++ K EF++E +I++ ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 135 KLLGCCLETEVPLL-----------HLHDHHRN--EEFPLTWEIRLRIATEVAGALSYLH 181
+LLG CL + L+ ++H+H N + L W ++A + YL
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLEPE 238
+ HRD+ + N+L+ K+ DFG ++ + D+ K+ + LE
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
+++ + T +SDV+S+GV + EL+T G KP
Sbjct: 184 HYR--KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+GQG GTVY + + G+ +A+K+ L ++ K E INEI+++ + + N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 138 GCCL---ETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIYHR 191
L E V + +L + T +IA E AL +LHS + + HR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHS---NQVIHR 139
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIKS NILL K+ DFG I +Q+ +T + GT ++ PE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 252 YSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQI 311
+S G++ +E++ G+ P + EN A +Y I + +L ++
Sbjct: 199 WSLGIMAIEMVEGEPPYLN------ENPLRA-----------LYLIATNGTPELQNPERL 241
Query: 312 MA-FANLAERCLDLNGKKRPTMEEV 335
A F + RCL+++ +R + +E+
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F + ++G G G VYKG ++ G++ A+K + D+EE +K E IN + S +HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE--INMLKKYS--HHR 63
Query: 132 NVVKLLGCCLETEVPLL--------------HLHDHHRNEE-FPLTWEIRLRIATEVAGA 176
N+ G ++ P + + D +N + L E I E+
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LS+LH + HRDIK N+LL E K+ DFG S + T I GT ++
Sbjct: 124 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 179
Query: 237 PEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291
PE + D KSD++S G+ +E+ G P+ +H MR
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---------------MHPMRA 224
Query: 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ I + +L K F + E CL N +RPT E++
Sbjct: 225 --LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 68/308 (22%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK--LEEFINEIVILSQI 128
+ + + +G G G V + GR +A+KK DD K L E I +L +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHL 56
Query: 129 NHRNVVKL-------------------------LGCCLETEVPLLHLHDHHRNEEFPLTW 163
H N++ L L +++ PL DH + +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--DHIQY----FLY 110
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+I LR L YLHSA + HRD+K +NIL++ K+ DFG ++ + D+
Sbjct: 111 QI-LR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
Query: 224 VTTKIQG--TFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280
+ T Y PE SS K+ D++S G + ELLT KP+F G + ++
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFP-GRDYIDQLN 217
Query: 281 LAAFFVHSMRKNHMYDILDDQVVKLVKK---------NQIMAFAN-----LAERCLDLNG 326
L + + + + I ++ +K +++ A+ L E+ L +
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277
Query: 327 KKRPTMEE 334
KKR T +E
Sbjct: 278 KKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 74/271 (27%), Positives = 116/271 (42%), Gaps = 46/271 (16%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G+G G VYKG+ D R V K+ +E ++E+ EI +LSQ + + + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 139 CCLETE---VPLLHLHDHHRNEEF---PLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192
L+ + + +L + PL I E+ L YLHS HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRD 126
Query: 193 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVY 252
IK+ N+LL E+ K+ADFG + + Q T + GT ++ PE + S K+D++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIW 185
Query: 253 SFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ-- 310
S G+ +EL G+ P +H MR V+ L+ KN
Sbjct: 186 SLGITAIELAKGEPPNSD---------------LHPMR-----------VLFLIPKNSPP 219
Query: 311 ------IMAFANLAERCLDLNGKKRPTMEEV 335
F E CL+ + + RPT +E+
Sbjct: 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 74/277 (26%), Positives = 111/277 (40%), Gaps = 55/277 (19%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G G G VY ++AVKK + + K ++ I E+ L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYS-GKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 138 GC-------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGAL---SYLH 181
GC CL + LL +H E + IA GAL +YLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE---------VEIAAITHGALQGLAYLH 138
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY-- 239
S + HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 240 -HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
Q K DV+S G+ +EL K P+F+ S +Y I
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHIA 233
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ L +F + CL ++RP E+
Sbjct: 234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 51/219 (23%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN-----EIVILSQINHRN 132
LG+G VYK E GRI+A+KK KL E + ++ IN EI +L ++ H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 133 VVKLLGC------------CLET--EVPLLHLHDHHRNEEFPLT------WEIR-LRIAT 171
++ LL +ET E + +++ LT + + LR
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMETDLEKVI-------KDKSIVLTPADIKSYMLMTLR--- 113
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
L YLHS + I HRD+K N+L+ K+ADFG ++ +T ++ T
Sbjct: 114 ----GLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 232 FGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
Y PE + D++S G + ELL P
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 71/272 (26%), Positives = 109/272 (40%), Gaps = 49/272 (18%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
R +G G G VY + + ++A+KK + + K ++ I E+ L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 136 LLGC-------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
GC CL + LL +H E + IA GAL L
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---------VEIAAVTHGALQGLAY 130
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY--- 239
S + HRD+K+ NILL E K+ DFG++ +A V GT ++ PE
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
Q K DV+S G+ +EL K P+F+ S +Y I
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHIAQ 228
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331
++ L + F N + CL + RPT
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V + GR +AVK +D + + E NE+VI+ H+NVV++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK----MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 138 GCCLETEVPLLHLHDHHRNEEFPLTWEIRL---RIAT---EVAGALSYLHSAASSPIYHR 191
L E + + + + RL +IAT V AL YLHS + HR
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHR 141
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIKS +ILL R K++DFG I+ D + + GT ++ PE + + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 252 YSFGVVLVELLTGKKPIFS 270
+S G++++E++ G+ P FS
Sbjct: 201 WSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-15
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G+G G V+KG+ D R V K+ +E ++E+ EI +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 139 CCLETEVPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHR 191
L+ + L + ++ E PL I E+ L YLHS HR
Sbjct: 70 SYLK-DTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIK+ N+LL E K+ADFG + + Q T + GT ++ PE + S K+D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADI 184
Query: 252 YSFGVVLVELLTGKKP 267
+S G+ +EL G+ P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 7e-15
Identities = 69/264 (26%), Positives = 128/264 (48%), Gaps = 31/264 (11%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+GQG GTV+ + + G+ +A+K+ L ++ K E INEI+++ ++ + N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 138 GCCL---ETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIYHR 191
L E V + +L + T +IA E AL +LH+ + + HR
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHA---NQVIHR 139
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
DIKS N+LL K+ DFG I +Q+ +T + GT ++ PE K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 252 YSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQI 311
+S G++ +E++ G+ P + EN A + + + N ++ + + + +
Sbjct: 199 WSLGIMAIEMVEGEPPYLN------ENPLRALYLIAT---NGTPELQNPEKLSPI----- 244
Query: 312 MAFANLAERCLDLNGKKRPTMEEV 335
F + RCL+++ +KR + +E+
Sbjct: 245 --FRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-15
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 27/201 (13%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
ILG G GTVYK L RI+AVK L + EL K + ++E+ IL + + ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQK--QIMSELEILYKCDSPYIIGF 64
Query: 137 LGCC-LETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
G +E + + L + + E L RIA V L+YL S I
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---I 116
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRD+K +N+L++ R + K+ DFG S + ++ +T+V GT Y+ PE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 247 DKSDVYSFGVVLVELLTGKKP 267
SDV+S G+ +EL G+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 47/226 (20%)
Query: 78 ILGQGGQGT---VYKGML---EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
I G G+GT VYK +DG+ A+KKFK + + EI +L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELKHE 62
Query: 132 NVVKLLGCCLE------------TEVPLLHL---HDHHRNEEFP------LTWEIRLRIA 170
NVV L+ LE E L + H + P L W+I
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI----- 117
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTS-KFIAMDQTHVT 225
+ YLH S+ + HRD+K NIL+ ER K+ D G + F A +
Sbjct: 118 ---LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 226 -TKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIF 269
+ T Y PE ++ T D+++ G + ELLT +PIF
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 66/218 (30%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKF-KLAVDDEELLKLEEFI-NEIVILSQINHRNVVK 135
LG GG G V ++ R A+K K + + +E I +E IL + NH +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE---TGQQEHIFSEKEILEECNHPFIVK 57
Query: 136 L-----------------LGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
L LG L T L D +E + R IA V A
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWT-----ILRDRGLFDE----YTARFYIAC-VVLAFE 107
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
YLH+ I +RD+K N+LLD K+ DFG +K + Q T GT Y+ PE
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPE 162
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
+ D +S G++L ELLTG+ P F +
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP-FGEDDEDP 199
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/222 (25%), Positives = 109/222 (49%), Gaps = 29/222 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLE-DGR---IMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+H +++G G G V++G+L+ GR +A+K K +++ ++F++E I+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 127 QINHRNVVKLLGCCLETEVPLLHLHDHHRN------------EEFPLTWEIRLRIATEVA 174
Q +H N+++L G + + P + + ++ N E LR +A
Sbjct: 62 QFSHHNIIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIA 117
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD--QTHVTTKIQGTF 232
+ YL + HRD+ + NIL++ KV+DFG S+ + D T+ T+ +
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
+ PE + T SDV+SFG+V+ E+++ G++P + N
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEF----INEIVIL 125
+ F++ +G+G G VYK +D G ++A+KK +L D+E+ E F I EI IL
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEK----EGFPITAIREIKIL 60
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWE--------------------- 164
Q+NHRN+V L + + L D F L +E
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDHDLMGLLESGLVHFSEDH 117
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224
I+ ++ L+Y H HRDIK +NILL+ + + K+ADFG ++ +++
Sbjct: 118 IK-SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGN 273
T T Y PE + + DV+S G +L EL T KKPIF
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDE-ELLKLEEFINEIVILSQ 127
T +NRI G+G G VY+ G I+A+KK ++ D+E + + + + EI +L
Sbjct: 7 TEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISS-LREITLLLN 62
Query: 128 INHRNVVKLL----GCCLET--------EVPLLHLHDHHRNEEFPLTWEIRLR-IATEVA 174
+ H N+V+L G L++ E L L D N P + E +++ + ++
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD---NMPTPFS-ESQVKCLMLQLL 118
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
L YLH + I HRD+K +N+LL ++ K+ADFG ++ + +T K+ T Y
Sbjct: 119 RGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 235 LEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
PE + D+++ G +L ELL KP+
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 50/286 (17%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F + ++G G G VYKG ++ G++ A+K + D+EE +KLE IN + S +HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE--INMLKKYS--HHR 73
Query: 132 NVVKLLGCCLETEVP-----------------LLHLHDHHRNEEFPLTWEIRLRIATEVA 174
N+ G ++ P + L + + W I E+
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREIL 131
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
L++LH+ + HRDIK N+LL E K+ DFG S + T I GT +
Sbjct: 132 RGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 187
Query: 235 LEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289
+ PE + D +SD++S G+ +E+ G P+ +H M
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD---------------MHPM 232
Query: 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
R ++ I + KL K F + E CL N RP+ E++
Sbjct: 233 RA--LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 52/218 (23%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG G G VYK E G A K ++ ++E LE+F+ EI ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE----LEDFMVEIDILSECKHPNIVGLY 68
Query: 138 GC-------------C---------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAG 175
C LE E L E +IR + ++
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGL--------TEP-----QIRY-VCRQMLE 114
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGY 234
AL++LHS + HRD+K+ NILL K+ADFG S K + Q T GT +
Sbjct: 115 ALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYW 169
Query: 235 LEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKP 267
+ PE D K+D++S G+ L+EL + P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNV 133
+G+G GTVYK L GR +A+KK ++ + +E + + EI +L Q+ H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL--STLREIALLKQLESFEHPNI 63
Query: 134 VKLLGCC----LETEVPLL----HLH-------DHHRNEEFPLTWEIRLRIATEVAGALS 178
V+LL C + E+ L H+ P I+ + ++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLP-PETIK-DLMRQLLRGVD 121
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQGTFGYLE 236
+LHS I HRD+K NIL+ + K+ADFG ++ M T V T Y
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV----TLWYRA 174
Query: 237 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
PE QSS T D++S G + EL ++P+F
Sbjct: 175 PEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPLF 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+ LG G G V+ G +A+K E + E+FI E ++ +++H +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN-----EGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 137 LGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
G C + + PL L ++ R + L+ ++ L + +V + YL +
Sbjct: 65 YGVCTQQK-PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NS 120
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
HRD+ + N L+ KV+DFG ++++ D+ ++ + + PE S+ +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 248 KSDVYSFGVVLVELLT-GKKPIFSTGN 273
KSDV+SFGV++ E+ T GK P N
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN--EIVILSQIN 129
+ V + LG G G+VY E G ++A+KK K ++ EE +N E+ L ++N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLN 55
Query: 130 -HRNVVKLLGCCLET----------EVPLLHLHDHHRNEEFPLTWEIRLR-IATEVAGAL 177
H N+VKL E E L L + + F E +R I ++ L
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGL 112
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+++H +HRD+K N+L+ K+ADFG ++ I + T + T Y P
Sbjct: 113 AHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAP 167
Query: 238 E-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
E +S+ + D+++ G ++ EL T +P+F
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTL-RPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 73/255 (28%), Positives = 105/255 (41%), Gaps = 24/255 (9%)
Query: 73 FNVNRILGQGGQGTVY----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
F + R+LG G G V+ G + G++ A+K K A ++ E E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 129 NHRNVVKLLGCCLETEVPL-----------LHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
+ L +T+ L L H + R E F + E+R+ IA E+ AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTES-EVRVYIA-EIVLAL 118
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+LH I +RDIK NILLD + DFG SK ++ GT Y+ P
Sbjct: 119 DHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 238 EY--HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG-NTSQENVSLAAFFVHSMRKNHM 294
E S D +S GV+ ELLTG P G SQ +S M
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM 235
Query: 295 YDILDDQVVKLVKKN 309
D + KL++K+
Sbjct: 236 SAEARDFIQKLLEKD 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVT 225
+I+ V L+YL I HRD+K +NIL++ R K+ DFG S + I +M + V
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159
Query: 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 268
GT Y+ PE Q + T +SD++S G+ LVE+ G+ PI
Sbjct: 160 ----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 61/286 (21%)
Query: 77 RILGQGGQGTVYKGMLED--GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
+ +G+G G V ML D G +AVK K +D + F+ E +++Q+ H N+V
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK---NDA---TAQAFLAEASVMTQLRHSNLV 62
Query: 135 KLLGCCLETEVPLL---------HLHDHHRNE-EFPLTWEIRLRIATEVAGALSYLHSAA 184
+LLG +E + L L D+ R+ L + L+ + +V A+ YL +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
+ HRD+ + N+L+ E AKV+DFG +K + Q ++ T PE + +
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304
+ KSDV+SFG++L E I+S G + L VV
Sbjct: 176 FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPL------------------KDVVP 210
Query: 305 LVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
V+K M ++ ++C L+ RP+ ++ +L I
Sbjct: 211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 79 LGQGGQGTVYKGMLEDG--RIMAVKKFKL------AVDDEELLKLEEFINEIVIL-SQIN 129
LG G G VYK ++ ++A+K+ + E + + ++E+ I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 130 HRNVVKLLGCCLETE-----------VPLLHL-----HDHHRNEEFPLTWEIRLRIATEV 173
H N+V+ LE + PL R E + W I +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMVL-- 124
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
AL YLH I HRD+ NI+L E + + DFG +K T + GT
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
Y PE ++ +K+DV++FG +L ++ T + P +ST +SLA V ++ +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAVYEPL 233
Query: 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336
+ + V ++ CL + + RP + +V+
Sbjct: 234 PEGMYSEDVTDVIT------------SCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDE-ELLKLEEFINEIVILSQINHRNVVKL 136
+G+G G V GR +AVKK L ELL NE+VI+ H N+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-----FNEVVIMRDYQHPNIVEM 81
Query: 137 LGCCL---ETEVPLLHLH--------DHHR-NEEFPLTWEIRLRIAT---EVAGALSYLH 181
L E V + L H R NEE +IAT V ALS+LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLAVLKALSFLH 132
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLEPEY 239
+ + HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 133 AQG---VIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
+ D++S G++++E++ G+ P F+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 18/181 (9%)
Query: 95 GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---------- 144
G +AVK K + L++ EI IL + H N+VK G C E
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 145 VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204
+P L ++ + + + +L+ A ++ + YL S HRD+ + N+L++ +
Sbjct: 90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146
Query: 205 RAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELL 262
+ K+ DFG +K I D+ + T K + + PE S+ SDV+SFGV L ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 263 T 263
T
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 79 LGQGGQGTVYKGML--EDGRIMAVKKFKLAVDDEELLKLEEFINEI-VILSQINHRNVVK 135
LG+G G V K M G IMAVK+ + V+ +E +L + ++ + + ++ V
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRL---LMDLDISMRSVDCPYTVT 64
Query: 136 LLGC---------CLE---TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
G C+E T + + + + P +I +IA + AL YLHS
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIP--EDILGKIAVSIVKALEYLHSK 122
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY---H 240
S + HRD+K +N+L++ + K+ DFG S ++ +D T G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA-GCKPYMAPERINPE 178
Query: 241 QSSQLTD-KSDVYSFGVVLVELLTGKKP 267
+ + D KSDV+S G+ ++EL TG+ P
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G V+ G +A+K K + + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 139 CCLETEVPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
T+ P+ + ++ N E LT + +A ++A ++++
Sbjct: 69 VV--TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY--- 123
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
HRD+++ NIL+ E K+ADFG ++ I ++ + + PE T K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 249 SDVYSFGVVLVELLT-GKKP 267
SDV+SFG++L E++T G+ P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 77 RILGQGGQGTV----YKGMLEDGRIMAVKKFK--LAVDDEELLKLEEFINEIVILSQINH 130
++LG+G G V KG + AVK K + + D+++ E + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDV---ECTMTEKRVLALAGK 54
Query: 131 RNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI-ATEVAGA 176
+ L C +T+ L H+ R F E R R A E+
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FD---EPRARFYAAEIVLG 108
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYL 235
L +LH I +RD+K N+LLD K+ADFG K I T T+ GT Y+
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE D ++ GV+L E+L G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLE-------EFINEIVILSQINHR 131
LG G G V K + ++ +K L+ LE + I E+ +L + N
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 132 NVVKLLGCCL---ETEVPLLHLH----DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
+V G E + + H+ D E + EI +++ V L+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLEPEYHQS 242
I HRD+K +NIL++ R K+ DFG S + +M + V GT Y+ PE Q
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQG 176
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPI 268
+ + +SD++S G+ LVEL G+ PI
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G V G +A+K K E + +EFI E ++ +++H +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 139 CCLETEVP-------------LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
C + P L +L +H + L + +V ++YL S
Sbjct: 67 VC-TKQRPIYIVTEYMSNGCLLNYLREHGKR----FQPSQLLEMCKDVCEGMAYLES--- 118
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
HRD+ + N L+D++ KV+DFG S+++ D+ + + + PE S+
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 246 TDKSDVYSFGVVLVELLT-GKKP 267
+ KSDV++FGV++ E+ + GK P
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK-KFKLAVDDEELLKLE 116
++ EL K ++LG G GTV+KG+ + +G + + K D +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 117 EFINEIVILSQINHRNVVKLLGCC------LETEV-PLLHLHDHHRNEEFPLTWEIRLRI 169
E + ++ + ++H +V+LLG C L T++ PL L DH R L + L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 228
++A + YL + HR++ + NILL ++ADFG + + D+ + ++
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
+ ++ E + T +SDV+S+GV + E+++ G +P
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 52/238 (21%)
Query: 72 HFNVNRILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+++ R++G+GG G VY D R +A+KK + + + LLK + F+ E I + +
Sbjct: 3 RYDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLK-KRFLREAKIAADL 59
Query: 129 NHRNVVKLLGCCLETEV-----------PLLHL-----------HDHHRNEEFPLTWEIR 166
H +V + C + + L L +
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---- 115
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--- 223
L I ++ + Y+HS + HRD+K NILL + D+G + F +++
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 224 --------------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ KI GT Y+ PE ++ +D+Y+ GV+L ++LT P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R LGQG G VY+G+ E +A+K A E + EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKEFNC 68
Query: 131 RNVVKLLGCCLETEVPLL------------HLHDHHRNEE-----FPLTWEIRLRIATEV 173
+VV+LLG + + L+ +L E P + + +++A E+
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTF 232
A ++YL++ + HRD+ + N ++ E + K+ DFG ++ I D K
Sbjct: 129 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
++ PE + T SDV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 53/203 (26%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 79 LGQGGQGTVYKGM--LEDGRI-MAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
LG G G V KG+ + +I +A+K K ++ E +E + E I+ Q+++ +V+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 136 LLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
++G C E E +L L+ ++ +T + + +V+ + YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEYHQSSQL 245
HRD+ + N+LL ++ AK++DFG SK + D ++ + G + + PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 246 TDKSDVYSFGVVLVELLT-GKKP 267
+ +SDV+S+G+ + E + G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 66/209 (31%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 77 RILGQGGQGTVYKG-MLEDGRIMAVKKFKLAV---DDEELLKLEEFINEIVILSQINHRN 132
R+LG+G G V + E GR+ AVK K V DD+ +E + E ILS +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD----VECTMTEKRILSLARNHP 56
Query: 133 VVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRI-ATEVAGALS 178
+ L CC +T L H+ R +E R R A E+ AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE------ARARFYAAEITSALM 110
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+LH I +RD+K N+LLD K+ADFG K + T+ GT Y+ PE
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPE 166
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
Q D ++ GV+L E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+F + + +G+G VY+ L DG +A+KK ++ D + + I EI +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 61
Query: 131 RNVVKLLGCCLE-TEVPL-LHLHD---------HHRNEEFPLTWEIRLRIATEVAGALSY 179
NV+K +E E+ + L L D H + ++ + + + ++ AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+HS + HRDIK N+ + K+ D G +F + +T + GT Y+ PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 177
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ KSD++S G +L E+ + P +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LGQG G V+ G +A+K K + E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 139 CCLETEVPLL-------HLHDHHRNEEFPLTWEIRL----RIATEVAGALSYLHSAASSP 187
E + ++ L D + E +RL +A ++A ++Y+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMN--- 122
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
HRD+++ NIL+ E KVADFG ++ I ++ + + PE + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 248 KSDVYSFGVVLVELLT-GKKP 267
KSDV+SFG++L EL T G+ P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G VYK ++ +A K +EEL E+++ EI IL+ NH +VKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 139 C-------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
C V + L + R P +I++ I ++ AL YLHS
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIML-ELDRGLTEP---QIQV-ICRQMLEALQYLHSMK- 130
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
I HRD+K+ N+LL K+ADFG S K + Q GT ++ PE
Sbjct: 131 --IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCET 186
Query: 245 LTD-----KSDVYSFGVVLVELLTGKKP 267
+ D K+D++S G+ L+E+ + P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 61/235 (25%), Positives = 109/235 (46%), Gaps = 41/235 (17%)
Query: 79 LGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
LG+ G +YKG L + +++A+K K D + EF E ++++++H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK---DINNPQQWGEFQQEASLMAELHHPNI 69
Query: 134 VKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIR-------------------------LR 168
V LLG + E P+ L ++ + +R L
Sbjct: 70 VCLLGVVTQ-EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 227
IA ++A + YL +S H+D+ + NIL+ E+ K++D G S+ I + D V K
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 281
++ PE + + SD++SFGVVL E+ + G +P + G ++QE + +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY--GFSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 84/311 (27%), Positives = 137/311 (44%), Gaps = 77/311 (24%)
Query: 73 FNVNRILGQGGQGTVYKGMLED---GRIMAVKK----FKLAVDDEELLKLEEFINEIVIL 125
+ + + LG+G G V+K + D ++A+KK F+ A D + + EI+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR------EIMFL 60
Query: 126 SQI-NHRNVVKLLGC--------------CLETEVPLLH-------LHDHHRNEEFPLTW 163
++ +H N+VKLL +ET+ LH L D H+
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKR------- 110
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 222
I ++ AL Y+HS + HRD+K +NILL+ R K+ADFG ++ ++ +++
Sbjct: 111 ----YIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 223 H---VTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF--------- 269
V T T Y PE S K D++S G +L E+L G KP+F
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQL 222
Query: 270 -----STGNTSQENV-SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLD 323
G S E++ S+ + F +M + + + +L+ K A +L ++ L
Sbjct: 223 EKIIEVIGPPSAEDIESIKSPFAATMLDS-LPSRPRKPLDELLPKASDDA-LDLLKKLLV 280
Query: 324 LNGKKRPTMEE 334
N KR T EE
Sbjct: 281 FNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 79 LGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V ++ G+++AVKK L + + E NE+VI+ H NVV++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL----RKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 138 GCCLETEV-----------PLLHLHDHHR-NEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
L + L + H R NEE + V ALS LH+
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQG- 136
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLEPEYHQSS 243
+ HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 244 QLTDKSDVYSFGVVLVELLTGKKPIFS 270
+ D++S G++++E++ G+ P F+
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 39/116 (33%), Positives = 51/116 (43%), Gaps = 12/116 (10%)
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV---- 224
E+ AL YLHS I HRD+K NIL+D K+ DFG SK + +
Sbjct: 98 YIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154
Query: 225 ---TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
+I GT Y+ PE + D +S G +L E L G P G T +E
Sbjct: 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH--GETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 36/245 (14%)
Query: 73 FNVNRILGQGGQGTVY--KGMLEDGR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + + +G+G G +Y K + I + K+ V ++E K E+++L+++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAKM 56
Query: 129 NHRNVVKLLGCCLETEV-----------PLLHLHDHHR----NEEFPLTWEIRLRIATEV 173
H N+V E L+ + R +E+ L+W + ++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QI 110
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTKIQGTF 232
+ L ++H I HRDIKS NI L + AK+ DFG ++ + D + GT
Sbjct: 111 SLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
YL PE Q+ +K+D++S G VL EL T K P F N Q + + + + N
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQGYFAPISPN 225
Query: 293 HMYDI 297
D+
Sbjct: 226 FSRDL 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 49/224 (21%)
Query: 79 LGQGGQGTVY----KGMLE---------DGR--IMAVKKFKLAVDDEELLKLEEFINEIV 123
LG+G G V+ +G+ E DG+ ++AVK + D +F+ EI
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR---ADVTKTARNDFLKEIK 69
Query: 124 ILSQINHRNVVKLLGCCLETEVPLLHLHDHHRN---EEFPLTWEIR-------------- 166
I+S++ + N+++LLG C+ + PL + ++ N +F EI
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDD-PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 167 ---LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
L +A ++A + YL AS HRD+ + N L+ Y K+ADFG S+ + +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 224 VTTKIQG----TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
+IQG ++ E + T SDV++FGV L E+ T
Sbjct: 186 ---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G V+ G +AVK K + E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 139 CCLETEV-----------PLLHLHDHH-RNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
E + L L D R + P + +A +VA ++Y+
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL----VDMAAQVAAGMAYIERMN-- 122
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRD++S NIL+ + K+ADFG ++ I ++ + + PE + T
Sbjct: 123 -YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 247 DKSDVYSFGVVLVELLT-GKKP 267
KSDV+SFG++L EL+T G+ P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 77/270 (28%), Positives = 115/270 (42%), Gaps = 37/270 (13%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAV-DDEELLKLEEFINEIVILSQINHRNVVKL 136
+G G G VYK L G + AVK KL DD L++ EI ++ + H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-----QEIFMVKECKHCNIVAY 71
Query: 137 LGCCLETE---VPLLHLHDHHRNEEFPLTWEI-RLRIA---TEVAGALSYLHSAASSPIY 189
G L E + + + + + +T + L+IA E L+YLHS
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE---YHQSSQLT 246
HRDIK NILL + K+ADFG + I + I GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
D+++ G+ +EL + P+F +H MR + + Q KL
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMSKSNFQPPKLK 232
Query: 307 KKNQ-IMAFANLAERCLDLNGKKRPTMEEV 335
K + F N + L N KKRPT E +
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 44/214 (20%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LG G G VYK ++ ++A K +D + +LE+++ EI IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAK---VIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 139 C-------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIA-TEVAGALSYLHSAA 184
C V + L E PLT E ++R+ + AL+YLH
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLE-----LERPLT-EPQIRVVCKQTLEALNYLHE-- 121
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLEPE 238
+ I HRD+K+ NIL K+ADFG S T IQ GT ++ PE
Sbjct: 122 -NKIIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPE 173
Query: 239 YHQSSQLTD-----KSDVYSFGVVLVELLTGKKP 267
D K+DV+S G+ L+E+ + P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 7e-13
Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 42/273 (15%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEF--INEIVILSQINHRNVV 134
R++G+G G V+ + + + + K + E++ K E NE +L ++H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIK---QIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 135 KLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
+ LE + L N + L ++ AL ++H+
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILHFFVQILLALHHVHTK 120
Query: 184 ASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I HRD+K+ NILLD+ K+ DFG SK ++ T + GT Y+ PE +
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEG 175
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
KSD+++ G VL EL + K+ E +L A + M + + D+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF--------EAANLPALVLKIMSGT--FAPISDRY 225
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+++ L L+L+ KRP + ++
Sbjct: 226 SPDLRQ--------LILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 105 LAVDDEELLKLEEFINEIVILSQINHRNVVKLL--GCC-------LETEVPLLHLHDHHR 155
A ++E F E + +++ H N+V LL G + VP L +
Sbjct: 14 DAPEEEHQRA--RFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLA 71
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFG 212
+ L R+ +V AL+ H+ I HRD+K NI++ R AKV DFG
Sbjct: 72 ADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFG 127
Query: 213 TSKFI----AMDQTHVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKK 266
+ D +T T++ GT Y PE + +T SD+Y++G++ +E LTG++
Sbjct: 128 IGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
Query: 267 PIFSTGNTSQE 277
+ G + E
Sbjct: 188 VV--QGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG G G V+K + G IMA K L + + I E+ +L + N +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 69
Query: 138 GCCL---ETEVPLLHLH----DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190
G E + + H+ D + + +I +++ V L+YL I H
Sbjct: 70 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 127
Query: 191 RDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
RD+K +NIL++ R K+ DFG S + +M + V GT Y+ PE Q + + +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQ 182
Query: 249 SDVYSFGVVLVELLTGKKPI 268
SD++S G+ LVE+ G+ PI
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 78 ILGQGGQGTVYKGML-----EDGRI-MAVKKFKLAVDDEELLKLEEFINEIVILSQI-NH 130
LG+G G V K + +AVK K +++L + ++E+ ++ I H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS---DLVSEMEMMKMIGKH 75
Query: 131 RNVVKLLGCCLETEVPLL-------------HLHDHH-----------RNEEFPLTWEIR 166
+N++ LLG C + E PL L R E LT +
Sbjct: 76 KNIINLLGVCTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVT 225
+ A +VA + +L AS HRD+ + N+L+ E + K+ADFG ++ I +D T
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
T + ++ PE T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 57/291 (19%)
Query: 74 NVNRILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ R LGQG G VY+G D G K + L + EF+NE ++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 131 RNVVKLLGCCLETEVPL--LHLHDHHRNEEF---------------PLTWEIRLRIATEV 173
+VV+LLG + + L + L H + + P T + +++A E+
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTF 232
A ++YL++ HRD+ + N ++ + K+ DFG ++ I D K
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
++ PE + T SD++SFGVVL E + S+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWE-------------------------ITSLAEQ 220
Query: 293 HMYDILDDQVVKLV--------KKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ ++QV+K V N +L C N K RPT E+
Sbjct: 221 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 77 RILGQGGQGTVY----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
++LG+G G V KG E + A+KK + +DD+ +E + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD----VECTMVEKRVLALAWENP 56
Query: 133 VVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
+ L C +T+ L H+ D R + + T+ A E+ L +
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQF 111
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
LHS I +RD+K N++LD K+ADFG K +T GT Y+ PE
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEI 167
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKP 267
Q + T D +SFGV+L E+L G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKF---KLAVDDEELLKLEEFINEIVILSQI 128
F R+LG+GG G V + G++ A KK ++ E + L NE IL ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL----NEKQILEKV 57
Query: 129 NHRNVVKLLGCCLETEVPL-----------LHLHDHHRNEE-FPLTWEIR-LRIATEVAG 175
N R VV L ET+ L L H +H E F E R + A E+
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICC 113
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
L LH I +RD+K NILLD+ +++D G + + QT + ++ GT GY+
Sbjct: 114 GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE ++ + T D ++ G +L E++ G+ P
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V + G+ +AVKK L + + E NE+VI+ +H NVV +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL----RKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 138 GCCL---ETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIYHR 191
L E V + L + T +IAT V ALSYLH+ + HR
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHR 142
Query: 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLEPEYHQSSQLTDKS 249
DIKS +ILL R K++DFG F A V + + GT ++ PE +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 250 DVYSFGVVLVELLTGKKPIFS 270
D++S G++++E++ G+ P F+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 55/220 (25%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 75 VNRILGQGGQGTVYKGMLE-DGR---IMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ ++G G G V +G L+ G+ +A+K K +++ +F++E I+ Q +H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDH 64
Query: 131 RNVVKLLGCCLETEVPLLHLHDHHRN-----------EEFPLTWEI-RLRIATEVAGALS 178
N++ L G + P++ + + N +F + + LR +A +
Sbjct: 65 PNIIHLEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMK 120
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTFG--Y 234
YL + HRD+ + NIL++ KV+DFG S+F+ D + T+ + G +
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
PE + T SDV+S+G+V+ E+++ G++P + N
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F + + +G+G VY+ L D + +A+KK ++ + + ++ + EI +L Q+NH
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-FEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 132 NVVKLLGCCLE-TEVPL-LHLHDHHRNEEFPLTWEIRLRIATE---------VAGALSYL 180
NV+K L +E E+ + L L D + ++ + R+ E + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS + HRDIK N+ + K+ D G +F + +T + GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
+ KSD++S G +L E+ + P +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVIL---SQINHRNVV 134
+G G GTVYK G +A+K ++ +E+ L L + E+ +L +H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ-TNEDGLPLST-VREVALLKRLEAFDHPNIV 65
Query: 135 KLLGCCL------ETEVPLL--HLHDHHRN--EEFP---LTWEIRLRIATEVAGALSYLH 181
+L+ C ET+V L+ H+ R ++ P L E + + L +LH
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
+ + I HRD+K NIL+ + K+ADFG ++ + T + T Y PE
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLL 180
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 279
S D++S G + E+ +KP+F GN+ + +
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 73 FNVNRILGQGGQGTV----YKGMLEDGRIMAVKK-FKLAVDDEELLKLEEFINEIVILSQ 127
F +LG+G G V YK E I A+KK +A D+ E L E+ I E +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NS 58
Query: 128 INHRNVVKLLGC-------CLETE-VP----LLHLHDHHRNEEFPLTWEIRLRI-ATEVA 174
H +V L C C E ++H+H + F E R A V
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFS---EPRAVFYAACVV 111
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
L YLH + I +RD+K N+LLD K+ADFG K M T+ GT +
Sbjct: 112 LGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEF 167
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
L PE + T D + GV++ E+L G+ P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 73 FNVNRILGQG--GQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+NV R++G+G G+ + + + D + A+K+ +L + E+ E V+L+++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAV---EDSRKEAVLLAKMKH 57
Query: 131 RNVVKL---------LGCCLE--TEVPLLHLHDHHRNEEFP----LTWEIRLRIATEVAG 175
N+V L +E L+ R + FP L W ++
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCL 111
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
+ ++H + HRDIKS NI L + + K+ DFG+++ + + T + GT Y+
Sbjct: 112 GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE ++ +KSD++S G +L EL T K P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
LGQG G V+ G +A+K K + E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 139 CCLETEV----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
E + LL + L + + A ++A ++Y+
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AAQIADGMAYIERMN---Y 123
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
HRD+++ NIL+ + K+ADFG ++ I ++ + + PE + T K
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 249 SDVYSFGVVLVELLT-GKKP 267
SDV+SFG++L EL+T G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 79 LGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEE----FINEIVILSQINHRNV 133
LG+GG G V ++ G++ A KK D++ LK + +NE IL +++ R +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL-----DKKRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 134 VKLLGCCLETEVPL-----------LHLHDHHRNEE-FPLTWEIRLRI-ATEVAGALSYL 180
V L ET+ L L H ++ E FP E R A ++ L +L
Sbjct: 56 VSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHL 111
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
H I +RD+K N+LLD+ +++D G + + + GT GY+ PE
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVL 166
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKP 267
Q D ++ G L E++ G+ P
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 47/236 (19%)
Query: 75 VNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN----------EIV 123
LG+G G V K G+I+A+KK K+ ++ K + + E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 124 ILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLR------IATEVAGAL 177
I+++I H N++ L+ +E + L + + + + +IRL I ++ L
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG-------------TSKFIAMDQTHV 224
+ LH HRD+ NI ++ + K+ADFG SK M +
Sbjct: 133 NVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 225 TTKIQGTFGYLEPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273
T T Y PE YH + D++S G + ELLTG KP+F N
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTG-KPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYKG + G+I+A+KK +L ++E + I EI +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 138 GCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGAL-------SYLHSAASSPIY- 189
++ L EF L+ +++ + + G SYL+ ++
Sbjct: 66 DVLMQESRLYLIF-------EF-LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 190 ------HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
HRD+K N+L+D + K+ADFG ++ + V T T Y PE S
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGS 176
Query: 244 QL-TDKSDVYSFGVVLVELLTGKKPIF 269
+ D++S G + E+ T KKP+F
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 40/269 (14%)
Query: 81 QGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140
+ Q ++YKG+ + + + ++ FK ++L ++ NEI L +I+ N++K+ G
Sbjct: 30 ENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVL-IDITENEIKNLRRIDSNNILKIYGFI 87
Query: 141 LETEVPL------------LHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
++ L +L + E+ L+++ +L +A + L L+ + P
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS--SQLT 246
++++ S + L+ E Y+ K+ G K ++ K Y + S+ T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
K D+YS GVVL E+ TGK P EN++ + + KN+ L +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPF--------ENLTTKEIYDLIINKNNSLK-LPLDCPLEI 251
Query: 307 KKNQIMAFANLAERCLDLNGKKRPTMEEV 335
K + E C + KRP ++E+
Sbjct: 252 K--------CIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 34/98 (34%), Positives = 44/98 (44%), Gaps = 8/98 (8%)
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
EV + LH I HRDIK N+L+D+ K+ DFG S+ ++ K
Sbjct: 103 IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFV 154
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT YL PE SD +S G V+ E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 79 LGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN---HRNV 133
+G+G G V+K + GR +A+K+ ++ EE + L I E+ +L + H NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLST-IREVAVLRHLETFEHPNV 66
Query: 134 VKLLGCCL------ETEVPLLHLH-DHHRN---EEFP---LTWEIRLRIATEVAGALSYL 180
V+L C ET++ L+ H D ++ P + E + ++ L +L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS + HRD+K NIL+ + K+ADFG ++ + T + T Y PE
Sbjct: 127 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVL 181
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
S D++S G + E+ +KP+F G++
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPLFR-GSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 78 ILGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
++G+G G V K E G+I+A+KKF + DD+ + K+ + EI +L Q+ H N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MREIRMLKQLRHENLVNL 65
Query: 137 LGCCLETEVPLL--HLHDH---HRNEEFP--LTWEIRLRIATEVAGALSYLHSAASSPIY 189
+ + L DH E++P L + ++ + + HS I
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNII 122
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKS 249
HRDIK NIL+ + K+ DFG ++ +A V T T Y PE ++
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 250 -DVYSFGVVLVELLTGKKPIF 269
D+++ G ++ E+LTG +P+F
Sbjct: 182 VDIWAVGCLVTEMLTG-EPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEF-------PLTWEIRLRIATEV 173
EI IL I+HR ++ L+ + + ++ + F PL E + I +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMP-KYKCDLFTYVDRSGPLPLEQAITIQRRL 194
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
AL+YLH I HRD+K+ NI LDE A + DFG + +D T + G G
Sbjct: 195 LEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSG 249
Query: 234 YLE---PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
LE PE K+D++S G+VL E+ +F S
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+ LG G G V+ G + +AVK K + ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRL 66
Query: 137 LGCCLETEVPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASS 186
+ E P+ + ++ E + + + ++A ++Y+
Sbjct: 67 YAVVTKEE-PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---K 122
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
HRD+++ N+L+ E K+ADFG ++ I ++ + + PE T
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 247 DKSDVYSFGVVLVELLT-GKKP 267
KSDV+SFG++L E++T GK P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 66/233 (28%), Positives = 97/233 (41%), Gaps = 40/233 (17%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
+ L T+ + + +G+G G VYK +DG + AVK D +E ++ E I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI--- 71
Query: 123 VILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEI----------------- 165
+ S NH NVVK G + + D + L E+
Sbjct: 72 -LQSLPNHPNVVKFYG--------MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 166 -RLR---IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221
RL I+ + GAL L ++ I HRD+K NILL K+ DFG S + +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 222 THVTTKIQGTFGYLEPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIF 269
T + GT ++ PE Q D S DV+S G+ +EL G P+F
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 34/197 (17%)
Query: 98 MAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL-------- 148
+AVK K DD L + ++E+ ++ I H+N++ LLG C + + PL
Sbjct: 47 VAVKMLK---DDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVLVEYASK 102
Query: 149 -HLHDHHRNEEFP---------------LTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192
+L ++ R P LT++ + A +VA + YL AS HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 193 IKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
+ + N+L+ E K+ADFG ++ + +D TT + ++ PE T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 252 YSFGVVLVELLT-GKKP 267
+SFGV+L E+ T G P
Sbjct: 220 WSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYK G I+A+KK +L +DE + I EI +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 138 -----GCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGALSYLHSAASSPIY 189
L L L + PLT I + ++ ++Y H S +
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVL 121
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTDK 248
HRD+K N+L+D K+ADFG ++ + T ++ T Y PE S Q +
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 249 SDVYSFGVVLVELLTGKKPIFS 270
D++S G + E++ ++P+F
Sbjct: 181 VDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 9/121 (7%)
Query: 147 LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206
+ H+ R +E + A E+ L +LH I +RD+K N+LLD+
Sbjct: 84 MFHIQSSGRFDEARARF-----YAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHI 135
Query: 207 KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKK 266
K+ADFG K M+ + GT Y+ PE + + + D +SFGV+L E+L G+
Sbjct: 136 KIADFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
Query: 267 P 267
P
Sbjct: 195 P 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 32/196 (16%)
Query: 98 MAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC---------------- 140
+AVK K DD L + ++E+ ++ I H+N++ LLG C
Sbjct: 50 VAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 141 -----LETEVP--LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDI 193
L P + + +D R + +T++ + +VA + YL AS HRD+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDL 163
Query: 194 KSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVY 252
+ N+L+ E K+ADFG ++ + +D TT + ++ PE T +SDV+
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 253 SFGVVLVELLT-GKKP 267
SFGV++ E+ T G P
Sbjct: 224 SFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG+G G+VYK + G MA+K+ +L +D+ K + I E+ IL + +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---KFNQIIMELDILHKAVSPYIVDFY 65
Query: 138 GC---------CLE--TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
G C+E L L+ E +R RI V L +L +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEEHN- 123
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
I HRD+K TN+L++ + K+ DFG S + + T I G Y+ PE +S
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGPN 179
Query: 247 D------KSDVYSFGVVLVELLTGKKP 267
+SDV+S G+ ++E+ G+ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 51/217 (23%), Positives = 81/217 (37%), Gaps = 27/217 (12%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+ + K ++AVKK L +E LKL EI+ Q+ H N++
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKL--LQQEIITSRQLQHPNILPY 64
Query: 137 LGCCLE-TEVPLLH----------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+ + +E+ ++ L H E P I I +V AL Y+HS
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAF-ILKDVLNALDYIHSKG- 121
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHV-----TTKIQGTFGYLEPEY 239
HR +K+++ILL + ++ S I + +L PE
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 240 HQSSQL--TDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
Q + +KSD+YS G+ EL G P T
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 78/254 (30%), Positives = 107/254 (42%), Gaps = 53/254 (20%)
Query: 52 DSVIDR-CKLFSSK-ELDKAT-----NHFNVNRILGQGGQGTV-YKGMLEDGRIMAVKKF 103
D++I R C+ F D+AT + ++R+LG G GTV + DG AVK
Sbjct: 6 DAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVK-- 63
Query: 104 KLAVDDEELLKLEEFIN----EIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEF 159
VD E + + + N E+ L + ++VK C E RN E
Sbjct: 64 --VVDMEGMSEAD--KNRAQAEVCCLLNCDFFSIVK----CHEDFA-----KKDPRNPEN 110
Query: 160 --------------PLTWEIRLRIAT------EVAG-----ALSYLHSAASSPIYHRDIK 194
L EI+ R T AG L +H S + HRDIK
Sbjct: 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK 170
Query: 195 STNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYS 253
S NILL K+ DFG SK + A V GT Y+ PE + + K+D++S
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 254 FGVVLVELLTGKKP 267
GV+L ELLT K+P
Sbjct: 231 LGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 72 HFNVNRILGQGGQGTV----YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
+ + + LGQG G V E+ + A+KK + L K + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAK--RALRELKLLRH 57
Query: 128 I-NHRNVVKLL-----------GCCLETEVPLLHLHDHHRNEEFPLT-WEIRLRIATEVA 174
H+N+ L L E+ LH R+ + PLT + I +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-PLTDAHFQSFIYQILC 116
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---T 231
G L Y+HSA + HRD+K N+L++ K+ DFG ++ + + + T
Sbjct: 117 G-LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 232 FGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
Y PE S Q K+ DV+S G +L ELL G+KP+F
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 45/118 (38%), Positives = 57/118 (48%), Gaps = 8/118 (6%)
Query: 154 HRNEEFPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212
R FP E R R A E+A AL YLHS I +RD+K NILLD + + DFG
Sbjct: 88 QRERSFP---EPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFG 141
Query: 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
K + Q+ TT GT YL PE + + D + G VL E+L G P +
Sbjct: 142 LCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 42/186 (22%), Positives = 81/186 (43%), Gaps = 21/186 (11%)
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR--------NEEFPLTWEIRLRIATE 172
E ++L +NH +V+++ + + + L H+ PL + L I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVL-PHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+ L YLH+ I HRD+K+ NI +++ + + D G ++F + + + GT
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAGTV 220
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
PE + K+D++S G+VL E+L IF ++ E + +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSC-------HS 273
Query: 293 HMYDIL 298
H+ I+
Sbjct: 274 HLLKII 279
|
Length = 357 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 41/223 (18%)
Query: 71 NHFNVNRILGQGGQGTVYKGML-EDGRIM--AVKKFK-LAVDDEELLKLEEFINEIVILS 126
N ++G+G G V K + +DG M A+K+ K A D+ +F E+ +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLC 62
Query: 127 QIN-HRNVVKLLGCC-------LETE-VPLLHLHDHHRN----EEFP-----------LT 162
++ H N++ LLG C L E P +L D R E P L+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 163 WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
+ L A +VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ Q
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 175
Query: 223 HVTTKIQGTFG--YLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
K G ++ E S T SDV+S+GV+L E+++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 35/229 (15%)
Query: 69 ATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
+ + LG+G G VYK ++ GR++A+KK L ++++ + EI IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITAL-REIKILKK 63
Query: 128 INHRNVVKLLGCCLETEVPLLHLH----------DHH-----RNEEFPLTW-EIRLRIAT 171
+ H NVV L+ +E DH N LT +I+ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG----------TSKFIAMDQ 221
+ G ++YLH I HRDIK+ NIL+D + K+ADFG K
Sbjct: 124 LLEG-INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 222 THVTTKIQGTFGYLEPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
T T + T Y PE + T D++ G V E+ T +PI
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 20/225 (8%)
Query: 72 HFNVNRILGQGGQGTVY-----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+F + ++LG G G V+ G + G++ A+K K A ++ E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 127 QINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIAT--------EVAGALS 178
I + L +T+ L + D+ E R R E+ AL
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+LH I +RDIK NILLD + DFG SK D+ GT Y+ P+
Sbjct: 120 HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 239 YHQSSQLT-DKS-DVYSFGVVLVELLTGKKPIFSTGN-TSQENVS 280
+ DK+ D +S GV++ ELLTG P G SQ +S
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 48/124 (38%), Positives = 63/124 (50%), Gaps = 13/124 (10%)
Query: 149 HLHDHHRNEEFPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207
HL R FP E R R A E+A AL YLHS I +RD+K NILLD +
Sbjct: 86 HLQ---RERSFP---EPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVV 136
Query: 208 VADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKK 266
+ DFG K ++ + T+ GT YL PE + Q D++ D + G VL E+L G
Sbjct: 137 LTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLP 194
Query: 267 PIFS 270
P +S
Sbjct: 195 PFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 75 VNRILGQGGQGTVYKGMLE-DGR---IMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ +++G G G V G L+ G+ +A+K K +++ +F++E I+ Q +H
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDH 64
Query: 131 RNVVKLLGCCLETEVPLLHLHDHHRN---EEFPLTWEIRLRIATEV------AGALSYLH 181
N++ L G +++ P++ + ++ N + F + + + V A + YL
Sbjct: 65 PNIIHLEGVVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL- 122
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLEPEY 239
+ HRD+ + NIL++ KV+DFG S+ + D T G + PE
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 240 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
+ T SDV+S+G+V+ E+++ G++P + N
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 39/215 (18%)
Query: 78 ILGQGGQGTVYKGMLE-DGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNV 133
++G+G G V + M++ DG M A+K K + + +F E+ +L ++ +H N+
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFAGELEVLCKLGHHPNI 65
Query: 134 VKLLGCC-------LETE-VPLLHLHDHHRN----EEFP-----------LTWEIRLRIA 170
+ LLG C + E P +L D R E P LT + L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
++VA + YL + HRD+ + N+L+ E +K+ADFG S+ ++ +V K G
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMG 178
Query: 231 TFG--YLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
++ E S T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKF---KLAVDDEELLKLEEFINEIVILSQI 128
F R+LG+GG G V + G++ A KK ++ E + L NE IL ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKQILEKV 57
Query: 129 NHRNVVKLLGCCLETEVPL-----------LHLHDHHR-NEEFPLTWEIR-LRIATEVAG 175
N R VV L ET+ L L H ++ N F E R + A E+
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITC 113
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
L LH I +RD+K NILLD+ +++D G + I +T + ++ GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE ++ + T D + G ++ E++ GK P
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 79 LGQGGQGTVYKGMLEDGR-IMAVKKFKLAVDDEELLKLEEFI-NEIVILSQINHRNVVKL 136
+G G G V+ A+K +A+ + LK E+ + NE +L +++H +++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 137 LGC--------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
L VP L + RN + L A+E+ AL YLHS I
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKE---I 122
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDK 248
+RD+K NILLD+ K+ DFG +K + D+T + GT YL PE QS
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVIQSKGHNKA 178
Query: 249 SDVYSFGVVLVELLTGKKPIF 269
D ++ G+++ E+L G P F
Sbjct: 179 VDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 78 ILGQGGQGTVYKGMLED-GRIMAVK---KFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
I+G+GG G VY D G++ A+K K ++ + E L L NE ++LS ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56
Query: 134 VKLLGCCLETEVP-----LLHLHD----HHRNEEFPLTWEIRLRI-ATEVAGALSYLHSA 183
++ P +L L + H+ + + E +R ATE+ L ++H+
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
+ +RD+K NILLDE +++D G + + + H + GT GY+ PE Q
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 244 QLTDKS-DVYSFGVVLVELLTGKKP 267
D S D +S G +L +LL G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 77 RILGQGGQGT---VYKGM-LEDGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQIN-H 130
+ILG+ G+GT V K + G+ A+K K E++ L EI L +++ H
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSPH 57
Query: 131 RNVVKLLGCCLET---------EVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+++L+ + E+ ++L++ + + PL + ++ +L ++H
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
+ I+HRDIK NIL+ + K+ADFG+ + I + T+ T Y PE
Sbjct: 118 R---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE--- 168
Query: 242 SSQLTD-----KSDVYSFGVVLVELLTGKKPIF 269
LTD K D+++ G V E+L+ P+F
Sbjct: 169 -CLLTDGYYGPKMDIWAVGCVFFEILS-LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 73/277 (26%), Positives = 113/277 (40%), Gaps = 39/277 (14%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F + + +G G G VYK + G + A+K KL ++ EI+++ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED----FAVVQQEIIMMKDCKHS 66
Query: 132 NVVKLLGCCLETEVPLL--------HLHD-HHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
N+V G L + + L D +H PL+ ++ E L YLHS
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE---Y 239
HRDIK NILL + K+ADFG S I + I GT ++ PE
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAV 180
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ D+++ G+ +EL + P+F +H MR + +
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMTKSN 225
Query: 300 DQVVKLVKKNQ-IMAFANLAERCLDLNGKKRPTMEEV 335
Q KL K + +F + + L N KKRPT E++
Sbjct: 226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 77 RILGQGGQGTVY----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
++LG+G G V KG E I +KK + DD+ ++ + E IL+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD----VDCTMTEKRILALAAKHP 56
Query: 133 VVKLLGCCLETEVPLLHLHDH----------HRNEEFPLTWEIRLRI-ATEVAGALSYLH 181
+ L CC +T+ L + ++ R+ +F E R R A EV AL +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD---EPRSRFYAAEVTLALMFLH 113
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
+ +RD+K NILLD K+ADFG K + TT GT Y+ PE Q
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKP 267
+ D ++ GV++ E++ G+ P
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 81/303 (26%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEE---FIN 120
++L ++V +++G+G G V ++ V KL + E++K + F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKL-LSKFEMIKRSDSAFFWE 92
Query: 121 EIVILSQINHRNVVKLLGCCLETE---------VPLLHLHDHHRNEEFPLTWEIRLRIAT 171
E I++ N VV+L C + + +P L + N + P W + A
Sbjct: 93 ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-KFYTA- 149
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKI 228
EV AL +HS + HRD+K N+LLD+ K+ADFGT + MD+T T +
Sbjct: 150 EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV 204
Query: 229 QGTFGYLEPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
GT Y+ PE +S + D +S GV L E+L G P ++ SL
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--------SLVGT 255
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNG----KKRPTMEEVTMELN 340
+ M + + +D + KN I AF E L NG K+ P + +
Sbjct: 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWD 315
Query: 341 GIR 343
IR
Sbjct: 316 NIR 318
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 41/108 (37%), Positives = 53/108 (49%), Gaps = 5/108 (4%)
Query: 164 EIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
E R R A EVA A+ YLHS I +RD+K NILLD + + DFG K ++
Sbjct: 95 EPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPE 150
Query: 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
T+ GT YL PE + D + G VL E+L G P +S
Sbjct: 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/230 (29%), Positives = 95/230 (41%), Gaps = 48/230 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEE---FINEIVILS 126
F + +GQGG G V+ +D G I+A+K+ K L KL E + E IL+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILT 56
Query: 127 QINHRNVVKLLGCCLETE--------VP------LLH----LHDHHRNEEFPLTWEIRLR 168
+VKLL + E VP LL+ L + H R
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFY 106
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTK 227
+A E+ A+ LH HRD+K N L+D K+ DFG SK + + V
Sbjct: 107 MA-EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV--- 159
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
G+ Y+ PE + D +S G +L E L G P FS G+T E
Sbjct: 160 --GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP-FS-GSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 62/249 (24%), Positives = 114/249 (45%), Gaps = 45/249 (18%)
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH------------HRNEEFPLTWE 164
+F+ EI I+S++ N+++LL C+ ++ PL + ++ H +E +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 165 IR-------LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217
+ + +AT++A + YL +S HRD+ + N L+ + Y K+ADFG S+ +
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 218 AMDQTHVTTKIQG----TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272
+ +IQG ++ E + T SDV++FGV L E+LT K+ +S
Sbjct: 181 YSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 273 NTSQENVSLAAFFVHSMRKNHMYD--ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP 330
+ Q + FF R+ ++ + D + KL+ C N K+RP
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS------------CWRRNAKERP 285
Query: 331 TMEEVTMEL 339
+ +E+ L
Sbjct: 286 SFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 32/174 (18%)
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEF----------------- 159
+F+ E+ ILS++ N+++LLG C++ + PL + ++ N +
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 160 ----------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209
+++ L +A ++A + YL +S HRD+ + N L+ E K+A
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 210 DFGTSK-FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELL 262
DFG S+ A D + + ++ E + T SDV++FGV L E+L
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 27/201 (13%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V+K E G+I+A+KKF + DD + K+ + EI +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66
Query: 138 GCCLETEV----PLLHL----HDH---HRNEEFP--LTWEIRLRIATEVAGALSYLHSAA 184
EV LHL DH + E+ P + + +I + A+++ H
Sbjct: 67 ------EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-- 118
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH-QSS 243
HRD+K NIL+ ++ + K+ DFG ++ + T + T Y PE +
Sbjct: 119 -HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDT 176
Query: 244 QLTDKSDVYSFGVVLVELLTG 264
Q DV++ G V ELLTG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 98 MAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLHL------ 150
+AVK K D++L L I+E+ ++ I H+N++ LLG C + E PL +
Sbjct: 47 VAVKMLKDNATDKDLADL---ISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAK 102
Query: 151 ------------------HDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192
D + E L+++ + A +VA + YL S HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRD 159
Query: 193 IKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
+ + N+L+ E K+ADFG ++ + +D T+ + ++ PE T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 252 YSFGVVLVELLT-GKKP 267
+SFG+++ E+ T G P
Sbjct: 220 WSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 78 ILGQGGQGTVYKGMLE-DGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHR-NV 133
++G+G G V K ++ DG M A+K+ K ++ +F E+ +L ++ H N+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNI 58
Query: 134 VKLLGCC-------LETE-VPLLHLHDHHRNEEF---------------PLTWEIRLRIA 170
+ LLG C L E P +L D R L+ + L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
+VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ + +V K G
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMG 171
Query: 231 TFG--YLEPEYHQSSQLTDKSDVYSFGVVLVELLT 263
++ E S T SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 56/178 (31%), Positives = 75/178 (42%), Gaps = 23/178 (12%)
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215
N + P W R A EV AL +HS HRD+K N+LLD+ K+ADFGT
Sbjct: 136 NYDIPEKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC- 189
Query: 216 FIAMDQT---HVTTKIQGTFGYLEPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPI 268
+ MD T + GT Y+ PE +S + D +S GV L E+L G P
Sbjct: 190 -MKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNG 326
++ SL + M + DD + K+ I AF E L NG
Sbjct: 248 YAD--------SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG 297
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 79 LGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIV---ILSQINHRNVV 134
LG+GG G V M G++ A KK ++ + L K + + +V IL++++ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK----LNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 135 KLLGCCLETEVPL-----------LHLHDHHRNEEFPLTWEIR-LRIATEVAGALSYLHS 182
L +T+ L L H ++ +EE P E R ++ L +LH
Sbjct: 57 SL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I +RD+K N+LLD +++D G + + Q+ T GT G++ PE Q
Sbjct: 116 ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
+ D ++ GV L E++ + P + G
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYK G ++A+KK +L + E + I EI +L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 138 GCCLETEVPLL----HLH-------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
+ TE L LH D PL I+ + + G L++ H S
Sbjct: 66 D-VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLP-LIKSYLFQLLQG-LAFCH---SH 119
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL- 245
+ HRD+K N+L++ K+ADFG ++ + T ++ T Y PE +
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYY 178
Query: 246 TDKSDVYSFGVVLVELLTGK 265
+ D++S G + E++T +
Sbjct: 179 STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G GTV+K E I+A+K+ +L DDE + + EI +L ++ H+N+V+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVR-- 63
Query: 138 GCCLETEVPLLHLHD-HHRNEEFPLTWE------------IRLRIATEVAGA-------- 176
L+D H +++ L +E I E+ +
Sbjct: 64 ------------LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L++ H S + HRD+K N+L+++ K+ADFG ++ + + ++ T Y
Sbjct: 112 LAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRP 167
Query: 237 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
P+ ++L S D++S G + EL +P+F
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVV 134
+G+G G VYK G+++A+KK +L +D+E + L E I+ + +LS+ + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLSESIY--IV 64
Query: 135 KLLGCCLETEV----PLLHL-------------HDHHRNEEFPLTWEIRLRIATEVAGAL 177
+LL E P L+L + R PL + ++ +
Sbjct: 65 RLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 178 SYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
++ H + HRD+K N+L+D ++ K+AD G + ++ T +I T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRA 179
Query: 237 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
PE S+ + D++S G + E+ K+P+F
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 49/226 (21%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKK---FKLAVDDEELLKLEEFINEIVILSQ 127
+ +G+G G V G +A+KK F + + + EI IL +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-----EHQTFCQRT-LREIKILRR 59
Query: 128 INHRNVVKLLG-----------------CCLETEVPLL----HLHDHHRNEEFPLTWEIR 166
H N++ +L +ET++ L HL + H ++I
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY---FLYQI- 115
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM--DQTHV 224
LR L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D T
Sbjct: 116 LR-------GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
T+ T Y PE +S+ K+ D++S G +L E+L+ +P+F
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 34/197 (17%)
Query: 98 MAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL-------- 148
+AVK K +++L + I+E+ ++ I H+N++ LLG C + + PL
Sbjct: 53 VAVKMLKSDATEKDL---SDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 108
Query: 149 -HLHDHHRNEEFP---------------LTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192
+L ++ R P L+++ + A +VA + YL AS HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRD 165
Query: 193 IKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251
+ + N+L+ E K+ADFG ++ I +D TT + ++ PE T +SDV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 252 YSFGVVLVELLT-GKKP 267
+SFGV+L E+ T G P
Sbjct: 226 WSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 37/98 (37%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+ A YLHS I +RD+K N+LLD + KV DFG +K + T + GT
Sbjct: 126 ELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGT 178
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
YL PE QS D ++ GV+L E + G P F
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 77 RILGQGGQGTVYKGMLED-GRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
R++G+G V L+ RI A+K K +L DDE++ ++ E + Q ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASNHPF 57
Query: 134 VKLLGCCLETEVPLLHLHDH--------HRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+ L C +TE L + ++ H + L E + E++ AL+YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 116
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 246 TDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
D ++ GV++ E++ G+ P G++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 83 GQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL-- 136
G+G+ K +L EDG+ +K+ ++ + + EE E+ +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPK--EREESRKEVAVLSNMKHPNIVQYQE 66
Query: 137 ----LGC-------CLETEVPLLHLHDHHRNEEFP----LTWEIRLRIATEVAGALSYLH 181
G C + L + R FP L W +++ +A L ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGD--LYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
I HRDIKS NI L + K+ DFG ++ + T I GT YL PE +
Sbjct: 119 D---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273
+ +KSD+++ G VL E+ T K F GN
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHA-FEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 56/177 (31%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 164 EIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
E R R A E+A AL YLHS I +RD+K NILLD + + DFG K ++
Sbjct: 95 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHN 150
Query: 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282
T+ GT YL PE D + G VL E+L G P +S NT++
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAE------ 203
Query: 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
MYD + ++ ++L K N + +L E L + KR ++ ME+
Sbjct: 204 -----------MYDNILNKPLQL-KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 38/196 (19%)
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLLHL-------HDHHRNEE--FPLTWEIR- 166
+ + E+ ++ ++ H+N+V+ + L L++ D RN + + + +I
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 167 ---LRIATEVAGALSYLHSAASSP----IYHRDIKSTNILLDERYR-------------- 205
+ I ++ AL+Y H+ P + HRD+K NI L R
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 206 ---AKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY--HQSSQLTDKSDVYSFGVVLVE 260
AK+ DFG SK I ++ + GT Y PE H++ DKSD+++ G ++ E
Sbjct: 178 RPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 261 LLTGKKPIFSTGNTSQ 276
L +GK P N SQ
Sbjct: 236 LCSGKTPFHKANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 30/214 (14%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKK----FKLAVDDEELLKLEEFINEIVI 124
TN + + +G G G V G+ +A+KK F V + + E+ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR------ELKL 62
Query: 125 LSQINHRNVVKLLGCCLE--------TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGA 176
L + H N++ L + TE LL H PL + ++
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTE--LLGTDLHRLLTSRPLEKQFIQYFLYQILRG 120
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L Y+HSA + HRD+K +NIL++E K+ DFG ++ Q T T Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRA 173
Query: 237 PEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIF 269
PE + Q D + D++S G + E+L G KP+F
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 23/225 (10%)
Query: 73 FNVNRILGQGGQGTVY----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
F + ++LG G G V+ + G++ A+K + A ++ +E E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 129 NHRNVVKLLGCCLETEVPLLHLHDH----------HRNEEFPLTWEIRLRI-ATEVAGAL 177
+ L +TE L + D+ ++ + F E +R + E+ AL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILAL 118
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+LH I +RDIK NILLD + DFG SK ++ T GT Y+ P
Sbjct: 119 EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 238 EYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGN-TSQENVS 280
E + K+ D +S G+++ ELLTG P G +Q VS
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAV----DDEELLKLEEFINEIVILSQINHR 131
++LG+G G V+ L+ + A+K K V DD E +E+ +LS
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEK-----RVLSLAWEH 55
Query: 132 NVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
+ L C +T+ L H+ H+ + T+ A E+ L
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEIICGLQ 110
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+LHS I +RD+K NILLD K+ADFG K + T GT Y+ PE
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPE 166
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ D +SFGV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 79 LGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
LG+ G VYKG L E + +A+K K D E EEF +E ++ S++ H N
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK---DKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 133 VVKLLGCCLETE--------VPLLHLH---------------DHHRNEEFPLTWEIRLRI 169
+V LLG + + LH D + + L + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 228
T++A + +L +S + H+D+ + N+L+ ++ K++D G + + A D +
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
++ PE + + SD++S+GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 77 RILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G G V + GR +A+KK K E+ +L ++H NV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK--RTYRELRLLKHMDHENVIG 78
Query: 136 LLGC-----CLE--TEVPLL-HLHD---HHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
LL LE +V L+ HL ++ + L+ + + ++ L Y+HSA
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG 138
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPE----- 238
I HRD+K +NI ++E K+ DFG ++ + T +V T+ Y PE
Sbjct: 139 ---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 190
Query: 239 --YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
Y+Q+ D++S G ++ ELLTG K +F
Sbjct: 191 MHYNQT------VDIWSVGCIMAELLTG-KTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 53/233 (22%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 55 IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKF--KLAVDDEEL 112
I R + + +L + +G G ++ G+L D + ++ K D
Sbjct: 3 ISRDR-VTLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE 49
Query: 113 LKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVPL-LHLHDHHRN--------EEFPLT 162
+++ + E +L ++H+N++ +L C+E E P L+ + + N
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 163 WEIRLR------IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK- 215
L +A ++A +SYLH + H+DI + N ++DE + K+ D S+
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
MD + ++ E + + + SDV+SFGV+L EL+T G+ P
Sbjct: 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 78 ILGQGGQGTVYKGMLED-GRIMAVK---KFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
I+G+GG G VY D G++ A+K K ++ + E L L NE ++LS ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56
Query: 134 VKLLGCCLETEVP-----LLHLHD----HHRNEEFPLTWEIRLRI-ATEVAGALSYLHSA 183
++ P +L L + H+ + + E +R A E+ L ++H+
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
+ +RD+K NILLDE +++D G + + + H + GT GY+ PE Q
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 244 QLTDKS-DVYSFGVVLVELLTGKKP 267
D S D +S G +L +LL G P
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 42/201 (20%)
Query: 152 DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211
+ + +PL + LR +++VA + +L AS HRD+ + N+LL + AK+ DF
Sbjct: 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDF 256
Query: 212 GTSKFIAMDQTHVTTKIQGT----FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
G ++ I D +V ++G ++ PE T +SDV+S+G++L E
Sbjct: 257 GLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE------- 306
Query: 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA---FA-----NLAE 319
IFS G + + +++ + K+VK+ M+ FA ++ +
Sbjct: 307 IFSLGKSPYPGI-----------------LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK 349
Query: 320 RCLDLNGKKRPTMEEVTMELN 340
C +L +RPT +++ +
Sbjct: 350 MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
+ + LG G G V+ +AVK K + +E F+ E ++ + H
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDK 62
Query: 133 VVKLLGCCLETEVPLL-------HLHDHHRNEE---FPLTWEIRLRIATEVAGALSYLHS 182
+VKL + + ++ L D +++E PL I + ++A ++++
Sbjct: 63 LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQ 120
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
HRD+++ NIL+ K+ADFG ++ I ++ + + PE
Sbjct: 121 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 243 SQLTDKSDVYSFGVVLVELLT-GKKP 267
T KSDV+SFG++L+E++T G+ P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKF---KLAVDDEELLKLEEFINEIVILSQI 128
F R+LG+GG G V + G++ A KK ++ E + L NE IL ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKRILEKV 57
Query: 129 NHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIR-LRIATEVAGALS 178
N R VV L ET+ L L H N P E R + A E+ L
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
L I +RD+K NILLD+R +++D G + I +T V ++ GT GY+ PE
Sbjct: 117 DLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPE 171
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ + T D + G ++ E++ G+ P
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 33/213 (15%)
Query: 75 VNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQIN 129
+NRI +G G VY+ + G I+A+KK K+ ++E E F + EI IL ++
Sbjct: 10 LNRI-EEGTYGVVYRARDKKTGEIVALKKLKM---EKEK---EGFPITSLREINILLKLQ 62
Query: 130 HRNVVKL----LGCCLET--------EVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
H N+V + +G L+ E L L + + + F L E++ + ++ +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPF-LQSEVKC-LMLQLLSGV 119
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
++LH + I HRD+K++N+LL+ R K+ DFG ++ T++ T Y P
Sbjct: 120 AHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAP 175
Query: 238 E-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
E + + + D++S G + ELLT KKP+F
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 228
A E+A L +LHS I +RD+K N++LD K+ADFG K TT+
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTF 161
Query: 229 QGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 267
GT Y+ PE + Q KS D ++FGV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 59/185 (31%), Positives = 82/185 (44%), Gaps = 39/185 (21%)
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT---TKIQGTF 232
AL Y+H+A ++HRD+K NIL + + K+ DFG ++ +A + T T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170
Query: 233 GYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFS--------------TGNTSQ 276
Y PE S S+ T D++S G + E+LTG KP+F G S
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 277 ENVSL-----AAFFVHSMRKNHMYDILDDQVVKLVKK--NQIMAFANLAERCLDLNGKKR 329
E +S A ++ SMRK Q V +K N L ER L + K R
Sbjct: 230 ETISRVRNEKARRYLSSMRKK--------QPVPFSQKFPNADPLALRLLERLLAFDPKDR 281
Query: 330 PTMEE 334
PT EE
Sbjct: 282 PTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 71 NHFNVNRILGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N F V ++G+G G V K E I+A+KKFK + ++EE+ E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK--ETTLRELKMLRTLK 58
Query: 130 HRNVVKL---------LGCCLE-TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
N+V+L L E E +L L + N P ++ + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE------KVRSYIYQLIKA 112
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+H + I HRDIK N+L+ K+ DFG ++ ++ T+ T Y PE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ D++S G +L EL G +P+F
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG-QPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 228
A E+A L +LHS I +RD+K N++LD K+ADFG K D VTTK
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTF 161
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT Y+ PE D ++FGV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G G V + G+ +A+KK A D L K + E+ IL H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK--RTLRELKILRHFKHDNIIA 68
Query: 136 LLGCCLETEVPL--------------LHLHDHHRNEEFPLTWE-IR------LRIATEVA 174
+ L LH H H ++ PLT E IR LR
Sbjct: 69 IRDI-LRPPGADFKDVYVVMDLMESDLH-HIIHSDQ--PLTEEHIRYFLYQLLR------ 118
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGT 231
L Y+HSA + HRD+K +N+L++E ++ DFG ++ ++ + + T+ T
Sbjct: 119 -GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 232 FGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIF 269
Y PE S + T D++S G + E+L G++ +F
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 52/213 (24%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFI------NEIV-------IL 125
LG+G GTVY +++D K AV +E L L+E NE V +L
Sbjct: 8 LGKGSFGTVY--LVKD---------KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL 56
Query: 126 SQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEE-FP----LTWEIRLR 168
S+++H +VK LE + + L + + W I+L
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
+ + Y+H I HRD+K+ NI L K+ DFG S+ + M + T
Sbjct: 117 LG------VHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTF 165
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVEL 261
GT Y+ PE + KSD++S G +L E+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G VYK +A+KK +L +DE + I EI +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 138 GCC-------LETEVPLLHLHDHHRNE-EFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189
L E L L H + +F + ++ ++Y HS +
Sbjct: 68 DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVL 124
Query: 190 HRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTD 247
HRD+K N+L+D R A K+ADFG ++ + T ++ T Y PE S +
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 248 KSDVYSFGVVLVELLTGKKPIF 269
D++S G + E++ +KP+F
Sbjct: 184 PVDIWSVGCIFAEMVN-QKPLF 204
|
Length = 294 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 54/175 (30%), Positives = 72/175 (41%), Gaps = 17/175 (9%)
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215
N + P W R A EV AL +HS HRD+K N+LLD+ K+ADFGT
Sbjct: 136 NYDVPEKWA-RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFST 271
+ + GT Y+ PE +S + D +S GV L E+L G P ++
Sbjct: 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNG 326
SL + M + DD + KN I AF E L NG
Sbjct: 251 --------SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 297
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 63/250 (25%), Positives = 96/250 (38%), Gaps = 60/250 (24%)
Query: 73 FNVNRILGQGGQGTVYKG-MLEDGRIMAVKKFKLAVDDEELLKLEE---FINEIVILSQI 128
F V +++G+G G V+ + G++ A+K + +++K + E IL+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILADA 58
Query: 129 NHRNVVKLLGCCLETE---------VP----LLHLHDHHRNEEFPLTWEIRLRIATEVAG 175
+ +VKL + E +P + L FP R IA E+
Sbjct: 59 DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-ARFYIA-ELVL 112
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------------------F 216
AL +H HRDIK NIL+D K+ADFG K F
Sbjct: 113 ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 217 IAMDQTHVTTKIQ---------GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
Q GT Y+ PE + + + D +S GV+L E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 268 IFSTGNTSQE 277
+S +T QE
Sbjct: 230 FYS--DTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTHVTTKIQGT 231
AL +HS + HRD+KS NI L K+ DFG SK +++D V + GT
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGT 234
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
YL PE + + + K+D++S GV+L ELLT +P
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 47/222 (21%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE-DGR---IMAVKKFKLAVDDEELLKLEEFIN 120
ELD + + RILG G G + +G L+ + +A+ + D++ F+
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLA 55
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATE 172
E + L Q +H N+V+L G ++ L R E L + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+A + YL + H+ + + +L++ K++ F + + + T +
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
+ PE Q + SDV+SFG+V+ E+++ G++P +
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 77 RILGQGGQGTV-YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
R++G+G G V DG+ +KK L K E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63
Query: 136 --------------LLGCCLETEVPLLHLHDHHRNEEFP----LTWEIRLRIATEVAGAL 177
++G C + L H + + P + W + ++A AL
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGD--LYHKLKEQKGKLLPENQVVEWFV------QIAMAL 115
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
YLH I HRD+K+ N+ L KV D G ++ + +Q + + + GT Y+ P
Sbjct: 116 QYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSP 171
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGK 265
E + KSDV++ G + E+ T K
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 164 EIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
E R R E+ AL YLHS I +RD+K N++LD+ K+ DFG K D
Sbjct: 94 EDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA 150
Query: 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
+ T GT YL PE + + D + GVV+ E++ G+ P ++
Sbjct: 151 TMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 61/231 (26%), Positives = 113/231 (48%), Gaps = 42/231 (18%)
Query: 65 ELDKATNH-FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN-E 121
+++++ N + + I+G G G VY+ + ++ +A+KK +L+ ++ N E
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK---------VLQDPQYKNRE 109
Query: 122 IVILSQINHRNVVKL-----------------LGCCLETEVPLLHLHDHH---RNEEFPL 161
++I+ +NH N++ L L +E +H + H N PL
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL 169
Query: 162 TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMD 220
+ ++L + ++ AL+Y+HS I HRD+K N+L+D + K+ DFG++K +
Sbjct: 170 -FLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 221 QTHVTTKIQGTFGYLEPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
Q V+ I F Y PE ++ T D++S G ++ E++ G PIFS
Sbjct: 225 QRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFS 272
|
Length = 440 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG+G TVYKG G I+A+K+ L D E I EI ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHL---DAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 138 GCCLETEVPLLHLHDHHRNEEFPLTWEIR-LRIATEVAGALSYLHS-------AASSPIY 189
+ TE L+ + ++ + + +R A + S+ + + +
Sbjct: 65 DV-IHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKS 249
HRD+K N+L+++R K+ADFG ++ + + ++ T Y P+ S+ S
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 250 -DVYSFGVVLVELLTGKKPIFSTGNTSQE 277
D++S G ++ E++TG +P+F G +++
Sbjct: 182 IDIWSVGCIMAEMITG-RPLF-PGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKF---KLAVDDEELLKLEEFINEIVILSQI 128
F R+LG+GG G V + G++ A K+ ++ E + L NE IL ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL----NEKQILEKV 57
Query: 129 NHRNVVKLLG--------CCLETEVPLLHLHDHHRNEEFPLTWEIR-LRIATEVAGALSY 179
N + VV L C + T + L H N P E R L A E+ L
Sbjct: 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
LH +RD+K NILLD+ +++D G + + + + GT GY+ PE
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEV 172
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ + T D + G ++ E++ G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+ AL YLHS + +RDIK N++LD+ K+ DFG K D + T GT
Sbjct: 103 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 158
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
YL PE + + D + GVV+ E++ G+ P ++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 160 PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
PLT E + + +VA + +L AS HRD+ + NILL E K+ DFG ++ I
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 220 DQTHVTT-KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
D +V + ++ PE T +SDV+SFGV+L E IFS G +
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-------IFSLGASPYPG 279
Query: 279 VSLAAFFVHSMR 290
V + F ++
Sbjct: 280 VQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 25/169 (14%)
Query: 120 NEIVILSQINHRNVVKLLGCC-------LETEVPLLHLHDHHRNEEF-----PLTWEIRL 167
NEI+ L ++NH N++K+ + T+ L+ +E F PL + R
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR- 270
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
I ++ A+ Y+H + HRDIK NI L+ + + DFGT+ ++
Sbjct: 271 AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT---------GKKP 267
GT PE + +D++S G++L+++L+ G KP
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
|
Length = 501 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 67/285 (23%)
Query: 84 QGTVYKGMLEDGRIMAVKKFK-LAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142
G ++GM R++ VK+ + A DE+LL F+ E+ ++NH NV++ LG C+E
Sbjct: 13 LGEAHRGM-SKARVV-VKELRASATPDEQLL----FLQEVQPYRELNHPNVLQCLGQCIE 66
Query: 143 TEVPLL---------HLHDHHRNEEFPLTW----EIRLRIATEVAGALSYLHSAASSPIY 189
+ +P L L ++ R+ + ++ R+A EVA L +LH A
Sbjct: 67 S-IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FI 122
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLEPEYHQSSQ--- 244
H D+ N L K+ D+G + + + TK +L PE +
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 245 ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
T KS+++S GV + EL T + + S E V + ++ +
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYP--DLSDEQV--------------LKQVVRE 225
Query: 301 QVVKLVKKN----------QIMAFANLAERCLDLNGKKRPTMEEV 335
Q +KL K ++M F C L+ + RPT EEV
Sbjct: 226 QDIKLPKPQLDLKYSDRWYEVMQF------CW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+ AL YLHS + +RD+K N++LD+ K+ DFG K D + T GT
Sbjct: 103 EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 158
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
YL PE + + D + GVV+ E++ G+ P ++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 47/234 (20%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRN 132
+GQG G V+K + +I+A+KK + +++E+ E F + EI IL + H N
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEK----EGFPITALREIKILQLLKHEN 72
Query: 133 VVKLLGCCLETEVP----------LLHLHDH-------HRNEEFPLTWEIRLRIATEVAG 175
VV L+ C P + +H ++N +F L+ EI+ ++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS-EIK-KVMKMLLN 130
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM---DQTHVTTKIQGTF 232
L Y+H + I HRD+K+ NIL+ + K+ADFG ++ ++ + + T T
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 233 GYLEPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
Y PE L ++ D++ G ++ E+ T + PI GNT Q ++L
Sbjct: 188 WYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQ-GNTEQHQLTL 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 77 RILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
R LG G G V+ + D + +AVKK + + D + +K + EI I+ +++H N+VK
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQSVK--HALREIKIIRRLDHDNIVK 66
Query: 136 L---LGC-----------------------CLETEVPLLHLHDHHRNEEFPLTWEIRLRI 169
+ LG +ET++ + E L LR
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR- 125
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKI 228
L Y+HSA + HRD+K N+ ++ E K+ DFG ++ + +H
Sbjct: 126 ------GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 229 QG--TFGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273
+G T Y P + T D+++ G + E+LTG KP+F+ +
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 77 RILGQGGQGTVYKGMLEDGR---IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
R++G+G V L+ M V K +L DDE++ ++ E + Q +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ---TEKHVFEQASSNPF 57
Query: 134 VKLLGCCLETEVPLLHLHDH--------HRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+ L C +T L + ++ H + L E A E+ AL++LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG- 116
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 246 TDKSDVYSFGVVLVELLTGKKP 267
D ++ GV++ E++ G+ P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 94 DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL--------GCCLETEV 145
DG+ +A+KK + L+ + E+ +L H NV+ L E V
Sbjct: 24 DGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81
Query: 146 --PLLHLHDHH---RNEEFPLTWE-IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNIL 199
L+ H + PL+ + +++ + + G L YLHSA I HRDIK N+L
Sbjct: 82 VTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRG-LKYLHSAG---ILHRDIKPGNLL 135
Query: 200 LDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVL 258
++ K+ DFG ++ D++ T+ T Y PE S+ T D++S G +
Sbjct: 136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195
Query: 259 VELLTGK 265
ELL +
Sbjct: 196 AELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+HS HRDIK N+L+D K+ADFG++ + ++ + GT Y+ PE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 240 HQSSQLTDKS------DVYSFGVVLVELLTGKKPIFSTGNT 274
+ K D +S GV+ E++ G+ P F G +
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-FHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+ AL YLHS + + +RD+K N++LD+ K+ DFG K D + T GT
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGT 159
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
YL PE + + D + GVV+ E++ G+ P ++
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-I 228
A E++ L +LH I +RD+K N++LD K+ADFG K +D VTT+
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTF 161
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT Y+ PE D +++GV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 44/130 (33%), Positives = 62/130 (47%), Gaps = 17/130 (13%)
Query: 150 LHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203
L D +EE PLT E + + +VA + +L AS HRD+ + NILL E
Sbjct: 153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSEN 209
Query: 204 YRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELL 262
K+ DFG ++ I D +V + ++ PE T +SDV+SFGV+L E
Sbjct: 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-- 267
Query: 263 TGKKPIFSTG 272
IFS G
Sbjct: 268 -----IFSLG 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
AT++ N+ + LG+G TVYKG+ +G+++A+K +++ EE + I E +L
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKV--ISMKTEEGVPFTA-IREASLLKG 59
Query: 128 INHRNVVKLLGCCLETEVPLLHLHDHHRNE------EFP---LTWEIRLRIATEVAGALS 178
+ H N+V LL + T+ L + ++ + + P + +RL + + G L+
Sbjct: 60 LKHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRG-LA 117
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLEP 237
Y+H I HRD+K N+L+ K+ADFG ++ ++ QT+ + + T Y P
Sbjct: 118 YIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPP 172
Query: 238 EYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIF 269
+ + TD S D++ G + +E+L G +P F
Sbjct: 173 DVLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 34/233 (14%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G+G G VYK +DG+ K++ L + + + EI +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQK 65
Query: 139 CCLE------------TEVPLLHLHDHHR-----NEEFPLTWEIRLRIATEVAGALSYLH 181
L E L H+ HR + L + + ++ + YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 182 SAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYL 235
+ + + HRD+K NIL+ ER R K+AD G ++ + + TF Y
Sbjct: 126 A---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 236 EPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
PE ++ K+ D+++ G + ELLT +PIF + QE++ + F H
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPFHH 231
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 21/146 (14%)
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
+E++ AL +LH I +RD+K NILLD + K+ DFG K ++ + VT G
Sbjct: 107 SEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCG 162
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-------NVSLAA 283
T Y+ PE S D +S G ++ ++LTG P F+ N + ++L
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP-FTAENRKKTIDKILKGKLNLPP 221
Query: 284 FFVHSMRKNHMYDILDDQVVKLVKKN 309
+ R D + KL+K+N
Sbjct: 222 YLTPEAR---------DLLKKLLKRN 238
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 42/119 (35%), Positives = 55/119 (46%), Gaps = 8/119 (6%)
Query: 153 HHRNEE--FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210
HH E F L+ R A E+ AL LH + +RD+K NILLD + + D
Sbjct: 82 HHLQREGRFDLS-RARFYTA-ELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCD 136
Query: 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
FG K + M T GT YL PE T D ++ GV+L E+LTG P +
Sbjct: 137 FGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 160 PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
LT E + + +VA + +L AS HRD+ + NILL E K+ DFG ++ I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 220 DQTHVTT-KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
D +V + ++ PE T +SDV+SFGV+L E+ + G P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+HS HRDIK N+LLD ++ADFG+ + D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 240 HQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFS 270
Q+ + + D +S GV + E+L G+ P ++
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 48/195 (24%)
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215
+E L E L + +VA +S+L AS HRD+ + NILL K+ DFG ++
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
Query: 216 FIAMDQTHVTTKIQGT----FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
I D +V ++G ++ PE + T +SDV+S+G++L E IFS
Sbjct: 263 DIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE-------IFSL 312
Query: 272 GNTSQENVSLAAFFVHSMRKNH-----------MYDILDDQVVKLVKKNQIMAFANLAER 320
G++ + + + F +++ + MYDI+ +
Sbjct: 313 GSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM--------------------KS 352
Query: 321 CLDLNGKKRPTMEEV 335
C D + KRPT +++
Sbjct: 353 CWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 58/288 (20%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKL---------EEFINEIVILSQIN 129
LGQG ++KG+ + V + E LLK+ E F ++SQ++
Sbjct: 3 LGQGTFTKIFKGIRRE-----VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS 57
Query: 130 HRNVVKLLGCCLETEVPL----------LHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
H+++V G C+ + + L + ++W +L +A ++A AL +
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHF 115
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE--- 236
L + H ++ + N+LL R + G FI + ++ + LE
Sbjct: 116 LEDKG---LTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP 169
Query: 237 ---PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
PE L+ +D +SFG L E IFS G+ L+A S +K
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWE-------IFSGGDK-----PLSAL--DSQKKL 215
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340
Y+ D + K ++ ANL +C+D RP+ + +LN
Sbjct: 216 QFYE--DRHQLPAPKWTEL---ANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 15/141 (10%)
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215
NE L++ + + +VA + +L AS HRD+ + N+L+ E K+ DFG ++
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 216 FIAMDQTHVTTKIQGTF---GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
I D +++ TF ++ PE ++ T SDV+SFG++L E IF+ G
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE-------IFTLG 338
Query: 273 NTSQENVSLAAFFVHSMRKNH 293
T + + F +++++ +
Sbjct: 339 GTPYPELPMNEQFYNAIKRGY 359
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 9/157 (5%)
Query: 119 INEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIR------LRIATE 172
E IL INH ++++L G + L L + + L + L I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERS 190
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
V A+ YLH + I HRDIK+ NI ++ + DFG + F + GT
Sbjct: 191 VLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
PE D++S G+VL E+ T +F
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284
|
Length = 391 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKL---------AVDDEELLKLEEFINEIVILSQI 128
LG+G TVYKG + +G+++A+K +L A+ + LLK + N +++ I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 129 NHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
+ + + L+ + T+ L D H P ++ L ++ LSY+H I
Sbjct: 73 HTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIHQRY---I 124
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTD 247
HRD+K N+L+ + K+ADFG ++ ++ +H + T Y P+ S++ +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 248 KSDVYSFGVVLVELLTG 264
D++ G + VE++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 77 RILGQGGQGTVYKGMLEDGR---IMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHR 131
R++G+G V L+ R M V K +L DDE++ ++ E+ + E + NH
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFE----TASNHP 56
Query: 132 NVVKLLGCCLETEVPLLHLHDH--------HRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
+V L C +TE L + + H + L E + E++ AL++LH
Sbjct: 57 FLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE +
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 244 QLTDKSDVYSFGVVLVELLTGKKP--IFSTGNTSQEN 278
D ++ GV++ E++ G+ P I + +N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 73 FNVNRILGQGGQGTVYKGMLEDGRI--MAVKKF-KLAVDDEELLKLEEFINEIVILSQIN 129
FN R LG G G V ++ +A+K+F K + ++ +++ +E IL+ IN
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK--QVDHVFSERKILNYIN 89
Query: 130 HRNVVKLLGCCLETEVPLLHLHD---------HHRNEEFPLTWEIRLRIATEVAGALSYL 180
H V L G + L L RN+ FP ++ A ++ YL
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN--DVGCFYAAQIVLIFEYL 147
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
S I +RD+K N+LLD+ K+ DFG +K + T + GT Y+ PE
Sbjct: 148 QSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEIL 200
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
+ +D ++ G+ + E+L G P ++
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 39/126 (30%), Positives = 55/126 (43%), Gaps = 20/126 (15%)
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT--- 222
R+ A E AL YLH+ I HRD+K N+L+ K+ DFG SK M T
Sbjct: 104 RMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 223 -----------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
+ ++ GT Y+ PE D ++ G++L E L G P F
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF-- 217
Query: 272 GNTSQE 277
G+T +E
Sbjct: 218 GDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-----SQ 244
HRDIK NIL+D ++ADFG+ + D T ++ GT Y+ PE Q+ +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFS 270
+ D +S GV + E+L G+ P ++
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-----SQ 244
HRDIK N+LLD+ ++ADFG+ + D T + GT Y+ PE Q+ +
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFS 270
+ D +S GV + E+L G+ P ++
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 39/208 (18%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G G G+V + G +A+KK E K E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK--RAYRELTLLKHMQHENVIGLL 80
Query: 138 GCCLETEVPLLH-LHD-----------------HHRNEEFPLTWEIRLRIATEVAGALSY 179
+ T D H +E+ +++ + + G L Y
Sbjct: 81 D--VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED-----KVQYLVYQMLCG-LKY 132
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPE 238
+HSA I HRD+K N+ ++E K+ DFG ++ + T +V T+ Y PE
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184
Query: 239 YHQS-SQLTDKSDVYSFGVVLVELLTGK 265
+ D++S G ++ E+LTGK
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 34/233 (14%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138
+G+G G VYK +DG+ + + L + + + EI +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQK 65
Query: 139 CCLE------------TEVPLLHLHDHHR-----NEEFPLTWEIRLRIATEVAGALSYLH 181
L E L H+ HR + L + + ++ + YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 182 SAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYL 235
+ + + HRD+K NIL+ ER R K+AD G ++ + + TF Y
Sbjct: 126 A---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 236 EPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
PE ++ K+ D+++ G + ELLT +PIF + QE++ + + H
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPYHH 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL- 136
LG+G TV+KG + ++A+K+ +L ++ I E+ +L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IREVSLLKNLKHANIVTLH 69
Query: 137 --------LGCCLE-TEVPLLHLHDHHRNEEFPLTWEIRLRIAT-EVAGALSYLHSAASS 186
L E + L D+ N L ++I ++ LSY H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHK---R 122
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQL 245
I HRD+K N+L++E+ K+ADFG ++ ++ + ++ T Y P+ S++
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 246 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
+ D++ G +L E+ TG +P+F G+T +E + L
Sbjct: 182 STPIDMWGVGCILYEMATG-RPMFP-GSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ ++ T+ T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRA 176
Query: 237 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
PE S+ T DV+S G + ELL G+KP+F
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 79 LGQGGQGTV---YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G QG V Y +LE R +A+KK ++ K E+V++ +NH+N++
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNIIG 87
Query: 136 LLGCCLETEVPLLHLHDHHRNEEF---PLTWEIRLRIATEVAGALSY--------LHSAA 184
LL + L D + E L I++ + E L Y LHSA
Sbjct: 88 LLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLEPEYHQ 241
I HRD+K +NI++ K+ DFG ++ M +V T+ Y PE
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVIL 198
Query: 242 SSQLTDKSDVYSFGVVLVELLTGK 265
+ D++S G ++ E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 75/295 (25%), Positives = 118/295 (40%), Gaps = 60/295 (20%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVD-DEELLKLEEFINEIVILSQ 127
++ + + +G+G G V+K + ++G AVK D DEE+ E N + LS
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI---EAEYNILKALS- 72
Query: 128 INHRNVVKLLG--------------CCLE-------TEVPLLHLHDHHRNEEFPLTWEIR 166
+H NVVK G LE T++ L R EE + +
Sbjct: 73 -DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY--- 128
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
I E L +LH + HRD+K NILL K+ DFG S + + T
Sbjct: 129 --ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 227 KIQGTFGYLEPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
+ GT ++ PE Q D + DV+S G+ +EL G P+
Sbjct: 184 SV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD----------- 231
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA-FANLAERCLDLNGKKRPTMEEV 335
+H MR ++ I + L + F + +CL + +KRPT+ ++
Sbjct: 232 ----LHPMRA--LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 79 LGQGGQGTVYKGMLED-GRIMAVKKF--KLAVDDEELLKLEEFINE--IVILSQINHRNV 133
+G+G G VY+ +D RI A+K K V +E+ I E I++ + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV---AHTIGERNILVRTLLDESPF 57
Query: 134 VKLLGCCLETEVPLLHLHDHHRNEEFPLTWEI-----------RLRIATEVAGALSYLHS 182
+ L +T+ L + D+ E L W + + IA E+ AL +LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGE--LFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHK 114
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQ 241
I +RD+K NILLD + DFG SK + T GT YL PE
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
T D +S GV++ E+ G P ++
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 49/284 (17%)
Query: 79 LGQGGQGTVYKGMLE---DGRIMAVKKF---KLAVDDEELLKLEEFINEIVILSQINHRN 132
LGQG +YKG+L D I+ + L V + F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 133 VVKLLGCCLETE-------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+VKL G C+ E V L E+ ++ +L +A ++A AL YL
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---D 119
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE-------PE 238
+ H ++ NIL+ RY + G FI + + + + PE
Sbjct: 120 KKLVHGNVCGKNILV-ARYG---LNEGYVPFIKLSDPGIPITV-LSREERVERIPWIAPE 174
Query: 239 YHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
+ + LT +D +SFG L+E I S G +S + K Y
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLE-------ICSNGEEPLSTLSSS-------EKERFYQ 220
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340
D + + ++ ANL +C + KRP+ + +LN
Sbjct: 221 --DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 42/222 (18%)
Query: 79 LGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
LG+G TVYKG L D ++A+K+ +L + EE I E+ +L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRL--EHEEGAPCTA-IREVSLLKDLKHANIVTL 69
Query: 137 LGCCLETEVPLLHLHDH-HRNEEFPLTWEI---RLRIATEVAGALSYLHSAA-------- 184
HD H + L +E L+ + G +H+
Sbjct: 70 --------------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 185 ------SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+ HRD+K N+L++ER K+ADFG ++ ++ + ++ T Y P+
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPD 174
Query: 239 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 279
S+ + + D++ G + E+ TG +P+F G+T +E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP-GSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 15/111 (13%)
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
L +VA + +L AS HRD+ + N+LL + K+ DFG ++ I D +V+
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 227 KIQGTF---GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
TF ++ PE + T SDV+S+G++L E IFS G T
Sbjct: 297 G--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE-------IFSLGGT 338
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 54/223 (24%), Positives = 103/223 (46%), Gaps = 40/223 (17%)
Query: 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
LG+G TV+KG + ++A+K+ +L + EE I E+ +L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA-IREVSLLKDLKHANIVTL- 69
Query: 138 GCCLETEVPLLHLHD-HHRNEEFPLTWEI---RLRIATEVAGALSYLHSAA--------- 184
HD H ++ L +E L+ + G + +H+
Sbjct: 70 -------------HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRG 116
Query: 185 -----SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE- 238
+ HRD+K N+L++ER K+ADFG ++ ++ + ++ T Y P+
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 175
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
SS+ + + D++ G + E+ +G +P+F G+T ++ + L
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFP-GSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+ +G G QG V G +AVKK ++ K E+V+L +NH+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK--RAYRELVLLKCVNHKNIIS 84
Query: 136 LLGCCLETEVPLLHLHDHHRNEEF---PLTWEIRLRIATEVAGALSY--------LHSAA 184
LL + L D + E L I + + E L Y LHSA
Sbjct: 85 LLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG 143
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLEPEYHQ 241
I HRD+K +NI++ K+ DFG ++ M +V T+ Y PE
Sbjct: 144 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVIL 195
Query: 242 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
+ D++S G ++ EL+ G T + Q N
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 58/229 (25%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G G G+V + G +AVKK L+ + ++ + E+ +L + H NV+ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 138 ----------------------GCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAG 175
G L V L D H +F L ++I LR
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH--VQF-LIYQI-LR------- 131
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGY 234
L Y+HSA I HRD+K +N+ ++E K+ DFG ++ + T +V T+ Y
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183
Query: 235 LEPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
PE Y+Q+ D++S G ++ ELLTG+ T + Q
Sbjct: 184 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGRTLFPGTDHIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 79 LGQGGQGTV---YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G QG V Y +L+ R +A+KK ++ K E+V++ +NH+N++
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNIIS 80
Query: 136 LLGCCLETEVPLLHLHDHHRNEEF---PLTWEIRLRIATEVAGALSY--------LHSAA 184
LL + L D + E L I++ + E L Y LHSA
Sbjct: 81 LLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ 244
I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 245 LTDKSDVYSFGVVLVELLTGK 265
+ D++S G ++ E++ K
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 36/111 (32%), Positives = 49/111 (44%), Gaps = 22/111 (19%)
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQT 222
E++ I ++ AL+ LH I H DIK N+L D + R + D+G K I
Sbjct: 110 EVKK-IIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 223 HVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT Y PE Y S D ++ GV+ ELLTGK P
Sbjct: 166 Y-----DGTLDYFSPEKIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 35/210 (16%)
Query: 79 LGQGGQGTVYKGMLEDGRI---MAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G GTV + D R +A+KK E K E+ +L + H NV+
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAK--RAYRELRLLKHMKHENVIG 78
Query: 136 LLGCCLETEVPLLHLHDHHRNEEFPLT-----------WEIRLR-IATEVAGALSYLHSA 183
LL ++ L HD + F T E R++ + ++ L Y+H+A
Sbjct: 79 LLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLEPEYH 240
I HRD+K N+ ++E K+ DFG ++ +++ G T Y PE
Sbjct: 138 G---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVI 187
Query: 241 QS-SQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ T D++S G ++ E+LTG KP+F
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTG-KPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 25/98 (25%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
+ ++ + +LHS I +RD+K N+LLD++ +++D G + + + T+
Sbjct: 101 SAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRA 155
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT GY+ PE + + D ++ G + E++ G+ P
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 22/144 (15%)
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 227
+A ++ A+ Y+H I HRDIK+ N+L++ + DFG + F T
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
I GT PE T D++S G+V+ E +FS S+ +
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS---ASRGD--------- 369
Query: 288 SMRKNHMYDILDDQVVKLVKKNQI 311
+ Y D Q+++++++ Q+
Sbjct: 370 ---ERRPY---DAQILRIIRQAQV 387
|
Length = 461 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 29/113 (25%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-TK 227
I ++ L Y+H I H DIK NI++D R + D+G + + H+ +K
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 228 IQ-----GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
Q GT Y + H + +T + D+ S G +++ K P G+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240
|
Length = 294 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 67/260 (25%)
Query: 71 NHFNVNRILGQGGQGTV-YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN---EIVILS 126
+ F +++G+G G V + G I A+KK + + E+L+ E+ + E IL+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEKEQVAHVRAERDILA 56
Query: 127 QINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFP----LTWEIRLRIATE------VAGA 176
+ ++ VVKL + E L + E P +T ++ TE +A
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIM-----EYLPGGDMMTLLMKKDTFTEEETRFYIAET 110
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------- 229
+ + S HRDIK N+LLD + K++DFG + ++H T +
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALP 168
Query: 230 --------------------------------GTFGYLEPEYHQSSQLTDKSDVYSFGVV 257
GT Y+ PE + + D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 258 LVELLTGKKPIFSTGNTSQE 277
+ E+L G P S + QE
Sbjct: 229 MYEMLVGYPPFCS--DNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
R A E+ AL LH I RD+ NILLD+R ++ F ++ ++ +
Sbjct: 89 RWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEA 143
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK 265
++ Y PE S+ T+ D +S G +L ELLTGK
Sbjct: 144 VENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 62/244 (25%)
Query: 72 HFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELL---KLEEFINEIVILSQ 127
HF ++LG+G G V+ L+ G++ A+K +D +E++ K++ + E IL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALK----VLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 128 INHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIR----LRI------ATEVAGAL 177
++H + L +TE L + D+ E + + L A EV AL
Sbjct: 58 LDHPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------- 229
YLH I +RD+K NILL E ++DF SK + +K
Sbjct: 117 EYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD-VEPPPVSKALRKGSRRSS 172
Query: 230 ---------------------GTFGYLEPEY-----HQSSQLTDKSDVYSFGVVLVELLT 263
GT Y+ PE H S+ D ++ G++L E+L
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-----VDWWTLGILLYEMLY 227
Query: 264 GKKP 267
G P
Sbjct: 228 GTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 64/241 (26%)
Query: 61 FSSKELDKAT----NHFNVNRILGQGGQGTVYKGMLEDGRI---MAVKKFKLAVDDEELL 113
F +EL+K + +G G G+V D R+ +AVKK L+ + L+
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAY--DTRLRQKVAVKK--LSRPFQSLI 56
Query: 114 KLEEFINEIVILSQINHRNVVKLL----------------------GCCLETEVPLLHLH 151
E+ +L + H NV+ LL G L V L
Sbjct: 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS 116
Query: 152 DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211
D H ++ I + G L Y+HSA I HRD+K +N+ ++E ++ DF
Sbjct: 117 DEH----------VQFLIYQLLRG-LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162
Query: 212 GTSKFIAMDQTHVTTKIQGTFGYLEPE-------YHQSSQLTDKSDVYSFGVVLVELLTG 264
G +A T T Y PE Y+Q+ D++S G ++ ELL G
Sbjct: 163 G----LARQADDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKG 212
Query: 265 K 265
K
Sbjct: 213 K 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 78/305 (25%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEE------------LLKLEE--------- 117
LGQG + +Y G L ++ ++ +D +LK+ +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 118 FINEIVILSQINHRNVVKLLGCCL-ETEVPLLHLHDHH-------RNEE--FPLTWEIRL 167
F ++SQ++H ++ + G C+ +E ++ H R E+ P+ W+I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT- 121
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+A ++A ALSYL + H ++ + NILL R +A+ GTS FI + V+
Sbjct: 122 -VAQQLASALSYLEDKN---LVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVSFT 173
Query: 228 IQG------TFGYLEPEYHQS-SQLTDKSDVYSFGVVLVEL-LTGKKPIFSTGNTSQENV 279
++ PE + L+ +D +SFG L+E+ G+ P+ T E
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL--KERTPSE-- 229
Query: 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQI-----MAFANLAERCLDLNGKKRPTMEE 334
K Y+ KK+++ A L +CL +RP+
Sbjct: 230 -----------KERFYE----------KKHRLPEPSCKELATLISQCLTYEPTQRPSFRT 268
Query: 335 VTMEL 339
+ +L
Sbjct: 269 ILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/52 (42%), Positives = 30/52 (57%), Gaps = 3/52 (5%)
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215
E+ ++ +EVA AL YLH I HRD+K N+L+ K+ DFG SK
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 55/236 (23%), Positives = 92/236 (38%), Gaps = 53/236 (22%)
Query: 128 INHRNVVKLLGCCLETEVPLLHL----------------HDHHRNEEFPLTWEIRLRIAT 171
+ H N+++ LG C+E +P L + H RN + L R+A
Sbjct: 52 LQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ----RMAC 106
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQ 229
E+A ++++H H D+ N L KV D+G + ++ T
Sbjct: 107 EIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKC 162
Query: 230 GTFGYLEPE----YHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282
+L PE +H +++ T S+V++ GV L EL +S + S V
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS--HLSDREV--- 217
Query: 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLD---LNGKKRPTMEEV 335
+ ++ DQ VKL K + ++ L L+ +KR T EEV
Sbjct: 218 -----------LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 70/299 (23%)
Query: 79 LGQGGQGTVYKGMLEDGRIMA---VKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G G G V G + G A VK+ +++ +E +K F+ E + H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLLQ 59
Query: 136 LLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
LG C E LL +L + E R+A E+A L +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHVTTKIQGTFGYLE 236
+ H D+ N LL K+ D+G S ++ DQ V ++ L
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELV 174
Query: 237 PEYHQSSQLTDK---SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
E H + + D+ S+V+S GV + EL F G+ ++S
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL-------FELGSQPYRHLS------------- 214
Query: 294 MYDILDDQVVKLVKKNQIMAFAN------LAERCLD------LNGKKRPTMEEVTMELN 340
D+QV+ + Q + L++R + L ++RP+ EEV + L+
Sbjct: 215 -----DEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 61/237 (25%)
Query: 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKL---------AVD 108
KL + K+LDK LG+G TVYKG + G+++A+K+ +L A+
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 109 DEELLKLEEFINEIVILSQINHRN---------VVKLLGCCLETEVPLLHLHDHHRNEEF 159
+ LLK + N IV L I H + L ++ L +H+
Sbjct: 53 EASLLKDLKHAN-IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN------- 104
Query: 160 PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
+RL + + G L+Y H + HRD+K N+L+ ER K+ADFG ++ ++
Sbjct: 105 -----VRLFLFQLLRG-LAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155
Query: 220 DQTHVTTKIQGTFGYLEP-------EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ + T Y P EY S+ L D++ G + E+ TG +P+F
Sbjct: 156 -PSKTYSNEVVTLWYRPPDVLLGSTEY--STSL----DMWGVGCIFYEMATG-RPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 46/214 (21%)
Query: 77 RILGQGGQGTV---YKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN---------EIVI 124
+ +G G QG V Y + G+ +A+KK F N E+V+
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-----------RPFQNVTHAKRAYRELVL 68
Query: 125 LSQINHRNVVKLLGC-----CLET--EVPL-LHLHDHHRNE--EFPLTWEIRLRIATEVA 174
+ +NH+N++ LL LE +V L + L D + + + L E + ++
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG---TSKFIAMDQTHVTTKIQGT 231
+ +LHSA I HRD+K +NI++ K+ DFG T+ M +V T+
Sbjct: 129 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 182
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK 265
Y PE + D++S G ++ E++ G
Sbjct: 183 --YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 22/114 (19%)
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLD----------------ERYRAKVADF 211
+I + AL Y H+ + H D+K NIL++ + R ++ D
Sbjct: 235 QIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK 265
G D+ H T I T Y PE +D++S G ++ EL TGK
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 36/144 (25%), Positives = 49/144 (34%), Gaps = 46/144 (31%)
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG---------TSKF 216
R IA E+ A+ +H HRDIK NIL+D K+ DFG SK+
Sbjct: 104 RFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 217 I--------------------------------AMDQTHVTT-KIQGTFGYLEPEYHQSS 243
+ GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 244 QLTDKSDVYSFGVVLVELLTGKKP 267
T D +S GV+L E+L G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 33/122 (27%), Positives = 46/122 (37%), Gaps = 36/122 (29%)
Query: 190 HRDIKSTNILLDERYRAKVADFG------------------------------TSKFIA- 218
HRDIK N+LLD + K++DFG SK A
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 219 ---MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
++ + GT Y+ PE + D +S GV++ E+L G P S T
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS--ETP 241
Query: 276 QE 277
QE
Sbjct: 242 QE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 366 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.14 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.87 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.82 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.33 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.33 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.19 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.84 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.33 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.23 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.7 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.58 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.35 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.18 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.07 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=351.17 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=204.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc-ceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-PLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 148 (366)
++.+.++.||+|..|+||++.++ ++..+|+|++...... ...+++.+|+++++..+|||||.+|+.|..... ..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~---~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP---ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 46778899999999999999976 5889999999765554 456789999999999999999999999999995 888
Q ss_pred EEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
.+|+..++.. ..+++..+-+++.+|++||.|||+ ++ ||||||||+|||+++.|+|||+|||.+..+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 8988877642 358999999999999999999996 76 999999999999999999999999999877543
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||........ .....+..... +..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~---~~~~Ll~~Iv~-~pp------ 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL---DIFELLCAIVD-EPP------ 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC---CHHHHHHHHhc-CCC------
Confidence 55678999999999999999999999999999999999999999977521111 11221211111 111
Q ss_pred HHhhhhcH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKK-NQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+|. .++++|++|+..||++||.+|||+.|+++
T Consensus 300 ---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 ---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12344 48899999999999999999999999964
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=361.34 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=207.9
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|...++||+|+|+.||.+.+ .+|+.||+|++......+. ...+.+.+|+++.+.|+|||||+++++|.+.+..|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 5699999999999999999997 6799999999987554433 4457889999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+|.+..+ ...++++..++.+..||+.|+.|||+++ |+|||||..|++++++.+|||+|||+|..+..+ .
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G 172 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence 9998776 3458999999999999999999999999 999999999999999999999999999988644 3
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
....+.|||+.|.|||++....++..+||||+||++|-|+.|++||....- ...+. .+....
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~-~Ik~~~--------- 234 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYN-KIKLNE--------- 234 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHH-HHHhcC---------
Confidence 455668999999999999999999999999999999999999999976431 00111 111111
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
-.+|...+.+..+||..+|+.||.+|||+++++.
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1234566678899999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=347.74 Aligned_cols=282 Identities=44% Similarity=0.705 Sum_probs=237.0
Q ss_pred cccccChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeE
Q 037297 57 RCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136 (366)
Q Consensus 57 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 136 (366)
....++..++..++++|.-...||+|+||.||+|...+|..||||.+....... ..+|..|+.++.+++|||+|++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccE
Confidence 567799999999999999999999999999999999888999999777644321 3459999999999999999999
Q ss_pred eeEEeeCCc-ceEEEeeccCCC--------CC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeE
Q 037297 137 LGCCLETEV-PLLHLHDHHRNE--------EF-PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206 (366)
Q Consensus 137 ~~~~~~~~~-~~~~~~~~~~~~--------~~-~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~v 206 (366)
+|||.+.+. .++++++...++ .. +++|..+++|+.++|.||+|||....++||||||||+|||+|++.+.
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999999995 999988876532 12 78999999999999999999999887899999999999999999999
Q ss_pred EEeecCCcccccCCCceeeeec-cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH
Q 037297 207 KVADFGTSKFIAMDQTHVTTKI-QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
||+|||+|...... ....... .||.+|+|||++..+..+.|+||||||+++.|+++|+.|.+... +.....+....
T Consensus 217 KlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~ 293 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWA 293 (361)
T ss_pred EccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHH
Confidence 99999999655431 1111222 79999999999999999999999999999999999998877544 22333355555
Q ss_pred HHHhhcCccccccchHHh-hhhcH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 286 VHSMRKNHMYDILDDQVV-KLVKK-NQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
...+....+..++|+.+. ...+. .....+..+...|++.+|.+||+|.|+++.|+.+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 666666788889999876 55554 5677799999999999999999999999999766544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=346.87 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=200.9
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH---HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL---LKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..+.|.+.+.||+|+||.|-+|..+ +|+.||+|++......... .......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4577899999999999999999954 6999999999764433211 12334679999999999999999999999999
Q ss_pred cceEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CeEEEeecCCc
Q 037297 145 VPLLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTS 214 (366)
Q Consensus 145 ~~~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~---~~vkl~Dfg~a 214 (366)
..|+++|+..++... .+.+.....++.|++.|+.|||++| |+||||||+|||++.+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999887543 5778888899999999999999999 9999999999999866 78999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCCC-cccccHHHHHHHHhh
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSTGNTS-QENVSLAAFFVHSMR 290 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 290 (366)
+..+ ......+.|||+.|.|||++.++.. ..++|+||+||+||-+++|.+||....+.. ..+ .+.
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---------QI~ 395 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---------QIL 395 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---------HHh
Confidence 9775 4556677899999999999977643 348899999999999999999998755322 110 001
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+. .........+++..+|+.+||..||++|||++|+++
T Consensus 396 ~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11110 001123456778999999999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=352.96 Aligned_cols=258 Identities=27% Similarity=0.395 Sum_probs=219.7
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
+.+......+.+++.||+|.||.||.|.++....||+|.++..... .+.|.+|+.+|++|+|+|||+++++|..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-----PEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-----hhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 3344445567778999999999999999987789999999976443 34788999999999999999999999999
Q ss_pred CcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 EVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 ~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++|+...+ ....+...+.+.++.|||+||+||++++ +|||||.++||||++++.+||+|||+|
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 9999999986554 3456888999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
+....+.............|.|||.+....++.|||||||||+||||+| |+.||..... .+
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~e 412 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------EE 412 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------HH
Confidence 9666555555555567889999999999999999999999999999999 9999876651 12
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
....++.+.+..-|..|++++.+++..||+.+|++|||++.+...|+++.....
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 222333444455688899999999999999999999999999999999886654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=326.92 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=207.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.|+.+.++|+|+||.||+++++ +|+.||||++....++. ...+..++|+.+|++++|||+|.++++|......+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 46888999999999999999976 59999999998755543 4456789999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
.+++... ....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||+|||.|+.+.. .+
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9987643 2335789999999999999999999999 99999999999999999999999999998865 45
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc------HHHHHHHHhhcCc--
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS------LAAFFVHSMRKNH-- 293 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~-- 293 (366)
..++.++.|..|+|||++.| ..|+..+||||+||++.||++|.+-|.+.+..++.... +.......+....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 66788899999999999988 68999999999999999999999988765532221111 0111111111111
Q ss_pred ----cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 294 ----MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 294 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
++..-+++..+.--+..+.-+.+|+..||+.||++|++.+|++
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1222222222222234455789999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=343.67 Aligned_cols=259 Identities=33% Similarity=0.504 Sum_probs=209.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-cc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 146 (366)
.......+.+.+|+|+||+||+|.++....||+|++......... .+.|.+|+.++..++|||||+++|+|.... ..
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 334555666779999999999999985555999999876555433 679999999999999999999999999998 68
Q ss_pred eEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCccc
Q 037297 147 LLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~ 216 (366)
.+++|+..++ ....+++..++.++.||+.||.|||+++. ||||||||+|||++.++ ++||+|||+++.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence 8888887655 24578999999999999999999999873 89999999999999997 999999999976
Q ss_pred ccCCCceeeeeccccCCcccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..... ...+...||+.|||||++. +..|+.|+||||||+++|||+||+.||..... ........ .
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~---~---- 260 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVV---V---- 260 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH---h----
Confidence 54332 2233367999999999999 56999999999999999999999999987541 11111111 1
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
...+..++..+++.+..++..||..||+.||++.+++..|+.+......
T Consensus 261 -----~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 -----GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1112233455788899999999999999999999999999988754443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=322.69 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=199.8
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeE-EeeCC-cc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGC-CLETE-VP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~-~~ 146 (366)
-.+|+++++||+|+||+||++.. .+|..+|.|.++-+..+. ...+....|+.+|++|+|||||++++. +.++. ..
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~--k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA--KARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH--HHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 45699999999999999999984 579999999998544443 456688999999999999999999993 43333 46
Q ss_pred eEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 147 LLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAA-SSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 147 ~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
+++++.+..+. ...+++.++|+++.|++.||..+|++- .+-|+||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 77777766553 336899999999999999999999932 133999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
+.+..... .....+||+-||+||.+.+.+|+.||||||+||++|||+..++||.+.. ......-+.....
T Consensus 176 r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---------~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---------LLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---------HHHHHHHHHcCCC
Confidence 98865443 3455789999999999999999999999999999999999999998753 1111122222222
Q ss_pred ccccchHHhhhhc-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 295 YDILDDQVVKLVK-KNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 295 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
+. +| .-++.++..++..|+..||+.||+...++..+
T Consensus 246 ~~---------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PP---------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CC---------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 11 23 56788999999999999999999855554444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=328.98 Aligned_cols=239 Identities=28% Similarity=0.367 Sum_probs=200.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|+++++||+|+||.||.++.+ +++.+|+|++++...-.. ...+....|..++..++||.||+++-.|.+.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 3578999999999999999999965 589999999987655433 34678899999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..++. ...+++..+.-++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+++....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999988763 457899999999999999999999999 99999999999999999999999999985433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.+....+++||+.|||||++.+.+|+..+|.||||+++|||++|.+||....... .........
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGK-------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCc--------
Confidence 2334455899999999999999999999999999999999999999998754211 111111111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRP 330 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 330 (366)
....+...+.+.++++..+|+.||++|.
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1123444677899999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=323.56 Aligned_cols=196 Identities=30% Similarity=0.482 Sum_probs=174.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|.+.+.||+|+||+||+|+++ ++..||||.+....-.. ...+-+..|+.+|+.++|||||.+++++...+..++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~--k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK--KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH--HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 467999999999999999999975 58999999998764322 345678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC------CeEEEeecCCcc
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER------YRAKVADFGTSK 215 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~------~~vkl~Dfg~a~ 215 (366)
++|++.+++ ...+++.+++.++.|++.||++||+++ ||||||||+|||++.+ -.+||+|||+|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999998764 337899999999999999999999999 9999999999999865 468999999999
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
.+. ......+.+|++.|||||++....|+.|+|+||+|+++|+|++|+.||....
T Consensus 164 ~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 886 4455567899999999999999999999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=332.01 Aligned_cols=262 Identities=26% Similarity=0.329 Sum_probs=209.6
Q ss_pred HHhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--C
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--E 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 144 (366)
...+.|+.+++||+|.||.||+|++ .+|+.||+|+++.+...... ...+.+|+.+|++|+||||+++.+...+. .
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~--~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF--PITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc--hHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3446789999999999999999995 46999999999987655432 34678999999999999999999998887 5
Q ss_pred cceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..|+++++... .....+++.++..++.|++.||+|||++| |.|||||.+||||+++|.+||+|||+|+++
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 67777776532 24457899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc-
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY- 295 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 295 (366)
........+..+-|..|+|||++.|. .|+.++|+||+||++.||++|++.|.+..+ .++.......+.......|.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhcccc
Confidence 87777777888899999999999886 699999999999999999999999987552 33333333333333322222
Q ss_pred ------ccc------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 ------DIL------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ------~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+ .+.+.+. -...+....+|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 1111121 3345567789999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=305.59 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=203.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|...+++|+|.||.||+|++ ++|+.||||+++.....+... -...+|+..|+.++||||+.++++|...+...++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~--~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN--RTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc--HHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 4788899999999999999995 479999999999875543322 3678999999999999999999999999999999
Q ss_pred EeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++... .....+...++..++.+++.|++|||++. |+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 887653 35557888999999999999999999999 99999999999999999999999999998876544
Q ss_pred eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc---c
Q 037297 223 HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI---L 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 298 (366)
... ..+.|..|+|||++.|. .|+..+|+||.||++.||+-|.+-|.+... -++...............+++. -
T Consensus 157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCccccccc
Confidence 333 23679999999988764 799999999999999999998876655442 2221111111122222222221 1
Q ss_pred --------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 299 --------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 299 --------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.......+-..++.+..||+..||..||.+|+|+.|+++.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111122444566778999999999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=330.37 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=205.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCC-c
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE-V 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~ 145 (366)
..++|.+.++||.|.||+||+|+.+ +|+.||||.++.....- ..-.-.+|+..|++|+ ||||+++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3578999999999999999999954 68999999998766552 2234578999999997 999999999999998 7
Q ss_pred ceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++|+... .....+++..++.|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 8888776433 35668999999999999999999999999 9999999999999988899999999999765
Q ss_pred CCCceeeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH------------HHHH
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL------------AAFF 285 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~------------~~~~ 285 (366)
. ....+.++.|..|+|||++. ...|+.+.|+||+||+++|+.+-++-|.+..+.++..... ....
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 3 45567788999999999765 5678999999999999999999999887654322211110 0011
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.....+-.++......+...++. ++.+..+++..|+.+||.+|||+.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111112222222233333444 88899999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=331.82 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=205.4
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (366)
....++|.+++.||+|+|++|++|+.+ +++.+|||++.+...-.+ .+.+-+..|-.+|.+| .||.|++++-.|.++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 445688999999999999999999965 589999999876544332 3445678899999999 8999999999999999
Q ss_pred cceEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.+|+++++...+... .+++...+.++.+|+.||+|||++| ||||||||+|||+++|++++|+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999998877533 6899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCce------------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH
Q 037297 218 AMDQTH------------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 218 ~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
...... ....++||..|.+||++.....++.+|||+|||++|+|+.|.+||....+ ...+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence 532221 12458899999999999999999999999999999999999999976441 1111
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
...+ .+.-.+++..++...+|++.+|..||.+|+|++||-
T Consensus 297 qkI~-----------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 297 QKIQ-----------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred HHHH-----------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 1111 111234566667899999999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.34 Aligned_cols=272 Identities=23% Similarity=0.319 Sum_probs=209.9
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
+.....+.|++.++||.|..++||+|+. ..++.||||++..+.... ..+.+.+|+..++.++||||++++.+|..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3444568899999999999999999995 468999999999876653 467899999999999999999999999999
Q ss_pred CcceEEEeeccCCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 EVPLLHLHDHHRNEEF---------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 ~~~~~~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++.+...+... .+++..+..|.++++.||.|||++| .||||||+.||||+.+|.|||+|||.+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 9999988876655322 4789999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCce---eeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 215 KFIAMDQTH---VTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 215 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
..+...+.. ....++||+.|||||++.. .+|+.|+||||||++..||.+|..||....... ....-+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--------vLl~tL 245 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--------VLLLTL 245 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--------HHHHHh
Confidence 766543322 2245789999999998543 479999999999999999999999997654111 111111
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcccCCCCccc
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRGSNFGHKM 351 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~~~~~~~~ 351 (366)
.+.. +...-.....+-....+..|..++..||+.||.+|||++++++ .++..+...+....
T Consensus 246 qn~p-p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~ 308 (516)
T KOG0582|consen 246 QNDP-PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKK 308 (516)
T ss_pred cCCC-CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchh
Confidence 1111 1000001111223445558999999999999999999999975 34555544444333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=347.51 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=212.4
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
.....+.+..+.||+|+||.||+|... +...||||.++..... ...+.|.+|++++..++|||||+++|+|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 444567778899999999999999843 2457999999976554 4567899999999999999999999999
Q ss_pred eeCCcceEEEeeccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 037297 141 LETEVPLLHLHDHHRNE---------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNIL 199 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nil 199 (366)
.+.+..++++|+...++ ..+++..+.+.|+.|||.||.||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999988754321 223888999999999999999999999 999999999999
Q ss_pred ecCCCeEEEeecCCcccccCCCceeee-eccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 037297 200 LDERYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 277 (366)
Q Consensus 200 l~~~~~vkl~Dfg~a~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 277 (366)
|+++..|||+|||+++.....+..... ...-..+|||||.|..+.+|.+|||||+||+|||+++ |+.||++..+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---- 711 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---- 711 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----
Confidence 999999999999999877655443322 3345788999999999999999999999999999999 9999987652
Q ss_pred cccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 278 NVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
+.+...++...+ -..|.+|+.++.+|+..||+.+|.+|||+.||-..|+.+-...
T Consensus 712 -----~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 -----QEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -----HHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222333333322 2357889999999999999999999999999999998765433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=314.66 Aligned_cols=251 Identities=29% Similarity=0.405 Sum_probs=197.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 146 (366)
..++...+.||+|+||+||++...+ |+..|+|.+....... .+.+.+|+.+|.+++|||||++++...... ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT----SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh----HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 4568888999999999999999654 8999999998763221 567899999999999999999999755444 57
Q ss_pred eEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~ 217 (366)
++.+++..+++ ..++++..+..+..|+++||.|||++| ++||||||+|||++. ++.+||+|||++...
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 77788776542 116999999999999999999999999 999999999999999 799999999999876
Q ss_pred cC--CCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AM--DQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~--~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.. ..........||+.|||||++..+ ....++||||+||++.||+||+.||.... ...............
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALLLIGREDSL 241 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHHHHhccCCC
Confidence 53 222233457899999999999853 34459999999999999999999997530 011111111111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
+ .+|...+.+..+|+..|++.||++|||++++++---...
T Consensus 242 P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 242 P---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred C---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 1 345667778999999999999999999999987654433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.40 Aligned_cols=241 Identities=28% Similarity=0.428 Sum_probs=205.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|.+.+.||+|+||+||+|+.+ +.+.||+|.+.+....+ ...+.+.+|+++++.++||||+.++++|......+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~--k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE--KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 57999999999999999999965 58899999998765543 4566799999999999999999999999999999999
Q ss_pred EeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
.++..+. .+..++++.+..++.|++.||.|||+.+ |.|||+||.|||++.+|.+|++|||+|+.+.. ...
T Consensus 80 te~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred ehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9887652 4557999999999999999999999999 99999999999999999999999999987654 345
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
..+...||+-|||||+..+.+|+..+|+||+||++|||++|++||.... .......+..++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------i~~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------ITQLVKSILKDPV--------- 217 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---------HHHHHHHHhcCCC---------
Confidence 5677889999999999999999999999999999999999999997533 1111111111111
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
..|...+..|.+|+..+|++||.+|.|..+++
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 12446778899999999999999999999885
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=318.47 Aligned_cols=246 Identities=24% Similarity=0.273 Sum_probs=198.2
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
....++|++++.||+|+||.||+|+.+ +|..+|+|++++...- ...+.+....|-++|...++|+||+++-.|.+.+.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 335689999999999999999999965 5999999999985443 33556789999999999999999999999999999
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+|++|++..++. ...|++.....++.+++.||..+|+.| +|||||||+|+||+..|++||+|||++.-+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999874 346899999999999999999999999 9999999999999999999999999985331
Q ss_pred C-----------------------CCce----e-------------------eeeccccCCccccccccCCCCCchhhHH
Q 037297 219 M-----------------------DQTH----V-------------------TTKIQGTFGYLEPEYHQSSQLTDKSDVY 252 (366)
Q Consensus 219 ~-----------------------~~~~----~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~Diw 252 (366)
. +... . ....+|||.|+|||++.+.+|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 1135699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 253 SFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 253 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
||||++|||+.|.+||.+... .+.-.........+..+ -....+.+..|||.+|++ ||++|...
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp--~~T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETP--QETYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999987552 21111111111111111 122344788999999999 99999763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=320.80 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=203.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH-HHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCC
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE-LLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 144 (366)
....+|.+.+.||+|+||.|+.|.+. +++.||+|++........ ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999854 689999997766422111 123456678999999998 999999999999999
Q ss_pred cceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~ 216 (366)
..++++++..++. ..++.+.....++.|++.|++|||++| |+||||||+|+|++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999987742 357899999999999999999999999 9999999999999999 9999999999987
Q ss_pred ccCCCceeeeeccccCCccccccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQ-LT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||..... ...... +....+
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~k-i~~~~~ 240 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRK-IRKGEF 240 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHH-HhcCCc
Confidence 64 2334556679999999999999987 86 689999999999999999999986321 111111 111111
Q ss_pred ccccchHHhhhhcHHH-HHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQ-IMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.+|... +.++.+|+++||..||.+|+|+.+++ .-.-++.
T Consensus 241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 123333 67899999999999999999999998 4444443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=315.54 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=201.6
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH----------HHHHHHHHHHHHHhcCCCCc
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL----------LKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~n 132 (366)
.+..+..++|++.+.||+|.||.|-+|+.. +++.||+|++......... ...+...+|+.+|+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 344556689999999999999999999965 6899999999764433211 12468899999999999999
Q ss_pred eeeEeeEEee--CCcceEEEeeccCCC------CCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 133 VVKLLGCCLE--TEVPLLHLHDHHRNE------EFP-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 133 iv~~~~~~~~--~~~~~~~~~~~~~~~------~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
||+++++..+ .+..|++++++..+. ..+ +.+.+.++++++++.||.|||.+| ||||||||+|+|++++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9999998654 457888999877653 334 889999999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCC----ceeeeeccccCCccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037297 204 YRAKVADFGTSKFIAMDQ----THVTTKIQGTFGYLEPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 275 (366)
|+|||+|||.+....... .......+||+.|+|||+..++. .+.+.||||+||+||+|+.|+.||.+...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999998663221 11223468999999999887632 34588999999999999999999986441
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+ . .+.+..+.-...++...++.+|+++||++||++|.+..++..-..-.+
T Consensus 325 ------~~l~-~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 ------LELF-D--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ------HHHH-H--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 0011 1 111111111223345678999999999999999999999976554443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=297.85 Aligned_cols=233 Identities=26% Similarity=0.316 Sum_probs=198.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
-.+|++.+.||.|+||.|.+++.+ +|..+|+|++..... -...+.+...+|..+|+.+.||.++++++.|.+.+..++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 357899999999999999999976 588999999987432 234556788999999999999999999999999999999
Q ss_pred EEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++.. .++++..++.++.||+.|++|||+.+ |++||+||+|||++.+|.+||+|||.|+....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999888743 37899999999999999999999999 99999999999999999999999999987642
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
...+.|||+.|+|||++.+++++.++|.|||||++|||+.|.+||..... ...+.......
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~--------- 257 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGK--------- 257 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCc---------
Confidence 25568999999999999999999999999999999999999999987652 11111111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCC
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKR 329 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~R 329 (366)
-.+|...+.++.+|++.+|+.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12455666789999999999999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=320.76 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=203.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|.-..+||+|+.|.||.|... +++.||+|.+...... ..+-+.+|+.+|+..+|+|||.+++.|...+...++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC----chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 56788889999999999999954 5888999999875443 456789999999999999999999999999999999
Q ss_pred EeeccCCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNEEF------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..++... .+++.++..+++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9998877532 4789999999999999999999999 99999999999999999999999999987754443
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+||+.|||||+.....|++++||||||++++||+.|++||.... + ..+.... .....+.+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--P----lrAlyLI---a~ng~P~l------ 489 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--P----LRALYLI---ATNGTPKL------ 489 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--h----HHHHHHH---hhcCCCCc------
Confidence 3455789999999999999999999999999999999999999997532 1 1111111 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..|.+|+.+||+.||++|||+.|||+
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 135567788999999999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=317.47 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=203.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|+..+.||+|.||.||+|.+. +++.||+|++..+... ...+.+.+|+.++.+++++||.++|+.+..+....++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~---deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE---DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc---hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45777899999999999999965 5899999999987666 4566788999999999999999999999999999999
Q ss_pred EeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++... .+.+..+..+.++++.|+.|||.++ .+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 8888776432 3477778889999999999999999 99999999999999999999999999987654433
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.. .+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..... .++.-++....
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIpk~~ 227 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIPKSA 227 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEeccCCC
Confidence 33 668999999999999999999999999999999999999999976552 11111111111
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+++.|++|+..||.+||+.||||.++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22234477888999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=323.03 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=193.7
Q ss_pred HhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
..++|++.+.||+|+||.||+|.. .+++.||+|+++..... ...+.+.+|+.+++.+ +||||++++++|.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch---HHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 346899999999999999999974 13567999998754332 2345788999999999 8999999999887
Q ss_pred eCC-cceEEEeeccCCC---------------------------------------------------------------
Q 037297 142 ETE-VPLLHLHDHHRNE--------------------------------------------------------------- 157 (366)
Q Consensus 142 ~~~-~~~~~~~~~~~~~--------------------------------------------------------------- 157 (366)
... ..++++++..++.
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 654 4566666554321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce-eeeeccc
Q 037297 158 ------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQG 230 (366)
Q Consensus 158 ------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~ 230 (366)
..++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... ......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 124677888999999999999999999 999999999999999999999999999765322211 1122345
Q ss_pred cCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHH
Q 037297 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKN 309 (366)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (366)
+..|+|||++.+..++.++|||||||++|||++ |..||....... ........... ...+..
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~---------~~~~~~ 301 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--------EFCQRLKDGTR---------MRAPEN 301 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHHHHhcCCC---------CCCCCC
Confidence 678999999999999999999999999999997 999996533110 01111111110 011334
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 310 QIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 310 ~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
+++.+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 55679999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.85 Aligned_cols=266 Identities=27% Similarity=0.439 Sum_probs=207.1
Q ss_pred cChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE
Q 037297 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 61 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
.+..++++..+...+...||+|.||+||+|.+- | .||||++.......+ +.+.|+.|+..+++-+|.||+-+.|+|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~--qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE--QLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH--HHHHHHHHHHHHhhcchhhheeeehhh
Confidence 344677888888999999999999999999974 3 399999998776654 778999999999999999999999999
Q ss_pred eeCCcceEEEeeccCCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 141 LETEVPLLHLHDHHRNEE--------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
..... .++...+.+... -.+...+.+.|+.||++||.|||.++ |||||||..||++.+++.|||+|||
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 98887 555555444432 25778889999999999999999999 9999999999999999999999999
Q ss_pred CcccccCC-CceeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 213 TSKFIAMD-QTHVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 213 ~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
++..-..- .........|...|||||++.. .+|+..+||||||+++|||++|..||.. .. .++.....
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~--~dqIifmV----- 605 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN--RDQIIFMV----- 605 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC--hhheEEEe-----
Confidence 98543211 1112223347788999998753 4789999999999999999999999983 21 11111000
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
=+....++. ......++.++.+|+..||..++++||++.+|+..|+.+..+..+
T Consensus 606 GrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 606 GRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred cccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 000001111 123456888999999999999999999999999988887765433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=319.27 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=190.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|++.+.||+|+||.||+|.+. +++.||+|.... ..+.+|+.+++.++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 368999999999999999999965 588999996432 246789999999999999999999998888888
Q ss_pred EEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 161 v~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 88776432 2335788999999999999999999999 99999999999999999999999999975432222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc--HHHHHHHHhhc--Cccc---
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS--LAAFFVHSMRK--NHMY--- 295 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~--- 295 (366)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||............ ........... ....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2334457999999999999999999999999999999999999888654321111000 00000000000 0000
Q ss_pred -cccc-------------hH--HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 -DILD-------------DQ--VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 -~~~~-------------~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..++ +. .........+.++.+|+.+||+.||.+|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00 000011234568999999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.77 Aligned_cols=260 Identities=22% Similarity=0.239 Sum_probs=198.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|.++ +++.+|+|++....... ...+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc--cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 47999999999999999999976 57889999987643322 2345778899999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++...+ ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9887654 2335888999999999999999999999 99999999999999999999999999987643333
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH---------HHHhhcCc
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF---------VHSMRKNH 293 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 293 (366)
.......++..|+|||++.+..++.++|+||+||++|+|++|+.||........ ....... ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ--LFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhCCCCHHHHHhhhccch
Confidence 333345689999999999988999999999999999999999999976432110 0000000 00000000
Q ss_pred c-----cccc-chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 M-----YDIL-DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~-----~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. +... ............+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000 000111122335678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=288.62 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=199.4
Q ss_pred HHHHhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
+....++|++.+.||+|||+.||++. ..+++.+|+|++.... ....+..++|++..+.++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34566899999999999999999998 4568899999998754 245678899999999999999999999876554
Q ss_pred c-----ceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEE
Q 037297 145 V-----PLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV 208 (366)
Q Consensus 145 ~-----~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl 208 (366)
. .|+++.++..+ ....+++.++++++.+++.||++||+.. ++++||||||.|||+++.+.++|
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence 3 77777666554 2336899999999999999999999986 68999999999999999999999
Q ss_pred eecCCcccccCC--Cce------eeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037297 209 ADFGTSKFIAMD--QTH------VTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277 (366)
Q Consensus 209 ~Dfg~a~~~~~~--~~~------~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 277 (366)
.|||++....-. ... .-.....|..|+|||++. +...++++|||||||+||+|+.|..||...-+ ...
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg 249 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG 249 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC
Confidence 999998654211 000 011223588999999875 44678899999999999999999999965321 000
Q ss_pred cccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 278 NVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
... ..+.+.+....-...++..+.+++++||+.||.+||++.+++..++++-
T Consensus 250 Sla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000 0111111111112237778999999999999999999999999988763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.85 Aligned_cols=242 Identities=28% Similarity=0.379 Sum_probs=202.1
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.-|.+++.||.|+.|.|-+|++ .+|+.+|||++....... ......+.+|+.+|+.+.||||+.+++++......|++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4588999999999999999995 479999999998763221 13345678999999999999999999999999999999
Q ss_pred EeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++..+ ++++....+++.||+.|+.|||..+ |+|||+||+|+|++..+++||+|||+|.... .+
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~g 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PG 165 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CC
Confidence 9999887544 7999999999999999999999999 9999999999999999999999999997532 34
Q ss_pred eeeeeccccCCccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
....+.||++.|.|||++.|.+|. .++||||+||+||.|++|+.||+++.- ...+. -...+.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLl-KV~~G~-------- 228 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLL-KVQRGV-------- 228 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHH-HHHcCc--------
Confidence 455667999999999999999985 589999999999999999999985431 00000 011111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
-.+|...+.+..+|+.+||..||+.|.|++||++
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1245566678999999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.88 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=210.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC--Cc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED--GR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..+.++.+.||+|+||.||.|...+ |. .||+|.++..... .....|++|..+|+.++|||||+++|+|...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~---~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE---QEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4667888999999999999999653 43 4899998876555 5567899999999999999999999999998
Q ss_pred CcceEEEeeccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 144 EVPLLHLHDHHRNE--------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
...++++++..++. ...++....+.++.|||+|+.||++++ +|||||.++|+|++....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 88888888776552 335889999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeee-ccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTK-IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
|||+|+.+...+...... ..-...|||||.+..+.++.|+|||||||++||+++ |..||....+. +....
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------~v~~~ 916 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------EVLLD 916 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------HHHHH
Confidence 999999665444333322 244578999999999999999999999999999999 99999775521 01111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcc
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHK 350 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~ 350 (366)
..... +...|..|+..+.++|..||+.+|++||++..+++.+..+..-..+-.
T Consensus 917 ~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 VLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred HHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 11111 334588899999999999999999999999999998887765444433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=298.74 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=195.6
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC---
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--- 143 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--- 143 (366)
.....|...+.||+|+||.|+.+.++ +|+.||+|++....... ...++..+|+.++++++|+||+.+.+++...
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 34566777899999999999999965 68999999988544443 4456889999999999999999999998762
Q ss_pred --CcceEEEeeccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 --EVPLLHLHDHHR------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 --~~~~~~~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.-.|++.+.... .....++...+..+..|++.|++|+|+.+ ++|||+||.|++++.+..+||+|||+|+
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 234555443221 23445899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC-ceeeeeccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC-
Q 037297 216 FIAMDQ-THVTTKIQGTFGYLEPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN- 292 (366)
Q Consensus 216 ~~~~~~-~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 292 (366)
...... ....+..+.|..|+|||++ ....|+.+.||||+||++.||++|++-|.+.+...+. .+.....+.....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql--~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL--QLILELLGTPSEED 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH--HHHHHhcCCCCHHH
Confidence 875431 2233667889999999966 4568999999999999999999999999765421111 1111100000000
Q ss_pred --------------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 --------------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+. ..+.....+-++.++...+|+++||..||.+|+|++|.++
T Consensus 252 l~~i~s~~ar~yi~slp~-~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQ-IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCC-CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 1111112223366678899999999999999999999964
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=307.00 Aligned_cols=258 Identities=21% Similarity=0.236 Sum_probs=191.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|..+ ++..||+|.++..... .....+.+|+.+++.++||||+++++++......+++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57999999999999999999965 5889999998754322 1234567899999999999999999999988888888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 8876531 2234788899999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc-----
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD----- 296 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 296 (366)
......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... +................+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccccch
Confidence 2233457889999998865 56899999999999999999999999754311 10000000000000000000
Q ss_pred ----ccchH----HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ----ILDDQ----VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+. .........+.++.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000112234567899999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=316.48 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=203.4
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
+...+...-++-||+|+.|.||+|+.. ++.||||+++.- -..++.-|++|+||||+.+.++|......
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 333344455678999999999999986 688999987642 12367789999999999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++|+++..++ ..+++......|..+||.||.|||.+. |||||||.-||||+.+..|||+|||.++....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999987653 447888899999999999999999998 99999999999999999999999999986643
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .....++||..|||||++...+.+.|+|||||||+||||+||..||.+.+... .++.+=.
T Consensus 265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------------IIwGVGs 325 (904)
T KOG4721|consen 265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------------IIWGVGS 325 (904)
T ss_pred h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------------eEEeccC
Confidence 3 33445889999999999999999999999999999999999999997654211 1222222
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+...+|..|++.|.-|+++||+..|..||++.+++.-|+-...
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 333445788899999999999999999999999999988876553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=301.40 Aligned_cols=249 Identities=19% Similarity=0.339 Sum_probs=197.0
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|..+ .+..+|+|.++..... .....+.+|+..++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 357999999999999999999753 3568999999875433 234578899999999999999999999999999
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+. ...+++..++.++.|++.|+.|||+++ ++||||||+||+++.++.++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999876542 236789999999999999999999999 999999999999999999999999987654
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
............++..|+|||.+.+..++.++||||+||++||+++ |..||...... . .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~-~~~~~~~~~--- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------D-VIKAVEDGF--- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------H-HHHHHHCCC---
Confidence 3221111112234578999999999999999999999999999775 99999754311 0 011111110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+..++..+.+++..||+.+|++|||++++.+.|..+
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112345667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=302.97 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=193.7
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-----------------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (366)
.++|++.+.||+|+||.||+|.+++ +..||+|.+...... .....+.+|+.++..++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---NARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH---HHHHHHHHHHHHHhhcCCCC
Confidence 3679999999999999999997532 336999998865433 34567899999999999999
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNEE--------------------------FPLTWEIRLRIATEVAGALSYLHSAASS 186 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 186 (366)
|+++++++...+..++++++...+.. ..+++..+..++.|++.||.|||+.+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999888888887654321 23567788999999999999999999
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh--
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-- 263 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-- 263 (366)
++||||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999998765433221 1223345788999999988899999999999999999987
Q ss_pred CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 264 GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 264 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
+..||..... .. ............... .....++.++..+.+++.+||+.||++|||+.|+.+.|+.
T Consensus 238 ~~~p~~~~~~--~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTD--EQ---VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCH--HH---HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5567765331 11 011111111110000 0001123456689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=304.36 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=191.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ +++.+|+|+++..... .....+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 467999999999999999999976 5889999998754332 122356789999999999999999999999998899
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 98876432 2245788899999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---cccc-
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMYD- 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 296 (366)
.......+|..|+|||++.+ ..++.++||||+||++|+|++|..||........ ............ .+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD----QLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhCCCChhhccch
Confidence 12233467899999998865 4588899999999999999999999976432100 000000000000 0000
Q ss_pred -----c--------cchHHhhh-hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 -----I--------LDDQVVKL-VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 -----~--------~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ........ -....+..+.+|+..||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00000000 00112357889999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.98 Aligned_cols=242 Identities=25% Similarity=0.283 Sum_probs=205.1
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (366)
.....+|.++++||+|+||.|+++..+ +++.+|||++++...-.. ...+..+.|.+++... +||.++.++.+|.+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 344578999999999999999999976 588999999998665433 4567888999988877 6999999999999999
Q ss_pred cceEEEeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 VPLLHLHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 ~~~~~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++..++.. ..+++..+.-++..|+.||.|||++| ||+||||.+|||++.+|.+||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999988752 36899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
. ....+++++||+.|+|||++.+..|+.++|.|||||++|||+.|+.||.++++. .....+...+.
T Consensus 520 ~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------e~FdsI~~d~~---- 585 (694)
T KOG0694|consen 520 G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------EVFDSIVNDEV---- 585 (694)
T ss_pred C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHhcCCC----
Confidence 3 334677899999999999999999999999999999999999999999876521 11112222111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
.+|...+.+..++++++|.+||++|..+
T Consensus 586 ------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2466677789999999999999999876
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=317.50 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=196.3
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeE
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKL 136 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 136 (366)
.......++|++.+.||+|+||.||+|.. .++..||+|+++..... ...+.+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc---HHHHHHHHHHHHHHHhcCCcceeee
Confidence 34445567899999999999999999963 23568999998754333 2345788999999999 89999999
Q ss_pred eeEEeeCCcceEEEeeccCCC-----------------------------------------------------------
Q 037297 137 LGCCLETEVPLLHLHDHHRNE----------------------------------------------------------- 157 (366)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~----------------------------------------------------------- 157 (366)
+++|...+..++++++..+++
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 999999998888887653321
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 158 -----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 158 -----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccc
Confidence 124678889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 215 KFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 215 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .........
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~ 333 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKMIKEG 333 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--------HHHHHHHhC
Confidence 7654332211 112234567999999999999999999999999999998 888986543110 011111111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
. ....+...+.++.+++..||+.||++|||+.|+++.|+.
T Consensus 334 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 Y---------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred c---------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0 001122335679999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.83 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=206.8
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEcCC-cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeE-Ee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDG-RIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGC-CL 141 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~ 141 (366)
.+.....++++.+.|.+|||+.||+|.+..+ ..+|+|++-.. +. ...+.+.+|+++|+.|+ |||||.++|. ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CH---HHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 3344557889999999999999999997765 99999998875 33 45678999999999995 9999999993 22
Q ss_pred eC-----Cc-ceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeE
Q 037297 142 ET-----EV-PLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206 (366)
Q Consensus 142 ~~-----~~-~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~v 206 (366)
.. .. .++.++++.+++ ...|++.++++|+.|+++|+.+||... +||||||||-+||||+.+|+.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCE
Confidence 21 12 334455554332 224899999999999999999999985 889999999999999999999
Q ss_pred EEeecCCcccccCCCcee-e-------eeccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037297 207 KVADFGTSKFIAMDQTHV-T-------TKIQGTFGYLEPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~~~-~-------~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 275 (366)
||||||.|.......... . -....|+.|+|||++ .+.++++|+|||||||+||-|+....||...+.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999987543222110 0 012268999999977 467899999999999999999999999976542
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCccccc
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMIY 353 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~ 353 (366)
..+++....-...+.++..|.+||..||+.||++||++-|+++.+..+.........++
T Consensus 264 -------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 -------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 11111111122235788899999999999999999999999999999998888877776
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.13 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=196.0
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (366)
+....++|++.+.||+|+||.||+|... ++..||+|.++..... ...+.+.+|+.+++.+ +||||+++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEee
Confidence 3445568999999999999999998742 2457999999865443 2345788999999999 8999999999
Q ss_pred EEeeCCcceEEEeeccCCC-------------------------------------------------------------
Q 037297 139 CCLETEVPLLHLHDHHRNE------------------------------------------------------------- 157 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~------------------------------------------------------------- 157 (366)
+|......++++++...+.
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999888888877653221
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 158 ----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 158 ----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
..++++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 124678889999999999999999999 9999999999999999999999999987654322
Q ss_pred cee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 222 THV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 222 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ... ...... .
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~----~~~~~~-~----- 332 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFY----KMVKRG-Y----- 332 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHH----HHHHcc-c-----
Confidence 211 112234567999999988899999999999999999997 999997543110 000 001110 0
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....+...+.++.+++..||+.||.+|||+.++++.|+.+-
T Consensus 333 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 ---QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00011223567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=303.53 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=186.6
Q ss_pred cCCcccceecccCceEEEEEEEc--CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEee---
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLE--- 142 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~--- 142 (366)
.+|++.+.||+|+||.||+|.+. ++..+|+|.++....... ....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 37999999999999999999863 467899999876443321 123455677666655 69999999999863
Q ss_pred --CCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 143 --TEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 143 --~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
....++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 33466677765431 2235788999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh--
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR-- 290 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 290 (366)
++...... .......+|..|+|||.+.+..++.++||||+||++|||++|++||........ .........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-----~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKILDVIGLP 228 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHHhCCC
Confidence 99765432 223345689999999999888999999999999999999999999976432110 000100000
Q ss_pred -cCcccc----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 -KNHMYD----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 -~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+.. ...........+..+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00000111122345667899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.57 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=193.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|+..+.||+|+||.||+|... +++.+|+|.+........ .....+.+|+.+++.++|+||+++++++...+..++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh-hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 3778899999999999999964 689999999876433221 22346788999999999999999999999999989998
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..++. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 8776542 225788999999999999999999999 999999999999999999999999999765322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......||..|+|||++.+..++.++||||+||++|+|++|+.||........ ...........
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~--------- 220 (285)
T cd05631 156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKED--------- 220 (285)
T ss_pred -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcc---------
Confidence 122345689999999999999999999999999999999999999976432110 00011101100
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
....+...+.++.+|+..||+.||.+||| ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01123445668999999999999999997 677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=300.73 Aligned_cols=241 Identities=23% Similarity=0.359 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee----CCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~~~~~ 152 (366)
..||+|++|.||+|.. +|+.||+|.++...... ....+.+.+|+.+++.++||||+++++++.+ ....++++++
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 58899999997643322 1234678899999999999999999999877 3456778887
Q ss_pred ccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 153 HHRN-------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 153 ~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
..++ ....+++.....++.|++.|+.|||+. + ++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 7654 234678889999999999999999984 6 8899999999999999999999999987653221
Q ss_pred eeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 225 TTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... . ...........
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~------~~~~~i~~~~~--------- 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--K------EIYDLIINKNN--------- 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--H------HHHHHHHhcCC---------
Confidence 23457889999999876 6889999999999999999999999975431 0 00111111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....+..++..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01123346778999999999999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=299.44 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=204.7
Q ss_pred HhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...+|++.+.||+|.||.|-+|+. ..|+.||||.++.+...+. ...-.+.+|+++|..|+||||+.++.+|...+...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 346899999999999999999995 6799999999988666544 44567899999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++|++..++. ...+++...+++++||..|+.|+|.++ ++|||||.+|||++.|+++||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999987764 347899999999999999999999998 999999999999999999999999999876533
Q ss_pred CceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
....++||++-|.+||++.|.+| .+.+|.||||++||-|+.|..||++.+ ...+...+....+.
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---------hk~lvrQIs~GaYr---- 271 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---------HKRLVRQISRGAYR---- 271 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---------HHHHHHHhhccccc----
Confidence 33456899999999999999998 568999999999999999999998754 12222222222221
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..+.+..-||++||..||++|.|++++..
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1223345677999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.61 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=196.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc-eeeEeeEEeeCC---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETE--- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~--- 144 (366)
...|..+++||+|+||+||+|+.+ +|+.||+|+++.....+. .-....+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG--~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG--VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC--CCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 455777888999999999999955 689999999998765322 1235689999999999999 999999998877
Q ss_pred ---cceEEEeeccCC-------CC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 145 ---VPLLHLHDHHRN-------EE---FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 145 ---~~~~~~~~~~~~-------~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
..++++++.... .. ..++...+..++.|++.|++|||+++ |+||||||+||||+++|.+||+||
T Consensus 88 ~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeecc
Confidence 677777654321 11 35677889999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
|+|+...... ...+..++|..|+|||++.|. .|+...||||+||+++||++++.-|.+..+ .++............
T Consensus 165 GlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCC
Confidence 9998665332 224556789999999998887 799999999999999999999988876553 111111111111111
Q ss_pred cCcccc-------------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 291 KNHMYD-------------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 291 ~~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
...++. ...+......-+....+..+++.+||+.+|.+|.|++.+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 112221 111111111112222478899999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=301.18 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=193.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|..+ +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 46899999999999999999976 5889999998753221 123445788999999999999999999999999989999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++.....++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 98876542 336788999999999999999999999 999999999999999999999999998765322
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...........
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~---------- 214 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK---------- 214 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC----------
Confidence 1234689999999999999999999999999999999999999975431 00011111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
...+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0123344567899999999999999995 777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=298.22 Aligned_cols=247 Identities=21% Similarity=0.373 Sum_probs=197.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++......+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 467999999999999999999987788899998765322 245788999999999999999999999998888888
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..++. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 88765432 335788889999999999999999998 999999999999999999999999999866433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... . . ..........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~------~-~~~~~~~~~~----- 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--S------D-VMSALQRGYR----- 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--H------H-HHHHHHcCCC-----
Confidence 3222233345678999999988889999999999999999998 9999865321 0 0 0011111100
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
......++.++.+++.+||..||++|||++++.+.|+++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=300.18 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=196.7
Q ss_pred cCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
++|++.+.||+|+||.||+|.... ...+|+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP---KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH---HHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468999999999999999998543 257999998754433 33457889999999999999999999999888
Q ss_pred cceEEEeeccCCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 145 VPLLHLHDHHRNEE-----------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 145 ~~~~~~~~~~~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
..++++++...+.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEc
Confidence 88888877644311 34778889999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 279 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 279 (366)
+++.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~--- 233 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--Q--- 233 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--H---
Confidence 999999999999876533221 12233446788999999988899999999999999999998 9999975431 0
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
........... ...+..++.++.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 234 ----~~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 ----EVIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----HHHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111 123456778899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=294.18 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=203.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|.+. +++.+|+|.+...... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 36888999999999999999864 6889999998764332 2345788999999999999999999999999999999
Q ss_pred EeeccCCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeee
Q 037297 150 LHDHHRNEE---FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226 (366)
Q Consensus 150 ~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 226 (366)
+++...... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 78 TEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred EecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 888766532 25788899999999999999999999 999999999999999999999999998755322 223
Q ss_pred eccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhh
Q 037297 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306 (366)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (366)
...++..|+|||.+.+..++.++|+||+||++|+|++|+.||............ .............. ..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~--------~~ 221 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP--LQLLQCIVDEDPPV--------LP 221 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch--HHHHHHHhccCCCC--------CC
Confidence 356889999999999999999999999999999999999999753321111100 00011111110000 01
Q ss_pred cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccccccchHHH-HhhhcC
Q 037297 307 KKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMIYSTGTLLR-LFWLIK 366 (366)
Q Consensus 307 ~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 366 (366)
....+.++.+++.+||+.||++||+++|+++.- +-..+..+.+.+ ++|.++
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~---------~~~~~~~~~~~~~~~~~~~ 273 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP---------FIVQYNDGNAEVVSMWVCR 273 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc---------ccccccCccHHHHHHHHHH
Confidence 122455789999999999999999999997531 112224444444 888753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=308.11 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=187.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-----c
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----V 145 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 145 (366)
+|++.+.||+|+||.||+|.++ +++.||+|.+....... .....+.+|+.+++.++||||+++++++.... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc--hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 5889999999999999999965 58999999987533221 23346889999999999999999999876543 3
Q ss_pred ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 146 PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 146 ~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 79 IYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 56777766432 1235889999999999999999999999 99999999999999999999999999875432
Q ss_pred CCc--eeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH--------HH
Q 037297 220 DQT--HVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF--------VH 287 (366)
Q Consensus 220 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 287 (366)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...... ..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL--DLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH--HHHHHHhCCCCHHHHH
Confidence 221 11234568999999998866 67899999999999999999999999654311000 000000 00
Q ss_pred HhhcCc-------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNH-------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... +......... ...+..++.+.+++..||+.||++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFS-QKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchH-HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0000000000 001123557889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=308.99 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=206.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc-ceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-PLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 148 (366)
++|..++.+|+|+||.++.++++ ++..+++|.+......+. .......|+.+++++.|||||.+.+.+.+.+. .++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57999999999999999999966 478899999988766543 23378899999999999999999999999988 888
Q ss_pred EEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++.++. ..-++++.+..++.|++.|+.|||+.+ |.|||||+.||+++.++.|+|+|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 888887763 235889999999999999999999888 99999999999999999999999999998875
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.. .......||+.|++||++.+.+|+.|+|||||||++|||++-+.+|...+-.. .... +.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---------Li~k---------i~ 219 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---------LILK---------IN 219 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---------HHHH---------Hh
Confidence 54 34556789999999999999999999999999999999999999997644100 0000 01
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
+.....++..++.++..+++.||+.+|..||++.+++..
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111234678889999999999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.41 Aligned_cols=237 Identities=23% Similarity=0.287 Sum_probs=189.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
+.||+|+||.||+|..+ +|+.+|+|+++...... ......+.+|+.+++.++||||+++++++...+..++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998643221 13345678899999999999999999999999999999998766
Q ss_pred CC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 156 NE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 156 ~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 53 236789999999999999999999999 999999999999999999999999998753222 1222345
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... ...... ..++.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~-~~~~~~----------~~~p~ 216 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE-LILMEE----------IRFPR 216 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHH-HHHcCC----------CCCCC
Confidence 689999999999999999999999999999999999999975331 00000 111110 01234
Q ss_pred HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..+.++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4566889999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.25 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=195.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999976 5888999998865333 234578999999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++. ...+++..+..++.|++.|+.|||+. + ++||||||+|||++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 998876542 23578899999999999999999985 5 999999999999999999999999998755322
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh-hc-Cc-----
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM-RK-NH----- 293 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~----- 293 (366)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ......... .. ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccCCcccc
Confidence 2233568999999999999999999999999999999999999996533100 000000000 00 00
Q ss_pred -----------------------cccccchHH----hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 294 -----------------------MYDILDDQV----VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 294 -----------------------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..+..+.-. ........+.++.+|+.+||+.||++|||++|+++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 000112356789999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=305.81 Aligned_cols=240 Identities=24% Similarity=0.304 Sum_probs=192.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 367999999999999999999975 5889999998753221 12334678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 998876542 236788999999999999999999999 9999999999999999999999999997653221
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... .....
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i-~~~~~------- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKI-LAGRL------- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHH-hcCCc-------
Confidence 234689999999999999999999999999999999999999975331 0001111 11100
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVT 336 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell 336 (366)
.++...+..+.+|+..||+.||.+||+ +++++
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 112234557889999999999999997 56664
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=294.46 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=193.5
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
++|++.+.||+|+||.||++..+++..+|+|.+...... .+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 568899999999999999999887788999987754322 246788999999999999999999999999889998
Q ss_pred eeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++..++ ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 877543 2235788999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||..... .............
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~------- 220 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRL------- 220 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCC-------
Confidence 22222335667999999988899999999999999999999 8999865431 0111111111100
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
..+...+..+.+++.+||+.||.+|||++++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 012223457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=307.39 Aligned_cols=248 Identities=24% Similarity=0.268 Sum_probs=193.3
Q ss_pred CCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
+|++.+.||+|+||.||++... +++.+|+|++............+.+..|+.+++.+ .||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999852 57899999997643333333456788899999999 599999999999999988
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99988876542 235889999999999999999999999 99999999999999999999999999976544
Q ss_pred CCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
..........||..|+|||++.+. .++.++|||||||++|||++|+.||......... ...........
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~------ 227 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKCD------ 227 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcCC------
Confidence 333333446799999999998765 4788999999999999999999999754321111 11111111100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..++...+..+.+++.+||+.||++|| +++++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 -----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 012334556789999999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.80 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=195.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|++.+.||+|++|.||+|..+ +++.+|+|.+.... ...+.+.+|+++++.++||||+++++++...+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45888899999999999999965 58889999987532 2245788999999999999999999999998888888
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..... ...+++..++.++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 88765431 235788999999999999999999998 999999999999999999999999998765433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........++..|+|||.+.+..++.++|+|||||++|||++ |..||..... . .... .....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~------~~~~-~~~~~------- 221 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S------QVYE-LLEKG------- 221 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H------HHHH-HHHCC-------
Confidence 2222222234567999999999999999999999999999998 8999864321 0 0001 11110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
.....+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 --YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01112334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=313.81 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=207.5
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEcC--C--cE-EEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEee
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLED--G--RI-MAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~--~~-vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (366)
..++...++..+.++||+|+||.||+|..+. + .. ||+|..+.... ........+++|++++++++|||||+++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3455556777888999999999999999542 2 23 89998886221 22356789999999999999999999999
Q ss_pred EEeeCCcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 139 CCLETEVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
++......++++|.+.++. ...++..+...++.+.+.||+|||+++ +|||||.++|+|++.++.+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999987753 225889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
||++....... .......-...|+|||.+....++.++|||||||++||+++ |..||.+.... ......
T Consensus 306 FGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------~v~~kI 375 (474)
T KOG0194|consen 306 FGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------EVKAKI 375 (474)
T ss_pred cccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------HHHHHH
Confidence 99987553111 11111235678999999999999999999999999999999 89999775421 011111
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
.....+...+...+.++..++..||..||++||||.++.+.|+.+.....
T Consensus 376 --------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 --------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111223445677789999999999999999999999999988875544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=287.13 Aligned_cols=262 Identities=21% Similarity=0.240 Sum_probs=200.9
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--C
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--E 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 144 (366)
...++|+.+..|++|+||.||+|+++ +++.||+|+++.+........ ...+|+.++.+++|||||.+-.+.... +
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI--tsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI--TSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc--hhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 34567999999999999999999965 689999999988665433222 457899999999999999998887654 3
Q ss_pred cceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..|++++++.. +...++....+..+..|++.|++|||+.. |+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 56777766432 23457888999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
+... ...+..+-|..|+|||++.|. .|+.+.|+||+||++.||+++++-|.+.+... +...............++.
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCC
Confidence 6542 335566789999999988875 69999999999999999999999998766322 2222222222222222222
Q ss_pred ccch--------------HHhhhhcHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDD--------------QVVKLVKKN-QIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~--------------~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+... .++..++.. .++.-.+|+..+|..||.+|.|++|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 2111 112222222 4566789999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=321.90 Aligned_cols=262 Identities=21% Similarity=0.381 Sum_probs=215.7
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
+...+...|.++||.|.||.|++|+.+- ...||||.++....+ .....|+.|+.||-+++||||+++.++...
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte---kqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH---HHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3445677889999999999999999652 356999999987666 455689999999999999999999999988
Q ss_pred CCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 143 TEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 143 ~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
....+++.|+...+ .+..++..++..+.+.|+.||+||-+++ +|||||.++|||++.|..+|++|||++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 88888887765443 4456788889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeec--cccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 215 KFIAMDQTHVTTKI--QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 215 ~~~~~~~~~~~~~~--~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
+.+..+.....+.. .-..+|.|||.+.-..++.++|+||+|+++||.++ |..||.+..+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------------------ 840 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------------ 840 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------------------
Confidence 97765543333322 23578999999999999999999999999999666 9999987662
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccc
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMI 352 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 352 (366)
.++..-++...+...|..|+..+.+|+.+||++|-.+||++.||+..|+.+-.+...++-+
T Consensus 841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~ 901 (996)
T KOG0196|consen 841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI 901 (996)
T ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence 1122222334444568889999999999999999999999999999999887655554443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.63 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=196.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|... +++.||+|+++..... .......+..|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 46999999999999999999976 5889999999864322 123345788999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99876542 335788999999999999999999999 99999999999999999999999999875432
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
......||+.|+|||.+.+..++.++|||||||++|||++|..||..... .+ ........... .....
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~------~~~~i~~~~~~---~~~~~ 221 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NE------TWENLKYWKET---LQRPV 221 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HH------HHHHHHhcccc---ccCCC
Confidence 23345689999999999999999999999999999999999999975431 10 00001000000 00000
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
........+.++.+++..||+.+|.+|||++++++-
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000112456789999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.36 Aligned_cols=257 Identities=23% Similarity=0.285 Sum_probs=191.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-----c
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----V 145 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 145 (366)
+|++.+.||+|+||.||++.+. +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL--VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch--HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 4788999999999999999964 68999999986543221 33457889999999999999999999988766 5
Q ss_pred ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 146 PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 146 ~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 79 IYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 67777665432 2346889999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH--------------
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF-------------- 284 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 284 (366)
..........++..|+|||.+.+. .++.++||||+||++|||++|+.||........ ......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHHhh
Confidence 333333334678899999988774 578999999999999999999999975432110 000000
Q ss_pred --HHH-HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 --FVH-SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ......... ............++++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 234 EGARAHILRGPHKPP--SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHHhCCCCCC--chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 000000000 000000122234667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.28 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=190.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
..+|++.+.||+|+||.||+|... +++.||+|++..... ...+|+.+++.++||||+++++++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ--------YKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 467999999999999999999965 588999998864321 2346999999999999999998765431
Q ss_pred ----cceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEe
Q 037297 145 ----VPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVA 209 (366)
Q Consensus 145 ----~~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~ 209 (366)
..++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 344566665432 2346888999999999999999999999 99999999999998664 79999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH------
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA------ 282 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------ 282 (366)
|||++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+............
T Consensus 214 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 214 DFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred ccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998654322 22335678999999988764 689999999999999999999999976432110000000
Q ss_pred -HHHH---HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhccc
Q 037297 283 -AFFV---HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRG 344 (366)
Q Consensus 283 -~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~ 344 (366)
.... .......++......+...++...+.++.+|+.+||+.||.+|||+.|+++ .+..+.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0000 000001111222223333445556778999999999999999999999973 3445444
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.90 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=196.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|++|.||+|...++..+|+|.++..... .+.+.+|+.+++.++||||+++++++......+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 4679999999999999999999877788999998754322 34678899999999999999999999999888888
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..+. ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 8876433 1235789999999999999999999999 999999999999999999999999999876532
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
..........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ............
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~------ 222 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYR------ 222 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC------
Confidence 2211122223457999999998899999999999999999999 9999865331 000101111100
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+...+..+.+++.+||+.||++||+++++++.|+.+
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011234556799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.65 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=191.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|+..+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++|+||+++++++......++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED---TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH---HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 356888899999999999999965 5899999998754332 334578899999999999999999999999999999
Q ss_pred EEeeccCCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 149 HLHDHHRNEE---FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 149 ~~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
++++..++.. ....+..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 150 v~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPC 225 (353)
T ss_pred EEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccc
Confidence 9888766532 23567788899999999999999999 9999999999999999999999999987654221 122
Q ss_pred eeccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 226 TKIQGTFGYLEPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
....||..|+|||.+.. ...+.++|||||||++|||++|+.||...... .............
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~-------- 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMSQ-------- 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhccC--------
Confidence 33568999999998743 23456899999999999999999999732211 1111111000000
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+...+.++.+|+..||+.||++|||+.|+++
T Consensus 293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123345668999999999999999999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=278.96 Aligned_cols=244 Identities=27% Similarity=0.311 Sum_probs=201.9
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...++|++++.||+|-||.||.|+.+ ++..||+|++.+..... .....++.+|+++-.+|+||||+++|++|.+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34578999999999999999999965 57889999987644322 23346899999999999999999999999999999
Q ss_pred eEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
|+++++...+. ...+++.....+..|+|.|+.|+|..+ ++||||||+|+|++..+.+||+|||=+..-
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999876652 335888899999999999999999998 999999999999999999999999987543
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
. .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||.+... ...+....
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~-------- 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIR-------- 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHH--------
Confidence 2 3344567899999999999999999999999999999999999999976441 01111111
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...-.+|...+.+..|++..|+..+|.+|.+..|+++
T Consensus 236 ---k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 ---KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1112235566778899999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.86 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=192.3
Q ss_pred HhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
..++|++.+.||+|+||.||+|... +++.||+|+++..... ...+.+..|+.+++++ +||||++++++|.
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA---SEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH---HHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3468999999999999999999632 2578999998754332 2345678899999999 8999999999887
Q ss_pred eCC-cceEEEeeccCCC---------------------------------------------------------------
Q 037297 142 ETE-VPLLHLHDHHRNE--------------------------------------------------------------- 157 (366)
Q Consensus 142 ~~~-~~~~~~~~~~~~~--------------------------------------------------------------- 157 (366)
..+ ..++++++...+.
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 654 4445555443211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce-eeeecccc
Q 037297 158 -----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGT 231 (366)
Q Consensus 158 -----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t 231 (366)
..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+...... ......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 125788899999999999999999998 999999999999999999999999999765332211 12223456
Q ss_pred CCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHH
Q 037297 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310 (366)
Q Consensus 232 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (366)
..|+|||++.+..++.++|||||||++|||++ |..||....... ........... ...+...
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~---------~~~~~~~ 301 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGTR---------MRAPEYA 301 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccCC---------CCCCccC
Confidence 78999999999999999999999999999998 999986532100 01111111110 1113345
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 311 IMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 311 ~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
+.++.+++..||+.+|++|||+.|+++.|+++..
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5679999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.09 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=194.9
Q ss_pred cCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+|.+.+.||+|+||.||+|...+ +..+|+|.++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH---HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 568899999999999999998532 478999998765443 23467899999999999999999999999999
Q ss_pred cceEEEeeccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 145 VPLLHLHDHHRN---------------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 145 ~~~~~~~~~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
..++++++..++ ....+++..+..++.|++.|+.|||+++ ++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 888888876432 1234788899999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccH
Q 037297 204 YRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 281 (366)
+.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------ 232 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------ 232 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 9999999999875432221 11222345678999999999999999999999999999998 999987543210
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.......... ...+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 233 ---~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 ---VIECITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111111 1112345567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.74 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=194.5
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++|++.++||+|+||.||+|..++++.+|+|.+...... .+.+.+|+.+++.++|||++++++++. .+..++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 34679999999999999999999888899999998754432 246788999999999999999998864 456677
Q ss_pred EEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++...+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 777654432 235788899999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
..........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... ... ......
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~----~~~~~~----- 220 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQ----NLERGY----- 220 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHH----HHHcCC-----
Confidence 32222223345678999999988889999999999999999999 999996543110 000 000100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+...+.++.+++.+||+.||++|||++++++.|+++
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 221 ----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0011233456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.64 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=192.5
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+|++.+.||+|+||.||+|... .+..+|+|+++..... ...+.+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45888899999999999999853 2467999999865433 23457889999999999999999999998888
Q ss_pred cceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 145 VPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 145 ~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
..++++++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 8777776643221 124778889999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 279 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 279 (366)
+++.+||+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||..... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~--- 233 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--Q--- 233 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--H---
Confidence 999999999999875532221 11223345778999999988889999999999999999998 8888865321 0
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
........... ...+..++..+.+++..||+.||.+|||+++++..|+.
T Consensus 234 ----~~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 ----DVIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111111111 11234566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=300.49 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=193.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..+|++.+.||+|+||.||+|.+. ++. .||+|.++..... ...+.+.+|+.+++.++||||++++++|....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence 357999999999999999999854 333 4899998754332 23457889999999999999999999987654
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++...+. ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 83 -~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred -ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 455555544332 234778889999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceee-eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHVT-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~-------~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SE-------ISSILEKGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HH-------HHHHHhCCCC
Confidence 654332221 22234667999999999999999999999999999997 9999865321 00 0011111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
...+..++.++.+++..||+.||++|||+.+++..|..+.....
T Consensus 230 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 230 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 01122345578999999999999999999999999988775443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.18 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=192.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.+|++.+.||+|+||.||.+...++..+|+|.+...... .+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 468899999999999999998776667999988754322 246889999999999999999999999888888888
Q ss_pred eeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++...+ ....+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 876543 1236889999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...... ....... .....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~-~~~~~------ 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVS-QGLRL------ 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHh-cCCCC------
Confidence 22222335677999999988889999999999999999998 99998653310 0001111 11000
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
..+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011224567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=291.89 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=193.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|..+++..+|+|.+...... .+.+.+|+.+++.++|||++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 4579999999999999999999887888999998764332 246889999999999999999999875 4456777
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 7766543 1235789999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ... .......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~-~~~~~~~------ 220 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVL-EQVERGY------ 220 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHH-HHHHcCC------
Confidence 2222222335667999999988889999999999999999999 88998653310 000 0111100
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
....+...+..+.+++.+||+.||.+|||+.++.+.|++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 ---RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011233455679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=291.31 Aligned_cols=253 Identities=21% Similarity=0.345 Sum_probs=200.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|... +++.+|+|.++..... .......+.+|+.+++.++||||+++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57999999999999999999965 6899999988653222 123445788999999999999999999999998888888
Q ss_pred EeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++...+. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 88765432 234788899999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ . ..........+.
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~-- 227 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF------S-LCQKIEQCDYPP-- 227 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH------H-HHHHHhcCCCCC--
Confidence 3221 11234578889999999888899999999999999999999999965432110 0 111111111111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
......+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus 228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112345567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.42 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=198.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..+|++.+.||.|+||.||+|...++..+|+|.+..... .....+..|+.+++.++||||+++++++......+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 456999999999999999999988889999999876432 2344688899999999999999999999999999999
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..+. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 8877543 2335788999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ...........
T Consensus 158 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~------- 221 (261)
T cd05148 158 VY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGY------- 221 (261)
T ss_pred cc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCC-------
Confidence 21 1223345678999999988899999999999999999998 8999865331 00011111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112345567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.39 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=196.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|..+. ...+|+|.++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD---KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 3579999999999999999998642 457999998765433 234578889999999999999999999998888
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 888888775532 235789999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---------DVIKAVEDGYR- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---------HHHHHHHcCCC-
Confidence 522221 1122334678999999998899999999999999999998 99998653210 01111111100
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 227 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 --------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=306.60 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=197.7
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGC 139 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 139 (366)
....++|++++.||+|+||.||+|.+. .+..||+|+++..... ...+.+.+|+.+++.+. ||||++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---SEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 344578999999999999999999853 1346999999765433 33467899999999995 9999999999
Q ss_pred EeeCCcceEEEeeccCCC--------------------------------------------------------------
Q 037297 140 CLETEVPLLHLHDHHRNE-------------------------------------------------------------- 157 (366)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~-------------------------------------------------------------- 157 (366)
|......+++++++..+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999988764321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 037297 158 -----------------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKST 196 (366)
Q Consensus 158 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~ 196 (366)
...+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 113677788899999999999999999 999999999
Q ss_pred CEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 037297 197 NILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274 (366)
Q Consensus 197 Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~ 274 (366)
|||++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999998765432221 1122346678999999998999999999999999999997 99998653210
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. .......... ....+..++.++.+++..||+.||++|||+.++.+.|+.+-
T Consensus 347 ~--------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 S--------TFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--------HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0 0000111110 01123345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=293.12 Aligned_cols=267 Identities=24% Similarity=0.274 Sum_probs=195.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc---
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP--- 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 146 (366)
-.|.-.+++|+|+||.||.|... +++.||||+.-.+..-. -+|+.+|+.++|||||++.-+|......
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 35777899999999999999954 57899999987654432 3699999999999999999888655432
Q ss_pred --eEEEeeccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCC
Q 037297 147 --LLHLHDHHR----------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGT 213 (366)
Q Consensus 147 --~~~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~ 213 (366)
.+++++... .....++...+.-+..|++.||.|||+.+ |+||||||.|+|++.+ |.+||+|||+
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence 223333211 23446777788889999999999999999 9999999999999966 8999999999
Q ss_pred cccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH-----
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH----- 287 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 287 (366)
|+.+...+.. ....-|..|+|||++.|. .|+.+.||||.||++.||+-|++-|.+.+...+. ...-....
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VEIIKVLGTPTRE 248 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HHHHHHhCCCCHH
Confidence 9988654433 344567789999988775 7999999999999999999999999875422111 11111110
Q ss_pred ---HhhcC----ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcccCCCCcccc
Q 037297 288 ---SMRKN----HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRGSNFGHKMI 352 (366)
Q Consensus 288 ---~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~~~~~~~~~ 352 (366)
.+... ..+.+.............+++..+|+.++|+.+|.+|.|+.|++. ..+.+++.+..+...
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g 322 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNG 322 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCC
Confidence 00000 111122111112345567788999999999999999999999974 456776665554443
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=290.88 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=192.6
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.+|++.+.||+|+||.||++..+++..+|+|.+...... ...+.+|+.+++.++||||+++++++......++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 458899999999999999999877778999998653322 235778999999999999999999999988888888
Q ss_pred eeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++..++. ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 8765432 235789999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .. .........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~------~~~~~~~~~--------- 218 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SE------VVESVSAGY--------- 218 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HH------HHHHHHcCC---------
Confidence 21122223457999999998999999999999999999999 8999865331 10 000000000
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
....+..++..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 -RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 01122335668999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=298.60 Aligned_cols=238 Identities=25% Similarity=0.259 Sum_probs=187.8
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||+|+||.||+|... +++.+|+|+++..... .......+.+|+.+++.++||||+++++++...+..++++++..++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999975 5889999998753221 11334577889999999999999999999999999999998876542
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccc
Q 037297 158 -------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230 (366)
Q Consensus 158 -------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 230 (366)
...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....... .......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 336889999999999999999999999 9999999999999999999999999987543222 22334568
Q ss_pred cCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHH
Q 037297 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310 (366)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (366)
|+.|+|||++.+..++.++||||+||++|+|++|+.||..... ........... ...+...
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~-----------~~~~~~~ 216 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEP-----------LRFPDGF 216 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC-----------CCCCCcC
Confidence 9999999999999999999999999999999999999975331 11111111110 0123345
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 311 IMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 311 ~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
+..+.+++..||+.||.+||++..+.+.|.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 667899999999999999987555544443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.76 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=193.5
Q ss_pred HhcCCcccceecccCceEEEEEEEcC--CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED--GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|.+++ +..+|+|.+....... ....+.+.+|+.+++.++||||+++++++......
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34679999999999999999998543 3689999987543221 13345788999999999999999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999876543 336888999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .....||+.|+|||++.+..++.++|+||+||++|||++|..||...... ....... ...
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~-~~~------ 244 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKIL-EGI------ 244 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHh-cCC------
Confidence 2 23356899999999999989999999999999999999999999754310 0000111 110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+...+..+.+++.+||+.||++|+ |++++++
T Consensus 245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 012333455788999999999999995 7888764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=299.89 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=192.2
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 144 (366)
...++|++.+.||+|+||.||++.+. +|..+|+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch--hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 34578999999999999999999965 58899999987543322 33457789999999999999999999886543
Q ss_pred ----cceEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 ----VPLLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ----~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++...+- ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 3567777654431 124778889999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc-------------c-HH
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-------------S-LA 282 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------------~-~~ 282 (366)
.... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||........-.. . ..
T Consensus 173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 4322 222345688999999999999999999999999999999999999976431100000 0 00
Q ss_pred HHHHHHhh-cCcccccc-----chHH---hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 283 AFFVHSMR-KNHMYDIL-----DDQV---VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 283 ~~~~~~~~-~~~~~~~~-----~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ........ .... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000000 0000 00011223567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=298.50 Aligned_cols=239 Identities=26% Similarity=0.293 Sum_probs=188.6
Q ss_pred cceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 76 NRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
.+.||+|+||.||++... +++.+|+|+++.............+..|+.+++.++||||+++++++......+++++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999852 4788999999864332222344567889999999999999999999999999999998
Q ss_pred eccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV 156 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence 876542 335778888999999999999999999 9999999999999999999999999986433222 22
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .. .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-~~----------~ 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-GK----------L 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CC----------C
Confidence 2335689999999999988899999999999999999999999975431 011111111 10 1
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
.++...++.+.+++..||+.||++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12334456789999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=293.44 Aligned_cols=247 Identities=25% Similarity=0.430 Sum_probs=194.0
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
++|++.+.||+|+||.||+|.. .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP---QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 5688999999999999999984 24578999998754333 334578889999999999999999999999998
Q ss_pred ceEEEeeccCCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 146 PLLHLHDHHRNE------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 146 ~~~~~~~~~~~~------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
.++++++..... ...+++..+..++.|++.||.|||+++ ++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence 899888765431 124678888999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 279 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 279 (366)
.++.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~--- 233 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--Q--- 233 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--H---
Confidence 999999999999976533221 11223345677999999988889999999999999999998 9999865331 0
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
............ ..+..++..+.+++.+||+.||++||++.++++.|..
T Consensus 234 ----~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 ----EVIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 001111111110 1233455678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.55 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChH-HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDE-ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
++|.+.+.||+|++|.||.|... +++.+|+|.+....... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46899999999999999999864 58999999987643322 22345678899999999999999999999999999998
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 888875542 235788889999999999999999999 9999999999999999999999999987653222
Q ss_pred ceee--eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 222 THVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 222 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.... ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~------- 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQP------- 223 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHhccC-------
Confidence 1111 2345778899999999988999999999999999999999999653210 0000000010
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...+..+.+++..||..||.+|||+.|+++
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 011234456667899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=294.12 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=194.8
Q ss_pred CCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
+|++.+.||+|+||.||+|... ....+++|.+...... .....+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4788999999999999999853 2356888888764433 334678899999999999999999999999988
Q ss_pred ceEEEeeccCCC-------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 146 PLLHLHDHHRNE-------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 146 ~~~~~~~~~~~~-------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
.++++++...+. ..++++..++.++.|++.|+.|||+.+ ++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhh
Confidence 888887765321 124778899999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
|+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999998755332221 1122345678999999988889999999999999999998 999986432
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. . ......... .....+..++.++.+++.+||+.||++|||+.|+++.|+++-.+
T Consensus 235 ~--~-------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 P--E-------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H--H-------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 1 000111110 01112334556899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=294.28 Aligned_cols=263 Identities=27% Similarity=0.361 Sum_probs=193.2
Q ss_pred CC-cccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-
Q 037297 72 HF-NVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE- 144 (366)
Q Consensus 72 ~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 144 (366)
+| ++.+.||+|+||+||++.. .++..+|+|.++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ---QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 44 8899999999999988653 24778999998765332 23457888999999999999999999887643
Q ss_pred -cceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 -VPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 -~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++...+. ...+++..++.++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 4567777655432 235889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK---QGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc---ccccchhhhh
Confidence 432211 11222355679999999888899999999999999999999999865432111000000 0000000000
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
+..+.......+..++..+.+++..||+.||++|||++++++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 001111111123445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=298.62 Aligned_cols=237 Identities=23% Similarity=0.287 Sum_probs=189.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
+.||+|+||.||++..+ +++.+|+|++....... ......+.+|+.+++.++||||+++++++...+..++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 58999999998643221 13345778899999999999999999999999999999998765
Q ss_pred CC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 156 NE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 156 ~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 43 235889999999999999999999999 9999999999999999999999999987532221 222345
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... ...... ..++.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~-~~~~~~----------~~~p~ 216 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFE-LILMED----------IKFPR 216 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHH-HhccCC----------ccCCC
Confidence 6899999999999999999999999999999999999999654310 0000 000000 01233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..+.++.+++.+||+.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 4566789999999999999997 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=304.65 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=189.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
...|.+.+.||+|+||.||+|.+. .++.||+|.... ..+.+|+++++.++||||+++++++......++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999976 478899995432 235679999999999999999999999988888
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 88765432 2236889999999999999999999999 9999999999999999999999999997654322
Q ss_pred ce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc-----Cccc
Q 037297 222 TH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK-----NHMY 295 (366)
Q Consensus 222 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 295 (366)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+............... ....+.. ..+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEFP 393 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccCC
Confidence 11 223456899999999999999999999999999999999988776654322211111111 1111110 0111
Q ss_pred cccchHHhhhh-------------------cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLV-------------------KKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......+...+ -...+.++.+|+..||+.||.+|||+.|+++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 10000000000 0023347889999999999999999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=283.26 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=196.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.+.|++-+.||+|.|+.|+++... +|+.+|+|++....... ...+.+.+|+.+.+.|+||||+++.+...+....++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 467889999999999999998854 68999999887544332 356788999999999999999999999999999999
Q ss_pred EEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeecCCccccc
Q 037297 149 HLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Dfg~a~~~~ 218 (366)
+.+...++... -+++..+.+.++||++++.|+|.++ |||||+||+|+++.+ ...+||+|||+|..++
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99887766422 3566777889999999999999999 999999999999963 4568999999998776
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
....-...+||+.|||||+....+|+..+||||.||+||=|+.|++||.+.++ ...+.......- +.-
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I~~g~y--d~~ 232 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQIKAGAY--DYP 232 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHHhcccc--CCC
Confidence 44455567899999999999999999999999999999999999999987431 111111111100 000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
...-...+++.++|+++||..||.+|.|+.|.+
T Consensus 233 -----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 -----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -----CcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 001223456789999999999999999999985
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=297.01 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=191.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|..+ +++.+|+|.++...... ....+.+|+.+++.++||||+++++++...+..+++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 67999999999999999999965 57889999987643321 223567899999999999999999999999999998
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 8876532 1234788889999999999999999999 99999999999999999999999999875433221
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc---
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL--- 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 298 (366)
......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ ...............+..+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhhcchh
Confidence 1223457889999998765 4688999999999999999999999976432110 00000000000000000000
Q ss_pred ----------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 ----------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+.......+..+.++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000112235667899999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=295.09 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=192.8
Q ss_pred cCCcccceecccCceEEEEEEEcC-C--cEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED-G--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
++|++.+.||+|+||.||+|..++ + ..+++|.++..... ...+.+.+|+.++.++ +||||+++++++......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE---NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH---HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 579999999999999999998653 3 34788887743333 2345788999999999 799999999999988888
Q ss_pred eEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 147 LLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 147 ~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
++++++...+. ...+++..++.++.|++.|++|||+.+ ++||||||+|||++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC
Confidence 88888754321 124788899999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHH
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 282 (366)
+.+||+|||++..... .........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------- 225 (297)
T cd05089 156 LASKIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------- 225 (297)
T ss_pred CeEEECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 9999999999863221 111111223457999999988899999999999999999997 99999654310
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
...... ... .....+..++..+.+++..||+.||.+|||++++++.|+.+....
T Consensus 226 ~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ELYEKL-PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHH-hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000000 000 011123345668999999999999999999999999998877544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=294.19 Aligned_cols=193 Identities=28% Similarity=0.433 Sum_probs=165.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+.+|+++++.++||||++++++|...+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 468999999999999999999976 5888999988765433 234578899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++. ...+++..+..++.|++.|+.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 998876542 23578889999999999999999974 6 999999999999999999999999998654321
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 271 (366)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346889999999999889999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.70 Aligned_cols=241 Identities=24% Similarity=0.296 Sum_probs=187.2
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHH---hcCCCCceeeEeeEEeeCCcceE
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVIL---SQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
|++.+.||+|+||.||+|... +++.||+|+++...... ....+.+.+|..++ +.++||||+++++++......++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 678899999999999999865 58999999998643211 12334566665554 56789999999999999999999
Q ss_pred EEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 998876543 336899999999999999999999999 9999999999999999999999999986432221
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... . ... .......
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~------~~~-~~i~~~~--------- 217 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--E------EVF-DSIVNDE--------- 217 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--H------HHH-HHHHhCC---------
Confidence 223345689999999999999999999999999999999999999975431 0 000 0111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 012334566789999999999999999 4555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.61 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=192.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..+|++.++||+|+||.||+|...++..+|+|.++..... .+.+.+|+++++.++||||+++++.+. ....+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 4679999999999999999999776677999998753322 246788999999999999999999864 4556777
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++...+. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 77655432 224688899999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........++..|+|||...+..++.++|+|||||++|+|++ |..||...... . ..........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~------~~~~~~~~~~------ 221 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E------VLDQVERGYR------ 221 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--H------HHHHHhcCCC------
Confidence 3222223346678999999988899999999999999999999 88888654310 0 0000000000
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011334566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=287.12 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 78 ILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.||+|+||.||+|.++ ++..+|+|+++...... ...+.+..|+.+++.++||||+++++++.. +..++++++..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP--ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 5899999999999642 57889999987544332 345678899999999999999999998754 45567777655
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee--
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-- 225 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-- 225 (366)
.+. ...+++..+..++.|++.|+.|||+++ ++||||||.||+++.++.++|+|||++...........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 442 235789999999999999999999999 99999999999999999999999999976654332211
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... . .......... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~-------~~~~~i~~~~---------~~ 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--N-------EVTQMIESGE---------RM 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H-------HHHHHHHCCC---------CC
Confidence 12234578999999988889999999999999999998 9999965331 0 0111111111 11
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
..+..++.++.+++.+||+.||++|||+.+|.+.|++.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12345667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.33 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=188.7
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
+.||+|+||.||++... +|..||+|+++...... ......+.+|+.+++.++||||+++++++...+..++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999965 58999999998643221 13345678899999999999999999999999999999998765
Q ss_pred CC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 156 NE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 156 ~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
+. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 53 335889999999999999999999999 9999999999999999999999999986532221 122335
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... ....... ... ..++.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~-~~~----------~~~p~ 216 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELIL-MEE----------IRFPR 216 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCC----------CCCCC
Confidence 6899999999999999999999999999999999999999754310 0000000 000 01233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..++++.+++..||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4566889999999999999998 7877764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=294.69 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=196.9
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..+|.+.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD----NARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 357899999999999999999842 245689998865321 2345788999999999999999999999999
Q ss_pred CcceEEEeeccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 144 EVPLLHLHDHHRNE--------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
+..++++++...+. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999888765332 124899999999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccH
Q 037297 204 YRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 281 (366)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~----- 229 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--N----- 229 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--H-----
Confidence 9999999999875533221 11222335678999999998899999999999999999998 8999865431 0
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ............ .+...+.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 230 -~-~~~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 -E-VIECITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -H-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 111111111110 1223455799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.28 Aligned_cols=247 Identities=29% Similarity=0.459 Sum_probs=187.4
Q ss_pred CcccceecccCceEEEEEEEcC-Cc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-----
Q 037297 73 FNVNRILGQGGQGTVYKGMLED-GR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----- 144 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 144 (366)
|.+++.||+|+||.||+|.... +. .+|+|.++...... ...+.+..|+.+++.++||||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 4577899999999999999654 32 58999887653332 34567889999999999999999999875322
Q ss_pred -cceEEEeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 145 -VPLLHLHDHHRN-------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 145 -~~~~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
..++++++...+ ....+++..+..++.|++.|+.|||+++ ++||||||+|||++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence 345666654432 1234788999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHH
Q 037297 211 FGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 211 fg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
||++.......... .....++..|+|||...+..++.++|+|||||++|+|++ |+.||..... . .... .
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~------~~~~-~ 226 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--S------EIYD-Y 226 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--H------HHHH-H
Confidence 99998664332211 122235678999999999999999999999999999999 8889865321 0 0111 1
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....... ..+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 227 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111110 11223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=308.07 Aligned_cols=247 Identities=24% Similarity=0.270 Sum_probs=195.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|... +++.||+|+++...... ......+..|+.++..++||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 47999999999999999999976 68999999998643221 12345788899999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
+++..+.. ...+++..+..++.|++.||.|||++| ++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 98876542 246889999999999999999999999 9999999999999999999999999987654332
Q ss_pred ---------------------------ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037297 222 ---------------------------THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274 (366)
Q Consensus 222 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 274 (366)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~- 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence 0112335689999999999999999999999999999999999999976431
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-MEEVTM 337 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell~ 337 (366)
. ............. ........++++.+++..||+ ||.+||+ ++|+++
T Consensus 236 -~------~~~~~i~~~~~~~-------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 -Q------ETYNKIINWKESL-------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred -H------HHHHHHhccCCcc-------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 0 0011111100000 000011146688999999998 9999999 999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=313.94 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=193.9
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 144 (366)
....+|++.+.||+|+||+||+|... +++.||+|++....... .....+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE--ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH--HHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34579999999999999999999864 68999999997654432 33456888999999999999999988765433
Q ss_pred ------cceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 145 ------VPLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 145 ------~~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
..++++++...+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 2456666655432 235788999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccCCC-ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHH
Q 037297 208 VADFGTSKFIAMDQ-THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286 (366)
Q Consensus 208 l~Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (366)
|+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~ 255 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMH 255 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH
Confidence 99999997654322 1223345689999999999999999999999999999999999999965321 11111
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... ... ..++...++++.+++..||+.||.+|||+.++++
T Consensus 256 ~~~~-~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLA-GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhc-CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111 100 1134456678999999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.72 Aligned_cols=241 Identities=21% Similarity=0.310 Sum_probs=186.6
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +++.||+|+++...... ....+.+..|..++..+ +||||+++++++......++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999965 58899999998643222 13345678899999888 79999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ......
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence 543 346899999999999999999999999 999999999999999999999999998643211 122334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|+||+||++|+|++|+.||...+...................... .++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CCC
Confidence 5789999999999999999999999999999999999999975332111111111111111111110 123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
...+..+.+++.+||+.||.+|||+
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 3455678999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=303.45 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=194.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||++..+ ++..+|+|++....... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 467999999999999999999975 58899999987532211 1233457789999999999999999999999999999
Q ss_pred EEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999876542 235788889999999999999999999 99999999999999999999999999976543332
Q ss_pred eeeeeccccCCccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.......||+.|+|||++.+. .++.++|+|||||++|||++|+.||..... ...............+.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 269 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKNSLTFP 269 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCcCCCC
Confidence 223345799999999988653 478899999999999999999999976431 11111111111000000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~ 337 (366)
.....+.++.+++..||+.+|.+ |||++|+++
T Consensus 270 -------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 270 -------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 01234668899999999999988 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.44 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=186.1
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +++.+|+|+++...... ....+.+..|..++..+ +||||+++++++...+..++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46999999999999965 57899999998643221 13345677888888776 89999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 542 236889999999999999999999999 9999999999999999999999999986532221 12234
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|+|||||++|+|++|+.||......................... ..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCC
Confidence 568999999999999999999999999999999999999996433221111111111111111111 1134
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
...+..+.+++.+||+.||.+|||+
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 4456678999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=289.35 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=196.5
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++|++.+.||+|+||.||+|..+++..+|+|.+...... .+.+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC-----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 45789999999999999999999877888999998754332 3468889999999999999999999988888888
Q ss_pred EEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++..... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 888765432 235788999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
...........+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||..... . ...........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~------~~~~~~~~~~~----- 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--R------EVLEQVERGYR----- 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H------HHHHHHHcCCC-----
Confidence 22211222234567999999998899999999999999999998 9999864321 0 00111111000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+...+.++.+++.+||+.||.+|||++++.+.|+.+
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 223 -----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 011223356799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.30 Aligned_cols=188 Identities=26% Similarity=0.381 Sum_probs=149.8
Q ss_pred cceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cceEEE
Q 037297 76 NRILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VPLLHL 150 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~~ 150 (366)
.++||+|+||.||+|..+ +++.+|+|.+...... ..+.+|+.+++.++||||+++++++.... ..++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999864 4678999998754322 24678999999999999999999886543 344555
Q ss_pred eeccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCeEEEeec
Q 037297 151 HDHHRN---------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADF 211 (366)
Q Consensus 151 ~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill----~~~~~vkl~Df 211 (366)
++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 543211 1225889999999999999999999999 9999999999999 45678999999
Q ss_pred CCcccccCCCc--eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 212 GTSKFIAMDQT--HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 212 g~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
|++........ .......+|..|+|||++.+. .++.++|+||+||++|+|++|+.||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99976543221 122345689999999988774 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=291.91 Aligned_cols=252 Identities=22% Similarity=0.384 Sum_probs=194.1
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..++|++.+.||+|+||.||+|.... +..|++|.+...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---IQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 35789999999999999999999765 678999988754333 3456788999999999999999999988764
Q ss_pred -CcceEEEeeccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 144 -EVPLLHLHDHHRNE---------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 144 -~~~~~~~~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
...+++.++...+. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence 44555554433211 145789999999999999999999998 99999999999999999999
Q ss_pred EeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHH
Q 037297 208 VADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
|+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|++++ |+.||..... .. .
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~---~---- 228 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FE---M---- 228 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HH---H----
Confidence 9999999765432221 1122345677999999988899999999999999999999 9999965321 00 1
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
......... ...+..+++++.+++.+||+.||++|||+.++++.|+++..
T Consensus 229 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 AAYLKDGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHcCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111100 00122345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.43 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=191.0
Q ss_pred CcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 73 FNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
|++.+.||+|+||.||.|.... +..+|+|.++...... ...+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5788999999999999998542 4679999988643332 345678999999999999999999998876554
Q ss_pred ---ceEEEeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 146 ---PLLHLHDHHRN-------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 146 ---~~~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
.++++++...+ ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEEC
Confidence 56666654432 1235788999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 210 DFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
|||++.......... ......+..|+|||.+.+..++.++|+|||||++|||++ |..||..... . ... .
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~------~~~-~ 226 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--H------EIY-D 226 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--H------HHH-H
Confidence 999987654332211 111234668999999988899999999999999999999 8888865331 0 011 1
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....... ...+..++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 227 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 112344566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.25 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=188.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|... +++.+|+|+++..... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 46899999999999999999865 5889999999764322 123345788899999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99876542 346889999999999999999999999 99999999999999999999999999875432110
Q ss_pred ----------------------------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 037297 223 ----------------------------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 268 (366)
Q Consensus 223 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 268 (366)
......+||+.|+|||++.+..++.++|+|||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCC---CCCCHHHHHH
Q 037297 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGK---KRPTMEEVTM 337 (366)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~---~Rpt~~ell~ 337 (366)
..... . .............. ..+ ....++++.+++.++++ +|. .||+++|+++
T Consensus 237 ~~~~~--~------~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETP--Q------ETYKKVMNWKETLI-FPP------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCH--H------HHHHHHHcCcCccc-CCC------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 75431 0 01111111000000 000 11234567888888665 444 4689999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=312.51 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=193.3
Q ss_pred cCCcccceecccCceEEEEEEEc-C-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-D-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..|.+.+.||+|++|.||.|... + ++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE----RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34999999999999999999854 3 67788887654322 233467789999999999999999999999999999
Q ss_pred EEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 149 HLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 149 ~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++..++. ..++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999876543 235788899999999999999999999 999999999999999999999999999865
Q ss_pred cCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......... ...
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~-~~~-- 288 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLY-GKY-- 288 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC--
Confidence 43221 123445689999999999999999999999999999999999999965331 011111111 110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+..++.++.+++..||+.||++|||+.+++.
T Consensus 289 -------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0123345668999999999999999999999864
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=291.75 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=191.8
Q ss_pred HhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
..++|++.+.||+|+||.||+|..+ ++..+|+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4577999999999999999998753 2567999988653322 234568899999999999999999999988
Q ss_pred CCcceEEEeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 143 TEVPLLHLHDHHRNE-----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
....++++++...+. ....++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCC
Confidence 888888888765431 123467788899999999999999998 999999999999999999
Q ss_pred EEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHH
Q 037297 206 AKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 283 (366)
++|+|||++.......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... . .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~------~ 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--E------Q 229 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H------H
Confidence 9999999987554322211 112335678999999998899999999999999999999 7888864321 0 0
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
........... ..+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 -~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 -VLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111111 112334567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.21 Aligned_cols=247 Identities=23% Similarity=0.278 Sum_probs=191.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|... +++.||+|++....... ......+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999975 58899999997642211 13345678899999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++.++ ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++........
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9987654 2346899999999999999999999999 99999999999999999999999999865432110
Q ss_pred e-------------------------------------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 037297 223 H-------------------------------------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK 265 (366)
Q Consensus 223 ~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 265 (366)
. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011245899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 037297 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT---MEEVTM 337 (366)
Q Consensus 266 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ell~ 337 (366)
.||..... . ................ .....++++.+++..|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~--~------~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNP--Q------ETYRKIINWKETLQFP-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCH--H------HHHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99975431 0 0111111110000000 011345678899999997 9999998 777754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.71 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=191.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|++|.||+|....+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 356999999999999999999987777899998765332 2346788999999999999999998875 4556777
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++...+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 77665432 224788899999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........++..|+|||...+..++.++|+||||+++|+|++ |..||...... ...........
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~------ 221 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYR------ 221 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC------
Confidence 2222223345678999999988889999999999999999999 89998653310 00000110100
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
...+...+..+.+++.+||..||++|||++++++.|+.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01233456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.15 Aligned_cols=240 Identities=26% Similarity=0.375 Sum_probs=189.2
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCC
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRN 156 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~ 156 (366)
+.||+|+||.||+|...++..+|+|.+...... .....+.+|+++++.++||||+++++++......++++++..+.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ---ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 468999999999999878889999998765433 23346889999999999999999999999999999998876544
Q ss_pred C--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 157 E--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 157 ~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
. ...+++..+..++.|++.++.|+|+.+ ++|+||+|+||+++.++.++|+|||++..............
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 2 235788999999999999999999999 99999999999999999999999999865432221111222
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||...... ........... ...+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~----------~~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYR----------MSCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCC----------CCCC
Confidence 34567999999988889999999999999999998 99999654310 00000111100 0112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=294.62 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=197.3
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 139 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (366)
....++|++.+.||+|+||.||++... ....+|+|.+...... .....+.+|+.+++.+ +||||++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 344567999999999999999999854 2367999998764333 2345688999999999 89999999999
Q ss_pred EeeCCcceEEEeeccCC-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 037297 140 CLETEVPLLHLHDHHRN-----------------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKST 196 (366)
Q Consensus 140 ~~~~~~~~~~~~~~~~~-----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~ 196 (366)
+......++++++...+ ....+++..++.++.|++.|+.|||+.+ ++||||||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~ 161 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR 161 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccccee
Confidence 99988888888876442 2335788899999999999999999998 999999999
Q ss_pred CEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 037297 197 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274 (366)
Q Consensus 197 Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~ 274 (366)
||+++.++.++|+|||.+.......... .....++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence 9999999999999999998654332211 122234567999999988899999999999999999997 9999864321
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. . .......... ...+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 -~------~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -E------E-LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -H------H-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 0 0111111110 0123344567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=298.35 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=191.8
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 144 (366)
...++|++.+.||+|+||.||++.+. .++.+|+|.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh--HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34578999999999999999999865 58899999987644332 23457788999999999999999999876543
Q ss_pred ----cceEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 ----VPLLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ----~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++....- ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 3466666654321 124678888999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH--------------
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA-------------- 282 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------------- 282 (366)
.... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 4322 222345689999999999999999999999999999999999999975431100000000
Q ss_pred HHHHHHhhc-CccccccchHH--------hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 283 AFFVHSMRK-NHMYDILDDQV--------VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 283 ~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
......... ........+.. ....+...+..+.+|+.+||+.||++|||+.|+++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000000 001122234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=290.58 Aligned_cols=241 Identities=35% Similarity=0.556 Sum_probs=184.4
Q ss_pred ccceecccCceEEEEEEEc-----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 75 VNRILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.+.||.|.||.||+|... .+..|++|.++..... ...+.+.+|+..++.++||||+++++++.......++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE---EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH---HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc---ccceeeeeccccccccccccccccccccccccccccc
Confidence 4578999999999999966 2567999999664333 3356889999999999999999999999977778888
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++...+ ....+++..+..++.|++.||.|||+++ ++|+||+++||++++++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 8876543 1357899999999999999999999998 999999999999999999999999999776322
Q ss_pred Cc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 221 QT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 221 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ...........|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~-~~~~~~~~~----- 222 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EE-IIEKLKQGQ----- 222 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HH-HHHHHHTTE-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cc-ccccccccc-----
Confidence 22 22233446778999999988889999999999999999999 7888755321 11 111111111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
....+..++..+.+++..||..||++|||+.++++.|
T Consensus 223 ----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112344566799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=299.14 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=194.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++..+ +++.+|+|+++..... .....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 46899999999999999999965 5889999999864332 123445788899999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..++. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 98875542 246889999999999999999999999 9999999999999999999999999998765443
Q ss_pred ceeeeeccccCCcccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
........||..|+|||++. +..++.++|||||||++|+|++|+.||..... ..............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence 33334456899999999886 45678899999999999999999999965431 11111111111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .....+..+.+|+..||+ ||.+|||++++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 100 112345678999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=286.72 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=199.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||++... ++..+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46889999999999999999954 6899999988753322 223446788999999999999999999999999888888
Q ss_pred EeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++..+. ....+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 8876543 2335788999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ...........
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~--- 226 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-------LCKKIEQCDYP--- 226 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-------HhhhhhcCCCC---
Confidence 3322 122345788999999998889999999999999999999999999653311100 00000000000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+...+..+.+++.+||+.||++|||+.++++.+..+.
T Consensus 227 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 -----PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0012345668999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.65 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=207.9
Q ss_pred cCCcccceecccCceEEEEEEEcC---Cc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED---GR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~---~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
......++||.|.||-||.|.+.+ |+ .||||..+.+... ...+.|+.|..+|++++||||++++|+|.+...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekflqEa~iMrnfdHphIikLIGv~~e~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHHHHHHHHHHhCCCcchhheeeeeeccce
Confidence 334556789999999999998542 33 4899999876555 346789999999999999999999999988765
Q ss_pred ceEEEeeccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHR--------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
. ++++.+.. .+...++..+...++.|++.||.|||+.. +|||||..+|||+.++.-|||+|||+++.+
T Consensus 466 W-ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 W-IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred e-EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 4 44554332 23446888899999999999999999998 999999999999999999999999999998
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
..+.....+...-...|||||.+.=..++.++|||.|||++||++. |..||.+.. +.++..
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDVI~ 603 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDVIG 603 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccceEE
Confidence 7766555555566789999999998999999999999999999887 999998754 233334
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.+..+-+...|+.|++.+..++.+||..||.+||++.|+...|+++..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 444555566789999999999999999999999999999999998774
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.61 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=201.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..-|.+.+.||+|.|..|-+|++- +|+.||||++.+...+. .....++.|+++|+..+|||||++|++...+...|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~--~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT--LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch--hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 456899999999999999999854 69999999998754432 445678999999999999999999999999999999
Q ss_pred EEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-cCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill-~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++.-..+. ...+.++...+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|-|||.|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 988765543 336889999999999999999999999 9999999999865 567899999999997654
Q ss_pred CCceeeeeccccCCccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.+...+..+|+..|.|||++.|..|+ +++|||||||+||.|++|++||......+... . ++
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT--------m---------Im 232 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT--------M---------IM 232 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh--------h---------hh
Confidence 34445678999999999999999886 58999999999999999999998654222110 0 00
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+.-.+|...+.++.+||..||..||.+|.|.+||+.
T Consensus 233 --DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 --DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1123467788889999999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=288.04 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=193.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||+||+|... +++ .||+|.++..... .....+.+|+.+++.+.||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP---KANKEILDEAYVMAGVGSPYVCRLLGICLTST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH---HHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence 357899999999999999999853 344 4899998764443 23457888999999999999999999987544
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++...+ ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++..
T Consensus 83 -~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 -VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred -cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 45555554432 1335788999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||..... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCc
Confidence 64332221 112234667999999988899999999999999999998 8999865321 001111111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
...+..++.++.+++..||+.||++|||+.++++.|..+.....
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 230 ---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 01123455678999999999999999999999999988875543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.83 Aligned_cols=240 Identities=26% Similarity=0.373 Sum_probs=186.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
+.||+|+||.||+|... +++.+|+|.+...... .....+.+|+++++.++||||+++++++......++++++..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999965 6889999988754333 2345788999999999999999999999999988999887654
Q ss_pred C--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee-ee
Q 037297 156 N--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TT 226 (366)
Q Consensus 156 ~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~ 226 (366)
. ....+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 3 2235789999999999999999999999 9999999999999999999999999987543211110 01
Q ss_pred eccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
....+..|+|||.+.+..++.++|+|||||++|+|++ |..||..... . .......... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~-------~~~~~~~~~~---------~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--Q-------QTREAIEQGV---------RLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--H-------HHHHHHHcCC---------CCC
Confidence 1123456999999998899999999999999999998 8888864321 0 0000110100 011
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23345667999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=284.66 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=200.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|... +|+.+|+|.++...... ....+.+.+|+.+++.++|+|++++++++...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999976 78999999887533222 13346788999999999999999999999999888888
Q ss_pred EeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++..++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 88765432 235788999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
..... .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... .... .........
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~---- 225 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSL-CKKIEKCDY---- 225 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHH-HhhhhcCCC----
Confidence 33221 22345788899999998889999999999999999999999998654311 0000 000111111
Q ss_pred chHHhhhhc-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 299 DDQVVKLVK-KNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 299 ~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+ ...+..+.+++..||..+|++|||+.++++.|+++.
T Consensus 226 -----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 -----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0112 255668999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.01 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=186.0
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 144 (366)
...++|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34578999999999999999999964 5789999998754322 133456778999999999999999999875432
Q ss_pred ----cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 145 ----VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 145 ----~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+++++..... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccce
Confidence 234444433211 1235889999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN-- 292 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 292 (366)
..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ............
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 237 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-----QLKRIMEVVGTPSP 237 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHHhCCCCH
Confidence 65322 233468999999998876 568899999999999999999999996533100 000000000000
Q ss_pred ----------------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 ----------------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.......... .......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhH-HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0011123446789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.26 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=192.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|+||.||++... +++.||+|++........ .....+.+|+.+++.++||||+++++++...+..++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh-hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 4888999999999999999965 588999999875432211 23346778999999999999999999999999899999
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..++. ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 8775432 235889999999999999999999999 9999999999999999999999999987653222
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||....... ............
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~--------- 220 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKED--------- 220 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhc---------
Confidence 1223468899999999998899999999999999999999999997543110 000111111100
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
....+...+..+.+++..||+.||.+|| +++++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0112344667889999999999999999 7777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.43 Aligned_cols=247 Identities=20% Similarity=0.212 Sum_probs=188.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|++++.||+|+||+||+|... +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 6889999999999999999865 58899999997643221 134567889999999999999999999999999999999
Q ss_pred eeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc-
Q 037297 151 HDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT- 222 (366)
Q Consensus 151 ~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~- 222 (366)
++..++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9876543 235788899999999999999999999 99999999999999999999999998753311000
Q ss_pred ---------------------------------------------eeeeeccccCCccccccccCCCCCchhhHHHHHHH
Q 037297 223 ---------------------------------------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVV 257 (366)
Q Consensus 223 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~ 257 (366)
......+||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhh--cCCCCCCCCHHHH
Q 037297 258 LVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCL--DLNGKKRPTMEEV 335 (366)
Q Consensus 258 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rpt~~el 335 (366)
+|||++|+.||....... ............. .......++++.+++.+|+ ..+|..|||++|+
T Consensus 238 l~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~-------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTE--------TQLKVINWENTLH-------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHhCCCCCcCCCHHH--------HHHHHHccccccC-------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999997543110 0000100000000 0001134567889998855 4455569999999
Q ss_pred HH
Q 037297 336 TM 337 (366)
Q Consensus 336 l~ 337 (366)
++
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.42 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred HHhcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEee
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 138 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (366)
....+|.+.+.||+|+||.||+|... ++..+|+|.+...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch---HHHHHHHHHHHHHHhhccCCCchheeE
Confidence 44577999999999999999999731 2457999988754322 3446788999999999 8999999999
Q ss_pred EEeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 139 CCLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
++......++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 165 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAA 165 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccccc
Confidence 9999988888888765431 124677888999999999999999999 99999999
Q ss_pred CCEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 037297 196 TNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 273 (366)
+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999999997664332221 222345678999999988889999999999999999998 7888754321
Q ss_pred CCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 274 TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
.. .......... ...+..++..+.+++.+||+.+|.+|||+.|+++.|+.+.....+
T Consensus 246 --------~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 --------EE-LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred --------HH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11 1111111110 011234566899999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=288.23 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=188.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.+|++.+.||+|+||.||+|... +++ .+++|.+...... .....+..|+..++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYIVRLLGICPGA-S 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch---HHHHHHHHHHHHHhcCCCCCcceEEEEECCC-c
Confidence 46888999999999999999864 344 4777777543222 2345677888899999999999999987644 4
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 555666554332 335788999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... .......++..|+|||.+.+..++.++|+|||||++|||++ |..||..... . ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~-------~~~~~~~~~~~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--H-------EVPDLLEKGERL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--H-------HHHHHHHCCCcC
Confidence 43222 12223446778999999988899999999999999999998 9999965431 0 011111111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+..++.++.+++.+||..||++|||+.|+++.|..+..
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 ---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0112244568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=288.05 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=201.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.-|.++++||+|+||+||+|.++ +|+.+|+|.++.+. ..+++..|+.++++++.|++|++|+.+....-..++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 34778899999999999999976 59999999998753 346788999999999999999999999999999999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+ ...++.++.+..++++.+.||.|||... -||||||+.|||++.+|..||+|||.|..+.. .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-T 182 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-T 182 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-h
Confidence 9998776 3558999999999999999999999998 89999999999999999999999999965431 1
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
-.......||+.|||||++..-.|+.++||||||++..||..|++||.+........ .++....+.
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPT----- 248 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPT----- 248 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCC-----
Confidence 122344679999999999999999999999999999999999999998754211100 011111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
-.-|..++.+|.+|+++||-++|++|.|+-++++
T Consensus 249 --F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 --FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred --CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1236789999999999999999999999988864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.11 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=183.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeC----
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLET---- 143 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~---- 143 (366)
+|++.+.||+|+||.||+|.++ +++.+|+|.++....... ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5889999999999999999976 588999999876432211 112345566666555 799999999987653
Q ss_pred -CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 -EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 -~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 2356666654431 1234789999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---c
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---K 291 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 291 (366)
....... ......+|..|+|||++.+..++.++||||+||++|+|++|++||........ ......... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-----~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-----LGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-----HHHHHHHhCCCCh
Confidence 7654222 22334678899999999988999999999999999999999999865431110 000000000 0
Q ss_pred Ccccc----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 292 NHMYD----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 292 ~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+.. ...+.......+..+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00001111222345667899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=297.81 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=191.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC---
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--- 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 144 (366)
..++|++.+.||+|+||.||++.+. .++.+|+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc--hhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4578999999999999999999965 58889999987643322 23456788999999999999999999876443
Q ss_pred ---cceEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 ---VPLLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ---~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++....- ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 3577777765431 124678888999999999999999999 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH-------HH------
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA-------AF------ 284 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------~~------ 284 (366)
... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 322 222345689999999999999999999999999999999999999975431110000000 00
Q ss_pred -HHHHhh-cCcccccc----chHH----hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 -FVHSMR-KNHMYDIL----DDQV----VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 -~~~~~~-~~~~~~~~----~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... .+...... .+.. ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00000000 0000 00111123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=304.52 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=192.7
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||++... +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++......+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3467999999999999999999976 58899999987532211 123346788999999999999999999999999999
Q ss_pred EEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 148 LHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 148 ~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999876542 235788899999999999999999999 9999999999999999999999999998664333
Q ss_pred ceeeeeccccCCccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
........||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||..... ...............+
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKNSLNF 268 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcccCC
Confidence 32334567999999999886543 78899999999999999999999975431 1111111111110000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTME 338 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~ 338 (366)
......+..+.+++..||+.+|.+ |+|+.|+++-
T Consensus 269 -------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001234567889999999855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.79 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=206.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+...+.++||+|-||.|.++....+..||+|.++..... .....|.+|+.+|.+|+||||+.++++|..++...++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3566888999999999999999887899999999986655 3457899999999999999999999999999999998
Q ss_pred EeeccCCCCC--------C-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNEEF--------P-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~~~--------~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++...+... + +......+|+.||+.||+||.+.+ ++||||.++|+|++.++++||+|||+++-+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 8876554211 2 244556779999999999999999 999999999999999999999999999866544
Q ss_pred Ccee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 221 QTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 221 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
+... ....+-..+|||||.+.-+.++.++|+|+||+++||+++ ...||..... + ...+.....+.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e---~vven~~~~~~~~~~--- 762 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--E---QVVENAGEFFRDQGR--- 762 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--H---HHHHhhhhhcCCCCc---
Confidence 4332 234556789999999999999999999999999999766 7789876541 1 112222222222211
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
+.....|..|+..+.+++..||+.|-++|||++++...|.+..
T Consensus 763 ---~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 ---QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ---ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1222347788999999999999999999999999998887643
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=292.04 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=197.4
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 139 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (366)
....++|++.+.||+|+||.||++... .+..+|+|.++..... ...+.+.+|+.+++.+ +||||++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh---HHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344568999999999999999999742 2457999988764433 2345788999999999 89999999999
Q ss_pred EeeCCcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 140 CLETEVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
+...+..++++++...+. ...+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.++++|
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECC
Confidence 999999999988765432 123789999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHH
Q 037297 211 FGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 211 fg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
||++......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||....... .....
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~ 256 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKL 256 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHH
Confidence 9998765433221 1122345678999999998999999999999999999998 999986543110 00011
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
.... . ....+...+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 257 ~~~~-~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEG-Y--------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcC-C--------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1110 0 0011223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=316.85 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=196.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|.+. +++.||+|+++....... ...+++.+|+.+++.++||||+++++++.+.+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e-~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH-HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999975 588999999976433221 3345789999999999999999999999999999999
Q ss_pred EeeccCCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 150 LHDHHRNEE------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 150 ~~~~~~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
+++..+.+. ..++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence 887654321 12445677889999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCc-----------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037297 212 GTSKFIAMDQT-----------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274 (366)
Q Consensus 212 g~a~~~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 274 (366)
|++........ .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976521110 0111246899999999999999999999999999999999999999653211
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHhhcccCC
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-TMEEVTMELNGIRGSN 346 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~L~~~~~~~ 346 (366)
... ..... .++. ........++.+.+++.+||+.||++|| +++++++.|+......
T Consensus 238 ki~-------~~~~i--------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 238 KIS-------YRDVI--------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhh-------hhhhc--------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 000 00000 0000 0001123456788999999999999995 6788888887765443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.62 Aligned_cols=240 Identities=29% Similarity=0.417 Sum_probs=199.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|.-++.||.|+||.||-|++. +.+.||||++.-... ....+-..+..|+..|+++.|||++.+.+||..+....+++
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4666788999999999999964 688999999875333 23355678999999999999999999999999999999999
Q ss_pred eeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++.+.. ..++.+..+..|+.+.++||.|||+++ .||||||+.|||++++|.|||+|||+|....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----- 177 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA----- 177 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence 9987752 347889999999999999999999999 9999999999999999999999999997653
Q ss_pred eeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 224 VTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
+...++||+.|||||++. .+.|+.++||||||++..||...++|++.+... .....+..+..+.
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---------SALYHIAQNesPt---- 244 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------SALYHIAQNESPT---- 244 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------HHHHHHHhcCCCC----
Confidence 345578999999999774 568999999999999999999999999876521 1111111111111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+.+++.|.+|+..||++-|.+|||.+++++
T Consensus 245 ----Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 ----LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ----CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 125689999999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=288.45 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=190.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
.++|.+.+.||+|++|.||+|.+.. +..+|+|.+...... .....+..|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE---QDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4679999999999999999998653 567899988654333 2335688899999999999999999999988
Q ss_pred CcceEEEeeccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eE
Q 037297 144 EVPLLHLHDHHRNE--------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RA 206 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~v 206 (366)
...++++++..++. ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcce
Confidence 88888888765431 124788999999999999999999999 99999999999998654 58
Q ss_pred EEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHH
Q 037297 207 KVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 284 (366)
||+|||++.......... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||..... .. ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~---~~~- 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QE---VME- 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH---HHH-
Confidence 999999997653222111 111223567999999998899999999999999999997 9999875431 10 010
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
....... ...+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 233 ---~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ---FVTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111100 1123344567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.57 Aligned_cols=195 Identities=30% Similarity=0.370 Sum_probs=164.8
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-C-----CceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-H-----RNVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~ 138 (366)
-+....+|.+.+.||+|+||.|.+|.+. +++.||||+++... ....+...|+.+|..|+ | -|+|++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 3445568999999999999999999964 69999999998643 23456678999999886 4 39999999
Q ss_pred EEeeCCcceEEEeecc--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CeEEE
Q 037297 139 CCLETEVPLLHLHDHH--------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER--YRAKV 208 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~--~~vkl 208 (366)
+|.-....+++.|... .+....++...++.++.||+.||..||+.+ |||+||||+|||+.+. ..+||
T Consensus 256 ~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence 9999999999987643 345667999999999999999999999999 9999999999999743 47999
Q ss_pred eecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 209 ADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
+|||+|+.... ... ....+..|+|||++.|.+|+.+.|||||||++.||++|.+-|.+..
T Consensus 333 IDFGSSc~~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 333 IDFGSSCFESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred EecccccccCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 99999987532 222 4567888999999999999999999999999999999977776543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.32 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=206.0
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 144 (366)
......|++.+.||+|.||.||.+..+. |+.+|+|.+........ ...+.+.+|+.+|+++. ||||+.++++|.+.+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3445689999999999999999999775 99999999987655432 24468899999999998 999999999999999
Q ss_pred cceEEEeeccCCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CeEEEeecCCc
Q 037297 145 VPLLHLHDHHRNEEF------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER----YRAKVADFGTS 214 (366)
Q Consensus 145 ~~~~~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~----~~vkl~Dfg~a 214 (366)
..+++++...++... .+++.....++.|++.++.|||+.| ++||||||+|+|+... +.+|++|||++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999998865422 2899999999999999999999999 9999999999999643 57999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..... .......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.......... ..... .+
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~-~~ 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRG-DF 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcC-CC
Confidence 98765 455677899999999999999999999999999999999999999998755211111 11111 11
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
++ ....-...+....+++..|+..||.+|+|+.++++
T Consensus 256 -~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -DF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 11123445678999999999999999999999987
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=288.60 Aligned_cols=239 Identities=21% Similarity=0.275 Sum_probs=187.0
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||+|+||+||++.++ +++.+|+|.+....... ....+.+..|+.+++.++||||+++.+++......++++++..++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999965 58899999987543221 1234567889999999999999999999999888999988775532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeee
Q 037297 158 -----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226 (366)
Q Consensus 158 -----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 226 (366)
...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 235889999999999999999999999 99999999999999999999999999876543222 223
Q ss_pred eccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhh
Q 037297 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306 (366)
Q Consensus 227 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (366)
...||..|+|||.+.+..++.++|+||+||++|+|++|+.||......... ........... ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~----------~~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-----KELKQRILNDS----------VTY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-----HHHHHhhcccC----------CCC
Confidence 356899999999999999999999999999999999999999754321110 00000000000 012
Q ss_pred cHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 307 KKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 307 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
+...+..+.+++..||+.||++|| |++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 344667899999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=292.53 Aligned_cols=237 Identities=24% Similarity=0.284 Sum_probs=186.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC-ceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR-NVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~ 149 (366)
+|++.+.||+|+||.||+|..+ +++.+|+|++....... ....+.+..|..++..+.|+ +|+.+++++...+..+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 4889999999999999999965 47889999998643221 12345678899999999765 588899999888999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 98876543 235788999999999999999999999 9999999999999999999999999986432222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.......||..|+|||++.+..++.++|+||+||++|+|++|+.||..... ..... ......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~-~i~~~~--------- 217 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQ-SIMEHN--------- 217 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHcCC---------
Confidence 223345689999999999999999999999999999999999999975431 00111 111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
...+...+.++.+++.+||..||.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11233445678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.69 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=195.8
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 140 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (366)
.++|.+.+.||+|+||.||++... ++..+|+|.+...... .....+..|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 467999999999999999999753 2346999998864332 2345688899999999 899999999999
Q ss_pred eeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 037297 141 LETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTN 197 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~N 197 (366)
...+..++++++...+. ...+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 99999898888765431 124788899999999999999999999 9999999999
Q ss_pred EEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 037297 198 ILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS 275 (366)
Q Consensus 198 ill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~ 275 (366)
|+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++|+||+||++|+|++ |..||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999987553221111 112234567999999988899999999999999999998 8888854321
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ........... ...+...+.++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 249 ~-------~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 E-------ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H-------HHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0 01111111110 112334566899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=284.08 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=194.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|+||.||++... ++..+|+|.++..... ...+.+..|+.+++.++||||+++++++......++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS---SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 5889999999999999999965 5889999998754333 23457788999999999999999999999999999998
Q ss_pred eeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++.... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 876543 2235788999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......++..|+|||++.+..++.++|+||+|+++|+|++|..||..... ..... .......
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~------- 217 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLIL-KVCQGSY------- 217 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHH-HHhcCCC-------
Confidence 222335688899999999988999999999999999999999999965321 00011 1111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
...+...+..+.+++.+||+.||++|||+.+++..
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.63 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=194.0
Q ss_pred hcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
.++|++.+.||+|+||.||+|..+. +..+|+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4679999999999999999998642 367999998654332 2345788999999999999999999999999
Q ss_pred CcceEEEeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeE
Q 037297 144 EVPLLHLHDHHRNE-----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206 (366)
Q Consensus 144 ~~~~~~~~~~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~v 206 (366)
...++++++...+. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCE
Confidence 98898888765322 123677889999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHH
Q 037297 207 KVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 284 (366)
+|+|||++........ .......++..|+|||.+.+..++.++|+|||||++||+++ |..||..... . ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~------~~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--E------EV 230 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--H------HH
Confidence 9999999876543322 11223346778999999988889999999999999999998 8999864321 0 01
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
. ......... ..+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 231 ~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 L-KFVIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred H-HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 111111111 1223346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=300.04 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=190.2
Q ss_pred hcCCcccceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
..+|++.+.||+|+||.||++... .+..||+|.+.... ...+|+.+++.++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 457999999999999999999753 35789999876431 345799999999999999999999988888
Q ss_pred eEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 147 LLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 147 ~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++.+... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 162 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 8888765432 2346889999999999999999999999 999999999999999999999999998765433
Q ss_pred Cce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--ccccc
Q 037297 221 QTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--HMYDI 297 (366)
Q Consensus 221 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 297 (366)
... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ .............. .....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS--SSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc--HHHHHHHHHHhccCccccCCc
Confidence 221 22345689999999999999999999999999999999999999976542210 00000000000000 00000
Q ss_pred c-----------chHHhh-------hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 L-----------DDQVVK-------LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~-----------~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ...... ......+.++.+++.+||+.||++|||+.|++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000 001123567889999999999999999999974
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=291.44 Aligned_cols=234 Identities=24% Similarity=0.319 Sum_probs=182.8
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|... +++.||+|+++....... ...+.+..|..++... +||||+++++++...+..++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999965 578899999986432211 2334556676666654 89999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 542 236888999999999999999999999 9999999999999999999999999987543222 22334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|+||+||++|+|++|+.||..... ..... ...... ..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~-~i~~~~----------~~~~ 216 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFD-SILNDR----------PHFP 216 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHcCC----------CCCC
Confidence 5689999999999999999999999999999999999999975431 00011 111100 1123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
...+.++.+++..||+.||.+||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 345567889999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.06 Aligned_cols=237 Identities=23% Similarity=0.282 Sum_probs=187.8
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
+.||+|+||.||++... +++.+|+|++....... ......+..|+.+++.++||||+++++++...+..++++++..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 68899999998643221 12345677899999999999999999999999999999998765
Q ss_pred CC-------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 156 NE-------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 156 ~~-------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
+. ...+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 42 3368899999999999999999997 68 9999999999999999999999999986532222 12233
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|||||||++|+|++|+.||...... . ......... ..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~-~~~~i~~~~----------~~~p 216 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------K-LFELILMEE----------IRFP 216 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------H-HHHHHhcCC----------CCCC
Confidence 56899999999999999999999999999999999999999653310 0 000110110 0123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+.++.+++.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 33456789999999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=289.86 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=196.2
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+|.+.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH----HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 46888999999999999999742 245688888765332 23456889999999999999999999999999
Q ss_pred cceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 145 VPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 145 ~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
..++++++..++. ...+++..++.++.|++.|+.|||+++ ++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 8888888765331 123788999999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 279 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 279 (366)
.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 232 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----- 232 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999875543221 11223446778999999999999999999999999999998 99998654311
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
............ ..+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 233 ----~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 ----EVIECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----HHHHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 011111111111 1123345679999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=294.19 Aligned_cols=233 Identities=27% Similarity=0.345 Sum_probs=182.0
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHH-HHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|.++ +|+.||+|++........ .....+..|.. +++.++||||+++++++...+..++++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999975 689999999976432221 22234555554 5678899999999999999999999998876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 653 236888999999999999999999999 999999999999999999999999998653222 222334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... . ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~----------~~~~ 216 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNK-P----------LRLK 216 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcC-C----------CCCC
Confidence 5689999999999999999999999999999999999999975431 0111111111 0 0112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
+..+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 33466789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=292.01 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=191.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|.++ +++.||+|.++...... ....+.+|+.+++.++||||+++++++......+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 57999999999999999999965 58899999987543321 223567899999999999999999999999988888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 8876531 2235788899999999999999999999 99999999999999999999999999875433221
Q ss_pred eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---cCcccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---KNHMYDIL 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 298 (366)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .. ......... ...+....
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQ---LHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHHHcCCCChhhchhhh
Confidence 12233568889999987654 5788999999999999999999999754321 10 000000000 00000000
Q ss_pred c-------------hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 D-------------DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~-------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00011122335667899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.75 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred HHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
...++|++.+.||+|+||.||+|..+ .+..+|+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL---RERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 34578999999999999999999743 2457999988754332 23346788999999999999999999999
Q ss_pred eCCcceEEEeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 142 ETEVPLLHLHDHHRNE-----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
.....++++++...+. ....+...+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~ 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDF 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCC
Confidence 8888888888764321 123456778899999999999999999 99999999999999999
Q ss_pred eEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHH
Q 037297 205 RAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 282 (366)
.++|+|||++......... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~------ 228 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--E------ 228 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--H------
Confidence 9999999998755322211 1122234677999999988899999999999999999998 7888865331 0
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ........... ..+...+..+.+++.+||+.||++|||+.++++.|......
T Consensus 229 ~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 229 Q-VLKFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred H-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 0 11111111111 11223456899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.60 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=187.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||.||+|... +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 36889999999999999999965 5889999998753221 123456788999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99876542 235788899999999999999999999 9999999999999999999999999975321000
Q ss_pred ---------------------------------------------ceeeeeccccCCccccccccCCCCCchhhHHHHHH
Q 037297 222 ---------------------------------------------THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGV 256 (366)
Q Consensus 222 ---------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 256 (366)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC---HH
Q 037297 257 VLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT---ME 333 (366)
Q Consensus 257 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ 333 (366)
++|||++|+.||...... .............. .......+++..+++..|+ .||.+|++ ++
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~-------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL--------ETQMKVINWQTSLH-------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCCHH--------HHHHHHHccCCCcC-------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999999754310 00001110000000 0011234556788888875 59999997 77
Q ss_pred HHH
Q 037297 334 EVT 336 (366)
Q Consensus 334 ell 336 (366)
|++
T Consensus 301 ei~ 303 (382)
T cd05625 301 EIK 303 (382)
T ss_pred HHh
Confidence 665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=284.76 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-C---CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-D---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
..+|++.+.||+|+||.||+|... + +..+|+|.++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 357899999999999999999864 2 337999988764433 234678899999999999999999999999999
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++. ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999988776542 235788899999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeee--eccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHVTT--KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
......... ...++..|+|||.+.+..++.++|+||||+++|++++ |..||...... + ... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~---~~~----~~~~~~- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--D---VIK----AIEEGY- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--H---HHH----HHhCCC-
Confidence 543322221 1223567999999998899999999999999999886 99998654311 0 000 111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=299.08 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=192.9
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
....++|++.+.||+|+||.||++..+ +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 344578999999999999999999976 58899999987532211 1234467889999999999999999999999999
Q ss_pred ceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 146 PLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 146 ~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
.++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999998876543 235788889999999999999999999 99999999999999999999999999986643
Q ss_pred CCceeeeeccccCCccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..............
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~ 266 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHKNSL 266 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence 3333334467999999999886543 78899999999999999999999975431 11111111111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC---CCCHHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKK---RPTMEEVTME 338 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~---Rpt~~ell~~ 338 (366)
.+. .....+..+.+++..||. +|.. ||+++|+++-
T Consensus 267 ~~~-------~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFP-------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCC-------CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence 110 122456678999999998 4444 6788887763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=288.91 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=191.6
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+|++.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE----SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH----HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 57888999999999999999632 356788998765322 23457889999999999999999999999888
Q ss_pred cceEEEeeccCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 037297 145 VPLLHLHDHHRNEE----------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 145 ~~~~~~~~~~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~ 202 (366)
..++++++...+.. ..+++..++.++.|++.|+.|||+.+ ++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 88888887654321 24788999999999999999999999 999999999999999
Q ss_pred CCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccccc
Q 037297 203 RYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS 280 (366)
Q Consensus 203 ~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 280 (366)
++.++|+|||++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----- 232 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence 999999999998755332211 1122335678999999999999999999999999999998 899986533110
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
.......... ...+..++..+.+++.+||+.||.+||+++|+++.|+.
T Consensus 233 ---~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 ---AIECITQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000001100 01123455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=282.70 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=185.8
Q ss_pred eecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 78 ILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.||+|+||.||+|... ++..+|+|++...... ...+.+.+|+.+++.++||||+++++++. .+..++++++..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK---SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh---HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 3899999999999753 3557999998765332 33457889999999999999999999875 445677777664
Q ss_pred CC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee-
Q 037297 155 RN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT- 225 (366)
Q Consensus 155 ~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~- 225 (366)
++ ....+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++...........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 43 2346889999999999999999999999 99999999999999999999999999876543322211
Q ss_pred -eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 226 -TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 226 -~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
....++..|+|||.+.+..++.++|+|||||++|++++ |..||...... .......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~---------~ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---------EVMSFIEQGK---------R 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHHCCC---------C
Confidence 11223568999999988889999999999999999996 99999754310 0001111110 1
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..++.++.+++..||+.||++||++.++.+.|+.+
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112345567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=300.24 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=189.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 46899999999999999999865 6889999998753221 123456788999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99876542 335788899999999999999999999 99999999999999999999999999863321000
Q ss_pred e----------------------------------------------eeeeccccCCccccccccCCCCCchhhHHHHHH
Q 037297 223 H----------------------------------------------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGV 256 (366)
Q Consensus 223 ~----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 256 (366)
. .....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCC---CCHH
Q 037297 257 VLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKR---PTME 333 (366)
Q Consensus 257 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~ 333 (366)
++|||++|..||..... . ..............+. -....+.++.+++.+||+ +|.+| +|+.
T Consensus 237 il~elltG~~Pf~~~~~--~------~~~~~i~~~~~~~~~p-------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 237 IMFECLIGWPPFCSENS--H------ETYRKIINWRETLYFP-------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhcCCCCCCCCCH--H------HHHHHHHccCCccCCC-------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999965431 0 0011111100000000 011245678999999998 77775 5888
Q ss_pred HHHH
Q 037297 334 EVTM 337 (366)
Q Consensus 334 ell~ 337 (366)
|+++
T Consensus 301 ~~l~ 304 (377)
T cd05629 301 EIKS 304 (377)
T ss_pred HHhc
Confidence 8865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=304.08 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=188.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|... +++.+|+|++...... .....+.+.+|+++++.++||||+++++.+...+..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 46999999999999999999965 5889999998753221 112345688999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99876542 235788899999999999999999999 9999999999999999999999999975321000
Q ss_pred -----------------------------------------ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHH
Q 037297 222 -----------------------------------------THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVE 260 (366)
Q Consensus 222 -----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~e 260 (366)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC---CHHHHHH
Q 037297 261 LLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP---TMEEVTM 337 (366)
Q Consensus 261 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~ell~ 337 (366)
|++|+.||........ ............ .......+.++.+++..|+ .+|.+|+ |+.|+++
T Consensus 237 ll~G~~Pf~~~~~~~~--------~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAET--------QLKVINWETTLH-------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHHH--------HHHHhccCcccc-------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999976431100 000000000000 0011234556788888876 5999999 7888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=285.05 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=193.6
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
...+|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 457899999999999999999997777889999887532 123578889999999999999999999877 66677
Q ss_pred EEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++...+. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 777665432 234678889999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
..........++..|+|||.+.+..++.++|+|||||++|++++ |..||....... ..........
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~~~---- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYR---- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhCCCC----
Confidence 22222222345677999999988889999999999999999998 999986543100 0001111100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+...+.++.+++.+||+.||++|||+.++.+.|+.+
T Consensus 222 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=283.34 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=194.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|... |+.+|+|.+..... ..+++.+|+.+++.++|+||+++++++...+..+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 467999999999999999999875 78899999876432 346788999999999999999999999988888888
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 88775432 125889999999999999999999999 999999999999999999999999998765322
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.. ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... . . ........ .
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~------~-~~~~~~~~-~----- 216 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--K------D-VVPHVEKG-Y----- 216 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--H------H-HHHHHhcC-C-----
Confidence 11 2234567999999988889999999999999999997 9999865321 0 0 00011110 0
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+...++.+.+++.+||..+|++|||++|+++.|+.+
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 ---RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112234467889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=284.52 Aligned_cols=245 Identities=33% Similarity=0.504 Sum_probs=192.5
Q ss_pred CcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|++++.||+|+||+||++.... ++.+|+|.+........ ......+|+.+++.++||||+++++++......+++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE--EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH--HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc--ccchhhhhhhcccccccccccccccccccccccccccc
Confidence 6788999999999999999764 67899999997644432 22344569999999999999999999999999999888
Q ss_pred eccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+.... ....+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.... .....
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccc
Confidence 87763 2446889999999999999999999999 9999999999999999999999999987542 22334
Q ss_pred eeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 225 TTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....++..|+|||++. +..++.++|+||+|+++|+|++|..||..... .. ........... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~---~~~~~~~~~~~---------~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DD---QLEIIEKILKR---------PLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HH---HHHHHHHHHHT---------HHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hh---hhhhhhhcccc---------ccc
Confidence 44567899999999998 88899999999999999999999999976410 00 00000000000 000
Q ss_pred hhh--cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLV--KKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~--~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .......+.+++..||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0011268999999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=283.38 Aligned_cols=244 Identities=25% Similarity=0.418 Sum_probs=192.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.+|++.+.||+|+||.||++...++..+|+|.+...... ...+.+|+++++.++|||++++++++......++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 568899999999999999999877888999988754332 236788999999999999999999999888888888
Q ss_pred eeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++..+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 8765532 235788999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||..... ........... ...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~--~~~--- 221 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---------SEVVETINAGF--RLY--- 221 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---------HHHHHHHhCCC--CCC---
Confidence 21222334568999999988899999999999999999998 9999865331 00111111100 000
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 222 ----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 ----KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11223567999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=292.07 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=192.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++..... .....+.+|+.++.++ +||||+++++++.....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH---HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 357899999999999999999964 344 4577776543222 3345788899999999 89999999999999999
Q ss_pred ceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 037297 146 PLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 146 ~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~ 202 (366)
.++++++..++. ...+++..++.++.|++.|+.|||+.+ ++||||||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 999988765431 125788999999999999999999999 999999999999999
Q ss_pred CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccH
Q 037297 203 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 203 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 281 (366)
++.++|+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------- 230 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------- 230 (303)
T ss_pred CCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------
Confidence 999999999998532211 11111224567999999988889999999999999999998 99999653311
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.... ...... ....+...+..+.+++.+||+.||++|||++++++.|.++....
T Consensus 231 -~~~~-~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 231 -ELYE-KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -HHHH-HHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0011 011100 00112234557899999999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=293.78 Aligned_cols=236 Identities=26% Similarity=0.317 Sum_probs=182.2
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHH-HHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEI-VILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|.+. +++.+|+|++........ .....+..|. .+++.++||||+++++++...+..++++++..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999976 578899999976432221 1223344444 45678899999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||++| ++||||||+|||++.++.++|+|||++...... ......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 642 235778888999999999999999999 999999999999999999999999998753222 122334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ........ ... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~-~~~----------~~~ 216 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILN-KPL----------QLK 216 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHh-CCc----------CCC
Confidence 56899999999999999999999999999999999999999754310 11111111 100 122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
+..+..+.+++.+||+.||.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 34556789999999999999999987533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.09 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=177.8
Q ss_pred cceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--CcceEEE
Q 037297 76 NRILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLLHL 150 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~~~~ 150 (366)
..+||+|+||.||+|..+ ++..+|+|.+...... ..+.+|+.+++.++||||+++++++... ...++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 357999999999999865 3578999988754322 2567899999999999999999988643 3455565
Q ss_pred eeccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCeEEEeec
Q 037297 151 HDHHRN---------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADF 211 (366)
Q Consensus 151 ~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill----~~~~~vkl~Df 211 (366)
++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 554321 1235788999999999999999999999 9999999999999 46679999999
Q ss_pred CCcccccCCCce--eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc----HHHH
Q 037297 212 GTSKFIAMDQTH--VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS----LAAF 284 (366)
Q Consensus 212 g~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~ 284 (366)
|++......... ......+|..|+|||.+.+ ..++.++||||+||++|||++|+.||............ ....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 999866433221 2233568899999998876 45789999999999999999999999754322111100 0000
Q ss_pred HHHHhhcC------------cccccc---------chHHh---hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRKN------------HMYDIL---------DDQVV---KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~~------------~~~~~~---------~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ...... ..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 000000 00000 0011122456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.96 Aligned_cols=240 Identities=28% Similarity=0.269 Sum_probs=189.0
Q ss_pred cceecccCceEEEEEEE----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 76 NRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
++.||+|+||.||++.. .+|+.+|+|++....... .....+..|+.++++++||||+++++++......+++++
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV--RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 36799999999999875 257899999998643221 233467789999999999999999999999999999998
Q ss_pred eccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+..++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 876542 335889999999999999999999999 9999999999999999999999999987653322 22
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
.....||..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........ ... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~-~~~----------~ 215 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMIL-KAK----------L 215 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHH-cCC----------C
Confidence 3345689999999999988899999999999999999999999965331 00011111 110 0
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCCCHHH--HHHHHh
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEE--VTMELN 340 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e--ll~~L~ 340 (366)
.++...+.++.+++..||+.||++|||+.+ +.+.++
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 123345667899999999999999999766 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=293.16 Aligned_cols=240 Identities=26% Similarity=0.316 Sum_probs=184.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHH-HHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEI-VILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|.+. +++.+|+|++........ .....+..|. .+++.++||||+++++++...+..++++++..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999975 588999999876432222 2233455555 46788999999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence 543 235788889999999999999999999 999999999999999999999999998753222 122334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... .......... . ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~-~----------~~~~ 216 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHK-P----------LQLP 216 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcC-C----------CCCC
Confidence 5689999999999988999999999999999999999999975431 1111111111 0 1123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH-HHHHHHh
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME-EVTMELN 340 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~-ell~~L~ 340 (366)
...+..+.+++.+||+.||.+||++. ++.+.++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 34556789999999999999999864 4444444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=291.71 Aligned_cols=233 Identities=26% Similarity=0.337 Sum_probs=183.8
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +++.||+|+++....... ...+.+..|..++..+ +||||+++++++...+..++++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc-cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999975 588999999876432211 2345677888888776 79999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 542 346889999999999999999999999 9999999999999999999999999987532221 22334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||+.|+|||++.+..++.++|+||+||++|+|++|+.||..... ........ .... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~-~~~~----------~~~ 216 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL-NDEV----------VYP 216 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCCC----------CCC
Confidence 5689999999999999999999999999999999999999975431 01111111 1110 112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
...+.++.+++..||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 33456789999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=285.80 Aligned_cols=239 Identities=21% Similarity=0.276 Sum_probs=184.5
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||+|+||.||++..+ +|+.+|+|.+........ .....+..|+++++.++||||+++++++......++++++..++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999865 589999999865322211 123355679999999999999999999999888999998876542
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 158 ---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 158 ---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 225788888999999999999999999 9999999999999999999999999987654322 22335
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.++..|+|||++.+..++.++|+||+||++|+|++|+.||........ ......... ..... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~---------~~~~ 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTL-EDEVK---------FEHQ 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhh-ccccc---------cccc
Confidence 688999999999988899999999999999999999999965321110 000000000 00000 0112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+.++.+++..||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 35667899999999999999999987763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=286.76 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=194.0
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----------------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-----------------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (366)
..+|++.+.||+|+||.||+|.... +..+|+|.+...... ...+.+.+|+++++.++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCC
Confidence 3579999999999999999988542 245899998865443 34567889999999999999
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNE------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
|+++++++...+..++++++..... ...+++..++.++.|++.||.|||+.+ ++|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 9999999999888888888765431 125789999999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFST 271 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~ 271 (366)
|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999999999999998755332211 1223345778999999988889999999999999999998 67777543
Q ss_pred CCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.. .. ............... .....+..++.++.+++.+||+.||.+|||+.|+++.|+
T Consensus 238 ~~--~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TD--QQ---VIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred Ch--HH---HHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 00 111111110000000 001112334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=288.18 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=193.7
Q ss_pred hcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
.++|++.+.||+|+||.||+|... ++..+|+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH---HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467999999999999999999853 4678999998764433 2345688999999999999999999999998
Q ss_pred CcceEEEeeccCCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 144 EVPLLHLHDHHRNE-----------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 144 ~~~~~~~~~~~~~~-----------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
+..++++++...+. ...+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 88888888654321 124678889999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
|+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998754322211 1112234567999999988899999999999999999997 888886533
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
.. ............ ..+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 238 ~~---------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HE---------EVIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH---------HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 10 011111111111 1123455679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.44 Aligned_cols=242 Identities=27% Similarity=0.424 Sum_probs=194.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||+|..+ +++.+++|.+....... ...+.+.+|+.+++.++|||++++++++......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR--REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH--HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4788899999999999999965 58899999987543332 34567889999999999999999999999999999999
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..+.. ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 8775432 346788899999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
. ......++..|+|||+..+..++.++|+||||+++|+|++|+.||..... . ...........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~-------~~~~~~~~~~~------- 218 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--G-------ALILKIIRGVF------- 218 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--H-------HHHHHHHcCCC-------
Confidence 2 22334578899999999999999999999999999999999999975431 0 00111111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++.+||+.+|++||++.++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1122345668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=300.37 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=196.8
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEe
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLL 137 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 137 (366)
.+....++|.+.+.||+|+||.||+|.+. .+..||+|+++...... ..+.+..|+.++..+. ||||++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS---EKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh---HHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 35555678999999999999999999853 34679999998654332 2346889999999997 99999999
Q ss_pred eEEeeCCcceEEEeeccCCC------------------------------------------------------------
Q 037297 138 GCCLETEVPLLHLHDHHRNE------------------------------------------------------------ 157 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~------------------------------------------------------------ 157 (366)
++|......++++++...+.
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999888888887654321
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 037297 158 ---------------------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192 (366)
Q Consensus 158 ---------------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d 192 (366)
...+++..+..++.|++.||.|||+.+ ++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 013566778889999999999999998 99999
Q ss_pred CCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037297 193 IKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFS 270 (366)
Q Consensus 193 ikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 270 (366)
|||+|||+++++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|||++ |..||..
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999976532221 11122346788999999988889999999999999999998 8899865
Q ss_pred CCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 271 TGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
..... .......... ....+..++.++.+++..||+.||.+||+++|+++.|+.+-
T Consensus 345 ~~~~~--------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 345 LPMNE--------QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCchH--------HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 33100 0001111110 01123345668999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=286.96 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=190.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||+|... ++..+|+|.++...... ...+.+.+|+.+++.++||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4888999999999999999965 58899999987643222 22346788999999999999999999999998888888
Q ss_pred eeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 876431 1246889999999999999999999999 9999999999999999999999999987554322
Q ss_pred ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh----------
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---------- 290 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 290 (366)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.......... .......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-----RIFRILGTPTEDVWPGV 229 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHHHhCCCChhhhhcc
Confidence 112233568889999987654 57889999999999999999999997543111000 0000000
Q ss_pred ------cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 ------KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........... ........++++.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 01112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=291.73 Aligned_cols=237 Identities=24% Similarity=0.284 Sum_probs=187.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 149 (366)
+|++.+.||+|+||.||+|..+ +++.+|+|++....... ....+.+..|..++..+ .||+|+.+++++...+..+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 4888999999999999999976 47899999998643221 12334567788888777 689999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99876542 235788999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||..... . ....... ...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~------~~~~~i~-~~~--------- 217 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--D------ELFQSIM-EHN--------- 217 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--H------HHHHHHH-hCC---------
Confidence 222345689999999999999999999999999999999999999975431 0 0011111 110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
...+...+.++.+++.+||+.||++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01233456678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.05 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=195.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|.+.+.||+|+||.||+|.+.+ ...+|+|........ ...+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 4568899999999999999998543 246899988765433 3445788999999999999999999988754 4
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+ ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 56777765433 1225789999999999999999999999 999999999999999999999999998766
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRIENGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCcC--
Confidence 4432222222334567999999988889999999999999999886 99999654311 001111111110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
..+..++..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12344567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.55 Aligned_cols=258 Identities=19% Similarity=0.266 Sum_probs=180.5
Q ss_pred HhcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHH-------HHHHHHHHHHHHhcCCCCceeeEe
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELL-------KLEEFINEIVILSQINHRNVVKLL 137 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~ 137 (366)
..++|++.+.||+|+||.||+|...+ +..+|+|+........... .......+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999653 3456777644332211000 011223344556677999999999
Q ss_pred eEEeeCCc----ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 138 GCCLETEV----PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 138 ~~~~~~~~----~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
+++..... .+++++..... .....++..+..++.|++.||.|||+++ ++||||||+|||++.++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 97665542 23334332211 1123577888999999999999999998 99999999999999999999
Q ss_pred EeecCCcccccCCCc------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH
Q 037297 208 VADFGTSKFIAMDQT------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 281 (366)
|+|||+|........ .......||+.|+|||...+..++.++|||||||++|||++|+.||.............
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999976643221 11123468999999999999999999999999999999999999997653211110000
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
............. ....++..+.+++..||+.+|++||+++++.+.|+
T Consensus 247 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000111111100 12234678999999999999999999999998874
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=291.86 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=186.0
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +++.+|+|+++...... ....+.+..|..++..+ +||||+++++++......++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 46999999999999975 47899999997643221 12345677888888866 89999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 542 335788899999999999999999999 9999999999999999999999999987543222 22334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|+||+||++|+|++|+.||..... ............ ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~-----------~~p 216 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDV-----------LYP 216 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC-----------CCC
Confidence 5689999999999999999999999999999999999999975431 011111111110 112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRP-------TMEEVTM 337 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rp-------t~~ell~ 337 (366)
...+.++.+++..||+.||++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 23456789999999999999999 7777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=289.26 Aligned_cols=240 Identities=22% Similarity=0.292 Sum_probs=186.5
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|... +++.+|+|+++...... ....+.+..|..++..+ .||||+.+++++......++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 46999999999999965 57899999998643322 23445688899998888 69999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ......
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 543 246899999999999999999999999 999999999999999999999999998743221 122334
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......... ............. ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~----------~~~p 223 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEKP----------IRIP 223 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhCC----------CCCC
Confidence 578999999999999999999999999999999999999996543211111 1111111111111 0123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
...+..+.+++.+||+.||.+|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 33456788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=290.20 Aligned_cols=237 Identities=23% Similarity=0.292 Sum_probs=186.9
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +++.+|+|+++...... ......+..|..+++.+ +||||+++++++...+..++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999975 47899999998643221 12345677888888888 79999999999999999999998876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 542 236899999999999999999999999 9999999999999999999999999986432221 22233
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..|+..|+|||++.+..++.++|+||+||++|+|++|+.||..... .. ......... ...+
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~-~~~~i~~~~----------~~~~ 216 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DE-LFQSILEDE----------VRYP 216 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HH-HHHHHHcCC----------CCCC
Confidence 4689999999999999999999999999999999999999965331 00 111111111 0123
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTM-----EEVTM 337 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~-----~ell~ 337 (366)
...+..+.+++.+||+.||.+|||+ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3456678999999999999999999 76653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=293.98 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=185.3
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...+|++.+.||+|+||.||+|... ++..||+|+.... ....|+.+++.++||||+++++++......+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3467999999999999999999975 4778999975432 2345899999999999999999999999888
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 888776432 2346889999999999999999999999 999999999999999999999999998753221
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc--cHHHHHHHHhh-----cCc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV--SLAAFFVHSMR-----KNH 293 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~-----~~~ 293 (366)
.......||..|+|||++.+..++.++|||||||++|||+++..|+........... ........... ...
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 122345689999999999999999999999999999999986555533221110000 00000000000 000
Q ss_pred cccccchHH------------------hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQV------------------VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+..-..... ........+.++.+++.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000000000 00001133456778999999999999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=306.17 Aligned_cols=276 Identities=20% Similarity=0.212 Sum_probs=187.4
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC------CCceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN------HRNVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~ 138 (366)
+....++|++.+.||+|+||+||+|.+. +++.||+|+++.... ....+..|+.+++.+. |++++.+++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3344578999999999999999999965 578899999874321 1123444565555554 556888988
Q ss_pred EEeeCC-cceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCC------
Q 037297 139 CCLETE-VPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERY------ 204 (366)
Q Consensus 139 ~~~~~~-~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~------ 204 (366)
++.... ..+++++.+... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 199 YFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 887654 445555543221 23368899999999999999999998 48 99999999999998765
Q ss_pred ----------eEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037297 205 ----------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274 (366)
Q Consensus 205 ----------~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 274 (366)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999875422 2223457899999999999999999999999999999999999999754321
Q ss_pred CcccccHHHHHHH-----------------Hhhc-CccccccchHHhh-------hhcHHHHHHHHHHHHHhhcCCCCCC
Q 037297 275 SQENVSLAAFFVH-----------------SMRK-NHMYDILDDQVVK-------LVKKNQIMAFANLAERCLDLNGKKR 329 (366)
Q Consensus 275 ~~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~R 329 (366)
+.......... .... .......++.... .......+.+.+|+..||+.||++|
T Consensus 352 --~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 352 --EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred --HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 00000000000 0000 0000000110000 0011124568899999999999999
Q ss_pred CCHHHHHH--HHhhcccCCCCccccccc
Q 037297 330 PTMEEVTM--ELNGIRGSNFGHKMIYST 355 (366)
Q Consensus 330 pt~~ell~--~L~~~~~~~~~~~~~~~~ 355 (366)
||++|+++ .+......+..++.-.+.
T Consensus 430 ~ta~e~L~Hp~~~~~~~~~~~~~~~~~~ 457 (467)
T PTZ00284 430 LNARQMTTHPYVLKYYPECRQHPNYPDN 457 (467)
T ss_pred CCHHHHhcCccccccCCccccCCCCCCc
Confidence 99999986 455554444444433333
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=287.69 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=191.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|+||.||+|.+. +|+.+|+|.++...... .....+.+|+.+++.++||||+++++++.+....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 5888999999999999999975 58899999987643321 12345778999999999999999999999888888888
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 876532 2346899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH--------HHH--Hh-hc
Q 037297 224 VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF--------FVH--SM-RK 291 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~--~~-~~ 291 (366)
......++..|+|||.+.+. .++.++||||+||++|+|++|..|+................ ... .. ..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234568889999988664 47899999999999999999998876533211100000000 000 00 00
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
................+..+.++.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000001122345678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.86 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=191.7
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCcee
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED---------------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 134 (366)
.++|++.+.||+|+||.||++.... ...+|+|.++..... .....+.+|+++++.++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---TARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCcC
Confidence 3679999999999999999987532 235899998765433 2345788999999999999999
Q ss_pred eEeeEEeeCCcceEEEeeccCCCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 135 KLLGCCLETEVPLLHLHDHHRNEE-------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
++++++......++++++..+... ..+++..++.++.|++.|+.|||+++ ++|+||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 999999999999999887654321 13678888999999999999999999 99999999
Q ss_pred CCEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 037297 196 TNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTG 272 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~ 272 (366)
+||+++.++.+||+|||++.......... .....++..|+|||...+..++.++|+|||||++|+|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999987653322111 122334678999999988889999999999999999998 566775432
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
. .. .............. ......+...+..+.+++.+||+.||++|||++++++.|.
T Consensus 238 ~--~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 D--EQ---VIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred h--HH---HHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 11 00000000110000 0001112234568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.16 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=191.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-----------------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-----------------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (366)
.++|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---NARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCC
Confidence 357999999999999999998532 2346899998764332 33457889999999999999
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNEE------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
|+++++++...+..++++++...... ..+++..+..++.|++.|+.|||+.+ ++|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 99999999999998998887654311 23667789999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFST 271 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~ 271 (366)
|+||+++.++.++|+|||++..+....... .....++..|+|||...+..++.++|+|||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999987654322111 112234678999998888889999999999999999998 67888643
Q ss_pred CCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
.. .+. ............. .. ....+..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus 238 ~~--~~~---~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SD--EQV---IENTGEFFRDQGR-QV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred Ch--HHH---HHHHHHHHhhccc-cc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 110 0000001100000 00 001123455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.88 Aligned_cols=242 Identities=25% Similarity=0.361 Sum_probs=186.8
Q ss_pred ceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. +..++++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEe
Confidence 469999999999998532 368999998865443 344678899999999999999999998764 445677776
Q ss_pred ccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 153 HHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 153 ~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
...+. ...+++..+..++.|++.|+.|||..+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 54432 225889999999999999999999999 99999999999999999999999999986643332221
Q ss_pred e--eccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 226 T--KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 226 ~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
. ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... ..... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~-~~~~~~--------- 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIA-MLESGE--------- 215 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH-HHHcCC---------
Confidence 1 1223467999999998899999999999999999998 9999865331 00010 111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01123345567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=295.64 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=191.0
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
.....|++++.||+||.+.||++...+.+.+|+|++.....+. .....|..|+..|.+| .|.+|+.++|+-..++..
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~--qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN--QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH--HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3457899999999999999999998778888988877655443 4567899999999999 699999999999999999
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
|+++|.-... .....+...++.+..||+.++.++|++| |||.||||.|+|+-.+ .+||+|||.|..+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence 9998864321 1112333478889999999999999999 9999999999998665 999999999998876
Q ss_pred CCceee-eeccccCCccccccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 220 DQTHVT-TKIQGTFGYLEPEYHQSSQ-----------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 220 ~~~~~~-~~~~~t~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
+.+... ...+||..||+||.+.... .++++|||||||+||+|+.|+.||.... +...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a---- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA---- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH----
Confidence 655433 4567999999999775332 5578999999999999999999996422 1111
Q ss_pred HhhcCccccccchHHhhh---hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKL---VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..+.++.-..+ ++... ++.++++.||.+||.+|||+.|+|+
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1112222211111 12222 2899999999999999999999974
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=291.16 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=195.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 139 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (366)
...+|.+.+.||+|+||.||+|... ....+|+|.++..... .....+..|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---KDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh---HHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3467899999999999999999742 2456899988754333 3345788899999999 69999999999
Q ss_pred EeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 037297 140 CLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKST 196 (366)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~ 196 (366)
+......++++++...+. ...+++..+..++.|++.|+.|||++| ++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 998888888888664431 134788889999999999999999999 999999999
Q ss_pred CEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 037297 197 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274 (366)
Q Consensus 197 Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~ 274 (366)
||+++.++.+||+|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~- 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV- 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999997654322111 112234467999999988899999999999999999999 8888854321
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.. .......... ...+..++.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 243 -~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 -EE-------LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HH-------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 00 0011111110 11233455678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=278.67 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=189.6
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCC
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRN 156 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~ 156 (366)
+.||+|++|.||++...+++.+|+|.+...... ...+.+..|+.++++++||||+++++++......++++++..+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999776999999998765443 24457889999999999999999999999999999998876543
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee-ee
Q 037297 157 --------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-TK 227 (366)
Q Consensus 157 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-~~ 227 (366)
....+++..+..++.+++.|+.|||+++ ++||||+|+||+++.++.++|+|||.+........... ..
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 2335788899999999999999999999 99999999999999999999999999875432111111 11
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhh
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (366)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. ...... . ....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~----~~~~~~-~--------~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TR----ERIESG-Y--------RMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HH----HHHhcC-C--------CCCC
Confidence 223567999999988899999999999999999999 888886543100 00 000000 0 0012
Q ss_pred cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 307 KKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 307 ~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
+...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 33445689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=286.18 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=191.1
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (366)
.+|++.+.||+|+||.||++..+ ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 57899999999999999999742 478899999875432 2345788999999999999999999987543
Q ss_pred CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++++++..++ ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 3566777766443 1235788999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceee--eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc-------ccHHHHHH
Q 037297 216 FIAMDQTHVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN-------VSLAAFFV 286 (366)
Q Consensus 216 ~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-------~~~~~~~~ 286 (366)
.......... ....++..|+|||...+..++.++|+|||||++|||++|..|+.......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6643322111 11223446999999988899999999999999999999887765432110000 00000000
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...... .....+..++.++.+++.+||..+|++|||+.|+++.|+.++
T Consensus 237 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 ELLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000 001112345567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.63 Aligned_cols=249 Identities=22% Similarity=0.419 Sum_probs=194.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-G---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|+..+.||+|+||.||+|..+. + ..+|+|.+...... ...+.+..|+.+++.++|||++++.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE---KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 3578889999999999999999652 3 36999988764333 234578899999999999999999999999999
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 999998776542 235788899999999999999999999 999999999999999999999999998766
Q ss_pred cCCCceeeee--ccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHVTTK--IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.......... ...+..|+|||.+.+..++.++|+|||||++|||++ |..||..... .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~-~~~~i~~~~~ 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HE-VMKAINDGFR 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HH-HHHHHhcCCC
Confidence 4332221111 123457999999988889999999999999999997 9999864321 01 1111111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 229 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ---------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.50 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=192.9
Q ss_pred cCCcccceecccCceEEEEEEEcC-C---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED-G---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
++|++.+.||+|+||.||+|..+. + ..||+|.+...... .....+..|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 458899999999999999998653 3 36999998764333 3346789999999999999999999999988888
Q ss_pred eEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++...+. ...+++..++.++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 88888765532 235788899999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceee--eec--cccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 219 MDQTHVT--TKI--QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 219 ~~~~~~~--~~~--~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
....... ... ..+..|+|||.+.+..++.++|+||+||++|||++ |..||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~~~ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQDYR 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCc
Confidence 3222111 111 12357999999998999999999999999999886 99998653310 00000000000
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..++..+.+++..||+.+|++||+++++++.|+.+
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011234556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=286.75 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=183.5
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|... +++.||+|+++....... ...+....|..++... +||||+++++++...+..++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999975 478999999986432111 2234566677777754 99999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 543 235788999999999999999999999 9999999999999999999999999986532221 22234
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|+||+||++|+|++|+.||..... . .... ...... ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~------~~~~-~i~~~~----------~~~~ 216 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--E------ELFQ-SIRMDN----------PCYP 216 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--H------HHHH-HHHhCC----------CCCC
Confidence 5689999999999999999999999999999999999999975431 0 0010 111000 0112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME-EVT 336 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~-ell 336 (366)
...+.++.+++.+||+.||.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 23456788999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=289.74 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=189.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++... +++.+|+|++...... .....+.+.+|..+++.++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 47999999999999999999965 5889999998752211 123345688899999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99875542 335788999999999999999999999 9999999999999999999999999987654333
Q ss_pred ceeeeeccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCccc
Confidence 322333468999999998863 4578899999999999999999999965321 011111111111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTME 338 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~ 338 (366)
+. ......+..+.+++.+||+.+++. ||+++++++-
T Consensus 229 ~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 011225667889999988754443 7788887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.81 Aligned_cols=245 Identities=25% Similarity=0.313 Sum_probs=191.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|+..+.||+|+||.||++... +++.+|+|.+........ .....+..|+.+++.++|+|++.+++.+...+..++++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch-HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 3778899999999999999965 588999999875433221 22345778999999999999999999999999888888
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 8765432 235788899999999999999999999 9999999999999999999999999986543222
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||......... ........ .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----~~~~~~~~----------~ 219 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----EEVERLVK----------E 219 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----HHHHhhhh----------h
Confidence 122346899999999999999999999999999999999999999754311100 00000000 0
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
.....+...+.++.+|+..||+.||++||| ++|+++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011123345667899999999999999999 778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=280.15 Aligned_cols=246 Identities=25% Similarity=0.283 Sum_probs=200.0
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++++.||+|.-|+||++..++ +..+|+|++....... ..+..+...|-+||..++||-++.+|+.+..+...+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34678889999999999999999764 6899999998765543 355678889999999999999999999999999999
Q ss_pred EEEeeccCCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRNEE---------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++.++.. ..+++..++.++.+|+.||+|||-+| ||.|||||+||||-++|++.|+||.++..+.
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999988643 35889999999999999999999999 9999999999999999999999998864432
Q ss_pred CC----------------------------------C---------------------ceeeeeccccCCccccccccCC
Q 037297 219 MD----------------------------------Q---------------------THVTTKIQGTFGYLEPEYHQSS 243 (366)
Q Consensus 219 ~~----------------------------------~---------------------~~~~~~~~~t~~y~aPE~~~~~ 243 (366)
.. . ......++||-.|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0011236799999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhc
Q 037297 244 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLD 323 (366)
Q Consensus 244 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 323 (366)
+.+.++|.|+||+++|||+.|..||-+.+.... +. .++.+.+.-.-.+..+..++|||+++|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------l~---------NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------LR---------NIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------HH---------HHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999987653111 11 1111111111123566789999999999
Q ss_pred CCCCCCCC----HHHH
Q 037297 324 LNGKKRPT----MEEV 335 (366)
Q Consensus 324 ~dp~~Rpt----~~el 335 (366)
+||.+|.. +.||
T Consensus 374 KdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEI 389 (459)
T ss_pred cChhhhhccccchHHh
Confidence 99999987 6665
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=286.60 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=193.5
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (366)
..|++.+.||+|+||.||.+.. .++..+|+|.++..... ...+.+.+|+.+++.++|||++++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4578999999999999999973 24788999998764333 2345789999999999999999999998775
Q ss_pred CcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++++++..+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 45677777765442 225788999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-------ccccHHHHHH
Q 037297 216 FIAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ-------ENVSLAAFFV 286 (366)
Q Consensus 216 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-------~~~~~~~~~~ 286 (366)
........ ......++..|+|||.+.+..++.++|||||||++|+|++++.|+........ ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HH
Confidence 66433221 12234467789999999888899999999999999999998876543211000 0000000 00
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....... ....+..++..+.+|+.+||+.||++|||++++++.|+.+
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011000 0112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=280.60 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=191.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|++.+.||+|+||.||+|... +++.+|+|++...... ....+.+|+.+++.++||||+++++++......++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 357999999999999999999964 5889999998754322 23467789999999999999999999999998888
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++...+. ..++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 888765432 235788999999999999999999998 9999999999999999999999999987653221
Q ss_pred ceeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.......++..|+|||.+. ...++.++|+||+||++|+|++|+.||.......... ....... .
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~~~---~ 227 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKSNF---Q 227 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecCCC---C
Confidence 1123345788999999874 3457889999999999999999999986433111000 0000000 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
.+.. ......+..+.+++..||+.||++|||++++++.|
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 01123456899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=287.57 Aligned_cols=236 Identities=25% Similarity=0.329 Sum_probs=183.7
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|..+ +|+.||+|+++....... ...+....|..++... +||||+++++++...+..++++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999976 588999999986432111 2334566777777654 89999999999999999999999876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++...... ......
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 543 236788899999999999999999999 999999999999999999999999998643211 122344
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++||||+||++|+|++|+.||..... . ... ....... ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~------~~~-~~~~~~~----------~~~~ 216 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--D------ELF-ESIRVDT----------PHYP 216 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--H------HHH-HHHHhCC----------CCCC
Confidence 5689999999999999999999999999999999999999975431 0 001 0111000 0112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTME-EVT 336 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~-ell 336 (366)
...+.++.+++..||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23455788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=279.93 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=194.7
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecccCh--HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD--EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ........+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 48889999999999999999878899999998764332 1223346788999999999999999999999999888888
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
+++..+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 88765532 235788999999999999999999999 9999999999999999999999999987543211
Q ss_pred ----ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 222 ----THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 222 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
........++..|+|||.+.+..++.++|+||+||++|+|++|+.||....... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~--- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHRGL--- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhccCC---
Confidence 111223458889999999998889999999999999999999999996533110 00000000000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01123345667899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=292.03 Aligned_cols=234 Identities=27% Similarity=0.362 Sum_probs=182.3
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHH-HHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|... +|+.+|+|++........ .....+..|.. +++.++||||+++++++...+..++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999965 589999999976432221 22334555554 5677899999999999999999999998876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||++| ++||||||+|||++.++.+||+|||++...... ......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 542 346889999999999999999999999 999999999999999999999999998653221 122234
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..||..|+|||++.+..++.++|||||||++|+|++|+.||..... ........... . ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~-~----------~~~ 216 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKP-L----------VLR 216 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCC-c----------cCC
Confidence 5689999999999999999999999999999999999999975431 01111111110 0 112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
+..+..+.+++..||+.||.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 234567889999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=281.45 Aligned_cols=241 Identities=26% Similarity=0.396 Sum_probs=184.7
Q ss_pred ceecccCceEEEEEEEcC-Cc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLED-GR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.||+|+||.||+|..++ +. .+++|.++..... ...+.+.+|+.+++.+ +||||+++++++......++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH---HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 368999999999999653 43 4688887743322 2345788899999999 899999999999999988899887
Q ss_pred ccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 153 HHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 153 ~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
...+. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEEC
Confidence 65331 124788999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
|||++..... .........+..|+|||.+.+..++.++|+|||||++|||++ |..||..... ......
T Consensus 155 dfgl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~- 223 (270)
T cd05047 155 DFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEK- 223 (270)
T ss_pred CCCCccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHH-
Confidence 9999853221 111111223567999999988889999999999999999997 9999965321 011111
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
..... ....+...+.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 224 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HhCCC---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11110 00112334567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=298.70 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=219.7
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
.++++....+..+-.+||-|.||.||.|.++. ...||||.++.+.. ..++|+.|..+|+.++|||+|+++++|.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-----eveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-----hHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 36677777788888999999999999999774 77899999986544 3579999999999999999999999999
Q ss_pred eCCcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 142 ETEVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
.+...|++.++...++ ...++...++.++.||..||.||..++ +|||||.++|.|+.++..||++|||
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 9999999988765443 234667778899999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
+++.+..+...........+.|.|||-+.-..++.|+|||+|||+|||+.| |..||.+.+ .
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------------l 472 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------L 472 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------------H
Confidence 999887666555555566889999999988999999999999999999998 889987654 1
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
..+.+++....+..-|..|++.+..|++.||+++|..||++.|+-+.++.+-.+
T Consensus 473 SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 123344555666677899999999999999999999999999999999876543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.63 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=190.2
Q ss_pred HhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
..++|++.+.||+|+||.||+|.+ .+++.||+|.++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh---HHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 346899999999999999999973 24678999999764433 2345788999999999 6899999999887
Q ss_pred eCC-cceEEEeeccCCC---------------------------------------------------------------
Q 037297 142 ETE-VPLLHLHDHHRNE--------------------------------------------------------------- 157 (366)
Q Consensus 142 ~~~-~~~~~~~~~~~~~--------------------------------------------------------------- 157 (366)
... ..++++++...+.
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 654 4455665543221
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce-ee
Q 037297 158 -----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VT 225 (366)
Q Consensus 158 -----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~ 225 (366)
...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 013577788899999999999999999 999999999999999999999999998765322111 11
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... . .......... .
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~----~~~~~~~~~~---------~ 301 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----E----FCRRLKEGTR---------M 301 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----H----HHHHHhccCC---------C
Confidence 12335677999999988899999999999999999997 999986532110 0 0111111100 0
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+...++++.+++..||+.||++|||+.|+++.|+.+..
T Consensus 302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112234578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.88 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=196.3
Q ss_pred HHhcCCcccceecccCceEEEEEEEcC--------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEee
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLED--------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 138 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (366)
....+|++++.||+|+||.||+|.... +..+|+|.++..... ...+.+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---KDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---HHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 334579999999999999999997421 236899988754333 3356788999999999 8999999999
Q ss_pred EEeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 139 CCLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
+|......++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 9998888888887765431 124677888999999999999999999 99999999
Q ss_pred CCEEecCCCeEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 037297 196 TNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 273 (366)
+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999987654322111 122234567999999999999999999999999999998 8888864321
Q ss_pred CCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 274 TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.. .......... ...+..++..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 243 --------~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 --------EE-LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --------HH-HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 1111111111 1122344567999999999999999999999999999887444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.12 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=181.2
Q ss_pred HHhcCCcccceecccCceEEEEEEEcC--CcEEEEEEeecc-------------cChHHHHHHHHHHHHHHHHhcCCCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLED--GRIMAVKKFKLA-------------VDDEELLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~-------------~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (366)
....+|++++.||+|+||.||+|..+. +...+.|.+... ...........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 222222211100 00011123456789999999999999
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
|+++++++...+..+++++.+...- ........+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999998888876543210 111234567789999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCccccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP-IFSTGNTSQENVS 280 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~~~~~~ 280 (366)
.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ +...........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~- 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL- 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH-
Confidence 999999999999987654433333445789999999999999999999999999999999998754 433221111110
Q ss_pred HHHHHHHHhh--cCcccc-------ccch--------HHhhhh-cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 281 LAAFFVHSMR--KNHMYD-------ILDD--------QVVKLV-KKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 281 ~~~~~~~~~~--~~~~~~-------~~~~--------~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ..... ...+++ .++. .....+ ....+.++.+++.+||+.||.+|||+.|+++
T Consensus 381 -~~~-~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 -LKI-IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred -HHH-HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00000 000000 0000 000000 1123456788999999999999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.54 Aligned_cols=242 Identities=27% Similarity=0.389 Sum_probs=194.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||.|++|.||+|... +++.+|+|.+...... .....+.+|+.+++.++|||++++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc---hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 46889999999999999999965 5889999998765432 2345678899999999999999999999999888888
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..... ..++++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 88766542 227899999999999999999999999 9999999999999999999999999997765332 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .. ...........
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~-------~~~~~~~~~~~-------- 216 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MR-------VLFLIPKNNPP-------- 216 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HH-------HHHHhhhcCCC--------
Confidence 22334678889999999888899999999999999999999999965331 00 00001111110
Q ss_pred hhhcHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKN-QIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+.. .+.++.+++..||..||++|||++++++
T Consensus 217 -~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 -SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111 5667899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=301.14 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=199.0
Q ss_pred CcccceecccCceEEEEEEE-cCCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 73 FNVNRILGQGGQGTVYKGML-EDGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
....++||+|+||+||+|.+ ..|+ +||+|++...... ....++++|+-+|..++|||+++++++|.... ..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34568999999999999984 3343 6899998765544 34568999999999999999999999998877 23
Q ss_pred EEEe--------eccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLH--------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~--------~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++.+ .+.......+.....+.|+.||++||.|||++. ++||||..+|||+.+...+||.|||+++.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 3322 233335557888999999999999999999999 99999999999999999999999999998876
Q ss_pred CCceeee-eccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQTHVTT-KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
+...... ...-.+.|||-|.+....|+.++|||||||++||++| |..|++.... .+++++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------------~eI~dl 912 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------------EEIPDL 912 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------------HHhhHH
Confidence 5544332 2234567999999999999999999999999999988 9999987652 223344
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
+...-+-..|+.++-++..++.+||..|+..||+++++...+..+
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 444444556888999999999999999999999999999888754
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.89 Aligned_cols=236 Identities=28% Similarity=0.445 Sum_probs=194.1
Q ss_pred eecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCC
Q 037297 78 ILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRN 156 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~ 156 (366)
+||+|.||+||.|++.+ ...+|||.+...... ..+-+.+|+.+.++|+|.|||+++|+|.+.....+.++...++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr----~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR----EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch----hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 59999999999999764 567899988764332 3456788999999999999999999999999888889988876
Q ss_pred CCC--------CC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEEeecCCcccccCCCceee
Q 037297 157 EEF--------PL--TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 157 ~~~--------~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
+.. ++ ++.++-.+..||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+..- +...
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 533 34 78889999999999999999998 99999999999997 5689999999999876532 3455
Q ss_pred eeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 226 TKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.++.||..|||||++..+ +|+.++|||||||++.||.||++||...+.+.. +.+-. .+... -
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----AMFkV------GmyKv-----H 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----AMFKV------GMYKV-----H 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----hhhhh------cceec-----C
Confidence 668899999999999876 588999999999999999999999987653211 11111 11111 1
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+|.+.+.+.++|+.+|+..||..||++.++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2368889999999999999999999999999975
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=278.98 Aligned_cols=240 Identities=31% Similarity=0.462 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.||+|+||.||+|.... +..+++|.+....... ..+.+.+|+..++.++|+|++++++++......++++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 469999999999999653 7889999998755442 456889999999999999999999999998888888887
Q ss_pred ccCC-------C---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 153 HHRN-------E---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 153 ~~~~-------~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++ . ...+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence 7433 1 356899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~-------~~~~~~~~~~- 224 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--E-------EVLEYLRKGY- 224 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--H-------HHHHHHHcCC-
Confidence 654321 12233457888999999988899999999999999999999 6999876421 0 0111111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
....+..++.++.+++.+||+.||.+|||+.|+++.|+
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11123445678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=267.42 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=195.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChH----HHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDE----ELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (366)
.+.|.-.+.||.|..++|-++.++ +|..+|+|++....... .....+.-..|+.+|+++ .||+|+.+.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 466888899999999999988855 68888999876543321 223456678899999999 799999999999999
Q ss_pred CcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 144 EVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 144 ~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
...+++.+....+. ..++++...+++++|+.+|+.|||..+ |+||||||+|||+++|.+++|+|||.|+.
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeec
Confidence 99888877766553 336889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
+.. +......|||++|+|||.+.. .+|+..+|+||+||++|.|+.|.+||.-.. +. .+...+.
T Consensus 173 l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qm----lMLR~Im 241 (411)
T KOG0599|consen 173 LEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QM----LMLRMIM 241 (411)
T ss_pred cCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HH----HHHHHHH
Confidence 753 344566899999999997743 468889999999999999999999996321 00 0111111
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+. .++.+++ -.+.+...++|+.+||+.||.+|.|++|.+.
T Consensus 242 eGk-yqF~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGK-YQFRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcc-cccCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111 1122221 2345567899999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.95 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=195.1
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
...+...+.||+|+||.||+|.. .++..||+|.+...... ...|++.+++++||||++++++|...+..++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 35677888999999999999996 46899999988643221 1245888999999999999999999999999
Q ss_pred EEeeccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 149 HLHDHHRNEE----FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 149 ~~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
++++..++.. ..+++..+..++.|++.|++|||....++++||||||+||+++.++..++. ||.+......
T Consensus 761 v~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 761 IHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred EEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9998766532 247889999999999999999996544459999999999999998887775 6655432211
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
....+|..|+|||++.+..++.++|||||||++|||++|+.||...... ...................+.++....
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHhcCccchhheeCccccC
Confidence 1235788999999999999999999999999999999999999543211 111222222122222222233333221
Q ss_pred --hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 305 --LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 305 --~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+.....++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2334556678999999999999999999999999998864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=278.51 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=188.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-CcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-EVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 148 (366)
..+|++.+.||+|+||.||++... |..+|+|..+... ..+.+.+|+.+++.++|+|++++++++... ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 357899999999999999999765 7789999886532 234688899999999999999999976544 45677
Q ss_pred EEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++...+ ....+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 77766543 2224788999999999999999999999 99999999999999999999999999875432
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .....+..|+|||++.+..++.++|+|||||++|+|++ |+.||..... .... .......
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~-~~~~~~~----- 216 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVV-PRVEKGY----- 216 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-HHHhcCC-----
Confidence 21 12234567999999988899999999999999999997 9999864321 0011 1111110
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 217 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 ----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0112234566889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=278.97 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=193.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH-----HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE-----LLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
+|.+.+.||+|++|.||+|... ++..+|+|.+........ ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788999999999999999864 578899998876443321 1234578899999999999999999999999999
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..+.. ...+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999888765542 246788899999999999999999998 9999999999999999999999999987664
Q ss_pred CCCce-----eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 219 MDQTH-----VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 219 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
..... ......++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~- 227 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKI-GEN- 227 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHH-hcc-
Confidence 22111 112245788999999999888999999999999999999999999753210 000000 000
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...+..+.+++.+||+.||.+||++.|+++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011123445678899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.45 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=190.2
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc--ceEE
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--PLLH 149 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~ 149 (366)
.++..+||+|+|-+||+|.+. +|-.||.-.++...........++|..|+.+|+.|+||||+++++++.+... ..++
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 356688999999999999975 4777877766654444444566899999999999999999999999988776 4455
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~~~~~~ 221 (366)
.+.+..+. ....+...+..|++||+.||.|||++. +||||||||.+||+|+.+ |.|||+|+|+|.......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 56554443 235677888999999999999999985 899999999999999854 899999999998764332
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.....|||.|||||+.. ..|+..+||||||+++.||+|+..||....+..+. .+.+.....+..+.
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI----YKKV~SGiKP~sl~------ 266 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI----YKKVTSGIKPAALS------ 266 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH----HHHHHcCCCHHHhh------
Confidence 33368999999999887 89999999999999999999999999765532221 12221111121121
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..-.+++++||.+||.. .++|||+.|+|+
T Consensus 267 ------kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 ------KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12244789999999999 999999999975
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=280.61 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=193.8
Q ss_pred hcCCcccceecccCceEEEEEEEcC-Cc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..+|++.+.||+|+||.||+|..+. |+ .+|+|........ .....+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP---KANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3678999999999999999998642 33 5899988765432 345678899999999999999999999887 6
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++...+. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 6777777665432 335889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCceee-eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHVT-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||..... . ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~-------~~~~~~~~~~~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--V-------EIPDLLEKGER 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--H-------HHHHHHhCCCC
Confidence 643322211 11223567999999988889999999999999999998 9999865431 0 01111111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
...+..++..+.+++..||..||.+|||+.++++.|+.+..
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01122344578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=281.92 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=189.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|+..+.||+|+||.||++... +++.+|+|.+........ .....+.+|+++++.++|+|++.+.+++...+..++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR-KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh-hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 3777899999999999999865 588999999876432211 22345778999999999999999999999999888888
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 8765432 235889999999999999999999999 9999999999999999999999999986543221
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......|+..|+|||.+.+..++.++|+||+||++|+|++|..||........ ............
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-----~~~~~~~~~~~~-------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-----REEVDRRVLETE-------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhhhccc--------
Confidence 12334689999999999988999999999999999999999999975431100 000000000000
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
...+...+..+.+|+..||+.||++||| +.++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0123345567899999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=283.59 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=192.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+++++.++||||+++++++...+..+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP---AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999965 5788999988764333 2345688999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..+.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 98876542 2457889999999999999999997 47 999999999999999999999999998654322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc--------
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH-------- 293 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 293 (366)
......++..|+|||...+..++.++|+||||+++|+|++|+.||....... .............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccc
Confidence 1233568889999999988889999999999999999999999986432100 0000000000000
Q ss_pred ------------cccccchHH---hhhh-cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 294 ------------MYDILDDQV---VKLV-KKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 294 ------------~~~~~~~~~---~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
.....+... .... ....+.++.+++.+||+.||++|||+.|+++.-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 0000 112566799999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=285.47 Aligned_cols=238 Identities=23% Similarity=0.282 Sum_probs=186.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 149 (366)
+|++.+.||+|+||.||+|..+ +++.||+|+++...... ....+.+..|..++..+. |++|+++++++...+..+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4778899999999999999965 58899999988643221 123456778888888885 57788899999998999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99876543 246889999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.......||..|+|||++.+..++.++|+||+||++|+|++|+.||..... . ........ ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~------~~~~~i~~-~~--------- 217 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--D------ELFQSIME-HN--------- 217 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--H------HHHHHHHh-CC---------
Confidence 122335689999999999999999999999999999999999999975431 0 00111111 10
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
...+...+.++.+++.+||+.||.+|++..
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 012334556789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=275.91 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=190.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-cceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 149 (366)
+|++.+.||+|++|.||++..+ +++.+|+|.+....... ...+.+.+|+.+++.++|||++++++.+...+ ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR--RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4889999999999999999965 47889999987543322 23456888999999999999999998876444 45677
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++.... ...++++.++..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 7765433 1335889999999999999999999999 999999999999999999999999998766433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.. ......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... ...... ......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~-~~~~~~------ 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYR-IIEGKL------ 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH-HHhcCC------
Confidence 22 22345678899999999999999999999999999999999999864321 000000 111111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123456678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=296.60 Aligned_cols=249 Identities=22% Similarity=0.245 Sum_probs=189.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++..+ +++.+|+|+++..... .......+..|+.++..++||||+++++.+......+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 36889999999999999999965 5889999999753221 123456788899999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9987654 2346889999999999999999999999 99999999999999999999999999865422110
Q ss_pred ----------------------------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 037297 223 ----------------------------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 268 (366)
Q Consensus 223 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 268 (366)
......+||+.|+|||++.+..++.++|+|||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011346899999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
...... .............. ..+ ....+.++.+++.+|+ .||.+|++...+-+++
T Consensus 237 ~~~~~~--------~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 237 CSETPQ--------ETYRKVMNWKETLV-FPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCHH--------HHHHHHHcCCCcee-cCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 754311 00111110000000 000 1124557888998876 4999999654333333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=276.96 Aligned_cols=243 Identities=27% Similarity=0.378 Sum_probs=195.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|+..+.||.|+||.||.|.+. ++..+|+|.+...... .....+.+|+.+++.+.||||+++++++......+++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45888899999999999999965 5889999998764332 3346788999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 98876542 235788899999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||........ . ...... ..
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~----~~~~~~---------~~ 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L----FLIPKN---------NP 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h----hhhhcC---------CC
Confidence 22234578889999999888899999999999999999999999865431100 0 000000 01
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..++...+..+.+++..||+.||++|||++++++-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12345567789999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=288.08 Aligned_cols=258 Identities=18% Similarity=0.224 Sum_probs=185.7
Q ss_pred ccceeccc--CceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 75 VNRILGQG--GQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 75 ~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
++++||+| +|++||++..+ +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..+++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 67899999864 68999999997654432 234567889999999999999999999999999999988
Q ss_pred eccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 152 DHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 152 ~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+...+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 765432 234789999999999999999999999 99999999999999999999999986543321111
Q ss_pred e------eeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH---------
Q 037297 223 H------VTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF--------- 285 (366)
Q Consensus 223 ~------~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------- 285 (366)
. ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 0112346677999999876 4688999999999999999999999975321100000000000
Q ss_pred -HHHh--hc------Ccccc---------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 286 -VHSM--RK------NHMYD---------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 286 -~~~~--~~------~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... .. ..... ..............++.+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00 00000 00000001123345678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.73 Aligned_cols=242 Identities=28% Similarity=0.405 Sum_probs=194.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|+++++.++||||+++++++......++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 3679999999999999999999764 78999999875321 4678999999999999999999999999988888
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 88876653 2346889999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.. ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ .. ........
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~-~~~~~~~~----- 217 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IF-MIPNKPPP----- 217 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hh-hhccCCCC-----
Confidence 21 22234578899999999988999999999999999999999999975331100 00 00000000
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 --TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01123345668999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=286.33 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=189.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++..+ +++.+|+|++...... .......+..|+.++..++|+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 46899999999999999999976 4788999998653211 112334578899999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..++. ...+++..+..++.|++.|+.|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99875542 235788899999999999999999999 9999999999999999999999999987654333
Q ss_pred ceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
........||+.|+|||++. ...++.++|+|||||++|||++|+.||..... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCcccc
Confidence 33333457999999999886 34678899999999999999999999975431 111111111110000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTME 338 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~~ 338 (366)
+ .......+.++.+++..|++.+|.. |++++|+++-
T Consensus 229 ~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0011234667899999999765544 6888888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=276.99 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=191.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.|++.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 66999999999999999999975 488999999876422 2356788899999999999999999999999889999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..++. ...+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 88776542 335789999999999999999999998 999999999999999999999999988654322
Q ss_pred ceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
........++..|+|||.+. ...++.++|+|||||++|+|++|..||..... .......... ....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~-~~~~ 234 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-EPPT 234 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcC-CCcc
Confidence 11223345788999999874 34578899999999999999999999865331 0011111111 0000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ..+...+.++.+++.+||+.||++||+++++++
T Consensus 235 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 113345567899999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.00 Aligned_cols=242 Identities=27% Similarity=0.398 Sum_probs=193.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|+..+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch---HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 34777888999999999999865 5788999998754333 2345788999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+.. ..++++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 98876542 245789999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... ......... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~~~~---------~ 218 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---------VLFLIPKNS---------P 218 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---------HHhhhhcCC---------C
Confidence 1222457888999999998899999999999999999999999986432100 000000110 1
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++.+||+.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1123345667899999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=281.54 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=193.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|++.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.+++.++||||+++++.+......+++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 57999999999999999999964 5889999998764433 235688899999999999999999999999989999
Q ss_pred EeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 887765432 24788899999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... . ... ...... ....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~-----~~~-~~~~~~-~~~~------ 236 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R-----ALY-LIATNG-TPEL------ 236 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--H-----hHH-HHhcCC-CCCC------
Confidence 122346788999999998888999999999999999999999999654310 0 000 000110 0000
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..+.+++.+||..||++|||+.++++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 113345567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=284.31 Aligned_cols=251 Identities=23% Similarity=0.405 Sum_probs=189.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.+|+..+.||+|+||.||+|... ++. .+|+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~- 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP---KANVEFMDEALIMASMDHPHLVRLLGVCLSPT- 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC-
Confidence 56888999999999999999864 343 5788888754433 22346888999999999999999999987544
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+ ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 44555554432 1225788899999999999999999999 999999999999999999999999999865
Q ss_pred cCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... . ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~-------~~~~~~~~~~~~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--R-------EIPDLLEKGERL 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H-------HHHHHHHCCCCC
Confidence 4322211 122335678999999998999999999999999999997 8999865321 0 011111111100
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
..+..++..+.+++..||..||++|||++++++.|..+....
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 012234457899999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.81 Aligned_cols=243 Identities=29% Similarity=0.426 Sum_probs=180.0
Q ss_pred ceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee-CCcceEEEe
Q 037297 77 RILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVPLLHLH 151 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~~~~ 151 (366)
+.||+|+||.||+|... ++..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. ....+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH---HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 46899999999999853 2457999987543222 334678899999999999999999998764 445666676
Q ss_pred eccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 152 DHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 152 ~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+...+. ....++..+..++.|++.|+.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 654332 223567778899999999999999998 999999999999999999999999998754322111
Q ss_pred ---eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 224 ---VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 224 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
......++..|+|||...+..++.++|||||||++|||++| .+||..... ..... ........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~---~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITV---YLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---HHhcCCCC-----
Confidence 11123456789999999888999999999999999999995 455543210 00111 11111000
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
..+...+..+.+++..||+.+|++|||+.|+++.|+.+.
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 012233457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=276.27 Aligned_cols=243 Identities=31% Similarity=0.479 Sum_probs=191.7
Q ss_pred CcccceecccCceEEEEEEEcC-----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 73 FNVNRILGQGGQGTVYKGMLED-----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
+++.+.||.|+||.||++.... +..+|+|.+...... ...+.+..|+..++.++||||+++++++......+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 4577899999999999999653 378999999765443 24567889999999999999999999999998888
Q ss_pred EEEeeccCCC-------CCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRNE-------EFP--LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~--l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++..+.. ... +++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 8888775532 112 899999999999999999999999 9999999999999999999999999997665
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
...........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..... ..... .......
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~-~~~~~~~--- 222 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLE-YLKKGYR--- 222 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH-HHhcCCC---
Confidence 442222222336788999999988889999999999999999998 7888765321 11111 1111111
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
...+...+.++.+++.+||+.||++|||+.|+++.|
T Consensus 223 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111233566899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=282.33 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=197.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|..+ +++.||+|.++...... ...+.+.+|+++++.++|+||+++++++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE--DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc--cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36899999999999999999976 58899999987643322 2345788999999999999999999999998888888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 8877643 2235789999999999999999999999 99999999999999999999999999877654433
Q ss_pred eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH--------Hhh-cC
Q 037297 223 HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH--------SMR-KN 292 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~-~~ 292 (366)
.......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||........ ......... ... ..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHhhhcccCc
Confidence 233445678889999999888 889999999999999999999999975432100 000000000 000 00
Q ss_pred -----ccccccchH-HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 -----HMYDILDDQ-VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 -----~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......++. .....+...+.++.+++..||..||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 001111111 111223345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=281.30 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=193.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|..+ +++.+|+|.+....... ...+.+.+|+++++.++||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46899999999999999999976 58899999887544332 2345678899999999999999999999998889999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 8877543 2235789999999999999999999999 9999999999999999999999999987654332
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH------HHHHHHHh------
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL------AAFFVHSM------ 289 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~------~~~~~~~~------ 289 (366)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............. ........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233457888999998865 357889999999999999999999986433110000000 00000000
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..................+..+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000001111111111123345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=279.85 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=192.4
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
++|++.+.||+|+||.||+|..+ +...+++|.+...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch---HHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 57899999999999999999854 2457899987653322 24457889999999999999999999999888
Q ss_pred cceEEEeeccCCC-------C---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEE
Q 037297 145 VPLLHLHDHHRNE-------E---------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV 208 (366)
Q Consensus 145 ~~~~~~~~~~~~~-------~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl 208 (366)
..++++++...+. . ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEE
Confidence 8899888765431 1 15789999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 209 ADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
+|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~-------~~~~ 229 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--E-------EVLN 229 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--H-------HHHH
Confidence 9999986543322222233345677999999988889999999999999999998 7888854321 0 0111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
........ ...+..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 230 ~~~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111110 0112235567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.75 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=187.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh-HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 146 (366)
.+|+..+.||+|+||.||+|... ++..+|+|.+...... ......+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999965 5889999998754332 2223456788999999999999999999988764 445
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..+. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 5666665443 2235788889999999999999999998 99999999999999999999999999875532
Q ss_pred CC--ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQ--THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~~---- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQPT---- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCCC----
Confidence 11 11122345788999999999888999999999999999999999999653210 00000000000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...++...++.+.+++ .||..||++|||++|+++
T Consensus 227 -----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0112344556677887 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=279.09 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=186.7
Q ss_pred CcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 73 FNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
|.+.+.||+|+||.||+|... ++..+|+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 677889999999999999853 36889999997654433 23467889999999999999999999876543
Q ss_pred --cceEEEeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 145 --VPLLHLHDHHRN-------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 145 --~~~~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
..++++++...+ ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEEC
Confidence 123444433222 1224788899999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 210 DFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 210 Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
|||.+......... ......++..|++||.+.+..++.++|||||||++|+|++ |+.||..... ......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~ 227 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNY 227 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHH
Confidence 99998765432211 1122334567999999988889999999999999999999 8888865331 000111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 228 ~~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111100 01123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.34 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=192.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|..+ +++.+|+|.+....... ...+.+.+|+.+++.++|||++++++++......+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46899999999999999999976 58899999987543221 2234678899999999999999999999999888888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 8876543 2335899999999999999999999999 99999999999999999999999999976643321
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH-------HHHhhcCcc
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF-------VHSMRKNHM 294 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 294 (366)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.......... ...... .........
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcccccc
Confidence 1223457788999998876 457889999999999999999999997543211100 000000 000000000
Q ss_pred c---cccchHH---hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 Y---DILDDQV---VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~---~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ....+.. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000 00011234668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=271.15 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=194.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|... ++..+++|.+...... ..+.+.+|+.+++.++||||+++++++......+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 57999999999999999999965 5788999999864332 346788999999999999999999999999988888
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..+. ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 8876543 2256889999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeeccccCCccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........ .. .........
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~--~~~~~~~~~-- 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LF--LISKSNFPP-- 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HH--HHHhccCCC--
Confidence 122334678889999998776 889999999999999999999999975331100 00 000010000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...+.++.+++.+||+.||.+|||++++++
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 ---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000123445678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.36 Aligned_cols=243 Identities=29% Similarity=0.399 Sum_probs=194.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|+..+.||.|+||.||.+... +++.+++|.+....... .....+.+|++++++++|+||+++++++.+....++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 5889999999999999999854 58899999987654332 23457889999999999999999999999999888888
Q ss_pred eeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..+. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 876542 1345788999999999999999999998 9999999999999999999999999987654333
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
. ......++..|+|||...+..++.++|+||+|+++|+|++|..||..... ........ .....
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~-~~~~~------ 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIV-QGNYT------ 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-cCCCC------
Confidence 2 22335688999999999888899999999999999999999999864321 01111111 11111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..+...+.++.+++.+||+.||++|||++++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123456679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.30 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=190.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.+++.++||||+++++++...+..+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 57889999999999999999864 5889999998764322 234577899999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++...+. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~ 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I 160 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence 88876532 336889999999999999999999999 999999999999999999999999998755322 1
Q ss_pred eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.......|+..|+|||.+. ...++.++|+||+||++|+|++|..||........ ... ............
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~-~~~~~~~~~~~~ 232 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFL-MTKSNFQPPKLK 232 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHh-hhccCCCCCccc
Confidence 2223456889999999874 45688899999999999999999999865431100 000 000000000000
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....++..+.+++.+||+.||++|||++++++
T Consensus 233 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 ------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01124457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=281.93 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=190.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE---SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999975 6899999998764333 2345788999999999999999999999999999999
Q ss_pred EeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++..+.. ...+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 88775532 1268899999999999999999997 47 9999999999999999999999999986543
Q ss_pred CCCceeeeeccccCCccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
.. ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||..... ........ .....
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~-~~~~~ 225 (286)
T cd06622 155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLS-AIVDG 225 (286)
T ss_pred CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHH-HHhhc
Confidence 22 12234578889999988554 357899999999999999999999965321 00000000 00010
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ....+..++.++.+++.+||+.+|++||+++++++
T Consensus 226 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 D---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 01134456778999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.18 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=191.8
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 143 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (366)
+...++|++.+.||+|+||+||+|.+. ++..+|+|.+....... .....+..|+.+++.++||||++++++|...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e--~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 344578999999999999999999975 47789999987644332 2345788999999999999999999988654
Q ss_pred CcceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEecC------
Q 037297 144 EVPLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAAS----SPIYHRDIKSTNILLDE------ 202 (366)
Q Consensus 144 ~~~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~----~~iiH~dikp~Nill~~------ 202 (366)
...++++++..... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 45677788765432 2368999999999999999999998531 33999999999999964
Q ss_pred -----------CCeEEEeecCCcccccCCCceeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037297 203 -----------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIF 269 (366)
Q Consensus 203 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~ 269 (366)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 235899999999765322 12234568999999998854 458899999999999999999999996
Q ss_pred CCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH--HHHhhc
Q 037297 270 STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT--MELNGI 342 (366)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell--~~L~~~ 342 (366)
..... .. .......... . .....+.++.+|+..||+.+|.+|||+.|++ ..+..+
T Consensus 245 ~~~~~-------~q-li~~lk~~p~--l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 245 KANNF-------SQ-LISELKRGPD--L--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCcH-------HH-HHHHHhcCCC--C--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 53311 01 1111111100 0 0122356799999999999999999999998 445444
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.06 Aligned_cols=240 Identities=24% Similarity=0.378 Sum_probs=187.3
Q ss_pred ceecccCceEEEEEEEcC--C--cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLED--G--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.||+|++|.||+|.+.+ + ..+|+|.+...... ...+.+.+|+.+++.++||||+++++.+.. ...++++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999998643 3 36899998875543 455688999999999999999999999888 777777776
Q ss_pred ccCCC--------C-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 153 HHRNE--------E-FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 153 ~~~~~--------~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
...+. . ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 64331 1 35789999999999999999999999 999999999999999999999999999876443221
Q ss_pred --eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 224 --VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 224 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... .............
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~------ 219 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGER------ 219 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCc------
Confidence 1122346778999999998899999999999999999998 9999864321 0000001100000
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112334567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.39 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=193.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|++.+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 367999999999999999999964 6899999998764333 23567889999999999999999999999999999
Q ss_pred EEeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..+... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9887765432 35788899999999999999999999 99999999999999999999999999876533221
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
......+++.|+|||...+..++.++|+||+||++|+|++|..||........... .... ...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~~~~-~~~------- 233 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IATN-GTP------- 233 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------eccC-CCC-------
Confidence 12234578899999999988899999999999999999999999965431110000 0000 000
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+...+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00113345567889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=277.64 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=195.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||+||++... ++..+|+|++...... ...+.+.+|+++++.++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS---SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc---hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 367899999999999999999965 5888999988764332 234678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++...+. ..++++..+..++.+++.|+.|||+ ++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 998876543 2357889999999999999999997 56 999999999999999999999999988654221
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc---HHHHHHHHhhcCccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS---LAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 297 (366)
. .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||............ ......... ......
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 232 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPR- 232 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCC-
Confidence 1 12346889999999998889999999999999999999999999764421111000 001111111 100000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
......+..+.+|+.+||+.||++|||++|+++...
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 233 -------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred -------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 001125567999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=275.25 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=188.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|++.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.+++.++|||++++++++......++++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 3788899999999999999976 477889998865321 23457888999999999999999999999999999998
Q ss_pred eeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++...+. ..++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... .
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 157 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-c
Confidence 8775432 346889999999999999999999999 999999999999999999999999998654322 1
Q ss_pred eeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.......++..|+|||++. +..++.++|+||+||++|+|++|+.||..... ........... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~ 228 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE-PPTL 228 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcC-CCCC
Confidence 1223346888999999874 44578899999999999999999999865331 00111111110 0000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+..++.++.+++..||+.||.+|||+.++++
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 -------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112335568999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=288.55 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=189.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++..+ +++.+|+|++...... .......+.+|..++..++|+||+.+++++...+..+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999965 5788999998753211 123345678899999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99876542 346788999999999999999999999 9999999999999999999999999997665433
Q ss_pred ceeeeeccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
........||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||..... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCccc
Confidence 333334568999999998865 4678899999999999999999999975331 011111111100000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~ 337 (366)
. . ......+.++.+++.+|++.++.+ |++++++++
T Consensus 229 ~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 F-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 0 001124567889999999866544 457777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=280.70 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=195.9
Q ss_pred cCCcccceecccCceEEEEEEEc-----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee--C
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--T 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 143 (366)
..|++.+.||+|+||.||+|... ++..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46888899999999999999843 3678999999865443 345678999999999999999999999877 4
Q ss_pred CcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++++++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 56777777765432 224888999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCcee--eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc------ccHHHHHHH
Q 037297 216 FIAMDQTHV--TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN------VSLAAFFVH 287 (366)
Q Consensus 216 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------~~~~~~~~~ 287 (366)
......... .....++..|+|||...+..++.++|+||||+++|+|++|..|+.......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 112234567999999988899999999999999999999999986543211000 000000111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...... ....+..++.++.+++.+||+.||++|||+.|+++.|+.++
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111100 01112345578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=277.53 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=186.1
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC---
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET--- 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--- 143 (366)
..+.|++.+.||+|+||.||+|... +++.+|+|.+...... ...+..|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3567899999999999999999965 5888999998764322 24677899999988 799999999998764
Q ss_pred ---CcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 144 ---EVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 144 ---~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
...++++++...+ ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 3456777766442 2335789999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHH
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (366)
|++....... .......|+..|+|||++. +..++.++|+||+||++|+|++|+.||....... ...
T Consensus 156 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~ 226 (272)
T cd06637 156 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALF 226 (272)
T ss_pred CCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHH
Confidence 9987553222 1223356888999999875 3468889999999999999999999996432100 000
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......... .....++..+.+|+.+||+.||.+|||+.++++
T Consensus 227 -~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 -LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHhcCCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000111000 112234567899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.38 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=190.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||.|++|.||+|... ++..+|+|.+....... .....+..|+++++.++||||+++++++...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4888999999999999999965 58899999887644322 22346888999999999999999999999988888888
Q ss_pred eeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++.... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 876431 2346789999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeccccCCccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc----------
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---------- 291 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 291 (366)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........ ... .......
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFR-IFRTLGTPDEVVWPGVT 229 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHH-HHHHhCCCChhhhhhhh
Confidence 122234678899999876644 68899999999999999999999965431100 000 0000000
Q ss_pred ------CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 292 ------NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 292 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.......... .....+..+.++.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0011111111 11122334567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=280.12 Aligned_cols=242 Identities=29% Similarity=0.423 Sum_probs=191.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|++.+.||+|+||.||+|... +++.||+|.+....... ....+.+.+|+.+++.++||||++++++|...+..+++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 56899999999999999999965 58899999986533221 23345788999999999999999999999999998888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ...++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 8876432 2346889999999999999999999999 999999999999999999999999998654322
Q ss_pred eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
....++..|+|||.+. ...++.++|+||||+++|+|++|+.||....... ... .........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~-~~~~~~~~~--- 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALY-HIAQNDSPT--- 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHH-HHhcCCCCC---
Confidence 2345778899999874 4568889999999999999999999986543100 000 000111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..+..++..+.+++.+||+.||++|||+.+++..
T Consensus 234 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1123466789999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.85 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=193.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||+|.+. +|..+|+|++....... ...+.+.+|+.+++.++|||++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 5889999999999999999965 58899999988754322 23457889999999999999999999999998889988
Q ss_pred eeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++. +.. ..++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 877 332 345889999999999999999999999 99999999999999999999999999876654332
Q ss_pred eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---ccc---
Q 037297 223 HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMY--- 295 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 295 (366)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||....... ............ .++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-----QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-----HHHHHHHHcCCCChHHHhhcc
Confidence 223345688899999988654 46889999999999999999988775533110 000000000000 000
Q ss_pred c----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 D----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ ...........+..+..+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00000011122234578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=278.78 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=188.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 148 (366)
++|+..+.||+|+||.||++.+. +++.+|+|.+...... .....+.+|+.++.++. ||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35667789999999999999965 5899999998764433 33457888999999995 9999999999988887777
Q ss_pred EEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 149 HLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 149 ~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
++++.... ....+++..+..++.|++.|++|||+. + ++||||||+||+++.++.++|+|||++..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 77764321 234688999999999999999999974 7 99999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
..... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||..... .......... ..
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~-~~ 227 (288)
T cd06616 158 LVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVK-GD 227 (288)
T ss_pred hccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcC-CC
Confidence 54322 12233578899999988766 688999999999999999999999964320 0011111111 00
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+ ......+..++..+.+|+..||+.||++|||++++++
T Consensus 228 ~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PP-----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CC-----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1111122346678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=275.66 Aligned_cols=295 Identities=21% Similarity=0.299 Sum_probs=208.7
Q ss_pred HcCchhHHHhhhhCCCcccccccccChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHH
Q 037297 37 QNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLE 116 (366)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~ 116 (366)
..++.++++++.....| .+-+-.+.-.......+.++.+.||+|.||.||+|.++ |+.||||++.... .+
T Consensus 179 ~~~~stl~Dll~~~~tS--GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-------E~ 248 (513)
T KOG2052|consen 179 LAGDSTLKDLLDDLETS--GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-------ER 248 (513)
T ss_pred ccCCccHHHHHHhhccC--CCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc-------hh
Confidence 34555666666544432 11233444445566788999999999999999999997 8999999998632 24
Q ss_pred HHHHHHHHHhcC--CCCceeeEeeEEeeCC----cceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHh--
Q 037297 117 EFINEIVILSQI--NHRNVVKLLGCCLETE----VPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHS-- 182 (366)
Q Consensus 117 ~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~-- 182 (366)
+..+|.++++.. +|+||+.+++.-..+. .++++.++...++ ..+++.+..++++..++.||++||-
T Consensus 249 SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI 328 (513)
T KOG2052|consen 249 SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEI 328 (513)
T ss_pred hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHH
Confidence 677888888765 9999999999865544 4556666655543 3478899999999999999999994
Q ss_pred ---CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce---eeeeccccCCccccccccCCC----CC--chhh
Q 037297 183 ---AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLEPEYHQSSQ----LT--DKSD 250 (366)
Q Consensus 183 ---~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~----~~--~~~D 250 (366)
+|++.|+|||||+.|||+..||.+.|+|+|+|......... .....+||.+|||||+++..- +. ..+|
T Consensus 329 ~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~AD 408 (513)
T KOG2052|consen 329 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRAD 408 (513)
T ss_pred hcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHH
Confidence 67899999999999999999999999999999776544332 234467999999999887542 21 2689
Q ss_pred HHHHHHHHHHHHhC----------CCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHH
Q 037297 251 VYSFGVVLVELLTG----------KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAER 320 (366)
Q Consensus 251 iwslG~~l~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 320 (366)
|||||.++||+... ++||++.-...-......+.+....-.+.++ ...........+.++++.
T Consensus 409 IYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-------nrW~s~~~l~~m~klMke 481 (513)
T KOG2052|consen 409 IYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-------NRWKSDPALRVMAKLMKE 481 (513)
T ss_pred HHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCC-------cccccCHHHHHHHHHHHH
Confidence 99999999998652 4777654321111111110000000001111 011223455578899999
Q ss_pred hhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 321 CLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 321 cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
||..||.-|.|+=-+-+.|..+..+..+
T Consensus 482 CW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 482 CWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred hhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 9999999999999998888877754433
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=276.60 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=193.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|++.+.||.|++|.||+|... +++.+++|.+...... ..+.+.+|+.+++.++|||++++++++...+..+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP----KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc----hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 56999999999999999999864 6899999998754322 345678899999999999999999999999989998
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+.. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 88765542 235789999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .. ........ ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~-~~~~~~~~-~~~~------ 235 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RA-LYLIATNG-TPEL------ 235 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHHHHhcC-Cccc------
Confidence 122345788999999998888999999999999999999999999654310 00 00011000 0000
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++.+.+++.+||+.||.+|||+.++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112345567889999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.65 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=193.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|... +++.+|+|.+....... ....+.+..|+.+++.++||||+++++.+......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 36899999999999999999976 48999999998654332 23456788999999999999999999999999989999
Q ss_pred EeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..+. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 8876543 2246888999999999999999999999 999999999999999999999999998654321
Q ss_pred Cce----------------------------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 221 QTH----------------------------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 221 ~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
... ......|+..|+|||+..+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999998899999999999999999999999997543
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT----MEEVTM 337 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~ell~ 337 (366)
.. ............ .......+..+.+++.+||+.||++||| ++|+++
T Consensus 237 ~~--------~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD--------ETFSNILKKEVT---------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH--------HHHHHHhcCCcc---------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 111111111000 0011125678999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.40 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=191.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cce
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VPL 147 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 147 (366)
++|+..+.||.|++|.||++.+. +++.+|+|.+...... .....+.+|+++++.++||||++++++|.... ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 36888999999999999999975 5889999998864333 33457889999999999999999999986644 567
Q ss_pred EEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 148 LHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 148 ~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
+++++..+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 7777765432 235788889999999999999999999 99999999999999999999999999865
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
..... .....++..|+|||.+.+..++.++|+||+||++|+|++|..||............. ...........
T Consensus 155 ~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~ 227 (287)
T cd06621 155 LVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL----LSYIVNMPNPE 227 (287)
T ss_pred ccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH----HHHHhcCCchh
Confidence 43221 123457888999999998899999999999999999999999997654311111111 11111111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+. ......+++.+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000 0001235678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=278.45 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=188.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|..+ +++.||+|.+....... ....+.+|+.+++.++||||+++++++...+..+++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 67999999999999999999976 58899999987643321 123466899999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9877531 1235788999999999999999999999 99999999999999999999999999865432211
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---cCcc----
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---KNHM---- 294 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 294 (366)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||......... ......... ...+
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH----HHHHHHhcCCCChhhhhhhh
Confidence 1122346788999998865 45889999999999999999999999654311110 000000000 0000
Q ss_pred ---------cccc-chHHhhhhcHHHH--HHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 ---------YDIL-DDQVVKLVKKNQI--MAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ---------~~~~-~~~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... ....... ..... .++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0111111 11122 57889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=277.38 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=188.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|... ++..+|+|.+....... ....+.+|+.+++.++|+||+++++++......++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 367999999999999999999865 58899999987643321 12356789999999999999999999998888888
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 88876432 1234678888999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh----------
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---------- 290 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 290 (366)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.......+. ... ......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ---LEK-IWTVLGVPTEDTWPGV 232 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH---HHH-HHHHcCCCChhhhhhh
Confidence 1 12233468899999988764 5788999999999999999999999754321100 000 000000
Q ss_pred --cCcc-cccc---chHHhhhh--cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 --KNHM-YDIL---DDQVVKLV--KKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 --~~~~-~~~~---~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... .... .+...... ....+..+.+++.+|++.||++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 0000 00000000 0012457889999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.21 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=185.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHH-HhcCCCCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
++|++.+.||+|+||.||++.++ +|+.||+|.++....... ...+..|+.. ++.++||||+++++++......++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE---QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH---HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 46899999999999999999975 589999999886544322 2345556654 666799999999999998888888
Q ss_pred EEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 149 HLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 149 ~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++..+. ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 88765431 223588999999999999999999987 7 999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
... ...+...++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||....... ..........
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~- 224 (283)
T cd06617 155 VDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVVEEP- 224 (283)
T ss_pred ccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHHhcC-
Confidence 322 11223457888999998765 456889999999999999999999986432110 0111111110
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... .....+.++.+++..||..||.+|||++++++
T Consensus 225 ~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01234667999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.58 Aligned_cols=238 Identities=26% Similarity=0.429 Sum_probs=186.6
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.+|++.+.||+|+||.||.+.. +++.+|+|.++... ..+.+.+|+.+++.++|||++++++++... ..++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 5689999999999999999875 57889999987532 224688899999999999999999998654 457777
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..++. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 7665432 235788899999999999999999998 999999999999999999999999998653221
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||..... . ..........
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~-------~~~~~~~~~~------- 214 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--K-------EVKECVEKGY------- 214 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--H-------HHHHHHhCCC-------
Confidence 111234567999999988899999999999999999997 9999865431 0 0011111110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
....+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 215 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 --RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011123455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.90 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=191.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccce
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPL 147 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 147 (366)
++|++.+.||+|+||.||+|..+ +++.+|+|.++...... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE--GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc--cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 57999999999999999999976 58899999998654332 2233567899999999999999999998877 7788
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 888776431 1235889999999999999999999999 999999999999999999999999998766543
Q ss_pred CceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---------
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR--------- 290 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 290 (366)
.. ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........ .........
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-----LNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCchHHHHH
Confidence 21 12234568889999988654 468899999999999999999999975432110 000000000
Q ss_pred --------cCccccccchHHhhhhcHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 --------KNHMYDILDDQVVKLVKKN-QIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 --------~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...........+....+.. .++.+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000001111112222222 4677899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=274.25 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=192.7
Q ss_pred CCcccceecccCceEEEEEEEcC--CcEEEEEEeecccCh------HHHHHHHHHHHHHHHHhc-CCCCceeeEeeEEee
Q 037297 72 HFNVNRILGQGGQGTVYKGMLED--GRIMAVKKFKLAVDD------EELLKLEEFINEIVILSQ-INHRNVVKLLGCCLE 142 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 142 (366)
+|++.+.||+|+||.||+|..+. ++.+|+|.+...... ........+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999754 688999988653221 111234567788887765 699999999999999
Q ss_pred CCcceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 143 TEVPLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 143 ~~~~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
.+..++++++..+. ....+++..++.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999998876543 23357889999999999999999996 66 99999999999999999999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---------SLATKIV 226 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---------HHHHHHh
Confidence 99997654332 233456888999999999888999999999999999999999998643210 0000111
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
...... ......+..+.+++.+||+.||++|||+.|+...+++
T Consensus 227 ~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 227 EAVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred hccCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111100 0112345678999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=274.33 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=194.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||++..+ +++.+|+|.+...... ...+.+.+|+.+++.++||||+++++.+......+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 36888899999999999999976 5889999998875443 3456788999999999999999999999999888888
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++..+. ...++++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 8877633 12567889999999999999999999 88 999999999999999999999999998655322
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
... ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... ...... .......
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~-~~~~~~~----- 222 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---FELLQY-IVNEPPP----- 222 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH---HHHHHH-HhcCCCC-----
Confidence 111 1567889999999998899999999999999999999999997653211111 111111 1111000
Q ss_pred HHhhhhcHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKN-QIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+.. .+..+.+++..||..||++|||+.++++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 ----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11222 6677999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=272.43 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=193.2
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh-HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+|+..+.||+|++|.||+|... +++.+++|.+...... ......+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999976 6899999998764322 1123456788999999999999999999999998888888
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 88775532 235788999999999999999999999 9999999999999999999999999987654332
Q ss_pred eeeeeccccCCccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||..... . ............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~------~~~~~~~~~~~~------- 220 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V------AAVFKIGRSKEL------- 220 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H------HHHHHHHhcccC-------
Confidence 223456788999999887766 89999999999999999999999865331 0 000000010001
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 221 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 --PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1123345667899999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=275.06 Aligned_cols=244 Identities=26% Similarity=0.346 Sum_probs=192.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||.|+||.||++... ++..+|+|.+..... ...+.+..|+.+++.++||||+++++.+......++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 357999999999999999999965 588999999875422 244678899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++...+ ...++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99877653 2346899999999999999999999999 999999999999999999999999988654322
Q ss_pred CceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
. .......++..|+|||.+. +..++.++|+||||+++|+|++|+.||...... ...... ......
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~ 226 (280)
T cd06611 157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKI-LKSEPP 226 (280)
T ss_pred c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHH-hcCCCC
Confidence 2 2223346888999999874 345778999999999999999999999654310 011111 111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ..+..++.++.+++..||+.||.+|||+.++++
T Consensus 227 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred Cc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00 113345667899999999999999999999965
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=272.10 Aligned_cols=231 Identities=21% Similarity=0.339 Sum_probs=176.5
Q ss_pred ceecccCceEEEEEEEcC-------------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 77 RILGQGGQGTVYKGMLED-------------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
+.||+|+||.||+|.... ...+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR----DISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh----hHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999998431 22588888765321 2345788899999999999999999999988
Q ss_pred CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe-------EEE
Q 037297 144 EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-------AKV 208 (366)
Q Consensus 144 ~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~-------vkl 208 (366)
...++++++...+ ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +++
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 8888888876543 2345888999999999999999999999 999999999999986654 899
Q ss_pred eecCCcccccCCCceeeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcccccHHHHHH
Q 037297 209 ADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELL-TGKKPIFSTGNTSQENVSLAAFFV 286 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~ 286 (366)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||....... ..
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~---- 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KE---- 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HH----
Confidence 999998654322 2234678899999876 567899999999999999997 5888876432100 00
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
... .... . .....+.++.+++..||+.||.+||++.++++.|
T Consensus 220 ~~~-~~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFY-EGQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHH-hcCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0000 0 0111245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=272.97 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=191.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--CcceE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLL 148 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~~ 148 (366)
+|++.+.||.|+||.||++... ++..+|+|.+....... ...+.+..|+.+++.++||||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE--KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH--HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 4888999999999999999864 57889999987644332 3346788899999999999999999987643 34566
Q ss_pred EEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 149 HLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLH-----SAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 149 ~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
++++..+. ...++++..++.++.|++.|+.||| +.+ ++|+||+|+||+++.++.++|+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 66665433 1346889999999999999999999 666 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..........
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~ 225 (265)
T cd08217 156 LAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------LQLASKIKEG 225 (265)
T ss_pred ccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------HHHHHHHhcC
Confidence 9987654332 12334688999999999988899999999999999999999999975431 0111111111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 1234456678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.84 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=180.4
Q ss_pred ceecccCceEEEEEEEcC---CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
+.||+|+||.||+|...+ +..+|+|.++..... .....+.+|+.+++.++||||+++++++......++++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV---QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999998543 457899988765433 23346888999999999999999999999888888888876
Q ss_pred cCCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 154 HRNEE------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 154 ~~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
..+.. ...++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 54321 13456677889999999999999999 9999999999999999999999999986543222
Q ss_pred cee-eeeccccCCccccccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 222 THV-TTKIQGTFGYLEPEYHQSS-------QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 222 ~~~-~~~~~~t~~y~aPE~~~~~-------~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
... .....++..|+|||++.+. .++.++|+||||+++|||++ |+.||....... .... ... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~---~~~-~ 225 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTY---TVR-E 225 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHH---Hhh-c
Confidence 211 1223467889999987642 35789999999999999996 999996533110 0000 000 0
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
......++. .....+..+.+++..|| .+|++|||++|++..|+
T Consensus 226 ~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111 12234456889999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=271.83 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=194.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||.|++|+||+|... ++..+|+|++....... ....+.+|+.+++.++|+|++++++.+......+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 46899999999999999999964 57889999987644332 456789999999999999999999999999988888
Q ss_pred EeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 150 LHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 150 ~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++...+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 88775432 235789999999999999999999999 99999999999999999999999999876654
Q ss_pred CCce---eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 220 DQTH---VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 220 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
.... ......++..|+|||.+... .++.++|+|||||++|+|++|+.||....... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~~ 225 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQND-PP 225 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCC-CC
Confidence 3222 22334588899999988776 78999999999999999999999997543210 000011110 00
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ... .......+..+.+++..||+.||++|||++++++
T Consensus 226 ~-~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 S-LET---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C-cCC---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000 0001345678899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.25 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=190.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 468999999999999999999865 6889999998643222 23456788999999999999999999876544
Q ss_pred -cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 -VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 -~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 345565554331 2236889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCce--eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---
Q 037297 219 MDQTH--VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--- 292 (366)
Q Consensus 219 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 292 (366)
..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||....... ...........+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~~~~ 232 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCCHH
Confidence 32211 1123467889999997654 568899999999999999999999996532100 000000000000
Q ss_pred ccccccc--------------hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hhhccc
Q 037297 293 HMYDILD--------------DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIRG 344 (366)
Q Consensus 293 ~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~~ 344 (366)
......+ ........+..+.++.+++.+||+.||++|||+.|+++. +....+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000 000001112346678999999999999999999999875 555554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.85 Aligned_cols=241 Identities=29% Similarity=0.416 Sum_probs=185.4
Q ss_pred ceecccCceEEEEEEEcC-------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 77 RILGQGGQGTVYKGMLED-------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.||+|+||.||+|...+ +..+|+|.+...... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch---hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998642 257899988654322 2345788899999999999999999999988888888
Q ss_pred EeeccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-----eEEEee
Q 037297 150 LHDHHRNE--------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-----RAKVAD 210 (366)
Q Consensus 150 ~~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-----~vkl~D 210 (366)
+++..++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 88765432 123678889999999999999999998 99999999999999877 899999
Q ss_pred cCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHH
Q 037297 211 FGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 211 fg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
||++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...... .... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~-~ 225 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQ-H 225 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHH-H
Confidence 9998755332211 1112235678999999998999999999999999999998 99998643210 0000 0
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
..... ....+...+..+.+++.+||+.+|.+|||++++++.|++
T Consensus 226 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VTAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HhcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01110 011233456688999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=272.56 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=188.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh-HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 146 (366)
.+|++.+.||+|+||.||.|... ++..||+|.+...... ......+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999965 5889999988653322 1123456788999999999999999999988764 345
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..+.. ...+++.....++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 56676654432 235788888999999999999999999 99999999999999999999999999875432
Q ss_pred CCc--eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQT--HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... . .........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~~~~----- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------A-AIFKIATQP----- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------H-HHHHHhcCC-----
Confidence 111 1122345788999999998888999999999999999999999999643210 0 000000000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...+..+.+++..|+. +|.+|||++|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0112345566778899999995 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=273.14 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=192.7
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||.|++|.||+|... +|..+|+|.++..... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 5889999999999999999975 5889999998865432 22346678999999999999999999999999989998
Q ss_pred eeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..+. ....+++..+..++.|++.|+.|||+++ ++||||+|+||++++++.++|+|||++.......
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 876532 1235889999999999999999999999 9999999999999999999999999987553322
Q ss_pred ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH-------HHHHHHhhc--
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA-------AFFVHSMRK-- 291 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~-- 291 (366)
. ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.............. .........
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 12233567889999987654 578899999999999999999999976432110000000 000000000
Q ss_pred --CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 292 --NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 292 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+.. .........+..+..+.+++..||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRY-PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCC-ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111 111112233455778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=289.25 Aligned_cols=236 Identities=25% Similarity=0.254 Sum_probs=178.1
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
||+|+||+||+|..+ +++.+|+|++........ .....+..|..++... .||||+++++++...+..++++++..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 699999999999965 589999999875322211 2233455666666555 79999999999999999999998876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 542 346889999999999999999999999 9999999999999999999999999986543222 22234
Q ss_pred ccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhh
Q 037297 228 IQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (366)
..||..|+|||.+.+. .++.++||||+||++|+|++|+.||..... ..... ....... .+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~-~i~~~~~-~~--------~ 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYR-NIAFGKV-RF--------P 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHH-HHHcCCC-CC--------C
Confidence 5689999999988754 588999999999999999999999975431 01111 1111100 00 0
Q ss_pred cHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 037297 307 KKNQIMAFANLAERCLDLNGKKRPT----MEEVTM 337 (366)
Q Consensus 307 ~~~~~~~l~~li~~cl~~dp~~Rpt----~~ell~ 337 (366)
....+.++.+++.+||+.||.+||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1124567889999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.46 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=192.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|+||.||.+... +++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 5889999999999999999864 58899999987643322 23457889999999999999999999999999899988
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++..... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 8775432 235788899999999999999999999 9999999999999999999999999987653322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
. ......++..|+|||...+..++.++|+|||||++|+|++|+.||..... ......... ...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~------- 218 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR-GSY------- 218 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc-CCC-------
Confidence 1 11224578889999999888899999999999999999999999864321 011111111 110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++.+||+.+|++||++.++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123445667999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=260.20 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=189.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
.++.+.++.||.|..|.|++++.+ +|...|||.++..... ...++++..++++... ++|+||+.+++|.......
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk---ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH---HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 355667788999999999999976 4889999999886555 3456778888876655 6999999999998877655
Q ss_pred EEEee-------ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHD-------HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+-++. .......++++..+-++...+..||.||.++++ |+|||+||+|||++..|++|++|||.+..+-.
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec-
Confidence 54332 222344578999999999999999999998653 99999999999999999999999999976642
Q ss_pred CceeeeeccccCCccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
+...+...|-+.|||||.+.-. .|+.++||||||++++||.||+.||...... ...+ ...+. ..+..
T Consensus 245 -SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~l----tkvln--~ePP~ 314 (391)
T KOG0983|consen 245 -SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVL----TKVLN--EEPPL 314 (391)
T ss_pred -ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHH----HHHHh--cCCCC
Confidence 3334556788899999988644 6888999999999999999999999775421 1111 11111 11111
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
++. ....++.|++|+..||++|+.+||...++++
T Consensus 315 L~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 211 2337889999999999999999999999864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.31 Aligned_cols=244 Identities=24% Similarity=0.328 Sum_probs=178.9
Q ss_pred ceecccCceEEEEEEEcC---CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
+.||+|+||.||+|...+ ...+++|.+...... .....+.+|+.+++.++||||+++++.+......++++++.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP---DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCCh---HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 358999999999997443 456888877654332 23456888999999999999999999999999999999887
Q ss_pred cCCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 154 HRNEE------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 154 ~~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
..+.. ...++.....++.|++.|+.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 54321 12356778899999999999999999 9999999999999999999999999986543222
Q ss_pred cee-eeeccccCCcccccccc-------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 222 THV-TTKIQGTFGYLEPEYHQ-------SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 222 ~~~-~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
... .....++..|+|||+.. ...++.++||||+||++|||++ |..||..... . ..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~------~~~~~~~~~~ 226 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--E------QVLKQVVREQ 226 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--H------HHHHHHhhcc
Confidence 111 12233567799999864 3456889999999999999999 7888865321 0 0011111111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
......+ ..+...+..+.+++..|| .||++|||++|+++.|+
T Consensus 227 -~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 -DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111 123345567788999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=278.17 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=190.3
Q ss_pred CCcccceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccc
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 146 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 146 (366)
+|++.+.||+|++|.||+|... ++..+|+|.+...... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4888999999999999999965 4789999999874311 111234677899999999999999999999888 677
Q ss_pred eEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC----CCeEEEeec
Q 037297 147 LLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE----RYRAKVADF 211 (366)
Q Consensus 147 ~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~----~~~vkl~Df 211 (366)
++++++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 7887765421 1236788999999999999999999999 999999999999999 999999999
Q ss_pred CCcccccCCCc--eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc----HHHH
Q 037297 212 GTSKFIAMDQT--HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS----LAAF 284 (366)
Q Consensus 212 g~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~ 284 (366)
|++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||............ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876543322 11223457888999998766 45789999999999999999999999765432210000 0000
Q ss_pred HHHHhhc------------Ccc---------ccccchHHhhhhcH--HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRK------------NHM---------YDILDDQVVKLVKK--NQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~------------~~~---------~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+.. ... .......+....+. ..+.++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000 00000111111111 44567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.88 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=191.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||++... +++.+|+|.+....... .....+.+|+.+++.++|||++++++.+...+..++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc--HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 5889999999999999999864 58889999987654332 23567889999999999999999999998888888888
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCcccccCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMD 220 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~~~~~ 220 (366)
++..+.. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 8775532 335889999999999999999999999 9999999999999854 46899999999766433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... . ..... ....
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~---~~~~~-~~~~------ 218 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----L---VLKIM-SGTF------ 218 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----H---HHHHH-hcCC------
Confidence 2 1223457889999999998889999999999999999999999986533100 0 00000 0000
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++..||+.||++|||+.|+++
T Consensus 219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122335667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=282.44 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=190.8
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC---
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--- 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 144 (366)
..++|++.+.||+|+||.||+|... +++.+|+|.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh--hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4578999999999999999999965 68999999986543222 23346778999999999999999999876443
Q ss_pred ---cceEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 ---VPLLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ---~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++....- ...++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3577777664320 113788889999999999999999999 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc----------HHHH---
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS----------LAAF--- 284 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----------~~~~--- 284 (366)
.... ......++..|+|||.+.+..++.++|+||+||++|+|++|+.||............ ....
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4322 123345788999999999999999999999999999999999999754311000000 0000
Q ss_pred -HHHHhhcCc------cccccc----hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 285 -FVHSMRKNH------MYDILD----DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 285 -~~~~~~~~~------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
......... +..... +......+...+..+.+++.+||+.||++|||+.|+++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000000 000001122346678999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.60 Aligned_cols=239 Identities=26% Similarity=0.334 Sum_probs=192.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||++... +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 46899999999999999999965 5899999998753322 123456788999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 98875432 346889999999999999999999999 999999999999999999999999998765433
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ ...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~--------- 214 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGK--------- 214 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCC---------
Confidence 2334688899999999888889999999999999999999999965431 00010111 100
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVT 336 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell 336 (366)
..++...+..+.+++.+||..||.+|+ +++|++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 012333456789999999999999999 667765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=272.71 Aligned_cols=242 Identities=28% Similarity=0.393 Sum_probs=193.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+-|++.+.||+|+||.||+|... +++.+|+|.+...... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 34778899999999999999864 5889999988654332 2345788999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 98775432 335789999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+||+||++|+|++|..||...... ...........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~--------- 218 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP--------- 218 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---------HHHHHHhcCCC---------
Confidence 122345788899999998888899999999999999999999998643210 00000111100
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++..||+.||.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1123345667899999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.71 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=188.0
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 142 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (366)
+.....+.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 33445578999999999999999999964 58899999886532 1234677889999888 79999999999853
Q ss_pred ------CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 143 ------TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 143 ------~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
....++++++...+ ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 34567788876543 2235788889999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccCCCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 208 VADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
|+|||++........ ......++..|+|||.+. +..++.++|+|||||++|+|++|..||.........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875432211 122345888999999875 346788999999999999999999999653311000
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ...... .......++..+.+++..||+.||.+|||+.|+++
T Consensus 236 ---~~-~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ---FL-IPRNPP--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hh-HhhCCC--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 01112345668999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=279.92 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=187.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 146 (366)
.++|++.+.||+|+||.||+|..+ +|+.||+|.++....... ....+.+|+.+++.++|+|++++++++... +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG--IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC--CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 467999999999999999999975 589999999876433221 122456799999999999999999998765 346
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++.... ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 7777765431 1246889999999999999999999999 99999999999999999999999999976643
Q ss_pred CCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Cccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NHMY 295 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (366)
... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||....... . .......... ..+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~---~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--Q---LDLIIQLLGTPNESIWP 234 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHHhcCCCChhhch
Confidence 321 1222345778999998865 567899999999999999999999997543111 0 0000000000 0000
Q ss_pred cc----------cchHH---hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DI----------LDDQV---VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~----------~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ..... ........++.+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000 00001123667889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=274.34 Aligned_cols=258 Identities=24% Similarity=0.297 Sum_probs=191.3
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--CcceEE
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLLH 149 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~~~ 149 (366)
|++.+.||+|++|.||+|... +++.+|+|.+....... .....+.+|+.+++.++|||++++++++... ...+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE--GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999976 48899999998754221 2234678899999999999999999999888 778888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 79 FEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred eccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 7766421 1246889999999999999999999999 99999999999999999999999999987654432
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc-----
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD----- 296 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 296 (366)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ................+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhccccccch
Confidence 22333456788999997765 467899999999999999999999997544211 0000000000000000000
Q ss_pred ---------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ---------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.............++..+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111111222223678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.61 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=194.1
Q ss_pred cCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.|.|++.||.|+||.||+|..++ +-..|.|++..... ..++.++-|+++|..++||+||++++.|.-+..+.+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse----EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE----EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch----hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 446778889999999999998764 44457777765432 3567899999999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.++. ...+++.++.-++.|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+.... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hH
Confidence 99888763 336899999999999999999999999 9999999999999999999999999986432 12
Q ss_pred ceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
......+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-.... -........ ....+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKia-KSePPT 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIA-KSEPPT 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHh-hcCCCc
Confidence 23344578999999999664 4589999999999999999999999965432 011111111 111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ .-|..++..|.||+..||.+||..||++.++++
T Consensus 255 L-------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 L-------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred c-------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 236678899999999999999999999999963
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=273.83 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=194.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||++... +++.|++|.+...... .....+.+.+|+.+++.++||||+++++.+...+..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 46899999999999999999975 4788999988764321 123345788999999999999999999999998888899
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+.. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 88766532 235788999999999999999999998 99999999999999999999999998864211100
Q ss_pred --------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 223 --------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 223 --------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+... . ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~------~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--E------ELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H------HHHHHH
Confidence 011123578889999999888899999999999999999999999965321 0 011111
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. ...... + ......+.++.+++.+||+.||++|||+.++.++|+.-.
T Consensus 229 ~-~~~~~~---~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 229 I-SDDIEW---P----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred H-hcccCC---C----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 1 110000 0 011235567899999999999999999888887777633
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=269.98 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=194.0
Q ss_pred CCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChH--HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 72 HFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDE--ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
+|+..+.||+|++|.||++.. .+++.+|+|.+....... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488889999999999999986 468899999987544221 12245688999999999999999999999999998888
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~~~~ 220 (366)
++++..+.. ..++++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 888776542 236788999999999999999999999 99999999999998775 6999999998766433
Q ss_pred Cce---eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 221 QTH---VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 221 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~----- 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASAT----- 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhccC-----
Confidence 111 11224578899999999888899999999999999999999999964331110 00000000000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...+.++.+++.+||+.||++|||+.++++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011234556678999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=276.75 Aligned_cols=272 Identities=23% Similarity=0.242 Sum_probs=205.3
Q ss_pred CCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
+|++.+.||+|++|.||++... ++..+|+|.++...........+.+..|+.++..+ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999998842 47889999987643333334456788999999999 699999999999888888
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++ ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 8888877553 2245788899999999999999999998 99999999999999999999999999876544
Q ss_pred CCceeeeeccccCCccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
..........++..|+|||...+.. .+.++|+||+|+++|+|++|..||...+..... ..........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~------ 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ----SEISRRILKS------ 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH----HHHHHHHHcc------
Confidence 3332233346788999999887654 788999999999999999999999643321110 0000000000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccccccchHHHHh
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMIYSTGTLLRLF 362 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~ 362 (366)
....+...+..+.+++.+||+.||++|||+.++.+.|+...-+...+... .++.....|
T Consensus 228 -----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~ 286 (288)
T cd05583 228 -----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL-AAKRIPAPF 286 (288)
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH-hhhccCCCC
Confidence 01123345567899999999999999999999999988876555555433 333333333
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=271.02 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=192.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||+|... +++.+++|.++..... ....+.+..|+.+++.++|+||+++++++...+..+++.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 5889999999999999999865 6889999999875443 235568899999999999999999999998888888888
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++.... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 876543 2234788899999999999999999999 999999999999999999999999998776433322
Q ss_pred ee---eeccccCCccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 224 VT---TKIQGTFGYLEPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 224 ~~---~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ..............+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~- 229 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGAGHKPPIPD- 229 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhcCCCCCCCc-
Confidence 11 1345788999999988766 8899999999999999999999996532100 0000000000111110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+..+.+++..||+.||.+|||+.|++.
T Consensus 230 ---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1123567889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.77 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=177.3
Q ss_pred ceecccCceEEEEEEEcCC---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQGGQGTVYKGMLEDG---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
+.||+|+||.||++...++ ..+++|.+...... ...+.+.+|+.+++.++||||+++++.|......++++++.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS---KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh---HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 3599999999999975433 34567766553332 23467899999999999999999999999998899999887
Q ss_pred cCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 154 HRNEE-----------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 154 ~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
..+.. ...+...+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 54321 23456677889999999999999998 9999999999999999999999999875432111
Q ss_pred ceeeeeccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
........++..|+|||+..+ ..++.++|||||||++|||++ |..||..... .......... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-~ 225 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD-Q 225 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-c
Confidence 112233457889999998743 245779999999999999997 5677754321 0011111111 1
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.....++. .+...++.+.+++..|| .+|++|||++++++.|.
T Consensus 226 ~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQ----LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCc----cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11112221 12234567888999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=277.62 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=186.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc--
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 146 (366)
.++|++.+.||+|+||.||+|... +++.+|+|.+........ ....+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC--chhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 457999999999999999999965 588999999875433221 123456899999999999999999998765533
Q ss_pred ------eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 147 ------LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 147 ------~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
++++++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 6777765431 2235789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce---eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 214 SKFIAMDQTH---VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 214 a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
+......... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... ..............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 8765432221 11234567889999987664 478899999999999999999999865431 11000000000000
Q ss_pred hcCccccc--------------cchHHhhh-hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDI--------------LDDQVVKL-VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~--------------~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....++.. ........ .+...+..+.+++.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 00000000 01112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.45 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=191.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChH------HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDE------ELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
+|.+.+.||+|++|.||+|... +++.+|+|.++...... .....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788999999999999999864 58899999886532221 1123457888999999999999999999999998
Q ss_pred cceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++..++. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 8899888775442 246888899999999999999999998 999999999999999999999999998754
Q ss_pred cCCCc-eeeeeccccCCccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQT-HVTTKIQGTFGYLEPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..... .......++..|+|||.+.+.. ++.++|+||+|+++|++++|..||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLGNKRSA 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhhccccC
Confidence 32211 1123345788999999887654 789999999999999999999998643210 000000000000
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+ ........+..+.+++..||..||++|||++++++
T Consensus 231 ~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPI-----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcC-----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000 01122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=272.27 Aligned_cols=242 Identities=25% Similarity=0.403 Sum_probs=190.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC---CCceeeEeeEEeeCCcce
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 147 (366)
.|++.+.||+|+||.||+|.+. +++.+|+|.++..... ...+.+.+|+.+++.+. |||++++++++......+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD---DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 4788899999999999999964 6899999998765433 23456778998888886 999999999999988888
Q ss_pred EEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 148 LHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 148 ~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++++..+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 8888775542 236889999999999999999999999 9999999999999999999999999987765433
Q ss_pred ceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ ...........+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---------~~~~~~~~~~~~~-- 223 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---------MMLIPKSKPPRLE-- 223 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---------hhccccCCCCCCC--
Confidence 2 2233468889999998765 4578899999999999999999999965431100 0000000001100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+.++.+++..||+.||++|||+.|+++
T Consensus 224 ------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 ------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1124567899999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.50 Aligned_cols=243 Identities=26% Similarity=0.385 Sum_probs=186.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++......||+|+||.||+|.+. ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44445578999999999999965 578899998875432 2345788999999999999999999999999988888
Q ss_pred EeeccCCC--------CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCccccc
Q 037297 150 LHDHHRNE--------EFPL--TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~--------~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~~ 218 (366)
+++..+.. ..++ ++..+..++.|++.|+.|||+.+ ++||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 88765432 1234 77888899999999999999999 999999999999976 6799999999987653
Q ss_pred CCCceeeeeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
.... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.......... ......
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~~~~------- 227 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKVGMF------- 227 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhhhhh-------
Confidence 2221 12234578899999988654 37889999999999999999999986532111000 000000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....++...++++.+++.+||+.+|.+|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011234456677999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=274.32 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=192.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC--CCCceeeEeeEEeeCC---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI--NHRNVVKLLGCCLETE--- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~--- 144 (366)
....++.+.||+|.||.||+|... ++.||||+++. ...+.+..|-+++... +|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 355677899999999999999986 59999999986 3456788888888765 8999999998754444
Q ss_pred -cceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 145 -VPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSA------ASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 145 -~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
...+++++...+. ...++|....+++..+++||+|||+. .|++|+|||||..||||.+|++..|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 5566677666553 44789999999999999999999963 3789999999999999999999999999
Q ss_pred CCcccccCCCc-eeeeeccccCCccccccccCCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc----
Q 037297 212 GTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQ-LT-----DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS---- 280 (366)
Q Consensus 212 g~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---- 280 (366)
|+|..+..... ......+||.+|||||++.|.. .. .+.||||+|.++|||++...-++. +..+.-+..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 99988764332 2233467999999999998753 22 268999999999999997654432 111111111
Q ss_pred ------HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 281 ------LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 281 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
.........+...-+.+.+.. .......-+++.++.||..||+.|.|+.=+-+.+..+.....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111111111111111111111 112344568999999999999999999988888877765544
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=274.87 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=188.9
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
+.+....++|++.+.||+|+||.||+|... +++.+|+|++...... ...+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-----DEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-----HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 344455688999999999999999999865 5789999987643221 23567899999999 7999999999875
Q ss_pred e-----CCcceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 142 E-----TEVPLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 142 ~-----~~~~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
. ....++++++..+.. ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 3 345677887765432 235788889999999999999999998 999999999999999999
Q ss_pred EEEeecCCcccccCCCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 037297 206 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 280 (366)
++|+|||++........ ......|+..|+|||.+. +..++.++|+||+||++|+|++|+.||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 99999999876543221 222345889999999874 3457889999999999999999999986543100
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..... ........ ..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~~~-~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ---ALFKI-PRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---HHhhc-cccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 00000000 0122345579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=276.34 Aligned_cols=259 Identities=25% Similarity=0.324 Sum_probs=189.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 144 (366)
...++|++.+.||+|+||.||+|..+ +++.+|+|.++...... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34578999999999999999999976 58899999987643322 12235678999999999999999999887655
Q ss_pred --------cceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 145 --------VPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 145 --------~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
..++++++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 566777665431 1236889999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
|||.+...............++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-----~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-----QLELISRL 233 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHH
Confidence 999987664333222222345778999998765 457889999999999999999999996533110 00000000
Q ss_pred hh---cCcccccc--------------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 289 MR---KNHMYDIL--------------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 289 ~~---~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ...++.+. .+.... .....+..+.+++..||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00000000 000001 11124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.40 Aligned_cols=231 Identities=22% Similarity=0.354 Sum_probs=176.3
Q ss_pred eecccCceEEEEEEEcC-------------------------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc
Q 037297 78 ILGQGGQGTVYKGMLED-------------------------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (366)
.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999987321 1358888876432 123457888999999999999
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
|++++++|......++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 9999999999999999998876542 345788999999999999999999998 99999999999997543
Q ss_pred -------eEEEeecCCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCC
Q 037297 205 -------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELL-TGKKPIFSTGNTS 275 (366)
Q Consensus 205 -------~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~ 275 (366)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|||+ +|..||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999987543211 12346778999998865 56899999999999999985 6999986543111
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
. .... ..... .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~-----~~~~---~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K-----ERFY---EKKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-----HHHH---HhccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0000 00001 11122346899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.90 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=197.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|... +++.+++|++...... ...+.+.+|+..+..++|||++++++++......+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 46889999999999999999976 4899999998875443 3456788999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..+. ...++++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 8887643 22468899999999999999999999 98 9999999999999999999999999987664333
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........... ....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~-~~~~------- 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAIC-DGPP------- 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHh-cCCC-------
Confidence 22 2234578889999999988999999999999999999999999976542 01111111111 1111
Q ss_pred HhhhhcHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKN-QIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+.. .+..+.+++..||..+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 --PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112223 5678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=276.56 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=189.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|.....||+|+||.||++... ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..+++++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH----HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 444567999999999999865 588999998865321 334578899999999999999999999999999999998
Q ss_pred eccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 152 DHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 152 ~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
+..+.. ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 876542 235788999999999999999999999 99999999999999999999999999875432221 22
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
....++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... . .... .... .......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~------~~~~-~~~~-~~~~~~~------ 239 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--L------QAMR-RIRD-NLPPRVK------ 239 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H------HHHH-HHHh-cCCCccc------
Confidence 334578899999999888899999999999999999999999965321 0 0000 0000 0000000
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.....+..+.+++..||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.35 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=188.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc---
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~--- 145 (366)
++|++.+.||+|+||.||+|.+. +++.||+|.++...... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE--GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc--CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46899999999999999999965 58899999987643321 1234678899999999 56999999999887665
Q ss_pred --ceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeec
Q 037297 146 --PLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADF 211 (366)
Q Consensus 146 --~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Df 211 (366)
.++++++.... ....+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+||
T Consensus 79 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeec
Confidence 67777765431 1235789999999999999999999999 999999999999998 889999999
Q ss_pred CCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
|.+......... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......... ........
T Consensus 156 g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-----~~~~~~~~ 229 (295)
T cd07837 156 GLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-----LHIFKLLG 229 (295)
T ss_pred ccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-----HHHHHHhC
Confidence 998765332211 122346788999998765 45789999999999999999999999764321110 00000000
Q ss_pred cC---cccc-----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KN---HMYD-----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~---~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+ .+.. ...+.......+..+..+.+++..||+.||.+|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00011111122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.83 Aligned_cols=244 Identities=28% Similarity=0.404 Sum_probs=189.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc-
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV- 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~- 145 (366)
..++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++.+ .||||+++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 3578999999999999999999975 578899999876432 235788999999999 79999999999876553
Q ss_pred -----ceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 146 -----PLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 146 -----~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
.++++++..+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 677777765431 346889999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
|||++....... .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...... ..
T Consensus 156 d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~ 226 (275)
T cd06608 156 DFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RA 226 (275)
T ss_pred CCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HH
Confidence 999987553222 12233457889999998753 34678999999999999999999999643210 00
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ....... ..+..++.++.+++.+||..||++|||+.|+++
T Consensus 227 ~~~~~-~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 LFKIP-RNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHhh-ccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1111111 112346678999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.92 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=194.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|...+.||+|+||.||++... ++..+|+|.+....... ......+..|+++++.++|||++++++++......+++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34778899999999999999964 58899999987543322 13345788999999999999999999999999998999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ...++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 8876542 2346889999999999999999999999 99999999999999999999999998864432
Q ss_pred eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.....++..|+|||.+. +..++.++|+||+||++|+|++|+.||...... .......... ..
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~-~~---- 242 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE-SP---- 242 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhcc-CC----
Confidence 12345788899999873 456889999999999999999999998653210 0000000000 00
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
......++..+.+++.+||+.+|.+|||+.++++.+..+....
T Consensus 243 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 243 ----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0112345567899999999999999999999998665544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.60 Aligned_cols=243 Identities=27% Similarity=0.317 Sum_probs=194.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||.|+||.||+|... ++..+|+|.+....... ....+.+.+|+.++++++||||+++++++......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 5889999999999999999976 58899999997643221 124567899999999999999999999999888899988
Q ss_pred eeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++..+.. ..++++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 8776542 247889999999999999999999999 9999999999999999999999999987654332
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .......... ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET----------AD 218 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc----------cc
Confidence 2233457889999999988889999999999999999999999997654210 1111111110 11
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTM--EEVT 336 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~ell 336 (366)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12344456789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=273.18 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=188.3
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|++.+.||.|++|.||+|..+ +|..+|+|++....... ...+.+.+|+++++.++|||++++++++...+..+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 678899999999999999965 68999999987653322 122467789999999999999999999999988888888
Q ss_pred eccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 152 DHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 152 ~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 76321 1125889999999999999999999998 999999999999999999999999998755322211
Q ss_pred eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC----------
Q 037297 224 VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---------- 292 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 292 (366)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||........ ... ........
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFR-IFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HHHHhCCCChHHhhhhhh
Confidence 1223467889999987654 578899999999999999999999965432110 000 00000000
Q ss_pred ------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 ------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... ........+..+..+.+++.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00011122334567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=281.23 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=193.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|.+.+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 457999999999999999999965 58999999987543221 22346678999999999999999999876543
Q ss_pred -cceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 -VPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 -~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++.... ...++++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 356666665421 2346889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Cc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NH 293 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 293 (366)
.... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... ........... ..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-----QLKLITELLGSPSEED 232 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHHHHhCCCChHH
Confidence 4322 22233457889999998764 468899999999999999999999996532100 00000000000 00
Q ss_pred c---------------ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HhhcccC
Q 037297 294 M---------------YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIRGS 345 (366)
Q Consensus 294 ~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~~~ 345 (366)
. ....+... ....+..++++.+++.+||+.||++|||++|+++- +..+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 00000000 11223466788999999999999999999999876 6665544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=271.67 Aligned_cols=232 Identities=22% Similarity=0.369 Sum_probs=177.3
Q ss_pred ceecccCceEEEEEEEcC-C-------cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 77 RILGQGGQGTVYKGMLED-G-------RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
+.||+|+||.||+|.... + ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 469999999999998542 2 347888765422 2344578889999999999999999999999888999
Q ss_pred EEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe--------EEEeecC
Q 037297 149 HLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR--------AKVADFG 212 (366)
Q Consensus 149 ~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~--------vkl~Dfg 212 (366)
++++...+. ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++. ++++|||
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 988776542 235788999999999999999999999 999999999999987654 6999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcccccHHHHHHHHhh
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGK-KPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
.+..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|. .||....... ......
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~ 219 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFYE 219 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHHH
Confidence 8864432 122457888999999876 45789999999999999999985 5554322100 000000
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.. ..++...+.++.+++..||+.||++|||++++++.|+
T Consensus 220 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DR-----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc-----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0122233457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=273.42 Aligned_cols=256 Identities=25% Similarity=0.263 Sum_probs=190.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH-HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE-LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+|++.+.||+|++|.||+|... +++.+|+|.++....... ......+..|+.+++.++|+||+++++++......+++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888899999999999999965 589999999986543311 12234567899999999999999999999998888998
Q ss_pred EeeccCC-------CC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN-------EE-FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~-------~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++. .+ .. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 8887 32 11 25889999999999999999999999 9999999999999999999999999997664332
Q ss_pred ceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--------
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN-------- 292 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 292 (366)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||....... ............
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-----QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-----HHHHHHHHcCCCchhhhhhc
Confidence 1 2222346778999998754 467899999999999999999977775433111 000000000000
Q ss_pred -ccccccc-----hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 -HMYDILD-----DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 -~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... +..........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000 00011122344678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=272.58 Aligned_cols=242 Identities=27% Similarity=0.380 Sum_probs=189.5
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|.....||+|+||.||++... +++.+|+|.+...... ..+.+.+|+.+++.++|||++++++++...+..+++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc----hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 334457999999999999865 5889999998754322 23567889999999999999999999999999999988
Q ss_pred eccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 152 DHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 152 ~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
+..++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 876542 235788999999999999999999999 9999999999999999999999999986543322 122
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... .... .......... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~-~~~~~~~~~~-------~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMK-RLRDSPPPKL-------K 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHhccCCCCc-------c
Confidence 3356889999999998888999999999999999999999999753310 0000 0111100000 0
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.....+..+.+++.+||+.||.+|||++++++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112345578899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=269.73 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=189.2
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
..+....++|++.+.||+|+||.||++... +++.+|+|.+...... .+.+.+|+.+++.+ +|||++++++++.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-----DEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-----HHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 334445688999999999999999999964 5889999998653221 24567788899988 8999999999987
Q ss_pred eCC-----cceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 142 ETE-----VPLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 142 ~~~-----~~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
..+ ..++++++..+. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 643 467778776543 2346789999999999999999999998 999999999999999999
Q ss_pred EEEeecCCcccccCCCceeeeeccccCCccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 037297 206 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 280 (366)
++|+|||++........ ......++..|+|||.+... .++.++|+||+||++|+|++|+.||......
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 99999999876543221 12234578899999987543 3688999999999999999999999754310
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... ......... .+......+.+++.+||+.||++|||+.|+++
T Consensus 240 --~~~~~~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 --KTLFKI-PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHHHH-hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 001111 111111111 12334557999999999999999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=269.39 Aligned_cols=255 Identities=22% Similarity=0.260 Sum_probs=185.4
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC--CcceE
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET--EVPLL 148 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~~ 148 (366)
|++.+.||+|+||.||+|... +++.+|+|.++....... .....+|+..+..+ +|||++++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 678899999999999999965 588999999876433221 12345788888888 599999999999887 77788
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++.......
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 78 VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 88766432 1236899999999999999999999999 999999999999999 999999999997654322
Q ss_pred ceeeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH------HHHHHHHhhcCc-
Q 037297 222 THVTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL------AAFFVHSMRKNH- 293 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~- 293 (366)
. .....++..|+|||... +..++.++|+||+||++|||++|..||............. ............
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 22345788999999764 4557889999999999999999999996543110000000 000000000000
Q ss_pred ----cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 ----MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ........+..+.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTG-LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCccccccc-HHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 11122356788999999999999999999999974
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=271.48 Aligned_cols=254 Identities=23% Similarity=0.284 Sum_probs=193.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|++.+.||+|++|.||+|... +++.+++|.+....... .....+.+|+.+++.++||||+++++++...+..+++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 677889999999999999965 68899999987654332 234577889999999999999999999999888888888
Q ss_pred eccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+.... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 76432 1246889999999999999999999999 9999999999999999999999999987665433 12
Q ss_pred eeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Ccccccc--
Q 037297 225 TTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NHMYDIL-- 298 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 298 (366)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......... ......... ..+....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL-----FKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHHcCCCchHhcccchhh
Confidence 2334577889999988776 7899999999999999999999999654321100 000000000 0000000
Q ss_pred -----------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 -----------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 -----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............+.++.+++..||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000112233456788999999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=270.24 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=189.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|++|.||+|..+ +++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE--GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc--cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 57999999999999999999975 58899999986543221 2234678899999999999999999999999999998
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcccccCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~~~~ 220 (366)
+++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 8876432 1223577888899999999999999998 999999999999985 567999999999755432
Q ss_pred CceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---ccc-
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMY- 295 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 295 (366)
. .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... ...........+ .+.
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-----ELFKIFRILGTPNEETWPG 230 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChhhccc
Confidence 1 11223456788999998765 457899999999999999999999997543210 000000000000 000
Q ss_pred --c---------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 --D---------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 --~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ...+.......+..++++.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000011112345667899999999999999999999975
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=264.37 Aligned_cols=230 Identities=24% Similarity=0.427 Sum_probs=176.9
Q ss_pred ceecccCceEEEEEEEcCCc-----------EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 77 RILGQGGQGTVYKGMLEDGR-----------IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-----SLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-----HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 46899999999999975422 4777876643211 4578899999999999999999999888 66
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-------eEEEee
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-------RAKVAD 210 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-------~vkl~D 210 (366)
.++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .++|+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 778887765442 225788899999999999999999999 99999999999999887 799999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
||++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...... .. .....
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~---~~~~~- 220 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EK---ERFYQ- 220 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hH---HHHHh-
Confidence 999876533 1223466789999998776 78999999999999999999 57777554311 00 00000
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
..... +......+.+++.+||..||.+|||+.++++.|+
T Consensus 221 --~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 0111157899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=280.33 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=189.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC----C
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----E 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~ 144 (366)
..+|++.+.||+|++|.||+|..+ +++.||+|++....... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc--cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 368999999999999999999965 58999999987643321 2345677899999999999999999887543 3
Q ss_pred cceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 VPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 ~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++..+. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 456666655321 2345899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCce---eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 219 MDQTH---VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 219 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||......... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~--~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL--KLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH--HHHHHHhCCChhHhh
Confidence 32211 1123468889999998765 46889999999999999999999999654321100 000000000000000
Q ss_pred ccccc--------------hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILD--------------DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... +.......+..+.++.+++..||+.||++|||+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 00001122345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.90 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=196.0
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-----c
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----V 145 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 145 (366)
+|++.+.||.|++|.||+|... ++..+|+|.+....... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL--IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc--hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5889999999999999999975 48999999987644321 33457889999999999999999999987775 5
Q ss_pred ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 146 PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 146 ~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
.++++++.... ...++++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||.+.....
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 79 VYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred eEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 66776654421 2236889999999999999999999999 99999999999999999999999999987654
Q ss_pred CCc--eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 037297 220 DQT--HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---- 292 (366)
Q Consensus 220 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 292 (366)
... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~ 230 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcCCCChhH
Confidence 321 122334578889999999887 889999999999999999999999976542110 00000000000
Q ss_pred -------ccccc------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hhhccc
Q 037297 293 -------HMYDI------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIRG 344 (366)
Q Consensus 293 -------~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~~ 344 (366)
..... ..+.......+..+..+.+++..||+.||++|||++++++. ++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000 00000111223356788999999999999999999999873 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=299.40 Aligned_cols=246 Identities=30% Similarity=0.434 Sum_probs=176.1
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
-.++|+.++.||+||||.||+++.+ +|+.+|||+++..... .....+.+|+.++.+|+|||||+++..+.+.....
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4467889999999999999999976 7999999999987622 34567899999999999999999987543221000
Q ss_pred ------------------------EE------------------------------------------------------
Q 037297 148 ------------------------LH------------------------------------------------------ 149 (366)
Q Consensus 148 ------------------------~~------------------------------------------------------ 149 (366)
+.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 00
Q ss_pred -----------------------------------------EeeccCC------CCCCC--CHHHHHHHHHHHHHHHHHH
Q 037297 150 -----------------------------------------LHDHHRN------EEFPL--TWEIRLRIATEVAGALSYL 180 (366)
Q Consensus 150 -----------------------------------------~~~~~~~------~~~~l--~~~~~~~i~~~i~~~l~~l 180 (366)
|+++... ..... .....++++++|++|+.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0000000 00001 1345688999999999999
Q ss_pred HhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC-----------------CCceeeeeccccCCccccccccCC
Q 037297 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-----------------DQTHVTTKIQGTFGYLEPEYHQSS 243 (366)
Q Consensus 181 H~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~-----------------~~~~~~~~~~~t~~y~aPE~~~~~ 243 (366)
|++| +|||||||.||++++++.|||+|||+|+.... ......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 99999999999999999999999999987210 111134567899999999998776
Q ss_pred C---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHH
Q 037297 244 Q---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAER 320 (366)
Q Consensus 244 ~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 320 (366)
. |+.|+|+||||++++||+. ||.... + .......++...++.- ..+..+..+.-.++|++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----E----Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----E----RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH----H----HHHHHHhcccCCCCCC------cccccccchHHHHHHHH
Confidence 5 9999999999999999985 454321 1 1112222222222211 11122223345689999
Q ss_pred hhcCCCCCCCCHHHHHH
Q 037297 321 CLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 321 cl~~dp~~Rpt~~ell~ 337 (366)
|++.||++|||+.|+|+
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999974
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.75 Aligned_cols=240 Identities=26% Similarity=0.357 Sum_probs=193.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||++..+ +++.+|+|.+....... .....+.+|+.+++.++||||+++.+++......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH--HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 5888999999999999999865 57899999987644332 23457788999999999999999999999888888888
Q ss_pred eeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 151 HDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 151 ~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++..+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 7764432 245788899999999999999999999 99999999999999999999999999876643
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. ......++..|+|||...+..++.++|+||+|+++|+|++|+.||...... ...........
T Consensus 156 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~----- 218 (256)
T cd08530 156 N---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---------DLRYKVQRGKY----- 218 (256)
T ss_pred C---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCC-----
Confidence 3 222345788999999999889999999999999999999999999654310 01111111111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++..||+.+|++|||+.++++
T Consensus 219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1123456778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=287.05 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=195.2
Q ss_pred cCCcccceecccCceEEEEEEEcC--Cc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED--GR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
+...+.+.||+|+||.|++|.++. |. .||||+++.+... .....|.+|+.+|.+|+|||++++|++..+ ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 456677899999999999999653 44 5899999876655 356789999999999999999999999887 444
Q ss_pred eEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.+++|....+ ....+....+..++.||+.||.||.+++ +|||||..+|+|+...-.|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 4454443322 3335777788899999999999999999 999999999999999999999999999887
Q ss_pred cCCCcee-e-eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHV-T-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~-~-~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...+... . ....-...|+|||.+....++.++|+|++||++|||++ |..||-+... ..+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qI 324 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQI 324 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHH
Confidence 6443221 1 11224567999999999999999999999999999999 8899976541 112
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
...+|..-+..-++.|++++.++++.||..+|.+|||+..|.+.+-
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2223333333457889999999999999999999999999975443
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=265.99 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=189.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh-HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 146 (366)
.+|++.+.||+|++|.||+|... ++..+|+|.+...... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999965 5889999987643221 12234567889999999999999999999987653 45
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..+. ....+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 6677765443 1235788899999999999999999999 99999999999999999999999999876532
Q ss_pred CC--ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQ--THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .........+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~----- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQP----- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCC-----
Confidence 11 11122345788999999999888999999999999999999999999653210 0011111000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....++...++.+.+++..||+ +|..|||+.+++.
T Consensus 226 ----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112355667789999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=262.91 Aligned_cols=241 Identities=30% Similarity=0.439 Sum_probs=192.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|++.+.||+|++|.||++... ++..+++|++..... ...+.+.+|++.++.++|||++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4788899999999999999975 688999999987543 24457889999999999999999999999988888888
Q ss_pred eeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++..+.. ...+++..+..++.|++.|+.+||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 8766332 246899999999999999999999998 99999999999999999999999999876654332
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .... ..........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~-~~~~~~~~~~---- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------ALFK-IATNGPPGLR---- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--------HHHH-HHhcCCCCcC----
Confidence 234467889999999988889999999999999999999999987543100 0000 0001111110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..++..+.+++..||+.||++|||+.|+++
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 ---NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01123567999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=268.06 Aligned_cols=242 Identities=22% Similarity=0.355 Sum_probs=190.3
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|+||.||+|..+ +|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 5888999999999999999975 47889999987642221 23456788999999999999999999999998889988
Q ss_pred eeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccccCC
Q 037297 151 HDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 220 (366)
Q Consensus 151 ~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~~~~ 220 (366)
++..... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 8765432 235789999999999999999999999 99999999999999885 4699999998766432
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.. ......++..|+|||...+..++.++|+||+|+++|+|++|..||..... ........ ....
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~------ 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKIC-QGYF------ 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHh-cccC------
Confidence 21 22234578899999999888899999999999999999999999864321 01111111 1111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+..+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112344567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=272.00 Aligned_cols=239 Identities=28% Similarity=0.420 Sum_probs=187.4
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|...+.||+|+||.||+|... ++..+++|.+........ ...+.+.+|+.+++.++|||++++++++......+++++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN-EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 666788999999999999964 588999999875433221 334578889999999999999999999999999999988
Q ss_pred eccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+..+. ...++++..+..++.|++.|+.|||+.| ++|+||+|+||+++.++.++|+|||++.... .
T Consensus 102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 76432 2346889999999999999999999999 9999999999999999999999999885432 1
Q ss_pred eeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 225 TTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.....++..|+|||.+. +..++.++|+|||||++|+|++|..||........ . ... ........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~---~~~-~~~~~~~~---- 240 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----L---YHI-AQNDSPTL---- 240 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----H---HHH-HhcCCCCC----
Confidence 22346788899999874 45688899999999999999999999876431110 0 000 00111110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12234456899999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=270.52 Aligned_cols=244 Identities=26% Similarity=0.384 Sum_probs=192.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|.+.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|+.+++.++|||++++++++...+..+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 68999999999999999999864 578899999864322 2345788999999999999999999999999989999
Q ss_pred EeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+... ..+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 887765422 25788889999999999999999999 99999999999999999999999998865543322
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||.+.+..++.++|+||||+++|++++|+.||.......... . ..... ...
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~------~~~~~-~~~------- 234 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L------IATNG-TPE------- 234 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e------hhcCC-CCC-------
Confidence 2223457888999999988889999999999999999999999997543211100 0 00000 000
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
...+...+..+.+++..||..||++||++.++++.
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345578899999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.33 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=191.0
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
.-..|+..+.||+|.||.||+|..++ ...+|+|+++...+....+ ....+|+.+++.++|||++.+..++...
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS--~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS--MSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC--HHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 34679999999999999999996332 2368999998764433222 3678999999999999999999999884
Q ss_pred C-cceEEEeecc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CeEE
Q 037297 144 E-VPLLHLHDHH-----------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER----YRAK 207 (366)
Q Consensus 144 ~-~~~~~~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~----~~vk 207 (366)
+ ..++++++.. ......++...+..++.||+.|+.|||+.- |+||||||.|||+..+ |.||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 4 4444444321 122346889999999999999999999998 9999999999999988 8999
Q ss_pred EeecCCcccccCCCcee--eeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc-cH--
Q 037297 208 VADFGTSKFIAMDQTHV--TTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-SL-- 281 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~~-- 281 (366)
|+|||+++.+.+.-... ....+-|..|+|||++.|. .|+++.|+||.||++.||++..+-|.+......... -.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999887544332 2345679999999998876 689999999999999999999988876543222221 11
Q ss_pred -HHHHHHHhh---cCccccccch----HHhhhhc----------------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 282 -AAFFVHSMR---KNHMYDILDD----QVVKLVK----------------KNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 282 -~~~~~~~~~---~~~~~~~~~~----~~~~~~~----------------~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.......+. ...++++.+- .....++ ..-++.-.+|+..+|..||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 111111111 1122211110 0000000 111233678999999999999999999876
Q ss_pred HH
Q 037297 338 EL 339 (366)
Q Consensus 338 ~L 339 (366)
-.
T Consensus 337 h~ 338 (438)
T KOG0666|consen 337 HP 338 (438)
T ss_pred cc
Confidence 43
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=265.18 Aligned_cols=242 Identities=29% Similarity=0.417 Sum_probs=194.9
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||.|++|.||++.+. ++..+++|++....... ...+.+.+|+++++.++|||++++.+.+......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE--KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh--HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 5888999999999999999965 58899999988654432 33457889999999999999999999999988888888
Q ss_pred eeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 151 HDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 151 ~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+...+.. ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 8765432 256889999999999999999999999 99999999999999999999999999876544
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.. .......+++.|+|||...+..++.++|+||+|+++|+|++|..||..... ...... ......
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~----- 220 (258)
T cd08215 156 TV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALK-ILKGQY----- 220 (258)
T ss_pred Cc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHH-HhcCCC-----
Confidence 32 223334678899999999888899999999999999999999999865431 001111 111111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..++...+..+.+++.+||..||++|||+.|+++
T Consensus 221 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 ----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123345567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=277.12 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=188.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|.+.+.||+|+||.||+|... +|+.+|+|.+....... .....+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 478999999999999999999965 58999999987543222 123467889999999999999999998865532
Q ss_pred ---ceEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 ---PLLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ---~~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 35555543221 1235889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh-------
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR------- 290 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 290 (366)
.. .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... ..........
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 169 AE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVPGPEFV 239 (342)
T ss_pred CC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCCHHHH
Confidence 21 123456788999998866 468899999999999999999999997543100 0000000000
Q ss_pred ----cCc-------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhccc
Q 037297 291 ----KNH-------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRG 344 (366)
Q Consensus 291 ----~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~ 344 (366)
... ......... ....+..+..+.+++.+||+.||++|||++|++. .++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 000000000 0011234567889999999999999999999984 3666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.14 Aligned_cols=270 Identities=24% Similarity=0.306 Sum_probs=192.1
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC--
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE-- 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-- 144 (366)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+....... .....+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3467999999999999999999975 58899999886432221 2234677899999999 9999999999886544
Q ss_pred cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 145 VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 145 ~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
..++++++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred eEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 466777665421 1125788888999999999999999999 99999999999999999999999999876543
Q ss_pred CCc----eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH----------HHH
Q 037297 220 DQT----HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL----------AAF 284 (366)
Q Consensus 220 ~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~----------~~~ 284 (366)
... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 322 12233568889999997755 457889999999999999999999996543211000000 000
Q ss_pred HHHHhhcC---ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hhhccc
Q 037297 285 FVHSMRKN---HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIRG 344 (366)
Q Consensus 285 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~~ 344 (366)
........ .......... ....+..+.++.+++..||+.||++|||+.++++. +.++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 00000000 0000000000 11112256789999999999999999999999864 444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=268.78 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=188.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.|.-.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 3455579999999999999864 688999998865322 23456889999999999999999999999888888888
Q ss_pred eeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 151 HDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 151 ~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
++..+... ..+++..+..++.|++.|+.|||+++ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 87654321 35788899999999999999999999 99999999999999999999999998865543222 1
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
.....++..|+|||...+..++.++|+||+|+++|+|++|+.||...... .... ...........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~-~~~~~~~~~~~------ 236 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMK-RIRDNLPPKLK------ 236 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHH-HHHhcCCCCCc------
Confidence 22345788999999998888999999999999999999999998653210 0000 01111000000
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11224567999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=278.60 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=200.8
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.....|.+.+.||+|.|+.|.+|++. ++..||+|.+....... ...+.+.+|+++++.++|||||+++.+.......
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34577999999999999999999965 68999999988755443 3445689999999999999999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
|+++++...+. .....+.....++.|+..|++|||+++ |+|||||++|||++.+-++||+|||++..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 99999987653 234666888999999999999999999 9999999999999999999999999998775
Q ss_pred CCceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|.+||.+..-....
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------------------- 264 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------------------- 264 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------------
Confidence 3344456789999999999999876 56999999999999999999999864411111
Q ss_pred chHHh--hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 299 DDQVV--KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 299 ~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
++-++ -.++...+.++.++++++|-.+|.+|++++++-
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhh
Confidence 11111 113445566789999999999999999999984
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=275.14 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=187.6
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
..++....++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh--HHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3445566789999999999999999999854 68899999987543221 23456788999999999999999999876
Q ss_pred eCC------cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 142 ETE------VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 142 ~~~------~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
... ..+++.+..... ....+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|
T Consensus 87 ~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 87 PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEec
Confidence 432 233443332111 1235889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
||++..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||........ ........
T Consensus 164 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~ 234 (345)
T cd07877 164 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLV 234 (345)
T ss_pred ccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHh
Confidence 999875432 1223457888999998766 5688899999999999999999999964331100 00000000
Q ss_pred h--cCccccccch----HH-----------hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 290 R--KNHMYDILDD----QV-----------VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 290 ~--~~~~~~~~~~----~~-----------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
. .......+.. .. ........+.++.+++..||+.||.+|||+.++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000000000 00 000011235678999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=265.12 Aligned_cols=238 Identities=26% Similarity=0.274 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||.|++|.||+|... +++.+|+|++........ ...+.+.+|+.+++.++||||+++++.+......++++++..+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET-GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh-hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999975 488999999976433221 234678999999999999999999999999988888888765432
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccc
Q 037297 158 -------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230 (366)
Q Consensus 158 -------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 230 (366)
...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 235788999999999999999999998 9999999999999999999999999997664332 2223457
Q ss_pred cCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHH
Q 037297 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310 (366)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (366)
+..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ............ ....+...
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~ 219 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNG---------KLEFPNYI 219 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCC---------CCCCCccc
Confidence 889999999988889999999999999999999999997654210 011111110000 11123334
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 311 IMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 311 ~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
++++.+++.+||+.||++||| ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 677654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=271.40 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=192.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|...+.||+|++|.||+|... +++.+|+|.+........ .....+.+|+.+++.++|+|++++.+++......+++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 44777889999999999999965 578899999875322211 2345678899999999999999999999999888888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ...++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 8876432 2335788999999999999999999998 999999999999999999999999998654322
Q ss_pred eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
....++..|+|||.+. ...++.++|||||||++|+|++|..||....... .. ........+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~-~~~~~~~~~---- 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------AL-YHIAQNESP---- 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HH-HHHhhcCCC----
Confidence 2345788899999874 3567889999999999999999999986532100 00 000011110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
...+...+..+.+++.+||+.+|++|||++++++.-.......
T Consensus 233 ----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred ----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 0112345667899999999999999999999987655554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=267.15 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=186.4
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|++|.||+|..++ ++.+|+|.++..... .....+..|+.++... .||||+++++++......
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 44679999999999999999999764 889999999764433 2234566677766666 599999999999999888
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++.... ...++++..+..++.|++.|+.|||+ .+ ++||||+|+||++++++.++|+|||++....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 8888875431 12368889999999999999999997 47 9999999999999999999999999987653
Q ss_pred CCCceeeeeccccCCccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... ........... .
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-~ 236 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE-P 236 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-C
Confidence 3221 12234678899999887553 788999999999999999999998642210 01111111111 0
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... ....++.++.+++.+||+.||.+|||++++++
T Consensus 237 ~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 237 PSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 01124567899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=271.48 Aligned_cols=260 Identities=24% Similarity=0.279 Sum_probs=185.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|++.+.||+|+||.||+|..+ +++.+|+|.+........ ....+.+|+++++.++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC--cchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 478999999999999999999965 588999999876443221 12356789999999999999999998765443
Q ss_pred -----ceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 146 -----PLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 146 -----~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
.++++++... .....+++..+..++.|+++||.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 3555555432 12346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce----------eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 214 SKFIAMDQTH----------VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 214 a~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
+......... ..+...++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.......... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~--~~ 239 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH--LI 239 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH
Confidence 8755322211 11223567889999987654 57899999999999999999999996543211000 00
Q ss_pred HHHHHHhhcCc------ccc--------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 283 AFFVHSMRKNH------MYD--------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 283 ~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........... ... ...+.+.. ........+.+++.+||+.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 000 00000000 11123357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=268.06 Aligned_cols=238 Identities=22% Similarity=0.274 Sum_probs=184.2
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCC-
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRN- 156 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~- 156 (366)
||+|+||+||+|... +|+.+|+|.+....... ......+..|+.+++.++||||+++++++...+..++++++..+.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999865 58899999987543221 123446678999999999999999999999988889998876543
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 157 --------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 157 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+...... ......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 2226889999999999999999999999 999999999999999999999999998765432 222234
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... .. ....... .....+.
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~-~~~~~~~----------~~~~~~~ 219 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EE-LKRRTLE----------MAVEYPD 219 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HH-HHhcccc----------ccccCCc
Confidence 5778899999998888999999999999999999999999754321110 00 0000000 0111233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..++.+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 4567889999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=272.96 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=182.9
Q ss_pred ceeccc--CceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQG--GQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
..||+| +||+||.+.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...+..++++++.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE--EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 456666 99999999975 68999999987654332 33468889999999999999999999999999888888775
Q ss_pred cCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 154 HRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 154 ~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 5421 224788889999999999999999998 9999999999999999999999998653322111110
Q ss_pred ------eeeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc-------------cHHH
Q 037297 225 ------TTKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-------------SLAA 283 (366)
Q Consensus 225 ------~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------------~~~~ 283 (366)
.....++..|+|||.+.+. .++.++|+||+||++|+|++|..||........... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112245679999998764 478999999999999999999999975431100000 0000
Q ss_pred HHHHH---------------hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 284 FFVHS---------------MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 284 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ..................+..+++.+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000000111111222234567788999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=264.24 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=193.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..+.|++.+.||+|++|.||+|.++ ++..+++|++..... ..+.+.+|++.++.++|+|++++++++......+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 3466889999999999999999976 588999999986433 3457788999999999999999999999999999
Q ss_pred EEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..+.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9988776432 126889999999999999999999998 99999999999999999999999998865543
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... ...........
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~-~~~~~~~~~~~- 237 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALF-LITTKGIPPLK- 237 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHHhcCCCCCc-
Confidence 221 122234678899999998888999999999999999999999998643210 0000 00111111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 238 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12235667999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=261.08 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=195.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--CcceE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLL 148 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~~ 148 (366)
+|+..+.||+|++|.||+|... ++..+++|++...... ....+.+.+|+..++.++||||+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4788899999999999999976 6889999998775443 23456889999999999999999999999888 77888
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++...... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 888764432 226889999999999999999999998 9999999999999999999999999987665433
Q ss_pred ce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 TH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.. ......++..|+|||...+...+.++|+||||+++|+|++|..||..... .......... .
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~---------~ 219 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGS---------S 219 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccc---------c
Confidence 21 12334578899999999888899999999999999999999999975431 0111111110 0
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....++...+..+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0111234445778999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=268.29 Aligned_cols=248 Identities=25% Similarity=0.296 Sum_probs=189.3
Q ss_pred CCcccceecccCceEEEEEEE----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 72 HFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
+|++.+.||+|+||.||.+.. .+|..+|+|+++...........+.+.+|+.+++.+ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488899999999999999985 358899999987643333223446778899999999 699999999999888888
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..+.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 88888876542 235788899999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
..........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.... ............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~----- 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSE----- 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhccC-----
Confidence 332223345688899999988653 467899999999999999999999964321100 111111111000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+...+..+.+++.+||+.||++|| +++++++
T Consensus 229 ------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 012333556789999999999999997 5666643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.68 Aligned_cols=237 Identities=23% Similarity=0.259 Sum_probs=179.2
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHH---HHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 78 ILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIV---ILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
.||+|+||.||++... +++.+|+|.+........ .....+.+|.. ++....||||+.+++++...+..++++++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999965 588999999876433211 11122334443 334457999999999999988899999887
Q ss_pred cCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeee
Q 037297 154 HRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226 (366)
Q Consensus 154 ~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 226 (366)
.++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 65532 35899999999999999999999999 9999999999999999999999999986543221 12
Q ss_pred eccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 227 KIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 227 ~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
...++..|+|||.+. +..++.++|+||+||++|+|++|..||.......... ...... .....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~----------~~~~~ 217 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRMTL----------TVNVE 217 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH------HHHHhh----------cCCcC
Confidence 245899999999886 4568899999999999999999999997543211110 000000 00112
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
++...+.++.+++..||+.||.+|| |++|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 3445677899999999999999999 5888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=263.74 Aligned_cols=241 Identities=24% Similarity=0.250 Sum_probs=182.5
Q ss_pred ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHH-HhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+||.||+|... +++.+|+|.++....... .....+..|..+ ....+|||++++++++...+..++++++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 57999999999999965 588999999875432211 222334455444 445589999999999999999999998876
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeee
Q 037297 155 RNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227 (366)
Q Consensus 155 ~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 227 (366)
++. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 542 236889999999999999999999998 99999999999999999999999998865432 223
Q ss_pred ccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 228 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... . ... ......... ......
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~------~~~-~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--D------AVF-DNILSRRIN------WPEEVK 217 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--H------HHH-HHHHhcccC------CCCccc
Confidence 4578889999999888889999999999999999999999965321 0 000 001110000 000112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhh
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~ 341 (366)
..++.++.+++.+||+.||++|||+.++.++|+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2456789999999999999999988777666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=263.08 Aligned_cols=270 Identities=23% Similarity=0.280 Sum_probs=211.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|.++++||+|.||.|-+++.+ +++.+|+|++++...-.. .....-..|-++|+..+||.+..+.-.|...+..+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4578999999999999999999965 689999999987654322 23445678899999999999999999999999999
Q ss_pred EEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..++... .+++...+.+-..|+.||.|||+++ ||.||||.+|.|++.+|++||+|||+++..-.
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-
Confidence 999998776433 5788888899999999999999998 99999999999999999999999999875332
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.......+|||+.|+|||++....|+.++|.|.+||++|||++|+.||+..+.... +.-.+...
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------FeLIl~ed-------- 384 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------FELILMED-------- 384 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------HHHHHhhh--------
Confidence 23445678999999999999999999999999999999999999999987552110 10011100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHhh-----c-------ccCCCCcccccccchHHHHh
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRP--TMEEVTMELNG-----I-------RGSNFGHKMIYSTGTLLRLF 362 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~ell~~L~~-----~-------~~~~~~~~~~~~~~~~~~~~ 362 (366)
..+|...+++...|+..+|.+||.+|. ..+++.++... + +....-.+|-.+|+|-+|.|
T Consensus 385 ---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryF 457 (516)
T KOG0690|consen 385 ---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYF 457 (516)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhh
Confidence 113556667889999999999999995 23344433321 1 12223334445777777765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.86 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=206.1
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc----C----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE----D----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVK 135 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (366)
.++...++..+.+.||+|+||.|++|... . ...||+|.++..... ...+.+..|+.+++.+ .||||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhh
Confidence 44555566677789999999999999833 1 456999999876665 4567899999999999 7999999
Q ss_pred EeeEEeeCCcceEEEeeccCCC--------C---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 037297 136 LLGCCLETEVPLLHLHDHHRNE--------E---------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192 (366)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~--------~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d 192 (366)
++++|......+++.++...+. . ..++....+.++.||+.|++||++.. ++|||
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRD 443 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRD 443 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchh
Confidence 9999999888888888755431 1 23889999999999999999999998 99999
Q ss_pred CCCCCEEecCCCeEEEeecCCcccccCCCceeeeecc--ccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037297 193 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 269 (366)
Q Consensus 193 ikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 269 (366)
|.++|||++.+..+||+|||+|+.............. -...|||||.+....++.++||||+|+++|||++ |..||.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999876555544433223 2456999999999999999999999999999999 889986
Q ss_pred CCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 270 STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
+... .. .+...+.++.+...|..|++++.++++.||+.+|++||++.|+.+.++..
T Consensus 524 ~~~~-------~~----------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 524 GIPP-------TE----------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCc-------HH----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 5220 00 01112233334456778899999999999999999999999999999884
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=265.63 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=186.1
Q ss_pred CcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeCCc---
Q 037297 73 FNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~--- 145 (366)
|++.+.||+|+||.||+|..+. ++.+|+|.++....... ....+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch--hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 6788999999999999999764 89999999986544321 223556677776665 69999999999988776
Q ss_pred --ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 146 --PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 146 --~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++++++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 67776654321 1235889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh--cCc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR--KNH 293 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 293 (366)
....... .....++..|+|||.+.+..++.++|+||+||++|+|++|..||........ .......... ...
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----LDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----HHHHHHHcCCCChHh
Confidence 6543321 1223478889999999998999999999999999999999999865331110 0000000000 000
Q ss_pred -----------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 -----------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... .......+..+..+.+++.+||+.||.+||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTP-RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccc-cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0011122345677899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=274.68 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=184.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
..+|++.+.||.|+||.||+|... ++..||+|.+..... ...+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 468999999999999999999965 588999999876543 23456788999999999999999998765432
Q ss_pred ----------cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEE
Q 037297 145 ----------VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKV 208 (366)
Q Consensus 145 ----------~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl 208 (366)
..++++++.... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++ .++.++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 345666655431 1235889999999999999999999999 99999999999997 4567899
Q ss_pred eecCCcccccCCCce--eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH----
Q 037297 209 ADFGTSKFIAMDQTH--VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL---- 281 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~---- 281 (366)
+|||.+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765322111 1122357888999997654 567889999999999999999999996543111000000
Q ss_pred ------HHHHHHHhhcCcc-ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 282 ------AAFFVHSMRKNHM-YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 282 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............. .............+..+.++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 0000000001112235567899999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.42 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=187.7
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
....++|++.+.||+|+||.||++... ++..||+|.+....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 335678999999999999999999854 68999999986543221 233467899999999999999999998876543
Q ss_pred ------ceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 146 ------PLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 146 ------~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
.++++++.... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 24555544211 1236889999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH------HHHHHH
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL------AAFFVH 287 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~------~~~~~~ 287 (366)
...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||............. ...+..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 754322 223456888999998876 457889999999999999999999997543110000000 000000
Q ss_pred HhhcC-------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 288 SMRKN-------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 288 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
..... ...... +..........+..+.+++.+|++.||++|||+.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFR-KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred hhcchhHHHHHHhccccC-cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000 000000 0001112234556789999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=260.85 Aligned_cols=242 Identities=25% Similarity=0.426 Sum_probs=193.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|++.+.||+|++|.||++... +++.+++|.+....... ...+.+.+|+++++.++|||++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH--HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 5888999999999999999865 57899999998764432 34567899999999999999999999999888888888
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++.... ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 766543 2246899999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....++..|+|||...+..++.++|+||+|+++|+|++|+.||..... ........ ....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~--------- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------MAALFRIV-QDDH--------- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHh-ccCC---------
Confidence 2334578899999998888889999999999999999999999865331 00000000 0111
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++.+||..+|++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1123344667899999999999999999999873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=272.50 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=189.6
Q ss_pred hcCCc-ccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHH----------HHHHHHHHHHHHhcCCCCceeeEe
Q 037297 70 TNHFN-VNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELL----------KLEEFINEIVILSQINHRNVVKLL 137 (366)
Q Consensus 70 ~~~y~-~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~ 137 (366)
.++|. +.+.||.|+||.||+|.++ +++.+|+|++.......... ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4577999999999999965 58999999987643332110 012467899999999999999999
Q ss_pred eEEeeCCcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 138 GCCLETEVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
+++...+..++++++..+. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 9999999888888876431 2235788999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCC-------------ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037297 212 GTSKFIAMDQ-------------THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277 (366)
Q Consensus 212 g~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 277 (366)
|.+....... ........++..|+|||.+.+. .++.++|+||+||++|+|++|..||.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-- 241 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-- 241 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9987654111 1111223467889999988764 46889999999999999999999997654211
Q ss_pred cccHHHHHHHHhhcCc---cccc-----------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 278 NVSLAAFFVHSMRKNH---MYDI-----------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 278 ~~~~~~~~~~~~~~~~---~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............. +... ..+..........+..+.+++..||+.||++|||++|++.
T Consensus 242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0000000000000 0000 0001111122344677899999999999999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.99 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=187.9
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee-CCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 145 (366)
...++|++.+.||.|+||.||+|... +++.+|+|++....... ...+.+..|+.+++.++||||+++.+++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 35678999999999999999999965 68999999886533221 233567789999999999999999998866 445
Q ss_pred ceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 146 PLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 146 ~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
.++++++.... ...++++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 66666654321 1235788888999999999999999999 999999999999999999999999998754321
Q ss_pred CceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc--------
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK-------- 291 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 291 (366)
.....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||........ ..........
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-----FSIITDLLGTPPDDVINT 232 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCCCHHHHHh
Confidence 123456788999998765 5789999999999999999999999965431000 0000000000
Q ss_pred ---C---ccc-cc--cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 292 ---N---HMY-DI--LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 292 ---~---~~~-~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
. ... .. ..+.......+..+..+.+++.+||+.||++|||+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 00 00000001112345789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=304.81 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=198.7
Q ss_pred HhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..-+++-...||.|.||.||.|.. .+|+..|+|-++..... ....+...+|+.++..++|||+|+++++=...+..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 345778889999999999999984 46999999998875544 345567889999999999999999999988888999
Q ss_pred EEEeeccCCCCCC-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNEEFP-------LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~~~~-------l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+.++++.++.... .++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|..+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999888775432 445556778999999999999999 999999999999999999999999999887654
Q ss_pred Ccee---eeeccccCCccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 221 QTHV---TTKIQGTFGYLEPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 221 ~~~~---~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.... .....||+.|||||++.+. +...++||||+||++.||+||+.||...+..... .+....-..+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI-----My~V~~gh~P-- 1460 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI-----MYHVAAGHKP-- 1460 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-----HhHHhccCCC--
Confidence 3111 1246799999999999764 5677999999999999999999999765532221 1111111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.+|...+.+-.+|++.||+.||.+|+++.|+++.
T Consensus 1461 ----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 ----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2455677888999999999999999999988753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=237.77 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=194.1
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|.-.++||+|.||+||+|+.. +++.||+|.++.+..++... ....+|+.+++.++|.|||+++++.-.+....++.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp--ssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc--HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4666788999999999999954 58999999999877665433 47889999999999999999999988888777777
Q ss_pred eecc-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHH-------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++. ..-...++.+.+..++.|++.|+.++|+++ +.|||+||.|.||+.||++|++|||+++.++..- .
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 6543 233456889999999999999999999999 9999999999999999999999999998776432 3
Q ss_pred eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc---c
Q 037297 224 VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI---L 298 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 298 (366)
..+..+-|..|++|.++.|. -|+...|+||.||++.|+.. |++-|.+.+. .++...............+++. .
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccCC
Confidence 34445679999999988775 58999999999999999998 5555544331 2222122222222222233322 1
Q ss_pred chHHhhh---------hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKL---------VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
|...... +-+.....-.+++...|.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111 12223334578999999999999999998864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=268.00 Aligned_cols=254 Identities=20% Similarity=0.230 Sum_probs=182.5
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
.+++.+|.|+++.|+++.. +++.+|+|++....... ...+.+.+|+.+++.++||||+++++++...+..++++++.
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK--EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccch--hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 3444455555555555444 58999999998653222 34567999999999999999999999999998888888876
Q ss_pred cCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc--
Q 037297 154 HRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-- 222 (366)
Q Consensus 154 ~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 222 (366)
..+. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 5431 235788899999999999999999999 99999999999999999999999998865432111
Q ss_pred ----eeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh------
Q 037297 223 ----HVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR------ 290 (366)
Q Consensus 223 ----~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 290 (366)
.......++..|+|||.+.+ ..++.++|+||+||++|||++|..||........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLEKVRGTVPCLLDKS 234 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCccccccC
Confidence 11122346778999998866 3588999999999999999999999975431110 0000000000
Q ss_pred -----cCccc--------cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 -----KNHMY--------DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 -----~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ...............+.++.+++..||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000011122234456678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=269.66 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=180.9
Q ss_pred CCcccceecccCceEEEEEEEc-C--CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC----
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-D--GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET---- 143 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~---- 143 (366)
+|++.+.||+|+||.||++... . +..+|+|.+....... ...+.+.+|+.+++.+ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4888999999999999999965 3 6789999987533222 2345678899999999 699999999875433
Q ss_pred CcceEEEeeccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 144 EVPLLHLHDHHR------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 144 ~~~~~~~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...+++++.... .....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 79 NELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred CcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 233444443321 12346789999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCce---eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---
Q 037297 218 AMDQTH---VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR--- 290 (366)
Q Consensus 218 ~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 290 (366)
...... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~ 230 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-----QLNQILQVLGTPD 230 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-----HHHHHHHHhCCCC
Confidence 432211 1223468899999998765 468999999999999999999999986533100 0000000000
Q ss_pred --------cCcc------ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 291 --------KNHM------YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 291 --------~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.... .............+..+..+.+++.+||+.||.+|||+.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000 000000000011122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=295.86 Aligned_cols=252 Identities=25% Similarity=0.306 Sum_probs=207.0
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
.++....++|.++++||+|+||.|..++.+ +++.+|.|++......+. .....|..|-++|..-+.+-|+.++-.|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 344555688999999999999999999976 588899999876332221 234578899999999999999999999999
Q ss_pred CCcceEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 143 TEVPLLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+.|++|+++.++... ++|++-++.++..|+.||+.+|+.| +|||||||+|||++..|++||+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999887432 5899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCceeeeeccccCCcccccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQ----S-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
.+..++.-.....+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||+... +...+...+.
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~KIm~ 295 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYGKIMN 295 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHHHHhc
Confidence 88877777777889999999999774 3 568999999999999999999999998654 3333333333
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC---HHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT---MEEV 335 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~el 335 (366)
.....++.+ ....+.+..+||+..++ +|+.|.. ++++
T Consensus 296 hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 296 HKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred hhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 322222221 13367788999999887 8888887 6666
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=266.74 Aligned_cols=243 Identities=27% Similarity=0.362 Sum_probs=193.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 148 (366)
++|.+.+.||+|++|.||+|... ++..+|+|++........ ...+.+.+|..+++.+. ||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch-HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 47999999999999999999965 689999999876332211 23457888999999998 9999999999998888888
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++...+.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 888775442 236899999999999999999999999 9999999999999999999999999987654322
Q ss_pred c-------------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 222 T-------------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 222 ~-------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
. .......++..|+|||...+..++.++|+||||++++++++|+.||..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------Y 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------H
Confidence 1 122234578899999999888899999999999999999999999975431 0
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH----HHHH
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM----EEVT 336 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~ell 336 (366)
........ .....+...+..+.+++..||+.||.+|||+ ++++
T Consensus 229 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 229 LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 00111110 0111233446678999999999999999999 7765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.54 Aligned_cols=245 Identities=24% Similarity=0.265 Sum_probs=196.3
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...+.|+.-++||+|+||.||-+..+ +|+.+|.|++........ ....-.+.|-.++..++.+.||.+--.|.+.+..
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-KGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34477888999999999999999854 699999999876544432 2334578899999999999999998889999988
Q ss_pred eEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++....++ +...+++..+..++.+|+.||.+||..+ ||.||+||+|||+|+.|++.|+|+|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 8887655443 2236899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. .......+||.+|||||++.++.|+...|.|||||++|||+.|+.||....+... .+....-..
T Consensus 338 ~~--g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~eEvdrr~~------- 403 (591)
T KOG0986|consen 338 PE--GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----REEVDRRTL------- 403 (591)
T ss_pred CC--CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HHHHHHHHh-------
Confidence 53 3444555899999999999999999999999999999999999999965331111 100100000
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
.-...++...+++..++.+..|++||++|....
T Consensus 404 ---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 ---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 011235677888999999999999999997654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=261.26 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=186.9
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceEEE
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 150 (366)
|++.+.||+|++|+||+|... +++.+++|.+....... ......+|+..++.++ |||++++++++...+..++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch---hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 678899999999999999975 47889999987644321 2224457899999998 999999999999988899998
Q ss_pred eeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 151 HDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 151 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++..+. ....+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 877332 1136789999999999999999999999 9999999999999999999999999987654322
Q ss_pred eeeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH-------HH-HHHHHhhcCc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------AA-FFVHSMRKNH 293 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------~~-~~~~~~~~~~ 293 (366)
......++..|+|||.+. +..++.++|+||||+++|+|++|+.||............. .. ..........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223345788899999774 4567899999999999999999999986543211100000 00 0000000000
Q ss_pred ----cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 ----MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......... .......+.++.+++..||+.||++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000001 1111122567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=273.90 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=187.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc--
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-- 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 145 (366)
..++|++.+.||+|++|.||+|... +++.+|+|++....... ...+.+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA--IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh--hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4578999999999999999999975 58899999887543222 233567789999999999999999987766554
Q ss_pred ----ceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 146 ----PLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 146 ----~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++.... ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 66666654321 1236889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--c
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--H 293 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~ 293 (366)
.... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... .. ........... .
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~---~~~i~~~~~~~~~~ 238 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQ---LKRIMNLVGTPDEE 238 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HH---HHHHHHhcCCCCHH
Confidence 5322 233457888999998765 36788999999999999999999999653311 00 00000000000 0
Q ss_pred c-ccc--------------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 M-YDI--------------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~-~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ ..+ ..+..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 000 0000000111234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=261.55 Aligned_cols=238 Identities=25% Similarity=0.366 Sum_probs=186.6
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 76 NRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
...||+|+||.||++..+ +++.+|+|.+..... .....+.+|+.+++.++|||++++++++...+..++++++..
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 467999999999999864 689999998764322 234578899999999999999999999999999999988765
Q ss_pred CCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeec
Q 037297 155 RNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 155 ~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
+.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 542 235788999999999999999999999 99999999999999999999999998865543221 12334
Q ss_pred cccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcH
Q 037297 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKK 308 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (366)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .... .... ....... ...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~-~~~~-~~~~~~~------~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMK-MIRD-NLPPKLK------NLH 240 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHH-HHHh-hCCcccC------Ccc
Confidence 5788999999998888999999999999999999999998653210 0000 0000 0000000 012
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 309 NQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 309 ~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+..+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 24556889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.14 Aligned_cols=239 Identities=26% Similarity=0.305 Sum_probs=187.7
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||.|+||.||++... +++.+++|.+...... .....+.+.+|+++++.++||||+++++.+......++++++..++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999976 4899999998764332 22445678899999999999999999999988888888888776532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc-------e
Q 037297 158 -------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-------H 223 (366)
Q Consensus 158 -------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-------~ 223 (366)
...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 236899999999999999999999999 99999999999999999999999999875533211 1
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......++..|+|||...+...+.++|+||||+++|+|++|..||..... ....... .....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~--------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNI-LNGKI--------- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hcCCc---------
Confidence 22334578889999999888899999999999999999999999965331 0011111 11000
Q ss_pred hhhcHH--HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 304 KLVKKN--QIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 304 ~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
..+.. .+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111 3667899999999999999999966666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=260.93 Aligned_cols=237 Identities=22% Similarity=0.246 Sum_probs=178.8
Q ss_pred eecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHH---HHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 78 ILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINE---IVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
.||+|+||.||+|... +++.||+|.+.......... ...+..| +..++...||||+.+++++...+..++++++.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999864 58899999987643221111 1122233 34455568999999999999999999998887
Q ss_pred cCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeee
Q 037297 154 HRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226 (366)
Q Consensus 154 ~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 226 (366)
.++. ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 6542 336899999999999999999999999 9999999999999999999999999987553221 12
Q ss_pred eccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 227 KIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 227 ~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
...|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.......... .. ...... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----~~-~~~~~~----------~~~ 217 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----ID-RMTLTM----------AVE 217 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----HH-HHhhcc----------CCC
Confidence 34689999999998754 68899999999999999999999997643211100 00 000000 011
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
.+...+..+.+++.+||..||.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2334467899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=256.11 Aligned_cols=235 Identities=23% Similarity=0.272 Sum_probs=180.1
Q ss_pred hcCCccccee--cccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRIL--GQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +|||++++++++...+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 4567777776 99999999999964 58889999987532211 122222222 79999999999999999
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~ 217 (366)
.++++++..+++ ..++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++ .++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999998876532 237899999999999999999999999 99999999999999988 9999999998765
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... ....++..|+|||++.+..++.++|+||+|+++|+|++|+.||....... ........ .. ..
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-~~-~~----- 225 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLK-RQ-QK----- 225 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHH-hh-cc-----
Confidence 322 12357889999999999999999999999999999999999997443211 11111100 00 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-HHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-MEEVT 336 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell 336 (366)
....+...+..+.+++..||+.||.+||+ ++|++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00122356678999999999999999996 58886
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=262.26 Aligned_cols=253 Identities=26% Similarity=0.328 Sum_probs=189.8
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|++.+.||+|++|.||+|... +++.+|+|.+....... ...+.+..|+.+++.++|||++++++++......+++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE--GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc--cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 567789999999999999965 48999999998754221 223567789999999999999999999998888888888
Q ss_pred eccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee
Q 037297 152 DHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 152 ~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+.... ....+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||.+........ .
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 66532 1136889999999999999999999999 99999999999999999999999999876543222 2
Q ss_pred eeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh-------------
Q 037297 225 TTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR------------- 290 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 290 (366)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........ .........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-----LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHHHhCCCcHHHHHhhccc
Confidence 2233457789999988766 789999999999999999999999865432110 000000000
Q ss_pred ---cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 ---KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............. ...+..+..+.+++..||+.||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000111111111 111223668999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=277.69 Aligned_cols=260 Identities=29% Similarity=0.442 Sum_probs=196.3
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee------C
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------T 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~ 143 (366)
..+...+.||+|+||.||+++. .+|+.||||.++..... ...+.-.+|++++++++|||||+++++=.+ .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~---r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL---RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc---chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3456678899999999999995 47999999999875533 345678899999999999999999987433 3
Q ss_pred CcceEEEeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCe--EEEe
Q 037297 144 EVPLLHLHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ERYR--AKVA 209 (366)
Q Consensus 144 ~~~~~~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--~~~~--vkl~ 209 (366)
....++++++.+++ ...+++...+.+..+++.||.|||++| |+||||||.||++- .+|. .||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence 35677888887763 235899999999999999999999999 99999999999984 3343 5999
Q ss_pred ecCCcccccCCCceeeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
|||.|+.+. +........||..|++||+.. .+.|+..+|.|||||++|+++||..||-+.+++.... ......
T Consensus 167 DfG~Arel~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~----~~~~~~ 240 (732)
T KOG4250|consen 167 DFGAARELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK----EIMWHI 240 (732)
T ss_pred cccccccCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc----hhhhhh
Confidence 999999765 444677889999999999998 4889999999999999999999999998766432111 011111
Q ss_pred hhcCc----------------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHhhccc
Q 037297 289 MRKNH----------------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP--TMEEVTMELNGIRG 344 (366)
Q Consensus 289 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~ell~~L~~~~~ 344 (366)
...+. +...+ |. ...+.......+...+..+|..||.+|. ...+.-..++++-.
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccC-CC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11100 01111 11 2223445556677888899999999998 66666666655543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=258.95 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=185.3
Q ss_pred CCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChH-HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDE-ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+|.+.+.||+|+||.||++.... +..+++|.++...... .......+..|+.+++.++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998653 4556666655422211 111233566789999999999999999999988888888
Q ss_pred EeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++..... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 88765432 345889999999999999999999999 999999999999976 479999999987654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... .......++..|+|||...+..++.++|+||+|+++|+|++|..||.... ......... ....
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~-~~~~---- 222 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV-EGPT---- 222 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cCCC----
Confidence 322 22233457889999999988889999999999999999999999985422 011111111 1111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+..++.++.+++.+||+.||++||++.|+++
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 -----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1124456678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.92 Aligned_cols=232 Identities=23% Similarity=0.262 Sum_probs=186.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
...|.+...+|.|+||.|-.+... +++..++|++...... ..+|+.++... +||||+++.+++.+....+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCceee
Confidence 567899999999999999888854 5788999999875222 23467665555 8999999999999999999
Q ss_pred EEEeeccCCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-cCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNEEF------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill-~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++...++... +.....+..|+++|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999988766322 2333567789999999999999999 9999999999999 68999999999999866443
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
....+-|..|.|||+....+|++++|+||||++||+|++|+.||....... .....+..+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--------ei~~~i~~~-------- 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--------EIHTRIQMP-------- 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------HHHHhhcCC--------
Confidence 233456889999999999999999999999999999999999998755320 000111111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
......+++.++|+.+||+.||.+||++.++.
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 12256777899999999999999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=254.40 Aligned_cols=261 Identities=22% Similarity=0.306 Sum_probs=196.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.+.|+-..+||+|.||.||+|+.+ +|+.||+|++-.+...+... ....+|+.++..++|+|++.+++.|....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp--italreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc--HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 355777788999999999999965 47888998765543332221 25678999999999999999999885543
Q ss_pred ----cceEEEeecc-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 145 ----VPLLHLHDHH-------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 145 ----~~~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
..++++..+. .+....++..++.+++.++..||.|+|+.. |+|||+||+|+||+.+|.+||+|||+
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 2444443322 233346888999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCc---eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 214 SKFIAMDQT---HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 214 a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
++.+..... ...+..+-|..|++||.+.|. .|+++.|||+.||++.||+++.+-+.+.. ++.+.........+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccC
Confidence 976654332 234555679999999988875 68999999999999999999998887654 455555555556666
Q ss_pred hcCccccccchHHhhhh-----c-------------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLV-----K-------------KNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~-----~-------------~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....++...+-.+...+ + -.-.++..+|++.++..||.+|+++++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 55555543333322221 1 111236789999999999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=251.93 Aligned_cols=232 Identities=31% Similarity=0.335 Sum_probs=184.5
Q ss_pred ecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||+|+||.||++... +++.+|+|.+....... ....+.+..|+.+++.++||||+++++.+......++++++.....
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999975 48899999987643322 2345678899999999999999999999999999999988875432
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccc
Q 037297 158 -------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230 (366)
Q Consensus 158 -------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 230 (366)
...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 236789999999999999999999998 9999999999999999999999999987654322 12233457
Q ss_pred cCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHH
Q 037297 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310 (366)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (366)
+..|+|||...+..++.++|+||||+++|+|++|..||..... ........ ... ...+...
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~----------~~~~~~~ 216 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKIL-KDP----------LRFPEFL 216 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHh-cCC----------CCCCCCC
Confidence 8889999999888899999999999999999999999965431 01111110 000 1123334
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 311 IMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 311 ~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
+..+.+++.+||..||++|||+.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 667899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=254.65 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=191.7
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--CC----ceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--HR----NVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~ 138 (366)
.+...++|.+.+.+|+|.||.|-.+.+. .+..||+|+++.-. ...+..+-|+++++++. -| -++.+.+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3555789999999999999999999865 47899999988532 34567788999999993 22 3667777
Q ss_pred EEeeCCcceEEEeecc--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---------
Q 037297 139 CCLETEVPLLHLHDHH--------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--------- 201 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--------- 201 (366)
+|.-....+++.+... .++-.+++..+++.++.|+++++++||+.+ ++|.||||+|||+.
T Consensus 159 wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 159 WFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence 8887888877776544 345668999999999999999999999999 99999999999983
Q ss_pred -----------CCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037297 202 -----------ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270 (366)
Q Consensus 202 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 270 (366)
.+..++++|||.|....... +..+.|..|+|||++.+-+++.++||||+||+|+|+.+|..-|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 13468999999998754333 556788999999999999999999999999999999999999987
Q ss_pred CCCCCcccccHHHHHHHHhhc--------------C--ccccccchH-------------HhhhhcHHHHHHHHHHHHHh
Q 037297 271 TGNTSQENVSLAAFFVHSMRK--------------N--HMYDILDDQ-------------VVKLVKKNQIMAFANLAERC 321 (366)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~c 321 (366)
.++.++. ...+...+.++. . .+.....+. ............|.||++.|
T Consensus 312 Hen~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 312 HENLEHL--AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred CCcHHHH--HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 6532221 011100000000 0 000000000 00111223444699999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 037297 322 LDLNGKKRPTMEEVTM 337 (366)
Q Consensus 322 l~~dp~~Rpt~~ell~ 337 (366)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=248.54 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=186.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 148 (366)
.+.+-++.||.|+||+|++-.++ +|+..|||.++..... ...+++..|.+...+- +.||||+++|.+..+.-..+
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 34455678999999999998865 6999999999987664 3445788888765554 89999999999888877776
Q ss_pred EEeecc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 149 HLHDHH-----------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 149 ~~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
-++... .-....++++.+-+|..-.+.||+||...-+ |||||+||+|||++..|.+||+|||.+..+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH
Confidence 665432 2244468888888999999999999987543 999999999999999999999999998755
Q ss_pred cCCCceeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
.. +...+...|-..|||||.+.. .+|+.+||+||||++|||+.||..||..... .-.... .......+
T Consensus 219 v~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~-~Vv~gdpp 288 (361)
T KOG1006|consen 219 VD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLC-QVVIGDPP 288 (361)
T ss_pred HH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHH-HHHcCCCC
Confidence 32 223344457778999998854 3588999999999999999999999976432 000111 11111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..+ .-....+..+..++-.||.+|.+.||...++.+
T Consensus 289 ~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11111 112346778999999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=245.11 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=185.2
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC---
Q 037297 70 TNHFNVN-RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET--- 143 (366)
Q Consensus 70 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--- 143 (366)
.++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++... ....+|++..-.. .|||||.++++|...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4556554 67999999999999865 6899999988642 3567899887766 799999999987543
Q ss_pred -CcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEee
Q 037297 144 -EVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVAD 210 (366)
Q Consensus 144 -~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~D 210 (366)
...+++++...++ ...++++..+..|+.||..|+.|||+.+ |+||||||+|+|.+. |..+||+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence 3455666655544 3446999999999999999999999999 999999999999974 56799999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||.|+.... .....+.+.|+.|.|||++-...|+..+|+||+||++|-|++|.+||++.....-..... .-+.
T Consensus 208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk-----~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----RRIR 280 (400)
T ss_pred cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH-----hHhh
Confidence 999986432 233445678999999999998999999999999999999999999999865322111100 0001
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.. ...+.+++ -...+++.+++++.+|+.+|.+|.|+.|+.
T Consensus 281 ~g-qy~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 281 TG-QYEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred cc-CccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 10 11111111 234667899999999999999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=264.90 Aligned_cols=251 Identities=21% Similarity=0.225 Sum_probs=201.5
Q ss_pred hcCCcccceecccCceEEEEEEEcCCc-EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGR-IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++..+..||-|+||.|=++..++.. .+|+|++++...- ++.+.+.+..|-.+|..++.|.||++|..|.+..+.|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 356777888999999999999876433 4899988764433 33566789999999999999999999999999999999
Q ss_pred EEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
.++.+.++..+ .++..+...++..+++|++|||++| ||.|||||+|.+++.+|-+||+|||.|+.+....
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99998887543 5788888999999999999999999 9999999999999999999999999999886543
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.+-+++||+.|.|||++..+..+.++|.||||+++|||++|.+||.+.+. ....+. .+..-.
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~------ILkGid-------- 636 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNL------ILKGID-------- 636 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHH------HHhhhh--------
Confidence 34558999999999999999999999999999999999999999987652 111111 111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC--HHHHHHHHhhcc
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT--MEEVTMELNGIR 343 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt--~~ell~~L~~~~ 343 (366)
....|...+....+|++.+.+.+|.+|.. ...+-++=...+
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 11234555667789999999999999986 444443333333
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=262.86 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=192.5
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 76 NRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.++||+|.||+||-|+++ +|+.||||++.+...... +.+++.+|+++|+++.||.||.+.--|.+.+..+++++...
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc--hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 589999999999999965 699999999977655433 34689999999999999999999999999999999998766
Q ss_pred CC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CeEEEeecCCcccccCCCce
Q 037297 155 RN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 155 ~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~---~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+. ....+++..-..+..||+.||.|||.++ |+|+||||+|||+.+. -++||+|||.|++++.. .
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 53 4457888888899999999999999999 9999999999999754 47999999999988643 3
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+||+.|+|||++..+.|+..-|+||.||++|--++|..||..+..... +...+.++ .+...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QIQNAaFM---yPp~P---------- 787 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QIQNAAFM---YPPNP---------- 787 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hhhccccc---cCCCc----------
Confidence 34557899999999999999999999999999999999999999976543221 11111111 11111
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
-.+.+.+..+||..+|+..=.+|-|.+.-+
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 234455788999999999999999887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=242.44 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEE-EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
+.||+|+|+.|-.+. ..+|..+|||++.+... ....+..+|++++.+. .|+||+.++++|.+++..|++++...
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 679999999999887 56799999999987522 3567899999999999 69999999999999999999999988
Q ss_pred CCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eEEEeecCCcccccCCC---
Q 037297 155 RNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQ--- 221 (366)
Q Consensus 155 ~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~vkl~Dfg~a~~~~~~~--- 221 (366)
++... .+++..+..+..+|+.||++||.+| |+|||+||+|||..+.. .|||+||.++.-+....
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 77433 5789999999999999999999999 99999999999997654 57999998765432111
Q ss_pred ---ceeeeeccccCCcccccccc---C--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC------cccccHHHHHHH
Q 037297 222 ---THVTTKIQGTFGYLEPEYHQ---S--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS------QENVSLAAFFVH 287 (366)
Q Consensus 222 ---~~~~~~~~~t~~y~aPE~~~---~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~ 287 (366)
+....+.+|+..|||||+.. + .-|+.++|.|||||++|=|++|++||.+..... +........+..
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11223467899999999653 2 358889999999999999999999998754211 111122222223
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+.... .++.+.. -...+.+..+++..+|..|+.+|.++.++++
T Consensus 317 sIQEGk-YeFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGK-YEFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccC-CcCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 333222 2222221 2345567889999999999999999988875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=251.14 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=197.6
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLG 138 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (366)
++.....+++....+-+|.||.||.|.+. +.+.|-+|.++..... .+...+..|--.+..+.|||+....+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34444567888888999999999999643 3455677777654333 45567888988999999999999999
Q ss_pred EEeeCC-cceEEEeeccC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 037297 139 CCLETE-VPLLHLHDHHR---------------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 139 ~~~~~~-~~~~~~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~ 202 (366)
++.+.. .++..+....- .....++..+...++.|++.|++|||.++ +||.||..+|.+|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 887654 33333332211 12235667788899999999999999999 999999999999999
Q ss_pred CCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccccc
Q 037297 203 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS 280 (366)
Q Consensus 203 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 280 (366)
...|||+|=.+++.+-..+. ...........||+||.+....|+.++|+|||||++|||+| |+.||...+..+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----- 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----
Confidence 99999999999886643332 22233446778999999999999999999999999999998 999997655211
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
+...+.++.+...|.+|++++..++.-||..+|++||+++|++.-|....
T Consensus 507 -------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 -------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11122333344457899999999999999999999999999999887765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=273.22 Aligned_cols=142 Identities=27% Similarity=0.303 Sum_probs=122.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|+++...... ......+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 367999999999999999999976 58999999997543221 1334578889999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
++++..+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999875542 235688889999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=252.75 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=194.9
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH---HHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE---LLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
....++|-++..||+|+|+.||+|.+- ..+.||+|+-.......+ ....+...+|-++.+.|+||.||++|+++..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 344578999999999999999999954 588999998655444322 1234678899999999999999999999865
Q ss_pred C-CcceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeec
Q 037297 143 T-EVPLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADF 211 (366)
Q Consensus 143 ~-~~~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Df 211 (366)
+ +..+-+++++.++.. ..+++..++.|+.||+.||.||... ++||||-||||.|||+.+ -|.+||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5 455667777776643 2578999999999999999999987 589999999999999954 478999999
Q ss_pred CCcccccCCCc------eeeeeccccCCccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH
Q 037297 212 GTSKFIAMDQT------HVTTKIQGTFGYLEPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 212 g~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 281 (366)
|+++++..+.. ...+...||+.|++||++.-+ .++.|+||||+||++|+++.|+.||...-. +..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQd--- 692 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQD--- 692 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHH---
Confidence 99998864322 234557799999999977432 468899999999999999999999975431 110
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..+.+.... ++.-...+..+.+..+||++||+.--+.|....++..
T Consensus 693 ------ILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ------ILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------HHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111110000 0011123456678899999999999999999888864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.66 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
-++|.++++||+|+|+.|..+..+ +.+.+|+|++++....++ ..+.-...|-.+..+- +||.+|.+..+|.++...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 368999999999999999999954 578899999887554432 3445667777777766 7999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++.++..++. ...++++.++.+...|..||.|||+.| ||.||||.+|||++..|.+||+|+|+++..- .
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 9999987764 347999999999999999999999999 9999999999999999999999999987532 3
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.....++++||+.|.|||++.|..|...+|.|+|||+++||+.|+.||.-.+....+.......+...+..
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------- 474 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------- 474 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---------
Confidence 34556779999999999999999999999999999999999999999986553333322222222211111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 331 (366)
+ ..+|...+-....+++.-|.+||.+|..
T Consensus 475 q--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 Q--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 1235555556778999999999999954
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=248.70 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=194.7
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (366)
.....+|.++.+||+|+||.|.+|..+ +.+.+|||+++.+..-.+ ...+--+.|-++|... +.|.++.++.+|.+.+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 344578999999999999999999865 467899999987655432 2233445677777766 6788999999999999
Q ss_pred cceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..|+++++..++.. ..+.+..+..++..|+-||-+||++| ||.||||.+|||++.+|++||+|||+++.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999887643 36778888999999999999999999 999999999999999999999999998743
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
-. +.....+++||+.|+|||++.-.+|+..+|.||+||+||||+.|++||.+.++. ..+.......
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehn----- 566 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHN----- 566 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHcc-----
Confidence 22 233456689999999999999999999999999999999999999999875521 1111111111
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 331 (366)
-.+|...+.+..++....|.+.|.+|..
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1256777788889999999999999954
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=242.40 Aligned_cols=213 Identities=23% Similarity=0.211 Sum_probs=167.7
Q ss_pred cCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCCC--
Q 037297 82 GGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNEE-- 158 (366)
Q Consensus 82 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~~-- 158 (366)
|.+|.||++.++ +++.+|+|.++... ....|...+....||||+++++++...+..++++++..++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999975 58899999987642 122344445556799999999999999999999988765432
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCC
Q 037297 159 -----FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233 (366)
Q Consensus 159 -----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~ 233 (366)
..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 25889999999999999999999999 999999999999999999999999987654322 122345677
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHH
Q 037297 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA 313 (366)
Q Consensus 234 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (366)
|+|||...+..++.++|+||+|+++|+|++|+.|+......... . .....+...+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----------------~-------~~~~~~~~~~~~ 204 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------H-------TTLNIPEWVSEE 204 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc----------------c-------cccCCcccCCHH
Confidence 99999998888999999999999999999999887532210000 0 000123345567
Q ss_pred HHHHHHHhhcCCCCCCCCHH
Q 037297 314 FANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 314 l~~li~~cl~~dp~~Rpt~~ 333 (366)
+.+++.+||+.||++|||+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 89999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=230.20 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=184.2
Q ss_pred HhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCC--
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE-- 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-- 144 (366)
..++|++.+++|+|-|+.||.|. ..+++.+++|++++ ...+.+.+|+.+|+.|. ||||++++++..+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 34789999999999999999998 45688999999987 45568899999999995 999999999876654
Q ss_pred cceEEEeeccCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCcccccC
Q 037297 145 VPLLHLHDHHRNEEF----PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAM 219 (366)
Q Consensus 145 ~~~~~~~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~~~~ 219 (366)
.+.++.++....... +++...+..++.+++.||+|||++| |+|||+||.|+||+.. -.++|+|||+|.+...
T Consensus 109 tpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred CchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 455555554433222 4677788999999999999999999 9999999999999954 5789999999998764
Q ss_pred CCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH-----HHHHhhcCc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF-----FVHSMRKNH 293 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 293 (366)
... ..-.+.+.-|--||++.. ..|+..-|+|||||++..|+..+.||.....-..+....+.. +........
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 432 222345666889997755 468889999999999999999999997533211111111110 000000000
Q ss_pred cccccchHHhh------------hh----cHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 037297 294 MYDILDDQVVK------------LV----KKNQIMAFANLAERCLDLNGKKRPTMEEV 335 (366)
Q Consensus 294 ~~~~~~~~~~~------------~~----~~~~~~~l~~li~~cl~~dp~~Rpt~~el 335 (366)
+ -++++... .+ ..-.+++..||+..+|+.|..+|||+.|.
T Consensus 264 i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 264 I--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred c--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 0 01111111 00 11134678999999999999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=262.69 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=153.7
Q ss_pred HhcCCcccceecccCceEEEEEEEc-C----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeE----
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-D----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGC---- 139 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~---- 139 (366)
..++|++.+.||+|+||.||+|.+. + +..+|+|++....... ....+ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e------~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE------IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH------HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3578999999999999999999965 4 6899999876432211 11111 1122222222222111
Q ss_pred --EeeCCcceEEEeeccCCCC---------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037297 140 --CLETEVPLLHLHDHHRNEE---------------------------FPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190 (366)
Q Consensus 140 --~~~~~~~~~~~~~~~~~~~---------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 190 (366)
+......++++++...... .......+..++.|++.||.|||+++ |+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 1233344555554332210 01123446679999999999999999 999
Q ss_pred CCCCCCCEEecC-CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCC----------------------CCCc
Q 037297 191 RDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS----------------------QLTD 247 (366)
Q Consensus 191 ~dikp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~ 247 (366)
|||||+|||++. ++.+||+|||+|...............+++.|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999985 67999999999986644433344456789999999965322 2344
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc-----cccc----cchHHhh--hhcHHHHHHHHH
Q 037297 248 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH-----MYDI----LDDQVVK--LVKKNQIMAFAN 316 (366)
Q Consensus 248 ~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~--~~~~~~~~~l~~ 316 (366)
++||||+||++|||+++..|+.... ..+. ..+.... +... ..+.... ...........+
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~---------~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL---------IQFN-RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH---------HHHH-HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 6799999999999999776643210 0000 0000000 0000 0000000 000111224568
Q ss_pred HHHHhhcCCCCCCCCHHHHHH
Q 037297 317 LAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 317 li~~cl~~dp~~Rpt~~ell~ 337 (366)
|+.+||+.||++|||+.|+++
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHccCCcccCCCHHHHhC
Confidence 999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=257.44 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=197.7
Q ss_pred HhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEee----
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE---- 142 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---- 142 (366)
..+.|++.+.||.|.+|.||+++. ++++..|+|+.......+ +++..|.++++.+ .|||++.+++++.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-----HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 456799999999999999999995 468899999988766553 3556688888888 79999999999854
Q ss_pred -CCcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 143 -TEVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 143 -~~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
.+.+.+++|++.+++ ...+.|..+..|++.++.|+.+||... ++|||||-.|||++.++.|||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 467889999988763 446889999999999999999999988 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
++..+... .....+..||+.|||||++... .|+..+|+||||++..||..|.+|+.++... ..+..
T Consensus 169 vSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~ 239 (953)
T KOG0587|consen 169 VSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFL 239 (953)
T ss_pred eeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhcc
Confidence 98765432 2334457899999999988643 4777999999999999999999999876520 01111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ..+|.+...-+..++..|.++|..||.+|-++||++.++++
T Consensus 240 I--------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 I--------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred C--------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 11222233347889999999999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=237.81 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=186.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--------CCceeeEeeEEe
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--------HRNVVKLLGCCL 141 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~ 141 (366)
.+|.+.++||.|-|++||+|.+. +.+.||+|+.+.. ....+..+.|+.+|++++ ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 78999999999999999999965 5789999998852 345678899999999872 248999999986
Q ss_pred eCC----cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--------
Q 037297 142 ETE----VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-------- 201 (366)
Q Consensus 142 ~~~----~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-------- 201 (366)
... ..+++++....+ .-..++...+..|++||+.||+|||...+ |||.||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhh
Confidence 543 566666654432 22357889999999999999999999764 99999999999980
Q ss_pred --------------------------------------------------------------------------------
Q 037297 202 -------------------------------------------------------------------------------- 201 (366)
Q Consensus 202 -------------------------------------------------------------------------------- 201 (366)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred ---------------------------C---------------------------------------------------C
Q 037297 202 ---------------------------E---------------------------------------------------R 203 (366)
Q Consensus 202 ---------------------------~---------------------------------------------------~ 203 (366)
. +
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence 0 0
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc----cc
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE----NV 279 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~----~~ 279 (366)
-.+||+|||.|+..... ++....|..|+|||++.|..|+..+||||++|++|||+||...|.+....... ..
T Consensus 391 i~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 12577777777665322 23345688899999999999999999999999999999999999876432211 11
Q ss_pred cHHHHHHHHhhc-----Cc-cccccc------------h-----HHh--hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 280 SLAAFFVHSMRK-----NH-MYDILD------------D-----QVV--KLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 280 ~~~~~~~~~~~~-----~~-~~~~~~------------~-----~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
.........++. .. ..++++ + -+. -..+.+...+|.+|+.-||+.+|++||||.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 111111111110 00 011111 1 111 1245677889999999999999999999999
Q ss_pred HHH
Q 037297 335 VTM 337 (366)
Q Consensus 335 ll~ 337 (366)
+++
T Consensus 547 cl~ 549 (590)
T KOG1290|consen 547 CLK 549 (590)
T ss_pred Hhc
Confidence 974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=247.39 Aligned_cols=201 Identities=22% Similarity=0.281 Sum_probs=168.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...+-|..++.||-|+||.|.+++.. +...+|.|.+++..... ..+....+.|.+||..-+.+-||++|-.|.+.+.+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34466888899999999999999844 46678999887643332 23456788999999999999999999999999999
Q ss_pred eEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc-
Q 037297 147 LLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA- 218 (366)
Q Consensus 147 ~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~- 218 (366)
|+++.+..++... -+++..++.++.++..|+++.|..| +|||||||+||||+.+|++||+|||++.-+.
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 9999998887544 4678888999999999999999999 9999999999999999999999999985431
Q ss_pred --C-----CCc---------------------------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHH
Q 037297 219 --M-----DQT---------------------------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVL 258 (366)
Q Consensus 219 --~-----~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l 258 (366)
+ .+. ......+||..|+|||++...+|+-.+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0 000 001135699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 037297 259 VELLTGKKPIFSTG 272 (366)
Q Consensus 259 ~el~~g~~p~~~~~ 272 (366)
|||+.|+.||....
T Consensus 862 ~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADT 875 (1034)
T ss_pred HHHhhCCCCccCCC
Confidence 99999999998755
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=234.40 Aligned_cols=232 Identities=29% Similarity=0.367 Sum_probs=181.7
Q ss_pred CceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC----
Q 037297 83 GQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE---- 157 (366)
Q Consensus 83 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~---- 157 (366)
+||.||+|... +++.+|+|++........ .+.+.+|+..++.++|+|++++++++......+++++......
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999976 489999999987544321 4688899999999999999999999998888888888766532
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCc
Q 037297 158 ---EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234 (366)
Q Consensus 158 ---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y 234 (366)
...++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 112788999999999999999999998 9999999999999999999999999997665432 22334578889
Q ss_pred cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHH
Q 037297 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAF 314 (366)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 314 (366)
+|||...+..++.++|+||+|+++|+|++|..||...... ............. .. ......+.++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~-~~------~~~~~~~~~~ 217 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--------LELFKKIGKPKPP-FP------PPEWKISPEA 217 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHhccCCC-Cc------cccccCCHHH
Confidence 9999998888999999999999999999999998653210 0011111111100 00 0000145679
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHH
Q 037297 315 ANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 315 ~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+++.+||..||++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=220.45 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=162.4
Q ss_pred HHHHhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 143 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (366)
.+...+...-+..||+|++|.|-+-++ .+|...|+|.++..... ...++..+|+++.... .+|.+|.+++.+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 455556677778899999999988775 47999999999876665 3456788899887766 899999999987777
Q ss_pred CcceEEEeeccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 144 EVPLLHLHDHHR----------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 144 ~~~~~~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
.-..+.++.... .....+++..+-+|+..+..||.|||++- .+||||+||+||||+.+|+||++|||.
T Consensus 118 gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 118 GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 766666654322 24557899999999999999999999964 399999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 273 (366)
+.++.+. -..+...|-..|+|||.+.. ..|+-++||||||+++.||.+++.||....+
T Consensus 196 sG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 196 SGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 9776422 11222446677999998754 3688999999999999999999999987553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=264.89 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=186.9
Q ss_pred CcccceecccCceE-EEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEE
Q 037297 73 FNVNRILGQGGQGT-VYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 73 y~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 150 (366)
|.-.+.+|.|+.|+ ||+|.+. |+.||||.+-... ...+.+|+..++.- +|||||++++.-.+....|+.+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~-------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF-------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh-------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34446789999875 5999985 7899999887532 23678999999998 7999999999888888888887
Q ss_pred eeccCC---------CCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---C--CeEEEeecCCcc
Q 037297 151 HDHHRN---------EEFP-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---R--YRAKVADFGTSK 215 (366)
Q Consensus 151 ~~~~~~---------~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~--~~vkl~Dfg~a~ 215 (366)
+.+... .... ......+....|++.|+++||+.+ ||||||||.||||+. + ..++|+|||+++
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 754332 1111 111445778899999999999998 999999999999975 3 468999999999
Q ss_pred cccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 216 FIAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 216 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
.+...... ......||.+|+|||++.....+.++||||+||++|+.++ |..||.+.-. .+. +.....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~--------NIl~~~ 729 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQA--------NILTGN 729 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhh--------hhhcCc
Confidence 88765433 2455679999999999998888889999999999999888 5899976431 110 011111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccccccchHHHHh
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMIYSTGTLLRLF 362 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~ 362 (366)
.-...+.+ ...+ +..+||.+|+..||..||++.++ .+|+..|++++-.++|
T Consensus 730 ~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~V-----------L~HPlFW~~ekrL~Fl 780 (903)
T KOG1027|consen 730 YTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDV-----------LNHPLFWDSEKRLSFL 780 (903)
T ss_pred cceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHH-----------hCCCccCChHHHHHHH
Confidence 10000100 1111 78899999999999999999999 5788888877665544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=245.01 Aligned_cols=196 Identities=22% Similarity=0.343 Sum_probs=165.7
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHH----HHHHHHHHHHHhcCC---CCceeeEeeEE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLK----LEEFINEIVILSQIN---HRNVVKLLGCC 140 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~----~~~~~~E~~~l~~l~---h~niv~~~~~~ 140 (366)
...+|...+.+|+|+||.|++|.++. ...|++|.+.+...-.+... .-..-.|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34679999999999999999999774 66789998877554433322 223567999999996 99999999999
Q ss_pred eeCCcceEEEeeccCCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 141 LETEVPLLHLHDHHRNEE--------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
.++++.|+.++....+-+ ..+++....-|+.||+.|+++||++| |||||||-+||.++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 999999998887655421 25788899999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFS 270 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~ 270 (366)
.|.+.. ......++||..|.|||++.|..|- ...|||++|++||.++....||+.
T Consensus 716 saa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 997764 3445567899999999999998875 468999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=244.73 Aligned_cols=257 Identities=18% Similarity=0.183 Sum_probs=167.8
Q ss_pred HhcCCcccceecccCceEEEEEEE-----------------cCCcEEEEEEeecccChHHHH----------HHHHHHHH
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-----------------EDGRIMAVKKFKLAVDDEELL----------KLEEFINE 121 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~----------~~~~~~~E 121 (366)
..++|++.++||+|+||.||+|.. ..++.||+|.+.......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999987543221100 11233456
Q ss_pred HHHHhcCCCCce-----eeEeeEEee--------CCcceEEEeeccCCC-------------------------------
Q 037297 122 IVILSQINHRNV-----VKLLGCCLE--------TEVPLLHLHDHHRNE------------------------------- 157 (366)
Q Consensus 122 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~~~~~~~~~~~------------------------------- 157 (366)
+..+..++|.++ ++++++|.. ....++++++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 566666643 234567766643311
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCcccc
Q 037297 158 EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237 (366)
Q Consensus 158 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aP 237 (366)
...+++..+..++.|++.+|.|||+++ ++||||||+|||++.++.++|+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 112456778899999999999999999 99999999999999999999999999865433222111222347899999
Q ss_pred ccccCCC----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCccc---ccHHHHHHHHhhc
Q 037297 238 EYHQSSQ----------------------LTDKSDVYSFGVVLVELLTGKK-PIFSTGNTSQEN---VSLAAFFVHSMRK 291 (366)
Q Consensus 238 E~~~~~~----------------------~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~---~~~~~~~~~~~~~ 291 (366)
|.+.... ...+.|+||+||++|+|++|.. ||.......... ......... ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence 9775322 1124799999999999999875 664322111000 000000000 000
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHH
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNG---KKRPTMEEVTM 337 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~ell~ 337 (366)
.. ..-......++...+|+.+||..+| .+|+|++|+++
T Consensus 459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 0001123346678999999999766 68999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=228.75 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=183.4
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE--
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL-- 148 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-- 148 (366)
+.+-.+.||-|+||.||.+.+. +|+.||+|++..-.. .....+.+.+|+.++..++|.|++..++...-....++
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4556789999999999999965 699999999875433 34566789999999999999999998887544332222
Q ss_pred ---EEeec------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 ---HLHDH------HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ---~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+.+.. ..-+..+++.+.+.-+..||+.||+|||+.+ |.||||||.|.|+++|..+||+|||+++.-..
T Consensus 132 iYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 11111 1113446788889999999999999999999 99999999999999999999999999986554
Q ss_pred CCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH-------------
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF------------- 285 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 285 (366)
++....+..+-|-.|+|||++.|. .|+.+.||||.||++.|++..+.-|...+.. ++..+....
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHh
Confidence 444444445567789999998875 6899999999999999999988888654421 111111100
Q ss_pred ----HHHhhcCccccccchHHh-hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 286 ----VHSMRKNHMYDILDDQVV-KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 286 ----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
...++...-..-+ +.+. ..-+.....+--+++..++..||+.|.+..+.+.-+
T Consensus 287 EGAk~H~LR~~~k~Ps~-~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDT-QRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCc-cceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0011110000000 0000 001112333456788899999999999998887544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=241.13 Aligned_cols=201 Identities=23% Similarity=0.266 Sum_probs=165.2
Q ss_pred cChHHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC------CCce
Q 037297 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN------HRNV 133 (366)
Q Consensus 61 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni 133 (366)
|...-.+..-.+|.+....|+|-||+|..|.+. .|..||||+++... ...+.=+.|+++|+.|. .-|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 444555666789999999999999999999965 48899999998632 33455678999999994 3488
Q ss_pred eeEeeEEeeCCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-
Q 037297 134 VKLLGCCLETEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER- 203 (366)
Q Consensus 134 v~~~~~~~~~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~- 203 (366)
++++-.|.....++++++...-+ ....|....+..++.|+..||..|-..| |+|.||||+|||++++
T Consensus 497 lrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 99999888899999888765332 3335677889999999999999999998 9999999999999865
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
..+||||||.|...+..+. +.+.-+..|.|||++.|-+|+...|+||.||+||||.||+..|.+..
T Consensus 574 ~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 4679999999987654433 33344667999999999999999999999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=221.41 Aligned_cols=259 Identities=22% Similarity=0.265 Sum_probs=185.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
..+|.-++.+|.|+- .|..+.+. .++.||+|+...+... ....++..+|+.++..+.|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 467888889999998 66666643 5889999998776443 234467889999999999999999999986554
Q ss_pred --cceEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 --VPLLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 --~~~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..|++++....+ ....++-.++..+..|++.|++|||+.| |+||||||+||++..++.+||.|||+|..-.
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 344444443322 1234667788999999999999999999 9999999999999999999999999997543
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC-------------ccccc----H
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS-------------QENVS----L 281 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------------~~~~~----~ 281 (366)
.. ...+..+.|.-|.|||++.+..+.+.+||||+||++.||++|..-|.+..... ..... .
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 22 45677788999999999999999999999999999999999998886532110 00000 0
Q ss_pred HHHHHHHhh-------cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 282 AAFFVHSMR-------KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 282 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+..... ...+++..-+.. ...++....-..+++.+||-.||++|.|++++|+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~-~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVV-LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhcChHhhccchhhhCCccccccc-ccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000000000 000011000000 0011223335789999999999999999999963
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=206.08 Aligned_cols=203 Identities=37% Similarity=0.564 Sum_probs=172.4
Q ss_pred ecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC
Q 037297 79 LGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE 157 (366)
Q Consensus 79 lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~ 157 (366)
||+|++|.||++.... ++.+++|++....... ..+.+.+|+..++.++|++++++++++......+++++...+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999999764 8999999998754432 34578899999999999999999999998888888888766332
Q ss_pred ------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcccccCCCceeeeec
Q 037297 158 ------E--FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHVTTKI 228 (366)
Q Consensus 158 ------~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~ 228 (366)
. ..++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 1 35788999999999999999999998 999999999999999 89999999999876543321 12334
Q ss_pred cccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhc
Q 037297 229 QGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK 307 (366)
Q Consensus 229 ~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (366)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999998877 888999999999999998
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 308 KNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 308 ~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..+.+++..|++.||++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=238.79 Aligned_cols=245 Identities=29% Similarity=0.395 Sum_probs=197.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|+.+..+|+|.||-||+++++ +++..|+|+++..... ..+-...|+-+++..+||||+.+++.+...+...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 478999999999999999999965 5899999999986554 34567789999999999999999999999999999
Q ss_pred EEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
.++++.+++.. ++.+.++...++..++|++|||++| -+|||||-.||++++.|.+|++|||.+..+...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 99999887544 6788999999999999999999999 799999999999999999999999998655422
Q ss_pred ceeeeeccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 222 THVTTKIQGTFGYLEPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
-.....+.||+.|||||+. ..+.|+.++|||++|+...|+-..++|.+.... .. + .+ .+.... +
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr----~-l~--LmTkS~----~ 232 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MR----A-LF--LMTKSG----F 232 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HH----H-HH--HhhccC----C
Confidence 1223457899999999965 456899999999999999999998888765331 00 0 00 111111 1
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
++. ...-+..+++.|.+|++.||-.+|.+|||++-++
T Consensus 233 qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 233 QPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 110 0111456788899999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=203.20 Aligned_cols=192 Identities=35% Similarity=0.507 Sum_probs=162.2
Q ss_pred CcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|.+.+.||+|++|.||++.... ++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++...+..+++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 5677899999999999999764 889999999875443 245678899999999999999999999988888888888
Q ss_pred eccCCC-------CCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 152 DHHRNE-------EFP-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 152 ~~~~~~-------~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
...... ... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 766532 112 788899999999999999999998 999999999999999999999999998876544311
Q ss_pred eeeeccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037297 224 VTTKIQGTFGYLEPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 270 (366)
......++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999988 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=214.21 Aligned_cols=197 Identities=26% Similarity=0.371 Sum_probs=161.3
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
....+.|..+++||+|.|++||++.+. .++.||+|.+...... ..+..|+++|..+ .+.||+++.+++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p------~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP------SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc------hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 344567999999999999999999843 4678999998875444 3678899999999 7999999999999
Q ss_pred eCCcceEEEeeccCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCccc
Q 037297 142 ETEVPLLHLHDHHRNEEF----PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKF 216 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~ 216 (366)
..+...++++++...... .++...+..+++.++.||.++|.+| ||||||||.|+|.+. .+.-.|+|||+|..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 999999999987665422 4678899999999999999999999 999999999999984 46779999999872
Q ss_pred ccCC------------------C-------------------------ceeeeeccccCCccccccccCC-CCCchhhHH
Q 037297 217 IAMD------------------Q-------------------------THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVY 252 (366)
Q Consensus 217 ~~~~------------------~-------------------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Diw 252 (366)
.... + ........||++|+|||++... .-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 2100 0 0001134599999999988765 468899999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 037297 253 SFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 253 slG~~l~el~~g~~p~~~~~ 272 (366)
|.|+++.-+++++.||....
T Consensus 263 s~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eccceeehhhccccccccCc
Confidence 99999999999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=243.68 Aligned_cols=157 Identities=18% Similarity=0.181 Sum_probs=110.9
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-------------------eEEEeecCCccccc
Q 037297 158 EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-------------------RAKVADFGTSKFIA 218 (366)
Q Consensus 158 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-------------------~vkl~Dfg~a~~~~ 218 (366)
...+++..+..++.||+.||.|||++| |+||||||+|||++..+ .+|++|||+++...
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 345899999999999999999999999 99999999999996544 45555555554321
Q ss_pred CCCc---------------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHH
Q 037297 219 MDQT---------------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 219 ~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 283 (366)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~~~ 223 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------TMS 223 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------HHH
Confidence 0000 001123578889999999999999999999999999999999887643210 000
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... ..+.. ........+++.+||+.||.+|||+.|+++
T Consensus 224 ----~~~~~~----~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 224 ----SLRHRV----LPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ----HHHHhh----cChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 000000 01110 111234568899999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=193.30 Aligned_cols=157 Identities=24% Similarity=0.276 Sum_probs=118.3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccc
Q 037297 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238 (366)
Q Consensus 159 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE 238 (366)
..+++..++.++.|++.||.|||+++ ||+|||++.++.+++ ||++....... ..||+.|+|||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE 74 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPE 74 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------CCCcccccChH
Confidence 46899999999999999999999875 999999999999999 99987653321 25789999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHH--HHHH
Q 037297 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--AFAN 316 (366)
Q Consensus 239 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~ 316 (366)
++.+..++.++||||+||++|||++|+.||........ ............... + ...+...+. ++.+
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~~ 143 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA----ILEILLNGMPADDPR---D----RSNLESVSAARSFAD 143 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH----HHHHHHHHhccCCcc---c----cccHHHHHhhhhHHH
Confidence 99999999999999999999999999999965331111 111111111110000 0 001222333 6999
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 317 LAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 317 li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
++..||..||.+|||+.|+++.+..+.
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=196.18 Aligned_cols=244 Identities=17% Similarity=0.268 Sum_probs=172.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEE-eeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC-LETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-~~~~~~ 146 (366)
.+.|.+.+.+|+|.||.+-++.++ ++..+++|.++... ...+.|.+|...--.| .|.||+.-|++. ...+..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 467999999999999999999976 47789999887643 3457899999877777 699999988864 455555
Q ss_pred eEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--~~~~vkl~Dfg~a~~~~ 218 (366)
+++.++...+ ....+.+.....++.|++.||.|+|+++ +||||||.+||||- +...|||+|||.....+
T Consensus 98 vF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 5555554433 2335778888999999999999999999 99999999999994 44589999999986543
Q ss_pred CCCceeeeeccccCCccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
.. -.....+..|.+||..... ...+.+|+|.||+++|.++||.+||+................... ...
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk--~~~ 248 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK--NPA 248 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc--Ccc
Confidence 11 1122345668999965432 246789999999999999999999985442222111111111000 011
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.+.. -...++.+..+.++-|..+|++|=-..+..
T Consensus 249 ~P~~---------F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 249 LPKK---------FNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred Cchh---------hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1111 122445677888899999999994444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=195.67 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=186.5
Q ss_pred CCcccceecccCceEEEEEEEcCC--cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC----CCceeeEeeEE-eeCC
Q 037297 72 HFNVNRILGQGGQGTVYKGMLEDG--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN----HRNVVKLLGCC-LETE 144 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~ 144 (366)
+|.+.+.||+|+||.||.|..... ..+|+|.......... ..+..|..++..+. .+++..+++.. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 799999999999999999997653 4788888776433211 14567888888885 36899999988 4666
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-----CeEEEeec
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-----YRAKVADF 211 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-----~~vkl~Df 211 (366)
..++++.....+ ....++..+...++.|++.+|.++|+.| ++||||||+|++++.. -.+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 777776654332 2457899999999999999999999999 9999999999999865 46999999
Q ss_pred CCcc--cccCCCce------e-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 212 GTSK--FIAMDQTH------V-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 212 g~a~--~~~~~~~~------~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
|+++ ........ . ...+.||..|.++.+..+...+.+.|+||++.++.++..|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 33222211 1 2345699999999999999999999999999999999999999965432111 1
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.............. .....+..+.++...+-..+..++|....+.+.|++....
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111111110000 1222344667777777779999999999999998766544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=185.00 Aligned_cols=259 Identities=16% Similarity=0.215 Sum_probs=199.2
Q ss_pred HHHHHhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 142 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (366)
.....+-+|.++++||+|+||..+.|. .-+++.||||.-+..... .++..|-...+.| ..++|...+-+-.+
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A------PQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA------PQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc------chHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 344556789999999999999999998 447999999987765544 3567788888888 68899888777666
Q ss_pred CCcceEEEeec-------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-----CeEEEee
Q 037297 143 TEVPLLHLHDH-------HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-----YRAKVAD 210 (366)
Q Consensus 143 ~~~~~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-----~~vkl~D 210 (366)
...-.++++.. ...-...++..++..++.|++.-++|+|++. +|.|||||+|+||... ..+.++|
T Consensus 96 G~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 66555554433 3334557889999999999999999999999 9999999999999744 3589999
Q ss_pred cCCcccccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 211 FGTSKFIAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 211 fg~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
||+|+.+....+. ......||.+||+--...|..-+.+.|+-|||-++.+.+-|..||.+.......+ .
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-----k 247 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-----K 247 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-----H
Confidence 9999877544332 2344669999999999999999999999999999999999999998754322111 0
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+.+....-....+..+.+.+|...++..-..+-.+-|..+-+-..+.++.
T Consensus 248 ------YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 248 ------YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ------HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11111111122234566778889999999999999999999988777665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=196.45 Aligned_cols=174 Identities=20% Similarity=0.103 Sum_probs=128.5
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecccCh-HHHHHHHHHHHHHHHHhcCCCCceee-Eee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDD-EELLKLEEFINEIVILSQINHRNVVK-LLG 138 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~-~~~ 138 (366)
.+.......+|++.+.||+|+||+||+|.++ +++.+|+|++...... ......+.+.+|+++++.++|+|+++ +++
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 3344556688999999999999999999864 4777899987533110 11123457899999999999999985 443
Q ss_pred EEeeCCcceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEecCCCeEEEeecCCcccc
Q 037297 139 CCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDI-KSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~di-kp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
+ ...++++++..+.............++.|++++|.|||++| |+|||| ||+|||++.++.++|+|||+|..+
T Consensus 90 ~----~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred c----CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 2 45688888876543321111112578899999999999999 999999 999999999999999999999876
Q ss_pred cCCCce-------eeeeccccCCccccccccCC
Q 037297 218 AMDQTH-------VTTKIQGTFGYLEPEYHQSS 243 (366)
Q Consensus 218 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~ 243 (366)
...... ..+...++..|.|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 533211 11345688889999987643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=212.80 Aligned_cols=246 Identities=22% Similarity=0.213 Sum_probs=174.8
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
+|...+.||++.|=.|.+|++.+|. |++|++-...+.-......+-..|+. ....++||++++..+-......|++-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6888899999999999999998777 99999877665544444444455555 556699999999887666666666544
Q ss_pred eccC-----CCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc--CCCc-
Q 037297 152 DHHR-----NEEFP-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MDQT- 222 (366)
Q Consensus 152 ~~~~-----~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~--~~~~- 222 (366)
+... ....| +...+...|+.|++.|+..+|..| |+|||||.+||||++-.-+.|+||..-+... .+..
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 3322 22222 566788899999999999999999 9999999999999999999999998765332 1111
Q ss_pred ---eeeeeccccCCccccccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHH
Q 037297 223 ---HVTTKIQGTFGYLEPEYHQSS----------Q-LTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 223 ---~~~~~~~~t~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
....+.....+|.|||.+... + .+++.||||+||++.||++ |++||.-..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------------- 243 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------------- 243 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------------
Confidence 122223345579999977542 2 5779999999999999988 788874210
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.+......+ .++ ...+..-.+..+++++..|++.||++|.++++.|+.-.
T Consensus 244 L~aYr~~~~-~~~--e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 LLAYRSGNA-DDP--EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHhHhccCc-cCH--HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 011000000 011 11122223346899999999999999999999987633
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=175.62 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=194.3
Q ss_pred HhcCCcccceecccCceEEEEEE-EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 146 (366)
....|.++++||+|+||-+|.|. ..+|+.||+|+-...... .++..|..+.+.|+ ...|..+..+..+...-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45789999999999999999998 457999999987665433 36778999999995 57888888888888888
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeecCCccc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Dfg~a~~ 216 (366)
.+++...... -...++..+++-++-|++.-++|+|.++ ++||||||+|+|..- -..+.++|||+|+.
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 8887765432 2235778899999999999999999999 999999999999973 35789999999987
Q ss_pred ccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 217 IAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 217 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
+....+. ......||.+|.+--...+..-+.+.|+-|+|.++.++--|..||.+.......+. ......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-----yEkI~E 238 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-----YEKISE 238 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-----HHHHHH
Confidence 7543322 23446699999999988888889999999999999999999999988653332211 100110
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
. .+ .-....+....+.+|.-.+..|-..--++-|+..-+-+.+.-+
T Consensus 239 k-K~-----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 239 K-KM-----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred h-hc-----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 0 00 1112335667778899999999999999999887766555433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=210.45 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=178.7
Q ss_pred cccceecccCceEEEEEEEc-CCcEEEEEEeecc--cChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 74 NVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLA--VDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.....+|.|++|.|+.+... .....+.|.++.. ...........+..|..+-..+.|||++.....+.+....+..+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999988887743 3444455544311 11111122223777888888899999988777665555444445
Q ss_pred eeccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc--
Q 037297 151 HDHHR------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-- 222 (366)
Q Consensus 151 ~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 222 (366)
+++.. .....+....+..++.|++.|++|+|+.| +.|||+||+|+++..+|.+||+|||.+........
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 55433 11225777888999999999999999999 99999999999999999999999999876543332
Q ss_pred -eeeeeccccCCccccccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 223 -HVTTKIQGTFGYLEPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 223 -~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||.......... ........... .
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~--~ 547 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNI--F 547 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccccc--c
Confidence 3445678999999999999999877 6899999999999999999997654322211 00001111111 0
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.-...+....+.+.+.++..||+.||.+|.|++++++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1112234455667889999999999999999999974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=183.63 Aligned_cols=275 Identities=19% Similarity=0.306 Sum_probs=179.0
Q ss_pred hcCCcccceecccCceEEEEEEEcC-Cc-----------------------------------EEEEEEe-ecccChHHH
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GR-----------------------------------IMAVKKF-KLAVDDEEL 112 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~-----------------------------------~vaiK~~-~~~~~~~~~ 112 (366)
.++|++++.||+|+...||.+...+ |. +.|+|.+ ..+..+.+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 4679999999999999999986432 10 2455543 222223333
Q ss_pred HHHHHHHHHHHH--------------Hh-------cC-CCCceeeEeeEEeeCC--------------------------
Q 037297 113 LKLEEFINEIVI--------------LS-------QI-NHRNVVKLLGCCLETE-------------------------- 144 (366)
Q Consensus 113 ~~~~~~~~E~~~--------------l~-------~l-~h~niv~~~~~~~~~~-------------------------- 144 (366)
...+.+.+|+.- .+ +| +|||||++..+|.++-
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 334444444311 11 22 5999999988764431
Q ss_pred -cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CC--CeEEEeecCCc
Q 037297 145 -VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ER--YRAKVADFGTS 214 (366)
Q Consensus 145 -~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--~~--~~vkl~Dfg~a 214 (366)
..|+++..+... .....+.....-+..|+++|+.|||++| +.|||+|++|||+. +| -.+.++|||++
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred ceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence 233344333221 1113455566778999999999999999 99999999999995 33 35799999987
Q ss_pred ccccCCC-----ceeeeeccccCCccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHH
Q 037297 215 KFIAMDQ-----THVTTKIQGTFGYLEPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 215 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 283 (366)
-...+.+ .......-|+..-||||+....+ .-.|+|.|+.|.+.||+++...||+..+....+...
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--- 469 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--- 469 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---
Confidence 5443311 11223344788899999875432 124899999999999999999999985532222111
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh-hcccCCCCcccccccchHHHHh
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN-GIRGSNFGHKMIYSTGTLLRLF 362 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~-~~~~~~~~~~~~~~~~~~~~~~ 362 (366)
+.......++..+++.+.+++...|+.||++|++..-....|. .++.....++........-.+=
T Consensus 470 --------------Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~~~~~~~ 535 (598)
T KOG4158|consen 470 --------------YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKCGISQMT 535 (598)
T ss_pred --------------hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccccHHHHH
Confidence 0111122356677888999999999999999999887777775 3444444444554544455555
Q ss_pred hh
Q 037297 363 WL 364 (366)
Q Consensus 363 ~~ 364 (366)
||
T Consensus 536 wL 537 (598)
T KOG4158|consen 536 WL 537 (598)
T ss_pred HH
Confidence 55
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-21 Score=176.89 Aligned_cols=254 Identities=28% Similarity=0.386 Sum_probs=187.3
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC-ceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR-NVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 151 (366)
|.+.+.||.|+||.||.+... ..+++|.+........ .....+.+|..++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999976 7789999887655432 2356789999999999888 79999999966666677776
Q ss_pred eccCCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccccCC
Q 037297 152 DHHRNEE----------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 220 (366)
Q Consensus 152 ~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~~~~ 220 (366)
....... ..++......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 6554421 26888899999999999999999999 99999999999999988 7999999999755433
Q ss_pred Cce-----eeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 221 QTH-----VTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 221 ~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
... ......++..|+|||.+.+ ..++...|+||+|++++++++|..||...... ....... ......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~-~~~~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTL-KIILEL 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHH-HHHHhc
Confidence 321 2355679999999999987 57888999999999999999999997554321 0000001 011111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
... .................+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 000000000002233568899999999999999998877653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=174.52 Aligned_cols=227 Identities=21% Similarity=0.254 Sum_probs=142.6
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC----------CceeeEeeEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH----------RNVVKLLGCC 140 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~ 140 (366)
.+...+.||.|+++.||.+.+. +++.+|+|++.... .......+.+.+|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4566789999999999999976 58999999998766 3333456777777655544322 2333333332
Q ss_pred eeCC-----------cce------EEEeecc-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037297 141 LETE-----------VPL------LHLHDHH-------------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190 (366)
Q Consensus 141 ~~~~-----------~~~------~~~~~~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 190 (366)
.... ..+ +.+.... ......+....+..+..|+++.+++||++| ++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 2111 111 1111100 001112334455677899999999999999 999
Q ss_pred CCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccC--------CCCCchhhHHHHHHHHHHHH
Q 037297 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS--------SQLTDKSDVYSFGVVLVELL 262 (366)
Q Consensus 191 ~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~ 262 (366)
+||+|+|++++.+|.++|+||+.....+. .......+..|.|||.... -.++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654321 1221345577999996643 24788999999999999999
Q ss_pred hCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCC
Q 037297 263 TGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKR 329 (366)
Q Consensus 263 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 329 (366)
+|+.||.......... ....... +.++.+.+||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~----------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE----------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG----------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc----------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999997653211110 0112233 778889999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=159.44 Aligned_cols=191 Identities=16% Similarity=0.031 Sum_probs=136.9
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceEEEee
Q 037297 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
.+...|++|+||+|+.+.. .+.+++.+.+..............+.+|++++++|. |+++++++++ ...++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 578888887776554332222336789999999994 5889998885 334666666
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEecCCCeEEEeecCCcccccCCCce----e---
Q 037297 153 HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDI-KSTNILLDERYRAKVADFGTSKFIAMDQTH----V--- 224 (366)
Q Consensus 153 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~di-kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----~--- 224 (366)
..+.............++.|++.++.++|++| |+|||| ||+|||++.++.++|+|||+|......... .
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 55443221111123467889999999999999 999999 799999999999999999999854432210 0
Q ss_pred -----eeeccccCCccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 225 -----TTKIQGTFGYLEPEYH--QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 225 -----~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
......++.|++|+.. ....--...+.++.|+-+|.++|++.|..+++
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0011257778888732 22233357788999999999999999887665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=170.00 Aligned_cols=245 Identities=19% Similarity=0.284 Sum_probs=181.0
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
...+.-+|.+...|..|+|++. |..++.|++....... ..-..|..|.-.++.+.||||+..++.|.......++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~--risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA--RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch--hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 4455677899999999999987 4446677766433221 233468889999999999999999999999888777766
Q ss_pred eccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 152 DHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 152 ~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+...+ .....+-.+..+++.+++.|+.|||+.. +-|-.--+.+..++|+++.+.+|. .+-+++ +
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf-----s 340 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----S 340 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee-----e
Confidence 54332 3334566788999999999999999975 334444688899999999877663 121111 1
Q ss_pred eeeeeccccCCccccccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.........+.|++||.+..++- -.++|+|||++++||+.|...||..... .+.. ..+.-
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--mecg---------------mkial 403 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--MECG---------------MKIAL 403 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--hhhh---------------hhhhh
Confidence 11222345678999998877653 3489999999999999999999986542 2111 11122
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
..++-.+|++.+..+.+|+.-|...||.+||.++.++-+|+.+.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34455678899999999999999999999999999999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=168.20 Aligned_cols=175 Identities=14% Similarity=0.131 Sum_probs=130.4
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHH------HHHHHHHHhcCCCCceeeEeeEE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEE------FINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
....++|++.+.+|.|+||.||++.. ++..+|+|+++........ ..+. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~-~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTER-FLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHH-HHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34568999999999999999999765 5778999999876544322 2222 67899999999999999999886
Q ss_pred eeCC--------cceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 141 LETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 141 ~~~~--------~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
.... ..++++++..+.+...+... ......+++.++..+|+.| ++|||++|.||+++.+| ++|+|||
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~-~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPEI-SEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhhc-cHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence 6443 46778888776543222110 1235669999999999999 99999999999999988 9999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHH
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVEL 261 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el 261 (366)
.......... .........++.++|+||||+++...
T Consensus 180 ~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 180 GKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred Ccccccchhh-------------HHHHHHHhHhcccccccceeEeehHH
Confidence 8754321110 01134455667899999999998764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=158.18 Aligned_cols=137 Identities=16% Similarity=0.129 Sum_probs=103.6
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHH----------------------HHHHHHHHHHHHhcCCCCce
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELL----------------------KLEEFINEIVILSQINHRNV 133 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~ni 133 (366)
.+.||+|++|.||+|...+|+.||+|+++......... .......|...+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57899999999999998789999999998753211100 01233458999999987776
Q ss_pred eeEeeEEeeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 134 VKLLGCCLETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYL-HSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 134 v~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
........ ...++++++..+.. ..+++......++.|++.+|.++ |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 44333221 22368888776532 23578888999999999999999 6888 99999999999998 478
Q ss_pred EEEeecCCccccc
Q 037297 206 AKVADFGTSKFIA 218 (366)
Q Consensus 206 vkl~Dfg~a~~~~ 218 (366)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=154.28 Aligned_cols=138 Identities=20% Similarity=0.210 Sum_probs=107.0
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecccChHH----------------------HHHHHHHHHHHHHHhcCCCCc
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEE----------------------LLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~n 132 (366)
+.+.||+|++|.||+|...+|+.||+|+++....... ......+..|...+..+.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999977899999999987532100 011223467899999999998
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~ 204 (366)
+.....+.... .++++++..+.. ...++......++.|++.++.++|+ .| ++||||||+||+++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 75544433322 467888876542 2246677889999999999999999 88 99999999999999 78
Q ss_pred eEEEeecCCccccc
Q 037297 205 RAKVADFGTSKFIA 218 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~ 218 (366)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-22 Score=182.46 Aligned_cols=230 Identities=26% Similarity=0.230 Sum_probs=178.6
Q ss_pred eecccCceEEEEEEE----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceEEEee
Q 037297 78 ILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
++|+|+||.|+++.. ..+.-+|.|+.+.......... ....|..++...+ ||.++++.-.+......++++.+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 379999999998762 3467788888876555433222 5566788888885 99999999999988888888777
Q ss_pred ccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 153 HHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 153 ~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
..++... ..++.....+...++-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 6654322 3566677788889999999999999 999999999999999999999999999765433222
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
+||..|||||++. ....++|.||+|++.+||++|..||... .....+.. .-.
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------------~~~~Il~~-----------~~~ 205 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------------TMKRILKA-----------ELE 205 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------------HHHHHhhh-----------ccC
Confidence 8999999999987 6678999999999999999999999751 11111111 112
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCCCH--HHHHHHHhhc
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRPTM--EEVTMELNGI 342 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rpt~--~ell~~L~~~ 342 (366)
.|...+....+++..++..+|..|.-. ..+.++.+..
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~ 244 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE 244 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence 467788889999999999999999755 5666665543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=179.92 Aligned_cols=248 Identities=16% Similarity=0.213 Sum_probs=177.1
Q ss_pred ChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC---CCceeeEee
Q 037297 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN---HRNVVKLLG 138 (366)
Q Consensus 62 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~ 138 (366)
+..+.......|.|.+.||+|+||+||.|...+|+.||+|+-+.....+- +--.+++.+|+ -+.|..+..
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-------YI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-------YICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-------eehHHHHHhhchhhhcchHHHHH
Confidence 34455666788999999999999999999988899999999888766632 22233444444 344555555
Q ss_pred EEeeCCcceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-------CCC
Q 037297 139 CCLETEVPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-------ERY 204 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-------~~~ 204 (366)
++.-.+..+++.++..-+ ...-+++..+..++.|++..++.||..+ |||+||||+|+||. .+.
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 556666677776665433 4446789999999999999999999999 99999999999994 345
Q ss_pred eEEEeecCCcccccCC-CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHH
Q 037297 205 RAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 283 (366)
.++|+|||.+-.+..- +........+|-.+-.+|+..|.+|+.+.|.|.++.+++-|+.|+.-=...+...
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~-------- 910 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW-------- 910 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce--------
Confidence 7899999998766432 2345666778999999999999999999999999999999999973211111000
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHH-HHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMA-FANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.++.. ++..+..+ ..+++..+|..|-..=|...+|...++....
T Consensus 911 -------------~~~~~----~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 911 -------------MVKTN----FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -------------ecccc----chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 00000 11222222 3456777777555555788888777776553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=175.84 Aligned_cols=206 Identities=26% Similarity=0.321 Sum_probs=141.7
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|..++.|..|+||.||.++++. .+.+|.|+-+.. -+.+- ++..-..|-+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~----------lilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN----------LILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc----------hhhhc--cccccCCccee--------------
Confidence 4789999999999999999999764 567788432211 01111 23333444444
Q ss_pred EEeeccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce---
Q 037297 149 HLHDHHR--NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--- 223 (366)
Q Consensus 149 ~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--- 223 (366)
..+.. ..-.+++.. ++.+++|+|+.+ |+|||+||+|.+|+.-|.+|++|||+++........
T Consensus 136 --gDc~tllk~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 11111 111123322 278999999999 999999999999999999999999998765432211
Q ss_pred -----------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 224 -----------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 224 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
.....+||+.|.|||++....|...+|.|++|+++||.+.|..||+++...+ .. ..+... ..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lf----g~visd--~i 275 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF----GQVISD--DI 275 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HH----hhhhhh--hc
Confidence 1234679999999999999999999999999999999999999998865211 11 111000 00
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP 330 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 330 (366)
.+++ -....+.+..+++.++|+.+|.+|-
T Consensus 276 ~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWPE---------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccc---------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111 0223345788999999999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-20 Score=167.08 Aligned_cols=144 Identities=26% Similarity=0.419 Sum_probs=104.9
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-----ceeeeeccccCCccccc
Q 037297 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-----THVTTKIQGTFGYLEPE 238 (366)
Q Consensus 164 ~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~t~~y~aPE 238 (366)
.....++.|++.|++| ++ .+|+|+||.||+...+..+||+|||+........ ....+...||..||+||
T Consensus 359 s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE 432 (516)
T KOG1033|consen 359 SLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPE 432 (516)
T ss_pred hHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHH
Confidence 3456688899999999 67 9999999999999999999999999987665443 22345567999999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHH
Q 037297 239 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANL 317 (366)
Q Consensus 239 ~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 317 (366)
.+.+..|+.++||||||++|+|++. -..++..... ...++...++ +......| .=..|
T Consensus 433 Qi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t------------~~d~r~g~ip----~~~~~d~p-----~e~~l 491 (516)
T KOG1033|consen 433 QIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT------------LTDIRDGIIP----PEFLQDYP-----EEYTL 491 (516)
T ss_pred HHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh------------hhhhhcCCCC----hHHhhcCc-----HHHHH
Confidence 9999999999999999999999987 3333322110 1111222221 11111122 23479
Q ss_pred HHHhhcCCCCCCCCHHH
Q 037297 318 AERCLDLNGKKRPTMEE 334 (366)
Q Consensus 318 i~~cl~~dp~~Rpt~~e 334 (366)
+.+++...|.+||++.+
T Consensus 492 l~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 492 LQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHhcCCCcccCchHHH
Confidence 99999999999995433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=138.75 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=108.9
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHH------------------HHHHHHHHHHHHHhc
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEEL------------------LKLEEFINEIVILSQ 127 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~~~~E~~~l~~ 127 (366)
+......|.+.+.||+|+||.||++...+|+.+|+|+++........ ........|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33444458889999999999999999878999999998764321100 111236778888888
Q ss_pred CCCC--ceeeEeeEEeeCCcceEEEeeccCCCCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 128 INHR--NVVKLLGCCLETEVPLLHLHDHHRNEEFPLTW-EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 128 l~h~--niv~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
+.|+ .++..++. ...++++++..+.....+.. .....++.+++.++.++|+.+ ++||||+|+||+++.++
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 8777 44444432 34567777766654333332 456678999999999999999 99999999999999999
Q ss_pred eEEEeecCCccccc
Q 037297 205 RAKVADFGTSKFIA 218 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~ 218 (366)
.++|+|||.+....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=155.45 Aligned_cols=211 Identities=24% Similarity=0.415 Sum_probs=152.2
Q ss_pred HhcCCCCceeeEeeEEeeCCcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeCCCCC
Q 037297 125 LSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPI-YHRDIKS 195 (366)
Q Consensus 125 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i-iH~dikp 195 (366)
|+.+.|.|+.++++.+........+..++..+. ...+++.-...+.++++.||.|+|.-. | .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 467899999999999999987777777765543 335677778889999999999999865 5 9999999
Q ss_pred CCEEecCCCeEEEeecCCcccccC-CCceeeeeccccCCccccccccCCC-------CCchhhHHHHHHHHHHHHhCCCC
Q 037297 196 TNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLEPEYHQSSQ-------LTDKSDVYSFGVVLVELLTGKKP 267 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwslG~~l~el~~g~~p 267 (366)
.|.+++....+||+|||+...... .............-|.|||.+.+.. .+.+.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999876532 1111112222455699999886641 45679999999999999999999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
|......... ....... .. .....+.|..... ....+++..++..||..+|.+||+++++-..++.+....
T Consensus 158 ~~~~~~~~~~-~eii~~~----~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDP-DEIILRV----KK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCCh-HHHHHHH----Hh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9764432222 1111111 11 0111111111111 144447999999999999999999999999998887644
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.3e-17 Score=140.04 Aligned_cols=142 Identities=15% Similarity=0.143 Sum_probs=105.3
Q ss_pred HhcCCcccceecccCceEEEEEE--EcCCcEEEEEEeecccChHH--------------------HHHHHHHHHHHHHHh
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGM--LEDGRIMAVKKFKLAVDDEE--------------------LLKLEEFINEIVILS 126 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~~~--------------------~~~~~~~~~E~~~l~ 126 (366)
.+.-|.+.+.||+|++|.||+|. ..+|+.||+|+++....... ......+..|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34468899999999999999998 45799999999986432100 001234678999999
Q ss_pred cCCCC--ceeeEeeEEeeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 037297 127 QINHR--NVVKLLGCCLETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTN 197 (366)
Q Consensus 127 ~l~h~--niv~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~N 197 (366)
.+.+. .+++.++. ...++++++..+.. ...........++.|++.++.+||++|. ++||||||+|
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~N 179 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYN 179 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhh
Confidence 99653 34444443 23467777766532 2234555677899999999999998763 9999999999
Q ss_pred EEecCCCeEEEeecCCcccc
Q 037297 198 ILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 198 ill~~~~~vkl~Dfg~a~~~ 217 (366)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 789999999998654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-17 Score=136.47 Aligned_cols=128 Identities=15% Similarity=0.122 Sum_probs=91.3
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-----CCCceeeEeeEEeeCCc---c
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-----NHRNVVKLLGCCLETEV---P 146 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~---~ 146 (366)
-.+.||+|++|.||. +......++|++...... ..+.+.+|+.+++.+ +||||+++++++.+... .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccc----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 347899999999996 443333479988764322 335789999999999 57999999999988752 2
Q ss_pred e-EEEeeccCCCC---------CCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEecC----CCeEEEeec
Q 037297 147 L-LHLHDHHRNEE---------FPLTWEIRLRIATEVAGAL-SYLHSAASSPIYHRDIKSTNILLDE----RYRAKVADF 211 (366)
Q Consensus 147 ~-~~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~iiH~dikp~Nill~~----~~~vkl~Df 211 (366)
+ +++++ .+... ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 80 ~~~I~e~-~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 80 YDVIADF-DGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEecC-CCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 2 23443 22111 123443 35577777777 9999999 999999999999974 347999995
Q ss_pred CCc
Q 037297 212 GTS 214 (366)
Q Consensus 212 g~a 214 (366)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=134.56 Aligned_cols=134 Identities=21% Similarity=0.266 Sum_probs=105.9
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChH----HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDE----ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.||+|++|.||+|.. .|..+++|......... .......+.+|+.++..+.|+++.....++......++++++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57789999866433211 112235678899999999999988777777777778888888
Q ss_pred ccCCCCCCC----CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 153 HHRNEEFPL----TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 153 ~~~~~~~~l----~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..+.....+ .. ....++.+++.++.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 765432211 11 56789999999999999999 99999999999999 78999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-16 Score=132.32 Aligned_cols=134 Identities=19% Similarity=0.252 Sum_probs=100.5
Q ss_pred eecccCceEEEEEEEcCCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 78 ILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
.||+|++|.||+|.. ++..+++|........ ......+++.+|+.+++.+.|+++.....++...+..++++++.
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 4778999986543221 11223467889999999998887665555555666677888876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 154 HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 154 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.+.....+.......++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 6543221111111178999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-16 Score=150.71 Aligned_cols=140 Identities=19% Similarity=0.247 Sum_probs=105.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEe-ecccCh---HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKF-KLAVDD---EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~-~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
..|...+.||+|+||.||++.+... .+++|+. ...... ......+.+.+|+.+++.++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456789999999999999987543 3444432 221111 1112345788999999999999999888777777778
Q ss_pred eEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 147 LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
++++++..+...... ......++.+++.++.+||+.+ ++||||||+|||+ .++.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~-l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDV-LEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHH-HHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 888888765432211 1235778999999999999999 9999999999999 677999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=128.12 Aligned_cols=135 Identities=20% Similarity=0.169 Sum_probs=94.6
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHH--------------------HHHHHHHHHHhcCCCC--c
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKL--------------------EEFINEIVILSQINHR--N 132 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~--------------------~~~~~E~~~l~~l~h~--n 132 (366)
+.+.||+|+||.||+|...+++.||+|+++........... .....|...+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 35789999999999999878999999998764332111110 0113455556555333 2
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCC-----CCCCCH-HHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCe
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNE-----EFPLTW-EIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~-~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~ 205 (366)
+.+.+++ ...++++++..+.. ...... .....++.+++.++.++|. .+ ++|+||||+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 4444432 23467777665521 111112 5678899999999999999 88 99999999999999 889
Q ss_pred EEEeecCCcccc
Q 037297 206 AKVADFGTSKFI 217 (366)
Q Consensus 206 vkl~Dfg~a~~~ 217 (366)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=162.04 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=181.0
Q ss_pred HhcCCcccceecccCceEEEEEEEcC--CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED--GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEV 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 145 (366)
....|.+.+.||+|+|+.|-...... ...+|.|.+..... .....+....|..+-+.+. |+|++.+++.....+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~--~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK--SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC--ccchhhhcCccccccccccccccccccCCccCCCcc
Confidence 35678889999999999998877532 44566666655431 1233445666888878886 9999999998888887
Q ss_pred ceEEEeeccCCCCC---------CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCc
Q 037297 146 PLLHLHDHHRNEEF---------PLTWEIRLRIATEVAGALSYLH-SAASSPIYHRDIKSTNILLDERY-RAKVADFGTS 214 (366)
Q Consensus 146 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH-~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a 214 (366)
.++..++..+.... ..+....-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 77776654332211 3455677889999999999999 888 99999999999999999 9999999999
Q ss_pred ccccC-CC-ceeeeeccc-cCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 215 KFIAM-DQ-THVTTKIQG-TFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 215 ~~~~~-~~-~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
..... .+ .......+| ++.|+|||...+. ...+..|+||+|+++.-+++|..|+.............
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~--------- 243 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW--------- 243 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee---------
Confidence 87765 22 333345667 9999999998885 45678999999999999999999997655333211111
Q ss_pred cCccccccchHH--hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 291 KNHMYDILDDQV--VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 291 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.+... .............+++..++..+|+.|.+.+++-
T Consensus 244 -------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 -------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -------cccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11000 0111223344577889999999999999998873
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.7e-15 Score=117.87 Aligned_cols=135 Identities=20% Similarity=0.151 Sum_probs=111.2
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC--CceeeEeeEEeeCCcceEEEee
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~ 152 (366)
+.+.||+|.++.||++...+ ..+++|....... ...+..|...++.+.| +++++++.+....+..++++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999754 7799998876433 2467789999999966 5889998888877788888888
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 153 HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 153 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..+.....++......++.+++.++.++|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus 75 ~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7766555556677888999999999999986333499999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-13 Score=120.22 Aligned_cols=132 Identities=19% Similarity=0.303 Sum_probs=95.1
Q ss_pred ceec-ccCceEEEEEEEcCCcEEEEEEeecccC-----hH----HHHHHHHHHHHHHHHhcCCCCce--eeEeeEEeeCC
Q 037297 77 RILG-QGGQGTVYKGMLEDGRIMAVKKFKLAVD-----DE----ELLKLEEFINEIVILSQINHRNV--VKLLGCCLETE 144 (366)
Q Consensus 77 ~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----~~----~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 144 (366)
..|| .|+.|+||.+... +..+++|.+..... .. .......+.+|++++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999998875 77899998864221 00 01233568889999999988775 66666644332
Q ss_pred c----ceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 145 V----PLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 145 ~----~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
. .+++++...+... .+++.. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 2366665543211 123332 3678999999999999 99999999999999988999999998
Q ss_pred ccc
Q 037297 214 SKF 216 (366)
Q Consensus 214 a~~ 216 (366)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.2e-12 Score=119.61 Aligned_cols=140 Identities=17% Similarity=0.178 Sum_probs=94.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHH------------------------------------HHHH
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKL------------------------------------EEFI 119 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~------------------------------------~~~~ 119 (366)
.+.||.|++|.||+|+.++|+.||||+.++.....-.... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999989999999998775432111000 0244
Q ss_pred HHHHHHhcC----CCCceeeEeeEEe-eCCcceEEEeeccCCCCCCCCHH-----HHHHHHHHHHH-HHHHHHhCCCCCe
Q 037297 120 NEIVILSQI----NHRNVVKLLGCCL-ETEVPLLHLHDHHRNEEFPLTWE-----IRLRIATEVAG-ALSYLHSAASSPI 188 (366)
Q Consensus 120 ~E~~~l~~l----~h~niv~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~-----~~~~i~~~i~~-~l~~lH~~~~~~i 188 (366)
+|...+..+ +|.+-+..-.++. .....++++++..+.....+... ....++.+++. .+..+|..| +
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---F 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---c
Confidence 455544444 2333333333332 23446788888776543322111 23456666665 478899998 9
Q ss_pred EeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 189 YHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 189 iH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+|+|++|.||+++.++.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7e-13 Score=123.58 Aligned_cols=243 Identities=21% Similarity=0.233 Sum_probs=174.9
Q ss_pred hcCCcccceecc--cCceEEEEEEE--c-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC
Q 037297 70 TNHFNVNRILGQ--GGQGTVYKGML--E-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 143 (366)
Q Consensus 70 ~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (366)
...+.+.+.+|. |.+|.||.+.. . ++..+|+|.-+....... ....-++|+.-.+.+ .|+|.++.+..+...
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~--~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL--DSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc--ccccccchhhcccccCccccccccCcccccC
Confidence 356777889999 99999999885 3 578899998554443221 112335677777777 699999988888888
Q ss_pred CcceEEEeeccC-------CCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeec
Q 037297 144 EVPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAG----ALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADF 211 (366)
Q Consensus 144 ~~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Df 211 (366)
+..++.++.... .....++....+....+..+ |+..+|+.+ ++|-|+||+||+...+ ...+++||
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 888888776542 23334788888999999999 999999998 9999999999999999 88999999
Q ss_pred CCcccccCCCce----eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 212 GTSKFIAMDQTH----VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 212 g~a~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
|+...++...-. ......+...|++||... ..++..+|++|+|.++.+-.++..+....-
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------------- 331 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK--------------- 331 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC---------------
Confidence 998877654311 112235778899999764 567889999999999999888775543210
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
...|..+..-.+..++....+.++...+..|++.+|-.|++++.+.
T Consensus 332 ---~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 332 ---NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0001111000011122223344566689999999999999987764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.1e-11 Score=105.50 Aligned_cols=178 Identities=17% Similarity=0.230 Sum_probs=123.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccc
Q 037297 161 LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240 (366)
Q Consensus 161 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~ 240 (366)
..|+-.++.++.++.+...||..| .+-+|+.++|+|+++++.|.|+|-..-... .........+|...|.+||..
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--~ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--ANGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec--cCCceEecccCccccCCHHHh
Confidence 578889999999999999999999 999999999999999999999997654433 334455566799999999954
Q ss_pred c-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcccccH-----HHHHHHHhhcCccccccchHHhhhhcHH
Q 037297 241 Q-----SSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGNTSQENVSL-----AAFFVHSMRKNHMYDILDDQVVKLVKKN 309 (366)
Q Consensus 241 ~-----~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (366)
. +..-+...|.|.||+++++++.| +.||.+........... ...+....... . -+.+......-..
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~--~-g~~p~P~~~P~~~ 265 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQR--R-GLKPPPRSIPLSM 265 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhcc--C-CCCCCCCCCChhh
Confidence 3 44567789999999999998885 99998753211111111 00010000000 0 0011111111223
Q ss_pred HHHHHHHHHHHhhcC--CCCCCCCHHHHHHHHhhcccCC
Q 037297 310 QIMAFANLAERCLDL--NGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 310 ~~~~l~~li~~cl~~--dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.++++..+..+|+.. ++.-|||++.++..|..+.++.
T Consensus 266 Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 266 LPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred cCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 455788888999954 4678999999999998877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.9e-11 Score=112.64 Aligned_cols=163 Identities=18% Similarity=0.157 Sum_probs=120.5
Q ss_pred cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeeccCCC--CCCCCHHHHHHHH
Q 037297 93 EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE--EFPLTWEIRLRIA 170 (366)
Q Consensus 93 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~~~~i~ 170 (366)
.++.+|.+...+.... ...+...+-+..++.++||||+++++........|++.+...... ...+....+..-+
T Consensus 35 ~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl 110 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGL 110 (690)
T ss_pred ccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHH
Confidence 3578888888876544 223456677888999999999999999999999999998875432 2223455566778
Q ss_pred HHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhh
Q 037297 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSD 250 (366)
Q Consensus 171 ~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 250 (366)
.||+.||.+||..++ ++|++|.-+.|+++..|..||++|.++.....-.. .......-..|..|+.+.... ...|
T Consensus 111 ~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 111 FQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchh
Confidence 899999999986543 99999999999999999999999988754322111 111111223466777654333 3569
Q ss_pred HHHHHHHHHHHHhC
Q 037297 251 VYSFGVVLVELLTG 264 (366)
Q Consensus 251 iwslG~~l~el~~g 264 (366)
.|.|||++++++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-13 Score=117.98 Aligned_cols=192 Identities=18% Similarity=0.231 Sum_probs=125.5
Q ss_pred HHHHhcCCCCceeeEeeEEeeCC-----cceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037297 122 IVILSQINHRNVVKLLGCCLETE-----VPLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAAS 185 (366)
Q Consensus 122 ~~~l~~l~h~niv~~~~~~~~~~-----~~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 185 (366)
...+-++.|.|+++++.++.+.. ...++.++...+ ....+......+|+.||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 45566678999999998875543 344445544332 223567777889999999999999997 4
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC----CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHH
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD----QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVEL 261 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el 261 (366)
++|+|+++..+.|++..+|-+|++--. ....... .....+...+.++|.+||.-.....+.++|||++|+...+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999988875321 1111100 00111223467889999987666778899999999999999
Q ss_pred HhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 262 LTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 262 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.-|..--.........+. .... .+...-++ .-..++..|++..|..||+|.+++
T Consensus 276 ailEiq~tnseS~~~~ee-~ia~--------~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEE-NIAN--------VIIGLENG------------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHheeccCCCcceeehhh-hhhh--------heeeccCc------------cccCcCcccccCCCCCCcchhhhh
Confidence 888754221111001000 0000 01111111 123567789999999999999885
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-11 Score=100.50 Aligned_cols=130 Identities=19% Similarity=0.052 Sum_probs=91.6
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCcee-eEeeEEeeCCcceEEEeecc
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV-KLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~~~ 154 (366)
.+.++.|.++.||++... +..+++|........ ...+..|..+++.+.+.+++ +++.+. .+..+++++...
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc-----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 357899999999999875 778999987654321 12356788888888554544 444433 334567777766
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 155 RNEEFPLTWEIRLRIATEVAGALSYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 155 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
+...... .........+++.++..||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6543322 1122356789999999999987 12249999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-10 Score=94.69 Aligned_cols=135 Identities=16% Similarity=0.109 Sum_probs=96.3
Q ss_pred cceecccCceEEEEEEEcC-------CcEEEEEEeecccChHH------------------HHHHHH----HHHHHHHHh
Q 037297 76 NRILGQGGQGTVYKGMLED-------GRIMAVKKFKLAVDDEE------------------LLKLEE----FINEIVILS 126 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~------------------~~~~~~----~~~E~~~l~ 126 (366)
..+||.|--+.||.|...+ +..+|+|+.+.....-. ....+. ..+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4689999999999998542 47899999876443200 001122 348999998
Q ss_pred cCC--CCceeeEeeEEeeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCC
Q 037297 127 QIN--HRNVVKLLGCCLETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYL-HSAASSPIYHRDIKST 196 (366)
Q Consensus 127 ~l~--h~niv~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dikp~ 196 (366)
++. .-+++..+++ ...+++|++..+.. ...++......+..+++.+|..+ |+.+ ++|+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 884 3566666654 45566777665421 11344456677889999999999 8888 999999999
Q ss_pred CEEecCCCeEEEeecCCccccc
Q 037297 197 NILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 197 Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
||++.+ +.+.|+|||-+....
T Consensus 155 NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEEC-CcEEEEECCCceeCC
Confidence 999974 689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=110.11 Aligned_cols=145 Identities=14% Similarity=0.128 Sum_probs=89.6
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHH------------------------------HHHHH-
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEEL------------------------------LKLEE- 117 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~------------------------------~~~~~- 117 (366)
...|+. +.||+|++|+||+|..++ |+.||||+.++.....-. ...+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999876 999999999865322100 00111
Q ss_pred -----HHHHHHHHhcC----CCCceeeEeeEEee-CCcceEEEeeccCCCCCCCCHH-----HHHHHHHHHH-HHHHHHH
Q 037297 118 -----FINEIVILSQI----NHRNVVKLLGCCLE-TEVPLLHLHDHHRNEEFPLTWE-----IRLRIATEVA-GALSYLH 181 (366)
Q Consensus 118 -----~~~E~~~l~~l----~h~niv~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~-----~~~~i~~~i~-~~l~~lH 181 (366)
+.+|+..+.++ .+.+.+.+-.++.+ ....++++++..+.....+... ....++...+ .-+..+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 34444444333 24444444444433 3456677777766543221100 0112222222 2233445
Q ss_pred hCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCccccc
Q 037297 182 SAASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIA 218 (366)
Q Consensus 182 ~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~~~~ 218 (366)
..| ++|+|++|.||+++.++ .++++|||++..+.
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 677 99999999999999888 99999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-11 Score=114.21 Aligned_cols=248 Identities=19% Similarity=0.215 Sum_probs=171.0
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 143 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (366)
.....+|..+..||.|.|+.|+.+..+ ++..+++|.......... ....-..|+.+...+ .|.+++.++..+..-
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 334467888999999999999988743 578899998776554432 222345666666666 799999988887777
Q ss_pred CcceEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~ 215 (366)
...++-.+++...... .+.+..++.+..|++.++.++|++. .+|+|++|+||++.++ +..+++|||++.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 7777666665443221 3566778889999999999999998 9999999999999986 788999999986
Q ss_pred cccCCCceeeeeccccCCc-cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 216 FIAMDQTHVTTKIQGTFGY-LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y-~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.+...... ....+..| .+|.......+..+.|++|||..+.+.++|..- ...+...... +...
T Consensus 416 ~~~~~~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~~~~~~i-----------~~~~- 479 (524)
T KOG0601|consen 416 RLAFSSGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SESGVQSLTI-----------RSGD- 479 (524)
T ss_pred ccceeccc---ccccccccccchhhccccccccccccccccccccccccCccc-Ccccccceee-----------eccc-
Confidence 43222111 11122233 355566667888999999999999999888632 2211101000 0000
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
. ...+.....+..+.+.+...|+..||.+.++....+-.++
T Consensus 480 --------~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 480 --------T-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred --------c-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0 1112223567788889999999999999988765554443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.8e-09 Score=95.22 Aligned_cols=206 Identities=18% Similarity=0.234 Sum_probs=141.8
Q ss_pred CceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC----CcceEEEeeccC--
Q 037297 83 GQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----EVPLLHLHDHHR-- 155 (366)
Q Consensus 83 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~~~~~~~~-- 155 (366)
...+.|++..+ +|..+++|++........ ..-..-++..+++.|+|+|++.+++... ...++++.++..
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 34678999854 799999999944322211 0122347789999999999999887633 234444443322
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 156 ---------------------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 156 ---------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
.+...+++..+|.++.|+..||.++|+.| ..-+-+.|.+|+++.+..++|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccce
Confidence 12235788999999999999999999999 999999999999999999999988876
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..+..+.. |.+.+ .-+-|.=.||.++..|.||..--...+
T Consensus 441 Dvl~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d---------------------- 480 (655)
T KOG3741|consen 441 DVLQEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD---------------------- 480 (655)
T ss_pred eeecCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccccccccc----------------------
Confidence 55433221 11111 126799999999999999964311100
Q ss_pred ccccchHH-hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 037297 295 YDILDDQV-VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339 (366)
Q Consensus 295 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L 339 (366)
..... ...+...++.++.+++......++++ -++.+++..+
T Consensus 481 ---~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 481 ---STQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---chHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00111 22345667778888888888888887 6777776544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-09 Score=85.74 Aligned_cols=134 Identities=22% Similarity=0.228 Sum_probs=96.0
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEe-ecccChH---HHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKF-KLAVDDE---ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~-~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
..+++|+-+.++.+.+. |..+++|.= ++....+ ..-..++..+|+.++..+.--.|....-+..+.+...+++++
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 444566542 2222222 223356778899999988666666655566677777788888
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 153 HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 153 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+......-+.....++..+=.-+.-||..| |+|+||.++||++.+++ +.++|||++.
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 77654332222224567788888889999999 99999999999998874 9999999986
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.8e-09 Score=88.49 Aligned_cols=137 Identities=20% Similarity=0.238 Sum_probs=100.8
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC--CceeeEeeEEeeCC---cceEEEe
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETE---VPLLHLH 151 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~~~~~ 151 (366)
+.|+.|..+.||++...+|..+++|........ .....+..|..+++.+.+ .++.+++.+..... ..+++++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998766688999987654321 122357789999999865 44566777665532 4567777
Q ss_pred eccCCCCC------CCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 037297 152 DHHRNEEF------PLTWEIRLRIATEVAGALSYLHSAA----------------------------------------- 184 (366)
Q Consensus 152 ~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------------- 184 (366)
+..+.... .++......++.+++.++..||+..
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 66544322 3566778888999999999998531
Q ss_pred ------------CCCeEeCCCCCCCEEecC--CCeEEEeecCCccc
Q 037297 185 ------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSKF 216 (366)
Q Consensus 185 ------------~~~iiH~dikp~Nill~~--~~~vkl~Dfg~a~~ 216 (366)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.8e-11 Score=116.06 Aligned_cols=246 Identities=21% Similarity=0.191 Sum_probs=161.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...+.+.+.+.+-+|+++.++.+.-. .|...+.|+......-. ....+....+-.++-...+|-++...--+......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34567788888999999999988743 34334444333211110 01122233333333334556666665555666677
Q ss_pred eEEEeeccCCCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++.++..+.... ....+-.+.....+.++.+|||... +.|+|++|.|.++..++..++.|||.....+.
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 7777766443211 2445566677788899999999987 89999999999999999999999984322210
Q ss_pred C---------------------C---------ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037297 220 D---------------------Q---------THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269 (366)
Q Consensus 220 ~---------------------~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 269 (366)
- . ........+|+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 001123458999999999999999999999999999999999999997
Q ss_pred CCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 037297 270 STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTME 333 (366)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 333 (366)
.... ++. +. .+.+.. .. ....+...+.+..+++...+..+|.+|..+.
T Consensus 1037 a~tp--q~~------f~-ni~~~~-~~------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETP--QQI------FE-NILNRD-IP------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccch--hhh------hh-ccccCC-CC------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6441 110 00 000000 00 1123455666788999999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.7e-08 Score=83.60 Aligned_cols=123 Identities=24% Similarity=0.230 Sum_probs=79.5
Q ss_pred EEEEEEcCCcEEEEEEeecccChH----------------------HHHHHHHHHHHHHHHhcCCCC--ceeeEeeEEee
Q 037297 87 VYKGMLEDGRIMAVKKFKLAVDDE----------------------ELLKLEEFINEIVILSQINHR--NVVKLLGCCLE 142 (366)
Q Consensus 87 V~~~~~~~~~~vaiK~~~~~~~~~----------------------~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~ 142 (366)
||.|...+|..+|+|..+.....- .........+|.+.|..+..- ++++.+++
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence 899998889999999987643320 112235678899999999655 56666654
Q ss_pred CCcceEEEeecc--CCCCCCC-----CHHHHHHHHHHHHHHHHH-HHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 143 TEVPLLHLHDHH--RNEEFPL-----TWEIRLRIATEVAGALSY-LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 143 ~~~~~~~~~~~~--~~~~~~l-----~~~~~~~i~~~i~~~l~~-lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
....++|++.. +.....+ +......++.+++..+.. +|..| ++|+|+.+.||+++++ .+.|+|||.+
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTE
T ss_pred -eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcc
Confidence 23457777766 2222211 123456778888885555 57888 9999999999999988 9999999987
Q ss_pred ccc
Q 037297 215 KFI 217 (366)
Q Consensus 215 ~~~ 217 (366)
...
T Consensus 154 v~~ 156 (188)
T PF01163_consen 154 VDS 156 (188)
T ss_dssp EET
T ss_pred eec
Confidence 643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.1e-10 Score=108.81 Aligned_cols=150 Identities=23% Similarity=0.298 Sum_probs=103.9
Q ss_pred HHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce--------eeeeccccCCcccccccc
Q 037297 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--------VTTKIQGTFGYLEPEYHQ 241 (366)
Q Consensus 170 ~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~~~t~~y~aPE~~~ 241 (366)
+.+++.|+.++|...+ +||++|.|++|.++.++..||+.|+.+......... ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998654 999999999999999999999999987544321111 111133567899999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHH
Q 037297 242 SSQLTDKSDVYSFGVVLVELLTGKKP-IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAER 320 (366)
Q Consensus 242 ~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 320 (366)
+...+.++|+||+|+++|-+..|..+ +...+...... .....+.........+.+.++.+=+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~---------------~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS---------------FSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh---------------hhhcccccccccccccCcHHHHHHHHH
Confidence 98889999999999999999854444 33322111100 000111111112335566688888999
Q ss_pred hhcCCCCCCCCHHHHH
Q 037297 321 CLDLNGKKRPTMEEVT 336 (366)
Q Consensus 321 cl~~dp~~Rpt~~ell 336 (366)
++..|+..||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999887764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.5e-08 Score=77.85 Aligned_cols=138 Identities=19% Similarity=0.187 Sum_probs=96.7
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEe-ecccCh---HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKF-KLAVDD---EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~-~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
....+-+|+-+.|+++.+. |+...||.- .+.... +..-...+..+|+..+.++.--.|....-++.+...-.+.|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999886 676666642 221111 22234567888999998886556655555555666666777
Q ss_pred eeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eEEEeecCCccc
Q 037297 151 HDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKF 216 (366)
Q Consensus 151 ~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~vkl~Dfg~a~~ 216 (366)
+...+.. ..+........++.++-+.+.-||..+ +||+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 7665421 112222333678899999999999998 99999999999997654 358999999853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.9e-08 Score=82.62 Aligned_cols=137 Identities=20% Similarity=0.175 Sum_probs=99.1
Q ss_pred CCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHH------------------HHHHHHHHHHHHHHhcCCCC--
Q 037297 72 HFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEE------------------LLKLEEFINEIVILSQINHR-- 131 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~~~~E~~~l~~l~h~-- 131 (366)
=+.++..||-|--|.||.|.+.+|..+|+|.=+....+-. ........+|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3467789999999999999999999999997655433211 11245678899999999655
Q ss_pred ceeeEeeEEeeCCcceEEEeeccCCCCCCCC--HHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHRNEEFPLT--WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
.|++.+++ +...++|+...+.....++ ....-.++..|++-+.-+-..| +||+|+++-||++++||.+.++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEE
Confidence 77777664 3444556665554444443 4445555666666566555777 9999999999999999999999
Q ss_pred ecCCcc
Q 037297 210 DFGTSK 215 (366)
Q Consensus 210 Dfg~a~ 215 (366)
||--+.
T Consensus 245 DwPQ~v 250 (304)
T COG0478 245 DWPQAV 250 (304)
T ss_pred eCcccc
Confidence 998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-06 Score=76.79 Aligned_cols=134 Identities=16% Similarity=0.115 Sum_probs=86.6
Q ss_pred eecccCceEEEEEEEcCCcEEEEEEeecccChHHHHH-------HHHHHHHHHHHhcCCCCce--eeEeeEEee-----C
Q 037297 78 ILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLK-------LEEFINEIVILSQINHRNV--VKLLGCCLE-----T 143 (366)
Q Consensus 78 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~ 143 (366)
.+-......|.+... +|+.+.+|............. ...+.+|...+..+...+| +..+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344666544 477899997754332210000 1136788888877743333 334444332 2
Q ss_pred CcceEEEeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-------CCeE
Q 037297 144 EVPLLHLHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-------RYRA 206 (366)
Q Consensus 144 ~~~~~~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-------~~~v 206 (366)
...+++++...+.. ..+.+......++.+++..+.-||+.| ++|+|+++.|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 23567777655431 123445567789999999999999999 999999999999975 4689
Q ss_pred EEeecCCcc
Q 037297 207 KVADFGTSK 215 (366)
Q Consensus 207 kl~Dfg~a~ 215 (366)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-06 Score=71.34 Aligned_cols=132 Identities=18% Similarity=0.147 Sum_probs=89.2
Q ss_pred cccCceEEEEEEEcCCcEEEEEEeecccChH-H-HHHHHHHHHHHHHHhcCCC--CceeeEeeEEeeCC----cceEEEe
Q 037297 80 GQGGQGTVYKGMLEDGRIMAVKKFKLAVDDE-E-LLKLEEFINEIVILSQINH--RNVVKLLGCCLETE----VPLLHLH 151 (366)
Q Consensus 80 g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~----~~~~~~~ 151 (366)
|+||-|.|+..... |..+-+|.-....... . ......|.+|...+..+.. -++.+...+..... ..+++++
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 66899999987765 4468888754111110 0 0134578999999988843 23444442221211 3555665
Q ss_pred eccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe--EEEeecCCcc
Q 037297 152 DHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR--AKVADFGTSK 215 (366)
Q Consensus 152 ~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~--vkl~Dfg~a~ 215 (366)
...+. ...+.+......+..+++..+.-||+.| +.|+|+-+.||+++.++. +.++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 44422 1223466677899999999999999999 999999999999986666 9999998664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.2e-06 Score=70.23 Aligned_cols=129 Identities=17% Similarity=0.101 Sum_probs=84.7
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC--ceeeEeeEEeeCCcceEEEeecc
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR--NVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
..||+|..+.||+. .+..+++|........ ....+|.++++.+..- .+.+.+++........++++...
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCH------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 2556788888754322 2457788888887433 34566666655555556666655
Q ss_pred CCC----CCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------CCCCeEe
Q 037297 155 RNE----EFPLTWEIRLRIATEVAGALSYLHSA----------------------------------------ASSPIYH 190 (366)
Q Consensus 155 ~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~----------------------------------------~~~~iiH 190 (366)
+.. ....+......++.++++.+.-||+. ..+.++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 532 11223333344555555555555542 1234789
Q ss_pred CCCCCCCEEecCCCeEEEeecCCcc
Q 037297 191 RDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 191 ~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
+|+.|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-05 Score=68.35 Aligned_cols=98 Identities=20% Similarity=0.248 Sum_probs=70.6
Q ss_pred HHHHHHHHHHhcCCC--CceeeEeeEEeeCC----cceEEEeeccCCCCC--------CCCHHHHHHHHHHHHHHHHHHH
Q 037297 116 EEFINEIVILSQINH--RNVVKLLGCCLETE----VPLLHLHDHHRNEEF--------PLTWEIRLRIATEVAGALSYLH 181 (366)
Q Consensus 116 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~----~~~~~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH 181 (366)
....+|...+..+.. -.+++.+++..... ..+++++...+.... ..+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467788887777743 33445555544422 345566655443211 1345667889999999999999
Q ss_pred hCCCCCeEeCCCCCCCEEecCCC---eEEEeecCCccc
Q 037297 182 SAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKF 216 (366)
Q Consensus 182 ~~~~~~iiH~dikp~Nill~~~~---~vkl~Dfg~a~~ 216 (366)
+.| ++|+|+++.|||++.++ .+.++||+.+..
T Consensus 136 ~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 99999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-05 Score=68.46 Aligned_cols=135 Identities=19% Similarity=0.214 Sum_probs=90.3
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHH--------------------HHHHHHHHHHHHhcC--CCCce
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELL--------------------KLEEFINEIVILSQI--NHRNV 133 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~--------------------~~~~~~~E~~~l~~l--~h~ni 133 (366)
..+|++|--+.||+|...++..+|+|+++......... ...-..+|...|+++ .+-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34677788889999988789999999998755442210 011235667677666 24444
Q ss_pred eeEeeEEeeCCcceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCe
Q 037297 134 VKLLGCCLETEVPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 134 v~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~ 205 (366)
.+.+++.. -.++|+..... ...++.......+..++++.+.-|-. .+ +||+||+.=|||+. ++.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCe
Confidence 44444321 22344443322 22233444677788888888888877 56 99999999999999 779
Q ss_pred EEEeecCCccccc
Q 037297 206 AKVADFGTSKFIA 218 (366)
Q Consensus 206 vkl~Dfg~a~~~~ 218 (366)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999876443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2e-05 Score=66.27 Aligned_cols=142 Identities=15% Similarity=0.141 Sum_probs=87.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHH-----HHHHHHHHHHhcCCCCce---eeEeeE
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKL-----EEFINEIVILSQINHRNV---VKLLGC 139 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~ni---v~~~~~ 139 (366)
...++|.+.+++-......|.+-... |..+++|..+.........-. ....+.+..+..+...++ ..++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 44578898899998888888877664 788999988765443221111 112333333333322222 222222
Q ss_pred -----EeeCCcceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 140 -----CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 140 -----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
+......++++++..+.....+.. .--.+...+.+++.-+|+.| +.|+|..|.|++++.+ .++++||+..
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-IDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-cCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccc
Confidence 222233445677766654332211 00135566788899999999 9999999999999966 5999999865
Q ss_pred c
Q 037297 215 K 215 (366)
Q Consensus 215 ~ 215 (366)
.
T Consensus 182 ~ 182 (229)
T PF06176_consen 182 R 182 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=77.32 Aligned_cols=136 Identities=18% Similarity=0.175 Sum_probs=83.2
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHH------------------------------------HHH
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEE------------------------------------FIN 120 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------------------~~~ 120 (366)
..|+.++-|.||+|..++|+.||||+.++.....-...... +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999999999999999988766532222111 223
Q ss_pred HHHHHhcC----CCCceeeEeeEEee-CCcceEEEeeccCCCCCC--------CCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 037297 121 EIVILSQI----NHRNVVKLLGCCLE-TEVPLLHLHDHHRNEEFP--------LTWEIRLRIATEVAG-ALSYLHSAASS 186 (366)
Q Consensus 121 E~~~l~~l----~h~niv~~~~~~~~-~~~~~~~~~~~~~~~~~~--------l~~~~~~~i~~~i~~-~l~~lH~~~~~ 186 (366)
|...+.++ +...=++.-.+|.+ .....+++++..+..... .+.. .++..++. -+..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~~dg-- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLLRDG-- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHHhcC--
Confidence 33322222 12222222233332 344556666665543222 2222 22222222 223333356
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+.|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.5e-05 Score=65.80 Aligned_cols=58 Identities=22% Similarity=0.258 Sum_probs=40.1
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC--ceeeEeeEE
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR--NVVKLLGCC 140 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~ 140 (366)
++.++.|..+.||.+...+ ..+++|..... .....+..|..+++.+... .+.+++..+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~ 61 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFD 61 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeec
Confidence 3578999999999999876 68999987653 2234666788888777422 455666644
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=9.2e-07 Score=83.88 Aligned_cols=179 Identities=20% Similarity=0.133 Sum_probs=127.3
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc-eeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~ 151 (366)
|....-.++|+++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+..++...+..+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 3344557899999999987543343445555432 23456889999999999 7777777777777666666
Q ss_pred eccCCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 152 DHHRNEEF---------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 152 ~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
....+... .+.......+++.-+.+++++|+.. -+|+| ||+..+ +..+..||+.+..+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 55544211 1222333456666778999999864 48998 777766 589999999987654332
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 270 (366)
......+++.++|||+.....+....|.|++|+-..+|.-|.+|-..
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 23446789999999999999999999999999988888878777543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.1e-05 Score=65.32 Aligned_cols=130 Identities=18% Similarity=0.083 Sum_probs=78.4
Q ss_pred eecccCc-eEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeeccC
Q 037297 78 ILGQGGQ-GTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHHR 155 (366)
Q Consensus 78 ~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~~ 155 (366)
.|..|.+ ..||+.... +..+.+|...... .....+|+++++.+ ++-.+.+++++....+..+++++...+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3455655 788998764 4778888876532 12455688888777 344566677766655556677666544
Q ss_pred CCCCCCC-HHHHHHHHHHHHHHHHHHHhC---------------------------------------------------
Q 037297 156 NEEFPLT-WEIRLRIATEVAGALSYLHSA--------------------------------------------------- 183 (366)
Q Consensus 156 ~~~~~l~-~~~~~~i~~~i~~~l~~lH~~--------------------------------------------------- 183 (366)
....... ......++.++++.+..||+.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 3211100 011112233333333333321
Q ss_pred ----CCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 184 ----ASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 184 ----~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.4e-05 Score=61.51 Aligned_cols=130 Identities=17% Similarity=0.122 Sum_probs=83.0
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
.+..+.|++|.+|.||++.+. |..+|+|+-+.+... ..+..|++++..+.-.++.+=+-.+.... +.+++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r------~~l~kEakiLeil~g~~~~p~vy~yg~~~---i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR------RNLEKEAKILEILAGEGVTPEVYFYGEDF---IRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcch------hhHHHHHHHHHHhhhcCCCceEEEechhh---hhhhh
Confidence 345678999999999999986 568999988776444 46677999999888777654332222221 22444
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC-CCCEEecCCCeEEEeecCCcc
Q 037297 153 HHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK-STNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 153 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik-p~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+..........-.+-...+++.-.-|-..| |-|+.|. |...++.+++.+.|+||..|.
T Consensus 94 i~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 44433222211101333444555555566667 9999997 444444444499999999886
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00047 Score=57.76 Aligned_cols=130 Identities=18% Similarity=0.225 Sum_probs=86.0
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHH------------HHHHHHHHHHHHHHhcCC------CCceeeEe
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEE------------LLKLEEFINEIVILSQIN------HRNVVKLL 137 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~~~E~~~l~~l~------h~niv~~~ 137 (366)
...||+|+.-.||. +.+....+||+......... .....+..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999986 55567789999887650000 011345556665555554 88999999
Q ss_pred eEEeeCCcceEEEeeccCCCCC-CCCHHHHH-------HHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---C-e
Q 037297 138 GCCLETEVPLLHLHDHHRNEEF-PLTWEIRL-------RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER---Y-R 205 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~-------~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~---~-~ 205 (366)
|+..+.....++.+......+. ..+..... .+...+-+-..||-+.+ |+.+|++|.||++..+ . .
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceE
Confidence 9999988888887765544322 22222211 23444445566777777 9999999999999632 2 5
Q ss_pred EEEee
Q 037297 206 AKVAD 210 (366)
Q Consensus 206 vkl~D 210 (366)
+.|+|
T Consensus 161 lvlID 165 (199)
T PF10707_consen 161 LVLID 165 (199)
T ss_pred EEEEe
Confidence 77777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00012 Score=60.94 Aligned_cols=94 Identities=22% Similarity=0.294 Sum_probs=74.0
Q ss_pred HHHHHHhcCCC-CceeeEeeEEeeCCcceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 037297 120 NEIVILSQINH-RNVVKLLGCCLETEVPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188 (366)
Q Consensus 120 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 188 (366)
.|.-+++.+.+ +++++++|+|-. +++.++.... ....-+|..+.+++.++++.+.+++......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47778888855 699999999833 3344444422 22356899999999999999999998554459
Q ss_pred EeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 189 YHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 189 iH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...|++|+|+-+++++.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00031 Score=58.45 Aligned_cols=129 Identities=28% Similarity=0.397 Sum_probs=85.3
Q ss_pred cCCcccceecccCc-eEEEEEEEcCCcEEEEEEeec---ccC--------hHHH------HHHHHHHHHHHHHhcC---C
Q 037297 71 NHFNVNRILGQGGQ-GTVYKGMLEDGRIMAVKKFKL---AVD--------DEEL------LKLEEFINEIVILSQI---N 129 (366)
Q Consensus 71 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~---~~~--------~~~~------~~~~~~~~E~~~l~~l---~ 129 (366)
.+++.++.||.|.- |.||++... |+.+|+|.++. ... .... ....-|..|.+..-+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999985 77999999322 111 0111 2234577887776666 4
Q ss_pred CCce--eeEeeEEeeCC-c----------------c-eEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037297 130 HRNV--VKLLGCCLETE-V----------------P-LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189 (366)
Q Consensus 130 h~ni--v~~~~~~~~~~-~----------------~-~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 189 (366)
+.++ ++.+++..-.. . . -++-+...... .+ ...-+.+|..-+..+|..| |+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--~~----~~~~~~~~~~dl~~~~k~g---I~ 186 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--PL----QIRDIPQMLRDLKILHKLG---IV 186 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--cc----chhHHHHHHHHHHHHHHCC---ee
Confidence 5566 88888864331 0 0 11111111111 12 2334556777788999999 99
Q ss_pred eCCCCCCCEEecCCCeEEEeecCCc
Q 037297 190 HRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 190 H~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
-+|+++.|.. .-+|+|||.+
T Consensus 187 ~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 187 PRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred eccCcccccc-----CCEEEecccC
Confidence 9999999987 4589999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00051 Score=70.62 Aligned_cols=139 Identities=18% Similarity=0.199 Sum_probs=87.4
Q ss_pred cceecccCceEEEEEEEcCC---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCce--eeEeeEEeeC---Ccc
Q 037297 76 NRILGQGGQGTVYKGMLEDG---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNV--VKLLGCCLET---EVP 146 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~ 146 (366)
.+.++.|.+..+|.....++ ..+++|+.+..... .....+.+|..+++.+. |+++ ++.+.+|.+. ...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 56789999999999876543 46777776543221 11235778999999984 6654 7777777654 356
Q ss_pred eEEEeeccCCCCC-----CCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 037297 147 LLHLHDHHRNEEF-----PLTWEIRLRIATEVAGALSYLHS--------------------------------------- 182 (366)
Q Consensus 147 ~~~~~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~--------------------------------------- 182 (366)
++++++..+.... .++...+..++.+++++|..||+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 7788776553211 12233333344444444443333
Q ss_pred --------------CC--------CCCeEeCCCCCCCEEecC-CCe-EEEeecCCcccc
Q 037297 183 --------------AA--------SSPIYHRDIKSTNILLDE-RYR-AKVADFGTSKFI 217 (366)
Q Consensus 183 --------------~~--------~~~iiH~dikp~Nill~~-~~~-vkl~Dfg~a~~~ 217 (366)
+- .+.++|+|+++.|++++. ++. .-|.||+++...
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 11 023999999999999985 334 579999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00065 Score=58.94 Aligned_cols=28 Identities=29% Similarity=0.520 Sum_probs=24.7
Q ss_pred eEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 188 IYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 188 iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
++|+|+.|.||+++.++..-|+||+.+.
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 8999999999999877656799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00026 Score=72.11 Aligned_cols=191 Identities=17% Similarity=0.161 Sum_probs=126.0
Q ss_pred HHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe----e-------ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037297 116 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH----D-------HHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184 (366)
Q Consensus 116 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~----~-------~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 184 (366)
.....|+..+..+.|+|++.++.+-.+.....+++. . ........++..+.+.+..+...|+.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344556777888899999999988665543332111 1 11123446788999999999999999999986
Q ss_pred CCCeEeCCCCCC---CEEecCCCeEEEe--ecCCcccccCCCceeeeeccccCCccccccccCCCCCc--hhhHHHHHHH
Q 037297 185 SSPIYHRDIKST---NILLDERYRAKVA--DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD--KSDVYSFGVV 257 (366)
Q Consensus 185 ~~~iiH~dikp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~DiwslG~~ 257 (366)
..|.-+... +.-.+..+.+.++ ||+.+........... ...+..+.+||......... ..|+|.+|..
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 566555554 5555666777777 8988876654332221 22345577888776665554 4799999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 258 LVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 258 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+..|..+-..... ... .++......+.+....|+..++++|+++.+++.
T Consensus 382 ~~~~~~~~~i~~~~~~--------------------~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV--------------------PVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HhhhhhcCcccccccc--------------------hhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999887654221110 000 011111115678889999999999999999986
Q ss_pred HH
Q 037297 338 EL 339 (366)
Q Consensus 338 ~L 339 (366)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 54
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0017 Score=56.27 Aligned_cols=29 Identities=28% Similarity=0.446 Sum_probs=26.1
Q ss_pred CeEeCCCCCCCEEecC-CCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDE-RYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~-~~~vkl~Dfg~a~ 215 (366)
.++|+|+.+.|||+++ ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999998 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0076 Score=54.82 Aligned_cols=29 Identities=21% Similarity=0.275 Sum_probs=25.3
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.+||+|+.|.||+++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999977556899999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0064 Score=54.68 Aligned_cols=73 Identities=10% Similarity=-0.026 Sum_probs=49.1
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC---CceeeEeeEEeeC---CcceEE
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH---RNVVKLLGCCLET---EVPLLH 149 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~~~ 149 (366)
.+.||.|..+.||.....++ .+.+|..+..... ..+..|...++.+.. ..+++.+++|... +..+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSFSTP------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecccccc------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 46799999999999876555 4666775431111 367789888888832 4677888776543 456777
Q ss_pred EeeccC
Q 037297 150 LHDHHR 155 (366)
Q Consensus 150 ~~~~~~ 155 (366)
++...+
T Consensus 92 mE~i~G 97 (297)
T PRK10593 92 LERLRG 97 (297)
T ss_pred EeccCC
Confidence 776443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.005 Score=55.36 Aligned_cols=29 Identities=28% Similarity=0.325 Sum_probs=26.1
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 39999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0027 Score=60.85 Aligned_cols=137 Identities=15% Similarity=0.159 Sum_probs=82.9
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHH---------------------------HHH------HHHHHH
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLK---------------------------LEE------FINEIV 123 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~---------------------------~~~------~~~E~~ 123 (366)
+.||.-+.|.||+|+.++|+.||||+-++.....-... .+. |..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999999887655421111 011 233332
Q ss_pred HH----hcCCCCc---eeeEeeEEee-CCcceEEEeeccCCCCCC--------CCHHHHHHHHHHHHHHH-HHHHhCCCC
Q 037297 124 IL----SQINHRN---VVKLLGCCLE-TEVPLLHLHDHHRNEEFP--------LTWEIRLRIATEVAGAL-SYLHSAASS 186 (366)
Q Consensus 124 ~l----~~l~h~n---iv~~~~~~~~-~~~~~~~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l-~~lH~~~~~ 186 (366)
.. +.+.|-+ =|..-.++.+ .....++||+..+..... ++... ++..+.++. .-+-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf~~G-- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIFKTG-- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHHhcC--
Confidence 22 2233444 1112222222 235667788777654332 23332 333332221 2223345
Q ss_pred CeEeCCCCCCCEEec----CCCeEEEeecCCcccccC
Q 037297 187 PIYHRDIKSTNILLD----ERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 187 ~iiH~dikp~Nill~----~~~~vkl~Dfg~a~~~~~ 219 (366)
++|+|=+|.||++. .++.+.+.|||+......
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 467899999999876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00047 Score=61.13 Aligned_cols=138 Identities=16% Similarity=0.152 Sum_probs=88.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHH------------------HHHHHHHHHHHHHhcCC-C
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEEL------------------LKLEEFINEIVILSQIN-H 130 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~-h 130 (366)
..-+.+++.||-|--+-||.+-+.+|...++|.-+....+-.. -..-...+|...|+.|. |
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred chhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3456788899999999999999988999999875443322110 01234577888888883 2
Q ss_pred -CceeeEeeEEeeCCcceEEEeeccCCCCCCCC-HHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEE
Q 037297 131 -RNVVKLLGCCLETEVPLLHLHDHHRNEEFPLT-WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV 208 (366)
Q Consensus 131 -~niv~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl 208 (366)
=.|++.+++.. .+++++...+.+..... ......+...+..-+.-|-.+| +||+|..--||++.+++.+++
T Consensus 171 gfpVPkpiD~~R----H~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 171 GFPVPKPIDHNR----HCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCCCcccccc----eeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEE
Confidence 23444554422 12222222221111111 1223345556666677788888 999999999999999999999
Q ss_pred eecCCc
Q 037297 209 ADFGTS 214 (366)
Q Consensus 209 ~Dfg~a 214 (366)
+||--.
T Consensus 244 IDFPQm 249 (465)
T KOG2268|consen 244 IDFPQM 249 (465)
T ss_pred eechHh
Confidence 999644
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0041 Score=57.89 Aligned_cols=74 Identities=23% Similarity=0.179 Sum_probs=46.2
Q ss_pred ceecccCceEEEEEEEcCC-cEEEEEEeecccCh--HH-HHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeCCcceEE
Q 037297 77 RILGQGGQGTVYKGMLEDG-RIMAVKKFKLAVDD--EE-LLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~--~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.||.|.+..||++...+| +.++||.-...... .. ....++...|.+.|+.+ ...++++++.+.. +..+++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 5789999999999998776 48999985422110 10 01234566777777776 2345677776633 334455
Q ss_pred Eee
Q 037297 150 LHD 152 (366)
Q Consensus 150 ~~~ 152 (366)
+++
T Consensus 110 ME~ 112 (401)
T PRK09550 110 MED 112 (401)
T ss_pred Eec
Confidence 544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0039 Score=54.79 Aligned_cols=29 Identities=17% Similarity=0.256 Sum_probs=25.5
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++|+|+.|.||++++++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.034 Score=50.26 Aligned_cols=30 Identities=27% Similarity=0.314 Sum_probs=26.5
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 349999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0082 Score=53.37 Aligned_cols=30 Identities=30% Similarity=0.521 Sum_probs=25.2
Q ss_pred CeEeCCCCCCCEEecCCCe-EEEeecCCccc
Q 037297 187 PIYHRDIKSTNILLDERYR-AKVADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~-vkl~Dfg~a~~ 216 (366)
.++|+|++|.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.018 Score=52.24 Aligned_cols=138 Identities=17% Similarity=0.165 Sum_probs=91.8
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecccChH---------------------HHH-HHHHHHHHHHHHhcCCCC
Q 037297 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDE---------------------ELL-KLEEFINEIVILSQINHR 131 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---------------------~~~-~~~~~~~E~~~l~~l~h~ 131 (366)
.+..+|..|--+-||-|...+|..+|||+++.....- ... ..--...|++.|+++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 5668899999999999998889999999987643310 000 011235577777777554
Q ss_pred ceeeEeeEEeeCCcceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
.|...--..... ..++|..... ....+++...+..+-.|++.-|.-|-+.++ +||.||+--|+|+.+ |
T Consensus 227 GIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 227 GIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-C
Confidence 443322222211 2233443332 123356777788888888888888887654 999999999999855 5
Q ss_pred eEEEeecCCccc
Q 037297 205 RAKVADFGTSKF 216 (366)
Q Consensus 205 ~vkl~Dfg~a~~ 216 (366)
.+.|+|-+-+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 899999886543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0094 Score=53.75 Aligned_cols=30 Identities=27% Similarity=0.366 Sum_probs=26.6
Q ss_pred CCeEeCCCCCCCEEecCC----CeEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDER----YRAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~----~~vkl~Dfg~a~ 215 (366)
..++|+|+.|.||+++.+ +.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 458999999999999974 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.041 Score=49.55 Aligned_cols=140 Identities=15% Similarity=0.180 Sum_probs=85.6
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeCC--cceEE
Q 037297 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETE--VPLLH 149 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~--~~~~~ 149 (366)
.+++.+..|..-.+|..... ++.+++. .+. ............+|..+++.+. -..+...+++|.++. ..+.+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 33444444444445554443 7778888 332 1112234456677888887773 445566677777776 66677
Q ss_pred EeeccCCCCC-CC-CHHHHHHHHH-HHHHHHHHHHhC-------------------------------------------
Q 037297 150 LHDHHRNEEF-PL-TWEIRLRIAT-EVAGALSYLHSA------------------------------------------- 183 (366)
Q Consensus 150 ~~~~~~~~~~-~l-~~~~~~~i~~-~i~~~l~~lH~~------------------------------------------- 183 (366)
++...+.... .+ +.....+++. .++..|..||+-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 7665552111 11 1111123333 677777777753
Q ss_pred ------------CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 184 ------------ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 184 ------------~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
+...++|+|+.+.|++++.++.+=+.||+++...
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1246999999999999999988999999998653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.055 Score=48.25 Aligned_cols=71 Identities=20% Similarity=0.097 Sum_probs=44.8
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeCCcceEEEee
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
.+.++.|.-..+|... .+++.+.+|+-..... ..|..|.+-|+.| ..-.+++.+++....+..+++++.
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~-------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR-------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC-------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChhhH-------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 4668889999999887 5578899998774322 2566777777777 345677888887777777887775
Q ss_pred cc
Q 037297 153 HH 154 (366)
Q Consensus 153 ~~ 154 (366)
..
T Consensus 94 l~ 95 (288)
T PF03881_consen 94 LE 95 (288)
T ss_dssp --
T ss_pred ec
Confidence 43
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.045 Score=50.34 Aligned_cols=29 Identities=24% Similarity=0.463 Sum_probs=25.6
Q ss_pred CeEeCCCCCCCEEecC-CCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDE-RYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~-~~~vkl~Dfg~a~ 215 (366)
.++|+|+++.|||+++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 5789999999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.14 Score=46.75 Aligned_cols=30 Identities=27% Similarity=0.431 Sum_probs=25.7
Q ss_pred CeEeCCCCCCCEEecC-CCeEEEeecCCccc
Q 037297 187 PIYHRDIKSTNILLDE-RYRAKVADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~ 216 (366)
..+|+|+.+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999974 57899999998753
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.13 Score=46.02 Aligned_cols=30 Identities=23% Similarity=0.337 Sum_probs=25.2
Q ss_pred CCeEeCCCCCCCEEecCC--C---eEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDER--Y---RAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~--~---~vkl~Dfg~a~ 215 (366)
+-++|||+++.|||+..+ | .++++||-.+.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 469999999999999754 3 58999998775
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.025 Score=46.70 Aligned_cols=29 Identities=14% Similarity=0.195 Sum_probs=25.5
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998887 88999998853
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.11 Score=49.39 Aligned_cols=81 Identities=22% Similarity=0.279 Sum_probs=47.7
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc-ccccchHHhhhhcHHHHHHHHHHHHHhhcCC
Q 037297 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM-YDILDDQVVKLVKKNQIMAFANLAERCLDLN 325 (366)
Q Consensus 247 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 325 (366)
+|+||||+|.++.++.-|..-+..... .........-... .+...-.....+.-.++..++++...|+-..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~--------s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~ 181 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTE--------SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLE 181 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHH--------HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccc
Confidence 499999999999999988765533221 1111111110000 0001111112344567778899999999999
Q ss_pred CCCCCCHHHH
Q 037297 326 GKKRPTMEEV 335 (366)
Q Consensus 326 p~~Rpt~~el 335 (366)
|..||...++
T Consensus 182 ~~ir~l~~~~ 191 (725)
T KOG1093|consen 182 PIIRPLPMEL 191 (725)
T ss_pred cccccchhHH
Confidence 9999866554
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.0098 Score=63.02 Aligned_cols=94 Identities=14% Similarity=0.040 Sum_probs=73.2
Q ss_pred HHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhH
Q 037297 174 AGALSYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDV 251 (366)
Q Consensus 174 ~~~l~~lH~~~--~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 251 (366)
.....-+|++. ++..+|+++|+.|.+|..+.+++++++|+.+...... .......+++-|++|+....-.++.++|+
T Consensus 1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred HhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence 45555555542 4567999999999999999999999999998433222 22233456777899998888888889999
Q ss_pred HHHHHHHHHHHhCCCCC
Q 037297 252 YSFGVVLVELLTGKKPI 268 (366)
Q Consensus 252 wslG~~l~el~~g~~p~ 268 (366)
|..|+.+|....|..+|
T Consensus 1424 lr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHhcccHHH
Confidence 99999999998888776
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.5 Score=44.18 Aligned_cols=66 Identities=14% Similarity=0.044 Sum_probs=41.0
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHH---HHHHHHHHHHHHHhcCC---CCceeeEeeEEee
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEEL---LKLEEFINEIVILSQIN---HRNVVKLLGCCLE 142 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 142 (366)
.+.||.|....||+.... +..++||.-......... ....+...|.+.|+.+. ..++++++.++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT 108 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC
Confidence 467899999999998874 556889976522221000 12234445566666553 3577788887763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.88 Score=48.19 Aligned_cols=30 Identities=33% Similarity=0.552 Sum_probs=25.4
Q ss_pred CeEeCCCCCCCEEecCCC--eEE-EeecCCccc
Q 037297 187 PIYHRDIKSTNILLDERY--RAK-VADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~--~vk-l~Dfg~a~~ 216 (366)
.+||+|+.+.||+++.++ .+. |+|||.+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 399999999999999875 565 999998753
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.03 Score=42.81 Aligned_cols=33 Identities=24% Similarity=0.351 Sum_probs=29.4
Q ss_pred ceecccCceEEEEEEEcCCcEEEEEEeecccCh
Q 037297 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD 109 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~ 109 (366)
+.||.|+.|+||+|+.++|+.||||+.++....
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~ 49 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIEE 49 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHHH
Confidence 679999999999999988999999999875544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.13 Score=46.40 Aligned_cols=28 Identities=32% Similarity=0.436 Sum_probs=24.6
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999988 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.59 Score=42.96 Aligned_cols=29 Identities=28% Similarity=0.439 Sum_probs=24.8
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++|||+.+.||+++.+ .++++|+..+..
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 38999999999999876 478999987754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.70 E-value=2.8 Score=38.25 Aligned_cols=27 Identities=22% Similarity=0.310 Sum_probs=23.1
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.+.|||++ + .+.++||+.+.
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 389999999999995 4 57899999774
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.14 Score=45.17 Aligned_cols=29 Identities=21% Similarity=0.302 Sum_probs=26.9
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.|+|++.++.+.++|+||..|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 48999999999999998999999998775
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.52 E-value=0.084 Score=47.55 Aligned_cols=37 Identities=22% Similarity=0.156 Sum_probs=23.5
Q ss_pred HHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEec
Q 037297 165 IRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 165 ~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~ 201 (366)
-+..++.||+--.--+-.. +....+|.||||+|||+-
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 313 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF 313 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence 3455677775433213222 244599999999999993
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.052 Score=46.11 Aligned_cols=29 Identities=28% Similarity=0.461 Sum_probs=20.9
Q ss_pred CeEeCCCCCCCEEe-cCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILL-DERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill-~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.|.||++ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 888999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.64 Score=42.53 Aligned_cols=53 Identities=26% Similarity=0.318 Sum_probs=45.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 161 LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 161 l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..+.+...++.+.+..++-+...- +.-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 457788888888888777777643 489999999999999 99999999999974
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.18 E-value=0.086 Score=44.60 Aligned_cols=86 Identities=16% Similarity=0.133 Sum_probs=51.9
Q ss_pred HHHHHHHHHhcCCCCceeeEeeEEeeCCc-ceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 117 EFINEIVILSQINHRNVVKLLGCCLETEV-PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 117 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
-+..+.+++.++ -.|+++.. +... ..+++|.+......+.. .+... +.+|.-.|+.. ...+|||-.|
T Consensus 104 ~y~nky~v~Arm--hGilrL~N---Dn~~~yGvIlE~Cy~~~i~~~N-----~i~ag-i~~L~~fH~~~-~~~lHGD~np 171 (308)
T PF07387_consen 104 LYFNKYRVFARM--HGILRLKN---DNNYKYGVILERCYKIKINFSN-----FITAG-IKDLMDFHSEN-QHCLHGDCNP 171 (308)
T ss_pred hhhhhhhHHHHh--hheeEeec---CCCceeEEEEeeccCcccchhH-----HHHHh-HHHHHHhhccC-CCeecCCCCh
Confidence 455666665543 34555552 1222 33445665544322211 11111 35667778542 3499999999
Q ss_pred CCEEecCCCeEEEeecCCc
Q 037297 196 TNILLDERYRAKVADFGTS 214 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a 214 (366)
+|||.+..|.+||.|-+.-
T Consensus 172 ~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 172 DNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred hheeecCCCCEEecChhhh
Confidence 9999999999999998754
|
The function of this family is unknown. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.092 Score=44.05 Aligned_cols=30 Identities=23% Similarity=0.346 Sum_probs=25.5
Q ss_pred CCeEeCCCCCCCEEecCCC-----eEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDERY-----RAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~-----~vkl~Dfg~a~ 215 (366)
+.++|||+.+.|+++..++ .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4599999999999998543 68999999875
|
subfamily of choline kinases |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 366 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-106
Identities = 108/298 (36%), Positives = 159/298 (53%), Gaps = 23/298 (7%)
Query: 58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEE 117
+L++ATN+F+ ++G G G VYKG+L DG +A+K+ E +EE
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR----TPESSQGIEE 81
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEI 165
F EI LS H ++V L+G C E +L HL+ ++WE
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM-SMSWEQ 140
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHV 224
RL I A L YLH+ I HRD+KS NILLDE + K+ DFG SK +DQTH+
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
+T ++GT GY++PEY +LT+KSDVYSFGVVL E+L + I + +E V+LA +
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEW 255
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
V S + I+D + ++ + F + A +CL L+ + RP+M +V +L
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 7e-98
Identities = 101/296 (34%), Positives = 160/296 (54%), Gaps = 18/296 (6%)
Query: 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLE-E 117
K FS +EL A+++F+ ILG+GG G VYKG L DG ++AVK+ K +E E +
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK----EERTQGGELQ 73
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEI 165
F E+ ++S HRN+++L G C+ LL L + ++ PL W
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPK 132
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225
R RIA A L+YLH I HRD+K+ NILLDE + A V DFG +K + THVT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285
T ++GT G++ PEY + + ++K+DV+ +GV+L+EL+TG++ + ++V L +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNG 341
+++ + ++D + K ++ +A C + +RP M EV L G
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-93
Identities = 95/308 (30%), Positives = 149/308 (48%), Gaps = 30/308 (9%)
Query: 57 RCKLFSSKELDKATNHFN------VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDE 110
R FS EL TN+F+ +G+GG G VYKG + + +AVKK VD
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 111 ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEE 158
++F EI ++++ H N+V+LLG + + L L +
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC--LDGT 127
Query: 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FI 217
PL+W +R +IA A +++LH HRDIKS NILLDE + AK++DFG ++
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
QT +T++I GT Y+ PE ++T KSD+YSFGVVL+E++TG + + +E
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV----DEHRE 239
Query: 278 NVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337
L + + D+ + + A ++A +CL KRP +++V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 338 ELNGIRGS 345
L + S
Sbjct: 300 LLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-67
Identities = 65/312 (20%), Positives = 111/312 (35%), Gaps = 39/312 (12%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
++ L + + + +G G V+K L +AVK F + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-----QNEY 67
Query: 121 EIVILSQINHRNVVKLLGCCLE-----------TE-VPLLHLHDH-HRNEEFPLTWEIRL 167
E+ L + H N+++ +G T L D N ++W
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC 124
Query: 168 RIATEVAGALSYLHSAASS-------PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220
IA +A L+YLH I HRDIKS N+LL A +ADFG +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 221 QTHVTTKIQ-GTFGYLEPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
++ T Q GT Y+ PE + + D+Y+ G+VL EL + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 275 SQ---ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM-AFANLAERCLDLNGKKRP 330
E + M++ ++ + +K+ M E C D + + R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 331 TMEEVTMELNGI 342
+ V + +
Sbjct: 305 SAGCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-63
Identities = 82/289 (28%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELL---KLEEFINEIVILS 126
N + +G+GG G V+KG ++D ++A+K L + E K +EF E+ I+S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 127 QINHRNVVKLLGCCLE-----TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
+NH N+VKL G E VP L+ ++ P+ W ++LR+ ++A + Y+
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 181 HSAASSPIYHRDIKSTNILLDER-----YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
+ + PI HRD++S NI L AKVADFG S+ H + + G F ++
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWM 193
Query: 236 EPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
PE + T+K+D YSF ++L +LTG+ P F + + F +
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGK-----IKFINMIREEGL 247
Query: 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
I +D N+ E C + KKRP + EL+ +
Sbjct: 248 RPTIPED---------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 5e-63
Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 58/307 (18%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINE 121
S +D V ++G+G G V K + +A+K+ + + E + FI E
Sbjct: 1 SLHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESER---KAFIVE 51
Query: 122 IVILSQINHRNVVKLLGCCLE-----TEVPLLH---LHD--HHRNEEFPLTWEIRLRIAT 171
+ LS++NH N+VKL G CL E L++ H T +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPVCLVME--YAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTKIQG 230
+ + ++YLHS + HRD+K N+LL K+ DFGT+ D T +G
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKG 165
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
+ ++ PE + S ++K DV+S+G++L E++T +KP + + AF
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------FDEIGGPAF------ 211
Query: 291 KNHMYDILDDQVVKLVKKNQ--------IMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+++ V +L RC + +RP+MEE+ + +
Sbjct: 212 ----------RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
Query: 343 RGSNFGH 349
G
Sbjct: 262 MRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-62
Identities = 80/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
N+ +G G GTV++ G +AVK E + EF+ E+ I+ ++ H
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV--NEFLREVAIMKRLRH 93
Query: 131 RNVVKLLGCCLE-------TEVPLLH---LHD--HHRNEEFPLTWEIRLRIATEVAGALS 178
N+V +G + TE L L+ H L RL +A +VA ++
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTE--YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
YLH+ + PI HR++KS N+L+D++Y KV DFG S+ A + GT ++ PE
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPE 209
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
+ +KSDVYSFGV+L EL T ++P + L
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP---------------------------WGNL 242
Query: 299 D-DQVVKLVKKNQI---------MAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ QVV V A + E C KRP+ + L +
Sbjct: 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-61
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 63/300 (21%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ I+G GG G VY+ G +AVK + D++ +E E + + + H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 131 RNVVKLLGCCLE-------TEVPLLH---LHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
N++ L G CL+ E L+ + P +I + A ++A ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVME--FARGGPLNRVLSGKRIP--PDILVNWAVQIARGMNYL 121
Query: 181 HSAASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMDQTHVTTKIQGTF 232
H A PI HRD+KS+NIL+ ++ K+ DFG ++ +T + G +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-GAY 178
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
++ PE ++S + SDV+S+GV+L ELLTG+ P
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP------------------------- 213
Query: 293 HMYDILDD-QVVKLVKKNQI---------MAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ +D V V N++ FA L E C + + RP+ + +L I
Sbjct: 214 --FRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-58
Identities = 51/297 (17%), Positives = 101/297 (34%), Gaps = 61/297 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
N L + G ++KG G + VK K+ K +F E L +H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTR--KSRDFNEECPRLRIFSH 66
Query: 131 RNVVKLLGCCLETEVPLLH----------LHDH-HRNEEFPLTWEIRLRIATEVAGALSY 179
NV+ +LG C P L++ H F + ++ A ++A +++
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE- 238
LH+ I + S ++++DE A+++ ++ PE
Sbjct: 127 LHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEA 179
Query: 239 --YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
+D++SF V+L EL+T + P +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP---------------------------FA 212
Query: 297 ILDD-QVVKLVKKNQI---------MAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
L + ++ V + + L + C++ + KRP + + L ++
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-57
Identities = 75/324 (23%), Positives = 128/324 (39%), Gaps = 72/324 (22%)
Query: 44 QQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKF 103
++ DD I ++ V + +G G GTVYKG +AVK
Sbjct: 10 HGSRDAADDWEIPDGQIT-------------VGQRIGSGSFGTVYKGKWHG--DVAVKML 54
Query: 104 KLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------TE-VPLLHLHDHHRN 156
+ + L+ F NE+ +L + H N++ +G T+ L+ H
Sbjct: 55 NVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA 112
Query: 157 EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216
E + + IA + A + YLH+ I HRD+KS NI L E K+ DFG +
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 217 IA-MDQTHVTTKIQGTFGYLEPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
+ +H ++ G+ ++ PE S+ + +SDVY+FG+VL EL+TG+ P
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----- 224
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILD--DQVVKLVKKNQIM------------AFANLA 318
Y ++ DQ++++V + + L
Sbjct: 225 ----------------------YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262
Query: 319 ERCLDLNGKKRPTMEEVTMELNGI 342
CL +RP+ + E+ +
Sbjct: 263 AECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-56
Identities = 63/322 (19%), Positives = 113/322 (35%), Gaps = 63/322 (19%)
Query: 44 QQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKF 103
Q + I +L + ++G+G G VY G G + A++
Sbjct: 19 SQTSIFLQEWDIPFEQLE-------------IGELIGKGRFGQVYHGRW-HGEV-AIRLI 63
Query: 104 KLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-------TEVPLLH---LHDH 153
+ D+E+ L + F E++ Q H NVV +G C+ T L L+
Sbjct: 64 DIERDNEDQL--KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS--LCKGRTLYSV 119
Query: 154 HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213
R+ + L +IA E+ + YLH+ I H+D+KS N+ D + + DFG
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVITDFGL 175
Query: 214 SKFIA----MDQTHVTTKIQGTFGYLEPEYHQSSQL---------TDKSDVYSFGVVLVE 260
+ G +L PE + + SDV++ G + E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 261 LLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAER 320
L + P F T + + ++ + K +++
Sbjct: 236 LHAREWP-FKTQPAEA-----IIWQMG---TGMKPNLSQIGMGK--------EISDILLF 278
Query: 321 CLDLNGKKRPTMEEVTMELNGI 342
C ++RPT ++ L +
Sbjct: 279 CWAFEQEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-51
Identities = 66/291 (22%), Positives = 115/291 (39%), Gaps = 49/291 (16%)
Query: 77 RILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+LG+G G K E G +M +K+ DEE + F+ E+ ++ + H NV+K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQR--TFLKEVKVMRCLEHPNVLK 71
Query: 136 LLGCCLETEVPLLH----------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+G + L+ L ++ + W R+ A ++A ++YLHS
Sbjct: 72 FIGVL--YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS--- 126
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------------GTF 232
I HRD+ S N L+ E VADFG ++ + ++T G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
++ PE +K DV+SFG+VL E++ + L + +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLN--VRGFLDRY 243
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+ +F + RC DL+ +KRP+ ++ L +R
Sbjct: 244 CPPNCPP-------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-51
Identities = 60/337 (17%), Positives = 114/337 (33%), Gaps = 52/337 (15%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
++ E ++ + ++G+G G VYKG L D R +AVK F + FIN
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANR----QNFIN 54
Query: 121 E--IVILSQINHRNVVKLLGCCLETEVPLLH-------------LHDHHRNEEFPLTWEI 165
E I + + H N+ + + L + W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVS 112
Query: 166 RLRIATEVAGALSYLHSAASS------PIYHRDIKSTNILLDERYRAKVADFGTSKFIA- 218
R+A V L+YLH+ I HRD+ S N+L+ ++DFG S +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 219 ------MDQTHVTTKIQGTFGYLEPEY-------HQSSQLTDKSDVYSFGVVLVELLTGK 265
++ + GT Y+ PE + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV-------KKNQIMAFANLA 318
+F + + ++ + M ++ + + + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 319 ERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMIYST 355
E C D + + R T + + + +K + T
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 60/298 (20%), Positives = 99/298 (33%), Gaps = 43/298 (14%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINE--IVILSQINHRNVV 134
+ +G+G G V+ G G +AVK F EE + E I + H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEE----ASWFRETEIYQTVLMRHENIL 94
Query: 135 KLLGCCLETEVPLLH------------LHDH-HRNEEFPLTWEIRLRIATEVAGALSYLH 181
+ ++ L+D+ L + L++A L +LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH 151
Query: 182 SAASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFG 233
+ S I HRD+KS NIL+ + +AD G + + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 234 YLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFF 285
Y+ PE Q +D+YSFG++L E+ ++ +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIM-AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
MR+ L ++ + L C N R T V L +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 58/306 (18%), Positives = 105/306 (34%), Gaps = 59/306 (19%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINE--IVILSQINHRNVV 134
+G+G G V++G G +AVK F +E + + E + + H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDE----KSWFRETELYNTVMLRHENIL 65
Query: 135 KLLGCCLE-----------TE-VPLLHLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLH 181
+ + T + L+D+ L LRI +A L++LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLH 122
Query: 182 SAASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA----MDQTHVTTKIQGTF 232
I HRD+KS NIL+ + + +AD G + + ++ GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 181
Query: 233 GYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286
Y+ PE + D+++FG+VL E+ + F
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-------NGIVEDYKPPFY 234
Query: 287 HSMRKNHMYDILDDQVV---------KLVKKNQIM-AFANLAERCLDLNGKKRPTMEEVT 336
+ + ++ + V + + + A L + C N R T +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 337 MELNGI 342
L I
Sbjct: 295 KTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-44
Identities = 65/308 (21%), Positives = 109/308 (35%), Gaps = 48/308 (15%)
Query: 78 ILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINE--IVILSQINHRNVVK 135
+G+G G V++G G +AVK F EE + E I + H N++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREE----RSWFREAEIYQTVMLRHENILG 100
Query: 136 LLGCCLETEVPLLH------------LHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+ + L D+ +R +T E +++A A L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHM 157
Query: 183 AASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI---QGTFGY 234
I HRD+KS NIL+ + +AD G + + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 235 LEPE--------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAF 284
+ PE H S ++D+Y+ G+V E+ + ++ +
Sbjct: 218 MAPEVLDDSINMKHFES--FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIM-AFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
V MRK L + + + + A + C NG R T + L+ +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 344 GSNFGHKM 351
G KM
Sbjct: 336 QQE-GIKM 342
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-39
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 55/290 (18%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLA-VDDEELLKLEEFINEIVILSQI 128
+ V +G G G K DG+I+ K+ + + E + ++E+ +L ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK---QMLVSEVNLLREL 62
Query: 129 NHRNVVKLLGCCLETEVPLLH----------LHDH---HRNEEFPLTWEIRLRIATEVAG 175
H N+V+ ++ L+ L E L E LR+ T++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 176 ALSYLHS--AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
AL H + HRD+K N+ LD + K+ DFG ++ + D + T + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
Y+ PE +KSD++S G +L EL P F S
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQ---- 221
Query: 294 MYDILDDQVVKLVKKNQI--------MAFANLAERCLDLNGKKRPTMEEV 335
++ +++ + + R L+L RP++EE+
Sbjct: 222 ------KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 36/279 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLA--VDDEELLKLEEFINEIVILSQ 127
+F + + +G+G VY+ L DG +A+KK ++ +D + + I EI +L Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQ 88
Query: 128 INHRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGA 176
+NH NV+K +E L + H + ++ + + ++ A
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L ++HS + HRDIK N+ + K+ D G +F + T + + GT Y+
Sbjct: 149 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 204
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PE + KSD++S G +L E+ + P F + ++
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSL--------------CKK 249
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
I L + L C++ + +KRP + V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 68/294 (23%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F ++G GG G V+K DG+ +K+ K E+ E+ L++++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLD 62
Query: 130 HRNVVKLLGCCLETEVP---------------------------LLHLHDHHRNEEFPLT 162
H N+V GC + L + R E+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD-- 120
Query: 163 WEIR-LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221
++ L + ++ + Y+HS + +RD+K +NI L + + K+ DFG ++
Sbjct: 121 -KVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKN 174
Query: 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
T+ +GT Y+ PE S + D+Y+ G++L ELL F T
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------- 226
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
F +R + DI D + L++K L + RP E+
Sbjct: 227 ---FFTDLRDGIISDIFDKKEKTLLQK------------LLSKKPEDRPNTSEI 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-37
Identities = 53/273 (19%), Positives = 106/273 (38%), Gaps = 38/273 (13%)
Query: 76 NRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVV 134
+ +G+G TVYKG+ E +A + + + + + F E +L + H N+V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIV 88
Query: 135 KLLGCCLETEVPLLHLH-----------DHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
+ T + + + ++ ++ L +LH+
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 184 ASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ PI HRD+K NI + K+ D G + + GT ++ PE ++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYE- 203
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF-VHSMRKNHMYDILDDQ 301
+ + DVY+FG+ ++E+ T + P S+ + + V S K +D +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
VK + E C+ N +R ++++
Sbjct: 258 EVK-----------EIIEGCIRQNKDERYSIKD 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 63/297 (21%), Positives = 109/297 (36%), Gaps = 62/297 (20%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLA-VDDEELLKLEEF 118
+ ++K + + +G+G G EDGR +K+ ++ + +E EE
Sbjct: 18 LYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EES 70
Query: 119 INEIVILSQINHRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIR- 166
E+ +L+ + H N+V+ E L + + F E +
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---EDQI 127
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
L ++ AL ++H I HRDIKS NI L + ++ DFG ++ +
Sbjct: 128 LDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286
I GT YL PE ++ +KSD+++ G VL EL T K F
Sbjct: 185 CI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----------------FEA 227
Query: 287 HSMRKNHMYDILDDQVVKLVKKNQI--------MAFANLAERCLDLNGKKRPTMEEV 335
SM +V + +L + N + RP++ +
Sbjct: 228 GSM----------KNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 62/295 (21%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+++ + +G GG V++ + E +I A+K L D + L+ + NEI L+++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQ 85
Query: 131 --RNVVKLLGC------------CLETEVPLLHLHDH-HRNEEFPLTWEIRLRIATEVAG 175
+++L C + L+ + + WE + +
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGNID-----LNSWLKKKKSIDP-WERK-SYWKNMLE 138
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 234
A+ +H I H D+K N L+ + K+ DFG + + D T V Q GT Y
Sbjct: 139 AVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 235 LEPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283
+ PE S+++ KSDV+S G +L + GK P N +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------ 248
Query: 284 FFVHSMRKNHMYDI---LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ NH + + + ++K CL + K+R ++ E+
Sbjct: 249 -LHAIIDPNHEIEFPDIPEKDLQDVLK------------CCLKRDPKQRISIPEL 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 58/273 (21%), Positives = 95/273 (34%), Gaps = 37/273 (13%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
F LG G G V+K EDGR+ AVK+ + + E+ ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQ 115
Query: 130 HRNVVKLLGC-------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H V+L L+TE+ L H L + AL++LHS
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ H D+K NI L R R K+ DFG + +G Y+ PE Q
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELLQ- 229
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+DV+S G+ ++E+ + G +R+ ++ +
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMEL-PHGGEG-----------WQQLRQGYLPPEFTAGL 277
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ L+ + K R T E +
Sbjct: 278 SS--------ELRSVLVMMLEPDPKLRATAEAL 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 69/331 (20%), Positives = 126/331 (38%), Gaps = 65/331 (19%)
Query: 43 LQQMLNSY---DDSVIDRCKLFSSKELDKAT-----NHFNVNRILGQGGQGTVYKGMLED 94
+ +++ + + + + + K + +G+G G V+ G L
Sbjct: 78 IPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRA 137
Query: 95 GRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL----- 148
+ AVK + + + +F+ E IL Q +H N+V+L+G C + + P+
Sbjct: 138 DNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMEL 193
Query: 149 ----HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204
R E L + L++ + A + YL S HRD+ + N L+ E+
Sbjct: 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKN 250
Query: 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LEPEYHQSSQLTDKSDVYSFGVVLVELL 262
K++DFG S+ A D + + PE + + +SDV+SFG++L E
Sbjct: 251 VLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
Query: 263 T-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY-DILDDQVVKLVKKNQIM-------- 312
+ G P Y ++ + Q + V+K +
Sbjct: 310 SLGASP---------------------------YPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 313 AFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
A L E+C +RP+ + EL IR
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 62/295 (21%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+++ + +G GG V++ + E +I A+K L D + L+ + NEI L+++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQ 66
Query: 131 --RNVVKLLGC------------CLETEVPLLHLHDH-HRNEEFPLTWEIRLRIATEVAG 175
+++L C + L+ + + WE + +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECGNID-----LNSWLKKKKSIDP-WERK-SYWKNMLE 119
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 234
A+ +H I H D+K N L+ + K+ DFG + + D T V Q GT Y
Sbjct: 120 AVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 235 LEPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283
+ PE S+++ KSDV+S G +L + GK P F
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQISK----- 229
Query: 284 FFVHSMRKNHMYDI---LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ NH + + + ++K CL + K+R ++ E+
Sbjct: 230 -LHAIIDPNHEIEFPDIPEKDLQDVLK------------CCLKRDPKQRISIPEL 271
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 33/209 (15%)
Query: 75 VNRILGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
V + GG G +Y +GR + +K + D E + E L+++ H +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHPS 140
Query: 133 VVKLLGCCLETEVPLLH-------------LHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
+V++ T+ L L + E+ ALSY
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSY 197
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
LHS + + D+K NI+L E + K+ D G ++ + GT G+ PE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGFQAPE- 247
Query: 240 HQ-SSQLTDKSDVYSFGVVLVELLTGKKP 267
+ T +D+Y+ G L L
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 59/299 (19%), Positives = 102/299 (34%), Gaps = 60/299 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F + LG+GG G V++ D A+K+ +L + E+ + E+ L+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLE 61
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHH----------------------RNEEFPLTWEIRL 167
H +V+ LE R + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
I ++A A+ +LHS + HRD+K +NI KV DFG + D+ T
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 228 IQ-----------GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
GT Y+ PE + + K D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------------- 225
Query: 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
F R + D+ + + L + + + L + +RP +
Sbjct: 226 ------PFSTQMERVRTLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 75 VNRILGQGGQGTVYKGMLED---GRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQIN 129
+ LG GG TVY ED +A+K + EE L+ F E+ SQ++
Sbjct: 15 IVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPR-EKEET--LKRFEREVHNSSQLS 69
Query: 130 HRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
H+N+V ++ E + L L ++ PL+ + + ++ + + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAH 128
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLEPEY 239
I HRDIK NIL+D K+ DFG +K A+ +T +T + GT Y PE
Sbjct: 129 DMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ + +D+YS G+VL E+L G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 62/313 (19%), Positives = 118/313 (37%), Gaps = 52/313 (16%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFI 119
F + H+ + LG+GG V L DG A+K+ + +++ EE
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR--ILCHEQQ--DREEAQ 74
Query: 120 NEIVILSQINHRNVVKLLGCCLE-----TEVPLL-------HLHDH---HRNEEFPLT-W 163
E + NH N+++L+ CL E LL L + +++ LT
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+I L + + L +H+ HRD+K TNILL + + + D G+ +
Sbjct: 135 QI-LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 224 VTTKIQ--------GTFGYLEPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
+ T Y PE + +++DV+S G VL ++ G+ P +
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMV 249
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
++V+LA V + + +L+ + ++ +RP +
Sbjct: 250 FQKGDSVALA---VQNQLSIPQSPRHSSALWQLLN------------SMMTVDPHQRPHI 294
Query: 333 EEVTMELNGIRGS 345
+ +L ++
Sbjct: 295 PLLLSQLEALQPP 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 60/295 (20%), Positives = 112/295 (37%), Gaps = 62/295 (21%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+++ + +G GG V++ + E +I A+K L D + L+ + NEI L+++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQ 113
Query: 131 --RNVVKLLGC------------CLETEVPLLHLHDH-HRNEEFPLTWEIRLRIATEVAG 175
+++L C + L+ + + WE + +
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNID-----LNSWLKKKKSIDP-WERK-SYWKNMLE 166
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 234
A+ +H I H D+K N L+ + K+ DFG + + D T V Q G Y
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 235 LEPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283
+ PE S+++ KSDV+S G +L + GK P F +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQISKL---- 277
Query: 284 FFVHSMRKNHMYDI---LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ NH + + + ++K CL + K+R ++ E+
Sbjct: 278 --HAIIDPNHEIEFPDIPEKDLQDVLK------------CCLKRDPKQRISIPEL 318
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 69/306 (22%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ F +LGQG G V K D R A+KK + + + +E+++L+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-----SEVMLLASL 59
Query: 129 NHRNVVKLLGCCLETEVPLLH---------------------LHDHHRNEEFPLTWEIRL 167
NH+ VV+ LE + L+D +E +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---------- 217
R+ ++ ALSY+HS I HRD+K NI +DE K+ DFG +K +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 218 ----AMDQTHVTTKIQGTFGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
++T+ I GT Y+ E + +K D+YS G++ E++ FSTG
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTG 231
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVK---KNQIMAFANLAERCLDLNGKKR 329
+ ++ L ++ N++ + +D + KR
Sbjct: 232 ME----------------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 330 PTMEEV 335
P +
Sbjct: 276 PGARTL 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 60/283 (21%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HR 131
F +LG G +GT+ + D R +AVK+ E+ +L + + H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-------CFSFADREVQLLRESDEHP 78
Query: 132 NVVKLLGCCLETEVPLLH---------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
NV++ C E + + L ++ ++F + + + L++LHS
Sbjct: 79 NVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 183 AASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFIAMDQ--THVTTKIQGTFGYL 235
I HRD+K NIL+ + +A ++DFG K +A+ + + + GT G++
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 236 EPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
PE T D++S G V +++ F Q N+ +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------LLGA 244
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
D L +K++ + L E+ + ++ +KRP+ + V
Sbjct: 245 CSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 75 VNRILGQGGQGTVYKGMLED---GRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQIN 129
+ R++G+GG G VY+ ED RI+A+K L+ D E ++
Sbjct: 38 LRRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLS-SDPVFR--TRMQREARTAGRLQ 92
Query: 130 HRNVVKL--LGCCLETE---------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
+VV + G E + + + L R + PL + I ++ AL
Sbjct: 93 EPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALD 148
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLE 236
H+A HRD+K NIL+ A + DFG + A +T GT Y+
Sbjct: 149 AAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMA 203
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE S T ++D+Y+ VL E LTG P
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 55/291 (18%), Positives = 89/291 (30%), Gaps = 51/291 (17%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
E + + +G+G G V++ + G AVKK +L V E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------- 99
Query: 121 EIVILSQINHRNVVKLLGCCLETE--------VP---LLHLHDHHRNEEFPLTWEIRLRI 169
E+V + ++ +V L G E + L L L
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYY 155
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQTHVTTK- 227
+ L YLH+ I H D+K+ N+LL RA + DFG + + D +
Sbjct: 156 LGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 228 ---IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
I GT ++ PE K D++S +++ +L G P
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ-------------- 258
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEE 334
I + A + L R + E
Sbjct: 259 -YFRGPL--CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 75 VNRILGQGGQGTVYKGMLED---GRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQIN 129
+ ILG GG V+ D R +AVK + LA D F E + +N
Sbjct: 16 LGEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLA-RDPSFY--LRFRREAQNAAALN 70
Query: 130 HRNVVKLL--GCCLETEVPLLHLH------------DHHRNEEFPLTWEIRLRIATEVAG 175
H +V + G E E P L + E P+T + + + +
Sbjct: 71 HPAIVAVYDTG---EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFG 233
AL++ H I HRD+K NI++ KV DFG ++ IA VT + GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
YL PE + + +SDVYS G VL E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 59/299 (19%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIM-AVKKFKLAVDDEELLKLEEFINEIV 123
E+++ + LG G G VY+G+ + + AVK K E+ +++EEF+ E
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 268
Query: 124 ILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEE-FPLTWEIRLRIATEV 173
++ +I H N+V+LLG C P +L D+ R ++ + L +AT++
Sbjct: 269 VMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
+ A+ YL HR++ + N L+ E + KVADFG S+ + D +
Sbjct: 328 SSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
+ PE ++ + KSDV++FGV+L E+ T G P
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------------------------- 419
Query: 293 HMY-DILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
Y I QV +L++K+ M L C N RP+ E+ +
Sbjct: 420 --YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 77 RILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
++G+G G VY G L DG+ + AVK D E+ +F+ E +I+ +H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 151
Query: 133 VVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
V+ LLG CL +E L L + RNE T + + +VA + +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPE 238
AS HRD+ + N +LDE++ KVADFG ++ + + T L E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALE 266
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 77 RILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ LG+G G+V + G ++AVKK + + ++ L +F EI IL + H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 71
Query: 132 NVVKLLGCCLE---------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VK G C E +P L D+ + + + L+ +++ + YL
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEY 239
+ HRD+ + NIL++ R K+ DFG +K + D+ K G + PE
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
S+ + SDV+SFGVVL EL T +++ S A F+ + + ++
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTY----------IEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 300 DQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+++L+K N + + C + N +RP+ ++ + ++ IR
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-33
Identities = 71/292 (24%), Positives = 130/292 (44%), Gaps = 42/292 (14%)
Query: 77 RILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ LG+G G+V + G ++AVKK + + ++ L +F EI IL + H
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 102
Query: 132 NVVKLLGCCLE---------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VK G C E +P L D+ + + + L+ +++ + YL
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 161
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEY 239
+ HRD+ + NIL++ R K+ DFG +K + D+ + K G + PE
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
S+ + SDV+SFGVVL EL T +++ S A F+ + + ++
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTY----------IEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 300 DQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+++L+K N + + C + N +RP+ ++ + ++ IR
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+LG+G G VY G L + +A+K+ D L E EI + + H+N+V+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHE---EIALHKHLKHKNIVQ 83
Query: 136 LLGCCLETE--------VPLLHLHD--HHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
LG E VP L + + ++ L YLH
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---D 140
Query: 186 SPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE--YHQS 242
+ I HRDIK N+L++ K++DFGTSK +A T GT Y+ PE
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKP 267
+D++S G ++E+ TGK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 77 RILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
++G+G G VY G L DG+ + AVK D E+ +F+ E +I+ +H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 87
Query: 133 VVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
V+ LLG CL +E L L + RNE T + + +VA + YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPE 238
AS HRD+ + N +LDE++ KVADFG ++ + + T L E
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----------------------- 239
Query: 298 LDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348
+ + + + + + +C + RP+ E+ ++ I + G
Sbjct: 240 ---DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 77 RILGQGGQGTVYKGML----EDGRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
++LG G GTVYKG+ E +I A+K+ + A + +E ++E +++ +++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77
Query: 132 NVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
+V +LLG CL T+ +P L D+ R + + + L ++A ++YL
Sbjct: 78 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLEPEYHQ 241
+ HRD+ + N+L+ K+ DFG +K + ++ +G ++ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKP 267
T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 33/316 (10%), Positives = 72/316 (22%), Gaps = 66/316 (20%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIV 123
L + + L G + V+ +E A+K F + ++ +LE
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-ELERLHEATF 114
Query: 124 ILSQINHRNVVKLLGC---------------------------------CLETEVP---- 146
+++ + + L
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 147 --LLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204
L D + ++ + L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231
Query: 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY--HQSSQLTDKSDVYSFGVVLVELL 262
R + D Y E+ ++ T + + G+ + +
Sbjct: 232 RLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 263 TGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI---LDDQVVKLVKKNQIMAFANLAE 319
P F + + + L D V L+
Sbjct: 288 CLFLP-FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------------ 334
Query: 320 RCLDLNGKKRPTMEEV 335
R L+ + ++R E
Sbjct: 335 RFLNFDRRRRLLPLEA 350
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 44/292 (15%)
Query: 77 RILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
R LG+G G V + G +AVK K + + EI IL + H
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 83
Query: 132 NVVKLLGCCLE---------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
N+VK G C E E +P L ++ + + + +L+ A ++ + YL
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEY 239
S HRD+ + N+L++ ++ K+ DFG +K I D+ + T K + PE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 240 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
S+ SDV+SFGV L ELLT + M +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK------------MIGPTHGQMT 248
Query: 299 DDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
++V +K+ + + L +C + R + + + +
Sbjct: 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 61/299 (20%)
Query: 77 RILGQGGQGTVYKGMLEDGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
R++G+G G VY G D A+K + +++ E F+ E +++ +NH N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV---EAFLREGLLMRGLNHPN 83
Query: 133 VVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
V+ L+G L E L R+ + T + + +VA + YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPE 238
A HRD+ + N +LDE + KVADFG ++ I + Q L E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALE 198
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
Q+ + T KSDV+SFGV+L ELLT G P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----------------------- 235
Query: 298 LDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348
+ + + + + + + ++C + + RPT + E+ I + G
Sbjct: 236 ---DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 57/297 (19%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
E+ + + LGQG G V+ G +A+K K + E F+ E +
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQV 315
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEE-FPLTWEIRLRIATEVA 174
+ ++ H +V+L +E P+ L D + E L + +A ++A
Sbjct: 316 MKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
++Y+ HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 374 SGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
PE + T KSDV+SFG++L EL T G+ P N
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------------- 471
Query: 294 MYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+V+ V++ M + +L +C ++RPT E + L
Sbjct: 472 -------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 48/278 (17%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
F +G+G G V+KG+ +++A+K L ++E+ E+ EI +LSQ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDS 79
Query: 131 RNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIAT---EVAGA 176
V K G L+ L L + +E +IAT E+
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE--------TQIATILREILKG 131
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L YLHS HRDIK+ N+LL E K+ADFG + + Q T + GT ++
Sbjct: 132 LDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 187
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PE + S K+D++S G+ +EL G+ P +H M+ ++
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSE---------------LHPMKV--LFL 230
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
I + L + N E CL+ RPT +E
Sbjct: 231 IPKNNPPTL-EGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 71/334 (21%), Positives = 119/334 (35%), Gaps = 59/334 (17%)
Query: 36 KQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLED- 94
+ G L D +V + + R LG+G G V +
Sbjct: 9 HHHHGALEVLFQGPGDPTVFHK-------------RYLKKIRDLGEGHFGKVSLYCYDPT 55
Query: 95 ----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-------- 142
G ++AVK K + + EI IL + H +++K GCC +
Sbjct: 56 NDGTGEMVAVKALKADAGPQHR---SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112
Query: 143 -TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL 200
E VPL L D+ L L A ++ ++YLH+ HRD+ + N+LL
Sbjct: 113 VMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQICEGMAYLHAQH---YIHRDLAARNVLL 167
Query: 201 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEYHQSSQLTDKSDVYSFGVVL 258
D K+ DFG +K + + + G + PE + + SDV+SFGV L
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 259 VELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM----- 312
ELLT + + ++ +L+++ + +
Sbjct: 228 YELLTHCDSS------------QSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 275
Query: 313 ---AFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
+L + C + RPT E + L +
Sbjct: 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 43/275 (15%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ +GQG GTVY M + G+ +A+++ L ++ E INEI+++ + +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVMRENKNP 77
Query: 132 NVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+V L L + L + +E +I + E AL +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAA-VCRECLQALEFL 132
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
HS + + HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
K D++S G++ +E++ G+ P + + +R +Y I +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---------------ENPLRA--LYLIATN 231
Query: 301 QVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEE 334
+L ++ F + RCL+++ +KR + +E
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 64/304 (21%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
N +ILG G GTV GR +AVK+ + + + EI +L++ +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDD 67
Query: 130 HRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIATEVA 174
H NV++ C ET L++ + + + ++A
Sbjct: 68 HPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQ 221
+++LHS I HRD+K NIL+ E R ++DFG K + Q
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 222 THVTTKIQ---GTFGYLEPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
+ T + GT G+ PE +LT D++S G V +L+ K F
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331
+ + N+ F + M + D ++ +L + +D + KRPT
Sbjct: 243 KYSRESNIIRGIF-----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPT 289
Query: 332 MEEV 335
+V
Sbjct: 290 AMKV 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-31
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 45/292 (15%)
Query: 77 RILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
LG+G G+V G ++AVK+ + + D++ +F EI IL ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSD 84
Query: 132 NVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
+VK G +P L D + L L ++++ + YL
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 182 SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEY 239
S HRD+ + NIL++ K+ADFG +K + +D+ + + G + PE
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 240 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
+ + +SDV+SFGVVL EL T K + + M
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR------------MMGCERDVPA 249
Query: 299 DDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
++++L+++ Q + L + C + + RP+ + +L+ +
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 49/299 (16%), Positives = 99/299 (33%), Gaps = 64/299 (21%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
T F+ +G G G+V+K + DG I A+K+ K + + + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--DEQNALREVYAHAVL 67
Query: 129 -NHRNVVKLLGCCLETE--------VP---LLHLHDHHRNEEFPLTWEIRLRIATEVAGA 176
H +VV+ E + L + + +V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDE-------------------RYRAKVADFGTSKFI 217
L Y+HS + H DIK +NI + + K+ D G I
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 218 AMDQTHVTTKIQGTFGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
+ Q G +L E ++ K+D+++ + +V +P+ G+
Sbjct: 185 SSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ-- 236
Query: 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
H +R+ + + + F L + + + ++RP+ +
Sbjct: 237 ---------WHEIRQGR-LPRIPQVLSQ--------EFTELLKVMIHPDPERRPSAMAL 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGML----EDGRIM-AVKKFKLAVDDEELLKLEEF 118
+ + ++LG G GTV+KG+ E +I +K + + +
Sbjct: 8 RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF---QAV 62
Query: 119 INEIVILSQINHRNVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIAT 171
+ ++ + ++H ++V+LLG C T+ +PL L DH R L ++ L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
++A + YL + HR++ + N+LL + +VADFG + + D +
Sbjct: 123 QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEA 177
Query: 232 ---FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
++ E + T +SDV+S+GV + EL+T G +P
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
F+ R +G G G VY + + ++A+KK + K ++ I E+ L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKL 111
Query: 129 NHRNVVKLLGCCLETE-------------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAG 175
H N ++ GC L LL +H E EI +
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAA-VTHGALQ 165
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
L+YLHS + HRD+K+ NILL E K+ DFG++ +A + V GT ++
Sbjct: 166 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 217
Query: 236 EPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
PE Q K DV+S G+ +EL K P+F+ +++M
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---------------MNAMSA- 261
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+Y I ++ L + F N + CL + RPT E
Sbjct: 262 -LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 77 RILGQGGQGTVYKGML----EDGRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
++LG G GTVYKG+ E +I A+K+ + A + +E ++E +++ +++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77
Query: 132 NVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
+V +LLG CL T+ +P L D+ R + + + L ++A ++YL
Sbjct: 78 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLEPEYHQ 241
+ HRD+ + N+L+ K+ DFG +K + ++ +G ++ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 242 SSQLTDKSDVYSFGVVLVELLT-GKKP 267
T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 57/297 (19%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
E+ + + LGQG G V+ G +A+K K + E F+ E +
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQV 232
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHR-NEEFPLTWEIRLRIATEVA 174
+ ++ H +V+L +E P+ L D + L + +A ++A
Sbjct: 233 MKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
++Y+ HRD+++ NIL+ E KVADFG ++ I ++ + +
Sbjct: 291 SGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
PE + T KSDV+SFG++L EL T G+ P N
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------------- 388
Query: 294 MYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+V+ V++ M + +L +C ++RPT E + L
Sbjct: 389 -------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 43/269 (15%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V GR +AVK L E NE+VI+ H NVV++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHFNVVEMY 108
Query: 138 GCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
L E L + R E +I + V AL+YLH+
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE----QIAT-VCEAVLQALAYLHA---Q 160
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT 246
+ HRDIKS +ILL R K++DFG I+ D + + GT ++ PE S
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 247 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLV 306
+ D++S G++++E++ G+ P FS ++ M + D KL
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFS---------------DSPVQA--MKRLRDSPPPKLK 262
Query: 307 KKNQI-MAFANLAERCLDLNGKKRPTMEE 334
+++ + ER L + ++R T +E
Sbjct: 263 NSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 77 RILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
LG G G V +G G+ + AVK K V + ++FI E+ + ++HRN
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDHRN 82
Query: 133 VVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+++L G L TE PL L D R + R A +VA + YL S
Sbjct: 83 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LEPEYHQSS 243
HRD+ + N+LL R K+ DFG + + + H + + PE ++
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 244 QLTDKSDVYSFGVVLVELLT-GKKP 267
+ SD + FGV L E+ T G++P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 25/220 (11%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGML---EDGRIM-AVKKFKLAVDDEELLKLEEFI 119
+E++ + ++ +I+G G G V G L + A+K K + + +F+
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFL 98
Query: 120 NEIVILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIA 170
+E I+ Q +H N+++L G + L R + T + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR-LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
V + YL + HRD+ + N+L+D KV+DFG S+ + D T G
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 231 TFGYL--EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + SDV+SFGVV+ E+L G++P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 49/296 (16%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
+ D +G+G G+V K + G+IMAVK+ + VD++E ++ +
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ---KQLLM 69
Query: 121 EI-VILSQINHRNVVKLLGCCL-ETEV------------PLLHLHDHHRNEEFPLTWEIR 166
++ V++ + +V+ G E + ++ P E
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP---EEI 126
Query: 167 L-RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225
L +I AL++L I HRDIK +NILLD K+ DFG S + +
Sbjct: 127 LGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAK 182
Query: 226 TKIQGTFGYLEPEYHQSSQLTD----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281
T+ G Y+ PE S +SDV+S G+ L EL TG+ P
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK----------- 231
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQI---MAFANLAERCLDLNGKKRPTMEE 334
+S+ + ++ +L + +F N CL + KRP +E
Sbjct: 232 ----WNSVFD-QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIM-----AVKKFKLAVDDEELLKLEEF 118
E+ + +++G G G VYKGML+ A+K K +++ +F
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDF 93
Query: 119 INEIVILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRI 169
+ E I+ Q +H N+++L G + + P++ L R ++ + + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
+A + YL A+ HRD+ + NIL++ KV+DFG S+ + D T
Sbjct: 153 LRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 230 GTFGY--LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
G PE + T SDV+SFG+V+ E++T G++P
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 75 VNRILGQGGQGTVYKGML--EDGRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ LG G G+V +G+ +I A+K K + + EE + E I+ Q+++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNP 70
Query: 132 NVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
+V+L+G C E LH + + + +V+ + YL
Sbjct: 71 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEYHQS 242
HRD+ + N+LL R+ AK++DFG SK + D ++ T + G + + PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 243 SQLTDKSDVYSFGVVLVELLT-GKKP 267
+ + +SDV+S+GV + E L+ G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 73/318 (22%), Positives = 122/318 (38%), Gaps = 75/318 (23%)
Query: 76 NRILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+R LGQG G VY+G+ + A+K A E EF+NE ++ + N
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFN 86
Query: 130 HRNVVKLLGCCLETEVPLL-------------HLHDH-----HRNEEFPLTWEIRLRIAT 171
+VV+LLG + + P L +L + P + +++A
Sbjct: 87 CHHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+A ++YL ++ HRD+ + N ++ E + K+ DFG ++ I + +G
Sbjct: 146 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGG 198
Query: 232 FGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFF 285
G L PE + T SDV+SFGVVL E+ T ++P N
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------------ 246
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTM 337
+QV++ V + ++ L C N K RP+ E+
Sbjct: 247 --------------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 338 ELNGIRGSNFGHKMIYST 355
+ F Y +
Sbjct: 293 SIKEEMEPGFREVSFYYS 310
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 52/286 (18%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + LG G G VYK E G + A K + ++E LE++I EI IL+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATC 73
Query: 129 NHRNVVKLLGCCLETE--------------VPLLHLHDHHRNEEFPLTWEIRLRIATEVA 174
+H +VKLLG ++ D E +I++ + ++
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQV-VCRQML 127
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
AL++LHS I HRD+K+ N+L+ ++ADFG S + I GT +
Sbjct: 128 EALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYW 183
Query: 235 LEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289
+ PE + + K+D++S G+ L+E+ + P ++ M
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE---------------LNPM 228
Query: 290 RKNHMYDILDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEE 334
R + I L+ ++ + F + + LD N + RP+ +
Sbjct: 229 RV--LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFIN 120
E+ + + R +G+G G V++G+ + + A+K K D E+F+
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQ 65
Query: 121 EIVILSQINHRNVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEV 173
E + + Q +H ++VKL+G E E L L + ++ L + A ++
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
+ AL+YL S HRDI + N+L+ K+ DFG S+++ + +K +
Sbjct: 126 STALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
++ PE + T SDV+ FGV + E+L G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
E+D + LG G G V G +A+K K E + +EFI E +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKV 72
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAG 175
+ ++H +V+L G C + P+ L ++ R + L + +V
Sbjct: 73 MMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGT 231
A+ YL S HRD+ + N L++++ KV+DFG S+++ D+ + V +K ++ +
Sbjct: 132 AMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE S+ + KSD+++FGV++ E+ + GK P
Sbjct: 189 ----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
EL + + + LG G G V G + +AVK K E + +EF E
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQT 56
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAG 175
+ +++H +VK G C + P+ L ++ R+ L L + +V
Sbjct: 57 MMKLSHPKLVKFYGVCSKEY-PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGT 231
+++L S HRD+ + N L+D KV+DFG ++++ DQ + V TK ++ +
Sbjct: 116 GMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + + KSDV++FG+++ E+ + GK P
Sbjct: 173 ----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 70/291 (24%), Positives = 113/291 (38%), Gaps = 48/291 (16%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + + ++G G V +A+K+ L + +E + EI +SQ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCH 71
Query: 130 HRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIR-LRIAT---EVA 174
H N+V + + +L + H + + + IAT EV
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF-G 233
L YLH HRD+K+ NILL E ++ADFG S F+A K++ TF G
Sbjct: 132 EGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 234 ---YLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289
++ PE Q K+D++SFG+ +EL TG P M
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK---------------YPPM 233
Query: 290 R------KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ +N + K + K +F + CL + +KRPT E
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 45/275 (16%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEI-VILSQINHRNVVKL 136
LG+G G V K + G+IMAVK+ + V+ +E + + ++ + + ++ V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 71
Query: 137 LGC---------CLE---TEVPLLHLHDHHRNEEFPLTWEIRL-RIATEVAGALSYLHSA 183
G C+E T + + + + P E L +IA + AL +LHS
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP---EDILGKIAVSIVKALEHLHSK 128
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE----Y 239
S + HRD+K +N+L++ + K+ DFG S + + G Y+ PE
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERINPE 184
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ KSD++S G+ ++EL + P S G + + +++
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--------------TPFQ--QLKQVVE 228
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ +L F + +CL N K+RPT E
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
+D + + +G G G V+ G + +A+K + E + E+FI E +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEV 56
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIATEVAG 175
+ +++H +V+L G CLE P+ L D+ R + E L + +V
Sbjct: 57 MMKLSHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGT 231
++YL + + HRD+ + N L+ E KV+DFG ++F+ DQ + TK ++
Sbjct: 116 GMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE S+ + KSDV+SFGV++ E+ + GK P
Sbjct: 173 ----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFI 119
KELD + ++++++G G G V G L + + A+K K+ +++ +F+
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFL 94
Query: 120 NEIVILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRIA 170
E I+ Q +H N+++L G +++ P++ L R + T + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
+A + YL + HRD+ + NIL++ KV+DFG + + D T G
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 231 TFGYL--EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + T SDV+S+G+VL E+++ G++P
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 77/301 (25%), Positives = 125/301 (41%), Gaps = 67/301 (22%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
L+ + + +G+G G V G G +AVK K + F+ E +
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK------NDATAQAFLAEASV 239
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHR-NEEFPLTWEIRLRIATEVA 174
++Q+ H N+V+LLG +E + L L D+ R L + L+ + +V
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTF 232
A+ YL + HRD+ + N+L+ E AKV+DFG +K T T K ++ T
Sbjct: 300 EAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWT- 353
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRK 291
PE + + + KSDV+SFG++L E+ + G+ P
Sbjct: 354 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------------------ 386
Query: 292 NHMY-DILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
Y I VV V+K M A ++ + C L+ RPT ++ +L I
Sbjct: 387 ---YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
Query: 343 R 343
R
Sbjct: 444 R 444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 79 LGQGGQGTVYKGML--EDGRIM-AVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
LG G G+V +G+ +I A+K K + + EE + E I+ Q+++ +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 400
Query: 136 LLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188
L+G C E LH + + + +V+ + YL
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 457
Query: 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LEPEYHQSSQLT 246
HR++ + N+LL R+ AK++DFG SK + D ++ T + G + PE + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 247 DKSDVYSFGVVLVELLT-GKKP 267
+SDV+S+GV + E L+ G+KP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 75 VNRILGQGGQGTVYKGMLEDGRIM---AVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
++ LG G GTV KG + +++ AVK K +D +E + E ++ Q+++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--LKDELLAEANVMQQLDNP 78
Query: 132 NVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
+V+++G C E L L+ + + + + + + +V+ + YL
Sbjct: 79 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---E 134
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLEPEYHQS 242
S HRD+ + N+LL ++ AK++DFG SK + D+ + + G + + PE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 243 SQLTDKSDVYSFGVVLVELLT-GKKP 267
+ + KSDV+SFGV++ E + G+KP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 53/312 (16%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFIN 120
K + + F LG G G V+K G +MA K L + + I
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIR 80
Query: 121 EIVILSQINHRNVVKLLGC---------CLE----TEVPLLHLHDHHRNEEFPLTWEIRL 167
E+ +L + N +V G C+E + + L R E L
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILG----- 134
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+++ V L+YL I HRD+K +NIL++ R K+ DFG S + + +
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSF 190
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
+ GT Y+ PE Q + + +SD++S G+ LVE+ G+ PI E +
Sbjct: 191 V-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249
Query: 288 SMRKNH-------------------------MYDILDDQVVKLVKKNQIMAFANLAERCL 322
+ + I+++ KL + F + +CL
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309
Query: 323 DLNGKKRPTMEE 334
N +R +++
Sbjct: 310 IKNPAERADLKQ 321
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIM-AVKKFKLAVDDEELLKLEEFINEIV 123
E+++ + LG G G VY+G+ + + AVK K E+ +++EEF+ E
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 61
Query: 124 ILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEE-FPLTWEIRLRIATEV 173
++ +I H N+V+LLG C P +L D+ R ++ + L +AT++
Sbjct: 62 VMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK----IQ 229
+ A+ YL HRD+ + N L+ E + KVADFG S+ + D I+
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
T PE ++ + KSDV++FGV+L E+ T G P
Sbjct: 178 WT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 37/309 (11%), Positives = 78/309 (25%), Gaps = 81/309 (26%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVK--KFKLAVDDEELLKLEE---------------- 117
+LGQ + E G V F + +++E
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 118 ------FINEIVILSQINHRNVVKLLG------------------CCLETEVPLLHLHDH 153
FI ++ + ++++ L+T +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL---LS 200
Query: 154 HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213
H + L RL++ +V L+ LH + H ++ +I+LD+R + F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 214 SKFIAMDQTHVTTKIQGTFGYLEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPI 268
+ H + +T D ++ G+ + + P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP- 316
Query: 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILD--DQVVKLVKKNQIMAFANLAERCLDLNG 326
+ + + V L+ E L
Sbjct: 317 NTDDA------------ALGGSEWIFRSCKNIPQPVRALL------------EGFLRYPK 352
Query: 327 KKRPTMEEV 335
+ R +
Sbjct: 353 EDRLLPLQA 361
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 73/335 (21%), Positives = 121/335 (36%), Gaps = 85/335 (25%)
Query: 45 QMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGML--EDGRIM--AV 100
++ +D +I + + R+LG+G G+V + L EDG + AV
Sbjct: 10 ELKEKLEDVLIPEQQF-------------TLGRMLGKGEFGSVREAQLKQEDGSFVKVAV 56
Query: 101 KKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH----------- 149
K K + +EEF+ E + + +H +V KL+G L +
Sbjct: 57 KMLKADIIASS--DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114
Query: 150 ---LHDH-----HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201
LH F L + +R ++A + YL +S HRD+ + N +L
Sbjct: 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLA 171
Query: 202 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGV 256
E VADFG S+ I + QG L E + T SDV++FGV
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 257 VLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--- 312
+ E++T G+ P N ++ + +
Sbjct: 228 TMWEIMTRGQTPYAGIENA--------------------------EIYNYLIGGNRLKQP 261
Query: 313 -----AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+L +C + K+RP+ + MEL I
Sbjct: 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 61/298 (20%), Positives = 117/298 (39%), Gaps = 59/298 (19%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
E+ + + + LG G G V+ +AVK K + +E F+ E +
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANV 236
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHR-NEEFPLTWEIRLRIATEVA 174
+ + H +VKL T+ P+ L D + +E + + ++A
Sbjct: 237 MKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
++++ HRD+++ NIL+ K+ADFG ++ I ++ + +
Sbjct: 295 EGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
PE T KSDV+SFG++L+E++T G+ P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP-------------------------- 385
Query: 294 MY-DILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
Y + + +V++ +++ M N+ RC ++RPT E + L+
Sbjct: 386 -YPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 49/278 (17%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
F+V LG+G G+VYK + E G+I+A+K+ + D L+E I EI I+ Q +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSP 84
Query: 132 NVVKLLGCCLETE--------------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
+VVK G + ++ L + E+ EI I L
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-----EIAT-ILQSTLKGL 138
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
YLH HRDIK+ NILL+ AK+ADFG + + T I GT ++ P
Sbjct: 139 EYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAP 194
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
E Q +D++S G+ +E+ GK P +H MR ++ I
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD---------------IHPMRA--IFMI 237
Query: 298 LDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEE 334
+ K F + ++CL + ++R T +
Sbjct: 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 50/252 (19%)
Query: 44 QQMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIM----A 99
+++ N +D VIDR L + +ILG+G G+V +G L+ A
Sbjct: 20 EELQNKLEDVVIDRNLL-------------ILGKILGEGEFGSVMEGNLKQEDGTSLKVA 66
Query: 100 VKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH---------- 149
VK KL + ++EEF++E + +H NV++LLG C+E +
Sbjct: 67 VKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 150 ---LHDH-----HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201
LH + + + L+ ++A + YL ++ HRD+ + N +L
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLR 181
Query: 202 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGV 256
+ VADFG SK I + QG + E T KSDV++FGV
Sbjct: 182 DDMTVCVADFGLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 257 VLVELLT-GKKP 267
+ E+ T G P
Sbjct: 238 TMWEIATRGMTP 249
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 56/300 (18%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFI 119
E+ + + R +G+G G V++G+ + M A+K K D E+F+
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR---EKFL 439
Query: 120 NEIVILSQINHRNVVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATE 172
E + + Q +H ++VKL+G E E L L + +F L + A +
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
++ AL+YL S HRDI + N+L+ K+ DFG S+++ + +K +
Sbjct: 500 LSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRK 291
++ PE + T SDV+ FGV + E+L G KP
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP------------------------ 592
Query: 292 NHMY-DILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ + ++ V+ ++ + + +L +C + +RP E+ +L+ I
Sbjct: 593 ---FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
E+ + + LG G G V+ G +AVK K + + + F+ E +
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANL 61
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHR-NEEFPLTWEIRLRIATEVA 174
+ Q+ H+ +V+L T+ P+ L D + LT L +A ++A
Sbjct: 62 MKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
++++ HRD+++ NIL+ + K+ADFG ++ I ++ T + F
Sbjct: 120 EGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPI 174
Query: 235 --LEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE T KSDV+SFG++L E++T G+ P
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 68/319 (21%), Positives = 125/319 (39%), Gaps = 59/319 (18%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFI 119
F + ++ V R+L +GG VY+ + GR A+K+ L ++EE K I
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEE--KNRAII 73
Query: 120 NEIVILSQI-NHRNVVKLLGCCLE---------TEVPLL------HLHDH--HRNEEFPL 161
E+ + ++ H N+V+ E LL L + PL
Sbjct: 74 QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 162 TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221
+ + L+I + A+ ++H PI HRD+K N+LL + K+ DFG++ I+
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 222 THVTTKIQ-----------GTFGYLEPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ + + T Y PE + + + +K D+++ G +L L + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGK 327
F ++ L I++ + Q F +L L +N +
Sbjct: 253 -F------EDGAKLR--------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291
Query: 328 KRPTMEEVTMELNGIRGSN 346
+R ++ EV +L I +
Sbjct: 292 ERLSIAEVVHQLQEIAAAR 310
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 65/301 (21%), Positives = 106/301 (35%), Gaps = 75/301 (24%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R LG G G VY+G + AVK +++ +F+ E +I+S+ NH
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 92
Query: 131 RNVVKLLGCCLETEVPL---------------LHLHDHHRNEEFPLTWEIRLRIATEVAG 175
+N+V+ +G L++ P L ++ L L +A ++A
Sbjct: 93 QNIVRCIGVSLQSL-PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
YL + HRDI + N LL AK+ DFG ++ I + +G
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGC 204
Query: 233 GYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFV 286
L PE T K+D +SFGV+L E+ + G P S N
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------- 251
Query: 287 HSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTME 338
+V++ V M + +C + RP +
Sbjct: 252 -------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
Query: 339 L 339
+
Sbjct: 299 I 299
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-29
Identities = 39/322 (12%), Positives = 84/322 (26%), Gaps = 82/322 (25%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---------------------- 101
EL + +LGQ + E G V
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 102 --KFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL--------- 150
+ + ++ FI ++ + ++++ + V
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 151 ------HDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204
H + L RL++ +V L+ LH + H ++ +I+LD+R
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 243
Query: 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL-----------TDKSDVYS 253
+ F + G+ PE T D ++
Sbjct: 244 GVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 254 FGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA 313
G+V+ + P +++ + ++ KN + V L++
Sbjct: 299 LGLVIYWIWCADLP-I-----TKDAALGGSEWIFRSCKN-----IPQPVRALLE------ 341
Query: 314 FANLAERCLDLNGKKRPTMEEV 335
L + R +
Sbjct: 342 ------GFLRYPKEDRLLPLQA 357
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 80/324 (24%)
Query: 71 NHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
+ + + LG+G G V + R +AVK K E ++E+ I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 83
Query: 125 LSQI-NHRNVVKLLGCCLETEVPLL---------HLHD---HHRNEEFP----------- 160
L I +H NVV LLG C + PL+ +L RNE P
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 161 -LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
LT E + + +VA + +L AS HRD+ + NILL E+ K+ DFG ++ I
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 220 DQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273
D +V + L PE T +SDV+SFGV+L E+ + G P
Sbjct: 201 DPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---- 252
Query: 274 TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLN 325
++ + + + +K+ M C
Sbjct: 253 --------------GVKIDE-------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 291
Query: 326 GKKRPTMEEVTMELNGIRGSNFGH 349
+RPT E+ L + +N
Sbjct: 292 PSQRPTFSELVEHLGNLLQANAQQ 315
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 44/291 (15%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN 120
+ N +G G G V+K + G ++AVK+ + + + EE + +
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---KRILM 72
Query: 121 EI-VILSQINHRNVVKLLGCCL-ETEVPL--------LHLHDHHRNEEFPLTWEIRL-RI 169
++ V+L + +V+ G + T+V + P E L ++
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILGKM 129
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
+ AL YL + HRD+K +NILLDER + K+ DFG S + +
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR--LVDDKAKDRSA 185
Query: 230 GTFGYLEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
G Y+ PE T ++DV+S G+ LVEL TG+ P +
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------- 234
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEE 334
+ +L ++ L F + + CL + +KRP +
Sbjct: 235 ---DFE--VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 75/292 (25%), Positives = 117/292 (40%), Gaps = 58/292 (19%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
F + ++G G G VYKG ++ G++ A+K + D+EE E EI +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQEINMLKKY 77
Query: 129 -NHRNVVKLLGCCLETEVP-----------------LLHLHDHHRNEEFPLTWEIRLRIA 170
+HRN+ G ++ P + L + + W IA
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IA 132
Query: 171 T---EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
E+ LS+LH + HRDIK N+LL E K+ DFG S + T
Sbjct: 133 YICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 228 IQGTFGYLEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282
I GT ++ PE + D KSD++S G+ +E+ G P+
Sbjct: 190 I-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD------------ 236
Query: 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+H MR ++ I + +L K F + E CL N +RP E+
Sbjct: 237 ---MHPMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 77 RILGQGGQGTVYKGML--EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
RILG+G G VY+G+ G + AVK K + E+F++E VI+ ++H +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPH 74
Query: 133 VVKLLGCCLE------TE-VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
+VKL+G E E P L + + L + + ++ A++YL S
Sbjct: 75 IVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ES 131
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
HRDI NIL+ K+ DFG S++I + + + + ++ PE +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 246 TDKSDVYSFGVVLVELLT-GKKP 267
T SDV+ F V + E+L+ GK+P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 81/313 (25%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
LG+G G V+ + AVK K A + ++F E +L+ + H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQH 102
Query: 131 RNVVKLLGCCLETEVPLL-----------------------HLHDHHRNEEFPLTWEIRL 167
+++V+ G C E PLL L PL L
Sbjct: 103 QHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+A++VA + YL A HRD+ + N L+ + K+ DFG S+ I + +
Sbjct: 162 AVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYR 215
Query: 228 IQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 281
+ G L PE + T +SDV+SFGVVL E+ T GK+P
Sbjct: 216 VGGR-TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-------------- 260
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTME 333
Y + + + + + + + + + C ++R +++
Sbjct: 261 ------------WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK 308
Query: 334 EVTMELNGIRGSN 346
+V L + +
Sbjct: 309 DVHARLQALAQAP 321
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 51/317 (16%), Positives = 89/317 (28%), Gaps = 62/317 (19%)
Query: 70 TNHFNVNRILGQGGQ--GTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+ + ++G+G + TV G + V++ L E + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGELHVSK 81
Query: 127 QINHRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWEIRLRIAT---E 172
NH N+V + L H + IA
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQG 136
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--- 229
V AL Y+H HR +K+++IL+ + ++ ++ +
Sbjct: 137 VLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 230 ---GTFGYLEPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF--------------- 269
+L PE Q + KSD+YS G+ EL G P
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 270 ------------STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANL 317
S + S+ + D + F +
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 318 AERCLDLNGKKRPTMEE 334
E+CL N RP+
Sbjct: 314 VEQCLQRNPDARPSAST 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 65/304 (21%), Positives = 106/304 (34%), Gaps = 75/304 (24%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R LG G G VY+G + AVK +++ +F+ E +I+S+ NH
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 133
Query: 131 RNVVKLLGCCLETEVPL---------------LHLHDHHRNEEFPLTWEIRLRIATEVAG 175
+N+V+ +G L++ P L ++ L L +A ++A
Sbjct: 134 QNIVRCIGVSLQSL-PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
YL + HRDI + N LL AK+ DFG ++ I + +G
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGC 245
Query: 233 GYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFV 286
L PE T K+D +SFGV+L E+ + G P S N
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------- 292
Query: 287 HSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTMEEVTME 338
+V++ V M + +C + RP +
Sbjct: 293 -------------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
Query: 339 LNGI 342
+
Sbjct: 340 IEYC 343
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 74/330 (22%), Positives = 116/330 (35%), Gaps = 113/330 (34%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG+G G V K +AVK K EL + ++E +L Q+NH
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNH 85
Query: 131 RNVVKLLGCCLETEVPLL---------HLHDHHRN-----------------------EE 158
+V+KL G C + PLL L R +E
Sbjct: 86 PHVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218
LT + A +++ + YL A + HRD+ + NIL+ E + K++DFG S+ +
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV- 200
Query: 219 MDQTHVTTKIQGTFGYLEPEYHQSSQ------------LTD-----KSDVYSFGVVLVEL 261
Y E Y + SQ L D +SDV+SFGV+L E+
Sbjct: 201 ---------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 262 LT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM-------- 312
+T G P +++ L+K M
Sbjct: 246 VTLGGNPYPGIPP--------------------------ERLFNLLKTGHRMERPDNCSE 279
Query: 313 AFANLAERCLDLNGKKRPTMEEVTMELNGI 342
L +C KRP +++ +L +
Sbjct: 280 EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
L+ + + +G+G G V G G +AVK K + F+ E +
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA------FLAEASV 67
Query: 125 LSQINHRNVVKLLGCCLETEVPLL---------HLHDHHR-NEEFPLTWEIRLRIATEVA 174
++Q+ H N+V+LLG +E + L L D+ R L + L+ + +V
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTF 232
A+ YL + HRD+ + N+L+ E AKV+DFG +K + T T K ++ T
Sbjct: 128 EAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWT- 181
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
PE + + + KSDV+SFG++L E+ + G+ P
Sbjct: 182 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 66/311 (21%), Positives = 117/311 (37%), Gaps = 82/311 (26%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R LG+G G V+ + AVK K ++F E +L+ + H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELLTNLQH 76
Query: 131 RNVVKLLGCCLETEVPLL------------------------HLHDHHRNEEFPLTWEIR 166
++VK G C + + PL+ + R + L
Sbjct: 77 EHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
L IA+++A + YL AS HRD+ + N L+ K+ DFG S+ + +
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY--- 189
Query: 227 KIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS 280
++ G L PE + T +SDV+SFGV+L E+ T GK+P F NT
Sbjct: 190 RVGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------ 242
Query: 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTM 332
+V++ + + +++ ++ C ++R +
Sbjct: 243 --------------------EVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNI 282
Query: 333 EEVTMELNGIR 343
+E+ L+ +
Sbjct: 283 KEIYKILHALG 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 63/280 (22%), Positives = 104/280 (37%), Gaps = 48/280 (17%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKL---EEFINEIVILSQ 127
+ R LG+GG ++ + + A K V LLK E+ EI I
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGK----IVPKSLLLKPHQREKMSMEISIHRS 97
Query: 128 INHRNVVKLLGCCLETE---------VPLLHLHDHHRNEEFPLT-WEIRLRIATEVAGAL 177
+ H++VV G E L + H+ + LT E R ++
Sbjct: 98 LAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEAR-YYLRQIVLGC 154
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
YLH + HRD+K N+ L+E K+ DFG + + D + GT Y+ P
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFFVHSMRKNHMY 295
E + + DV+S G ++ LL GK P F T + + + +
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEY--------SIP 261
Query: 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ L++ + L + RPT+ E+
Sbjct: 262 KHINPVAASLIQ------------KMLQTDPTARPTINEL 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 63/308 (20%)
Query: 68 KATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+ + + LG GG G V + + + G +A+K+ + + + + EI I+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC---LEIQIMK 67
Query: 127 QINHRNVVKLLGCCLETEVPLL-------------------HLHDHHRNEEFPLTWEIRL 167
++NH NVV + L +L+ IR
Sbjct: 68 KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIR- 124
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHV 224
+ ++++ AL YLH + I HRD+K NI+L +R K+ D G +K +DQ +
Sbjct: 125 TLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGEL 179
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN----------- 273
T+ GT YL PE + + T D +SFG + E +TG +P
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239
Query: 274 ------TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGK 327
+ F NH+ IL ++ + ++ L + +
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------------LMWHQR 287
Query: 328 KRPTMEEV 335
+R T +
Sbjct: 288 QRGTDPQN 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 65/283 (22%), Positives = 104/283 (36%), Gaps = 54/283 (19%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKL---EEFINEIVILSQ 127
+ R LG+GG ++ + + A K V LLK E+ EI I
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGK----IVPKSLLLKPHQREKMSMEISIHRS 71
Query: 128 INHRNVVKLLGCCLETE---------VP---LLHLHDHHRNEEFPLT-WEIRLRIATEVA 174
+ H++VV G E LL LH + LT E R ++
Sbjct: 72 LAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEAR-YYLRQIV 125
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
YLH + HRD+K N+ L+E K+ DFG + + D + GT Y
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNY 181
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFFVHSMRKN 292
+ PE + + DV+S G ++ LL GK P F T + + +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEY-------- 232
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ ++ L++ + L + RPT+ E+
Sbjct: 233 SIPKHINPVAASLIQ------------KMLQTDPTARPTINEL 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 53/323 (16%), Positives = 109/323 (33%), Gaps = 88/323 (27%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIM--------AVKKFKLAVDDEELLKLE 116
++ N LGQG ++KG+ + +K A + E
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS----E 57
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRL 167
F ++S+++H+++V G C+ + + L + + + + +L
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGD-ENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAM 219
+A ++A A+ +L + + H ++ + NILL K++D G S +
Sbjct: 117 EVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 220 DQTHVTTKIQGTFGYLE-------PE-YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFS 270
L+ PE L +D +SFG L E+ + G KP+ +
Sbjct: 174 KD------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 271 TGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA------FANLAERCLDL 324
+ + ++ + + ANL C+D
Sbjct: 222 LDSQ--------------------------RKLQFYEDRHQLPAPKAAELANLINNCMDY 255
Query: 325 NGKKRPTMEEVTMELNGIRGSNF 347
RP+ + +LN + +
Sbjct: 256 EPDHRPSFRAIIRDLNSLFTPDL 278
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 65/325 (20%), Positives = 119/325 (36%), Gaps = 108/325 (33%)
Query: 77 RILGQGGQGTVYKGML------EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ LG+G G V + + AVK K +++L + ++E+ ++ I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 143
Query: 129 -NHRNVVKLLGCCLETEVPLL---------HLHDHHRN---------------EEFPLTW 163
H+N++ LLG C + PL +L ++ R E +T+
Sbjct: 144 GKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+ + ++A + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------ 253
Query: 224 VTTKIQGTFGYLEPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GK 265
Y +++ L D +SDV+SFGV++ E+ T G
Sbjct: 254 ----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANL 317
P +++ KL+K+ M +
Sbjct: 304 SPYPGIPV--------------------------EELFKLLKEGHRMDKPANCTNELYMM 337
Query: 318 AERCLDLNGKKRPTMEEVTMELNGI 342
C +RPT +++ +L+ I
Sbjct: 338 MRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 65/325 (20%), Positives = 117/325 (36%), Gaps = 108/325 (33%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM--------AVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ LG+G G V AVK K +++L + ++E+ ++ I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 97
Query: 129 -NHRNVVKLLGCCLETEVPLL---------HLHDHHRN---------------EEFPLTW 163
H+N++ LLG C + PL +L ++ R E +T+
Sbjct: 98 GKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+ + ++A + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 157 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------ 207
Query: 224 VTTKIQGTFGYLEPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GK 265
Y +++ L D +SDV+SFGV++ E+ T G
Sbjct: 208 ----------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANL 317
P +++ KL+K+ M +
Sbjct: 258 SPYPGIPV--------------------------EELFKLLKEGHRMDKPANCTNELYMM 291
Query: 318 AERCLDLNGKKRPTMEEVTMELNGI 342
C +RPT +++ +L+ I
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 59/304 (19%), Positives = 108/304 (35%), Gaps = 51/304 (16%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + ++ ILGQG V++G + G + A+K F + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM---REFEVLKKLN 65
Query: 130 HRNVVKLLGCCLETEVPLL---------------HLHDHHRNEEFPLTWEIRLRIATEVA 174
H+N+VKL E L + P + E + +V
Sbjct: 66 HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVV 122
Query: 175 GALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
G +++L I HR+IK NI+ D + K+ DFG ++ ++ + G
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYG 177
Query: 231 TFGYLEPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL- 281
T YL P+ ++ + L D++S GV TG P F + N +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNKEVM 236
Query: 282 ----------AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331
A V + D V + + + + L+ + +K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 332 MEEV 335
++
Sbjct: 297 FDQF 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 74/278 (26%), Positives = 108/278 (38%), Gaps = 48/278 (17%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKL---EEFINEIVILSQI 128
F + R LG+G G VY + I+A+K + +L K + E+ I S +
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALK----VLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 129 NHRNVVKLLGCCLETE---------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
H N+++L G PL ++ + + TE+A ALSY
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
HS + HRDIK N+LL K+ADFG S A GT YL PE
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEM 178
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFFVHSMRKNHMYDI 297
+ +K D++S GV+ E L GK P F + + +S F D
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEF--------TFPDF 229
Query: 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + L+ R L N +RP + EV
Sbjct: 230 VTEGARDLIS------------RLLKHNPSQRPMLREV 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 61/330 (18%), Positives = 114/330 (34%), Gaps = 49/330 (14%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + ++ ILGQG V++G + G + A+K F + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM---REFEVLKKLN 65
Query: 130 HRNVVKLLGC--CLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVAG 175
H+N+VKL T +L L + P + E + +V G
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVG 123
Query: 176 ALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
+++L I HR+IK NI+ D + K+ DFG ++ ++ + GT
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGT 178
Query: 232 FGYLEPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-- 281
YL P+ ++ + L D++S GV TG P F + N +
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNKEVMY 237
Query: 282 ----AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFA-----NLAERCLDLNGKKRPTM 332
+ D + + + L+ + +K
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 333 EEVTMELNGIRGSNFGHKMIYSTGTLLRLF 362
++ E + I H T +++
Sbjct: 298 DQFFAETSDILHRMVIHVFSLQQMTAHKIY 327
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 47/281 (16%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK---LEEFINEIVILS 126
F V +LG+G VY+ + G +A+K +D + + K ++ NE+ I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK----MIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 127 QINHRNVVKLLGCCLETE---------VPLLHLHDHHRNEEFPLT-WEIRLRIATEVAGA 176
Q+ H ++++L E ++ + +N P + E R ++
Sbjct: 67 QLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
+ YLHS I HRD+ +N+LL K+ADFG + + M T + GT Y+
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFFVHSMRKNHM 294
PE S +SDV+S G + LL G+ P F T V LA + M
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPP-FDTDTVKNTLNKVVLADY--------EM 231
Query: 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
L + L+ + L N R ++ V
Sbjct: 232 PSFLSIEAKDLIH------------QLLRRNPADRLSLSSV 260
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 59/307 (19%), Positives = 113/307 (36%), Gaps = 41/307 (13%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVK---KFKLAVDDEELLKLEEF 118
KE DK N + + R L QG + +D + A+K K L + +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 119 I----------NEIVILSQINHRNVVKLLGCCLETEVPLL-------------HLHDHHR 155
I NE+ I++ I + + G + +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 156 ---NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212
N + ++ I V + SY+H+ + I HRD+K +NIL+D+ R K++DFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFS 270
S+++ +GT+ ++ PE+ + + K D++S G+ L + P
Sbjct: 198 ESEYM---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 271 TGNTSQ--ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKK 328
+ + N+ R + +Y + + + + + L N +
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED-IDFLKLFLRKNPAE 313
Query: 329 RPTMEEV 335
R T E+
Sbjct: 314 RITSEDA 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 72/320 (22%), Positives = 116/320 (36%), Gaps = 83/320 (25%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
+ LG G G V + + +AVK K + E E ++E+ +LS + N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGN 85
Query: 130 HRNVVKLLGCCLETEVPLL--------------------------HLHDHHRNEEFPLTW 163
H N+V LLG C P L ++E L
Sbjct: 86 HMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
E L + +VA +++L AS HRD+ + NILL K+ DFG ++ I D +
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 224 VTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 277
V L PE + T +SDV+S+G+ L EL + G P
Sbjct: 202 V----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------- 249
Query: 278 NVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKR 329
M + + K++K+ M ++ + C D + KR
Sbjct: 250 ----------GMPVDS-------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 330 PTMEEVTMELNGIRGSNFGH 349
PT +++ + + H
Sbjct: 293 PTFKQIVQLIEKQISESTNH 312
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 74/325 (22%), Positives = 124/325 (38%), Gaps = 84/325 (25%)
Query: 76 NRILGQGGQGTVYKGML------EDGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQ 127
+ LG+G G V + R+ AVK K +++L + I+E+ ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEMEMMKM 130
Query: 128 I-NHRNVVKLLGCCLETEVPLL------------------------HLHDHHRNEEFPLT 162
I H+N++ LLG C + PL + ++ N E L+
Sbjct: 131 IGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 163 WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
+ + A +VA + YL AS HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 190 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 223 HVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 276
+ + T G L PE T +SDV+SFGV+L E+ T G P
Sbjct: 247 YK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299
Query: 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKK 328
+++ KL+K+ M + C +
Sbjct: 300 -----------------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 336
Query: 329 RPTMEEVTMELNGIRGSNFGHKMIY 353
RPT +++ +L+ I +M Y
Sbjct: 337 RPTFKQLVEDLDRIVALTSNQEMGY 361
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 68/331 (20%), Positives = 115/331 (34%), Gaps = 107/331 (32%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
+ LG G G V + + +AVK K +E E ++E+ I+S +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQ 108
Query: 130 HRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEF---------PLTWEIRL 167
H N+V LLG C P+L L R E + L
Sbjct: 109 HENIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+++VA +++L AS HRD+ + N+LL + AK+ DFG ++ I
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI---------- 214
Query: 228 IQGTFGYLEPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKPIF 269
+ Y + D +SDV+S+G++L E+ + G P
Sbjct: 215 ------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-- 266
Query: 270 STGNTSQENVSLAAFFVHSMRKNHMY--DILDDQVVKLVKKNQIMA--------FANLAE 319
Y +++ + KLVK MA ++ +
Sbjct: 267 -------------------------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ 301
Query: 320 RCLDLNGKKRPTMEEVTMELNGIRGSNFGHK 350
C L RPT +++ L + +
Sbjct: 302 ACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 48/225 (21%)
Query: 77 RILGQGGQGTVYKGMLE-DGRIM--AVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRN 132
++G+G G V K ++ DG M A+K+ K ++ +F E+ +L ++ +H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPN 87
Query: 133 VVKLLGCCLETEVPLL---------HLHDHHRN---------------EEFPLTWEIRLR 168
++ LLG C L +L D R L+ + L
Sbjct: 88 IINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
A +VA + YL + HRD+ + NIL+ E Y AK+ADFG S+ + T
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKTM- 200
Query: 229 QGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
G L E S T SDV+S+GV+L E+++ G P
Sbjct: 201 ----GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 61/308 (19%), Positives = 112/308 (36%), Gaps = 81/308 (26%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
LG+ G VYKG L A+K K + EEF +E ++ +++ H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR---EEFRHEAMLRARLQH 71
Query: 131 RNVVKLLGCCLETEVPLL-------------HLHDH-----------HRNEEFPLTWEIR 166
NVV LLG + + PL L R + L
Sbjct: 72 PNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
+ + ++A + YL +S + H+D+ + N+L+ ++ K++D G + +
Sbjct: 131 VHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYY 184
Query: 227 KIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS 280
K+ G L PE + + SD++S+GVVL E+ + G +P
Sbjct: 185 KLLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP------------- 230
Query: 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIM--------AFANLAERCLDLNGKKRPTM 332
+ VV++++ Q++ L C + +RP
Sbjct: 231 -------------YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277
Query: 333 EEVTMELN 340
+++ L
Sbjct: 278 KDIHSRLR 285
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 91/319 (28%)
Query: 77 RILGQGGQGTVYKGMLEDGRIM------AVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
R +G+G G V++ AVK K + +F E ++++ ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAALMAEFDN 109
Query: 131 RNVVKLLGCCLETEVPLL-------H--LHD---HHRNEEF------------------- 159
N+VKLLG C + P+ + L++
Sbjct: 110 PNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 160 -PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218
PL+ +L IA +VA ++YL + HRD+ + N L+ E K+ADFG S+ I
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 219 MDQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272
+ + PE ++ T +SDV+++GVVL E+ + G +P
Sbjct: 226 SADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----- 276
Query: 273 NTSQENVSLAAFFVHSMRKNHMY-DILDDQVVKLVKKNQIM--------AFANLAERCLD 323
Y + ++V+ V+ I+ NL C
Sbjct: 277 ----------------------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWS 314
Query: 324 LNGKKRPTMEEVTMELNGI 342
RP+ + L +
Sbjct: 315 KLPADRPSFCSIHRILQRM 333
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 54/292 (18%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAV-DDEELLKLEEFINEIVI 124
+ + +++ LG G G V + + +A++ K K A+ E EI I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 125 LSQINHRNVVKLLGCCLETEVPLL-------HLHDH-----HRNEEFPLTWEIRLRIATE 172
L ++NH ++K+ + ++ L D E + +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFYQ 247
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
+ A+ YLH I HRD+K N+LL +E K+ DFG SK + +T + +
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 302
Query: 230 GTFGYLEPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ---ENVSLAA 283
GT YL PE ++ D +S GV+L L+G P FS T + ++
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVSLKDQITSGK 361
Query: 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + ++ ++ + LVKK L ++ K R T EE
Sbjct: 362 Y---NFIPEVWAEV-SEKALDLVKK------------LLVVDPKARFTTEEA 397
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 42/268 (15%), Positives = 80/268 (29%), Gaps = 43/268 (16%)
Query: 42 LLQQM---LNSYDDSVIDRCKLFSSK---ELDKATNHFNVNRILGQGGQGTVYKGM---- 91
LL + ++SY ++ +CKL + K E + V+ +LG+G VY+
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 92 --LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGC-------CLE 142
++ + +K K + + L +K L
Sbjct: 90 NDAKNKQKFVLKVQK----PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 143 TE-VPLLHLHDH----HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTN 197
E L + E + + + A + + +H I H DIK N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202
Query: 198 ILLDERYRA-----------KVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
+L + + D G S + + + T T G+ E +
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262
Query: 246 TDKSDVYSFGVVLVELLTGKKPIFSTGN 273
+ D + + +L G
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEG 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-24
Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKG-MLEDGRIMAVKKFKLAVDDEELLKL---EEFINEIVILS 126
+ F++ R LG+G G VY ++ IMA+K + +L K + EI I S
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALK----VLFKSQLEKEGVEHQLRREIEIQS 69
Query: 127 QINHRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEV 173
+ H N++++ + L H R +E E+
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSA-TFMEEL 123
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
A AL Y H + HRDIK N+L+ + K+ADFG S + GT
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLD 177
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
YL PE + +K D++ GV+ E L G P
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 68/303 (22%)
Query: 61 FSSKELDKATNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLKLE 116
F + + + + + LG G G V A+K K ++ L
Sbjct: 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-- 84
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPL 161
E+ +L ++H N++KL E + +L H NE
Sbjct: 85 ---EEVAVLKLLDHPNIMKLYDFF-EDKR-NYYLVMECYKGGELFDEIIHRMKFNEV--- 136
Query: 162 TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIA 218
+ I +V ++YLH I HRD+K N+LL ++ K+ DFG S
Sbjct: 137 --DAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF- 189
Query: 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
+ + GT Y+ PE + +K DV+S GV+L LL G P G T QE
Sbjct: 190 -ENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG--GQTDQE- 244
Query: 279 VSLAAFFVHSMRKNHMY------DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
+ + K + + L+K+ L + ++R +
Sbjct: 245 ------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ------------MLQFDSQRRISA 286
Query: 333 EEV 335
++
Sbjct: 287 QQA 289
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 55/235 (23%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
++LG G G V +AVK K D E E ++E+ +++Q+ +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKMMTQLGS 107
Query: 130 HRNVVKLLGCCLETEVPLL-------------------------------HLHDHHRNEE 158
H N+V LLG C + P+ +
Sbjct: 108 HENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218
LT+E L A +VA + +L HRD+ + N+L+ K+ DFG ++ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 219 MDQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267
D +V L PE T KSDV+S+G++L E+ + G P
Sbjct: 224 SDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 32/274 (11%), Positives = 75/274 (27%), Gaps = 68/274 (24%)
Query: 79 LGQGGQGTVYKGMLED---GRIMAVK--KFKLAVDDEELLKLEEFINEIVILSQINHRNV 133
G ++ D R +A+ + + D+ L +E ++ + LS+I+ V
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGV 93
Query: 134 VKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
++L L+ L + + +R +A A H A
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL 245
+ + + + +A +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA------- 179
Query: 246 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305
+ D+ G L LL + P + ++ A Q ++
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP-LP-EAGVRSGLAPA------------ERDTAGQPIEP 225
Query: 306 VKKNQIM--AFANLAERCLDLNGKKRPTMEEVTM 337
++ + + +A R + +G R + +
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSASTLLNL 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 62/303 (20%), Positives = 113/303 (37%), Gaps = 63/303 (20%)
Query: 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLK 114
+F ++ + R+LG+G G V G+ AVK K ++ ++
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--- 70
Query: 115 LEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH-----------------DHHRNE 157
E + E+ +L Q++H N++KL E + + + +E
Sbjct: 71 -ESLLREVQLLKQLDHPNIMKLYEFF-EDK---GYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 158 EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTS 214
+ RI +V ++Y+H I HRD+K N+LL + ++ DFG S
Sbjct: 126 V-----DAA-RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
+ + GT Y+ PE + +K DV+S GV+L LL+G P F+ N
Sbjct: 177 THF--EASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANE 232
Query: 275 SQ--ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
+ V + + + + + L++K L R +
Sbjct: 233 YDILKKVEKGKYTFELPQ----WKKVSESAKDLIRK------------MLTYVPSMRISA 276
Query: 333 EEV 335
+
Sbjct: 277 RDA 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 67/295 (22%), Positives = 104/295 (35%), Gaps = 70/295 (23%)
Query: 70 TNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+N+ +LG+G G V K + AVK K D + E+ +L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----REVELL 75
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIRLR 168
+++H N++KL E + D +E + R
Sbjct: 76 KKLDHPNIMKLFEIL-EDSS---SFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-R 125
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 225
I +V ++Y+H I HRD+K NILL ++ K+ DFG S Q
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM 180
Query: 226 TKIQGTFGYLEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280
GT Y+ PE Y +K DV+S GV+L LL+G P F G + +
Sbjct: 181 KDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP-F-YGKNEYDILK 232
Query: 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ I D L++K L + R T +
Sbjct: 233 RVETGKYAFDLPQWRTI-SDDAKDLIRK------------MLTFHPSLRITATQC 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 68/248 (27%), Positives = 102/248 (41%), Gaps = 36/248 (14%)
Query: 51 DDSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAV- 107
D +R + E T N F R+LG+GG G V + G++ A KK +
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 108 ---DDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-------------LHLH 151
E + NE IL ++N R VV L ET+ L H++
Sbjct: 223 KKRKGEAMAL-----NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY 276
Query: 152 DHHRNEEFPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210
H FP E R A E+ L LH I +RD+K NILLD+ +++D
Sbjct: 277 -HMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
G + + QT GT GY+ PE ++ + T D ++ G +L E++ G+ P F
Sbjct: 330 LGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-FQ 386
Query: 271 TGNTSQEN 278
+
Sbjct: 387 QRKKKIKR 394
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 73/311 (23%), Positives = 111/311 (35%), Gaps = 71/311 (22%)
Query: 60 LFSSKELDKATNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELL-- 113
++ K+ K + R LG G G V A+K K +
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 114 ----KLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL---------------HDHH 154
EE NEI +L ++H N++KL + + +L + H
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHK 142
Query: 155 RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADF 211
+E + I ++ + YLH I HRDIK NILL + K+ DF
Sbjct: 143 FDEC-----DAA-NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 212 GTSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
G S F + + GT Y+ PE + +K DV+S GV++ LL G P F
Sbjct: 194 GLSSFF--SKDYKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPP-F- 247
Query: 271 TGNTSQENVSLAAFFVHSMRKNHMY------DILDDQVVKLVKKNQIMAFANLAERCLDL 324
G Q+ + + K Y + D+ +L+K L
Sbjct: 248 GGQNDQD-------IIKKVEKGKYYFDFNDWKNISDEAKELIKL------------MLTY 288
Query: 325 NGKKRPTMEEV 335
+ KR T EE
Sbjct: 289 DYNKRCTAEEA 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 59/264 (22%), Positives = 105/264 (39%), Gaps = 29/264 (10%)
Query: 23 KKRMDIKLKERFFKQNGGLLLQQMLNSYDDSV-IDRCKLFSSKELDKAT-NHFNVNRILG 80
+ L + + L Q + DS+ R + E + F R+LG
Sbjct: 135 RAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLG 194
Query: 81 QGGQGTVYKGMLED-GRIMAVKKFKLAV----DDEELLKLEEFINEIVILSQINHRNVVK 135
+GG G V+ ++ G++ A KK + E IL++++ R +V
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM-----VEKKILAKVHSRFIVS 249
Query: 136 LLGCCLETEVPL-----------LHLHDHHRNEEFPLTWEIRLRI-ATEVAGALSYLHSA 183
L ET+ L + H ++ +E+ P E R ++ L +LH
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
I +RD+K N+LLD+ +++D G + + QT GT G++ PE
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 244 QLTDKSDVYSFGVVLVELLTGKKP 267
+ D ++ GV L E++ + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 68/308 (22%), Positives = 110/308 (35%), Gaps = 82/308 (26%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK-----KFKLAVDDEELLKL 115
K+ + + + +LG+GG GTV+ G L D +A+K + + +
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 116 EEFINEIVILSQIN----HRNVVKLL-------GCCLETEVPLL------HLHDHHRNEE 158
E+ +L ++ H V++LL G L E PL ++ + E
Sbjct: 82 P---LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE 138
Query: 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFI 217
R +V A+ + HS + HRDIK NIL+D R AK+ DFG+
Sbjct: 139 G----PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL- 189
Query: 218 AMDQTHVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
+ T GT Y PE YH + V+S G++L +++ G P
Sbjct: 190 -LHDEPYTD-FDGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIP---- 238
Query: 272 GNTSQENVSLAAFFVHSMR-KNHMYDI---LDDQVVKLVKKNQIMAFANLAERCLDLNGK 327
F + L++ RCL
Sbjct: 239 -------------FERDQEILEAELHFPAHVSPDCCALIR------------RCLAPKPS 273
Query: 328 KRPTMEEV 335
RP++EE+
Sbjct: 274 SRPSLEEI 281
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 60/295 (20%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAV-DDEELLKLEEFINEIVI 124
+ + +++ LG G G V + + +A+K K K A+ E EI I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 125 LSQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRI 169
L ++NH ++K+ + ++ + E +
Sbjct: 69 LKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LY 119
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTT 226
++ A+ YLH I HRD+K N+LL +E K+ DFG SK + +T +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR 174
Query: 227 KIQGTFGYLEPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ---ENVS 280
+ GT YL PE ++ D +S GV+L L+G P FS T + ++
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVSLKDQIT 233
Query: 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ ++ + ++ + LVKK L ++ K R T EE
Sbjct: 234 SGKYNFIP----EVWAEVSEKALDLVKK------------LLVVDPKARFTTEEA 272
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 45/210 (21%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKF-KLAVDDEELLKLEEFINEIVILSQ 127
+H++++ LG G G V++ G A K D+E ++ EI +S
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-----KEIQTMSV 210
Query: 128 INHRNVVKLLGCC-LETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
+ H +V L + E+ ++ L + +E ++ + + +V L +
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 180 LHSAASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+H H D+K NI+ + K+ DFG + + D GT + P
Sbjct: 271 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAP 325
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
E + + +D++S GV+ LL+G P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 49/239 (20%), Positives = 98/239 (41%), Gaps = 24/239 (10%)
Query: 44 QQMLNSYDDSVIDRCKLFSSKELDKAT----NHFNVNRILGQGGQGTVYKGM-LEDGRIM 98
+N YD D K + + ++ +++++ LG G G V++ + GR+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 99 AVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC-LETEVPLL-------HL 150
K ++ L NEI I++Q++H ++ L + E+ L+ L
Sbjct: 80 VAK----FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 151 HDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL--DERYRAKV 208
D E++ ++ + + L ++H + I H DIK NI+ + K+
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKI 192
Query: 209 ADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
DFG + + + + T + PE + +D+++ GV+ LL+G P
Sbjct: 193 IDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 68/300 (22%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKF-KLAVDDEELLKLEEFI 119
KE + + + V +LG GG G+VY G+ + D +A+K K + D L +
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 120 N-EIVILSQINHR--NVVKLLGCCLETEVPLL--------------HLHDHHRNEEFPLT 162
E+V+L +++ V++LL E + + + +E
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE--- 149
Query: 163 WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQ 221
R +V A+ + H+ + HRDIK NIL+D R K+ DFG+ +
Sbjct: 150 -LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL--LKD 202
Query: 222 THVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
T T GT Y PE YH + V+S G++L +++ G P F
Sbjct: 203 TVYTD-FDGTRVYSPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGDIP-FE----H 251
Query: 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
E + + + L++ CL L RPT EE+
Sbjct: 252 DEEIIRGQV--------FFRQRVSSECQHLIR------------WCLALRPSDRPTFEEI 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 21/209 (10%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + LG+G G V++ + + K K+ D+ L+K EI IL+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIA 58
Query: 129 NHRNVVKLLGCC-LETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
HRN++ L E+ ++ + + F L + +V AL +L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 181 HSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
HS I H DI+ NI+ R + K+ +FG ++ + + Y PE
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPE 173
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
HQ ++ +D++S G ++ LL+G P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 51/225 (22%)
Query: 70 TNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+N+ +LG+G G V K + AVK K D + E+ +L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----REVELL 75
Query: 126 SQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIA 170
+++H N++KL E ++ +E + RI
Sbjct: 76 KKLDHPNIMKLFEIL-EDSS-SFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RII 127
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTK 227
+V ++Y+H I HRD+K NILL ++ K+ DFG S Q
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD 182
Query: 228 IQGTFGYLEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT Y+ PE Y +K DV+S GV+L LL+G P
Sbjct: 183 RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-21
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 66/294 (22%)
Query: 70 TNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+ F R LG G G V+ G +K K + V E++ EI +L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE------AEIEVL 74
Query: 126 SQINHRNVVKLLGCCLETEVPLLHL-------------------HDHHRNEEFPLTWEIR 166
++H N++K+ E +++ +E +
Sbjct: 75 KSLDHPNIIKIFEVF-EDYH-NMYIVMETCEGGELLERIVSAQARGKALSEG-----YVA 127
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTH 223
+ ++ AL+Y HS + H+D+K NIL K+ DFG ++
Sbjct: 128 -ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDE 181
Query: 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSL 281
+T GT Y+ PE + +T K D++S GVV+ LLTG P F+ + + + +
Sbjct: 182 HSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEEVQQKATY 239
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ L Q V L+K+ L + ++RP+ +V
Sbjct: 240 KEPNYAVECRP-----LTPQAVDLLKQ------------MLTKDPERRPSAAQV 276
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 28/220 (12%)
Query: 73 FNVNRILGQGGQGTVYKG-MLEDGRIMAVKKFKLAVDDEELLKLEEF---INEIVILSQI 128
F +ILG+G TV L R A+K + ++K + E ++S++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMSRL 87
Query: 129 NHRNVVKLLGC---------CLETEVPLLHLHDHHRNEE-FPLTWEIRLRI-ATEVAGAL 177
+H VKL L L + R F E R E+ AL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSY-AKNGELLKYIRKIGSFD---ETCTRFYTAEIVSAL 143
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLE 236
YLH I HRD+K NILL+E ++ DFGT+K ++ + GT Y+
Sbjct: 144 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
PE SD+++ G ++ +L+ G P F GN
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 57/291 (19%), Positives = 102/291 (35%), Gaps = 54/291 (18%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+ + + ++G+G V + + E G+ AVK K L E+ E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT--SSPGLSTEDLKREASIC 80
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLH---------------DHHRNEEFPLTWEIRLRIA 170
+ H ++V+LL ++ L+ + F + +
Sbjct: 81 HMLKHPHIVELLETY-SSDG---MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTK 227
++ AL Y H I HRD+K +LL + K+ FG + + +
Sbjct: 137 RQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
+ GT ++ PE + DV+ GV+L LL+G P + T E +
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK---- 248
Query: 288 SMRKNHMYDILD---DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
Y + + + K +L R L L+ +R T+ E
Sbjct: 249 -------YKMNPRQWSHISESAK--------DLVRRMLMLDPAERITVYEA 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 55/309 (17%), Positives = 97/309 (31%), Gaps = 47/309 (15%)
Query: 49 SYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVD 108
+ + R K+ + H + R + K E I +
Sbjct: 40 RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99
Query: 109 DEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-----------LLHLHDHHRNE 157
+ +I + + +N V L L + +
Sbjct: 100 SSPSPM-DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 158 EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217
E L I ++A A+ +LHS + HRD+K +NI KV DFG +
Sbjct: 159 EDREHGVC-LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 218 AMDQTHVTTKIQ-----------GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKK 266
D+ T GT Y+ PE + + K D++S G++L ELL
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-- 272
Query: 267 PIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNG 326
FST E V + + +R + + + + + L +
Sbjct: 273 --FSTQM---ERVRI----ITDVRNLKFPLLFTQKYPQE---------HMMVQDMLSPSP 314
Query: 327 KKRPTMEEV 335
+RP ++
Sbjct: 315 TERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F + +G+GG G V++ D A+K+ +L + E+ + E+ L+++
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA---REKVMREVKALAKLE 62
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTW 163
H +V+ LET + T
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 71 NHFNVNRILGQGGQGTVYK-GMLEDGRIMAVKKFKLAVDDEELLKLEE---FINEIVILS 126
+ V +++G+G G V ++ A+K E++K + F E I++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMA 124
Query: 127 QINHRNVVKLLGC-------CLETE-VPLLHLHDHHRNEEFPLTWEIRLRI-ATEVAGAL 177
N VV+L + E +P L + N + P E R EV AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP---EKWARFYTAEVVLAL 181
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+HS HRD+K N+LLD+ K+ADFGT + + GT Y+ P
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 238 EYHQSSQLT---DKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 276
E +S + D +S GV L E+L G P F +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVG 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFK---LAVDDEELLKLEEFINEIVILS 126
N F+V+RI+G+GG G VY D G++ A+K + + E L L NE ++LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244
Query: 127 QIN---HRNVVKLLGCCLETEVPLL---------HLHDH-HRNEEFPLTWEIRLRI-ATE 172
++ +V + T L LH H ++ F E +R A E
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAE 300
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+ L ++H+ + +RD+K NILLDE +++D G + + + H + GT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 354
Query: 233 GYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 267
GY+ PE Q D S D +S G +L +LL G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 66/350 (18%), Positives = 111/350 (31%), Gaps = 82/350 (23%)
Query: 46 MLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK--- 101
M + + S F L + +++ +GQG G V + + I A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 102 KFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC--------------------- 140
K K+ + + +E E+ ++ +++H N+ +L
Sbjct: 61 KNKIRQINPK--DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118
Query: 141 -----------------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATE---------VA 174
P ++ N E + E +
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 175 GALSYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIA---MDQTHVTTKIQ 229
AL YLH+ I HRDIK N L ++ + K+ DFG SK + + T
Sbjct: 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 230 GTFGYLEPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFF 285
GT ++ PE + K D +S GV+L LL G P F N + V
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP-FPGVNDADTISQVLNKKLC 294
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ Y++L L+ L+ N +R
Sbjct: 295 FENPN----YNVLSPLARDLLSN------------LLNRNVDERFDAMRA 328
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+++++V LG+G V + + G A K KL+ D + L+ E I
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-----REARIC 59
Query: 126 SQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIA 170
++ H N+V+L + E +L +E +
Sbjct: 60 RKLQHPNIVRLHDSI-QEES-FHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCI 111
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTK 227
++ +++Y HS I HR++K N+LL + K+ADFG + + + +
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG 166
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT GYL PE + + D+++ GV+L LL G P
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-20
Identities = 56/220 (25%), Positives = 84/220 (38%), Gaps = 43/220 (19%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKF-KLAVDDEELLKLEEFINEIVILSQ 127
F +LG G V+ G++ A+K K + L+ NEI +L +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKK 62
Query: 128 INHRNVVKLLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIRLRIA 170
I H N+V L E+ H + D E+ + +
Sbjct: 63 IKHENIVTLEDIY-ESTT---HYYLVMQLVSGGELFDRILERGVYTEK-----DAS-LVI 112
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTK 227
+V A+ YLH I HRD+K N+L +E + + DFG SK Q + +
Sbjct: 113 QQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMST 166
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT GY+ PE + D +S GV+ LL G P
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 35/229 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKG-MLEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVILS 126
+ F + +++G+G V M + G++ A+K K+ + E + F E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE----VSCFREERDVLV 116
Query: 127 QINHRNVVKLLGCCLETEVPL-----------LHLHDHHRNEEFPLTWEIRLRI-ATEVA 174
+ R + +L + E L L E P R E+
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIV 172
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
A+ +H HRDIK NILLD ++ADFG+ + D T + GT Y
Sbjct: 173 MAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 235 LEPEYHQSSQLTDKSDVY-------SFGVVLVELLTGKKPIFSTGNTSQ 276
L PE Q+ + Y + GV E+ G+ P F +T++
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-FYADSTAE 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 70 TNHFNVNR--ILGQGGQGTVYKGM-LEDGRIMAVKKF-KLAVDDEELLKLEEFINEIVIL 125
+ + V++ ILG G G V+K G +A K + D+E +K NEI ++
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK-----NEISVM 140
Query: 126 SQINHRNVVKLLGC-------CLETEVPLLH---LHDHHRNEEFPLT-WEIRLRIATEVA 174
+Q++H N+++L L E + L D +E + LT + ++
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVME--YVDGGELFDRIIDESYNLTELDTI-LFMKQIC 197
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTF 232
+ ++H I H D+K NIL R K+ DFG ++ GT
Sbjct: 198 EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTP 252
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
+L PE ++ +D++S GV+ LL+G P F G+ E
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP-F-LGDNDAE 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 37/221 (16%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+H+ + LG G V K G+ A K K +L+ + + EE E+ IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNIL 62
Query: 126 SQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIA 170
+I H N++ L E + + L E+ E +
Sbjct: 63 REIRHPNIITLHDIF-ENKTDV-VLILELVSGGELFDFLAEKESLTED-----EAT-QFL 114
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTT 226
++ + YLHS I H D+K NI+L R K+ DFG + I + +
Sbjct: 115 KQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFK 169
Query: 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
I GT ++ PE L ++D++S GV+ LL+G P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVK---KFKLAVDDEELLKLEEFINEIVILS 126
+HF + R +G+G G V D ++ A+K K K +E + E+ I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE----VRNVFKELQIMQ 70
Query: 127 QINHRNVVKLLGC-------CLETE-VPLLHLHDH-HRNEEFPLTWEIRLRI-ATEVAGA 176
+ H +V L + + + L H +N F E +++ E+ A
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---EETVKLFICELVMA 127
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L YL + I HRD+K NILLDE + DF + + + T + GT Y+
Sbjct: 128 LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMA 182
Query: 237 PEYHQSSQLT--DKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 277
PE S + + D +S GV ELL G++P +TS +
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+++++V LG+G V + + G A K KL+ D + L+ E I
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-----REARIC 82
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIA-----TE-------- 172
++ H N+V+L + E H+ + E+ I +E
Sbjct: 83 RKLQHPNIVRLHDSI-QEE------SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135
Query: 173 -VAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKI 228
+ +++Y HS I HR++K N+LL + K+ADFG + + + +
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 190
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT GYL PE + + D+++ GV+L LL G P
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 60/293 (20%), Positives = 100/293 (34%), Gaps = 68/293 (23%)
Query: 70 TNHFNVNRILGQGGQGTVYKG-MLEDGRIMAVKKF-KLAVDDEELLKLEEFINEIVILSQ 127
++ + +G+G G V A KK K V+D + K EI I+
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-----QEIEIMKS 62
Query: 128 INHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIATE 172
++H N+++L E ++L H E + RI +
Sbjct: 63 LDHPNIIRLYETF-EDNT-DIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKD 114
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
V A++Y H + HRD+K N L K+ DFG + +
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV 169
Query: 230 GTFGYLEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLA 282
GT Y+ P+ Y + D +S GV++ LL G P FS S+ +
Sbjct: 170 GTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP-FSAPTDSEVMLKIREG 222
Query: 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
F + + Q L+++ L + K+R T +
Sbjct: 223 TFTFPEKD----WLNVSPQAESLIRR------------LLTKSPKQRITSLQA 259
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 64/292 (21%), Positives = 107/292 (36%), Gaps = 72/292 (24%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVD-DEELLKLEEFINEIVILS 126
++ LG G G V+ + E + + VK K K+ D E KL + EI ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 127 QINHRNVVKLLGCCLETEVPLL--------------HLHDHHRNEEFPLTWEIRLRIATE 172
++ H N++K+L E + + H R +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+ A+ YL I HRDIK NI++ E + K+ DFG++ ++ + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTI 193
Query: 233 GYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286
Y PE Y + +++S GV L L+ + P F
Sbjct: 194 EYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENP----------------FCE 232
Query: 287 HSMRKNHMYDI---LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ +++ LV L ++R T+E++
Sbjct: 233 LEETVEAAIHPPYLVSKELMSLVS------------GLLQPVPERRTTLEKL 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 37/230 (16%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK--KFKLAVDDEELLKLEEFINEIVILS 126
+ +++ LG G V K G A K K + + + EE E+ IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 127 QINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIAT 171
Q+ H NV+ L E + L +EE E
Sbjct: 71 QVLHHNVITLHDVY-ENRTDV-VLILELVSGGELFDFLAQKESLSEE-----EAT-SFIK 122
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTK 227
++ ++YLH+ I H D+K NI+L K+ DFG + I +
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
I GT ++ PE L ++D++S GV+ LL+G P F G+T QE
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FL-GDTKQE 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
++++ LG G V K G A K K + + + E+ E+ IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSIL 68
Query: 126 SQINHRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRLRIA 170
+I H NV+ L E + + L EE E
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDV-ILILELVAGGELFDFLAEKESLTEE-----EAT-EFL 120
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTT 226
++ + YLHS I H D+K NI+L + R K+ DFG + I D +
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
I GT ++ PE L ++D++S GV+ LL+G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
+ +++ LG G V K G A K K + + + EE E+ IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSIL 69
Query: 126 SQINHRNVVKLLGCC-LETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
Q+ H N++ L T+V L+ L D +E L+ E ++ +
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGV 128
Query: 178 SYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
+YLH+ I H D+K NI+L K+ DFG + I + I GT
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPE 183
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
++ PE L ++D++S GV+ LL+G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 37/219 (16%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
T + + LG+G V + + + G+ A KL+ D + L+ E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-----REARIC 64
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIA-----TE-------- 172
+ H N+V+L E H+ + E+ I +E
Sbjct: 65 RLLKHPNIVRLHDSI-SEE------GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 173 -VAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKI 228
+ A+ + H + HR++K N+LL + K+ADFG + + +Q
Sbjct: 118 QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF 173
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT GYL PE + D+++ GV+L LL G P
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 41/226 (18%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK-----KFKLAVDDEELLKLEEFINEIV 123
++ ILG+G V + + + AVK +E E + E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 124 ILSQIN-HRNVVKLLGCCLETEVPLLHL---------------HDHHRNEEFPLTWEIRL 167
IL +++ H N+++L ET L +E+ E R
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNT-FFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR- 127
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+I + + LH I HRD+K NILLD+ K+ DFG S + D +
Sbjct: 128 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE 182
Query: 228 IQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT YL PE + D++S GV++ LL G P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 63/294 (21%), Positives = 105/294 (35%), Gaps = 68/294 (23%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVILSQ 127
+ + +LG+G G V + + E AVK K KL ++ EI +L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRR 62
Query: 128 INHRNVVKLL-------------------GCCLETEVPLLHLHDHHRNEEFPLTWEIRLR 168
+ H+NV++L+ E +L R +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE----MLDSVPEKRFPV----CQAH-G 113
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS---KFIAMDQTHVT 225
++ L YLHS I H+DIK N+LL K++ G + A D T T
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 226 TKIQGTFGYLEPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSL 281
+ QG+ + PE K D++S GV L + TG P F N + EN+
Sbjct: 171 S--QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGK 227
Query: 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ + + L+K L+ KR ++ ++
Sbjct: 228 GSY--------AIPGDCGPPLSDLLK------------GMLEYEPAKRFSIRQI 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 75/299 (25%), Positives = 115/299 (38%), Gaps = 67/299 (22%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEE 117
S + ++ + + +G+G V + GR +A+K K +L + L
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF--- 62
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWE 164
E+ I+ +NH N+VKL +ETE L +L H R +E E
Sbjct: 63 --REVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----E 115
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224
R ++ A+ Y H I HRD+K+ N+LLD K+ADFG S +
Sbjct: 116 AR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 225 TTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ-- 276
G Y PE Y + DV+S GV+L L++G P F N +
Sbjct: 172 AF--CGAPPYAAPELFQGKKYDGP-----EVDVWSLGVILYTLVSGSLP-FDGQNLKELR 223
Query: 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
E V + + + L+K R L LN KR T+E++
Sbjct: 224 ERVLRGKYRIPFY--------MSTDCENLLK------------RFLVLNPIKRGTLEQI 262
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 68/227 (29%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 71 NHFNVNRILGQGGQGTVY----KGMLEDGRIMAVK---KFKLAVDDEELLKLEEFINEIV 123
+ F + ++LGQG G V+ + ++ A+K K L V D E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-----RTKMERD 78
Query: 124 ILSQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI- 169
IL ++NH +VKL +TE L L + F E ++
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFT---EEDVKFY 131
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
E+A AL +LHS I +RD+K NILLDE K+ DFG SK ++D
Sbjct: 132 LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC 187
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
GT Y+ PE T +D +SFGV++ E+LTG P F + +
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 65/260 (25%), Positives = 104/260 (40%), Gaps = 34/260 (13%)
Query: 36 KQNGGLLLQQMLNSYDDSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGMLED 94
KQ + + + D+S + ++ +K + T N F ++LG+G G V +
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 95 -GRIMAVK---KFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL--- 147
GR A+K K + DE + + E +L H + L +T L
Sbjct: 172 TGRYYAMKILKKEVIVAKDE----VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFV 226
Query: 148 ----------LHLHDHHRNEEFPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKST 196
HL R F E R R E+ AL YLHS + + +RD+K
Sbjct: 227 MEYANGGELFFHLS---RERVFS---EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLE 278
Query: 197 NILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGV 256
N++LD+ K+ DFG K + GT YL PE + + D + GV
Sbjct: 279 NLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 257 VLVELLTGKKPIFSTGNTSQ 276
V+ E++ G+ P F + +
Sbjct: 338 VMYEMMCGRLP-FYNQDHEK 356
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 60/234 (25%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
D ++ F V LG+G VY+ + A+K K VD + + EI
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEI 99
Query: 123 VILSQINHRNVVKLLGCCLETEVPLLHLH------------DHHRNEEFPLTWEIRLRIA 170
+L +++H N++KL ET + D RI
Sbjct: 100 GVLLRLSHPNIIKLKEIF-ETPT---EISLVLELVTGGELFD---------------RIV 140
Query: 171 -----TE---------VAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGT 213
+E + A++YLH I HRD+K N+L K+ADFG
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197
Query: 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
SK + + + + GT GY PE + + D++S G++ LL G +P
Sbjct: 198 SKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 29/225 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKG-MLEDGRIMAVKKFKLAVDDEELLKLEE---FINEIVILS 126
F + +++G+G G V + ++ A+K E+LK E F E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLV 129
Query: 127 QINHRNVVKLLGCCLETEVPLL---------HLHDHHRNEEFPLTWEIRLRI-ATEVAGA 176
+ + + L + + L L E L E R E+ A
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIA 187
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
+ +H HRDIK NIL+D ++ADFG+ + D T ++ GT Y+
Sbjct: 188 IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 237 PEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQ 276
PE Q+ + D +S GV + E+L G+ P F + +
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVE 288
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFI-NEIVI 124
++ ++G+G V + + G AVK + E+L ++ E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 125 LSQI-NHRNVVKLLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIR 166
L Q+ H +++ L+ E+ + D+ +E+ E R
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSS---FMFLVFDLMRKGELFDYLTEKVALSEK-----ETR 203
Query: 167 LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 226
I + A+S+LH+ I HRD+K NILLD+ + +++DFG S ++
Sbjct: 204 -SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR 257
Query: 227 KIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
++ GT GYL PE + D+++ GV+L LL G P
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 60/288 (20%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN-EIVILSQIN 129
+++ + LG+G G V + +AVK VD + + E I EI I +N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLN 63
Query: 130 HRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
H NVVK G + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYL 235
+ YLH I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 236 EPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE--NVSLAAFFVH 287
PE +H DV+S G+VL +L G+ P ++ QE + +++
Sbjct: 175 APELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ +D + L+ + L N R T+ ++
Sbjct: 230 P------WKKIDSAPLALLH------------KILVENPSARITIPDI 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 9e-18
Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 30/224 (13%)
Query: 71 NHFNVNRILGQGGQGTVY----KGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
F + R+LG+GG G V+ G+I A+K K A+ E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 127 QINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI-ATE 172
++ H +V L+ +T L + L R F E E
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFM---EDTACFYLAE 129
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
++ AL +LH I +RD+K NI+L+ + K+ DFG K ++ VT GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTI 185
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
Y+ PE S D +S G ++ ++LTG P F+ N +
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKK 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 57/315 (18%), Positives = 110/315 (34%), Gaps = 73/315 (23%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + +G G QG V R +A+KK ++ K E+V++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 81
Query: 129 NHRNVVKLLG------------------CCLETEVPLLH-------LHDHHRNEEFPLTW 163
NH+N++ LL ++ L H+ L +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN---LCQVIQMELDHERMS----YLLY 134
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
++ L + +LHSA I HRD+K +NI++ K+ DFG ++ +
Sbjct: 135 QM-LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSF 181
Query: 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS------------- 270
+ T T Y PE + D++S G ++ E++ G +F
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIE 240
Query: 271 -TGNTSQENV----SLAAFFVHSMRK------NHMYDILDDQVVKLVKKNQIMAFANLAE 319
G E + +V + K ++ + K + +L
Sbjct: 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300
Query: 320 RCLDLNGKKRPTMEE 334
+ L ++ KR +++E
Sbjct: 301 KMLVIDASKRISVDE 315
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 61/319 (19%), Positives = 120/319 (37%), Gaps = 70/319 (21%)
Query: 75 VNRILGQGGQGTVYKGM-LEDGRIMAVK------KFKLAVDDEELLKLEEFINEIVILSQ 127
+ R LG G TV+ + + +A+K + A +DE +KL + +N+ +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE--IKLLQRVNDADNTKE 80
Query: 128 --INHRNVVKLLGC-----------CLETEV---PLLHLHDHHRNEEFPLTWEIRLRIAT 171
+ +++KLL + EV LL L + + PL + ++ +I+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-VK-QISK 138
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA------KVADFGTSKFIAMDQTHVT 225
++ L Y+H I H DIK N+L++ K+AD G + + H T
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYT 193
Query: 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF---STGNTSQENVSLA 282
IQ Y PE + +D++S ++ EL+TG +F + ++++ +A
Sbjct: 194 NSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIA 251
Query: 283 AF------FVHSM------------RKNHMYDILDDQVVKL---------VKKNQIMAFA 315
+ + + +I + L K++ +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 316 NLAERCLDLNGKKRPTMEE 334
+ L L+ +KR
Sbjct: 312 DFLSPMLQLDPRKRADAGG 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 67/288 (23%), Positives = 109/288 (37%), Gaps = 60/288 (20%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN-EIVILSQIN 129
+++ + LG+G G V + +AVK VD + + E I EI I +N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLN 63
Query: 130 HRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
H NVVK G + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYL 235
+ YLH I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 236 EPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE--NVSLAAFFVH 287
PE +H DV+S G+VL +L G+ P ++ QE + ++
Sbjct: 175 APELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL- 228
Query: 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ D + L+ + L N R T+ ++
Sbjct: 229 -NPWKKI----DSAPLALLH------------KILVENPSARITIPDI 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 57/231 (24%)
Query: 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFIN-EIVILSQ 127
+ +++G G G VY+ L + G ++A+KK + F N E+ I+ +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------KRFKNRELQIMRK 103
Query: 128 INHRNVVKLLGC------------------CLETEVPLLHLHDHHRNEEFPLTWEIR--- 166
++H N+V+L + V + H + P+ ++
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI-YVKLYM 162
Query: 167 ---LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ- 221
R +L+Y+HS I HRDIK N+LLD K+ DFG++K + +
Sbjct: 163 YQLFR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 222 -TH-VTTKIQGTFGYLEPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ ++ Y PE ++ T DV+S G VL ELL G +PIF
Sbjct: 213 NVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIF 257
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 48 NSYDDSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKK 102
+ D K + + + A + F+ + LG G G V ML E G A+K
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKI 73
Query: 103 FKLAVDDEELLKLEEF---INEIVILSQINHRNVVKLLGC-------CLETE-VPLLHLH 151
++++KL++ +NE IL +N +VKL + E V +
Sbjct: 74 LD----KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 152 DHHRNEE-FPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209
H R F E R A ++ YLHS + +RD+K N+L+D++ +V
Sbjct: 130 SHLRRIGRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVT 183
Query: 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
DFG +K + T + GT L PE S D ++ GV++ E+ G P F
Sbjct: 184 DFGFAKRV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239
Query: 270 S 270
+
Sbjct: 240 A 240
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 61/318 (19%), Positives = 112/318 (35%), Gaps = 78/318 (24%)
Query: 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN--------- 120
+ + V R + G G V G+ +G +A+K+ V D + + +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI--LSDSFLCKRVLR 78
Query: 121 EIVILSQINHRNVVKLLGCCLETEVPLLH------------LHDHHRNEEFPLTWE-IR- 166
EI +L+ +H N++ L + E P +H L ++ ++ + I+
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 167 -----LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221
L L LH A + HRD+ NILL + + DF ++ D
Sbjct: 139 FMYHILL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 222 T---HVTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF-------- 269
+VT + Y PE + K D++S G V+ E+ K +F
Sbjct: 189 NKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQ 242
Query: 270 ------STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKN--QIMAFAN----- 316
G E V D L + + + + ++ A+
Sbjct: 243 LNKIVEVVGTPKIE-------DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 317 LAERCLDLNGKKRPTMEE 334
L + L+ N ++R + E+
Sbjct: 296 LIAKMLEFNPQRRISTEQ 313
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 56/300 (18%), Positives = 110/300 (36%), Gaps = 43/300 (14%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + +G G QG V R +A+KK ++ K E+V++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 118
Query: 129 NHRNVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
NH+N++ LL + V L + + + L E + ++ +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+LHSA I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 233
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS--------------TGNTSQENV----S 280
+ D++S G ++ E++ K +F G E +
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 281 LAAFFVHSMRK------NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+V + K ++ K + +L + L ++ KR ++++
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 54/237 (22%)
Query: 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFIN- 120
K ++ + +++G G G V++ L + +A+KK D+ F N
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKR------FKNR 81
Query: 121 EIVILSQINHRNVVKLLGCCLET-----EVPL----------LH-LHDHHRNEEFPLTWE 164
E+ I+ + H NVV L EV L ++ H+ + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 165 -IR------LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKF 216
I+ LR +L+Y+HS I HRDIK N+LLD K+ DFG++K
Sbjct: 142 LIKLYMYQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 217 IAMDQ--TH-VTTKIQGTFGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ + + ++ Y PE ++ T D++S G V+ EL+ G +P+F
Sbjct: 192 LIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF 242
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 56/255 (21%), Positives = 93/255 (36%), Gaps = 49/255 (19%)
Query: 59 KLFSSKELDKATNHFNVN-RILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELL 113
+ + ++ N + + + LG+G V + + G+ A K K + D +
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75
Query: 114 KLEEFINEIVILSQINHR-NVVKLLGCCLETEVPLLHL-----------------HDHHR 155
+EI +L V+ L E + L
Sbjct: 76 L-----HEIAVLELAKSCPRVINLHEVY-ENTSEI-ILILEYAAGGEIFSLCLPELAEMV 128
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFG 212
+E ++ R+ ++ + YLH I H D+K NILL K+ DFG
Sbjct: 129 SEN-----DVI-RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
S+ I +I GT YL PE +T +D+++ G++ LLT P F G
Sbjct: 180 MSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-FV-G 235
Query: 273 NTSQE---NVSLAAF 284
+QE N+S
Sbjct: 236 EDNQETYLNISQVNV 250
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 68/310 (21%), Positives = 111/310 (35%), Gaps = 77/310 (24%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKL-------------------AV 107
N + + +G+G G V D A+K K KL
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 108 DDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE-----EF--- 159
+ +E+ EI IL +++H NVVKL+ EV L D + + E
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLV------EV----LDDPNEDHLYMVFELVNQ 122
Query: 160 ----------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209
PL+ + ++ + YLH I HRDIK +N+L+ E K+A
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIA 179
Query: 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT---DKSDVYSFGVVLVELLTGKK 266
DFG S + + GT ++ PE ++ DV++ GV L + G+
Sbjct: 180 DFGVSNEF-KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 267 PIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFA-NLAERCLDLN 325
P F ++ + Q ++ + I +L R LD N
Sbjct: 239 P-FMDERIMC-----------------LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN 280
Query: 326 GKKRPTMEEV 335
+ R + E+
Sbjct: 281 PESRIVVPEI 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 89/317 (28%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +G G G+V + G +A+KK E K E+++L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYRELLLLKHM 80
Query: 129 NHRNVVKLLG------------------CCLETEVPLLH-------LHDHHRNEEFPLTW 163
H NV+ LL ++T+ L + + L +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQ----YLVY 133
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
++ L+ L Y+HSA + HRD+K N+ ++E K+ DFG ++ + T
Sbjct: 134 QM-LK-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 224 -VTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS----------- 270
V T+ Y PE S +++ D++S G ++ E+LTG K +F
Sbjct: 183 YVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQI 236
Query: 271 ---TGNTSQENVSL-----AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFAN-----L 317
TG E V A ++ S+ + D Q+ A+ L
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-----------TQLFPRASPQAADL 285
Query: 318 AERCLDLNGKKRPTMEE 334
E+ L+L+ KR T +
Sbjct: 286 LEKMLELDVDKRLTAAQ 302
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNV 133
+GQG G V+K + G+ +A+KK + ++E+ E F + EI IL + H NV
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLM--ENEK----EGFPITALREIKILQLLKHENV 78
Query: 134 VKLLGCCLETEVPL------LHL------HD-----HHRNEEFPLTWEIRLRIATEVAGA 176
V L+ C P ++L HD + +F L+ EI+ R+ +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIK-RVMQMLLNG 136
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 233
L Y+H + I HRD+K+ N+L+ K+ADFG ++ ++ + + T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 234 YLEPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
Y PE D++ G ++ E+ T + PI GNT Q
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIM-QGNTEQH 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 30/237 (12%)
Query: 52 DSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVY----KGMLEDGRIMAVKKFKLA 106
+ + +K +F + ++LG G G V+ + G++ A+K K A
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 107 VDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-------------LHLHDH 153
++ E E +L I + L +TE L HL
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-- 151
Query: 154 HRNEEFPLTWEIRLRI-ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212
+ E F E ++I E+ AL +LH I +RDIK NILLD + DFG
Sbjct: 152 -QRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204
Query: 213 TSKFIAMDQTHVTTKIQGTFGYLEPE-YHQSSQLTDKS-DVYSFGVVLVELLTGKKP 267
SK D+T GT Y+ P+ DK+ D +S GV++ ELLTG P
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 49/232 (21%)
Query: 68 KATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
K + F V R+ GQG GTV G G +A+KK V + + E + + L+
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNRE-LQIMQDLA 74
Query: 127 QINHRNVVKLL------GCCLETEVPL----------LH-LHDHHRNEEFPLTWE-IR-- 166
++H N+V+L G ++ L LH ++ + I+
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 167 ----LRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ 221
+R ++ LH S + HRDIK N+L++E K+ DFG++K ++ +
Sbjct: 135 LFQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 222 TH---VTTKIQGTFGYLEPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ + ++ Y PE + T D++S G + E++ G +PIF
Sbjct: 187 PNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIF 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVK---KFKLAVDDEELLKLEEFINEIVILS 126
N F+ ++LG+G G V + GR A+K K + DE + + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI-ATE 172
H + L +T L HL F E R R E
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV---FT---EERARFYGAE 113
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
+ AL YLHS + +RDIK N++LD+ K+ DFG K + GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
YL PE + + D + GVV+ E++ G+ P F + +
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER 212
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 68/290 (23%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKL-AVDDEELLKLEEFINEIVILS 126
H+ + LG G G V G G +AVK + K+ ++D +K EI L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-----REIQNLK 66
Query: 127 QINHRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEV 173
H +++KL + T ++ H R EE E R R+ ++
Sbjct: 67 LFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQI 120
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
A+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPN 175
Query: 234 YLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFF 285
Y PE Y + D++S GV+L LL G P F + + + F
Sbjct: 176 YAAPEVISGRLYAGP-----EVDIWSCGVILYALLCGTLP-FDDEHVPTLFKKIRGGVF- 228
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
++ + L+ V L+ L ++ KR T++++
Sbjct: 229 -------YIPEYLNRSVATLLM------------HMLQVDPLKRATIKDI 259
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-16
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 51/218 (23%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNV 133
+G+G GTV+K E I+A+K+ +L DD++ E + EI +L ++ H+N+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRL--DDDD----EGVPSSALREICLLKELKHKNI 63
Query: 134 VKLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIR------LRIATEVAGA 176
V+L + L L D N + ++ L+
Sbjct: 64 VRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLK-------G 113
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
L + H S + HRD+K N+L++ K+A+FG ++ + + ++ T Y
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRP 169
Query: 237 PEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
P+ S+ + D++S G + EL +P+F
Sbjct: 170 PDVLFGAKLYSTSI----DMWSAGCIFAELANAGRPLF 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 58/285 (20%), Positives = 103/285 (36%), Gaps = 57/285 (20%)
Query: 76 NRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNV 133
++ LG+G K + + + AVK + EI L H N+
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK----IISKR---MEANTQKEITALKLCEGHPNI 68
Query: 134 VKLLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIRLRIATEVAGA 176
VKL ++ H + H +E E I ++ A
Sbjct: 69 VKLHEVF-HDQL---HTFLVMELLNGGELFERIKKKKHFSET-----EAS-YIMRKLVSA 118
Query: 177 LSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
+S++H + HRD+K N+L ++ K+ DFG ++ D + T T
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLH 174
Query: 234 YLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293
Y PE + + D++S GV+L +L+G+ P F + + S S ++K
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP-FQSHDRSLTCTSAVEIM-KKIKKGD 232
Query: 294 MYDILD---DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ V + K +L + L ++ KR M +
Sbjct: 233 -FSFEGEAWKNVSQEAK--------DLIQGLLTVDPNKRLKMSGL 268
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 65/301 (21%), Positives = 109/301 (36%), Gaps = 70/301 (23%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVK 135
+LG+G V + L + AVK ++ + E+ +L Q HRNV++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 136 LLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIRLRIATEVAGALS 178
L+ E E + H H NE E + +VA AL
Sbjct: 76 LIEFF-EEED---RFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALD 125
Query: 179 YLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ------ 229
+LH+ I HRD+K NIL ++ K+ DF I ++
Sbjct: 126 FLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 230 GTFGYLEPE----YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
G+ Y+ PE + + + + DK D++S GV+L LL+G P F G +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-FV-GRCGSDCGWDRGE 240
Query: 285 FVHSMRKNHMYDILD----------DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ + I + + K +L + L + K+R + +
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAK--------DLISKLLVRDAKQRLSAAQ 292
Query: 335 V 335
V
Sbjct: 293 V 293
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 72/340 (21%), Positives = 116/340 (34%), Gaps = 99/340 (29%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK------KFKLAVDDEELLKLEEFI 119
D + V +++G+G G V K + + +A+K +F
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----------A 141
Query: 120 NEIVILSQINHR------NVVKLLGC-------CLETEVPLLH--LHDHHRNEEF-PLTW 163
EI IL + + NV+ +L C+ E LL L++ + +F +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSL 199
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQ 221
+ + A + L LH I H D+K NILL ++ R+ KV DFG+S + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EH 253
Query: 222 THVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
V T IQ F Y PE Y D++S G +L ELLTG P+ +
Sbjct: 254 QRVYTYIQSRF-YRAPEVILGARYGMPI------DMWSLGCILAELLTG-YPLLPGEDEG 305
Query: 276 Q-----------------ENVSLAAFFVHSM------------------------RKNHM 294
+ A FV S R
Sbjct: 306 DQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLR 365
Query: 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ +K F + ++CL+ + R T +
Sbjct: 366 GPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFK----LAVDDEELLKLEEFINEI 122
+ F+ +++G+G G V +L + AVK + L +E+ + E
Sbjct: 38 SDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN---- 90
Query: 123 VILSQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI 169
V+L + H +V L +T L HL F E R R
Sbjct: 91 VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC---FL---EPRARF 143
Query: 170 -ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
A E+A AL YLHS I +RD+K NILLD + + DFG K ++ T+
Sbjct: 144 YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTF 199
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
GT YL PE D + G VL E+L G P F + NT++
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAE 246
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 51/217 (23%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNVV 134
+G+G G VYK GRI+A+K+ +L D E+ E I EI +L +++H N+V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRL--DAED----EGIPSTAIREISLLKELHHPNIV 82
Query: 135 KLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIR------LRIATEVAGAL 177
L+ L L D + +I+ LR +
Sbjct: 83 SLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDS-QIKIYLYQLLR-------GV 132
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
++ H I HRD+K N+L++ K+ADFG ++ + T ++ T Y P
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 238 EY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ S+ + D++S G + E++TG KP+F
Sbjct: 189 DVLMGSKKYSTSV----DIWSIGCIFAEMITG-KPLF 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V K + GRI+A+KKF + DD+ + K+ + EI +L Q+ H N+V LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLL 90
Query: 138 GCCLET----------EVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
C + + +L + N L +++ + ++ + + HS
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
I HRDIK NIL+ + K+ DFG ++ +A ++ T Y PE
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYG 203
Query: 248 KS-DVYSFGVVLVELLTGKKPIF 269
K+ DV++ G ++ E+ G +P+F
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EPLF 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 52/299 (17%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + +G G G V + G +A+KK E K E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--RAYRELRLLKHM 81
Query: 129 NHRNVVKLLGCCLETEVPLLHLHDHHRNEEF------------PLTWEIRLRIATEVAGA 176
H NV+ LL + L D + F L + + ++
Sbjct: 82 RHENVIGLLDV-FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYL 235
L Y+H+A I HRD+K N+ ++E K+ DFG ++ + T +V T+ Y
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YR 192
Query: 236 EPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVS 280
PE + ++ D++S G ++ E++TG K +F TG E V
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 281 L-----AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
A ++ + + D ++ +A NL E+ L L+ ++R T E
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDF-----ASILTNASPLA-VNLLEKMLVLDAEQRVTAGE 304
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 35/225 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFK----LAVDDEELLKLEEFINEIVIL 125
FN +LG+G G V + + AVK K + DD E +E+ + +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 126 SQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI-AT 171
+ +L C +T L H+ R F E A
Sbjct: 400 ---KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FK---EPHAVFYAA 449
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E+A L +L S I +RD+K N++LD K+ADFG K + T GT
Sbjct: 450 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGT 505
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
Y+ PE D ++FGV+L E+L G+ P F + +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 549
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 73 FNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEF---INEIVIL 125
F + R LG G G V L +GR A+K K E +++L++ +E ++L
Sbjct: 8 FQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLK----KEIVVRLKQVEHTNDERLML 60
Query: 126 SQINHRNVVKLLGC-------CLETE-VPLLHLHDHHRNEE-FPLTWEIRLRI-ATEVAG 175
S + H ++++ G + + + L R + FP + A EV
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCL 117
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
AL YLHS I +RD+K NILLD+ K+ DFG +K++ VT + GT Y+
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYI 170
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 270
PE + D +SFG+++ E+L G P +
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 47/223 (21%)
Query: 79 LGQGGQGTVYKGM---LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135
+G+G G VYK +D + A+K+ + + EI +L ++ H NV+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 136 LLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIRLRIAT------EVAGALS 178
L L + L HD ++L ++ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 179 YLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAM---DQTHVTTKIQGT 231
YLH+ + HRD+K NIL+ ER R K+AD G ++ + + T
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 232 FGYLEPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
F Y PE H + + D+++ G + ELLT +PIF
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT-SEPIF 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 64/255 (25%), Positives = 109/255 (42%), Gaps = 48/255 (18%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVK--KFKLAVDDEELLKLEEFINEIVI 124
F++ R++G+G V +L + RI A+K K +L DDE++ + E +
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDI---DWVQTEKHV 62
Query: 125 LSQI-NHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI- 169
Q NH +V L C +TE L H+ + P E R
Sbjct: 63 FEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LP---EEHARFY 115
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 229
+ E++ AL+YLH I +RD+K N+LLD K+ D+G K + T+
Sbjct: 116 SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC 171
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289
GT Y+ PE + D ++ GV++ E++ G+ P F +S
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP-FDIVGSSDNP--------DQN 222
Query: 290 RKNHMYD-ILDDQVV 303
+++++ IL+ Q+
Sbjct: 223 TEDYLFQVILEKQIR 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137
+G+G G V+K + G+I+A+KKF + DD + K+ + EI +L Q+ H N+V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68
Query: 138 GCCLET----------EVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
+ +LH D ++ + + I + A+++ H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
HRD+K NIL+ + K+ DFG ++ + + ++ T Y PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 248 KS-DVYSFGVVLVELLTGKKPIF 269
DV++ G V ELL+G P++
Sbjct: 182 PPVDVWAIGCVFAELLSG-VPLW 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 53/217 (24%), Positives = 85/217 (39%), Gaps = 51/217 (23%)
Query: 79 LGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNVV 134
+G+G G VYK G A+KK +L + E+ E I EI IL ++ H N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL--EKED----EGIPSTTIREISILKELKHSNIV 63
Query: 135 KLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIR------LRIATEVAGAL 177
KL + L L D + L +
Sbjct: 64 KLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESV-TAKSFLLQLLN-------GI 113
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+Y H + HRD+K N+L++ K+ADFG ++ + T +I T Y P
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 238 E-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
+ S+ + D++S G + E++ G P+F
Sbjct: 170 DVLMGSKKYSTTI----DIWSVGCIFAEMVNG-TPLF 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 60/256 (23%), Positives = 107/256 (41%), Gaps = 50/256 (19%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVK---KFKLAVDDEELLKLEEFINEIV 123
F++ R++G+G V +L + RI A++ K + D++ ++ E
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDED----IDWVQTEKH 104
Query: 124 ILSQI-NHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI 169
+ Q NH +V L C +TE L H+ + P E R
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LP---EEHARF 157
Query: 170 -ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
+ E++ AL+YLH I +RD+K N+LLD K+ D+G K + T+
Sbjct: 158 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTF 213
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288
GT Y+ PE + D ++ GV++ E++ G+ P F +S
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP-FDIVGSSDNP--------DQ 264
Query: 289 MRKNHMYD-ILDDQVV 303
+++++ IL+ Q+
Sbjct: 265 NTEDYLFQVILEKQIR 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 71/228 (31%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFK----LAVDDEELLKLEEFINEI 122
++F R+LG+G G V ML E G + AVK K L DD E E+ I +
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 123 VILSQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI 169
NH + +L CC +T L H+ R F E R R
Sbjct: 80 AR----NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FD---EARARF 128
Query: 170 -ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
A E+ AL +LH I +RD+K N+LLD K+ADFG K + T
Sbjct: 129 YAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATF 184
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
GT Y+ PE Q D ++ GV+L E+L G P F N
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDD 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 69/318 (21%), Positives = 116/318 (36%), Gaps = 90/318 (28%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +G G G+V + G +AVKK K E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK--RTYRELRLLKHM 85
Query: 129 NHRNVVKLLG------------------CCLETEVPLLH--------LHDHHRNEEFPLT 162
H NV+ LL + + L+ DH + L
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHVQ----FLI 138
Query: 163 WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222
++I LR L Y+HSA I HRD+K +N+ ++E K+ DFG ++ A + T
Sbjct: 139 YQI-LR-------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 223 -HVTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS---------- 270
+V T+ Y PE + +++ D++S G ++ ELLTG + +F
Sbjct: 188 GYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKL 241
Query: 271 ----TGNTSQENVSL-----AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFAN----- 316
G E + A ++ S+ + + + AN
Sbjct: 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF-----------ANVFIGANPLAVD 290
Query: 317 LAERCLDLNGKKRPTMEE 334
L E+ L L+ KR T +
Sbjct: 291 LLEKMLVLDSDKRITAAQ 308
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + + R LG+G V++ + + + + VK K V +++ + EI IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKR------EIKILENL 87
Query: 129 -NHRNVVKLLGCCLETE-------VPLLHLHDHHRNEEFPLT-WEIR------LRIATEV 173
N++ L + ++ D + + LT ++IR L+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLTDYDIRFYMYEILK----- 141
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQT---HVTTKIQ 229
AL Y HS I HRD+K N+++D +R ++ D+G ++F Q V ++
Sbjct: 142 --ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY- 195
Query: 230 GTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
+ PE Q+ D S D++S G +L ++ K+P F
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 61/312 (19%), Positives = 116/312 (37%), Gaps = 66/312 (21%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + + LG GG G V+ + + + +A+KK + + D + +K + EI I+ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVK--HALREIKIIRRL 65
Query: 129 NHRNVVKLLGCCL-ETEVPLLHLHDHHRNEEFPLTWE---------IRLRIATE------ 172
+H N+VK+ + + E + E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 173 ---VAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH----- 223
+ L Y+HSA + HRD+K N+ ++ E K+ DFG ++ + +H
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 224 --VTTKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF----------- 269
+ TK Y P S K+ D+++ G + E+LTG K +F
Sbjct: 183 EGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQL 236
Query: 270 ---STGNTSQENV----SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCL 322
S +E+ S+ ++ + + +L+ A + E+ L
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-----TQLLPGISREAV-DFLEQIL 290
Query: 323 DLNGKKRPTMEE 334
+ R T EE
Sbjct: 291 TFSPMDRLTAEE 302
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 39/220 (17%)
Query: 75 VNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQIN 129
V I G G GTVYK G +A+K ++ + E+ +L ++
Sbjct: 14 VAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---GGLPISTVREVALLRRLE 69
Query: 130 ---HRNVVKLLGCCLETEVP---------------LLHLHDHHRNEEFPLTWEIRLRIAT 171
H NVV+L+ C + L D P I+ +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIK-DLMR 127
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQ 229
+ L +LH+ + I HRD+K NIL+ K+ADFG ++ M T V
Sbjct: 128 QFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--- 181
Query: 230 GTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
T Y PE S D++S G + E+ +KP+F
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 68/290 (23%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKL-AVDDEELLKLEEFINEIVILS 126
H+ + LG G G V G G +AVK + K+ ++D ++ EI L
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-----REIQNLK 71
Query: 127 QINHRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEV 173
H +++KL + T + ++ + R +E E R R+ ++
Sbjct: 72 LFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQI 125
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+
Sbjct: 126 LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPN 180
Query: 234 YLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFF 285
Y PE Y + D++S GV+L LL G P F + + + F
Sbjct: 181 YAAPEVISGRLYAGP-----EVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKICDGIF- 233
Query: 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ L+ V+ L+K L ++ KR T++++
Sbjct: 234 -------YTPQYLNPSVISLLK------------HMLQVDPMKRATIKDI 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 60/219 (27%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAV----DDEELLKLEEFINEI 122
FN +LG+G G V ML + AVK K V DD E +E+ + +
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 123 VILSQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI 169
+ +L C +T L H+ R F E
Sbjct: 77 PG----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FK---EPHAVF 125
Query: 170 -ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
A E+A L +L S I +RD+K N++LD K+ADFG K + T
Sbjct: 126 YAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTF 181
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
GT Y+ PE D ++FGV+L E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 41/228 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFK----LAVDDEELLKLEEFINEI 122
F ++++LG+G G V L + + A+K K L DD E +E+ + +
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 123 VILSQINHRNVVKLLGCCLETEVPL-------------LHLHDHHRNEEFPLTWEIRLRI 169
H + + C +T+ L H+ H+ F R
Sbjct: 74 AW----EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FD---LSRATF 122
Query: 170 -ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 228
A E+ L +LHS I +RD+K NILLD+ K+ADFG K M T
Sbjct: 123 YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTF 178
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276
GT Y+ PE + D +SFGV+L E+L G+ P F + +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 67/289 (23%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKL-AVDDEELLKLEEFINEIVILS 126
+ + LG+G G V + + +A+K + L D ++ EI L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-----REISYLK 64
Query: 127 QINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFPLTWEIRLRIATEVA 174
+ H +++KL + T ++ ++ + R E E R R ++
Sbjct: 65 LLRHPHIIKLYDV-ITTPTDIVMVIEYAGGELFDYIVEKKRMTED----EGR-RFFQQII 118
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
A+ Y H I HRD+K N+LLD+ K+ADFG S + T+ G+ Y
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNY 173
Query: 235 LEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAFFV 286
PE Y + DV+S G+VL +L G+ P F + V+ +
Sbjct: 174 AAPEVINGKLYAGP-----EVDVWSCGIVLYVMLVGRLP-FDDEFIPNLFKKVNSCVY-- 225
Query: 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
M D L L++ R + + +R T++E+
Sbjct: 226 ------VMPDFLSPGAQSLIR------------RMIVADPMQRITIQEI 256
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 74/339 (21%), Positives = 122/339 (35%), Gaps = 95/339 (28%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + + LG+G G V+K + G ++AVKK A + + EI+IL+++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFREIMILTEL 65
Query: 129 N-HRNVVKLLGCC--------------LETEVPLLHL--------HDHHRNEEFPLTWEI 165
+ H N+V LL +ET+ LH H + + +++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETD---LHAVIRANILEPVHKQY----VVYQL 118
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225
++ + YLHS + HRD+K +NILL+ KVADFG S+ +
Sbjct: 119 -IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 226 TKIQGTFGYLEPEYHQSSQLTD---------------------KSDVYSFGVVLVELLTG 264
E LTD D++S G +L E+L G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 265 KKPIF--------------STGNTSQENVS-----LAAFFVHSMRK-----NHMYDILDD 300
KPIF S E+V A + S+++ +
Sbjct: 228 -KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 301 QVVKLVKKNQIMAFAN-----LAERCLDLNGKKRPTMEE 334
+ L+ K A N L ++ L N KR + +
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 41/212 (19%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNV 133
LG+G TVYKG ++A+K+ +L + EE I E+ +L + H N+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRL--EHEE-----GAPCTAIREVSLLKDLKHANI 62
Query: 134 VKLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
V L + L L D + ++L ++ L+Y H
Sbjct: 63 VTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMH-NVKL-FLFQLLRGLAYCHR 118
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY--- 239
+ HRD+K N+L++ER K+ADFG ++ ++ ++ T Y P+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174
Query: 240 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
S+Q+ D++ G + E+ TG +P+F
Sbjct: 175 STDYSTQI----DMWGVGCIFYEMATG-RPLF 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 45/233 (19%), Positives = 83/233 (35%), Gaps = 49/233 (21%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK---KFKLAVDDEELLKLEEFINEIVIL 125
T+ + V +G G + + AVK K K +E ++L
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI----------EILL 70
Query: 126 SQINHRNVVKLLGCCLETEVPLLHLH------------DH-----HRNEEFPLTWEIRLR 168
H N++ L + +++ D +E E
Sbjct: 71 RYGQHPNIITLKDVY-DDGK---YVYVVTELMKGGELLDKILRQKFFSER-----EAS-A 120
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHV 224
+ + + YLH+ + HRD+K +NIL ++ DFG +K + + +
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
T T ++ PE + D++S GV+L +LTG P + + + E
Sbjct: 178 MTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 42/215 (19%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNV 133
LG G TVYKG+ G +A+K+ KL D E E I EI ++ ++ H N+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKL---DSE----EGTPSTAIREISLMKELKHENI 65
Query: 134 VKLLGCC------------LETEVPLLHLHDHHRNEEFPLTWEIRL--RIATEVAGALSY 179
V+L ++ + L D P E+ L ++ L++
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDND--LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
H + I HRD+K N+L+++R + K+ DFG ++ + ++++ T Y P+
Sbjct: 124 CH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDV 179
Query: 240 -----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
S+ + D++S G +L E++TG KP+F
Sbjct: 180 LMGSRTYSTSI----DIWSCGCILAEMITG-KPLF 209
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 51/233 (21%), Positives = 82/233 (35%), Gaps = 58/233 (24%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVV 134
++LG G G V + A+K + D + E+ + + ++V
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKM----LQDCPKAR-----REVELHWRASQCPHIV 118
Query: 135 KLLGCCLETEVPLLHLH------------DH---HRNEEFPLTWEIRLRIATEV----AG 175
+++ L ++ F E R A+E+
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT---E---REASEIMKSIGE 172
Query: 176 ALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
A+ YLHS I HRD+K N+L K+ DFG +K + T T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTP 227
Query: 233 GYLEPE------YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
Y+ PE Y DKS D++S GV++ LL G P +S +
Sbjct: 228 YYVAPEVLGPEKY-------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 52/236 (22%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK------KFKLAVDDEELLKLEEFI 119
+K + + ++ ++G+G G V K + +A+K F
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----------Q 98
Query: 120 NEIVILSQINHR------NVVKLLGC-------CLETEVPLLHLHDHHRNEEF-PLTWEI 165
E+ +L +N +V L CL E+ +L+D RN F ++ +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTH 223
+ A ++ AL +L + S I H D+K NILL R+ K+ DFG+S
Sbjct: 159 TRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQR 214
Query: 224 VTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273
+ IQ F Y PE Y + D++S G +LVE+ TG +P+FS N
Sbjct: 215 IYQYIQSRF-YRSPEVLLGMPYDLAI------DMWSLGCILVEMHTG-EPLFSGAN 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 46/157 (29%), Positives = 66/157 (42%), Gaps = 40/157 (25%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFIN-----EIVILSQINHRN 132
LG+G TVYK +I+A+KK KL E ++ IN EI +L +++H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPN 73
Query: 133 VVKLLGCCLETEVPLLHL------HD-----HHRNEEFPLTWEIR------LRIATEVAG 175
++ LL + L D + + I+ L+
Sbjct: 74 IIGLLD--AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-HIKAYMLMTLQ------- 123
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212
L YLH I HRD+K N+LLDE K+ADFG
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 157
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 70/318 (22%), Positives = 123/318 (38%), Gaps = 86/318 (27%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +G+G G V + +A+KK + + + + EI IL +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQ--RTLREIKILLRF 82
Query: 129 NHRNVVKLL-----------------GCCLETEVPLLH--------LHDHHRNEEFPLTW 163
H N++ + +ET+ L+ +DH +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETD---LYKLLKTQHLSNDHICY----FLY 135
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+I LR L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D H
Sbjct: 136 QI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 224 VT--TKIQGTFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF----------- 269
T+ T Y PE +S+ KS D++S G +L E+L+ +PIF
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNH 243
Query: 270 ---STGNTSQENVSL-----AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFAN----- 316
G+ SQE+++ A ++ S+ + N++ A+
Sbjct: 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW-----------NRLFPNADSKALD 292
Query: 317 LAERCLDLNGKKRPTMEE 334
L ++ L N KR +E+
Sbjct: 293 LLDKMLTFNPHKRIEVEQ 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 13/125 (10%)
Query: 149 HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV 208
+ LT E + + +VA + +L AS HRD+ + NILL E+ K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234
Query: 209 ADFGTSKFIAMDQTHVTTKIQGTFGYL-----EPEYHQSSQLTDKSDVYSFGVVLVELLT 263
DFG ++ I D +V + L PE T +SDV+SFGV+L E+ +
Sbjct: 235 CDFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 264 -GKKP 267
G P
Sbjct: 291 LGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 25/79 (31%), Positives = 35/79 (44%), Gaps = 10/79 (12%)
Query: 77 RILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-N 129
+ LG+G G V + R +AVK K E ++E+ IL I +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKILIHIGH 84
Query: 130 HRNVVKLLGCCLETEVPLL 148
H NVV LLG C + PL+
Sbjct: 85 HLNVVNLLGACTKPGGPLM 103
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/353 (17%), Positives = 121/353 (34%), Gaps = 107/353 (30%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+++ + ++G+G G VY + +A+KK +D K + EI IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--RILREITILNRL 82
Query: 129 NHRNVVKL-------------------------LGCCLETEVPLLHLHDHHRNEEFPLTW 163
+++L L +T + L +H + + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE--EHIKT----ILY 136
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-T 222
+ L +++H + I HRD+K N LL++ KV DFG ++ I ++ T
Sbjct: 137 NL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 223 HVTTKIQGTFGYLEPEYHQSSQLTD--------------------KS-DVYSFGVVLVEL 261
++ ++ + QLT KS D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 262 LTG----------KKPIFSTGNTSQENVSLAAFFVHSMRKNH----------------MY 295
L + P+F + + + VH +
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 296 DILDDQVVKLVKK---------NQIMAFAN-----LAERCLDLNGKKRPTMEE 334
+I +V+K +K Q + L E L N KR T+++
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 43/221 (19%)
Query: 75 VNRILGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQI 128
V I G+G G V+K + GR +A+K+ ++ E E I E+ +L +
Sbjct: 16 VAEI-GEGAYGKVFKARDLKNGGRFVALKRVRV--QTGE----EGMPLSTIREVAVLRHL 68
Query: 129 N---HRNVVKLLGCCLETEVP---------------LLHLHDHHRNEEFPLTWEIRLRIA 170
H NVV+L C + L D P I+ +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIK-DMM 126
Query: 171 TEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKI 228
++ L +LHS + HRD+K NIL+ + K+ADFG ++ M T V
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 181
Query: 229 QGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
T Y PE S D++S G + E+ +KP+F
Sbjct: 182 --TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 46/208 (22%), Positives = 74/208 (35%), Gaps = 33/208 (15%)
Query: 78 ILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVK 135
+LG G G V + G+ A+K + D + E+ Q ++V
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKL----LYDSPKAR-----QEVDHHWQASGGPHIVC 86
Query: 136 LLGCCLETEVPLLHLH------------DH-HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+L L + T I ++ A+ +LHS
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 183 AASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
I HRD+K N+L ++ K+ DFG +K Q + T T Y+ PE
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEV 200
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ D++S GV++ LL G P
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEF----INEIVILSQINHRNV 133
LG+G G VYK + +A+K+ +L + EE E I E+ +L ++ HRN+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEE----EGVPGTAIREVSLLKELQHRNI 95
Query: 134 VKLLGCCLETEVPLLHL------HDHHR--NEEFPLTWEIRLRIATEVAGALSYLHSAAS 185
++L LHL +D + ++ ++ + ++ +++ HS
Sbjct: 96 IELKSVIHHNHR--LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR- 152
Query: 186 SPIYHRDIKSTNILLDERYRA-----KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY- 239
HRD+K N+LL + K+ DFG ++ + T +I T Y PE
Sbjct: 153 --CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209
Query: 240 ----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
H S+ + D++S + E+L P+F
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMK-TPLF 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 58/236 (24%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
++ F + +LG+G G V G I+A+KK + D + EI IL
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFAL--RTLREIKILKHF 66
Query: 129 NHRNVVKLLG-----------------CCLETEVPLLH--------LHDHHRNEEFPLTW 163
H N++ + ++T+ LH DH + +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTD---LHRVISTQMLSDDHIQY----FIY 119
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+ LR A+ LH + + HRD+K +N+L++ KV DFG ++ I
Sbjct: 120 QT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 224 VTTKIQGTFG---------YLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 269
+ G Y PE +S ++ DV+S G +L EL +PIF
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIF 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 64/359 (17%), Positives = 115/359 (32%), Gaps = 111/359 (30%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ + + ++G G G V + + R++A+KK +D K + EI IL+++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK--RILREIAILNRL 109
Query: 129 NHRNVVKLLGCCLETEVPLLH------------LH-----------DHHRNEEFPLTWEI 165
NH +VVK+L + +V H + L + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT----LLYNL 165
Query: 166 RLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG------TSKFIAM 219
L + Y+HSA I HRD+K N L+++ KV DFG +
Sbjct: 166 -LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTD--------------------KS-DVYSFGVVL 258
+ + QLT ++ DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 259 VELLT----------GKKPIF---STGNTSQENVSLAAFFVHSMRKNH------------ 293
ELL + P+F S S + + F H+
Sbjct: 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334
Query: 294 ----MYDILDDQVVKLVKK---------NQIMAFAN-----LAERCLDLNGKKRPTMEE 334
+ + + + ++ + ++ L +R L N KR T+ E
Sbjct: 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 54/218 (24%), Positives = 81/218 (37%), Gaps = 43/218 (19%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
++ + +G G G ++AVK ++ + E EI+ + H
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVK----YIERGAAID-ENVQREIINHRSLRH 75
Query: 131 RNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
N+V+ + T L + + R E E R ++ +
Sbjct: 76 PNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSED----EAR-FFFQQLLSGV 129
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 235
SY HS I HRD+K N LLD R K+ DFG SK + +T GT Y+
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYI 184
Query: 236 EPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
PE Y +DV+S GV L +L G P
Sbjct: 185 APEVLLRQEYDGK-----IADVWSCGVTLYVMLVGAYP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 71/349 (20%), Positives = 112/349 (32%), Gaps = 108/349 (30%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK------KFKLAVDDEELLKLEEFI 119
N F V R +G G G V +++ + AVK K+ +
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----------K 79
Query: 120 NEIVILSQINHR-----NVVKLLGC-------CLETEVPLLHLHD---HHRNEEFPLTWE 164
E IL +I + N+VK G CL E L++ + F + +
Sbjct: 80 IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIE-D 138
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---------------------- 202
I+ E+ AL+YL + + H D+K NILLD+
Sbjct: 139 IK-LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 203 ---RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYS 253
K+ DFG + F + + I Y PE + SS D++S
Sbjct: 195 RTKSTGIKLIDFGCATF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSS------DMWS 244
Query: 254 FGVVLVELLTGKKPIFSTGN---------------------TSQENVSLAAFFVHSMRKN 292
FG VL EL TG +F T + + ++
Sbjct: 245 FGCVLAELYTG-SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 293 HMYDILDDQVVKLVKKNQIM-------AFANLAERCLDLNGKKRPTMEE 334
+ +K VKK + F + L ++ RP+ E
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 60/338 (17%), Positives = 109/338 (32%), Gaps = 98/338 (28%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM--LEDGRIMAVKKFKLAVDDEELLKLEEFIN----EIV 123
+ + LG+G G V + + +A+K + + ++ EI
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR---------NVGKYREAARLEIN 68
Query: 124 ILSQINHR------NVVKLLGC-------CLETEVPLLHLHD---HHRNEEFPLTWEIRL 167
+L +I + V + C+ E+ + + + + +PL +R
Sbjct: 69 VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP-HVR- 126
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA-------------------KV 208
+A ++ AL +LH + H D+K NIL +V
Sbjct: 127 HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 209 ADFGTSKFIAMDQTHVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFGVVLVELL 262
ADFG++ F D H TT + Y PE + Q DV+S G +L E
Sbjct: 184 ADFGSATF---DHEHHTTIVATRH-YRPPEVILELGWAQPC------DVWSIGCILFEYY 233
Query: 263 TGKKPIFSTGNTSQ-----------------ENVSLAAFFVH---------SMRKNHMYD 296
G +F T + +F S + +
Sbjct: 234 RG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ L + + +L R L+ + +R T+ E
Sbjct: 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 63/277 (22%), Positives = 90/277 (32%), Gaps = 86/277 (31%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVIL 125
D ++V R LG G TV+ ++ + +A+K K A E +EI +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-----DEIRLL 87
Query: 126 SQI--------NHRNVVKLLGC-----------CLETEV---PLLHLHDHHRNEEFPLTW 163
+ N VV+LL C+ EV LL + PL
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPL-- 145
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----------------------- 200
+I +V L YLH+ I H DIK NILL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 201 --------------------------DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
E+ + K+AD G + + H T IQ T Y
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQY 259
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
E S +D++S + EL TG +F
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEP 295
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 14/99 (14%)
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH---VTTKIQGT 231
A+ ++HS I HRDIK N+L++ + K+ DFG++K + + + ++
Sbjct: 153 AVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF--- 206
Query: 232 FGYLEPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 269
Y PE +++ T D++S G V EL+ G KP+F
Sbjct: 207 --YRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPLF 242
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 53/224 (23%), Positives = 82/224 (36%), Gaps = 45/224 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N F + R +G G G +Y G ++ +A+K + +LL E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY------ESKIYRILQ 60
Query: 130 HRN-----------------VVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATE 172
V+ LLG LE D L+ + L +A +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLE---------DLFNFCSRKLSLKTVLMLADQ 111
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV----- 224
+ + ++HS + HRDIK N L+ RA + DFG +K TH
Sbjct: 112 MINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 225 -TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT Y H + + + D+ S G VL+ L G P
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 68/345 (19%), Positives = 120/345 (34%), Gaps = 106/345 (30%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKG--MLEDGRIMAVK------KFKLAVDDEELLKLEEF 118
D + + + LG+G G V + GR +AVK ++ A
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----------- 58
Query: 119 INEIVILSQINHR------NVVKLLGC-------CLETEVPLLH--LHD---HHRNEEFP 160
+EI +L +N V++L C+ E LL +D + F
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFR 116
Query: 161 LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA-------------- 206
L IR ++A ++ ++++LHS + H D+K NIL +
Sbjct: 117 LD-HIR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 207 -----KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE------YHQSSQLTDKSDVYSFG 255
KV DFG++ + D H +T + Y PE + Q DV+S G
Sbjct: 172 INPDIKVVDFGSATY---DDEHHSTLVSTRH-YRAPEVILALGWSQPC------DVWSIG 221
Query: 256 VVLVELLTGKKPIFSTGNTSQ-----------------ENVSLAAFFVH---------SM 289
+L+E G +F T ++ + + +F H S
Sbjct: 222 CILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280
Query: 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ + L + + +L ++ L+ + KR T+ E
Sbjct: 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 47/240 (19%), Positives = 82/240 (34%), Gaps = 52/240 (21%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLE--------- 116
D N + + + +G GG G +Y A K+ + L E
Sbjct: 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK 92
Query: 117 -EFINEIVILSQINHRN--------------------VVKLLGCCLETEVPLLHLHDHHR 155
+ I + + Q+++ V++ LG L+ + +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ------KISGQNG 146
Query: 156 NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGT 213
F L++ + L Y+H H DIK+ N+LL + +V AD+G
Sbjct: 147 T--FKK--STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 214 SKFIAMDQTHV------TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
S + H GT + + H+ L+ +SDV G ++ L GK P
Sbjct: 200 SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 44/233 (18%), Positives = 82/233 (35%), Gaps = 35/233 (15%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKF---KLAVDDEELLKLE------- 116
D A + V +GQGG G +Y + + K+ D L E
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 117 ---EFINEIVILSQINHRNVVKLLGCCLETEVPLLH-----------LHDHHRNEEFPLT 162
E I + + ++ + V K G L + + L + +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFS 150
Query: 163 WEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGTSKFIAMD 220
+ L+++ + L Y+H H DIK++N+LL+ + +V D+G + +
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 221 QTHV------TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
H GT + + H + + D+ G +++ LTG P
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 48/224 (21%), Positives = 79/224 (35%), Gaps = 45/224 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N + + R +G G G +Y G + G +A+K + +L E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI------ESKIYKMMQ 62
Query: 130 HRN-----------------VVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATE 172
V++LLG LE D + + L +A +
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLE---------DLFNFCSRKFSLKTVLLLADQ 113
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV----- 224
+ + Y+HS HRD+K N L+ + + DFG +K +TH
Sbjct: 114 MISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
Query: 225 -TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT Y H + + + D+ S G VL+ G P
Sbjct: 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 45/229 (19%), Positives = 77/229 (33%), Gaps = 59/229 (25%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI- 128
++ +++LG G G V + A+K + D + E+ + +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM----LQDCPKAR-----REVELHWRAS 68
Query: 129 NHRNVVKLLGCCLETEVPLLHLH---------------DHHRNEEFPLTWEIRLRIATEV 173
++V+++ L ++ F T I +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSI 126
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG 230
A+ YLHS I HRD+K N+L K+ DFG +K T +
Sbjct: 127 GEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE--- 173
Query: 231 TFGYLEPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
Y DKS D++S GV++ LL G P +S +
Sbjct: 174 --KY------------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 39/244 (15%), Positives = 78/244 (31%), Gaps = 57/244 (23%)
Query: 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLE---------- 116
DK+ + + + QG +Y+ + + LKL+
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAA----PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 117 ---------EFINEIVILSQINHRNVVKLLGCCLETE------VPLL-----HLHDHHRN 156
+N+ L + +G + + +P L D
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK 153
Query: 157 EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKV--ADFGTS 214
L++A + AL +LH H ++ + NI +D +++V A +G +
Sbjct: 154 HVLSE--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 215 KFIAMDQTHV------TTKIQGTFGYLEPEY-----HQSSQLTDKSDVYSFGVVLVELLT 263
HV + +G E+ H+ + +SD+ S G +++ L
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 264 GKKP 267
G P
Sbjct: 264 GFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 47/226 (20%), Positives = 80/226 (35%), Gaps = 47/226 (20%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
H+ V R +G+G G +++G L + + +A+K D +L +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR------DEYRTYKLLA 63
Query: 130 HRN-----------------VVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATE 172
V+ LLG LE L D +F + + A +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE------DLLDLC-GRKFSV--KTVAMAAKQ 114
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV--- 224
+ + +H + + +RDIK N L+ V DFG KF T
Sbjct: 115 MLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 225 ---TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT Y+ H + + + D+ + G V + L G P
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 8e-08
Identities = 32/209 (15%), Positives = 60/209 (28%), Gaps = 52/209 (24%)
Query: 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD----EELLKLEEFINEIVI 124
T +G+G G V++ + D +A+K + D EE + EI+I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 125 LSQI---------NHRNVVKLLGCCLETEVP---LLHLHDHHRNE--------------- 157
++ + L LL DH+ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 158 -----EFP-------------LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNIL 199
EF + I ++ +L+ ++ HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194
Query: 200 LDERYRAKVADFGTSKFIAMDQTHVTTKI 228
L + K+ K + + I
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 35/220 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK------KFKLAVDDEELLKL---EEFIN 120
+F V + +G G G + G L +A+K + + K + I
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 121 EIVILSQINHRN--VVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
++ N V++LLG LE L D + F L + L IA ++ +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLE------DLFDLC-DRTFSL--KTVLMIAIQLISRME 119
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV------TTK 227
Y+HS + +RD+K N L+ + DF +K +T
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267
+ GT Y+ H + + + D+ + G + + L G P
Sbjct: 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 366 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.93 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.28 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.09 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.69 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.14 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.66 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.42 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=388.10 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=201.4
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...+++++.+.||+|+||+||+|.++ ..||||+++...... ...+.|.+|+.+++.++|||||+++++|.. +..+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTP--EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34578899999999999999999865 359999997654433 345789999999999999999999998764 5678
Q ss_pred EEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..+++ ..++++..+..++.|++.||.|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 8999877652 346899999999999999999999999 99999999999999999999999999986643
Q ss_pred CC-ceeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC-cc
Q 037297 220 DQ-THVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN-HM 294 (366)
Q Consensus 220 ~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 294 (366)
.. .......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... ......... ..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--------~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--------QIIFMVGRGYAS 256 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHHTTCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcCCCC
Confidence 22 223345689999999998864 468999999999999999999999997543110 111111111 11
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
+. ....+..+++++.+|+.+||+.||++|||+.|+++.|+.++.+..
T Consensus 257 p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11 012345567789999999999999999999999999999886543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=398.22 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=203.8
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
++|.+.+.||+|+||.||+|.+. ++..||||+++... . ...+.|.+|+.++++++|||||+++++|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-D---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-H---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-h---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 57899999999999999999853 36789999997532 2 34568999999999999999999999999999
Q ss_pred cceEEEeeccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 145 VPLLHLHDHHRNE--------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
..++++|+..+++ ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 9999999887642 236899999999999999999999999 99999999999999999
Q ss_pred eEEEeecCCcccccCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHH
Q 037297 205 RAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 282 (366)
.+||+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~ 237 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------N 237 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------H
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 99999999998765433222 233468999999999999999999999999999999998 8999976431 1
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
... ........ ...|..+++++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 238 ~~~-~~i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 238 EVI-ECITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHH-HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 11111111 12345567789999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-56 Score=398.22 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=203.9
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
+++++.+.||+|+||.||+|.+. +++.||||+++..... ...+.|.+|+.++++++|||||+++++|.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG---PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 45788899999999999999852 4678999999765433 33467999999999999999999999999999
Q ss_pred cceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 145 VPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 145 ~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
..++++++...++ ...+++..+..++.||+.||.|||+++ ||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 9999999876542 135889999999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 279 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 279 (366)
+++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~--- 254 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--Q--- 254 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--H---
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--H---
Confidence 999999999999986643322 22344679999999999999999999999999999999998 8999976431 1
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
........... ...|..+++++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 255 ----~~~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 ----DVVEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ----HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----HHHHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11111111111 1234567788999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=399.23 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=198.8
Q ss_pred cCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
++|.+.++||+|+||.||+|.++ ++..||||+++... . ...+.|.+|++++++++|||||+++++|.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-E---SARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-H---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-H---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56888899999999999999864 47889999997532 2 34568999999999999999999999999999
Q ss_pred cceEEEeeccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 037297 145 VPLLHLHDHHRNE----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 145 ~~~~~~~~~~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~ 202 (366)
..++++|+..+++ ..++++..+..++.|++.||.|||+++ |+||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 9999999876643 135899999999999999999999999 999999999999999
Q ss_pred CCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccccc
Q 037297 203 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS 280 (366)
Q Consensus 203 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 280 (366)
++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------- 266 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------- 266 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999986643332 23344679999999999999999999999999999999999 8999976431
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
............ ...|..+++++.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 267 -~~~~~~i~~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 -TEAIDCITQGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHHHcCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111111111 123455677899999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=400.67 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=196.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||.||+|.++ +|+.||+|++....... ...+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 68999999999999999999975 58999999998755443 3456899999999999999999999999999999999
Q ss_pred EeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 150 LHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 150 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+|++.+++ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99987653 335789999999999999999999999 999999999999999999999999999865321
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ........ ....+
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~-~~~~~----- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKII-SGSFP----- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-HTCCC-----
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH-cCCCC-----
Confidence 1223446799999999999999999999999999999999999999975431 11111111 11111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+..+++++.+|+.+||+.||++|||++|+++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123345678999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=380.28 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=184.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|.++ +|+.||+|++........ ...+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS-DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999965 699999999986543322 3356789999999999999999999999999999999
Q ss_pred EeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+++..+. ...++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 9986431 2347999999999999999999999999 999999999999999999999999999865432 2
Q ss_pred eeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ....... .....
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i-~~~~~-------- 229 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNI-SNGVY-------- 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHTCC--------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-HcCCC--------
Confidence 3345689999999999998886 5799999999999999999999965321 1111111 11111
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.++...++++.+|+.+||+.||++|||++|+++
T Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 123345667899999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=392.22 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=200.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|++.+.||+|+||.||+|.++ +|+.||+|++...... ..+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56999999999999999999976 6999999999764332 234678999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+|++.++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 99987653 236899999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ...... .........
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~-i~~~~~~~~------ 290 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKM-IRDNLPPRL------ 290 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSSCCCC------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHcCCCCCC------
Confidence 34557899999999999999999999999999999999999999975431 111111 111111110
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112345668999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=387.62 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=202.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.++ +|+.||+|++....... ....+.+.+|+++++.++|||||++++++.+.+..+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57999999999999999999975 68999999997643221 12356789999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
++++.+++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99987653 346899999999999999999999999 9999999999999999999999999998775433
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||..... .......... ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~-~~------- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKL-EY------- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CC-------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CC-------
Confidence 3344567899999999999999999999999999999999999999975431 1111111111 11
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
.++...++++.+|+.+||+.||++|||++|++
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12334556789999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=389.40 Aligned_cols=246 Identities=21% Similarity=0.215 Sum_probs=199.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.+.|++.++||+|+||.||+|.++ +|+.||+|+++.... ..+|+.+++.++|||||++++++.+.+..++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356888899999999999999975 589999999986432 2469999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~~~~ 220 (366)
++++..+++ ..++++..+..++.|++.||.|||+++ |+||||||+|||++.+| .+||+|||+|+.....
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999987753 236899999999999999999999999 99999999999999987 5999999999876543
Q ss_pred Cce----eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 221 QTH----VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 221 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .... .....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i---~~~~~--- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-----CLKI---ASEPP--- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-----HHHH---HHSCC---
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-----HHHH---HcCCC---
Confidence 221 12335799999999999999999999999999999999999999976432111 1111 11110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....+++.+++++.+|+.+||+.||++|||+.|+++.|....
T Consensus 274 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 274 -----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011245567788999999999999999999999998886554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=379.59 Aligned_cols=242 Identities=20% Similarity=0.323 Sum_probs=191.6
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee----CCcce
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEVPL 147 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 147 (366)
|++.+.||+|+||+||+|.+. ++..||+|++....... ...+.+.+|+.+++.++|||||+++++|.. ....+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 467788999999999999976 58899999998654433 345689999999999999999999999865 24578
Q ss_pred EEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..++.. ..+++..+..++.||+.||.|||+++ ++|+||||||+|||+++ ++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 88888876542 36899999999999999999999975 45999999999999984 79999999999975432
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... .. ..........+
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~-~~~~i~~~~~~---- 248 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQ-IYRRVTSGVKP---- 248 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HH-HHHHHTTTCCC----
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HH-HHHHHHcCCCC----
Confidence 23345689999999998865 6999999999999999999999999653311 11 11111111111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 249 ----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334557899999999999999999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=393.51 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=200.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|++.+.||+|+||.||+|.++ +|+.||+|++...... ..+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 56999999999999999999976 5999999999764333 234688999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+|++.++. ...+++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|..+.... .
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 99987653 236899999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+... ..... ..........
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~-~i~~~~~~~~------ 367 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMK-MIRDNLPPRL------ 367 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH-HHHHSCCCCC------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHH-HHHcCCCCCC------
Confidence 34557899999999999999999999999999999999999999975431 11111 1111111110
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+++++.+|+.+||+.||++|||++|+++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112345668999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=390.70 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=209.2
Q ss_pred ChHHHHHHhcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC-Ccee
Q 037297 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH-RNVV 134 (366)
Q Consensus 62 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv 134 (366)
..++++...++|++.+.||+|+||.||+|.+.. ++.||+|.++..... ...+.+.+|+.++.+++| ||||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~---~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh---HHHHHHHHHHHHHHHcCCCCcEE
Confidence 345566677899999999999999999998542 357999999875544 345679999999999965 8999
Q ss_pred eEeeEEeeC-CcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037297 135 KLLGCCLET-EVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190 (366)
Q Consensus 135 ~~~~~~~~~-~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 190 (366)
+++++|... ...++++|+...++ ...+++..+..++.||+.||.|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999999775 45788888875532 234889999999999999999999999 999
Q ss_pred CCCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 037297 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI 268 (366)
Q Consensus 191 ~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 268 (366)
|||||+|||+++++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433 33445679999999999999999999999999999999998 99999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....... .......... +...|..+++++.+++..||+.||++|||+.|+++.|+.+..
T Consensus 289 ~~~~~~~--------~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 289 PGVKIDE--------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp TTCCCSH--------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHH--------HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 7643211 0111111111 112344566789999999999999999999999999988753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=378.31 Aligned_cols=238 Identities=27% Similarity=0.273 Sum_probs=188.2
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++++.||+|+||+||+|+.. +++.||+|+++....... ....+.+|+.+++.++|||||++++++.+.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 367999999999999999999863 478899999976433211 12357789999999999999999999999999
Q ss_pred ceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999877643 36899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ......... ...
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~-~~~---- 243 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILK-AKL---- 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC----
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHc-CCC----
Confidence 322 233456899999999999999999999999999999999999999975431 111111111 111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
..+...++++.+|+.+||+.||++|||+
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1233456689999999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=371.48 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=180.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc----
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV---- 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 145 (366)
++|++++.||+|+||+||+|.++ +|+.||+|+++..... ...+.+.+|+.+++.++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999975 6899999999875543 344678999999999999999999999876553
Q ss_pred --------ceEEEeeccCCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 146 --------PLLHLHDHHRNEE----------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 146 --------~~~~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
.+++++++.++.. ...++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence 5788888765431 13456678899999999999999999 99999999999999999999
Q ss_pred EeecCCcccccCCCce-----------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 037297 208 VADFGTSKFIAMDQTH-----------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 276 (366)
|+|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 9999999876543211 1234579999999999999999999999999999999996 775311
Q ss_pred ccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ ... ..........+ ......++...+|+.+||+.||++|||+.|+++
T Consensus 232 ~---~~~-~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 E---RVR-TLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H---HHH-HHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HHH-HHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000 11111111111 112334456788999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=371.16 Aligned_cols=265 Identities=20% Similarity=0.258 Sum_probs=193.8
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----cc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----VP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 146 (366)
.+|.+.+.||+|+||+||+|.+ +|+.||||++..... ....+..|+..+..++|||||+++++|...+ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5688999999999999999998 489999999875321 1112334566667789999999999998765 46
Q ss_pred eEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 147 LLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAA-----SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
++++++..+++ ..++++..+..++.|++.||.|||+++ .++|+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 78888877653 236899999999999999999999871 2239999999999999999999999999998
Q ss_pred cccCCCcee---eeeccccCCccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc------cc
Q 037297 216 FIAMDQTHV---TTKIQGTFGYLEPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN------VS 280 (366)
Q Consensus 216 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------~~ 280 (366)
......... ....+||+.|+|||++.+. .++.++|||||||++|||+||..||.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765443322 2345799999999998764 36779999999999999999988875432111100 00
Q ss_pred HHHHHHHHhhcCccccccchHHh-hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVV-KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.............. ++.+. ...+..++..+.+|+.+||+.||++|||+.|+++.|+.+..+
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111111111 11110 112335667899999999999999999999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=377.32 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=196.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++++.||+|+||+||+|.++ +|+.||||+++...... ...+.+.+|+.+|+.++|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV--TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch--HHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 357999999999999999999975 69999999997654433 3346788999999999999999999987643
Q ss_pred -CcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 144 -EVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 144 -~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
...+++++++.+. ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 4678888887532 3457999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCC---ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 217 IAMDQ---THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 217 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... +. ...........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~~---l~~I~~~~g~p 282 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--HQ---LQLIMMVLGTP 282 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HH---HHHHHHHHCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--HH---HHHHHHhcCCC
Confidence 64322 2233457899999999998875 5699999999999999999999999764311 10 00010110000
Q ss_pred c---cccc--------------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 H---MYDI--------------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ~---~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. +... ..+.......+..++++.+|+.+||+.||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000 0000011122334678899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=365.29 Aligned_cols=195 Identities=22% Similarity=0.344 Sum_probs=164.4
Q ss_pred HhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (366)
..++|++.+.||+|+||+||+|.++ +++.||+|.+...... .++.+|+.+++.+ +||||+++++++...
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP------IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH------HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH------HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 3578999999999999999999853 4678999998764332 3577899999998 799999999999999
Q ss_pred CcceEEEeeccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCccccc
Q 037297 144 EVPLLHLHDHHRNEE----FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIA 218 (366)
Q Consensus 144 ~~~~~~~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~~~ 218 (366)
+..++++++..++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999876532 26899999999999999999999999 9999999999999876 899999999997553
Q ss_pred CCCc---------------------------eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037297 219 MDQT---------------------------HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFS 270 (366)
Q Consensus 219 ~~~~---------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~ 270 (366)
.... ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2211 112345799999999998876 589999999999999999999999976
Q ss_pred CC
Q 037297 271 TG 272 (366)
Q Consensus 271 ~~ 272 (366)
..
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 44
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=352.06 Aligned_cols=282 Identities=35% Similarity=0.577 Sum_probs=231.9
Q ss_pred ccccccChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceee
Q 037297 56 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK 135 (366)
Q Consensus 56 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 135 (366)
.....++..++....++|++.+.||+|+||.||+|...+++.||+|++...... .....+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccc
Confidence 345678889999999999999999999999999999878999999998764332 12236889999999999999999
Q ss_pred EeeEEeeCCcceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEeCCCCCCCEEec
Q 037297 136 LLGCCLETEVPLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSA---ASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~~iiH~dikp~Nill~ 201 (366)
+++++......++++++..++ ...++++..+..++.|++.||.|||++ + ++||||||+|||++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 999999999999999887553 223589999999999999999999999 7 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH
Q 037297 202 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 281 (366)
.++.+||+|||++...............||+.|+|||.+.+..++.++|||||||++|+|++|+.||.............
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 99999999999998776555555555679999999999988899999999999999999999999996322112222233
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.................+.......+...+..+.+++..||+.||.+|||+.|+++.|++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 33333333344455556666666778888999999999999999999999999999998644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=373.03 Aligned_cols=244 Identities=18% Similarity=0.244 Sum_probs=200.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|+.+|+.++|||||++++++.+....++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 368999999999999999999976 589999999976432 234678899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CeEEEeecCCccccc
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~--~~vkl~Dfg~a~~~~ 218 (366)
+++++.++ ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99988764 2346899999999999999999999999 9999999999999854 899999999998775
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+... ......... ... ..
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~-~~~-~~- 375 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKS-CDW-NM- 375 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHT-TCC-CC-
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHh-CCC-CC-
Confidence 33 334456899999999999999999999999999999999999999976431 111111111 110 00
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .......++++.+|+.+||+.||.+|||+.|+++
T Consensus 376 ~----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 D----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1112345667899999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.78 Aligned_cols=245 Identities=22% Similarity=0.237 Sum_probs=193.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH--HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++++.||+|+||.||+|.++ +|+.||+|++........ .........++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999976 599999999975432111 11122233446777888999999999999999999
Q ss_pred eEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
|+++++..++.. ..+++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999887643 36899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ....+||+.|+|||++.+ ..|+.++|+|||||++|||++|+.||....... ............
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~~------ 410 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMA------ 410 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCCC------
Confidence 32 344689999999999964 579999999999999999999999997533211 111111111111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVT 336 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell 336 (366)
..++...++++.+|+..||+.||.+|++ ++|++
T Consensus 411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 0123445668999999999999999998 56653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.43 Aligned_cols=273 Identities=38% Similarity=0.618 Sum_probs=223.9
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
..++....++|++.+.||+|+||.||+|.+++++.||+|++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ----GIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS----HHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 33444566899999999999999999999888999999998765432 34578899999999999999999999999
Q ss_pred CCcceEEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 143 TEVPLLHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
.+..++++++..++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 999999998875432 124889999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCC-ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 212 GTSKFIAMDQ-THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 212 g~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
|++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...............
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHN 261 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccc
Confidence 9997654322 2223345689999999999889999999999999999999999999976542 222223332233333
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
........++......+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 444555666666666788899999999999999999999999999999987754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=337.03 Aligned_cols=271 Identities=25% Similarity=0.386 Sum_probs=216.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||+||+|.+. +++.+|+|.+... .. ...+.+.+|+.+++.++||||+++++++......++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CH---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 467999999999999999999975 5899999988653 22 345688999999999999999999999999999999
Q ss_pred EEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999876542 356899999999999999999999999 999999999999999999999999999876433
Q ss_pred Ccee-------------eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 221 QTHV-------------TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 221 ~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~---- 237 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR---- 237 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH----
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh----
Confidence 2211 11456899999999999999999999999999999999999998764322222111111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccc-cccchHHHHhh
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMI-YSTGTLLRLFW 363 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~-~~~~~~~~~~~ 363 (366)
.......+..+++.+.+++..||+.||++|||+.|+++.|+.++....+..+. -..++.-+.+|
T Consensus 238 ------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~~~~~~~~~~~~w 302 (310)
T 3s95_A 238 ------------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFW 302 (310)
T ss_dssp ------------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ------------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccCCcchhhccchHH
Confidence 11112223445567999999999999999999999999999998665555444 34566666777
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.11 Aligned_cols=268 Identities=24% Similarity=0.387 Sum_probs=209.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. ++..||+|.+........ ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE-ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH-HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 468999999999999999999965 588999999876443322 445688999999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+.. ..++++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999876643 236899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... .. +.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~-~~-----~~ 231 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQD-SV-----PN 231 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSS-CC-----CC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhc-cC-----CC
Confidence 3344456799999999999999999999999999999999999999975431 0001111111 11 11
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHhhcccCCCCccccccc
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRP-TMEEVTMELNGIRGSNFGHKMIYST 355 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~L~~~~~~~~~~~~~~~~ 355 (366)
.....+...++.+.+++.+||+.||.+|| +++++.+.|+.+..........++.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~ 286 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYEL 286 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC-
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhh
Confidence 11223445567899999999999999998 9999999999988776665555543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=339.50 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=204.4
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|.+. .+..||+|+++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 478999999999999999999974 3456999999865444 345678999999999999999999999999999
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999987653 2347899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||..... .. .........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~-~~~~~~~~~- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RD-VISSVEEGY- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HH-HHHHHHTTC-
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHHHcCC-
Confidence 543222 2223346778999999998999999999999999999999 9999965431 01 111111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHK 350 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~ 350 (366)
....+..++..+.+++..||+.||.+|||+.|+++.|+.+..+..+..
T Consensus 272 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 272 --------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred --------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence 011234556789999999999999999999999999999987655544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.85 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=203.2
Q ss_pred hcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 140 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (366)
.++|++.+.||+|+||.||+|.+. ++..||+|+++..... ...+.+.+|+.+++.+ +||||++++++|
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH---HHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 468999999999999999999852 3457999999865433 3456789999999999 899999999999
Q ss_pred eeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 037297 141 LETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTN 197 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~N 197 (366)
......++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999876532 124788999999999999999999999 9999999999
Q ss_pred EEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 037297 198 ILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS 275 (366)
Q Consensus 198 ill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~ 275 (366)
||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-- 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999986643322 12233456788999999999999999999999999999999 9999975431
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.. ... ...... ....+..++.++.+++..||+.||++|||+.|+++.|+.+..
T Consensus 312 ~~---~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 312 EE---LFK----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GG---HHH----HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111 111111 112244566789999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=329.06 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=198.3
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++|++.+.||+|+||+||+|.+.+++.||+|++....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE--GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc--hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 347899999999999999999999889999999997653332 234578899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99876542 3345899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---ccc--
Q 037297 222 THVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMY-- 295 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 295 (366)
.......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ........... .+.
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-----LPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-----HHHHHHHHCCCCTTTSGGG
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHHCCCChHHhhhh
Confidence 22334568999999998876 5689999999999999999999999976442211 11111111110 010
Q ss_pred -----------cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 -----------DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............+..++++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011111112233345668899999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.78 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=205.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|..+++..||+|+++..... .+.+.+|+.+++.++||||+++++++......+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 4689999999999999999999888889999999865433 24688999999999999999999999999899999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99876542 235899999999999999999999999 9999999999999999999999999998765544
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
........+|..|+|||.+.+..++.++||||+|+++|+|++ |+.||...... ...........
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~------- 223 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHR------- 223 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCC-------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCC-------
Confidence 444444556778999999998899999999999999999999 99999654310 11111111110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
...+...++.+.+++..||+.||++|||+.|+++.|+.++...
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0112234557999999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=328.35 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=205.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 4689999999999999999999988899999999865443 24688999999999999999999999999999999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9887653 3345899999999999999999999999 9999999999999999999999999998664333
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
........+|..|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ............
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~------- 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------- 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC-------
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCcc-------
Confidence 223333456778999999998999999999999999999999 9999975431 111111111100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
...+...++.+.+++..||+.||++|||+.|+++.|+.+..+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111233456799999999999999999999999999988765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=334.65 Aligned_cols=260 Identities=29% Similarity=0.403 Sum_probs=199.1
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+....++|++.+.||+|+||+||+|.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA--ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3344567899999999999999999987 48889999997655433 34567899999999999999999999999999
Q ss_pred cceEEEeeccCCCCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 145 VPLLHLHDHHRNEEF----------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 145 ~~~~~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
..++++++..++... .+++..++.++.|++.||.|||+++ ++++||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999987654211 2889999999999999999999975 45999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~- 256 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCK- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHSCC-
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC-
Confidence 7543221 223345789999999999999999999999999999999999999975431 001110000100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
....+..+++.+.+++..||+.||.+|||+.|+++.|+.+..+.
T Consensus 257 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 --------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 01123445667999999999999999999999999999887553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=330.54 Aligned_cols=242 Identities=25% Similarity=0.342 Sum_probs=198.9
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP--TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46899999999999999999997 469999999998654432 345678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999876542 236899999999999999999999999 999999999999999999999999999765433
Q ss_pred ceeeeeccccCCccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......... ...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~-~~~------ 231 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLR-GKY------ 231 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC------
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC------
Confidence 223456799999999999888775 799999999999999999999975431 111111111 110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+.+||+.||.+|||++|+++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 123335567899999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.26 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=198.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||+||+|.+. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 468999999999999999999964 6899999999765433 23568899999999999999999999999999999
Q ss_pred EEeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRNEE------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..++.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9998766432 25889999999999999999999999 99999999999999999999999999876654332
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........... ....
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~-~~~~----- 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNG-TPEL----- 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHC-SCCC-----
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCCC-----
Confidence 23445799999999999999999999999999999999999999965431 00010111111 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 113345667899999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=321.22 Aligned_cols=279 Identities=32% Similarity=0.504 Sum_probs=215.7
Q ss_pred ccccChHHHHHHhcCCccc------ceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC
Q 037297 58 CKLFSSKELDKATNHFNVN------RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131 (366)
Q Consensus 58 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 131 (366)
...++..++....++|... +.||+|+||.||+|.. +++.+|+|++............+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567788888888777666 8999999999999987 58899999987643322223456789999999999999
Q ss_pred ceeeEeeEEeeCCcceEEEeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~ 201 (366)
||+++++++......++++++..+.. ..++++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999999999999999988875432 235899999999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 037297 202 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 280 (366)
.++.++|+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......... .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-D 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-H
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-H
Confidence 999999999999986654322 22334568999999998865 47899999999999999999999997654221111 1
Q ss_pred HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 281 LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
..... ......+.+.+++.. ...+...+..+.+++..||+.||.+|||+.++++.|+.+.+|
T Consensus 246 ~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 246 IKEEI--EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp HHHHH--HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHh--hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 11100 000111111122111 224567788999999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.99 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=204.4
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
+....++|++.+.||+|+||.||+|.+. +++.||+|.++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH---HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3344578999999999999999999986 6899999999865433 33457889999999999999999999999999
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999876543 235889999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCceee-eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTHVT-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..........
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~- 332 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---------QTREFVEKGG- 332 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---------HHHHHHHTTC-
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCC-
Confidence 432211111 11235678999999998899999999999999999998 99999754310 0111111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....+..+++.+.+++..||+.||++|||+.++++.|+.+..
T Consensus 333 --------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 --------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111234456789999999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=322.27 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=190.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|.+. ++.+|+|+++...........+.+.+|+.+++.++||||+++++++......+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999975 8899999988755443334456789999999999999999999999999999999
Q ss_pred EeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--------CCeEEEeecCCcc
Q 037297 150 LHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE--------RYRAKVADFGTSK 215 (366)
Q Consensus 150 ~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~--------~~~vkl~Dfg~a~ 215 (366)
+++..+. ....+++..++.++.|++.||.|||+++..+++||||||+||+++. ++.++|+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9887543 2347899999999999999999999987555889999999999985 7789999999997
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... .
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~- 231 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAMNK-L- 231 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHTSC-C-
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHhhhcCC-C-
Confidence 654322 2234689999999999999999999999999999999999999975431 00011111111 0
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 -------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0112344566899999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=322.60 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=189.0
Q ss_pred HhcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..++|++.+.||+|+||.||+|.+.. +..||+|.++..... ...+.+.+|+.+++.++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 35789999999999999999998643 456999998764433 34567899999999999999999999974 45
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 677888876542 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
.............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~----~i~~~~~- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIG----RIENGER- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH----HHHTTCC-
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHH----HHHcCCC-
Confidence 65433333334456788999999998999999999999999999997 999997643211 111 0111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+..+++.+.+++..||+.||++|||+.|+++.|+.+.
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1123455678999999999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=346.42 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=205.2
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..+....++|++.+.||+|+||.||+|.++++..||+|+++.... ..+.+.+|+.+++.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 444556688999999999999999999998888999999986443 2457899999999999999999999986 5
Q ss_pred CcceEEEeeccCCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 EVPLLHLHDHHRNEE---------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 ~~~~~~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
+..++++++...+.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 667888887765421 25788899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~ 403 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYR 403 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTCC
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 8664322222223346778999999998999999999999999999999 9999975431 011111111111
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
...+..+++++.+++..||+.||++|||++++++.|+++...
T Consensus 404 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 ----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 112345667899999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=332.99 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=195.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|..+ +++.+|+|+++....... ...+.+..|..++..+ +||||+++++++......
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3478999999999999999999976 588999999987543322 2334678899998877 899999999999999999
Q ss_pred eEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999998876532 46899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..........................
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 279 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 279 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred -CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence 22334556899999999999999999999999999999999999999975432221111111111111111111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
.++...+.++.+|+..||+.||.+||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1234456679999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=322.02 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=198.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC--CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57999999999999999999976 58999999998655432 2345788999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9887642 2456899999999999999999999999 9999999999999999999999999998664332
Q ss_pred eeeeeccccCCccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---cccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMYDIL 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 298 (366)
.......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||........ ............ .+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH----HHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHHhCCCChhhhhhhc
Confidence 2234456899999999987765 79999999999999999999888754332111 111111111110 000000
Q ss_pred ------------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 ------------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.........+..+.++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000011122345678899999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=325.52 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=200.1
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
..++|++.+.||+|+||+||+|.+. ++.||+|++..... .......|+.+++.++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 3478999999999999999999876 78999999975422 22345668899999999999999999988654
Q ss_pred -ceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeCCCCCCCEEecCCCeEEE
Q 037297 146 -PLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSA----------ASSPIYHRDIKSTNILLDERYRAKV 208 (366)
Q Consensus 146 -~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~----------~~~~iiH~dikp~Nill~~~~~vkl 208 (366)
.++++++...+. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 477888776543 23589999999999999999999998 8 999999999999999999999
Q ss_pred eecCCcccccCCCce-eeeeccccCCccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc--
Q 037297 209 ADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS-- 280 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-- 280 (366)
+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999776543322 22335689999999998763 5566899999999999999999999765432211100
Q ss_pred -----HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 281 -----LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 281 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.................... .......+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01111111111111111111 01223566789999999999999999999999999998863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.59 Aligned_cols=252 Identities=22% Similarity=0.402 Sum_probs=192.4
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|... ++..||+|.++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 468999999999999999999864 4678999999865433 345679999999999999999999999999999
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999987553 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCcee--eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHV--TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .. ........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~-~~~~i~~~-- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QD-VIKAVDEG-- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HH-HHHHHHTT--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcC--
Confidence 5332221 122235778999999999999999999999999999998 9999965431 00 11111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.....+..++..+.+++..||+.||++|||+.|+++.|+.+...
T Consensus 267 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 -------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00112334566899999999999999999999999999988654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=321.12 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=193.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhc--CCCCceeeEeeEEeeC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ--INHRNVVKLLGCCLET---- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~---- 143 (366)
.++|++.+.||+|+||+||+|.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999988 58999999987532 2345556666665 7999999999987653
Q ss_pred CcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 144 EVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLH--------SAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 144 ~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
...++++++...+ ....+++..++.++.|++.||.||| +++ ++||||||+|||++.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 3466777776553 2346899999999999999999999 878 9999999999999999999999
Q ss_pred ecCCcccccCCCcee---eeeccccCCccccccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 037297 210 DFGTSKFIAMDQTHV---TTKIQGTFGYLEPEYHQSS------QLTDKSDVYSFGVVLVELLTG----------KKPIFS 270 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g----------~~p~~~ 270 (366)
|||++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997665443332 2234789999999998876 455799999999999999999 788765
Q ss_pred CCCCCcccccHHHHHHHHhh-cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 271 TGNTSQENVSLAAFFVHSMR-KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
........ ........ ........ ....+...+..+.+++..||+.||++|||+.|+++.|+.+
T Consensus 236 ~~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSF----EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCH----HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcch----hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43211111 11111111 11111111 1123456778999999999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=325.19 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=201.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...++|++.+.||+|+||.||++.+.++..||+|++...... .+.+.+|+.+++.++||||+++++++......+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 345789999999999999999999988889999999865443 246889999999999999999999999998889
Q ss_pred EEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9988875542 346899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
..........+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ............
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~----- 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLR----- 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCC-----
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcccC-----
Confidence 32222333456778999999998899999999999999999998 9999975431 011111111100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
...+...++.+.+++..||+.||.+|||+.|+++.|+++.+
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 -----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11123345678999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.02 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=205.1
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
....++|++.+.||+|+||.||+|.+. +++.||+|+++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344588999999999999999999975 3478999999865443 3456789999999999999999999999
Q ss_pred eeCCcceEEEeeccCCC-------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037297 141 LETEVPLLHLHDHHRNE-------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 189 (366)
......++++++..+.. ...+++..++.++.|++.||.|||+++ ++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999998775431 146889999999999999999999999 99
Q ss_pred eCCCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 037297 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267 (366)
Q Consensus 190 H~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 267 (366)
||||||+||+++.++.+||+|||++........ .......+|..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976543221 22233467889999999998899999999999999999999 9999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
|..... ............. ..+..++..+.+++..||+.||++|||+.++++.|+++.....
T Consensus 277 ~~~~~~---------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 277 YYGMAH---------EEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTTSCH---------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCCCh---------HHHHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 975431 0111111111111 1234456689999999999999999999999999999886544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=319.67 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=193.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
++|++.+.||+|+||+||+|.+.+++.+|+|++....... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc--ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5799999999999999999999889999999997654322 22356789999999999999999999999999999998
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 876542 2346899999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---cccc---
Q 037297 224 VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---HMYD--- 296 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 296 (366)
......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...... . ............ .+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--D---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHHHHCCCChhhchhhhc
Confidence 22345689999999988764 5899999999999999999999999754311 0 011111111100 0000
Q ss_pred ---------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ---------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+..........++++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000011122345668899999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.77 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=204.3
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
....++|.+.+.||+|+||.||+|.+. ++..||+|+++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 334578999999999999999999852 3578999999865443 3456789999999999999999999999
Q ss_pred eeCCcceEEEeeccCCC-------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037297 141 LETEVPLLHLHDHHRNE-------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 189 (366)
......++++++..+.. ...+++..++.++.|++.||.|||+++ ++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999998875431 123789999999999999999999999 99
Q ss_pred eCCCCCCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 037297 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 267 (366)
Q Consensus 190 H~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 267 (366)
||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999866543322 2233456788999999998899999999999999999999 9999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
|...... . ... ....... ...+..+++.+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 253 ~~~~~~~--~---~~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPE--R---LFN----LLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGG--G---HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHH--H---HHH----HhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9754321 0 111 1111110 11233456689999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.16 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=208.1
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEe
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLL 137 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (366)
....++|++.+.||+|+||.||+|.+. .+..||+|+++..... ...+.+.+|+.+++.+ +||||++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH---HHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 444578999999999999999999853 2357999999876444 3456789999999999 999999999
Q ss_pred eEEeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 138 GCCLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
+++......++++++..++. ...+++..++.++.|++.||.|||+++ |+|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99999999999998875531 135899999999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
|+|||++.++.+||+|||++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986643322 22233457888999999999999999999999999999999 999996543
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCccc
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKM 351 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 351 (366)
. ............ ...+..++.++.+++..||+.||++|||+.|+++.|+.+.......+.
T Consensus 299 ~---------~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 299 V---------EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp H---------HHHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred H---------HHHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 1 111111111111 112334566899999999999999999999999999988755444433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.98 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=195.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ......+.+|+.+++.++||||+++++++......++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 368999999999999999999974 68999999987532211 1123468899999999999999999999999999999
Q ss_pred EEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..+. ....+++..+..++.|++.||.|||++| ++||||||+|||++.++.+||+|||++......
T Consensus 87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 98887322 1236899999999999999999999999 999999999999999999999999999765432
Q ss_pred eeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........... . ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------------i----~~- 222 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------------V----NS- 222 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC--------------C----CS-
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH--------------H----Hc-
Confidence 22344579999999999988876 7899999999999999999999976432111100 0 00
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+...++++.+|+.+||+.||.+|||++|+++
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 001123345667899999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.31 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=198.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 367999999999999999999976 5899999999764221 11234578899999999999999999999999999999
Q ss_pred EEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++......
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9998876532 36899999999999999999999999 999999999999999999999999999754322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .......... ..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~------- 222 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-EI------- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC-------
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CC-------
Confidence 2233456799999999999999999999999999999999999999975431 1111111111 10
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
.++...++++.+++..||+.||++|| +++|+++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12334566899999999999999999 8888864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=329.48 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=198.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH--HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++.+.||+|+||.||+|.++ +|+.||+|+++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 5899999999875433210 1235788999999999999999999999999999
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCcc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~ 215 (366)
++++++..++ ....+++..+..++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999987654 2346899999999999999999999999 99999999999998776 79999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ...... ......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~-i~~~~~- 235 (361)
T 2yab_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN-ITAVSY- 235 (361)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HHTTCC-
T ss_pred EcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhcCC-
Confidence 76432 223445799999999999999999999999999999999999999976431 111111 111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .++. .....+..+.+|+..||+.||.+|||+.|+++
T Consensus 236 ~-~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D-FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1111 12234567899999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=319.58 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 4689999999999999999999888889999999875433 24688999999999999999999999999899999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 8887653 2345889999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ............
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~------- 223 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------- 223 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC-------
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCc-------
Confidence 222233456778999999998899999999999999999999 8999875431 011111111100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+..+.
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0112334567899999999999999999999999999987653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=332.44 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=198.3
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +|+.+|+|++....... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3467999999999999999999965 68999999998765443 34567899999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~---~~~~vkl~Dfg~a~~~ 217 (366)
+++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999887653 246899999999999999999999999 99999999999998 5678999999999766
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ..... ....... ..
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~-~i~~~~~-~~ 232 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQ-QIKAGAY-DF 232 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH-HHHHTCC-CC
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHH-HHHhCCC-CC
Confidence 5332 223446799999999999999999999999999999999999999965431 11111 1111110 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+ .....++++.+|+..||+.||.+|||+.|+++
T Consensus 233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 11234567899999999999999999999976
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=326.43 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=194.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 368999999999999999999976 6899999999764433 233568899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99887543 2335899999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-eeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 222 T-HVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 222 ~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .......... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~---~- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY---L- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTT---S-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhccccc---C-
Confidence 2 22344679999999999987775 77999999999999999999999764421111 0001111100 0
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011234567889999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=317.27 Aligned_cols=241 Identities=27% Similarity=0.383 Sum_probs=195.8
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEe
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH 151 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 151 (366)
|...+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..+++++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 777789999999999999976 6999999999764432 34568899999999999999999999999999999998
Q ss_pred eccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 152 DHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 152 ~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
+..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 198 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cc
Confidence 87654 2346899999999999999999999999 99999999999999999999999999976643322 23
Q ss_pred eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhh
Q 037297 226 TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKL 305 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (366)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..... ...........
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~~~~~-~~~~~~~~~~~------- 262 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMK-RLRDSPPPKLK------- 262 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH-HHHHSSCCCCT-------
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHhcCCCCCcC-------
Confidence 445799999999999999999999999999999999999999975431 01111 11111111110
Q ss_pred hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 306 VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 306 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+...++.+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12234567899999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.26 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=206.8
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.....+|++.+.||+|+||.||+|.++. +..||+|.++..... .+.+.+|+.+++.++||||++++++|.....
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3445678999999999999999999764 889999999865432 4578999999999999999999999999999
Q ss_pred ceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 146 PLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 146 ~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++...+ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999987643 2346889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
.............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... ...
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~~----~~~---- 434 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYEL----LEK---- 434 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHH----HHT----
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHH----HHc----
Confidence 65433333333456778999999998899999999999999999999 99999764311 11111 111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
......+..++..+.+|+..||+.||++|||+.++++.|+.+...
T Consensus 435 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111123445667899999999999999999999999999988643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.97 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=196.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|..+ +++.||+|++........ ...+.+.+|..+++.+ +||||+++++++......+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch-HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 367999999999999999999976 588999999986543221 3456788999999888 8999999999999999999
Q ss_pred EEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99998766432 36899999999999999999999999 999999999999999999999999999754322
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+......................
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2234456799999999999999999999999999999999999999976432221111111111111111111
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
.++...+.++.+++.+||+.||.+||++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1233456679999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=336.42 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=199.6
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.....++|++.++||+|+||.||+|..+. ++.||+|+++...... ....+.+.+|..++..++||||++++++|.+..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33445789999999999999999999764 7899999997532111 112234788999999999999999999999999
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 9999999876542 357899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
............+||+.|+|||++. +..++.++|||||||++|||++|+.||..... .+ ...........
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~---~~~~i~~~~~~ 299 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VE---TYGKIMNHKER 299 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHHHHTHHHH
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hH---HHHhhhhcccc
Confidence 6555444445568999999999886 56789999999999999999999999976431 00 00000000001
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTM 337 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~ 337 (366)
..++.. ....++++.+|+.+||+.+|++ ||+++|+++
T Consensus 300 ~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111110 1124567899999999998888 999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=320.89 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=197.4
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (366)
.++|++.+.||+|+||+||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH----HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 47899999999999999999984 2588999999875422 3446789999999999999999999998654
Q ss_pred -CcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 -EVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 -~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 45778888775532 234899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCc--eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-------CcccccHHHHH
Q 037297 215 KFIAMDQT--HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT-------SQENVSLAAFF 285 (366)
Q Consensus 215 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~ 285 (366)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87643322 1223344677899999999999999999999999999999999998643210 00000000000
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
....... .....+..+++++.+++..||+.||++|||+.|+++.|+.+.++.
T Consensus 242 ~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0011110 011224456678999999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=327.71 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=186.8
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-C---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-G---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..++|++.+.||+|+||.||+|.+.. + ..||+|+++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34689999999999999999999653 3 279999997653322 34568899999999999999999999998776
Q ss_pred cc------eEEEeeccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 145 VP------LLHLHDHHRNE-------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 145 ~~------~~~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
.. ++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 54 77777765532 225899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHH
Q 037297 206 AKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 283 (366)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||....... ...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----IYN 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----HHH
Confidence 99999999976643322 12233456788999999999999999999999999999999 999997644211 111
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCc
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGH 349 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~ 349 (366)
. ...... ...+..+++++.+++.+||+.||++|||+.++++.|+++....+-.
T Consensus 251 ~---~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 251 Y---LIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp H---HHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred H---HhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 0 111110 1123345568999999999999999999999999999887655433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.14 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=190.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||+||+|.+. +++ .||+|.++..... ...+.+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 367999999999999999999964 344 3588877643322 34467899999999999999999999998765
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++...+ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 45566655443 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||....... ... ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~----~~~~~~- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISS----ILEKGE- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH----HHHTTC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHH----HHHcCC-
Confidence 6543322 2233456889999999999999999999999999999999 999997643211 111 111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....+..++.++.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011233455679999999999999999999999999987753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.00 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=200.2
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-cce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 147 (366)
..++|++.+.||+|+||.||+|..+ ++.||+|+++... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 4578999999999999999999886 7899999998643 2357889999999999999999999988776 677
Q ss_pred EEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 8888776542 224789999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..... ....
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i---~~~~----- 403 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV---EKGY----- 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHHHH---HTTC-----
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH---HcCC-----
Confidence 21 122356889999999999999999999999999999998 999997643211 11111 1110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
....+..+++.+.+++..||+.||++|||+.++++.|+.+.....
T Consensus 404 -----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 404 -----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 112344567789999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=320.31 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=206.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 346789999999999999999999764 88999999976433 245788999999999999999999999999988
Q ss_pred eEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++++..+. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9998877542 3446899999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~----~~~~---- 228 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYEL----LEKD---- 228 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHH----HHTT----
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH----Hhcc----
Confidence 6555444455567889999999999999999999999999999999 99998754311 01111 0110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.....+..+++.+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 229 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 229 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 0111233456689999999999999999999999999988764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=318.10 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=203.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 146 (366)
.++|++.+.||+|+||+||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 467999999999999999999976 4899999999764332 23456789999999999999999999988766 56
Q ss_pred eEEEeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCeEEEeecC
Q 037297 147 LLHLHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFG 212 (366)
Q Consensus 147 ~~~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill----~~~~~vkl~Dfg 212 (366)
++++++..+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78888775432 223899999999999999999999999 9999999999999 788889999999
Q ss_pred CcccccCCCceeeeeccccCCcccccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQ--------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
++....... ......||..|+|||++. +..++.++|||||||++|||++|+.||........... ....
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~ 238 (319)
T 4euu_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYK 238 (319)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH-HHHH
T ss_pred CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH-HHHH
Confidence 998764332 233456899999999876 57789999999999999999999999976443222111 1111
Q ss_pred HHHHhhcCcccccc-----------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 285 FVHSMRKNHMYDIL-----------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 285 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.....+...+.... +......++...+..+.+++..||+.||++|||++|+++-.++..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111110000 001122456788889999999999999999999999999887554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.27 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=197.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 468999999999999999999976 58899999987542 233568899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--CCeEEEeecCCccccc
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~--~~~vkl~Dfg~a~~~~ 218 (366)
++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99987653 2346899999999999999999999999 999999999999987 7899999999998765
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......... ... . .
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~-~~~-~-~ 222 (321)
T 1tki_A 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMN-AEY-T-F 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCC-C-C
T ss_pred CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHc-CCC-C-C
Confidence 33 233445789999999999998899999999999999999999999975431 111111111 110 0 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .....+.++.+++.+||+.||.+|||+.|+++
T Consensus 223 ~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11234567899999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=325.15 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=207.0
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEe
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLL 137 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (366)
.+....++|++.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+.+|+.+++.+ +||||++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH---HHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 3444567899999999999999999984 24678999999865443 3456789999999999 999999999
Q ss_pred eEEeeCCcceEEEeeccCCC-------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 037297 138 GCCLETEVPLLHLHDHHRNE-------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d 192 (366)
+++...+..++++++...+. ..++++..++.++.|++.||.|||+++ ++|||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 99999999999988765421 124899999999999999999999999 99999
Q ss_pred CCCCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037297 193 IKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFS 270 (366)
Q Consensus 193 ikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 270 (366)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999876544332 2233457888999999999999999999999999999999 9999976
Q ss_pred CCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 271 TGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
...... ... ..... . ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+..+..
T Consensus 251 ~~~~~~----~~~----~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 251 MPVDSK----FYK----MIKEG-F--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCSSHH----HHH----HHHHT-C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ccchhH----HHH----HhccC-C--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 432110 011 01110 0 011123455679999999999999999999999999998775443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=333.82 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=200.9
Q ss_pred HhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
..++|++.+.||+|+||.||+|... ++..||+|+++..... .....+.+|+.+++.++||||+++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh---hhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3478999999999999999999843 4678999999764444 334578899999999999999999999999
Q ss_pred CCcceEEEeeccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---e
Q 037297 143 TEVPLLHLHDHHRN--------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---R 205 (366)
Q Consensus 143 ~~~~~~~~~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~ 205 (366)
....++++++..++ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 99999999887542 1235889999999999999999999999 99999999999999554 5
Q ss_pred EEEeecCCcccccCCC-ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHH
Q 037297 206 AKVADFGTSKFIAMDQ-THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 283 (366)
+||+|||++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~ 294 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE 294 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 9999999997553221 122233457889999999999999999999999999999998 9999975431 11
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.. ........ ...+..++..+.+++..||+.||++|||+.|+++.|+.+...
T Consensus 295 ~~-~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 295 VL-EFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH-HHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 11111110 112334556799999999999999999999999999887643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=320.41 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=202.0
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
....++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.+++.++||||+++++++.. +..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 3445789999999999999999999888889999999765433 3478899999999999999999998764 457
Q ss_pred eEEEeeccCCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRNEE---------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++++..+... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 778877654321 15889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
............++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~-~~~~~~--- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQ-NLERGY--- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH-HHHTTC---
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHH-HHhccc---
Confidence 5443333334456788999999988889999999999999999999 9999965431 01111 111110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
....+..++..+.+++..||+.||++|||++++++.|+.+...
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 228 ------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0112334556899999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=319.51 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=189.3
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH----------------------HHHHHHHHHHHHHHh
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE----------------------LLKLEEFINEIVILS 126 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~ 126 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++........ ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999975 588999999976532211 112356889999999
Q ss_pred cCCCCceeeEeeEEee--CCcceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 037297 127 QINHRNVVKLLGCCLE--TEVPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNI 198 (366)
Q Consensus 127 ~l~h~niv~~~~~~~~--~~~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Ni 198 (366)
.++||||+++++++.. ....++++++..... ..++++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 9999999999999886 456778888765432 336899999999999999999999999 99999999999
Q ss_pred EecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037297 199 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275 (366)
Q Consensus 199 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 275 (366)
|++.++.+||+|||++....... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 99999999999999998765332 2234457999999999987765 37789999999999999999999965321
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. .......... ... .....++++.+++.+||+.||++|||+.|+++
T Consensus 246 ------~~-~~~~~~~~~~-~~~-------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ------MC-LHSKIKSQAL-EFP-------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HH-HHHHHHHCCC-CCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HH-HHHHHhcccC-CCC-------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 00 1111111110 000 01234567899999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.79 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=204.4
Q ss_pred cChHHHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCce
Q 037297 61 FSSKELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNV 133 (366)
Q Consensus 61 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 133 (366)
+....+....++|++.+.||+|+||.||+|.+. +++.||+|+++..... ...+.+.+|+.+++.+ +||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH---HHHHHHHHHHHHHHhhcCCcce
Confidence 344555666789999999999999999999832 3678999999865444 3456789999999999 89999
Q ss_pred eeEeeEEeeCCc-ceEEEeeccCCC-------------------------------------------------------
Q 037297 134 VKLLGCCLETEV-PLLHLHDHHRNE------------------------------------------------------- 157 (366)
Q Consensus 134 v~~~~~~~~~~~-~~~~~~~~~~~~------------------------------------------------------- 157 (366)
+++++++...+. .++++++..++.
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999887665 677777654311
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 158 ------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 158 ------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 112889999999999999999999999 99999999999999999999999999986643
Q ss_pred CCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........ ..........
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~~~~~~--- 314 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLKEGTR--- 314 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--------HHHHHHHTCC---
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--------HHHHHHcCCC---
Confidence 332 23344568899999999999999999999999999999998 9999976432110 1111111110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
...+..+++++.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 315 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 ------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11233355679999999999999999999999999988753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=341.14 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=199.5
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.+....++|++.+.||+|+||.||+|.++++..||+|+++..... .+.+.+|+.+++.++||||+++++++.. .
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 344556789999999999999999999987788999999865432 3478899999999999999999999876 6
Q ss_pred cceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 145 VPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 145 ~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..++++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence 6778888776542 235889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...........
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~-- 398 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGY-- 398 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC--
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC--
Confidence 665333222333456788999999998999999999999999999999 9999975431 01111111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
....+..+++.+.+++..||+.||++|||++++++.|+.+..+
T Consensus 399 --------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 --------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1112445677899999999999999999999999999988754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=323.48 Aligned_cols=248 Identities=26% Similarity=0.316 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH--HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++......... ...+.+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999976 5899999999865433110 1245788999999999999999999999999999
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCcc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~ 215 (366)
++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999987653 3446899999999999999999999999 99999999999999887 89999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .......... ..
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~-~~- 234 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAV-NY- 234 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHT-CC-
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhc-CC-
Confidence 764322 23345799999999999999999999999999999999999999965431 0111111110 00
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ... ......+..+.+|+..||+.||++|||+.|+++
T Consensus 235 ~-~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 001 112234567899999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.52 Aligned_cols=253 Identities=16% Similarity=0.193 Sum_probs=200.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... +.+.+|+.+++.+ +||||+++++++......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 468999999999999999999964 6899999998765332 2577899999999 9999999999999999999
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe-----EEEeecCCcc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-----AKVADFGTSK 215 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~-----vkl~Dfg~a~ 215 (366)
+++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999987321 1347899999999999999999999999 999999999999998887 9999999998
Q ss_pred cccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 216 FIAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 216 ~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~~~i~~~~ 236 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERYQKIGDTK 236 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHHHHHHhhh
Confidence 76443321 124567999999999999999999999999999999999999999765321110 0001000000
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.... .......++ ++.+++..||+.||.+|||++++.+.|+++.
T Consensus 237 ~~~~---------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 RATP---------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHSC---------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCC---------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000 001111234 8999999999999999999999999998765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=323.65 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=198.2
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.++ +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3567999999999999999999975 58999999998654432 34567899999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CeEEEeecCCcccc
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~---~~vkl~Dfg~a~~~ 217 (366)
+++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999876542 346899999999999999999999999 9999999999999864 45999999999766
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..... ....... ..
T Consensus 182 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~-~i~~~~~-~~ 249 (362)
T 2bdw_A 182 NDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYA-QIKAGAY-DY 249 (362)
T ss_dssp TTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHTCC-CC
T ss_pred cCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHhCCC-CC
Confidence 432 223346799999999999999999999999999999999999999975431 11111 1111110 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+ .....++++.+|+..||+.||++|||+.|+++
T Consensus 250 ~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 11234567899999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.55 Aligned_cols=255 Identities=16% Similarity=0.194 Sum_probs=202.5
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... +.+.+|+.+++.+ +|+|++++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc------HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 46899999999999999999996 46899999998754332 3567899999999 8999999999999999999
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe-----EEEeecCCcc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-----AKVADFGTSK 215 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~-----vkl~Dfg~a~ 215 (366)
+++++.... ...++++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++.
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999887221 1336899999999999999999999999 999999999999987766 9999999998
Q ss_pred cccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 216 FIAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 216 ~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
........ ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~ 237 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKK 237 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH--HHHHHHhhc
Confidence 76543321 2344569999999999999999999999999999999999999997654221111 111110000
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.... .......+++++.+++..||+.||++|||++++++.|+.+..
T Consensus 238 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 238 QSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCcc---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 011223456789999999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.88 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=210.8
Q ss_pred ccccChHHHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC
Q 037297 58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131 (366)
Q Consensus 58 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 131 (366)
...+...++....++|++.+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.++||
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCH 88 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCT
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH---HHHHHHHHHHHHHHhcCCC
Confidence 344555566667789999999999999999999854 3678999999865443 3445788999999999999
Q ss_pred ceeeEeeEEeeCCcceEEEeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHRNE-----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
||+++++++......++++++..++. ..++++..++.++.|++.||.|||+++ ++|||||
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dik 165 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLA 165 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCS
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCc
Confidence 99999999999999999998876532 135688999999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
|+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999999999999999999765432221 1223356888999999999999999999999999999999 889986543
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
. . ............ ..+..++..+.+++..||+.||.+|||+.|+++.|+.+....+
T Consensus 246 ~--------~-~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 246 N--------E-QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp H--------H-HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred H--------H-HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 1 0 111111111111 1233456679999999999999999999999999998866444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=328.64 Aligned_cols=263 Identities=18% Similarity=0.222 Sum_probs=197.3
Q ss_pred hcCCcccceeccc--CceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQG--GQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++.+.||+| +||.||+|.++ +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 4789999999999 99999999976 68999999998765443 3456788999999999999999999999999999
Q ss_pred eEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 LLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 ~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999876532 246899999999999999999999999 999999999999999999999999988654
Q ss_pred cCCCc------eeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 218 AMDQT------HVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 218 ~~~~~------~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
..... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 32211 11122468899999999987 57899999999999999999999999765432211111110000000
Q ss_pred hcCc------------------cccc---------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNH------------------MYDI---------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~------------------~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... .... .........+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000 0000 0000011234456678999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=333.46 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=185.6
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCC-
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE- 144 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~- 144 (366)
...++|++.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS--TDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 34578999999999999999999975 68999999987543332 34467889999999996 999999999997655
Q ss_pred -cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 -VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 -~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++..+. ....+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 567788776532 1236888999999999999999999999 9999999999999999999999999997653
Q ss_pred CC--------------------CceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 037297 219 MD--------------------QTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277 (366)
Q Consensus 219 ~~--------------------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 277 (366)
.. .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~- 239 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ- 239 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 21 1122344679999999999876 6789999999999999999999999976431110
Q ss_pred cccHHHHHHHHhhcCc-----------------------------cccccch---H-HhhhhcHHHHHHHHHHHHHhhcC
Q 037297 278 NVSLAAFFVHSMRKNH-----------------------------MYDILDD---Q-VVKLVKKNQIMAFANLAERCLDL 324 (366)
Q Consensus 278 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~---~-~~~~~~~~~~~~l~~li~~cl~~ 324 (366)
..........+. ....... . .....+..+++++.+|+.+||+.
T Consensus 240 ----~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 240 ----LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp ----HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred ----HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 000111110000 0000000 0 00000113456899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 037297 325 NGKKRPTMEEVTME 338 (366)
Q Consensus 325 dp~~Rpt~~ell~~ 338 (366)
||++|||++|+++-
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=333.44 Aligned_cols=256 Identities=20% Similarity=0.277 Sum_probs=191.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++++.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh--HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 478999999999999999999965 58999999998653322 34567889999999999999999999987654
Q ss_pred --cceEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 --VPLLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 --~~~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++.... -...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 347888876543 1224889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh--------
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR-------- 290 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 290 (366)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... .........
T Consensus 216 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-----~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 216 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-----WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCSCCHHHHT
T ss_pred CC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCCCHHHHH
Confidence 32 233456799999999999999999999999999999999999999976431100 000000000
Q ss_pred -----------cC-cccc-----ccchHH---hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 -----------KN-HMYD-----ILDDQV---VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 -----------~~-~~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. .... ...... ........++++.+|+.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000 000000 00112234678999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.62 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=182.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.++ +++.||+|+++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 467999999999999999999965 5899999999865432 123467889999999999999999999999999999
Q ss_pred EEeeccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 149 HLHDHHRN------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 149 ~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
++++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99877531 1135889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC---
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--- 292 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 292 (366)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... . ............
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~---~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 158 FGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--E---QLKLIFDIMGTPNES 231 (317)
T ss_dssp TTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHHHHHHCSCCTT
T ss_pred cCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H---HHHHHHHHhCCCChh
Confidence 643222 2234568999999999876 46899999999999999999999999754311 1 011111110000
Q ss_pred cccc-----------------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 HMYD-----------------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+.. .+........+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00011111122235568999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=327.79 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=189.4
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC--CceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||++.+.+++.||+|++....... ...+.+.+|+.+++.++| |||+++++++......+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch--HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 46799999999999999999998889999999998654433 345678999999999976 99999999999999999
Q ss_pred EEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 148 LHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 148 ~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 86 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 86 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 988832211 2346889999999999999999999999 99999999999997 5789999999998664333
Q ss_pred ce-eeeeccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 222 TH-VTTKIQGTFGYLEPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 222 ~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~ 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAII 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHH
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHHHHh
Confidence 22 2334579999999998864 6789999999999999999999999965321 111111111
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.... ....+...+.++.+++..||+.||.+|||+.|+++-
T Consensus 235 ~~~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 111222334578999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.86 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=196.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467999999999999999999976 5889999998763321 11234678899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++ ....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 99887654 2346899999999999999999999999 999999999999999999999999999866432
Q ss_pred ceeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .... ......
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~-~~~~~~----- 236 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVH-TFETTV----- 236 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHH-HHHHCC-----
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHH-HHhhcc-----
Confidence 33445679999999999864 46899999999999999999999999754322111 1111 111110
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-HHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-MEEVT 336 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell 336 (366)
...+..++..+.+|+..||+.||.+||+ ++++.
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 1123445678999999999999999998 66654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.41 Aligned_cols=251 Identities=30% Similarity=0.514 Sum_probs=196.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHH---HHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLK---LEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++........... .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999975 689999999876544322222 267899999999999999999999986554
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe-----EEEeecC
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-----AKVADFG 212 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~-----vkl~Dfg 212 (366)
++++++.... ...++++..+..++.|++.||.|||+++ ++++||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 5777776543 3346899999999999999999999975 45999999999999988776 9999999
Q ss_pred CcccccCCCceeeeeccccCCccccccc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYH--QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
++..... ......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||........ .... ...
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~-~~~ 243 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------KFIN-MIR 243 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------HHHH-HHH
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------HHHH-HHh
Confidence 9974332 23446789999999998 445678999999999999999999999975432111 0011 111
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
.... ....+..+++.+.+++..||+.||.+|||++|+++.|+.+
T Consensus 244 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1112345567899999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=325.60 Aligned_cols=241 Identities=25% Similarity=0.295 Sum_probs=190.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 145 (366)
...++|++.+.||+|+||.||+|.++ +++.||+|+++...... ....+.+.+|..+++.+ +||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34578999999999999999999976 58999999998643221 13345788899999988 79999999999999999
Q ss_pred ceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999998876532 36899999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ............
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~----- 241 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEV----- 241 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-----
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCC-----
Confidence 22 2234456799999999999999999999999999999999999999976431 111111111110
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
..+...+.++.+++..||+.||.+||++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 1233355678999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.97 Aligned_cols=242 Identities=22% Similarity=0.246 Sum_probs=188.1
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 145 (366)
...++|++.+.||+|+||+||+|.+. +++.||+|++........ .......|+..+..+ +||||++++++|.....
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH--HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 34468999999999999999999976 689999999876544332 233445555555544 99999999999999999
Q ss_pred ceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999887432 1235899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ........ .
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------~~~~~~~~----~ 269 (311)
T 3p1a_A 209 TA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------WQQLRQGY----L 269 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------HHHHTTTC----C
T ss_pred cC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------HHHHhccC----C
Confidence 32 22334568999999998876 789999999999999999999776643210 00111111 1
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+ ..+...+.++.+++..||+.||++|||++|+++
T Consensus 270 ~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 123345678999999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.36 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=195.8
Q ss_pred HhcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..++|++.+.||+|+||.||+|.+.+ +..||+|.+...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH---HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc---hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 34789999999999999999998543 345999999875433 3456789999999999999999999997654
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4577777765432 235889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
.............+|..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~---~~~~~- 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLE---KGDRL- 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHH---HTCCC-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHh---cCCCC-
Confidence 65443333344557888999999998999999999999999999998 999997543211 111111 01000
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+..+++.+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 234 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 ---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1123345679999999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=312.73 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=188.9
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++|++.+.||+|+||+||+|.+. ..+|+|+++...... ...+.+.+|+.+++.++||||+++++++ .....++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCH--HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3578999999999999999999864 359999998655443 3456789999999999999999999965 4455677
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..+. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 77766432 3456899999999999999999999999 999999999999999999999999999765432
Q ss_pred C-ceeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 221 Q-THVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 221 ~-~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
. ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||....... .............
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 245 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIEMVGRGSLSP 245 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------HHHHHHHHTSCCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------HHHHHhcccccCc
Confidence 2 22234456899999999886 6678899999999999999999999997643211 1111111111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.. ......+++.+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 246 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 11233456789999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.69 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=189.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcE----EEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRI----MAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||.||+|.+. +++. +|+|.+...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC---CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 367999999999999999999965 3443 577777543332 23457889999999999999999999998765
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++...+ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 55555555443 2346889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... ......+|..|+|||.+.+..++.++|||||||++|+|++ |..||....... ... ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~----~~~~~~- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISS----ILEKGE- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH----HHHTTC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHH----HHHcCC-
Confidence 6433222 2233446778999999999999999999999999999999 999997643211 111 111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....+..++.++.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 237 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 --------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011233455679999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=327.24 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (366)
+....++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3445688999999999999999999962 3568999999854322 3446789999999999 9999999999
Q ss_pred EEeeCCcceEEEeeccCCCC------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 037297 139 CCLETEVPLLHLHDHHRNEE------------------------------FPLTWEIRLRIATEVAGALSYLHSAASSPI 188 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 188 (366)
++...+..++++++..++.. ..+++..++.++.|++.||.|||+++ +
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 193 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99999999999988754311 23789999999999999999999999 9
Q ss_pred EeCCCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 037297 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKK 266 (366)
Q Consensus 189 iH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~ 266 (366)
+||||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986654332 22334557889999999999999999999999999999998 999
Q ss_pred CCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 267 PIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 267 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
||........ ......... ....+..+++++.+++..||+.||.+|||+.|+++.|+.+...
T Consensus 274 p~~~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVDAN--------FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCSHH--------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcHHH--------HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9976432110 011111110 0112334466899999999999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=320.96 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=188.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|++.+.||+|+||.||+|.++ +++.||+|+++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT---THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 467999999999999999999976 6899999999865433 234678999999999999999999999866542
Q ss_pred ------------------------------------------------------ceEEEeeccCCC----------CCCC
Q 037297 146 ------------------------------------------------------PLLHLHDHHRNE----------EFPL 161 (366)
Q Consensus 146 ------------------------------------------------------~~~~~~~~~~~~----------~~~l 161 (366)
.++++++..+.. ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 567777765532 1234
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc-----------eeeeeccc
Q 037297 162 TWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-----------HVTTKIQG 230 (366)
Q Consensus 162 ~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-----------~~~~~~~~ 230 (366)
++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........ .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 66678999999999999999999 99999999999999999999999999987654321 12233568
Q ss_pred cCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHH
Q 037297 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQ 310 (366)
Q Consensus 231 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (366)
|+.|+|||++.+..++.++|||||||++|+|++|..|+... ............ .......
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----------~~~~~~~~~~~~---------~~~~~~~ 298 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----------VRIITDVRNLKF---------PLLFTQK 298 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----------HHHHHHHHTTCC---------CHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----------HHHHHHhhccCC---------CcccccC
Confidence 99999999999999999999999999999999987664210 000111111111 1123445
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 311 IMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 311 ~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
++.+.+++..||+.||++|||+.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 567899999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.44 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=200.0
Q ss_pred hcCCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNR-ILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|.+.+ .||+|+||.||+|.+. ++..||+|+++..... ...+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 35677776 9999999999999853 5778999999875433 3456789999999999999999999998 5556
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 77787776542 3446899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceee--eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
........ ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~-~~i~~~~- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVM-AFIEQGK- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHH-HHHHTTC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHH-HHHhcCC-
Confidence 54333221 22346788999999988889999999999999999998 99999764321 000 1111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....+..+++.+.+++..||+.||++|||+.++++.|+.+..
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011234566789999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=316.16 Aligned_cols=240 Identities=26% Similarity=0.375 Sum_probs=196.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++..... .....+.+.+|..+++.++||||+++++++.+....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 367999999999999999999976 6899999999763221 11234577889999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999876642 346899999999999999999999999 999999999999999999999999999865432
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ........... .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-~------- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE-L------- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC-C-------
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-C-------
Confidence 2345799999999999999999999999999999999999999975431 11111111111 0
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVT 336 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell 336 (366)
..+...+.++.+++.+||+.||++|| +++|++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 12334556799999999999999999 888886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.69 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=189.6
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH-HHHHHHHHHHHHHHhcC---CCCceeeEeeEEee
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE-LLKLEEFINEIVILSQI---NHRNVVKLLGCCLE 142 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~ 142 (366)
...++|++.+.||+|+||+||+|.+. +++.||+|++........ ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44678999999999999999999964 689999999975432110 00112445666666665 59999999999987
Q ss_pred CC-----cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 143 TE-----VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 143 ~~-----~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
.. ..++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 65 356667665431 2223899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . .........
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~---~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--D---QLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--H---HHHHHHHHH
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHHHh
Confidence 99999765432 2234467899999999999999999999999999999999999999764311 1 111111111
Q ss_pred hc---Cccccc----------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RK---NHMYDI----------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~---~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ..+... ..+.......+..++.+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 10 011000 0001111223345678999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=317.95 Aligned_cols=245 Identities=26% Similarity=0.309 Sum_probs=186.4
Q ss_pred hcCCcccceecccCceEEEEEEE----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|.. .+++.+|+|+++.............+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999996 36899999999875433322344567889999999999999999999999999
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999876532 235789999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... .
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~-~----- 237 (327)
T 3a62_A 173 HD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKC-K----- 237 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHT-C-----
T ss_pred cC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC-C-----
Confidence 22 2223445799999999999999999999999999999999999999975431 0111111111 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+...+.++.+++.+||+.||.+|| ++.|+++
T Consensus 238 -----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 012334566789999999999999999 6666654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=324.74 Aligned_cols=242 Identities=27% Similarity=0.414 Sum_probs=195.7
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|++.+.||+|+||+||+|.. .+++.||+|++....... ....+.+.+|+.+++.++||||+++++++......+++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 5589999999999999999996 468999999998654332 23456789999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ...++++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9987542 2346899999999999999999999999 99999999999999999999999999976532
Q ss_pred eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .......... .....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~-~~~~~-- 273 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN-ESPAL-- 273 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-CCCCC--
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhc-CCCCC--
Confidence 22356899999999884 56789999999999999999999999975431 0111111111 11111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.+..++..+.+++..||+.||++|||++++++-
T Consensus 274 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122345678999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.11 Aligned_cols=248 Identities=23% Similarity=0.266 Sum_probs=198.0
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...++|++.+.||+|+||.||+|.++ +++.+|+|+++...... ....+.+.+|..+++.++||||+++++++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34578999999999999999999976 58899999997532111 11123478899999999999999999999999999
Q ss_pred eEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 147 LLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 147 ~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999876542 235889999999999999999999999 999999999999999999999999999876554
Q ss_pred CceeeeeccccCCccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Cc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NH 293 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 293 (366)
........+||+.|+|||++.+.. ++.++|+|||||++|||++|+.||..... .......... ..
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHKNSLT 293 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHHHCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHhcccccc
Confidence 444445678999999999987765 78899999999999999999999975431 1111111110 01
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKK--RPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ell~ 337 (366)
.+ .....+.++.+|+..||+.+|.+ ||+++|+++
T Consensus 294 ~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 294 FP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11 01134567899999999999988 999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.77 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=197.6
Q ss_pred ChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC--CCCceeeEeeE
Q 037297 62 SSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI--NHRNVVKLLGC 139 (366)
Q Consensus 62 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~ 139 (366)
+........++|++.+.||+|+||.||+|.+. ++.||+|++..... .....|.+++... +||||++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-------ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-------chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 34444555678999999999999999999886 89999999875321 2344566666555 99999999999
Q ss_pred EeeC----CcceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeCCCCCCCEEec
Q 037297 140 CLET----EVPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSA--------ASSPIYHRDIKSTNILLD 201 (366)
Q Consensus 140 ~~~~----~~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~--------~~~~iiH~dikp~Nill~ 201 (366)
+... ...++++++..++. ...+++..++.++.|++.||.|||++ + ++||||||+|||++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 9887 56788888776542 23688999999999999999999998 7 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCcee---eeeccccCCccccccccCCCCCch------hhHHHHHHHHHHHHhC--------
Q 037297 202 ERYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLEPEYHQSSQLTDK------SDVYSFGVVLVELLTG-------- 264 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~------~DiwslG~~l~el~~g-------- 264 (366)
.++.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997664333221 124568999999999987766654 9999999999999999
Q ss_pred --CCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 265 --KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 265 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
+.||......... .................. ....+..+++++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 257 ~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS----YEDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCTTTTTSCSSCC----HHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCc----hhhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 5555443211111 111111111111111110 1112346788999999999999999999999999999988
Q ss_pred ccC
Q 037297 343 RGS 345 (366)
Q Consensus 343 ~~~ 345 (366)
..+
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.84 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=203.3
Q ss_pred HHhcCCcccceecccCceEEEEEEEc--------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEee
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE--------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 138 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (366)
...++|++.+.||+|+||.||+|.+. ++..||+|+++..... ...+.+.+|+.+++.+ +||||+++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH---HHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34578999999999999999999863 4678999999865443 3456788999999999 9999999999
Q ss_pred EEeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 139 CCLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
++......++++++..++. ...+++..++.++.|++.||.|||+++ ++||||||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 185 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCcc
Confidence 9999999999998875531 124789999999999999999999999 99999999
Q ss_pred CCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 037297 196 TNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 273 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 273 (366)
+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999999999999999999876543322 2233456788999999988899999999999999999999 9999965431
Q ss_pred CCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 274 TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.. .......... ...+..++..+.+++..||+.||.+|||+.|+++.|+.+...
T Consensus 266 --------~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 266 --------EE-LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp --------HH-HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HH-HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01 1111111110 112334566899999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=320.23 Aligned_cols=241 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.++ +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 367999999999999999999976 5899999999763221 11234678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999886543 236899999999999999999999999 999999999999999999999999999865432
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... ......... ...
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~------- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVS-GKV------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC-------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHc-CCC-------
Confidence 2345789999999999999999999999999999999999999975431 111111111 110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
..+...+.++.+++.+||+.||.+||+ ++|+++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 123345667999999999999999998 777753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=323.97 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=189.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|.+. +++.||+|++...... .....+.+|+.+++.++||||+++++++......+++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999976 6899999999764322 1122455799999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..+. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 9887542 2335889999999999999999999999 9999999999999999999999999997554322
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---cCcccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---KNHMYDIL 298 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 298 (366)
.......+|..|+|||++.+ ..++.++||||+||++|+|++|+.||..... .+ .......... ...+....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~---~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EE---QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHHHhCCCChHhchhhh
Confidence 22334568999999998876 5689999999999999999999999976431 11 1111111111 11111111
Q ss_pred chH-------------HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQ-------------VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ......+..+.++.+|+.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 110 001122345668899999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=329.45 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=189.3
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 147 (366)
..+|++.+.||+|+||.||+|...+++.||+|++....... ...+.+.+|+.+++.++ ||||+++++++...+..+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH--HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 35699999999999999999998889999999998654432 34568899999999996 599999999999999999
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++. ... ....+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 133 lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 98883 322 1236788899999999999999999999 99999999999995 579999999999866433
Q ss_pred Cce-eeeeccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 221 QTH-VTTKIQGTFGYLEPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 221 ~~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~~ 280 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAI 280 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHH
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHHH
Confidence 222 2344579999999998865 4688999999999999999999999965321 11111111
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... ...+...+.++.+|+..||+.||.+|||+.|+++
T Consensus 281 ~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 281 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCcccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111110 0112223457899999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=325.66 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=192.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcE----EEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRI----MAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||.||+|.+. +++. +|+|.+...... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 367999999999999999999965 3443 788877543322 12245678999999999999999999886 45
Q ss_pred cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++...+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 5677777765442 236888899999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 217 IAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 217 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... ......+|..|+|||.+.+..++.++|||||||++|+|++ |+.||....... .. ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~----~~~~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VP----DLLEKGER 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HH----HHHHTTCB
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HH----HHHHcCCC
Confidence 6544322 2344567889999999999999999999999999999999 999997643111 00 01111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+..++.++.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112234456889999999999999999999999998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=322.00 Aligned_cols=263 Identities=18% Similarity=0.215 Sum_probs=194.9
Q ss_pred HhcCCcccceecccCceEEEEEEEcC------CcEEEEEEeecccChHHH-------HHHHHHHHHHHHHhcCCCCceee
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEEL-------LKLEEFINEIVILSQINHRNVVK 135 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~ 135 (366)
..++|++.+.||+|+||.||+|.+.. ++.||+|++......... .....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 478999998765322110 01123455667788889999999
Q ss_pred EeeEEeeC----CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--
Q 037297 136 LLGCCLET----EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-- 201 (366)
Q Consensus 136 ~~~~~~~~----~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-- 201 (366)
+++++... ...++++++. +. ....+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99998775 3467777776 32 2356899999999999999999999999 99999999999999
Q ss_pred CCCeEEEeecCCcccccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 037297 202 ERYRAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275 (366)
Q Consensus 202 ~~~~vkl~Dfg~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 275 (366)
.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999766432211 1133459999999999999999999999999999999999999997532111
Q ss_pred cccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. ......... ......+.++.+ .+..++.++.+++..||+.||.+|||+.++++.|+.+.
T Consensus 269 ~----~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 269 K----YVRDSKIRY-RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp H----HHHHHHHHH-HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred H----HHHHHHHHh-hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1 000000000 011111111100 01234678999999999999999999999999998765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=325.90 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=200.3
Q ss_pred cCC-cccceecccCceEEEEEEEc-----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-
Q 037297 71 NHF-NVNRILGQGGQGTVYKGMLE-----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET- 143 (366)
Q Consensus 71 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (366)
++| ++++.||+|+||+||++.+. +++.||+|+++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh---HHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 345 99999999999999998642 5889999999875443 3456789999999999999999999999885
Q ss_pred -CcceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 144 -EVPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 144 -~~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
...++++++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 45677777765432 235899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc---cccHHHHHHHHhhc
Q 037297 217 IAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAFFVHSMRK 291 (366)
Q Consensus 217 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 291 (366)
....... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||......... .........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 258 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL----- 258 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-----
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH-----
Confidence 6543322 223345788899999999989999999999999999999999998653210000 000000000
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
..............+..++.++.+++..||+.||++|||+.|+++.|+.+...
T Consensus 259 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 259 -RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 00000011111123445667899999999999999999999999999988643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=316.82 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=198.3
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (366)
..+|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 35699999999999999999983 35889999999864332 2346788999999999999999999999877
Q ss_pred -CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 -EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 -~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 5567888877553 2346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC------CcccccHHHHHH
Q 037297 215 KFIAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT------SQENVSLAAFFV 286 (366)
Q Consensus 215 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~ 286 (366)
......... ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+...... ............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 876544332 223456788899999999999999999999999999999999986432100 000000011111
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....... ....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 254 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111110 11123456678999999999999999999999999998763
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=333.76 Aligned_cols=190 Identities=27% Similarity=0.418 Sum_probs=147.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL--IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH--HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 478999999999999999999965 68999999987644332 3456889999999999999999999998544
Q ss_pred CcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 144 EVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 144 ~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...++++++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 3567777754321 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCc--------------------------eeeeeccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHhC
Q 037297 218 AMDQT--------------------------HVTTKIQGTFGYLEPEYH-QSSQLTDKSDVYSFGVVLVELLTG 264 (366)
Q Consensus 218 ~~~~~--------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g 264 (366)
..... ...+..+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43211 123446789999999976 566799999999999999999993
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=321.19 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=195.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH-HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE-LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.++ +++.||+|++........ ....+.+.+|+.+++.++||||+++++++......+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999975 589999999875321100 012457889999999999999999999999999999
Q ss_pred EEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe---EEEeecCC
Q 037297 148 LHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGT 213 (366)
Q Consensus 148 ~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~---vkl~Dfg~ 213 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999887543 224889999999999999999999999 999999999999986554 99999999
Q ss_pred cccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......... ..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~-~~ 248 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIK-GK 248 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHH-TC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHc-CC
Confidence 98765432 22334579999999999999999999999999999999999999997532 011111111 11
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ..+.. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 01111 1234567899999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.75 Aligned_cols=256 Identities=19% Similarity=0.269 Sum_probs=194.7
Q ss_pred HhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE-eeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC-LETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... +.+.+|+.+++.++|++++..+..+ ...+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 357899999999999999999996 46889999987654322 3577899999999888877766665 556667
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCccc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~ 216 (366)
++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 7777776221 2446899999999999999999999999 9999999999999 7889999999999987
Q ss_pred ccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 217 IAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 217 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 235 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh--hhhhhhcccc
Confidence 6543321 2234578999999999999999999999999999999999999998654322211 1111110000
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
... .......+++++.+++..||+.||++|||++++++.|+.+..
T Consensus 236 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 STP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cch---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 000 011122345689999999999999999999999999988764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=315.62 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=192.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||+||+|.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP--VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 67999999999999999999976 48999999987654433 3346788999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 9887653 2446899999999999999999999999 9999999999999999999999999997654322
Q ss_pred eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH--------HHHhhcCc
Q 037297 223 HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF--------VHSMRKNH 293 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 293 (366)
.......+|..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ ....... ........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhccccccccccccccc
Confidence 22334568999999998876 6789999999999999999999999976432110 0000000 00000000
Q ss_pred ------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 ------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....+........+..+..+.+|+..||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000001111345667899999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=314.93 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=198.7
Q ss_pred cCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
..|.+.+.||+|+||+||+|.+.+ +..+|+|.+...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM---QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 356777999999999999998542 236999998764443 3456889999999999999999999999877655
Q ss_pred -eEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 -LLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 -~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++++...+ ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 6777765443 2346789999999999999999999999 999999999999999999999999999765
Q ss_pred cCCC---ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQ---THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.... ........+|..|+|||.+.+..++.++||||||+++|+|++|..|+........ .... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----~~~~----~~~~~- 245 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHF----LAQGR- 245 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----HHHH----HHTTC-
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----HHHH----hhcCC-
Confidence 4322 1122335678899999999999999999999999999999996666543321111 1111 00110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHK 350 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~ 350 (366)
....+..+++.+.+++..||+.||.+|||+.++++.|+.+.....+..
T Consensus 246 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 246 --------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred --------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 011133445679999999999999999999999999999876655544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=311.92 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 147 (366)
.++|++.+.||+|+||.||+|.++ ++.+|+|++....... ...+.+.+|+.+++.++||||+++++++... ...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST--RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH--HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 467999999999999999999985 8889999998754433 3346799999999999999999999999887 6778
Q ss_pred EEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++..++ ....+++..+..++.|++.||.|||+++ ++++||||||+||+++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 888877653 2225899999999999999999999875 559999999999999999999999998875432
Q ss_pred CCCceeeeeccccCCccccccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
. ....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||..... .............
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~- 229 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEGLR- 229 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSCCC-
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcCCC-
Confidence 2 2235789999999988765544 89999999999999999999975431 1111111111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
...+..+++.+.+++..||+.||++|||++|+++.|+.+..
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11234456689999999999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=324.27 Aligned_cols=244 Identities=19% Similarity=0.266 Sum_probs=196.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.++ +++.+|+|++...... ....+.+|+.+++.++||||+++++++......++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL----DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh----hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 468999999999999999999976 5889999999764322 23478899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--CCeEEEeecCCccccc
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~--~~~vkl~Dfg~a~~~~ 218 (366)
++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99987653 2336899999999999999999999999 999999999999974 5789999999998765
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ...+. .
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~-~~~~~--~ 269 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVK-RCDWE--F 269 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHH-HCCCC--C
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCCC--C
Confidence 432 23345789999999999999999999999999999999999999975431 11111111 11100 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ .......++++.+|+..||+.||++|||+.|+++
T Consensus 270 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 D----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp C----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0112234567999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=318.59 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=190.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
...++|.+.+.||+|+||.||+|... ++..||+|.++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch--hHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34578999999999999999999854 24579999998654433 3456789999999999999999999998876
Q ss_pred Cc-----ceEEEeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe
Q 037297 144 EV-----PLLHLHDHHRN-------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR 205 (366)
Q Consensus 144 ~~-----~~~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~ 205 (366)
.. .++++++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 53 37777766542 2346899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHH
Q 037297 206 AKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 283 (366)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~ 260 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----MYD 260 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHH
Confidence 99999999976543322 12233456788999999999999999999999999999999 889986543211 111
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ...... ...+..++..+.+++..||+.||.+|||+.++++.|+.+..+
T Consensus 261 ~---~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 261 Y---LLHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp H---HHTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 011100 112334556899999999999999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.01 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=204.6
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcC-C-----cEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLED-G-----RIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVK 135 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (366)
........++|++.+.||+|+||.||+|.+.. + ..||+|.+...... ...+.+.+|+.+++.+ +||||++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA---DEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh---HHHHHHHHHHHHHHhhcCCCCeee
Confidence 33455566899999999999999999999643 2 47999999875543 3456789999999999 8999999
Q ss_pred EeeEEeeCCcceEEEeeccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 037297 136 LLGCCLETEVPLLHLHDHHRNE---------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIK 194 (366)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dik 194 (366)
+++++......++++++...++ ...+++..++.++.|++.||.|||+++ ++|||||
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 191 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcc
Confidence 9999999999999988865421 235789999999999999999999999 9999999
Q ss_pred CCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 195 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 195 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
|+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999999999866433322 2233457888999999998999999999999999999998 999997543
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.... ... ...... ....+...+..+.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 272 ~~~~----~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 272 VNSK----FYK----LVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp SSHH----HHH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHH----HHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 2110 000 111100 00112234567899999999999999999999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=321.04 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=196.0
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (366)
....++|++.+.||+|+||.||+|..+ +++.||+|+++...... ....+.+..|..++..+ +||||+++++++.+..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345688999999999999999999976 58999999998642211 12345677899888876 9999999999999999
Q ss_pred cceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999998866532 36899999999999999999999999 999999999999999999999999999754
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ............
T Consensus 169 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~---- 235 (345)
T 1xjd_A 169 MLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNP---- 235 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC----
T ss_pred ccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCC----
Confidence 322 2234456799999999999999999999999999999999999999975431 111111111110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTME-EVT 336 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell 336 (366)
..+...+.++.+++.+||+.||++||++. |++
T Consensus 236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 12233456789999999999999999997 553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=323.87 Aligned_cols=244 Identities=21% Similarity=0.258 Sum_probs=185.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||+||++.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++......++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 478999999999999999999976 6899999999764432 2457789999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe--EEEeecCCcccccC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR--AKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~--vkl~Dfg~a~~~~~ 219 (366)
++++..++. ...+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||+|||++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999876542 236899999999999999999999999 999999999999987765 99999999874322
Q ss_pred CCceeeeeccccCCccccccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC-ccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN-HMYDI 297 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 297 (366)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ............ ..+
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~-- 242 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVKYSIP-- 242 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTCCCCC--
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCCCCCC--
Confidence 2 22334569999999999988888765 8999999999999999999976442111 111111111110 110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 243 --------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 243 --------DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp --------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 01124567899999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.49 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=198.3
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE-eeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC-LETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... +.+.+|+.+++.++|++++..+..+ ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 47899999999999999999996 46899999998765433 2577899999999988877666655 5556667
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~~ 217 (366)
+++++.... ....+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 777776221 2346899999999999999999999999 9999999999999 48889999999999876
Q ss_pred cCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 218 AMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 218 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~ 236 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERISEKKMS 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh--hhhhhcccccC
Confidence 543321 1234579999999999999999999999999999999999999998654222211 11111110000
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.. ....+..+++++.+++..||+.||++|||+.++++.|+.+..
T Consensus 237 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 237 TP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred Cc---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 00 011223456789999999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=318.80 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=197.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC-----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||.||+|.... +..||+|.++..... .....+.+|+.+++.++||||+++++++....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4678899999999999999998653 235999999865443 34457899999999999999999999999988
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++..+. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 899999887553 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 217 IAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 217 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
....... ......+|..|+|||.+.+..++.++|||||||++|+|++ |+.||..... .... .......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~-~~~~~~~ 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVM-KAINDGF 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH-HHHHTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHH-HHHHCCC
Confidence 6433221 1222345778999999999999999999999999999999 9999965431 0111 1111110
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
. ...+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 268 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 268 R---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp C---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred c---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 0 011234556799999999999999999999999999987754433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=306.41 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=197.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 478999999999999999999975 58899999998755432 344678899999999999999999999999998899
Q ss_pred EEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe---EEEeecCCccccc
Q 037297 149 HLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~---vkl~Dfg~a~~~~ 218 (366)
++++..+... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9888765432 35889999999999999999999999 999999999999976654 9999999997654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..... .... ........ ...
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~-~~~~~~~~-~~~ 227 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLY-AQIKAGAY-DYP 227 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHTCC-CCC
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHH-HHHHhccc-cCC
Confidence 322 23345689999999999999999999999999999999999999965431 0111 11111110 000
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ......++++.+++..||+.||++|||+.|+++
T Consensus 228 ~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 S-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011234567899999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.15 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=197.1
Q ss_pred HhcCCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 69 ATNHFNVNR-ILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 69 ~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..++|++.+ .||+|+||.||+|.+. +++.||+|+++...... ...+.+.+|+.+++.++||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C--HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 346788888 9999999999999643 46889999998653322 3456789999999999999999999998 566
Q ss_pred cceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 6778887765431 235889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceee--eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTHVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
........ ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~ 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTAMLEKGER 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------HHHHHHHTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCC
Confidence 54433222 22346788999999988889999999999999999999 99999764310 01111111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
...+..++..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11234556789999999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.66 Aligned_cols=195 Identities=24% Similarity=0.363 Sum_probs=160.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh--HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 478999999999999999999975 58899999997644332 3456889999999999999999999998776
Q ss_pred CcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 144 EVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 144 ~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...++++++..+. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 4577888865431 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCc---------------------eeeeeccccCCccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037297 218 AMDQT---------------------HVTTKIQGTFGYLEPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIF 269 (366)
Q Consensus 218 ~~~~~---------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~ 269 (366)
..... ...+..+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43321 123556799999999986 56679999999999999999998655554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.90 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=197.8
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
+.....++|++.+.||+|+||.||+|..+ +|+.||+|+++...... ....+.+.+|..++..++||||+++++++.+.
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 33444578999999999999999999975 68999999997532211 12234578899999999999999999999999
Q ss_pred CcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999876542 236899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCcccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQ-------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
.............+||+.|+|||++. +..++.++|+|||||++|||++|+.||..... .......
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i 282 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYGKI 282 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 76554444444568999999999887 45789999999999999999999999976431 0111111
Q ss_pred hh---cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHH
Q 037297 289 MR---KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKR---PTMEEVTM 337 (366)
Q Consensus 289 ~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~ell~ 337 (366)
.. ....+ ..+...+.++.+|+.+||+ +|.+| |+++|+++
T Consensus 283 ~~~~~~~~~p---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEHLSLP---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccCcCCC---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 10 00010 0123456689999999999 99998 58888753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=317.31 Aligned_cols=260 Identities=18% Similarity=0.251 Sum_probs=189.9
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
....++|++.+.||+|+||+||+|.+. +++.||+|+++...... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE--GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc--ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 445578999999999999999999965 68999999997654332 234567899999999999999999999999999
Q ss_pred ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-----CCCeEEEeecCCc
Q 037297 146 PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-----ERYRAKVADFGTS 214 (366)
Q Consensus 146 ~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-----~~~~vkl~Dfg~a 214 (366)
.++++++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999887542 1235889999999999999999999999 99999999999994 4556999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC-
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN- 292 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 292 (366)
....... .......+|..|+|||++.+. .++.++|||||||++|+|++|+.||...... + ............
T Consensus 185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~---~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--D---QLFKIFEVLGLPD 258 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H---HHHHHHHHHCCCC
T ss_pred cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--H---HHHHHHHHhCCCc
Confidence 8664332 223345689999999998774 5899999999999999999999999754311 0 011111111000
Q ss_pred ---------------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 ---------------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.............++...++++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 011111112222233345678899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=319.02 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=195.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch--HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 368999999999999999999976 48999999987654443 334568899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99887543 2346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH------HHHHHHhh----
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA------AFFVHSMR---- 290 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~---- 290 (366)
.......+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.............. ........
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345689999999998775 789999999999999999999999976431110000000 00000000
Q ss_pred --cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 --KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.................+..++.+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00111111111112222345778999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=322.13 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=195.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH----HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE----LLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++........ ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999965 588999999987542211 01223567799999999999999999999999
Q ss_pred CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...+++++++..+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999976544 2336899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .
T Consensus 179 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~- 240 (335)
T 3dls_A 179 YLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA---------------A- 240 (335)
T ss_dssp ECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT---------------C-
T ss_pred ECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh---------------c-
Confidence 765332 2334578999999999988876 78999999999999999999999653210000 0
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
. ..+...+.++.+|+..||+.||++|||+.|+++-
T Consensus 241 ---~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 ---I------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---C------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---c------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0122245678999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=319.03 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=191.0
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc--
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 146 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|+++...... ......+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 478999999999999999999974 68999999998754332 23456789999999999999999999998776654
Q ss_pred --eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 147 --LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 147 --~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++++..+.. ..++++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 78888775432 236899999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCc--eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQT--HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPIP 238 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCCC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCCC
Confidence 43322 222345689999999999999999999999999999999999999965431 01111111111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHH-HHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE-VTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-ll~~L~~~~ 343 (366)
........+.++.+++.+||+.||++||++.+ +...+..+.
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 01112335668999999999999999996555 445555543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.32 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++......++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 368999999999999999999976 6999999999763221 11234578899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 99987543 3446899999999999999999999999 999999999999999999999999999876432
Q ss_pred ceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... ....... ....
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~-~~~~------ 233 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKIC-DGIF------ 233 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHH-TTCC------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHh-cCCc------
Confidence 22344579999999999988765 68999999999999999999999754310 0111111 1110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+..||+.||.+|||++|+++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112234567899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.49 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=191.8
Q ss_pred cCCcccceecccCceEEEEEEEc--CC--cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-Cc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE--DG--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-EV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~ 145 (366)
..|++.+.||+|+||.||+|... ++ ..+|+|.++..... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS---HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 45778899999999999999854 22 36899988764333 3456889999999999999999999987654 46
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 77788876553 2345788999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCce---eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 218 AMDQTH---VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 218 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
...... ......+|..|+|||.+.+..++.++|||||||++|||++ |.+||....... ..... .....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~---~~~~~ 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYL---LQGRR 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHH---HTTCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHH---HcCCC
Confidence 432211 1233457788999999999999999999999999999999 677776543211 11111 11110
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccc
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMI 352 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 352 (366)
...+..++..+.+++..||+.||++|||+.|+++.|+.+..+..+....
T Consensus 315 ----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~ 363 (373)
T 3c1x_A 315 ----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363 (373)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence 0113345567999999999999999999999999999988776655443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.52 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=196.4
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-C
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-E 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~ 144 (366)
..+|++.+.||+|+||+||+|...+ ...+|+|.+...... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH---HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4679999999999999999998542 235899988764443 3456789999999999999999999986554 4
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++++++..++ ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 667777776553 2345789999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCc---eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 217 IAMDQT---HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 217 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... .... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~---~~~~~ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVY---LLQGR 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHH---HHTTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHH---HhcCC
Confidence 543221 12233457788999999999999999999999999999999 555554432111 1100 00110
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
. ...+..++..+.+++..||+.||++|||+.|+++.|+.+.....+
T Consensus 250 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 R----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred C----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 011233456799999999999999999999999999998876554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=320.52 Aligned_cols=262 Identities=18% Similarity=0.219 Sum_probs=192.9
Q ss_pred hcCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHH-------HHHHHHHHHHHHHhcCCCCceeeEee
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEEL-------LKLEEFINEIVILSQINHRNVVKLLG 138 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (366)
.++|++.+.||+|+||.||+|.+. ++..+|+|+.......... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 478999999999999999999975 4778999998865432111 11234678889999999999999999
Q ss_pred EEee----CCcceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC--e
Q 037297 139 CCLE----TEVPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY--R 205 (366)
Q Consensus 139 ~~~~----~~~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~--~ 205 (366)
++.. ....++++++. +. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 9988 66778888876 32 1226899999999999999999999999 99999999999999877 9
Q ss_pred EEEeecCCcccccCCCc------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 037297 206 AKVADFGTSKFIAMDQT------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 279 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 279 (366)
+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~- 270 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV- 270 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH-
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH-
Confidence 99999999976643211 11134568999999999999999999999999999999999999996422111110
Q ss_pred cHHHHHHHHhhcCccccccchHHhhhh-cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQVVKLV-KKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
......... .. .+...... ...++.++.+++..||+.||++|||++++++.|+.+.-
T Consensus 271 ---~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 ---QTAKTNLLD-EL----PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp ---HHHHHHHHH-TT----THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ---HHHHHhhcc-cc----cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 000000000 00 01111100 11455689999999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=315.05 Aligned_cols=269 Identities=20% Similarity=0.304 Sum_probs=205.3
Q ss_pred ccChHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhc--CCCCceeeEe
Q 037297 60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ--INHRNVVKLL 137 (366)
Q Consensus 60 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~ 137 (366)
..+........++|++.+.||+|+||.||+|... ++.||+|++.... ...+.+|.++++. ++||||++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 4555556667789999999999999999999984 8999999987531 2356778888877 7999999999
Q ss_pred eEEeeCC----cceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEE
Q 037297 138 GCCLETE----VPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLH--------SAASSPIYHRDIKSTNIL 199 (366)
Q Consensus 138 ~~~~~~~----~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~iiH~dikp~Nil 199 (366)
+++.... ..++++++...+. ...+++..++.++.|++.||.||| +.+ ++||||||+||+
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 9998876 6778888776542 236889999999999999999999 777 999999999999
Q ss_pred ecCCCeEEEeecCCcccccCCCce---eeeeccccCCccccccccCCC------CCchhhHHHHHHHHHHHHhC------
Q 037297 200 LDERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLEPEYHQSSQ------LTDKSDVYSFGVVLVELLTG------ 264 (366)
Q Consensus 200 l~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g------ 264 (366)
++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876544332 123456899999999987652 34689999999999999999
Q ss_pred ----CCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 265 ----KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 265 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
..||......... . .................. ......++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 260 ~~~~~~p~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPS---V-EEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCCTTTTTSCSSCC---H-HHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccCccccCcCccc---H-HHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 7787654321111 1 111111111111111111 1123467778999999999999999999999999999
Q ss_pred hcccCC
Q 037297 341 GIRGSN 346 (366)
Q Consensus 341 ~~~~~~ 346 (366)
.+..+.
T Consensus 333 ~i~~~~ 338 (342)
T 1b6c_B 333 QLSQQE 338 (342)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 987553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=342.73 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=203.9
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..+....++|++.+.||+|+||.||+|.++++..||+|+++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3344556789999999999999999999988888999999865432 3478999999999999999999999876
Q ss_pred CcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 144 EVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 144 ~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
...++++++...+. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 66778888765431 235889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~ 482 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYR 482 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCC
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 7654322112223446788999999998999999999999999999999 9999975431 011111111111
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
...+..++..+.+|+..||+.||++|||++++++.|+.+..+
T Consensus 483 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 112345667899999999999999999999999999988754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=311.84 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=194.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++......+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3578999999999999999999976 68899999987643332 234567889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..+.. ..++++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9988876532 235899999999999999999999999 999999999999999999999999999766544
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~-~~~~---- 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQ-AIPR---- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHS-CCCC----
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhcc-CCCC----
Confidence 33334455689999999999999999999999999999999999999965321 011111111 1100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHhhcccCC
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRP-TMEEVTMELNGIRGSN 346 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~L~~~~~~~ 346 (366)
....+..++..+.+++.+||+.||++|| |++++++.|+......
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1122344566799999999999999999 9999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.06 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=194.4
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChH-HHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDE-ELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
.+....++|++.+.||+|+||.||+|.+. ++..+|+|++....... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999975 58899999987542110 11234678999999999999999999999999
Q ss_pred CCcceEEEeeccCCCC-----------------------------------------------CCCCHHHHHHHHHHHHH
Q 037297 143 TEVPLLHLHDHHRNEE-----------------------------------------------FPLTWEIRLRIATEVAG 175 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~~-----------------------------------------------~~l~~~~~~~i~~~i~~ 175 (366)
....++++++..++.. ..+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999988754321 12356778899999999
Q ss_pred HHHHHHhCCCCCeEeCCCCCCCEEecCCC--eEEEeecCCcccccCCCc---eeeeeccccCCccccccccC--CCCCch
Q 037297 176 ALSYLHSAASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQT---HVTTKIQGTFGYLEPEYHQS--SQLTDK 248 (366)
Q Consensus 176 ~l~~lH~~~~~~iiH~dikp~Nill~~~~--~vkl~Dfg~a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~ 248 (366)
||.|||+++ ++||||||+||+++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999986543221 12344568999999999865 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCC
Q 037297 249 SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKK 328 (366)
Q Consensus 249 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 328 (366)
+|||||||++|+|++|+.||..... .............. ..+ .....++.+.+++..||+.||.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF--ENP-----NYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT--TSG-----GGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc--CCc-----ccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999975431 11111111111100 000 11234567999999999999999
Q ss_pred CCCHHHHHH
Q 037297 329 RPTMEEVTM 337 (366)
Q Consensus 329 Rpt~~ell~ 337 (366)
|||+.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.31 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=194.0
Q ss_pred HhcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|..+. ++.||+|+++...... ....+.+..|..++..+ +||||+++++++...+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45789999999999999999999764 7889999998643211 12345778899999988 899999999999999999
Q ss_pred eEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++.. ..+++..++.++.|++.||.|||++| |+||||||+|||++.+|.+||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999998876532 36899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .......... ..
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~----- 238 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NV----- 238 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC-----
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CC-----
Confidence 2 2233456799999999999999999999999999999999999999975431 1111111111 10
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
.++...+.++.+++..||+.||.+||++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1233456689999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=320.63 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=193.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 368999999999999999999974 68999999987654332 12346778999999999999999999988743
Q ss_pred ----cceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 145 ----VPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 145 ----~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
..++++++..+ .....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 46777777653 23346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC---ceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 214 SKFIAMDQ---THVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 214 a~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence 98664322 222344568999999998876 4689999999999999999999999976431 11100110000000
Q ss_pred hcCccccccc--------------hHHhhh-hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILD--------------DQVVKL-VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~--------------~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+..... ...... .....++.+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0110110000 000000 01112457899999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=310.74 Aligned_cols=242 Identities=29% Similarity=0.361 Sum_probs=192.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. ++..+|+|++....... ......+.+|+.+++.++||||+++++++......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 467999999999999999999976 47789999987633221 1234578899999999999999999999999998899
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++...+. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 988775432 236889999999999999999999999 99999999999999999999999998854432
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .....
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~-------- 223 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKR-ISRVE-------- 223 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH-HHHTC--------
T ss_pred -ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHH-HHhCC--------
Confidence 223345689999999999999999999999999999999999999975331 001111 11100
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++..||+.||.+|||++|+++
T Consensus 224 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1123335567899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=316.39 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=187.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh--HHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 478999999999999999999975 58899999998654332 34567889999999999999999999987765
Q ss_pred --cceEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 --VPLLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 --~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++..+.- ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 5677777765421 125789999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc--------------HHHH
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS--------------LAAF 284 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~--------------~~~~ 284 (366)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus 179 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred cc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 22 2233457899999999999999999999999999999999999999764311000000 0000
Q ss_pred HHHHhhc-Ccccc-----ccchH---HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRK-NHMYD-----ILDDQ---VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~-~~~~~-----~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... ..... ..... .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000 00000 00000 001122345778999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.62 Aligned_cols=243 Identities=22% Similarity=0.299 Sum_probs=171.3
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeCCcceEEEeec
Q 037297 76 NRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
.+.||+|+||.||+|.++ +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++++++.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 378999999999999975 5899999999753 2245678999999996 999999999999999999999987
Q ss_pred cCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eEEEeecCCcccccCCCce
Q 037297 154 HRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 154 ~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~vkl~Dfg~a~~~~~~~~~ 223 (366)
.++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++....... .
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~ 164 (325)
T 3kn6_A 89 NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q 164 (325)
T ss_dssp CSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence 6542 346899999999999999999999999 99999999999998765 89999999997654332 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... .......... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-~~~~i~~~~~-~~~----- 236 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVE-IMKKIKKGDF-SFE----- 236 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHH-HHHHHTTTCC-CCC-----
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHH-HHHHHHcCCC-CCC-----
Confidence 234456899999999999999999999999999999999999999764421111 11111 1111111111 000
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.......++++.+|+..||+.||.+|||++|+++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0112345678999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.60 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=190.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 478999999999999999999975 68999999987644332 345678999999999999999999999877643
Q ss_pred ---ceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 ---PLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ---~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++.... ....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 47777765221 1236889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc---
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH--- 293 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (366)
... .....+|..|+|||++.+ ..++.++||||+||++|+|++|+.||.+..... . ............
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~---l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--Q---LKEIMKVTGTPPAEF 249 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHHHCCCCHHH
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHHhcCCCCHHH
Confidence 422 234578999999998877 679999999999999999999999997643110 0 000000000000
Q ss_pred ---------------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcc
Q 037297 294 ---------------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIR 343 (366)
Q Consensus 294 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~ 343 (366)
.+.... ..........++.+.+|+.+||+.||.+|||++|+++ .++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhHHHHHHHHhCCCCCC-CCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000000 0011122345678999999999999999999999987 344443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=316.30 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=182.0
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++......
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 34577999999999999999999976 47899999998643 234678899999999999999999999999999
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeecCCccc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Dfg~a~~ 216 (366)
++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999887653 2345899999999999999999999999 999999999999975 88999999999976
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....... .... .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~-~~~~-~ 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRIL-NCEY-Y 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHH-TTCC-C
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHH-hCCC-c
Confidence 5432 22334568999999999999999999999999999999999999997543210 0111111 1111 0
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 270 ~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 112234567899999999999999999999976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.74 Aligned_cols=203 Identities=29% Similarity=0.269 Sum_probs=171.5
Q ss_pred ccccChHHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-----CC
Q 037297 58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-----HR 131 (366)
Q Consensus 58 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ 131 (366)
...++..+.....++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+..|+.+++.+. ||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-----KYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-----HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-----hhhhhhHHHHHHHHHhcccCCCCC
Confidence 344556666666789999999999999999999975 58899999987421 23346677999999886 99
Q ss_pred ceeeEeeEEeeCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE- 202 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~- 202 (366)
||+++++++...+..++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred CeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 9999999999999999998876321 2235899999999999999999999999 999999999999975
Q ss_pred ------------------------CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHH
Q 037297 203 ------------------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVL 258 (366)
Q Consensus 203 ------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l 258 (366)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999764332 2345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 037297 259 VELLTGKKPIFSTG 272 (366)
Q Consensus 259 ~el~~g~~p~~~~~ 272 (366)
|+|++|+.||....
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=317.40 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=202.9
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVK 135 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (366)
..++....++|++.+.||+|+||.||+|.+ .+++.||+|+++..... ...+.+.+|+.+++.+ +||||++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc---HHHHHHHHHHHHHHhcccCCCeee
Confidence 344455668999999999999999999984 24678999999875443 3445788999999999 7999999
Q ss_pred EeeEEeeCCc-ceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 037297 136 LLGCCLETEV-PLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHR 191 (366)
Q Consensus 136 ~~~~~~~~~~-~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~ 191 (366)
+++++...+. .++++++..+.. ...+++..++.++.|++.||.|||+++ ++||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 9999887654 677777654321 112789999999999999999999999 9999
Q ss_pred CCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037297 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 269 (366)
Q Consensus 192 dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 269 (366)
||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986644332 22334567889999999999999999999999999999998 999996
Q ss_pred CCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 270 STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....... .......... ...+...++.+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 253 ~~~~~~~--------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 253 GVKIDEE--------FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TCCCSHH--------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhHH--------HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5432110 0111111110 01123345679999999999999999999999999998764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=311.91 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=191.4
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-cce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 147 (366)
..++|++.+.||+|+||.||++... |+.||+|+++... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 3578999999999999999999875 8899999997643 2357889999999999999999999876554 677
Q ss_pred EEEeeccCCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRNEEF---------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++..+.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 777776553211 2788889999999999999999999 9999999999999999999999999987543
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... ......
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~----~~~~~~---- 231 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP----RVEKGY---- 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHH----HHTTTC----
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH----HHhcCC----
Confidence 22 122357888999999998999999999999999999998 99999754311 0100 011110
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
....+..+++.+.+++..||+.||++|||+.|+++.|+.++...
T Consensus 232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 -----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 11123445678999999999999999999999999999987544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=317.29 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=196.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcE--EEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRI--MAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~--vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
++|++.+.||+|+||.||+|.+. ++.. +|+|.++..... ...+.+.+|+.+++.+ +||||+++++++......
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 67999999999999999999965 4554 499988754322 3345788999999999 999999999999999999
Q ss_pred eEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 147 LLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 147 ~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
++++++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence 99998875431 236899999999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHH
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 282 (366)
+.+||+|||++..... ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||..... .
T Consensus 179 ~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~ 248 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A 248 (327)
T ss_dssp GCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred CeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------H
Confidence 9999999999864321 111223456888999999988889999999999999999998 9999975431 1
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
. ......... ....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 249 ~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 E-LYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H-HHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H-HHHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 111111110 011233455689999999999999999999999999998775543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.93 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=197.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH--HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++.+.||+|+||.||+|.+. +|+.+|+|++......... ...+.+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999976 5899999999865433210 1245788999999999999999999999999999
Q ss_pred eEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCcc
Q 037297 147 LLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~ 215 (366)
++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999887553 2346889999999999999999999999 99999999999999887 79999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... ......
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~-i~~~~~- 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN-ITSVSY- 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HHTTCC-
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH-HHhccc-
Confidence 664322 22345689999999999999999999999999999999999999965431 011111 111100
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..++. .....+..+.+++..||+.||++|||+.|+++
T Consensus 236 -~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -ccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01111 12234567899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=319.36 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=193.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc---HHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 468999999999999999999975 5888999999754333 34467889999999999999999999987653
Q ss_pred -cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 145 -VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 145 -~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
..++++++..+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 103 KDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 456666665431 1235899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCce--eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc--
Q 037297 219 MDQTH--VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH-- 293 (366)
Q Consensus 219 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (366)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-----LNHILGILGSPSQE 254 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-----HHHHHHHHCSCCHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-----HHHHHHHhCCCCHH
Confidence 32221 1234578999999997654 5589999999999999999999999976442111 111111110000
Q ss_pred -cccccc--------------hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 -MYDILD--------------DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 -~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+....+ ........+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00011122345668999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=322.90 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=204.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC--cc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 146 (366)
.++|++.+.||+|+||+||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 467999999999999999999976 4899999999764332 23456789999999999999999999988766 56
Q ss_pred eEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCeEEEeecC
Q 037297 147 LLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYRAKVADFG 212 (366)
Q Consensus 147 ~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill----~~~~~vkl~Dfg 212 (366)
++++++..++ ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7788776542 1223899999999999999999999999 9999999999999 778889999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQS--------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
++...... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 162 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~ 238 (396)
T 4eut_A 162 AARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYK 238 (396)
T ss_dssp GCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHH
T ss_pred CceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHH
Confidence 99865432 22334568999999998865 567789999999999999999999997644322111 11111
Q ss_pred HHHHhhcCccccc----------c-chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 285 FVHSMRKNHMYDI----------L-DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 285 ~~~~~~~~~~~~~----------~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.....+...+... . +......++...+..+.+++..||+.||++|||++|+++.++.+....
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1111111000000 0 001122355788889999999999999999999999999998876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.07 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=200.0
Q ss_pred cCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee--C
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--T 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 143 (366)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP----DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH----HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 6799999999999999999984 3588999999976432 334678999999999999999999998874 4
Q ss_pred CcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 144 EVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 144 ~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++++++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 45777888775542 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc------ccccHHHHHHH
Q 037297 216 FIAMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ------ENVSLAAFFVH 287 (366)
Q Consensus 216 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 287 (366)
........ ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76543322 22334578889999999998999999999999999999999999865321000 00000000111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCccc
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKM 351 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 351 (366)
.... ......+..+++.+.+++..||+.||.+|||+.|+++.|+.+.....+...
T Consensus 256 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 256 LLEE---------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred Hhhc---------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 1111 111123445667899999999999999999999999999999876655543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.33 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=188.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 478999999999999999999975 5899999999764211 11234567889999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++. ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++......
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999887653 2368899999999999999999998 88 999999999999999999999999999754322
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ...
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~------ 366 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM-EEI------ 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCC------
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh-CCC------
Confidence 2233456799999999999999999999999999999999999999975431 111111111 110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..+...++++.+|+..||+.||.+|| |++|+++
T Consensus 367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12334556799999999999999999 9999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=305.89 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=196.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 467999999999999999999976 6899999999765433 234578899999999999999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 98876542 2336889999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-eeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 222 T-HVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 222 ~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .......||..|+|||.+.+..+ +.++||||||+++|+|++|+.||......... .......... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~---~- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY---L- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTT---S-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccc---c-
Confidence 1 22334568999999999987765 77999999999999999999999764421111 0001111100 0
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......+..+.+++..||+.||++|||++|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011234567899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.74 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=191.6
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE- 144 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 144 (366)
+...++|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence 345678999999999999999999964 6899999998764322 236999999999999999999985432
Q ss_pred -------------------------------------cceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHH
Q 037297 145 -------------------------------------VPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGAL 177 (366)
Q Consensus 145 -------------------------------------~~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l 177 (366)
..++++++..+. ....+++..+..++.|++.||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 366777766532 235789999999999999999
Q ss_pred HHHHhCCCCCeEeCCCCCCCEEec-CCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHH
Q 037297 178 SYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFG 255 (366)
Q Consensus 178 ~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG 255 (366)
.|||++| |+||||||+|||++ .++.+||+|||++....... ......+|..|+|||++.+. .++.++||||+|
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999999 99999999999997 68899999999998664332 23345689999999988775 489999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh---------------cCccccccchHHhhhhcHHHHHHHHHHHHH
Q 037297 256 VVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR---------------KNHMYDILDDQVVKLVKKNQIMAFANLAER 320 (366)
Q Consensus 256 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 320 (366)
|++|+|++|+.||........ ......... ...++...........+...+.++.+|+.+
T Consensus 230 ~il~ell~g~~pf~~~~~~~~-----~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQ-----LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 999999999999976431110 000100000 011122222223334555677789999999
Q ss_pred hhcCCCCCCCCHHHHHH
Q 037297 321 CLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 321 cl~~dp~~Rpt~~ell~ 337 (366)
||+.||.+|||+.|+++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999973
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=310.35 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=193.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...+|++.+.||+|+||.||+|... +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++......+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4468999999999999999999964 68999999998633221 234567889999999999999999999999999999
Q ss_pred EEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 148 LHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 148 ~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
+++++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9998876532 345889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
..... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ............
T Consensus 186 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEQCDYPP 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHH-HHHHHHTTCSCC
T ss_pred ecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHH-HHHHhhcccCCC
Confidence 54322 2223356899999999999999999999999999999999999999753311 001 111111111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ....++.++.+++..||+.||++|||+.++++.|+.+...
T Consensus 258 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 L--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1123456799999999999999999999999999988754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.17 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=193.4
Q ss_pred CCcccc-eecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 72 HFNVNR-ILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 72 ~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
++.+.+ .||+|+||.||+|.++ ++..||+|+++..... ...+.+.+|+.+++.++||||++++++|.. +..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS---TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344444 7999999999999864 4567999999865433 234678999999999999999999999876 5578
Q ss_pred EEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 888876554 2346899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceee--eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 220 DQTHVT--TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 220 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... . . .......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~---~-~~i~~~~--- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----V---M-AFIEQGK--- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----H---H-HHHHTTC---
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----H---H-HHHHcCC---
Confidence 322211 22335688999999999999999999999999999998 999997644210 0 1 1111111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
....+..+++++.+++..||+.||++|||+.++++.|+.+..
T Consensus 557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112344567789999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=323.77 Aligned_cols=257 Identities=22% Similarity=0.282 Sum_probs=194.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV---- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 145 (366)
..+|++.+.||+|+||.||+|.+..+..+|+|++...... ..+|+.+++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4679999999999999999999877777999988654322 2369999999999999999999865443
Q ss_pred --ceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEEeecC
Q 037297 146 --PLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFG 212 (366)
Q Consensus 146 --~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl~Dfg 212 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 66777776442 2457899999999999999999999999 99999999999999 79999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh-
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR- 290 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (366)
++....... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+...... .........
T Consensus 188 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-----l~~i~~~~g~ 260 (394)
T 4e7w_A 188 SAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-----LVEIIKVLGT 260 (394)
T ss_dssp TCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCC
T ss_pred CcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCC
Confidence 998664332 23345689999999988765 589999999999999999999999976431110 000000000
Q ss_pred --------------cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hhhccc
Q 037297 291 --------------KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIRG 344 (366)
Q Consensus 291 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~~ 344 (366)
................+...++++.+|+.+||+.||.+|||+.|+++- ++.++.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011111111122223344466789999999999999999999999863 444443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.26 Aligned_cols=262 Identities=23% Similarity=0.234 Sum_probs=190.8
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH-HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL-LKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
...++|++.+.||+|+||.||+|.+. +|+.||+|++......... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 5899999999764332211 112467899999999999999999999999999
Q ss_pred ceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 99998876542 2345888899999999999999999999 9999999999999999999999999998664
Q ss_pred CCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Ccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NHM 294 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 294 (366)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... .+ ........... ..+
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~---~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LD---QLTRIFETLGTPTEEQW 237 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHHHCCCCTTTS
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HH---HHHHHHHHcCCCChhhh
Confidence 332 223345689999999988664 589999999999999999999999865431 10 01111111110 011
Q ss_pred cccc-----------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 295 YDIL-----------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 295 ~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.+.. ............+.++.+|+..||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1000 0000111223456789999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=304.84 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=188.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|... ++..+|+|++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 367999999999999999999975 5889999999875433 234578899999999999999999999999999999
Q ss_pred EEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCc
Q 037297 149 HLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTS 214 (366)
Q Consensus 149 ~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a 214 (366)
++++..++. ...+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 998876542 246899999999999999999999999 9999999999999 45688999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...... .......+|+.|+|||.+. ..++.++||||||+++|+|++|+.||..... .............
T Consensus 175 ~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~ 243 (285)
T 3is5_A 175 ELFKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPN 243 (285)
T ss_dssp CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC
T ss_pred eecCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCcc
Confidence 765432 2233456899999999875 5689999999999999999999999975431 0011111111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .....++.+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAV--------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc--------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00113457889999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.81 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=178.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 478999999999999999999965 58999999997644332 3456788999999999999999999998654
Q ss_pred -CcceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 144 -EVPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 144 -~~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...+++++..... ....+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 3456666554221 1236899999999999999999999999 999999999999999999999999999764
Q ss_pred cCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc---
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH--- 293 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (366)
... .....+|..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... . ...........+.
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~---~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--D---QLKLILRLVGTPGAEL 253 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHHHHHHCSCCHHH
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHHHhCCCCHHH
Confidence 322 334578999999999877 67899999999999999999999999764311 1 0011111000000
Q ss_pred cccccch--------------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDD--------------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+..+... ..........++.+.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 0001111234567899999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.78 Aligned_cols=245 Identities=28% Similarity=0.427 Sum_probs=188.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|... ++.||+|.+.... ..+.+.+|+.+++.++||||+++++++. +..+++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT------HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh------HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence 367999999999999999999875 7889999986431 2357889999999999999999999876 346788
Q ss_pred EeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEeCCCCCCCEEecCCCe-EEEeecCCcc
Q 037297 150 LHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHS---AASSPIYHRDIKSTNILLDERYR-AKVADFGTSK 215 (366)
Q Consensus 150 ~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~---~~~~~iiH~dikp~Nill~~~~~-vkl~Dfg~a~ 215 (366)
+++..+.. ...++...++.++.|++.||.|||+ ++ ++||||||+||+++.++. +||+|||++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccc
Confidence 88775532 1146788999999999999999999 66 999999999999998876 7999999997
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... .....||..|+|||++.+..++.++||||||+++|+|++|+.||........ ...... ......
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~~~~~ 223 (307)
T 2eva_A 155 DIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAV-HNGTRP 223 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHH-HTTCCC
T ss_pred ccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHH-hcCCCC
Confidence 54322 2234589999999999999999999999999999999999999975432110 001001 111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
..+..++..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 224 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 224 ---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 122344567899999999999999999999999999887543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.45 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=182.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|+++...... ...+.+.++...++.++||||+++++++......++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH--HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 478999999999999999999974 68999999998654443 223345555566888899999999999999999999
Q ss_pred EEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 149 HLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 149 ~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
++++..+. ....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99887542 234789999999999999999999998 8 999999999999999999999999999765
Q ss_pred cCCCceeeeeccccCCccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
.... ......||+.|+|||.+ .+..++.++||||+||++|+|++|+.||...... ...........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~- 230 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEEP- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHSC-
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhccC-
Confidence 4322 22334689999999986 5667899999999999999999999999653311 11111111111
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... .+...+.++.+++..||+.||++|||+.|+++
T Consensus 231 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1110 11234567999999999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.14 Aligned_cols=242 Identities=26% Similarity=0.310 Sum_probs=187.4
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHH-HhcCCCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|..+ +++.+|+|+++....... .....+..|..+ ++.++||||+++++++...+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3478999999999999999999976 488999999987543322 233456677776 4678999999999999999999
Q ss_pred eEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 147 LLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 147 ~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++++..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999998876532 35889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ........... .
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~-~----- 256 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-L----- 256 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSC-C-----
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcc-c-----
Confidence 2 2234456799999999999999999999999999999999999999975431 11111111111 0
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
.++...+..+.+++..||+.||.+||++.+
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 122335567899999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=306.63 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=175.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 367999999999999999999974 68999999997532211 1224678899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++.... ...++++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 98887542 2356899999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
.. ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ......
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~---- 228 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------------KVVLAD---- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCSSC----
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------------HHhhcc----
Confidence 22 2233568999999999999899999999999999999999999997643211100 000000
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+.++.+++.+||+.||++|||++++++
T Consensus 229 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 ---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0123334567899999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=311.47 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=193.3
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C-------cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-G-------RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
.++|++.+.||+|+||.||+|.+.. + ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG----GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4679999999999999999998653 3 4699999875432 23467899999999999999999999999
Q ss_pred eCCcceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe--------
Q 037297 142 ETEVPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR-------- 205 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~-------- 205 (366)
..+..++++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 9999999999886542 223889999999999999999999999 999999999999998877
Q ss_pred EEEeecCCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 206 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
+||+|||++..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..|+..... ....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------hHHH
Confidence 99999999865422 123457889999999887 6799999999999999999996555443221 0001
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
......... .+...+.++.+++..||+.||++|||+.|+++.|+.+..+..
T Consensus 228 ~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 228 LQFYEDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHHHTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HHHhhccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111111111 112224468899999999999999999999999999886544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=327.66 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=194.7
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||+||+|.+. +++.||+|++....... .....+.+|+.+++.++||||+++++++......+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3467999999999999999999976 68999999987532111 22457889999999999999999999999999999
Q ss_pred EEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~---~~~~vkl~Dfg~a~~~ 217 (366)
++++++.++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99998766532 36899999999999999999999999 99999999999995 5568999999999765
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..... .........
T Consensus 175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~-~i~~~~~~~- 241 (486)
T 3mwu_A 175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILK-RVETGKYAF- 241 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHTCCCS-
T ss_pred CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCCCC-
Confidence 432 22344579999999999876 589999999999999999999999976431 11111 111111100
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
.. ......++++.+|+..||+.||.+|||+.|+++-
T Consensus 242 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CS-----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC-----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0122345678999999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=303.00 Aligned_cols=244 Identities=21% Similarity=0.284 Sum_probs=194.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. ++..+|+|++...... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3567999999999999999999976 4778999998865433 2457889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~~ 217 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999876543 235889999999999999999999999 9999999999999 78899999999999766
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.... ......+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... ..... ........ .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~~-~ 226 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVML-KIREGTFT-F 226 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCCCC-C
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHhCCCC-C
Confidence 4332 23345689999999988764 89999999999999999999999975431 01111 11111100 0
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .....++.+.+++..||+.||.+|||+.|+++
T Consensus 227 -~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 -PEK----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -Cch----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01134568999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.84 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=175.1
Q ss_pred cCCcc-cceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee--CC
Q 037297 71 NHFNV-NRILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TE 144 (366)
Q Consensus 71 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 144 (366)
+.|++ +++||+|+||+||+|..+ +++.||+|++...... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 45666 458999999999999965 4788999999764433 357789999999999999999999965 55
Q ss_pred cceEEEeeccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCe
Q 037297 145 VPLLHLHDHHRN---------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL----DERYR 205 (366)
Q Consensus 145 ~~~~~~~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill----~~~~~ 205 (366)
..++++++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 677777765431 1224899999999999999999999999 9999999999999 67789
Q ss_pred EEEeecCCcccccCCCc--eeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc----
Q 037297 206 AKVADFGTSKFIAMDQT--HVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN---- 278 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~---- 278 (366)
+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999987643221 223446789999999998874 58999999999999999999999997654211110
Q ss_pred ccHHHHHHHHhhcCc---cccccc------------h---------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 037297 279 VSLAAFFVHSMRKNH---MYDILD------------D---------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334 (366)
Q Consensus 279 ~~~~~~~~~~~~~~~---~~~~~~------------~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 334 (366)
.............+. +..+.. . ..........+..+.+|+..||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 001111111111110 000000 0 0000000111457889999999999999999999
Q ss_pred HHH
Q 037297 335 VTM 337 (366)
Q Consensus 335 ll~ 337 (366)
+++
T Consensus 331 ~L~ 333 (405)
T 3rgf_A 331 AMQ 333 (405)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=319.44 Aligned_cols=269 Identities=22% Similarity=0.351 Sum_probs=192.1
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHH--HhcCCCCceeeEeeEEeeC---
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI--LSQINHRNVVKLLGCCLET--- 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~--- 143 (366)
..++|++.+.||+|+||.||+|.. +++.||+|++..... ..+..|.++ +..++||||+++++.+...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-------QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 347899999999999999999977 589999999975322 233344444 4457999999999865432
Q ss_pred --CcceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeCCCCCCCEEecCCCeE
Q 037297 144 --EVPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSA---------ASSPIYHRDIKSTNILLDERYRA 206 (366)
Q Consensus 144 --~~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~---------~~~~iiH~dikp~Nill~~~~~v 206 (366)
...++++++..++. ....++..+..++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 24467777765542 22468889999999999999999998 7 9999999999999999999
Q ss_pred EEeecCCcccccCCC-------ceeeeeccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 207 KVADFGTSKFIAMDQ-------THVTTKIQGTFGYLEPEYHQS-------SQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
||+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764322 112234569999999999877 456679999999999999999988876544
Q ss_pred CCCcccccHHH---------HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 273 NTSQENVSLAA---------FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 273 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
........... ..............+... ......+++.+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 32222111110 000001111000000000 0112346778999999999999999999999999999988
Q ss_pred cCCCCcc
Q 037297 344 GSNFGHK 350 (366)
Q Consensus 344 ~~~~~~~ 350 (366)
.....-+
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 6655433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=317.37 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=193.5
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChH-------HHHHHHHHHHHHHHHhcCCCCceee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDE-------ELLKLEEFINEIVILSQINHRNVVK 135 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~ 135 (366)
..++....++|++.+.||+|+||.||+|.+.+|+.||+|++....... .....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 445667779999999999999999999998889999999986543321 1223468899999999999999999
Q ss_pred EeeEEeeCC-----cceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 136 LLGCCLETE-----VPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 136 ~~~~~~~~~-----~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
+++++...+ ..++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADN 170 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCC
Confidence 999986533 457777765532 3346899999999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
+.+||+|||++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..
T Consensus 171 ~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~ 243 (362)
T 3pg1_A 171 NDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-----QL 243 (362)
T ss_dssp CCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HH
T ss_pred CCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 99999999999754322 22334568999999998877 678999999999999999999999997643110 01
Q ss_pred HHHHHHhhcCcc------------------ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 283 AFFVHSMRKNHM------------------YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 283 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
............ .............+..++.+.+|+..||+.||.+|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111100000000 0000011112233345677999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=310.12 Aligned_cols=244 Identities=28% Similarity=0.399 Sum_probs=198.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
...|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 356999999999999999999965 5889999999865433 234678899999999999999999999999999999
Q ss_pred EEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 149 HLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 149 ~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++..+. ...++++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 98887553 2346899999999999999999999999 9999999999999999999999999997664332
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... .......
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~-------- 236 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLF-LIPKNNP-------- 236 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHH-HHHHSCC--------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHH-HhhcCCC--------
Confidence 222345689999999999999999999999999999999999999965331 00011 1111111
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
...+..++..+.+++..||+.||.+|||+.|+++.
T Consensus 237 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01223345678999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.61 Aligned_cols=247 Identities=21% Similarity=0.248 Sum_probs=192.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe--eCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL--ETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 146 (366)
.++|++.+.||+|+||.||+|.+. +++.+|+|++............+.+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 588999999976432221234567899999999999999999999984 34567
Q ss_pred eEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++...+ ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 7888776532 2446899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCC-ceeeeeccccCCccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 219 MDQ-THVTTKIQGTFGYLEPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 219 ~~~-~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
... ........||..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~i~~~~~- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFE-NIGKGSY- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH-HHHHCCC-
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHH-HHhcCCC-
Confidence 322 22334456899999999987654 37799999999999999999999975331 11111 1111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1233455678999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=312.10 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=196.2
Q ss_pred HhcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee----C
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----T 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~ 143 (366)
..++|++.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ----QDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH----HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 457899999999999999999997 4689999999876322 345678899999999999999999999873 2
Q ss_pred CcceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 144 EVPLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 144 ~~~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
...++++++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 3566777776553 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce--------eeeeccccCCccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH
Q 037297 213 TSKFIAMDQTH--------VTTKIQGTFGYLEPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 213 ~a~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 281 (366)
++......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~ 256 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SV 256 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hh
Confidence 98654311100 011234689999999987654 68899999999999999999999953210000 00
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
.... ... .....+...+..+.+++..||+.||.+|||+.++++.|+.+.....+
T Consensus 257 ~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 257 ALAV----QNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHH----HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hHHh----hcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0000 000 00011233456799999999999999999999999999998865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=329.93 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=198.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ +|+.||+|++....... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 467999999999999999999975 68999999997632211 1234568899999999999999999999999999999
Q ss_pred EEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999876542 234899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.. .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||........ ............
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~~------- 405 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVP------- 405 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHCC-------
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhccc-------
Confidence 32 23445799999999999999999999999999999999999999976432111 111111111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
...+...+.++.+|+..||+.||.+|| +++|+++
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 012334566899999999999999999 6777753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.94 Aligned_cols=238 Identities=23% Similarity=0.265 Sum_probs=186.8
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeecc
Q 037297 76 NRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++++++..
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 578999999999999975 589999999986432 234678899999999999999999999999999999999876
Q ss_pred CCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe--cCCCeEEEeecCCcccccCCCcee
Q 037297 155 RNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAMDQTHV 224 (366)
Q Consensus 155 ~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill--~~~~~vkl~Dfg~a~~~~~~~~~~ 224 (366)
+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 542 235889999999999999999999999 9999999999999 567899999999998764332 2
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (366)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... .+ ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~-~~-~~~~----- 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILAC-RW-DLED----- 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-CC-CSCS-----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-cC-CCCh-----
Confidence 2334689999999999999999999999999999999999999975431 1111111111 10 0000
Q ss_pred hhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 305 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......++++.+|+..||+.||.+|||+.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111234568999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=319.43 Aligned_cols=256 Identities=23% Similarity=0.244 Sum_probs=193.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--------CCceeeEeeEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--------HRNVVKLLGCC 140 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~ 140 (366)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|+.+++.++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 578999999999999999999965 58899999997531 23457888999998885 78899999998
Q ss_pred e----eCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCC---
Q 037297 141 L----ETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERY--- 204 (366)
Q Consensus 141 ~----~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~--- 204 (366)
. .....++++++.... ....+++..++.++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 7 444677777766332 224689999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------------eEEEeecCCcccccCCCceeeeeccccCCccccc
Q 037297 205 ----------------------------------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238 (366)
Q Consensus 205 ----------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE 238 (366)
.+||+|||++...... .....||..|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999765432 23346899999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc-cHHHHHHHHhhcCc-------------------ccccc
Q 037297 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-SLAAFFVHSMRKNH-------------------MYDIL 298 (366)
Q Consensus 239 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-------------------~~~~~ 298 (366)
++.+..++.++|||||||++|+|++|+.||........... .............. .....
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999976543221110 01111111110000 00000
Q ss_pred c-------hHH--hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 D-------DQV--VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~-------~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+ ..+ ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 000 11235677889999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=315.99 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=191.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc--
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 146 (366)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch--hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 478999999999999999999975 58999999998654433 3456788999999999999999999999877654
Q ss_pred ----eEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 ----LLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ----~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 7777765431 1235899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--ccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--HMY 295 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 295 (366)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ............ ...
T Consensus 196 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 196 A----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVPGTEFV 266 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCHHHH
T ss_pred c----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCcHHHH
Confidence 2 2334578999999999877 688999999999999999999999997643110 000000000000 000
Q ss_pred cccch---------------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDD---------------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ..........++.+.+|+..||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 0001122345678999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.52 Aligned_cols=249 Identities=29% Similarity=0.342 Sum_probs=194.0
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH---------HHHHHHHHHHHHHHhcCCCCceeeEe
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE---------LLKLEEFINEIVILSQINHRNVVKLL 137 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~~~ 137 (366)
...++|++++.||+|+||+||+|.++ +++.+|+|++........ ....+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999999976 588999999986543211 01245788999999999999999999
Q ss_pred eEEeeCCcceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eEE
Q 037297 138 GCCLETEVPLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RAK 207 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~vk 207 (366)
+++......+++++++.++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999998876532 46899999999999999999999999 99999999999998776 699
Q ss_pred EeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 208 VADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
|+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||..... .. ...
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~ 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QD-IIK 257 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHH
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHH
Confidence 9999999876433 2234457999999999886 4689999999999999999999999976431 01 111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ .... .....++++.+|+..||+.||.+|||++|+++
T Consensus 258 ~i~~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYY--FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCC--CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111110 0000 11234567999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=323.14 Aligned_cols=251 Identities=27% Similarity=0.303 Sum_probs=195.2
Q ss_pred hcCCcccceecccCceEEEEEEE----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||.||+|.. .+++.||+|+++...........+.+.+|+.+++.+ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 368999999987543211111223566799999999 7999999999999999
Q ss_pred cceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 VPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 ~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999876542 236889999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSE--- 282 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhccC---
Confidence 4433333445679999999999886 3578999999999999999999999976442211 111111111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTME 338 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~~ 338 (366)
...+...+..+.+|+.+||+.||.+|| |++|+++-
T Consensus 283 --------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 012334556789999999999999999 88888754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.65 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=198.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.+|+|++........ ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH-HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 468999999999999999999976 488899999876543221 345678899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999876542 236889999999999999999999999 9999999999999999999999999998664322
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......+|..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....... .....
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~------- 232 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKNEY------- 232 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HTTCC-------
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hhccC-------
Confidence 223345689999999999998999999999999999999999999965431 0111111 11110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 122334567899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=317.73 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH---HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 367999999999999999999976 6899999999876443 345678999999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..+.. ...+++..+..++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++.....
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999876543 23688999999999999999999996 8 99999999999999999999999999875532
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHH-----------------
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA----------------- 283 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~----------------- 283 (366)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1223456899999999999999999999999999999999999999764311100000000
Q ss_pred ----HHHHHhhcCccccccchHHh----hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 284 ----FFVHSMRKNHMYDILDDQVV----KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 284 ----~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...............+.... ...+...+.++.+|+..||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000000000 0011224567999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=310.25 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred hcCCcccceecccCceEEEEEEE-----cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
..+|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS----HHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 46799999999999999999984 3588999999986433 24467899999999999999999999987654
Q ss_pred --cceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 145 --VPLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 145 --~~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
..++++++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 6677777765432 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee--eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-------CcccccHHHHH
Q 037297 215 KFIAMDQTHV--TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT-------SQENVSLAAFF 285 (366)
Q Consensus 215 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~ 285 (366)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765433221 22344677899999998888999999999999999999999998642100 00000000000
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
........ ....+..++.++.+++..||+.||++|||+.|+++.|+.+++
T Consensus 273 ~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111100 111234566789999999999999999999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=306.49 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=197.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH--HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++.+.||+|+||.||+|.+. +++.+|+|+++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 5899999998865433211 1245788999999999999999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCcc
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~ 215 (366)
++++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .++|+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99998875542 236899999999999999999999999 99999999999998877 89999999997
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..... .......
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~~~- 228 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLT-NISAVNY- 228 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHTTCC-
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHH-HhHhccc-
Confidence 654322 23345689999999999999999999999999999999999999975431 00111 1111100
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~ 343 (366)
.... ......+..+.+++.+||+.||++|||+.|+++ .++.++
T Consensus 229 -~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 -DFDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -CCCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -CCcc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0011 112234567899999999999999999999986 445544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.43 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=180.1
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLET 143 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 143 (366)
+.....+|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE----EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH----HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch----HHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3344568999999999999999999975 689999999865422 34457889999999995 99999999998532
Q ss_pred --------CcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeE
Q 037297 144 --------EVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206 (366)
Q Consensus 144 --------~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~v 206 (366)
...++++++..+. ...++++..++.++.|++.||.|||+++ ++++||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence 2355666655431 2346899999999999999999999875 459999999999999999999
Q ss_pred EEeecCCcccccCCCcee-----------eeeccccCCccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 207 KVADFGTSKFIAMDQTHV-----------TTKIQGTFGYLEPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~~~-----------~~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
||+|||++.......... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765432211 1134589999999988 56778999999999999999999999996532
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
.... . . ... ....+...+..+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 258 ~~~~--------~----~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 258 KLRI--------V----N-GKY--------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------C--------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh--------h----c-Ccc--------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1100 0 0 000 000111223357899999999999999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.04 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=191.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEee--CCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLE--TEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~ 145 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 367999999999999999999864 68999999987532 246789999999996 9999999999987 556
Q ss_pred ceEEEeeccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCCcccccCC
Q 037297 146 PLLHLHDHHRNEE----FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMD 220 (366)
Q Consensus 146 ~~~~~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~a~~~~~~ 220 (366)
.++++++...... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||++......
T Consensus 108 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 7778887665432 24789999999999999999999999 99999999999999776 8999999999865433
Q ss_pred CceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH-----HHHhhcCc-
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF-----VHSMRKNH- 293 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~- 293 (366)
. ......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||................. ........
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 2334568899999999877 6789999999999999999999999965432111100000000 00000000
Q ss_pred -c------------ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 -M------------YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 -~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ............+...++++.+|+..||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000001112235678999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=328.58 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=195.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++.+.||+|+||.||+|..+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++......+++
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 68999999999999999999976 58999999997643221 12345788999999999999999999999999999999
Q ss_pred EeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 150 LHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 150 ~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99876542 235899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||........ ............
T Consensus 341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~~------ 409 (543)
T 3c4z_A 341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQA------ 409 (543)
T ss_dssp TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHCC------
T ss_pred CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhcc------
Confidence 332 223345799999999999999999999999999999999999999976532111 111111111111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
...+...+..+.+++..||+.||.+||++
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 01234456689999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=313.23 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=197.4
Q ss_pred cChHHHHHHhcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEe
Q 037297 61 FSSKELDKATNHFNVN-RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLL 137 (366)
Q Consensus 61 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (366)
......+...++|.+. +.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++.+ .||||++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 3444455666788888 89999999999999976 58999999998654432 2245788999999999 579999999
Q ss_pred eEEeeCCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCe
Q 037297 138 GCCLETEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYR 205 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~ 205 (366)
+++......++++++..++ ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999876552 2346899999999999999999999999 999999999999987 789
Q ss_pred EEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH
Q 037297 206 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 206 vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....
T Consensus 173 ~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~ 242 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETY 242 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred EEEeeCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHH
Confidence 999999999866432 223345789999999999999999999999999999999999999965431 0011
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... . .. .......++..+.+++..||+.||++|||++|+++
T Consensus 243 ~~i~~~~-~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 243 LNISQVN-V-DY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHTC-C-CC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhcc-c-cc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111100 0 00 01112345567899999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.38 Aligned_cols=257 Identities=24% Similarity=0.293 Sum_probs=191.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-----
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----- 144 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 144 (366)
.+|++.+.||+|+||.||+|.+. +++.||+|++..... ...+|+.+++.++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 47999999999999999999975 589999999875422 2346999999999999999999885432
Q ss_pred -cceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecC
Q 037297 145 -VPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFG 212 (366)
Q Consensus 145 -~~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg 212 (366)
..++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccch
Confidence 245666665432 2456899999999999999999999999 9999999999999955 678999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh-
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR- 290 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (366)
++....... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 203 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-----l~~i~~~lg~ 275 (420)
T 1j1b_A 203 SAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-----LVEIIKVLGT 275 (420)
T ss_dssp TCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHHCS
T ss_pred hhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCC
Confidence 998654322 23345789999999998765 789999999999999999999999976431110 000100000
Q ss_pred ---------cC-----ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcccC
Q 037297 291 ---------KN-----HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRGS 345 (366)
Q Consensus 291 ---------~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~~ 345 (366)
.. .++..........++...+.++.+|+.+||+.||.+|||+.|+++ .++.+...
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 00 011111111122233445678999999999999999999999985 44555443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=328.03 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=196.8
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS-SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3467999999999999999999976 689999999875432211 23457889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~~ 217 (366)
++++++.++. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9998876542 346899999999999999999999999 9999999999999 56789999999999866
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..... ........ .
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~-~i~~~~~~-~ 246 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILK-KVEKGKYT-F 246 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCCCC-C
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHcCCCC-C
Confidence 4332 2334569999999999876 689999999999999999999999976431 11111 11111110 0
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ......++.+.+|+..||+.||.+|||+.|+++
T Consensus 247 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 011234567899999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=306.38 Aligned_cols=242 Identities=25% Similarity=0.415 Sum_probs=195.4
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee-----
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----- 142 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 142 (366)
...+|++.+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 4567999999999999999999976 68999999998643 245689999999999999999998754
Q ss_pred -----------CCcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 037297 143 -----------TEVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 143 -----------~~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~ 202 (366)
....++++++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 334667777765532 246889999999999999999999999 999999999999999
Q ss_pred CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHH
Q 037297 203 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 203 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 282 (366)
++.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------- 225 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------- 225 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence 9999999999998765332 2234568999999999999999999999999999999999998864210
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.......... .+...+..+.+++..||+.||.+|||+.|+++.|+.+..+.
T Consensus 226 -~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 -KFFTDLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHHHHHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -HHHHHhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0111111111 12234456889999999999999999999999999887554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.37 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=197.0
Q ss_pred HHhcCCcccceecccCceEEEEEEE------cCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
...++|++.+.||+|+||.||+|.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch---hhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3457899999999999999999983 24778999999754433 33457889999999999999999999999
Q ss_pred eCCcceEEEeeccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CC
Q 037297 142 ETEVPLLHLHDHHRNE--------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RY 204 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~ 204 (366)
.....++++++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcc
Confidence 9998999988764421 134889999999999999999999999 999999999999984 44
Q ss_pred eEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHH
Q 037297 205 RAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA 282 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 282 (366)
.++|+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... .
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~ 252 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------Q 252 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------H
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------H
Confidence 699999999875543222 22233457889999999988999999999999999999998 9999865431 0
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
........... ...+..++..+.+++..||+.||.+|||+.++++.|+.+...
T Consensus 253 -~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 -EVLEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 01111111111 112334556799999999999999999999999999987643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.23 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=188.5
Q ss_pred hcCCcccceecccCceEEEEEEEc--CCc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE--DGR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||+||+|.+. ++. .||+|+++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 467999999999999999999853 233 68999987643221 234568899999999999999999999988765
Q ss_pred ceEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 667777765432 235889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 218 AMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 218 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
...... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 243 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGER 243 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccCCC
Confidence 543322 1223457778999999988889999999999999999999 9999975431 1111111111100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCC
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNF 347 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~ 347 (366)
...+..++..+.+++..||..||++|||+.++++.|+.+.....
T Consensus 244 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 244 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 01123456689999999999999999999999999998876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=310.80 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=189.2
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVN-RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
.++|++. +.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++.++ +||||+++++++...+..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH----IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC----CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch----hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 4678885 78999999999999964 6899999999765332 245788999999885 799999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe---EEEeecCCccc
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGTSKF 216 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~---vkl~Dfg~a~~ 216 (366)
++++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999876542 236889999999999999999999999 999999999999998766 99999999876
Q ss_pred ccCCCc------eeeeeccccCCccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc-----
Q 037297 217 IAMDQT------HVTTKIQGTFGYLEPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS----- 280 (366)
Q Consensus 217 ~~~~~~------~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----- 280 (366)
...... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223458999999998865 56889999999999999999999999765422111000
Q ss_pred -HHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 281 -LAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 281 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.............. ... .. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~-~~~-~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY-EFP-DK----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCC-CCC-HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCc-ccC-ch----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011111111110 000 00 01124567999999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.16 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=199.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...+|.+.+.||+|+||.||++.+. +++.+|+|++........ ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3478999999999999999999976 478999999876543221 34567889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9998876542 236889999999999999999999999 999999999999999999999999999866433
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
. .......||..|+|||++.+..++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~-~~~~~------ 258 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKNEY------ 258 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HHTCC------
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHH-hcCCC------
Confidence 2 223345689999999999999999999999999999999999999965331 0111111 11110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122334567899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=313.21 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=192.3
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... ..+|++++..+ +||||+++++++.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3467999999999999999999976 5889999999764332 34578888877 899999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CeEEEeecCCcc
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER----YRAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~----~~vkl~Dfg~a~ 215 (366)
++++++..++. ...+++..+..++.|++.||.|||++| |+||||||+|||+..+ +.+||+|||++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999876642 346899999999999999999999999 9999999999998543 359999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. ...........
T Consensus 169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~-~~~~i~~~~~~ 241 (342)
T 2qr7_A 169 QLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EE-ILARIGSGKFS 241 (342)
T ss_dssp ECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HH-HHHHHHHCCCC
T ss_pred cCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HH-HHHHHccCCcc
Confidence 664332 223445789999999999888899999999999999999999999975321111 11 11111111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. .......++++.+|+..||+.||++|||+.|+++
T Consensus 242 -~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -LS-----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CC-----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cC-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0112345667999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.47 Aligned_cols=244 Identities=20% Similarity=0.244 Sum_probs=181.5
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHh-cCCCCceeeEeeEEee----
Q 037297 70 TNHFNVN-RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILS-QINHRNVVKLLGCCLE---- 142 (366)
Q Consensus 70 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~---- 142 (366)
.++|.+. +.||+|+||+||+|.++ +++.||+|++... ..+.+|+.++. ..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 3567666 68999999999999976 5889999998742 24567888764 4589999999999875
Q ss_pred CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEee
Q 037297 143 TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVAD 210 (366)
Q Consensus 143 ~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~D 210 (366)
....++++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEe
Confidence 45677888876543 2235899999999999999999999999 999999999999997 78999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .... ..
T Consensus 208 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~i~--~~ 282 (400)
T 1nxk_A 208 FGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIR--MG 282 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH-HHHH--HT
T ss_pred cccccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH-HHHH--cC
Confidence 9999865422 22344678999999999999999999999999999999999999997654322111111 1110 00
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~ 338 (366)
..... . .....++.++.+|+..||+.||++|||+.|+++-
T Consensus 283 ~~~~~---~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFP---N-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCC---T-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCC---C-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 0012345679999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=320.88 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=184.6
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
....++|.+.+.||+|+||.||+|.+. +++.||+|++...... ........+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345688999999999999999999975 5889999998764321 11122335789999999999999999999975
Q ss_pred eCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---eEEEeec
Q 037297 142 ETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY---RAKVADF 211 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~---~vkl~Df 211 (366)
. ...++++++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 4 44678888775532 346899999999999999999999999 99999999999997544 5999999
Q ss_pred CCcccccCCCceeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
|++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~---- 356 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQ---- 356 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHHH----
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHHH----
Confidence 999876432 23344679999999998853 5788899999999999999999999976432111 1110
Q ss_pred hhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 289 MRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... .. .+. .....++.+.+|+.+||+.||++|||++|+++
T Consensus 357 i~~~~~-~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKY-NF-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCC-CC-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCC-CC-Cch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111111 00 011 11234567999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=318.95 Aligned_cols=192 Identities=25% Similarity=0.295 Sum_probs=162.4
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC------CCCceeeEeeEEe
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI------NHRNVVKLLGCCL 141 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~ 141 (366)
...+|++.+.||+|+||+||+|.+. +++.||+|+++... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3467999999999999999999875 58899999997532 2234566777777666 5789999999999
Q ss_pred eCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe--EEEeec
Q 037297 142 ETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR--AKVADF 211 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~--vkl~Df 211 (366)
.....++++++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence 999999998876432 2235899999999999999999999999 999999999999999887 999999
Q ss_pred CCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
|++...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999754322 233578999999999999999999999999999999999999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.07 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=194.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee--CCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 146 (366)
.++|++.+.||+|+||.||+|... +++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 468999999999999999999976 68999999998654433 345678999999999999999999998854 4567
Q ss_pred eEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 147 LLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 147 ~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
++++++..+. ....+++..++.++.|++.||.|||+++ ..+++||||||+||+++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 7788876543 2234899999999999999999999976 23499999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH 293 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (366)
+........ ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~i~~~~ 232 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAGKIREGK 232 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHTC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---------HHHHHHHhhcc
Confidence 976543221 12335689999999999999999999999999999999999999975431 01111111111
Q ss_pred cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.. .++..++.++.+++.+||+.||++|||+.|+++.+.
T Consensus 233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11 123345668999999999999999999999987554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.20 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=190.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC----C
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----E 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~ 144 (366)
...|.+.+.||+|+||+||+|.+. ++..||+|.+....... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 356899999999999999999975 57889999998654433 3456789999999999999999999988653 4
Q ss_pred cceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEEeecCCccc
Q 037297 145 VPLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKF 216 (366)
Q Consensus 145 ~~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl~Dfg~a~~ 216 (366)
..++++++...... ..+++..+..++.|++.||.|||+++ .+++||||||+||+++ .++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 46777777655432 36889999999999999999999975 4599999999999997 789999999999975
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .... .........
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~-~~~~~~~~~- 248 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIY-RRVTSGVKP- 248 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHH-HHHTTTCCC-
T ss_pred cccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHH-HHHhccCCc-
Confidence 4332 2334568999999998864 5899999999999999999999999654311 1111 111111110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...++++.+++..||+.||.+|||+.|+++
T Consensus 249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122233457999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=338.36 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
+.||+|+||.||+|.+. .++.||+|+++...... ...+.+.+|+.+++.++||||+++++++.. +..++++++.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG--GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999753 46789999998653322 234679999999999999999999999864 4567788776
Q ss_pred cCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce--e
Q 037297 154 HRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--V 224 (366)
Q Consensus 154 ~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~--~ 224 (366)
..+ ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......... .
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 543 2346899999999999999999999999 999999999999999999999999999876543321 2
Q ss_pred eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 225 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+|..|+|||++.+..++.++|||||||++|||++ |+.||...... .......... .
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---------~~~~~i~~~~---------~ 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTAMLEKGE---------R 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------HHHHHHHTTC---------C
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCC---------C
Confidence 233446788999999999999999999999999999998 99999764410 0111111111 1
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+..++.++.+++..||+.||++|||+.++++.|+++.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1224456678999999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.18 Aligned_cols=242 Identities=25% Similarity=0.305 Sum_probs=195.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 367999999999999999999976 57889999987532211 1223578899999999999999999999999998899
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 888775432 235889999999999999999999999 999999999999999999999999998655432
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ........ ...
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~-~~~-------- 228 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIV-NVD-------- 228 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTC--------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHh-ccc--------
Confidence 22345689999999999999999999999999999999999999975431 00111111 110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...+..+.+++..||+.||.+|||++|+++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0123345567899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.13 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=178.8
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
.....++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 3445688999999999999999999964 6889999998764322 33457889999999999999999999999999
Q ss_pred cceEEEeeccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 145 VPLLHLHDHHRN---------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 145 ~~~~~~~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
..++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEE
Confidence 999999887553 2345899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCc----eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 210 DFGTSKFIAMDQT----HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 210 Dfg~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
|||++........ .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~-- 236 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----VL-- 236 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HH--
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----HH--
Confidence 9999876543221 11234568999999998866 568999999999999999999999997643211 00
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... .................++.++.+++..||+.||.+|||+.|+++
T Consensus 237 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 237 -MLTLQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HHHHTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHhcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001111 111111111111122334567899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.26 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC-CceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+..|+.+++.++| +++..+..++...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 478999999999999999999964 6899999998765433 246789999999976 55556666667777778
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~~ 217 (366)
+++++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 888876221 1446899999999999999999999999 9999999999999 58899999999999876
Q ss_pred cCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 218 AMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 218 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~~ 234 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKVA 234 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH--HHHHHHHHHHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH--HHHHHhhcccc
Confidence 543322 1235679999999999999999999999999999999999999998654221111 00000000000
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. ....+...++.++.+++..||+.||++||++.++++.|+++.
T Consensus 235 ~---------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 T---------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp S---------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred c---------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0 011122345678999999999999999999999999998874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.45 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=190.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||+||+|.++ ++..+|+|++....... .....+.+|+.+++.++||||+++++++......+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457999999999999999999976 58899999998654322 12457889999999999999999999999999999
Q ss_pred EEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Dfg~a~~~ 217 (366)
++++++.++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99998876532 36889999999999999999999999 999999999999976 455999999999876
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .... ........ ..
T Consensus 190 ~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~-~~i~~~~~-~~ 256 (494)
T 3lij_A 190 ENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEIL-RKVEKGKY-TF 256 (494)
T ss_dssp BTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHTCC-CC
T ss_pred CCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhCCC-CC
Confidence 533 2234457999999999876 5689999999999999999999999976431 0111 11111111 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+ .....++.+.+|+..||+.||.+|||+.|+++
T Consensus 257 ~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 11234567899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=307.84 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=191.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc---hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 478999999999999999999976 5899999999754333 3345778999999999999999999987764
Q ss_pred CcceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 144 EVPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 144 ~~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
...++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 4566777765431 1235889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCce---------eeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHH
Q 037297 219 MDQTH---------VTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288 (366)
Q Consensus 219 ~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (366)
..... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... . ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~ 238 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--H---QLLLIFGI 238 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--H---HHHHHHHH
Confidence 32211 1223468999999998754 67899999999999999999999999764310 0 00000000
Q ss_pred hhcCc----cccccch--------------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 289 MRKNH----MYDILDD--------------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 289 ~~~~~----~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ....... .......+..++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0000000 0011122345678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=337.36 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=198.6
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEE
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 140 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (366)
......++|++.+.||+|+||.||+|.+.. +..+|+|.++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344455789999999999999999998642 457999998764433 3456789999999999999999999998
Q ss_pred eeCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 141 LETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
. .+..++++++...+ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 5 45678888887654 2336889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .... .....
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~-~~i~~ 607 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVI-GRIEN 607 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH-HHHHH
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHH-HHHHc
Confidence 998765443333334457789999999998999999999999999999997 9999975431 0111 11111
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
... ...+..+++.+.+++.+||..||++|||+.|+++.|+.+.
T Consensus 608 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 608 GER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 1123455678999999999999999999999999998875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.09 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=197.5
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcC-CCCceeeEeeEE
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQI-NHRNVVKLLGCC 140 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (366)
....++|++.+.||+|+||.||+|.+. +|+.||+|+++..... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999986 6999999999765421 1122346788999999999 899999999999
Q ss_pred eeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 141 LETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
......++++++..+.. ...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999876643 236899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .....
T Consensus 247 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~~~~- 315 (365)
T 2y7j_A 247 SCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------ILMLR- 315 (365)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-
T ss_pred ccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HHHHH-
Confidence 98665332 2344678999999998853 3578899999999999999999999965321 00111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... ....+ .....+..+.+++..||+.||++|||+.|+++
T Consensus 316 ~i~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQY-QFSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCC-CCCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCC-CCCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111110 00000 01123557899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.66 Aligned_cols=236 Identities=17% Similarity=0.186 Sum_probs=178.0
Q ss_pred hcCCcccceecccCceEEEEEEE-cCCcEEEEEEeecccChHHHHHHHHHHHHHH---HHhcCCCCceeeEe-------e
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIV---ILSQINHRNVVKLL-------G 138 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~ 138 (366)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++........ ...+.+.+|+. .++.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT-THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch-HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 46799999999999999999996 4689999999975422211 23467889994 55555899999998 5
Q ss_pred EEeeCC-----------------cceEEEeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 037297 139 CCLETE-----------------VPLLHLHDHHRN-------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPI 188 (366)
Q Consensus 139 ~~~~~~-----------------~~~~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 188 (366)
++.... ..++++++..+. ....+++..++.++.|++.||.|||+++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 555443 256666665321 0112234778889999999999999999 9
Q ss_pred EeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCC-----------CCCchhhHHHHHHH
Q 037297 189 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-----------QLTDKSDVYSFGVV 257 (366)
Q Consensus 189 iH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DiwslG~~ 257 (366)
+||||||+|||++.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999997532 23344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 258 LVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 258 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+|||++|+.||.......... .+.. ....+++++.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE-----------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSG-----------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchh-----------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997543211100 0000 01234567899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.23 Aligned_cols=237 Identities=20% Similarity=0.300 Sum_probs=190.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+..+..+ +||||+++++++...+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS--HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 467999999999999999999976 68999999998654432 2345788899999999 9999999999999999999
Q ss_pred EEEeeccCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-------------
Q 037297 148 LHLHDHHRNEE-----------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER------------- 203 (366)
Q Consensus 148 ~~~~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~------------- 203 (366)
+++++..+.+. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99998765421 45899999999999999999999999 9999999999999844
Q ss_pred ------CeEEEeecCCcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 037297 204 ------YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 276 (366)
Q Consensus 204 ------~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 276 (366)
..++|+|||.+....... ...||..|+|||.+.+. .++.++|||||||++|+|++|..|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998664322 23589999999998766 56789999999999999999987764321
Q ss_pred ccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 277 ENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. . ......... ..+..++.++.+++..||+.||++|||+.|+++
T Consensus 236 ----~---~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----Q---W-HEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----H---H-HHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H---H-HHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 0 011111111 123345567999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=303.24 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=193.7
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3467999999999999999999976 6899999999864322 2346889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCeEEEeecCCcccc
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill---~~~~~vkl~Dfg~a~~~ 217 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9998876542 235789999999999999999999999 9999999999999 78899999999998654
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ........ ..
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~-~~i~~~~~-~~ 226 (304)
T 2jam_A 160 QN---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLF-EKIKEGYY-EF 226 (304)
T ss_dssp CC---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH-HHHHHCCC-CC
T ss_pred CC---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHH-HHHHcCCC-CC
Confidence 32 122334689999999999999999999999999999999999999975431 0111 11111110 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 E-----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp C-----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred C-----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0112334567999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.29 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=174.7
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHH-HHhcCCCCceeeEeeEEeeCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~ 145 (366)
...++|++.+.||+|+||.||+|..+ +++.||+|++....... ....+..|+. +++.++||||+++++++...+.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH---HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch---HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 34578999999999999999999975 68999999998754442 2345555665 6777899999999999999998
Q ss_pred ceEEEeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 146 PLLHLHDHHRN-----------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 146 ~~~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
.++++++..+. ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 88988877642 245789999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
+....... ......||..|+|||++ .+..++.++|||||||++|+|++|+.||............ .
T Consensus 173 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~ 242 (327)
T 3aln_A 173 SGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ--------V 242 (327)
T ss_dssp SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC--------C
T ss_pred ceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH--------H
Confidence 97654322 22334689999999998 4667899999999999999999999999754321110000 0
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... ........++..+.+++..||+.||++|||+.|+++
T Consensus 243 ~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000 001112234567999999999999999999999965
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.09 Aligned_cols=255 Identities=14% Similarity=0.210 Sum_probs=194.1
Q ss_pred hcCCcccceecccCceEEEEEEEcC---------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceee-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED---------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVK----- 135 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----- 135 (366)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 4789999999999999999999763 788999998754 25678999999999999987
Q ss_pred ----------EeeEEee-CCcceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 037297 136 ----------LLGCCLE-TEVPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKS 195 (366)
Q Consensus 136 ----------~~~~~~~-~~~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp 195 (366)
+++++.. ....++++++. +.. ...+++..++.++.|++.||.|||+++ ++||||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp 187 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence 5667666 56677787766 321 257899999999999999999999999 99999999
Q ss_pred CCEEecCCC--eEEEeecCCcccccCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 037297 196 TNILLDERY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267 (366)
Q Consensus 196 ~Nill~~~~--~vkl~Dfg~a~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 267 (366)
+|||++.++ .+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999766432211 11334789999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 268 IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
|......... ... ....... ......+.. ......+..+.+++..||+.||++|||++++++.|+.+...
T Consensus 268 f~~~~~~~~~---~~~-~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 268 WTNCLPNTED---IMK-QKQKFVD-KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TGGGTTCHHH---HHH-HHHHHHH-SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccCCcCHHH---HHH-HHHhccC-Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 9754311111 111 1110111 011111100 00112356799999999999999999999999999887643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=312.56 Aligned_cols=249 Identities=15% Similarity=0.190 Sum_probs=199.0
Q ss_pred HHHHHhcCCcccceecccCceEEEEEE------EcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC---CCceee
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGM------LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN---HRNVVK 135 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 135 (366)
++....++|++.+.||+|+||+||+|. ..+++.||+|++.... ...+..|+.+++.+. |+||+.
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 334456789999999999999999994 3458899999997642 225667777777775 999999
Q ss_pred EeeEEeeCCcceEEEeeccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-
Q 037297 136 LLGCCLETEVPLLHLHDHHRN------------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE- 202 (366)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~- 202 (366)
+++++...+..++++++..++ ....+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccc
Confidence 999999999999999987654 3456899999999999999999999999 999999999999998
Q ss_pred ----------CCeEEEeecCCcccccC-CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 037297 203 ----------RYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271 (366)
Q Consensus 203 ----------~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 271 (366)
++.+||+|||++..... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999976542 2334455677999999999999999999999999999999999999999643
Q ss_pred CCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHhhcccCC
Q 037297 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKR-PTMEEVTMELNGIRGSN 346 (366)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~ell~~L~~~~~~~ 346 (366)
...... ....... . ..++.+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 289 ~~~~~~----------------~~~~~~~-----~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 289 EGGECK----------------PEGLFRR-----L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ETTEEE----------------ECSCCTT-----C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcee----------------echhccc-----c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 211100 0000000 0 124467899999999999999 68889998888876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.60 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=188.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++......+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 3478999999999999999999976 6899999998763221 1123457889999999999999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9998876542 235789999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. ......+|+.|+|||.+.+..+ +.++|+||||+++|+|++|+.||..... .... ........
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~----- 228 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLF-KKIRGGVF----- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHCCC-----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHH-HHhhcCcc-----
Confidence 2 2234568999999999988765 6899999999999999999999965321 0111 11111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...+..+.+++..||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112334567899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.95 Aligned_cols=244 Identities=27% Similarity=0.373 Sum_probs=191.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .+.+.+|+.+++.++||||+++++++......
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 34578999999999999999999976 589999999986432 24678899999999999999999999999999
Q ss_pred eEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++..+. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999887653 2346899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ..........
T Consensus 177 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~~~~ 246 (314)
T 3com_A 177 DTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFM-IPTNPPPTFR 246 (314)
T ss_dssp TTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSCCCCCS
T ss_pred hhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH-HhcCCCcccC
Confidence 332 222345689999999999999999999999999999999999999975431 000111 1111111110
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..++..+.+++..||+.||.+|||+.++++
T Consensus 247 -------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12334567999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=316.45 Aligned_cols=248 Identities=12% Similarity=0.084 Sum_probs=173.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHH---HHhcCCCCceeeEe-------e
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIV---ILSQINHRNVVKLL-------G 138 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~ 138 (366)
..+|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+.+|+. .++. +||||++++ +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 456999999999999999999975 68999999999865432 234557777854 5555 799988755 4
Q ss_pred EEeeCC-----------------cceEEEeeccCCC--------CCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 037297 139 CCLETE-----------------VPLLHLHDHHRNE--------EFPLTWEIR------LRIATEVAGALSYLHSAASSP 187 (366)
Q Consensus 139 ~~~~~~-----------------~~~~~~~~~~~~~--------~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~~ 187 (366)
++.... ..++++++.. .+ ...+++..+ ..++.|++.||.|||+++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 443332 2577777654 21 112344445 678899999999999999
Q ss_pred eEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCC
Q 037297 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGK 265 (366)
Q Consensus 188 iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~ 265 (366)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2224457799999999987 68999999999999999999999
Q ss_pred CCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 266 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.||........... .....................++.+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99976532111100 000000000001111112345668999999999999999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=309.11 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=187.6
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
........++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+++..+..++||||+++++++.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 4455667789999999999999999999975 5899999998654322 124567788888899999999999987
Q ss_pred eCCc-------ceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCCCCCEEecC
Q 037297 142 ETEV-------PLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLH--SAASSPIYHRDIKSTNILLDE 202 (366)
Q Consensus 142 ~~~~-------~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~~~iiH~dikp~Nill~~ 202 (366)
.... .++++++..+. ....+++..+..++.|++.|+.||| +++ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 6443 66777776543 3456889999999999999999999 888 999999999999996
Q ss_pred -CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 037297 203 -RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 280 (366)
Q Consensus 203 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 280 (366)
++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----- 239 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----- 239 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred CCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-----
Confidence 8999999999998665332 23345689999999988665 48999999999999999999999997643110
Q ss_pred HHHHHHHHhhcC------------cccccc------chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hh
Q 037297 281 LAAFFVHSMRKN------------HMYDIL------DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LN 340 (366)
Q Consensus 281 ~~~~~~~~~~~~------------~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~ 340 (366)
............ ...... -.......+...+.++.+|+.+||+.||.+|||+.|+++- ++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 011111100000 000000 0011111222356789999999999999999999999752 44
Q ss_pred hcc
Q 037297 341 GIR 343 (366)
Q Consensus 341 ~~~ 343 (366)
++.
T Consensus 320 ~~~ 322 (360)
T 3e3p_A 320 ELH 322 (360)
T ss_dssp GGG
T ss_pred ccC
Confidence 444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=309.61 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=190.8
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc--
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 146 (366)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 468999999999999999999975 58999999997654332 3446788999999999999999999998876543
Q ss_pred ----eEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 ----LLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ----~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++..+. -...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 7777765431 1235899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC--ccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN--HMY 295 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 295 (366)
.. .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ............ .+.
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-----HHHHHHHHHCBCCHHHH
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCCHHHH
Confidence 22 234568999999998877 678999999999999999999999997643110 000000000000 000
Q ss_pred cccch---------------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDD---------------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0001123345678999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=306.75 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=189.6
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLET 143 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 143 (366)
+....++|++.+.||+|+||.||++.+.+++.||+|++....... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc--cchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 334457899999999999999999998889999999998654432 34567899999999996 59999999999999
Q ss_pred CcceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 144 EVPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 144 ~~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
...+++++..... ....+++..+..++.|++.||.|||+++ ++||||||+||++++ +.+||+|||++...
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9888888832211 2346889999999999999999999999 999999999999965 79999999999766
Q ss_pred cCCCce-eeeeccccCCccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH
Q 037297 218 AMDQTH-VTTKIQGTFGYLEPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 218 ~~~~~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~ 249 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 249 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHH
Confidence 433221 2234568999999998865 47888999999999999999999999654311 1111
Q ss_pred HHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 286 VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ....+...+.++.+++..||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111111 01112223457899999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=307.83 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=187.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLET 143 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ........+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999975 5889999998764321 1112234578999999999999999999998765
Q ss_pred CcceEEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe---EEEeecCC
Q 037297 144 EVPLLHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR---AKVADFGT 213 (366)
Q Consensus 144 ~~~~~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~---vkl~Dfg~ 213 (366)
. .++++++..+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 67777776543 2346899999999999999999999999 999999999999987654 99999999
Q ss_pred cccccCCCceeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
+...... .......||..|+|||++. +..++.++|||||||++|+|++|..||........ ..... .
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~----~ 233 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQI----T 233 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HHHHH----H
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HHHHH----H
Confidence 9765422 2223456899999999863 56789999999999999999999999975432111 11111 1
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ..+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~--~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc--cCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 0011 12234567899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=331.02 Aligned_cols=241 Identities=24% Similarity=0.271 Sum_probs=195.4
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCc
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 145 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 145 (366)
...++|++.+.||+|+||.||+|.++ +++.||+|+++...... ....+.+..|..++..+ .||+|+.+++++.+.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34578999999999999999999976 58889999998632211 12345678899999988 79999999999999999
Q ss_pred ceEEEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999998876532 36899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ........... .
T Consensus 494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~-~---- 559 (674)
T 3pfq_A 494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN-V---- 559 (674)
T ss_dssp CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSC-C----
T ss_pred cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-C----
Confidence 22 2234456899999999999999999999999999999999999999976431 11111111111 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 332 (366)
.++...+.++.+|+..||+.||++||++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1234456789999999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.98 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=195.8
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHH-------------HHHHHHHHHHHHHhcCCCCceeeE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEEL-------------LKLEEFINEIVILSQINHRNVVKL 136 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~ 136 (366)
.++|++.+.||+|+||.||+|.+ +++.||+|++......... ...+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999998754221100 011578899999999999999999
Q ss_pred eeEEeeCCcceEEEeeccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEe
Q 037297 137 LGCCLETEVPLLHLHDHHRNE---------------EFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILL 200 (366)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill 200 (366)
++++...+..++++++..+.. ...+++..++.++.|++.||.|||+ ++ ++||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999988765421 3468999999999999999999999 88 9999999999999
Q ss_pred cCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 037297 201 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS-QLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278 (366)
Q Consensus 201 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 278 (366)
+.++.++|+|||++...... ......+|..|+|||.+.+. .++. ++|||||||++|+|++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 99999999999999765432 33445689999999999887 6666 9999999999999999999997644210
Q ss_pred ccHHHHHHHHhhc-Ccccc-------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 279 VSLAAFFVHSMRK-NHMYD-------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 279 ~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......... ...+. ...+..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 260 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111111 00110 00000011112445678999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=304.88 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=191.0
Q ss_pred HhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEe--
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCL-- 141 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-- 141 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|+++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3478999999999999999999973 578999999876543221 112455677666665 8999999999987
Q ss_pred ---eCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEee
Q 037297 142 ---ETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVAD 210 (366)
Q Consensus 142 ---~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~D 210 (366)
.....++++++..+. ....+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 445667777766531 2234899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||++...... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcC
Confidence 9999765422 2233456899999999999999999999999999999999999999764311 01111111111
Q ss_pred c---Cccccc----------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 K---NHMYDI----------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~---~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ..+... .............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000000 0000111233445678899999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=301.55 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=189.5
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++......+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3478999999999999999999976 588999999876432 23457889999999999999999999999998889
Q ss_pred EEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..+.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9988875531 346899999999999999999999999 99999999999999999999999998754321
Q ss_pred CCceeeeeccccCCccccccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYH-----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
. ........||..|+|||++ .+..++.++||||||+++|+|++|..||..... .......... ..
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~ 239 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-DP 239 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-CC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhcc-CC
Confidence 1 1112334689999999987 466789999999999999999999999975431 1111111111 11
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ..+..++..+.+++..||+.||++|||+.|+++
T Consensus 240 ~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 113345567999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.16 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=184.5
Q ss_pred hcCCcccceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe-------
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL------- 141 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------- 141 (366)
.++|++.+.||+|+||.||+|.+.. ++.||+|++.... . ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-P---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-H---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-h---HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4789999999999999999999764 8999999987642 1 34567889999999999999999999874
Q ss_pred -------eCCcceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEE
Q 037297 142 -------ETEVPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKV 208 (366)
Q Consensus 142 -------~~~~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl 208 (366)
.....++++++..+. ...++++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 334567777765431 2346889999999999999999999999 99999999999997 5679999
Q ss_pred eecCCcccccCCCc--eeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH
Q 037297 209 ADFGTSKFIAMDQT--HVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF 285 (366)
Q Consensus 209 ~Dfg~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 285 (366)
+|||++........ .......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-----QMQLI 237 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH
Confidence 99999986543211 12233457899999998765 678999999999999999999999997643110 00000
Q ss_pred HHHhhcCc------cccccch----------HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 286 VHSMRKNH------MYDILDD----------QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 286 ~~~~~~~~------~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ....... ..........+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 0000000 0001122345678999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.92 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=187.5
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
+|.....||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++......++++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 3444559999999999999975 588999999986533 23457889999999999999999999999999999998
Q ss_pred eeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcccccC
Q 037297 151 HDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAM 219 (366)
Q Consensus 151 ~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~~~~~ 219 (366)
++..+. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 876432 2235678899999999999999999999 999999999999987 89999999999976543
Q ss_pred CCceeeeeccccCCccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (366)
.. .......||..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ......... ..
T Consensus 176 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~---- 243 (295)
T 2clq_A 176 IN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMF-KV---- 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHH-CC----
T ss_pred CC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccc-cc----
Confidence 22 2223456899999999987653 8899999999999999999999996533110 000000000 00
Q ss_pred cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 298 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 244 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 -----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01123445668899999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.91 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccC-----hHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEE
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVD-----DEELLKLEEFINEIVILSQIN-HRNVVKLLGCC 140 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 140 (366)
...++|++.+.||+|+||.||+|.++ +++.||+|++..... .......+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999976 588999999976532 112234567889999999995 99999999999
Q ss_pred eeCCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 141 LETEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
......++++++..+.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999876542 236889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeeeccccCCcccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (366)
+....... ......++..|+|||++. ...++.++||||||+++|+|++|+.||..... ......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 240 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM 240 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHHHHH
Confidence 97664322 233456899999999874 45688999999999999999999999965331 011111
Q ss_pred HhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. .... .... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~-~~~~-~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IM-SGNY-QFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH-HTCC-CCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hh-cCCc-ccCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 1110 0000 011235567999999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=295.76 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=194.8
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
....++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 344578999999999999999999976 68999999997654322 234578899999999999999999999999988
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CeEEEeecCCcc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER---YRAKVADFGTSK 215 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~---~~vkl~Dfg~a~ 215 (366)
.++++++..+.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 888888876543 236889999999999999999999999 9999999999999754 479999999987
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......+|..|+|||.+.+ .++.++||||||+++|+|++|..||..... .... .........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~~ 240 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDIL-KRVETGKYA 240 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHCCCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHcCCCC
Confidence 654322 2233458899999998876 489999999999999999999999976431 0111 111111110
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 011234567899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.03 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=186.5
Q ss_pred HHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEee--
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE-- 142 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 142 (366)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-----HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334678999999999999999999974 6899999999765433 24678899999998 89999999999987
Q ss_pred ----CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEe
Q 037297 143 ----TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVA 209 (366)
Q Consensus 143 ----~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~ 209 (366)
....++++++.... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 45677888876542 2246889999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 284 (366)
|||++....... .......||..|+|||++. +..++.++|||||||++|+|++|+.||..... ...
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~ 242 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRA 242 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHH
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHH
Confidence 999987654321 1223456899999999886 56788999999999999999999999965431 001
Q ss_pred HHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ......... .+..++..+.+++.+||..||.+|||+.|+++
T Consensus 243 ~~~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFL-IPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH-HHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH-hhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 111111111 12234567999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.79 Aligned_cols=256 Identities=20% Similarity=0.240 Sum_probs=187.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-----------CCceeeEe
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-----------HRNVVKLL 137 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~ 137 (366)
..+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.+. ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 468999999999999999999974 68999999987532 23456778988888875 89999999
Q ss_pred eEEeeCC----cceEEEeeccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEec---
Q 037297 138 GCCLETE----VPLLHLHDHHR--------NEEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLD--- 201 (366)
Q Consensus 138 ~~~~~~~----~~~~~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~--- 201 (366)
+++.... ..+++++.... .....+++..+..++.|++.||.|||++ + |+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 9987654 45666665421 1234589999999999999999999998 8 99999999999994
Q ss_pred ---CCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 037297 202 ---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278 (366)
Q Consensus 202 ---~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 278 (366)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999765432 233468999999999999999999999999999999999999997654211110
Q ss_pred -ccHHHHHHHHhhcCc------------------cccc--------cch--HHhhhhcHHHHHHHHHHHHHhhcCCCCCC
Q 037297 279 -VSLAAFFVHSMRKNH------------------MYDI--------LDD--QVVKLVKKNQIMAFANLAERCLDLNGKKR 329 (366)
Q Consensus 279 -~~~~~~~~~~~~~~~------------------~~~~--------~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~R 329 (366)
............... .... ... ......+...+.++.+|+.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 000111111000000 0000 000 00112457788999999999999999999
Q ss_pred CCHHHHHH
Q 037297 330 PTMEEVTM 337 (366)
Q Consensus 330 pt~~ell~ 337 (366)
||+.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=302.90 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=191.9
Q ss_pred hcCCcccceecccCceEEEEEEE-c-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC------ceeeEeeEEe
Q 037297 70 TNHFNVNRILGQGGQGTVYKGML-E-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR------NVVKLLGCCL 141 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~ 141 (366)
.++|++.+.||+|+||.||+|.+ . +++.||+|+++... ...+.+.+|+.+++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46899999999999999999986 3 58899999987531 2345678888888887655 5999999999
Q ss_pred eCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----------
Q 037297 142 ETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE----------- 202 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~----------- 202 (366)
.....++++++.... ...++++..+..++.|++.||.|||+++ ++||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999887322 2236889999999999999999999999 999999999999987
Q ss_pred --------CCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 037297 203 --------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274 (366)
Q Consensus 203 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 274 (366)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764322 23456899999999999999999999999999999999999999754311
Q ss_pred CcccccHHHHHHHHhhcCc-------------------cccccc-----------hHHhhhhcHHHHHHHHHHHHHhhcC
Q 037297 275 SQENVSLAAFFVHSMRKNH-------------------MYDILD-----------DQVVKLVKKNQIMAFANLAERCLDL 324 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~ 324 (366)
. ............. +..... .......+...++++.+|+.+||+.
T Consensus 241 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 E-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp H-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 1 0000100000000 000000 0000112345678899999999999
Q ss_pred CCCCCCCHHHHHH
Q 037297 325 NGKKRPTMEEVTM 337 (366)
Q Consensus 325 dp~~Rpt~~ell~ 337 (366)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=310.42 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=193.4
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
..++....++|++.+.||+|+||.||+|.+.. .+|+|+++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34445556889999999999999999998753 49999987643322 122356789999999999999999999999
Q ss_pred CCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 143 TEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 143 ~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
....++++++..+. ....+++..++.++.|++.||.|||+++ ++||||||+||+++ ++.++|+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 98888888876532 2336889999999999999999999999 99999999999998 679999999998
Q ss_pred ccccCCC----ceeeeeccccCCccccccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH
Q 037297 215 KFIAMDQ----THVTTKIQGTFGYLEPEYHQS---------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 281 (366)
Q Consensus 215 ~~~~~~~----~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 281 (366)
....... ........||..|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------- 248 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------- 248 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 7553211 112233458999999998864 4578899999999999999999999975431
Q ss_pred HHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 282 AAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
.. .............. +..++.++.+++..||..||++|||+.++++.|+.+....
T Consensus 249 ~~-~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 249 EA-IIWQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HH-HHHHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HH-HHHHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 11111111111110 1123456899999999999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=296.70 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=177.2
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++........ ..+.+.++..+++.++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH--HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 3478999999999999999999976 689999999987654432 2334455556788889999999999999999999
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++.... ....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 988876321 134689999999999999999999995 8 99999999999999999999999999976543
Q ss_pred CCceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
.. ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||...... ............
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~- 247 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEP- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCC-
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCC-
Confidence 22 223456899999999984 557889999999999999999999999753311 111111111110
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.... ....++.++.+++..||+.||.+|||++|+++
T Consensus 248 ~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 01124567899999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=311.40 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=179.1
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.|.+.+.||+|+||+||.+...+|+.||+|++.... .+.+.+|+.+++.+ +||||+++++++......+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 4566778999999999987766679999999987632 23567899999876 899999999999999999999
Q ss_pred EeeccCC------CCCC-------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-------------
Q 037297 150 LHDHHRN------EEFP-------LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER------------- 203 (366)
Q Consensus 150 ~~~~~~~------~~~~-------l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~------------- 203 (366)
+++..+. .... .++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCc
Confidence 8876431 0000 122345679999999999999999 9999999999999754
Q ss_pred CeEEEeecCCcccccCCCce---eeeeccccCCccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 037297 204 YRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLEPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSTG 272 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 272 (366)
+.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999876543322 1234579999999999865 678999999999999999999 999996533
Q ss_pred CCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... ...... ...... .....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~-------~~i~~~--~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRE-------SNIIRG--IFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THH-------HHHHHT--CCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH-------HHHhcC--CCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 110 000000 000100 011124567788999999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.40 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=191.6
Q ss_pred cccChHHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH--HHHHHHHHHHHHHHhcCC--CCce
Q 037297 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE--LLKLEEFINEIVILSQIN--HRNV 133 (366)
Q Consensus 59 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--h~ni 133 (366)
...+..+.....++|++.+.||+|+||.||+|.+. +++.||+|++........ ....+.+.+|+.+++.++ ||||
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 44455566667789999999999999999999965 688999999976533210 011234667999999995 5999
Q ss_pred eeEeeEEeeCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCC
Q 037297 134 VKLLGCCLETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERY 204 (366)
Q Consensus 134 v~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~ 204 (366)
+++++++...+..++++++.... ....+++..++.++.|++.||.|||+++ ++||||||+|||++ .++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 99999999999888888877541 2346889999999999999999999999 99999999999999 789
Q ss_pred eEEEeecCCcccccCCCceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHH
Q 037297 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 283 (366)
.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred CEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 9999999999866432 2234568999999998877665 6789999999999999999999964210
Q ss_pred HHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...... ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 255 ----~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----IIRGQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HHHCCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hhcccc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000100 012234567899999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.81 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=191.2
Q ss_pred HhcCCcccceecccCceEEEEEEEc-CC-cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc------eeeEeeEE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE-DG-RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN------VVKLLGCC 140 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~ 140 (366)
..++|++.+.||+|+||.||+|.+. ++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3578999999999999999999975 34 689999997532 23456778999998887655 89999999
Q ss_pred eeCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe------------
Q 037297 141 LETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL------------ 200 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill------------ 200 (366)
......++++++.... ...++++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence 9999999999887432 2246899999999999999999999999 9999999999999
Q ss_pred -------cCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 037297 201 -------DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273 (366)
Q Consensus 201 -------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 273 (366)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999764322 2345689999999999999999999999999999999999999976431
Q ss_pred CCcccccHHHHHHHHhhcCc-------------------cccccch-----------HHhhhhcHHHHHHHHHHHHHhhc
Q 037297 274 TSQENVSLAAFFVHSMRKNH-------------------MYDILDD-----------QVVKLVKKNQIMAFANLAERCLD 323 (366)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~ 323 (366)
.. . ............ +...... ..........+..+.+|+.+||+
T Consensus 245 ~~--~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 RE--H---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp HH--H---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred HH--H---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 10 0 000000000000 0000000 00001123456789999999999
Q ss_pred CCCCCCCCHHHHH
Q 037297 324 LNGKKRPTMEEVT 336 (366)
Q Consensus 324 ~dp~~Rpt~~ell 336 (366)
.||++|||+.|++
T Consensus 320 ~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 320 FDPAQRITLAEAL 332 (355)
T ss_dssp SSTTTSCCHHHHT
T ss_pred CChhhCcCHHHHh
Confidence 9999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=301.62 Aligned_cols=195 Identities=24% Similarity=0.303 Sum_probs=162.3
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CC-----ceeeEee
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HR-----NVVKLLG 138 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~ 138 (366)
.....++|++.+.||+|+||+||+|.+. +++.||+|+++... .....+..|+.+++.++ |+ +|+++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 3444678999999999999999999976 58899999997532 22346677888887774 44 4999999
Q ss_pred EEeeCCcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCCCCCEEec--CCCeE
Q 037297 139 CCLETEVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHS--AASSPIYHRDIKSTNILLD--ERYRA 206 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~~~iiH~dikp~Nill~--~~~~v 206 (366)
++...+..++++++.... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+
T Consensus 124 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred eeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 999999999999976542 22358999999999999999999995 56 99999999999995 47789
Q ss_pred EEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 037297 207 KVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272 (366)
Q Consensus 207 kl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 272 (366)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999866432 234568999999999999999999999999999999999999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.25 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=181.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 143 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 467999999999999999999975 68999999997531 3346788999999999999999999988653
Q ss_pred --------CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEE
Q 037297 144 --------EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAK 207 (366)
Q Consensus 144 --------~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vk 207 (366)
...++++++..+. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3566777776543 2335778899999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccCCC-------------ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 037297 208 VADFGTSKFIAMDQ-------------THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGN 273 (366)
Q Consensus 208 l~Dfg~a~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 273 (366)
|+|||++....... ........||..|+|||++.+. .++.++|||||||++|+|++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999997654221 1122345689999999998765 68999999999999999998 554211
Q ss_pred CCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 274 TSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ............. ......+...+..+.+++..||+.||.+|||+.|+++
T Consensus 233 ---~----~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---E----RVNILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---H----HHHHHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---h----HHHHHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 0001111111000 0011233445567899999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.74 Aligned_cols=243 Identities=27% Similarity=0.361 Sum_probs=182.0
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH--HHHHHHHHHHHHHHhcC----CCCceeeE
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE--LLKLEEFINEIVILSQI----NHRNVVKL 136 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l----~h~niv~~ 136 (366)
.......++|++.+.||+|+||.||+|.+. +++.||+|++........ ......+.+|+.+++.+ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 344556688999999999999999999864 588999999976543211 11233456788888888 89999999
Q ss_pred eeEEeeCCcceEEEeeccC-C-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEE
Q 037297 137 LGCCLETEVPLLHLHDHHR-N-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAK 207 (366)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~-~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vk 207 (366)
++++...+..++++++... . ....+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999998888888887322 2 1235899999999999999999999999 99999999999999 889999
Q ss_pred EeecCCcccccCCCceeeeeccccCCccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHH
Q 037297 208 VADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286 (366)
Q Consensus 208 l~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (366)
|+|||++....... .....+|..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------- 244 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------
Confidence 99999998764322 2345689999999988776664 589999999999999999999964210
Q ss_pred HHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
... .. ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 245 -~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -ILE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -Hhh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 0122345567899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.88 Aligned_cols=241 Identities=23% Similarity=0.340 Sum_probs=178.6
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 148 (366)
..+|++.+.||+|+||+|+.....+++.||+|++...... .+.+|+.+++.+ +||||+++++++......++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 3569999999999999976555567899999998754322 345799999999 89999999999999999999
Q ss_pred EEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----CCeEEEeecCCccc
Q 037297 149 HLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKF 216 (366)
Q Consensus 149 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-----~~~vkl~Dfg~a~~ 216 (366)
++++..+. ......+..+..++.|++.||.|||+++ |+||||||+|||++. ...+||+|||++..
T Consensus 96 v~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 98876431 2223445566789999999999999999 999999999999953 23588999999987
Q ss_pred ccCCCc--eeeeeccccCCcccccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 217 IAMDQT--HVTTKIQGTFGYLEPEYHQ---SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 217 ~~~~~~--~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
...... .......||+.|+|||++. +..++.++|||||||++|||++ |..||...... . ......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~---~~~~~~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------Q---ANILLG 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------H---HHHHTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------H---HHHHhc
Confidence 653321 2234467999999999987 4567889999999999999999 99998543210 0 000111
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
... ..... .+...+..+.+|+.+||+.||.+|||+.|++
T Consensus 244 ~~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 244 ACS-LDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CCC-CTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCC-ccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 111 11111 1234556788999999999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.24 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=162.7
Q ss_pred HhcCCcccc-eecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHH-HHHHhcCCCCceeeEeeEEee---
Q 037297 69 ATNHFNVNR-ILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINE-IVILSQINHRNVVKLLGCCLE--- 142 (366)
Q Consensus 69 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E-~~~l~~l~h~niv~~~~~~~~--- 142 (366)
..++|++.+ .||+|+||.||+|.++ +++.||+|++.... ...+| ...++.+.||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---------KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 346899865 6999999999999976 68999999987531 11223 234566799999999999876
Q ss_pred -CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEe
Q 037297 143 -TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVA 209 (366)
Q Consensus 143 -~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~ 209 (366)
....++++++..++ ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEe
Confidence 34467778876542 2236899999999999999999999999 999999999999976 4569999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 174 Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~ 245 (336)
T 3fhr_A 174 DFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-----RI 245 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-----hh
Confidence 99999765422 22345689999999999888899999999999999999999999976442111000000 00
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... .. .......++.++.+|+..||+.||.+|||+.|+++
T Consensus 246 ~~~~~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 RLGQY-GF-----PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CC-----CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcccc-cc-----CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 00 00011235567999999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.98 Aligned_cols=236 Identities=22% Similarity=0.313 Sum_probs=189.6
Q ss_pred HhcCCcccceecccCceEEEEEEEc--CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc-
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE--DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV- 145 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 145 (366)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA---EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH---HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3478999999999999999999975 5899999998764433 344578899999999999999999999988765
Q ss_pred ----ceEEEeeccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 146 ----PLLHLHDHHRNE-----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 146 ----~~~~~~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
.++++++..+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.+ .+||+|||++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp SCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 588888765432 226899999999999999999999999 9999999999999986 999999999986
Q ss_pred ccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 217 IAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 217 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||...... ...
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC-
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc-
Confidence 5432 3456899999999887654 88999999999999999999887642110 000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHHHhhc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-MEEVTMELNGI 342 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ell~~L~~~ 342 (366)
. .......++.+.+++.+||+.||.+||+ ++++...|..+
T Consensus 286 --~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 --E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0011234467899999999999999994 66666666544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=313.77 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=193.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee------
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------ 142 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 142 (366)
.++|++.+.||+|+||.||+|.+. +|+.||+|+++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH---HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 478999999999999999999974 5899999998865443 345678999999999999999999998765
Q ss_pred CCcceEEEeeccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCe---EEEe
Q 037297 143 TEVPLLHLHDHHRNE----------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYR---AKVA 209 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~---vkl~ 209 (366)
....++++++..++. ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++. ++|+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence 566788888875531 225888899999999999999999999 999999999999997664 9999
Q ss_pred ecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH-HHHHHHH
Q 037297 210 DFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-AAFFVHS 288 (366)
Q Consensus 210 Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 288 (366)
|||++....... ......||..|+|||.+.+..++.++||||+||++|+|++|..||........-.... .......
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 999998664332 2344578999999999999999999999999999999999999997532110000000 0000000
Q ss_pred hhcCccc---cccc-hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHH-----HHHHHhhcccC
Q 037297 289 MRKNHMY---DILD-DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE-----VTMELNGIRGS 345 (366)
Q Consensus 289 ~~~~~~~---~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-----ll~~L~~~~~~ 345 (366)
....... .+.. ......+....+..+.+++..||..||++|||+.| +.+.++.+...
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000000 0000 00112244557788999999999999999999988 45666655543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.45 Aligned_cols=234 Identities=12% Similarity=0.052 Sum_probs=180.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.+. +++.||+|++........ ...+.+.+|+..+..++||||+++++++...+..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD-DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH-HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 467999999999999999999976 489999999987544322 345678999999999999999999999999999999
Q ss_pred EEeeccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 149 HLHDHHRNEE-----FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 149 ~~~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++++..+... .......+..++.|++.||.|||++| |+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9998754321 12355678889999999999999999 9999999999999999999998544
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
|++ .++.++|||||||++|+|++|+.||............. ...... ....
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~~~~--~~~~ 225 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDTAGQ--PIEP 225 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCTTSC--BCCH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHhccC--CCCh
Confidence 333 36789999999999999999999998654321110000 000000 0001
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCC
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFG 348 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~ 348 (366)
.......++++.+++.+||+.||++| |+.|+++.|+.+......
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 12234456789999999999999999 999999999998866543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=300.10 Aligned_cols=234 Identities=15% Similarity=0.151 Sum_probs=168.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC-Ccee---------eEeeE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH-RNVV---------KLLGC 139 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv---------~~~~~ 139 (366)
.+|...+.||+|+||.||+|.+. +|+.||||++........ ...+.+.+|+.+++.+.| +|.. ...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH-HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 45788899999999999999965 689999999885433322 335678899999999977 2211 11111
Q ss_pred Eee------------C-----CcceEEEeecc-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 037297 140 CLE------------T-----EVPLLHLHDHH-------------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIY 189 (366)
Q Consensus 140 ~~~------------~-----~~~~~~~~~~~-------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ii 189 (366)
+.. . ...+++++... ......+++..++.++.|++.||.|||+++ |+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 1 11122222111 112334677888999999999999999999 99
Q ss_pred eCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccc----------cCCCCCchhhHHHHHHHHH
Q 037297 190 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH----------QSSQLTDKSDVYSFGVVLV 259 (366)
Q Consensus 190 H~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~DiwslG~~l~ 259 (366)
||||||+|||++.++.+||+|||++..... .....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999876432 2344567 999999998 5667889999999999999
Q ss_pred HHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 260 ELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 260 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
||++|+.||......... ...+. .....++.+.+|+..||+.||++|||+.|++
T Consensus 309 elltg~~Pf~~~~~~~~~-----------------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS-----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS-----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhH-----------------HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999764311110 00000 0112346799999999999999999977764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=273.91 Aligned_cols=222 Identities=20% Similarity=0.269 Sum_probs=167.9
Q ss_pred hcCCccc-ceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHH-hcCCCCceeeEeeEEee----
Q 037297 70 TNHFNVN-RILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVIL-SQINHRNVVKLLGCCLE---- 142 (366)
Q Consensus 70 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~---- 142 (366)
.++|.+. +.||+|+||.||+|.+. +++.||+|+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 3567777 78999999999999975 6899999998742 2456788887 55699999999999877
Q ss_pred CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEee
Q 037297 143 TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVAD 210 (366)
Q Consensus 143 ~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~D 210 (366)
....++++++..++ ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.++|+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence 56677888877553 2236899999999999999999999999 999999999999998 78999999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||++.... +..++.++|||||||++|+|++|+.||............. .
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------~ 212 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------T 212 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--------C
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--------H
Confidence 99985432 2446789999999999999999999997643211100000 0
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....... .........+++++.+++..||+.||++|||+.|+++
T Consensus 213 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 0000011235678999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.00 Aligned_cols=240 Identities=14% Similarity=0.148 Sum_probs=177.9
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcCC---------CCceeeE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQIN---------HRNVVKL 136 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~---------h~niv~~ 136 (366)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... ......+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 6899999999875421 01112356778888888775 7777776
Q ss_pred eeEEe-----------------e-------------CCcceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHH
Q 037297 137 LGCCL-----------------E-------------TEVPLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYL 180 (366)
Q Consensus 137 ~~~~~-----------------~-------------~~~~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~l 180 (366)
.+++. . ....++++++...+. ...+++..+..++.|++.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 66532 2 567888888865432 23579999999999999999999
Q ss_pred H-hCCCCCeEeCCCCCCCEEecCCC--------------------eEEEeecCCcccccCCCceeeeeccccCCcccccc
Q 037297 181 H-SAASSPIYHRDIKSTNILLDERY--------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239 (366)
Q Consensus 181 H-~~~~~~iiH~dikp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~ 239 (366)
| +++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||+
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 899 99999999999999887 8999999999865422 3468999999999
Q ss_pred ccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHH
Q 037297 240 HQSSQLTDKSDVYSFGVV-LVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLA 318 (366)
Q Consensus 240 ~~~~~~~~~~DiwslG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 318 (366)
+.+.. +.++||||+|++ .+++++|..||.... ................. ......+...++++.+|+
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCc----ccchhhhhhcCHHHHHHH
Confidence 98777 889999998777 777888999974210 00000001111111111 111224567888999999
Q ss_pred HHhhcCCCCCCCCHHHHH
Q 037297 319 ERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 319 ~~cl~~dp~~Rpt~~ell 336 (366)
.+||+.| |++|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999977 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=243.02 Aligned_cols=181 Identities=18% Similarity=0.128 Sum_probs=123.6
Q ss_pred ecccCceEEEEEE-EcCCcEEEEEEeecccC------hHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEE
Q 037297 79 LGQGGQGTVYKGM-LEDGRIMAVKKFKLAVD------DEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 79 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~------~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 150 (366)
.+.|+.|.+..++ .-.|+.+|+|++..... .......+.+.+|+++|+++ .|+||+++++++.++...|+++
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3455555555444 22478899999976532 12234567899999999999 7999999999999999999999
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
|+..+. ...+++.. .|+.||+.||.|+|++| ||||||||+|||++.+|.+||+|||+|+...... .
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 998764 23456654 58899999999999999 9999999999999999999999999998664332 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 267 (366)
.....+||+.|+|||++.+. +..++|+||+|++++++.++..|
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 33456799999999998764 56789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=223.67 Aligned_cols=189 Identities=13% Similarity=0.151 Sum_probs=140.9
Q ss_pred cccceecccCceEEEEEEEcCCcEEEEEEeecccCh----HHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 74 NVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
...+.||+|+||.||+|.. .++.+++|........ ......+.+.+|+.+++.++||||+++..++...+..+++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 4788899886543322 1122346789999999999999999666666677888999
Q ss_pred EeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCcee-----
Q 037297 150 LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV----- 224 (366)
Q Consensus 150 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~----- 224 (366)
+++..+.+...+-.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++.........
T Consensus 418 mE~~~ggsL~~~l~~-~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~ 491 (540)
T 3en9_A 418 MSYINGKLAKDVIED-NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV 491 (540)
T ss_dssp EECCCSEEHHHHSTT-CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHH-HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence 998765432211111 5689999999999999999 999999999999999 99999999998765322211
Q ss_pred -eeeccccCCccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037297 225 -TTKIQGTFGYLEPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIF 269 (366)
Q Consensus 225 -~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~ 269 (366)
.....||+.|+|||++.+ ..|+..+|+||...-..+.+.++.+|.
T Consensus 492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 235679999999999987 678888999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=189.02 Aligned_cols=153 Identities=15% Similarity=0.111 Sum_probs=118.1
Q ss_pred HHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHH--------------HHHHHHHHHHHHHHhcCCCCc
Q 037297 67 DKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEE--------------LLKLEEFINEIVILSQINHRN 132 (366)
Q Consensus 67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~--------------~~~~~~~~~E~~~l~~l~h~n 132 (366)
......|.+.+.||+|+||.||+|.+.+|+.||+|+++....... ......+.+|+.+++.++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 344566777899999999999999997799999999975432110 013467899999999998 4
Q ss_pred eeeEeeEEeeCCcceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecC
Q 037297 133 VVKLLGCCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFG 212 (366)
Q Consensus 133 iv~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg 212 (366)
+++.+++. .+..++++++..+.+...+.......++.|++.||.|||++| |+||||||+|||++ ++.+||+|||
T Consensus 164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 164 -LAVPKVYA-WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp -SSSCCEEE-EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred -CCcCeEEe-ccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 56666443 355688888876654433444556789999999999999999 99999999999999 9999999999
Q ss_pred CcccccCCCceeeeeccccCCcccccccc
Q 037297 213 TSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241 (366)
Q Consensus 213 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~ 241 (366)
+|.. +..+.|||.+.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9853 34478899774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=158.34 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=102.6
Q ss_pred cCCcccceecccCceEEEEEEE-cCCcE--EEEEEeecccChH--------------------HHHHHHHHHHHHHHHhc
Q 037297 71 NHFNVNRILGQGGQGTVYKGML-EDGRI--MAVKKFKLAVDDE--------------------ELLKLEEFINEIVILSQ 127 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~ 127 (366)
.-|++.+.||+|+||.||+|.. .+|+. ||+|+++...... .......+.+|+.+++.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999997 67888 9999976542110 01122467889999999
Q ss_pred CCCCce--eeEeeEEeeCCcceEEEeeccCCC----C-C----CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCC
Q 037297 128 INHRNV--VKLLGCCLETEVPLLHLHDHHRNE----E-F----PLTWEIRLRIATEVAGALSYLH-SAASSPIYHRDIKS 195 (366)
Q Consensus 128 l~h~ni--v~~~~~~~~~~~~~~~~~~~~~~~----~-~----~l~~~~~~~i~~~i~~~l~~lH-~~~~~~iiH~dikp 195 (366)
+.|+++ +..+++ ...++++++..... . . ..++..+..++.|++.||.||| +.| |+||||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 987754 334432 35677788773211 0 0 1123367889999999999999 998 99999999
Q ss_pred CCEEecCCCeEEEeecCCcccc
Q 037297 196 TNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 196 ~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=143.93 Aligned_cols=143 Identities=12% Similarity=0.094 Sum_probs=98.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccCh----------------HHHH--HHHHHHHHHHHHhcCCCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD----------------EELL--KLEEFINEIVILSQINHR 131 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------~~~~--~~~~~~~E~~~l~~l~h~ 131 (366)
..-|++.+.||+|++|.||+|...+|+.||+|+++..... .... ..-...+|...+..+.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3459999999999999999999888999999997643211 0000 011234567777777544
Q ss_pred ceeeEeeEEeeCCcceEEEeeccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC------
Q 037297 132 NVVKLLGCCLETEVPLLHLHDHHRNEEFP-LTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY------ 204 (366)
Q Consensus 132 niv~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~------ 204 (366)
++....-+.. ...++++++..+..... ........++.|++.+|.+||+.| +|||||||.|||+++++
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccccc
Confidence 4322211111 12357777765433221 122345678899999999999999 99999999999998776
Q ss_pred ----eEEEeecCCcccc
Q 037297 205 ----RAKVADFGTSKFI 217 (366)
Q Consensus 205 ----~vkl~Dfg~a~~~ 217 (366)
.+.|+||+-+...
T Consensus 249 ~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECCCTTCEET
T ss_pred ccccceEEEEeCCcccC
Confidence 4899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.3e-11 Score=104.51 Aligned_cols=142 Identities=15% Similarity=0.071 Sum_probs=106.8
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcce
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 147 (366)
....|++...++.|+.+.||++... ++.+++|......... ...+.+|..+++.+ .+.++.++++++......+
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3456888899999999999999754 6889999987532111 12477899999888 4778889999988888888
Q ss_pred EEEeeccCCCCCC--CCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 037297 148 LHLHDHHRNEEFP--LTWEIRLRIATEVAGALSYLHSAA----------------------------------------- 184 (366)
Q Consensus 148 ~~~~~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------------- 184 (366)
++++...+..... .+......++.++++++..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred EEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 8888876643211 012234578899999999999811
Q ss_pred ---------------CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 185 ---------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 185 ---------------~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876566799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=8.6e-11 Score=102.30 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=97.5
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCc--eeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN--VVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~ 148 (366)
..|.+....+.|..+.||++...+|..+++|....... ..+..|..+++.+.+.+ +.+++++....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~-------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc-------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 34554444446667999999876678899999765311 24667888888885434 5568888777777788
Q ss_pred EEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 037297 149 HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA-------------------------------------------- 184 (366)
Q Consensus 149 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------------- 184 (366)
+++...+.... .+......++.+++..+..||+..
T Consensus 93 v~e~i~G~~l~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 93 LLGEVPGQDLL-SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EEECCSSEETT-TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEecCCcccC-cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 88877654432 222223467888899999999753
Q ss_pred -----------CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 185 -----------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 185 -----------~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++|+|++|.||+++.++.+.|+|||.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=2.6e-09 Score=97.61 Aligned_cols=138 Identities=13% Similarity=0.138 Sum_probs=100.7
Q ss_pred ccceecccCceEEEEEEEcCCcEEEEEEee--cccChHHHHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeCC---cce
Q 037297 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFK--LAVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETE---VPL 147 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~---~~~ 147 (366)
-.+.++.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +.++++++.++.+.. ..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4567899999999998865 4678888776 32211 12346778999999886 456788888887663 477
Q ss_pred EEEeeccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 037297 148 LHLHDHHRNEE-----FPLTWEIRLRIATEVAGALSYLHSAA-------------------------------------- 184 (366)
Q Consensus 148 ~~~~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------- 184 (366)
+++++..+... ..++......++.+++..|..||+..
T Consensus 118 ~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 78887765433 24567888899999999999999731
Q ss_pred -----------------CCCeEeCCCCCCCEEecCCCe--EEEeecCCccc
Q 037297 185 -----------------SSPIYHRDIKSTNILLDERYR--AKVADFGTSKF 216 (366)
Q Consensus 185 -----------------~~~iiH~dikp~Nill~~~~~--vkl~Dfg~a~~ 216 (366)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=4.1e-09 Score=94.04 Aligned_cols=179 Identities=21% Similarity=0.212 Sum_probs=114.5
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCc--eeeEeeEEeeCC---cceEE
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRN--VVKLLGCCLETE---VPLLH 149 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~~~ 149 (366)
.+.++.|....||++. ..+++|..... .....+.+|.++++.+ .+.. +.+.+....... ..+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 45888886532 2335678899999887 3333 334444433332 34666
Q ss_pred EeeccCCCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 037297 150 LHDHHRNEEF-----PLTWEIRLRIATEVAGALSYLHSAA---------------------------------------- 184 (366)
Q Consensus 150 ~~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------------- 184 (366)
++...+.... .++......++.+++..+..||+..
T Consensus 95 m~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred EcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 6666554322 3566677889999999999999621
Q ss_pred ---------------CCCeEeCCCCCCCEEecC--CCeEEEeecCCcccccCCCceeeeeccccCCc---ccccccc---
Q 037297 185 ---------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY---LEPEYHQ--- 241 (366)
Q Consensus 185 ---------------~~~iiH~dikp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y---~aPE~~~--- 241 (366)
...++|+|++|.||+++. +..+.++||+.+....... . ......+ ..|+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D----l~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D----FISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H----HHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H----HHHHHhhccccCHHHHHHHH
Confidence 134799999999999998 5567899999886542110 0 0001111 2222111
Q ss_pred -CCC-C---------CchhhHHHHHHHHHHHHhCCCCCC
Q 037297 242 -SSQ-L---------TDKSDVYSFGVVLVELLTGKKPIF 269 (366)
Q Consensus 242 -~~~-~---------~~~~DiwslG~~l~el~~g~~p~~ 269 (366)
..+ . ....+.|+++.++|.+.+|..+|.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 110 0 113689999999999999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=6.2e-06 Score=71.82 Aligned_cols=131 Identities=19% Similarity=0.150 Sum_probs=92.4
Q ss_pred eecccCce-EEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcceEEEeecc
Q 037297 78 ILGQGGQG-TVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 78 ~lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.+..|..+ .||+.... ++..+++|.-+.. ....+.+|...++.+ .+-.+.+.++++...+..+++++...
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 34556555 69988755 4667899987643 233577899888888 34457788888888888888888876
Q ss_pred CCCCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 037297 155 RNEEF---PLTWEIRLRIATEVAGALSYLHSAA----------------------------------------------- 184 (366)
Q Consensus 155 ~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------------------- 184 (366)
+.... .........+..+++..+..||+..
T Consensus 104 G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 104 GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp SEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred CccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 54211 0112234457777888888888631
Q ss_pred --------CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 185 --------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 185 --------~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0137999999999999987777799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.3e-05 Score=71.22 Aligned_cols=131 Identities=16% Similarity=0.148 Sum_probs=90.3
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCC---ceeeEeeEEe-eCCcceEEEe
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR---NVVKLLGCCL-ETEVPLLHLH 151 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~~~~~ 151 (366)
.+.++.|....||.. +..+++|+... . .....+.+|.++++.+.+. .+.+.+.++. .....+++++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---Q---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---H---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---c---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 356888988999987 56688887432 1 2345788999999998642 3556666654 3345667777
Q ss_pred eccCCCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 037297 152 DHHRNEEF-----PLTWEIRLRIATEVAGALSYLHSAA------------------------------------------ 184 (366)
Q Consensus 152 ~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------ 184 (366)
...+.... .++......++.++...+..||+..
T Consensus 94 ~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 94 KVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 66554321 2455666777788888877777642
Q ss_pred ---------------CCCeEeCCCCCCCEEecC---CCe-EEEeecCCccc
Q 037297 185 ---------------SSPIYHRDIKSTNILLDE---RYR-AKVADFGTSKF 216 (366)
Q Consensus 185 ---------------~~~iiH~dikp~Nill~~---~~~-vkl~Dfg~a~~ 216 (366)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 455 48999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=2e-05 Score=71.52 Aligned_cols=139 Identities=12% Similarity=0.057 Sum_probs=85.8
Q ss_pred ccee-cccCceEEEEEEEc-------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-C--CceeeEeeEEeeCC
Q 037297 76 NRIL-GQGGQGTVYKGMLE-------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-H--RNVVKLLGCCLETE 144 (366)
Q Consensus 76 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~ 144 (366)
.+.| +.|....+|+.... +++.+++|......... ......+.+|..+++.+. + ..+.+++.++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 3567 88889999988754 26678898765432000 000124566788877773 2 35677777765542
Q ss_pred ---cceEEEeeccCCCCC-------------CCCHHHHHHHHHHHHHHHHHHHhC-------------------------
Q 037297 145 ---VPLLHLHDHHRNEEF-------------PLTWEIRLRIATEVAGALSYLHSA------------------------- 183 (366)
Q Consensus 145 ---~~~~~~~~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lH~~------------------------- 183 (366)
..+++++...+.... .++......++.+++..|.-||+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFN 183 (357)
T ss_dssp TTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHH
T ss_pred ccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHH
Confidence 456777766554322 234444444445555544444421
Q ss_pred ------------------------------------CCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 184 ------------------------------------ASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 184 ------------------------------------~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
....++|+|+.|.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 184 WVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp HHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred HHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 02358999999999999965457899999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00047 Score=61.19 Aligned_cols=71 Identities=17% Similarity=0.051 Sum_probs=52.4
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC---CCceeeEeeEEeeCCcceEEEee
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
.+.|+.|....+|+... ++..+++|..... ....+..|.+.++.|. ...+++.+.++...+..+++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999876 4677889987643 1346778888888872 36778888887776777777765
Q ss_pred cc
Q 037297 153 HH 154 (366)
Q Consensus 153 ~~ 154 (366)
..
T Consensus 113 l~ 114 (312)
T 3jr1_A 113 LN 114 (312)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00017 Score=66.51 Aligned_cols=77 Identities=18% Similarity=0.189 Sum_probs=44.7
Q ss_pred cceecccCceEEEEEEEc-CCcEEEEEEeecccC-hHH--HHHHHHHHHHHHHHhcCC-C-C-ceeeEeeEEeeCCcceE
Q 037297 76 NRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVD-DEE--LLKLEEFINEIVILSQIN-H-R-NVVKLLGCCLETEVPLL 148 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~--~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~~ 148 (366)
.+.+|.|..+.||++... +++.+++|....... ... ....+.+..|.++++.+. + | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899998654321 000 001234567888887763 2 3 34455543 3445566
Q ss_pred EEeecc
Q 037297 149 HLHDHH 154 (366)
Q Consensus 149 ~~~~~~ 154 (366)
++++..
T Consensus 113 vmE~l~ 118 (397)
T 2olc_A 113 VMEDLS 118 (397)
T ss_dssp EECCCT
T ss_pred EEEeCC
Confidence 766654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0012 Score=59.21 Aligned_cols=30 Identities=30% Similarity=0.371 Sum_probs=26.8
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999888899999999774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00095 Score=55.15 Aligned_cols=96 Identities=17% Similarity=0.146 Sum_probs=61.7
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCc
Q 037297 155 RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234 (366)
Q Consensus 155 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y 234 (366)
..-..+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|+|.+.+ +.+. .....+
T Consensus 40 ~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~ 103 (229)
T 2yle_A 40 RLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPP 103 (229)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------------------
T ss_pred HHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-------------ccccCC
Confidence 3345589999999999999999877632211 1 1233457899999999998864 2110 112236
Q ss_pred cccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 037297 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 267 (366)
Q Consensus 235 ~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 267 (366)
.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 104 ~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 104 VAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 7888763 4556789999999999998875444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00084 Score=62.28 Aligned_cols=79 Identities=11% Similarity=0.083 Sum_probs=46.8
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceeeeeccccCCccccccccCCC---CCchhhHHHHHHHHHHHH
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQ---LTDKSDVYSFGVVLVELL 262 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~ 262 (366)
+.++|+|++|.|||++.++ +.++||+.+........-......-...|.+|+...... .....++.++...+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3499999999999999876 999999988654211000000000112356665443111 112355567788888776
Q ss_pred hCC
Q 037297 263 TGK 265 (366)
Q Consensus 263 ~g~ 265 (366)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0015 Score=57.09 Aligned_cols=56 Identities=18% Similarity=0.105 Sum_probs=41.7
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 129 (366)
.....-++.+|.|..+.||+....+|+.+.+|+.+...... ...+..|...|+.|.
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~----~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL----DGLFRAEALGLDWLG 69 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC----TTHHHHHHHHHHHHT
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch----hhHHHHHHHHHHHHH
Confidence 34555667899999999999999899999999876433221 124667888888773
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0049 Score=54.66 Aligned_cols=29 Identities=17% Similarity=0.189 Sum_probs=25.3
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.+.|||++.++.+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 48999999999999987666899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.002 Score=56.82 Aligned_cols=126 Identities=15% Similarity=0.094 Sum_probs=77.2
Q ss_pred cceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCce-eeEeeEEeeCCcceEEEeecc
Q 037297 76 NRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~~~ 154 (366)
.+.|+.|....+|++ ..+++|+....... ......|..+++.+...++ .+++.. ..+..+++++...
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 678999999999998 45888887653211 0112347766666632222 344443 2333455566651
Q ss_pred CCCCCCCCHHHHH---HHHHHHHHHHHHHHhCCC----------------------------------------------
Q 037297 155 RNEEFPLTWEIRL---RIATEVAGALSYLHSAAS---------------------------------------------- 185 (366)
Q Consensus 155 ~~~~~~l~~~~~~---~i~~~i~~~l~~lH~~~~---------------------------------------------- 185 (366)
.+ .++...... .+..+++..|.-||+.+.
T Consensus 91 ~g--~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~ 168 (301)
T 3dxq_A 91 GA--QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA 168 (301)
T ss_dssp TC--EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred CC--ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence 22 123333322 256777777777776431
Q ss_pred ----CCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 186 ----SPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 186 ----~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++|+|+.|.||+ ..++.+.++||..+..
T Consensus 169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12799999999999 5666889999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0072 Score=53.74 Aligned_cols=29 Identities=21% Similarity=0.227 Sum_probs=24.9
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3489999999999999 5 899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0042 Score=57.68 Aligned_cols=59 Identities=15% Similarity=0.222 Sum_probs=37.9
Q ss_pred cceecccCceEEEEEEEcC--------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCce-eeEeeEE
Q 037297 76 NRILGQGGQGTVYKGMLED--------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCC 140 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~ 140 (366)
.+.|+.|....||++...+ ++.+++|+...... .+.+..|..+++.+...++ +++++.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------ESHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc------HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 4568888889999998653 47899998843211 0234468888887743333 4555543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.007 Score=55.13 Aligned_cols=30 Identities=33% Similarity=0.371 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCCEEecCC----CeEEEeecCCcc
Q 037297 186 SPIYHRDIKSTNILLDER----YRAKVADFGTSK 215 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~----~~vkl~Dfg~a~ 215 (366)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 348999999999999876 789999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.004 Score=55.60 Aligned_cols=32 Identities=31% Similarity=0.389 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCCEEecCC----CeEEEeecCCcccc
Q 037297 186 SPIYHRDIKSTNILLDER----YRAKVADFGTSKFI 217 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~----~~vkl~Dfg~a~~~ 217 (366)
..++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999874 68999999988653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.04 Score=49.28 Aligned_cols=31 Identities=19% Similarity=0.363 Sum_probs=27.1
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.019 Score=53.65 Aligned_cols=60 Identities=13% Similarity=0.084 Sum_probs=36.3
Q ss_pred cceecccCceEEEEEEEcC-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCce-eeEeeEE
Q 037297 76 NRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCC 140 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~ 140 (366)
.+.|+.|-...+|++...+ +..+++|+........ . ...+|..+++.+...++ .++++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--i---dR~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--I---NREREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--S---CHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--c---CHHHHHHHHHHHHhcCCCCCEEEEe
Confidence 3567888889999998764 4788899875422110 0 11468888888854444 4555554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.91 E-value=0.34 Score=44.31 Aligned_cols=28 Identities=36% Similarity=0.528 Sum_probs=24.2
Q ss_pred eEeCCCCCCCEEe------cCCCeEEEeecCCcc
Q 037297 188 IYHRDIKSTNILL------DERYRAKVADFGTSK 215 (366)
Q Consensus 188 iiH~dikp~Nill------~~~~~vkl~Dfg~a~ 215 (366)
++|+|+.+.|||+ +++..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.93 E-value=0.1 Score=47.08 Aligned_cols=28 Identities=25% Similarity=0.453 Sum_probs=23.9
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.++|+|+.+.|||++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999998664 8999999875
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.42 E-value=0.12 Score=30.48 Aligned_cols=10 Identities=10% Similarity=0.441 Sum_probs=4.1
Q ss_pred HHHHHHHHhh
Q 037297 16 MLLRIIRKKR 25 (366)
Q Consensus 16 ~~~~~~~~~~ 25 (366)
.+..+.|||+
T Consensus 30 ~~~~~~RRR~ 39 (44)
T 2jwa_A 30 VFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHC
T ss_pred HHHhheehhh
Confidence 3334444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.28 E-value=0.083 Score=31.23 Aligned_cols=6 Identities=17% Similarity=0.634 Sum_probs=2.3
Q ss_pred HHHHHh
Q 037297 19 RIIRKK 24 (366)
Q Consensus 19 ~~~~~~ 24 (366)
++.|||
T Consensus 33 ~~~RRr 38 (44)
T 2ks1_B 33 LFMRRR 38 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.09 E-value=0.08 Score=31.22 Aligned_cols=6 Identities=33% Similarity=0.611 Sum_probs=2.3
Q ss_pred HHHHHh
Q 037297 19 RIIRKK 24 (366)
Q Consensus 19 ~~~~~~ 24 (366)
++.|||
T Consensus 32 ~~~RRR 37 (44)
T 2l2t_A 32 VYVRRK 37 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 333333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.69 E-value=0.27 Score=28.99 Aligned_cols=23 Identities=17% Similarity=0.170 Sum_probs=15.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhh
Q 037297 4 TLLVFLFQVIGRMLLRIIRKKRM 26 (366)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~ 26 (366)
+++++++.++..+++.+.+++++
T Consensus 21 v~~~~ii~~~~~~~~RRr~~~~k 43 (44)
T 2ks1_B 21 LLLLLVVALGIGLFMRRRHIVRK 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSC
T ss_pred HHHHHHHHHHHHHHhhhhHhhcc
Confidence 44445556666788888877764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.63 E-value=0.087 Score=49.28 Aligned_cols=63 Identities=8% Similarity=-0.015 Sum_probs=18.0
Q ss_pred cccceecccCceEEEEEEEcC-CcEEEE------EEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEe
Q 037297 74 NVNRILGQGGQGTVYKGMLED-GRIMAV------KKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 141 (366)
Q Consensus 74 ~~~~~lg~G~~g~V~~~~~~~-~~~vai------K~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (366)
.+.+.|| ||.||+|.+.. ...||+ |..+...... .....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~--e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE--KRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccc--cccccccccccccccccccccCCCcceEE
Confidence 4556676 99999999754 357888 6655433222 23456888999999999999999888643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.46 E-value=1.8 Score=35.50 Aligned_cols=111 Identities=7% Similarity=0.092 Sum_probs=73.2
Q ss_pred CCCceeeEeeEEeeCCcceEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 037297 129 NHRNVVKLLGCCLETEVPLLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY 204 (366)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~ 204 (366)
.||+.+.. .+-...+...+........ .-...+...+++++.+++....+++. =+|--++|+|++++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCC
Confidence 68888866 3444555433333222111 22357888999999999988855554 37888999999999999
Q ss_pred eEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHH-HHHHHHHHHHhCCCCCC
Q 037297 205 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVY-SFGVVLVELLTGKKPIF 269 (366)
Q Consensus 205 ~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw-slG~~l~el~~g~~p~~ 269 (366)
.+++.--|+... ++|. ..+ ..|.| .+=|++..+++++..|.
T Consensus 117 ~p~i~~RGik~~------------------l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV------------------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT------------------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC------------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999986665322 2222 112 23443 47888999999998874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.14 E-value=0.5 Score=43.49 Aligned_cols=30 Identities=20% Similarity=0.393 Sum_probs=26.2
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCccc
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKF 216 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~ 216 (366)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 34899999999999 7888999999998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.66 E-value=0.49 Score=27.84 Aligned_cols=23 Identities=9% Similarity=0.125 Sum_probs=14.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhh
Q 037297 4 TLLVFLFQVIGRMLLRIIRKKRM 26 (366)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~ 26 (366)
+++++++.++..+++.+.+++++
T Consensus 20 v~~v~ii~~~~~~~~RRRr~~~k 42 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKSIKKK 42 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHHhhhhhhhhc
Confidence 34444555666788888877764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.42 E-value=0.63 Score=27.34 Aligned_cols=25 Identities=24% Similarity=0.359 Sum_probs=17.8
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHhhh
Q 037297 2 ISTLLVFLFQVIGRMLLRIIRKKRM 26 (366)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~ 26 (366)
+++++++++.++..+++.+++.+++
T Consensus 19 VGvll~vi~~l~~~~~~RRR~~~~k 43 (44)
T 2jwa_A 19 VGILLVVVLGVVFGILIKRRQQKIR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCSCCC
T ss_pred HHHHHHHHHHHHHHhheehhhhhcc
Confidence 4555666667778888888877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 366 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-64
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 31/286 (10%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
V + +G G GTVYKG +AVK + + +L+ F NE+ +L + H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63
Query: 131 RNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
N++ +G ++ ++ L+ H E + IA + A + YLH+
Sbjct: 64 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLEPEY--- 239
I HRD+KS NI L E K+ DFG + + +H ++ G+ ++ PE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ + +SDVY+FG+VL EL+TG+ P + N Q + + + ++ L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIFMVGRGYLSPDLS 232
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
V+ N A L CL +RP ++ + + S
Sbjct: 233 K-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 5e-62
Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 33/277 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG G G V+ G +AVK K + + + F+ E ++ Q+ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67
Query: 131 RNVVKLLGCCLETEVPLL-------HLHDH-HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+ +V+L + + ++ L D LT L +A ++A ++++
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
HRD+++ NIL+ + K+ADFG ++ I ++ + + PE
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
T KSDV+SFG++L E++T + + + + L+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----------------VIQNLERGY 227
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ N L C + RPT + + L
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 9e-62
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 33/283 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ + +G G G V+ G + +A+K + EE +FI E ++ +++H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSH 59
Query: 131 RNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+V+L G CLE L L D+ R + E L + +V ++YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ + HRD+ + N L+ E KV+DFG ++F+ DQ +T + + PE
Sbjct: 120 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
S+ + KSDV+SFGV++ E+ + K + + + + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKI-----------------PYENRSNSEVVEDISTGF 219
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345
+ + C + RP + +L I S
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 9e-60
Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 33/277 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LGQG G V+ G +A+K K E F+ E ++ ++ H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRH 71
Query: 131 RNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+V+L E + ++ L L + +A ++A ++Y+
Sbjct: 72 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
HRD+++ NIL+ E KVADFG ++ I ++ + + PE
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+ T KSDV+SFG++L EL T + + + + D ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQVERGY 231
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ +L +C ++RPT E + L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 41/303 (13%)
Query: 66 LDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
++ + F LG G G V+K G +MA K L + + I E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIRELQV 57
Query: 125 LSQINHRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
L + N +V G + D + + +I +++ V L
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEP 237
+YL I HRD+K +NIL++ R K+ DFG S + + GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-------------------- 277
E Q + + +SD++S G+ LVE+ G+ PI E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 278 -NVSLAAFFVHSMRKNHMYDILD----DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
L+++ + S ++++LD + KL + F + +CL N +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 333 EEV 335
+++
Sbjct: 293 KQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 7e-59
Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 37/288 (12%)
Query: 65 ELDKATNHFNVNRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEELLKLEEFINEIV 123
E+++ + LG G G VY+G+ + +AVK K E+ +++EEF+ E
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 65
Query: 124 ILSQINHRNVVKLLGCCLETEVPLLH---------LHDHHRNEEFPLTWEIRLRIATEVA 174
++ +I H N+V+LLG C + L ++ + L +AT+++
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
A+ YL HRD+ + N L+ E + KVADFG S+ + D + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294
PE ++ + KSDV++FGV+L E+ T + + SQ +
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------V 225
Query: 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
Y++L+ + L C N RP+ E+ +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-58
Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 50/324 (15%)
Query: 45 QMLNSYDDSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLED----GRIMAV 100
+++ + VI L + N ++G+G G VY G L D AV
Sbjct: 12 ELVQAVQHVVIGPSSLI-----------VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 101 KKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL---------HLH 151
K D E+ +F+ E +I+ +H NV+ LLG CL +E L L
Sbjct: 61 KSLNRITDIGEV---SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 152 DHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211
+ RNE T + + +VA + +L S HRD+ + N +LDE++ KVADF
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 212 GTSKFIA---MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 268
G ++ + D H T + ++ E Q+ + T KSDV+SFGV+L EL+T P
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKK 328
+ NT ++ R+ + D + +C +
Sbjct: 235 YPDVNTFD-----ITVYLLQGRRLLQPEYCPDP------------LYEVMLKCWHPKAEM 277
Query: 329 RPTMEEVTMELNGIRGSNFGHKMI 352
RP+ E+ ++ I + G +
Sbjct: 278 RPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-57
Identities = 55/277 (19%), Positives = 106/277 (38%), Gaps = 33/277 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ LG G G V G +A+K K E+ EFI E ++ ++H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSH 58
Query: 131 RNVVKLLGCCLETEVPLLH--------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
+V+L G C + + L ++ R + L + +V A+ YL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
HRD+ + N L++++ KV+DFG S+++ D+ + + + PE
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
S+ + KSD+++FGV++ E+ + K + S+ + + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQGL 218
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ C +RPT + + +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-57
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+ + +G+G G V G G +AVK K + F+ E +++Q+ H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRH 59
Query: 131 RNVVKLLGCCLETEVPLL---------HLHDH-HRNEEFPLTWEIRLRIATEVAGALSYL 180
N+V+LLG +E + L L D+ L + L+ + +V A+ YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYH 240
+ HRD+ + N+L+ E AKV+DFG +K + Q + + PE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEAL 172
Query: 241 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
+ + + KSDV+SFG++L E+ + + + V + K + D D
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPDG 224
Query: 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
A + + C L+ RP+ ++ +L I+
Sbjct: 225 CP---------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 8e-57
Identities = 59/307 (19%), Positives = 119/307 (38%), Gaps = 48/307 (15%)
Query: 61 FSSKELDKATNHFN---------VNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAV 107
F+ ++ ++A F + +++G G G V G L + +A+K K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 108 DDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH--------LHDHHRNEEF 159
+++ +F++E I+ Q +H NV+ L G ++ ++ L R +
Sbjct: 67 TEKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 160 PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
T + + +A + YL HRD+ + NIL++ KV+DFG S+F+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 220 DQTHVTTK----IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 275
D + T + + PE Q + T SDV+S+G+V+ E+++ + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 276 QENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + ++ + A L C + RP ++
Sbjct: 241 D-----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 336 TMELNGI 342
L+ +
Sbjct: 284 VNTLDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-56
Identities = 60/295 (20%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDG-----RIMAVKKFKLAVDDEELLKLEE 117
+ E+ + +++G G G VYKGML+ +A+K K +++ +
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VD 55
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRI 169
F+ E I+ Q +H N+++L G + + ++ L R ++ + + +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 170 ATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK 227
+A + YL + HRD+ + NIL++ KV+DFG S+ + D T+ T+
Sbjct: 116 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 228 IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH 287
+ + PE + T SDV+SFG+V+ E++T + +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-----------------W 215
Query: 288 SMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ + + ++D + A L +C +RP ++ L+ +
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 2e-55
Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 40/291 (13%)
Query: 56 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK 114
D +LF + +K F+ R +G G G VY + + ++A+KK + K
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-K 58
Query: 115 LEEFINEIVILSQINHRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRL 167
++ I E+ L ++ H N ++ GC L L D + PL
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 227
+ L+YLHS + HRD+K+ NILL E K+ DFG++ +A + V
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV--- 172
Query: 228 IQGTFGYLEPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
GT ++ PE Q K DV+S G+ +EL K P+F+ S
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------- 222
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+Y I ++ L + F N + CL + RPT E +
Sbjct: 223 ---------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-55
Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 34/283 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+ R +G+G G V++G+ +A+K K D E+F+ E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQEALTMR 63
Query: 127 QINHRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
Q +H ++VKL+G E V ++ L + ++ L + A +++ AL+Y
Sbjct: 64 QFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
L S HRDI + N+L+ K+ DFG S+++ + +K + ++ PE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
+ T SDV+ FGV + E+L F + + + + M
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPMPPNCP 235
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+L +C + +RP E+ +L+ I
Sbjct: 236 PT------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-55
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 37/279 (13%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ V +G G G K DG+I+ K+ E + + ++E+ +L ++ H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKHP 63
Query: 132 NVVKLLGCCLETEVP-------------LLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
N+V+ ++ L + E L E LR+ T++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 179 YLH--SAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
H S + HRD+K N+ LD + K+ DFG ++ + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PE +KSD++S G +L EL P F +K
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----------------FTAFSQKELAGK 225
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
I + + ++ + R L+L RP++EE+
Sbjct: 226 IREGKFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 60/276 (21%), Positives = 116/276 (42%), Gaps = 33/276 (11%)
Query: 76 NRILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRN 132
++ LG G GTV KG + + +AVK K +D L +E + E ++ Q+++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 133 VVKLLGCC------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASS 186
+V+++G C L E+ L + + + + + + + +V+ + YL S
Sbjct: 70 IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 187 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLEPEYHQSSQ 244
HRD+ + N+LL ++ AK++DFG SK + D+ + + + PE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 245 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVK 304
+ KSDV+SFGV++ E + + + S+ + +L+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGERM 229
Query: 305 LVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340
+L C + + RP V + L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-54
Identities = 73/273 (26%), Positives = 109/273 (39%), Gaps = 34/273 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F + R LG+G G VY + I+A+K A ++ ++ + E+ I S +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLR 64
Query: 130 HRNVVKLLGCCLETEVPLLH-------LHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H N+++L G + L + + TE+A ALSY HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ HRDIK N+LL K+ADFG S + + GT YL PE +
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+K D++S GV+ E L GK P NT QE + S + D + +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQE-----TYKRISRVEFTFPDFVTEGA 231
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
L+ R L N +RP + EV
Sbjct: 232 RDLIS------------RLLKHNPSQRPMLREV 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 8e-54
Identities = 58/283 (20%), Positives = 121/283 (42%), Gaps = 36/283 (12%)
Query: 73 FNVNRILGQGGQGTVYKGML-----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
F ++LG G GTVYKG+ + +A+K+ + A + +E ++E +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMAS 67
Query: 128 INHRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYL 180
+++ +V +LLG CL + V L+ L D+ R + + + L ++A ++YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 181 HSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEY 239
+ HRD+ + N+L+ K+ DFG +K + ++ + + ++ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
T +SDV+S+GV + EL+T + + + + IL+
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----------------DGIPASEISSILE 227
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ + +C ++ RP E+ +E + +
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-53
Identities = 63/302 (20%), Positives = 108/302 (35%), Gaps = 34/302 (11%)
Query: 77 RILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL 136
+G+G G V++G G +AVK F + EI + H N++
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-----REAEIYQTVMLRHENILGF 62
Query: 137 LGCCLETEVPLLHLH---DHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAA-- 184
+ + L D+H + + +T E +++A A L++LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 185 ---SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLEPE 238
I HRD+KS NIL+ + +AD G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 239 YHQSS------QLTDKSDVYSFGVVLVELLTGKKP--IFSTGNTSQENVSLAAFFVHSMR 290
S + ++D+Y+ G+V E+ I ++ + V MR
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 291 KNHMYDILDDQVVKLVKKNQIM-AFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGH 349
K L + + + + A + C NG R T + L+ + G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE-GI 301
Query: 350 KM 351
KM
Sbjct: 302 KM 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-53
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEE 117
KL S + + +GQG GTVY M + G+ +A+++ L ++ E
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----EL 63
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDHHRNE------EFPLTWEIRLRIAT 171
INEI+++ + + N+V L L + + + E + +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
E AL +LHS + HRDIKS NILL K+ DFG I +Q+ +T + GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291
++ PE K D++S G++ +E++ G+ P +++
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPL 222
Query: 292 NHMYDILDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEEV 335
+Y I + +L ++ F + RCLD++ +KR + +E+
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-53
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 36/292 (12%)
Query: 64 KELDKATNHFNV-NRILGQGGQGTVYKGML---EDGRIMAVKKFKLAVDDEELLKLEEFI 119
K+L ++ + + LG G G+V +G+ + +A+K K + + EE +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMM 57
Query: 120 NEIVILSQINHRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATE 172
E I+ Q+++ +V+L+G C + L+ LH + + + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 173 VAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQG 230
V+ + YL HRD+ + N+LL R+ AK++DFG SK + D ++ T + +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
+ PE + + +SDV+S+GV + E L+ + + + F+ +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQGK 229
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342
+ + L C + RP V +
Sbjct: 230 RMECPPECPPE------------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-53
Identities = 48/276 (17%), Positives = 100/276 (36%), Gaps = 36/276 (13%)
Query: 73 FNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ +G+G TVYKG+ E +A + + + + + F E +L + H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHP 68
Query: 132 NVVKLLGCCLETEVPLLHLH-----------DHHRNEEFPLTWEIRLRIATEVAGALSYL 180
N+V+ T + + + ++ ++ L +L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 181 HSAASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
H+ + PI HRD+K NI + K+ D G + + + GT ++ PE
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEM 184
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299
++ + + DVY+FG+ ++E+ T + P + +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYP----------------YSECQNAAQIYRRVTS 227
Query: 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
K I + E C+ N +R +++++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-52
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 41/288 (14%)
Query: 63 SKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINE 121
+++L+ + + + LG G G VYK E + A K ++E LE+++ E
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVE 59
Query: 122 IVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEV 173
I IL+ +H N+VKLL + + E PLT + +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 174 AGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 233
AL+YLH I HRD+K+ NIL K+ADFG S + I GT
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 234 YLEPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHS 288
++ PE D K+DV+S G+ L+E+ + P
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----------------HHEL 218
Query: 289 MRKNHMYDILDDQVVKLVKKNQI-MAFANLAERCLDLNGKKRPTMEEV 335
+ I + L + ++ F + ++CL+ N R T ++
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-52
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+++ + LG+G G V + +AVK + + E EI I +N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLN 61
Query: 130 HRNVVKLLGCCLETEVPLL-------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H NVVK G E + L + + R ++ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLEPEYHQ 241
I HRDIK N+LLDER K++DFG + ++ + K+ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 242 SSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300
+ + DV+S G+VL +L G+ P ++ QE + + + +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDS 234
Query: 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ L+ + L N R T+ ++
Sbjct: 235 APLALLH------------KILVENPSARITIPDI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 7e-52
Identities = 66/317 (20%), Positives = 116/317 (36%), Gaps = 61/317 (19%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEE 117
L+ N+ R +G+G G V++ E ++AVK K + +
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QAD 62
Query: 118 FINEIVILSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEF------ 159
F E ++++ ++ N+VKLLG C + L L +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 160 -------------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRA 206
PL+ +L IA +VA ++YL HRD+ + N L+ E
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179
Query: 207 KVADFGTSKFIAM-DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK 265
K+ADFG S+ I D ++ PE ++ T +SDV+++GVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 266 KPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLN 325
+ + +Y + D ++ +N + NL C
Sbjct: 240 LQPYYGMAHEE----------------VIYYVRDGNILACP-ENCPLELYNLMRLCWSKL 282
Query: 326 GKKRPTMEEVTMELNGI 342
RP+ + L +
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 8e-52
Identities = 69/321 (21%), Positives = 122/321 (38%), Gaps = 55/321 (17%)
Query: 55 IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVD 108
ID +L + + N + + LG G G V + + +AVK K +
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 109 DEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL------------HLHDHH- 154
E E ++E+ +LS + NH N+V LLG C L+ L
Sbjct: 67 LTER---EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 155 ------------RNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE 202
++E L E L + +VA +++L S HRD+ + NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180
Query: 203 RYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVEL 261
K+ DFG ++ I D + V + ++ PE + T +SDV+S+G+ L EL
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 262 LTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERC 321
+ + + Y ++ + L ++ ++ + C
Sbjct: 241 FSLGSSPYPGMPVDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 322 LDLNGKKRPTMEEVTMELNGI 342
D + KRPT +++ +
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-51
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 33/282 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+ LG G G V +G + +AVK K V + +++FI E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVNAMH 66
Query: 127 QINHRNVVKLLGCCLETE-------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
++HRN+++L G L PL L D R + R A +VA + Y
Sbjct: 67 SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTFGYLEP 237
L S HRD+ + N+LL R K+ DFG + + + H + + F + P
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 238 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDI 297
E ++ + SD + FGV L E+ T + + N SQ ++ I
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------------ILHKI 227
Query: 298 LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMEL 339
+ ++ N+ +C + RPT + L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (430), Expect = 3e-50
Identities = 57/301 (18%), Positives = 112/301 (37%), Gaps = 39/301 (12%)
Query: 50 YDDSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFK 104
YD+ V D K + + + D +H++++ LG G G V++ G A K
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 105 LAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRN 156
+ ++ E EI +S + H +V L + ++ L + +
Sbjct: 61 TPHESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116
Query: 157 EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL--DERYRAKVADFGTS 214
E ++ + + +V L ++H H D+K NI+ K+ DFG +
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 274
+ Q+ T GT + PE + + +D++S GV+ LL+G P F N
Sbjct: 174 AHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-FGGEND 230
Query: 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
+ K+ +++ D + + + + L + R T+ +
Sbjct: 231 DE---------TLRNVKSCDWNMDDSAFSGISE-----DGKDFIRKLLLADPNTRMTIHQ 276
Query: 335 V 335
Sbjct: 277 A 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-50
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 52/300 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDG---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQ 127
N ++G+G G V K ++ A+K+ K ++ +F E+ +L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCK 66
Query: 128 I-NHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEFP-----------LTW 163
+ +H N++ LLG C L L E P L+
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 164 EIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223
+ L A +VA + YL HRD+ + NIL+ E Y AK+ADFG S+ +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYV 181
Query: 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 283
T + ++ E S T SDV+S+GV+L E+++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-------------- 227
Query: 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343
M +Y+ L N +L +C +RP+ ++ + LN +
Sbjct: 228 ---CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-50
Identities = 61/308 (19%), Positives = 108/308 (35%), Gaps = 60/308 (19%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLED------GRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
+ ++LG G G V +AVK K D E E ++E+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKM 93
Query: 125 LSQI-NHRNVVKLLGCCLETEVPLL------------HLHDHHRN--------------- 156
++Q+ +H N+V LLG C + L +L
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 157 ---EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213
+ LT+E L A +VA + +L HRD+ + N+L+ K+ DFG
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 214 SKFIAMDQTHVT-TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 272
++ I D +V + ++ PE T KSDV+S+G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
Y ++ + + + C + +KRP+
Sbjct: 271 PVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 333 EEVTMELN 340
+T L
Sbjct: 315 PNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 47/301 (15%)
Query: 71 NHFNVNRILGQGGQGTVYKGML------EDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
++R LGQG G VY+G+ E +A+K A E EF+NE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASV 76
Query: 125 LSQINHRNVVKLLGCCLETEVPLL------------HLHDHHRNEEF-----PLTWEIRL 167
+ + N +VV+LLG + + L+ +L P + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 168 RIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTT 226
++A E+A ++YL++ + HRD+ + N ++ E + K+ DFG ++ I D
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 227 KIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFV 286
K ++ PE + T SDV+SFGVVL E+ T + + + Q +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VL 245
Query: 287 HSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346
+ + + D D+ L L C N K RP+ E+ +
Sbjct: 246 RFVMEGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
Query: 347 F 347
F
Sbjct: 297 F 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 5e-47
Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 54/308 (17%)
Query: 71 NHFNVNRILGQGGQGTVYKGM------LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVI 124
+ + + LG+G G V + R +AVK K E ++E+ I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 69
Query: 125 LSQINHR-NVVKLLGCCLETEVPLL---------HLHDHHRNE---------------EF 159
L I H NVV LLG C + PL+ +L + R++ +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 160 PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219
LT E + + +VA + +L S HRD+ + NILL E+ K+ DFG ++ I
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 220 DQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 278
D +V + ++ PE T +SDV+SFGV+L E+ + + +E
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245
Query: 279 VSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338
L + C +RPT E+
Sbjct: 246 ---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 339 LNGIRGSN 346
L + +N
Sbjct: 291 LGNLLQAN 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 8e-47
Identities = 56/304 (18%), Positives = 115/304 (37%), Gaps = 39/304 (12%)
Query: 47 LNSYDDSVIDRCKLFSSKELDKAT----NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVK 101
+N YD D K + + ++ +++++ LG G G V++ + GR+ K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 102 KFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDH 153
++ NEI I++Q++H ++ L + +L L D
Sbjct: 61 FINTPYPLDK----YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 154 HRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADF 211
E++ ++ + + L ++H I H DIK NI+ + + K+ DF
Sbjct: 117 IAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 173
Query: 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 271
G + + D+ T T + PE + +D+++ GV+ LL+G P F+
Sbjct: 174 GLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-FAG 230
Query: 272 GNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT 331
+ + K ++ +D + + + L +KR T
Sbjct: 231 EDDLE---------TLQNVKRCDWEFDEDAFSSVSP-----EAKDFIKNLLQKEPRKRLT 276
Query: 332 MEEV 335
+ +
Sbjct: 277 VHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-46
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 39/283 (13%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
KEL + + LG+G G V++ + + K K+ D+ L EI
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-----VKKEI 52
Query: 123 VILSQINHRNVVKLLGCCLETE--------VPLLHLHDHHRNEEFPLTWEIRLRIATEVA 174
IL+ HRN++ L E + L + + F L + +V
Sbjct: 53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 232
AL +LHS I H DI+ NI+ K+ +FG ++ +
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAP 167
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
Y PE HQ ++ +D++S G ++ LL+G P F Q + N
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQ---------IIENIMN 217
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
Y ++ ++ + +R L K R T E
Sbjct: 218 AEYTFDEEAFKEISI-----EAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (397), Expect = 2e-46
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 38/291 (13%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
++ + + ILG GG V+ L R +AVK + + + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF-YLRFRREAQNAAAL 64
Query: 129 NHRNVVKLLGCCLETEVPLLHLH-----------DHHRNEEFPLTWEIRLRIATEVAGAL 177
NH +V + + + E P+T + + + + AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 178 SYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYL 235
++ H I HRD+K NI++ KV DFG ++ IA V T + GT YL
Sbjct: 125 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 236 EPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295
PE + + +SDVYS G VL E+LTG+ P F + Y
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----------------FTGDSPVSVAY 224
Query: 296 DILDDQVVKLVKKNQIM--AFANLAERCLDLNGKKRP-TMEEVTMELNGIR 343
+ + + +++ + + + L N + R T E+ +L +
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-46
Identities = 66/277 (23%), Positives = 106/277 (38%), Gaps = 32/277 (11%)
Query: 68 KATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
K F +ILG+G TV L R A+K + +E K+ E ++S
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMS 63
Query: 127 QINHRNVVKLLGCCLETEVPLLHL-------HDHHRNEEFPLTWEIRLRIATEVAGALSY 179
+++H VKL + E L + + E+ AL Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLEPE 238
LH I HRD+K NILL+E ++ DFGT+K ++ + + GT Y+ PE
Sbjct: 124 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 239 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
SD+++ G ++ +L+ G P F GN + + +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL------------IFQKIIKLEY 227
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
D + +L E+ L L+ KR EE+
Sbjct: 228 D------FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (396), Expect = 4e-46
Identities = 57/282 (20%), Positives = 103/282 (36%), Gaps = 22/282 (7%)
Query: 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
++ +G+G G VYK G A+KK +L +DE + I EI IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKH 59
Query: 131 RNVVKLLGCC-------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSA 183
N+VKL L E L E L ++ ++Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 184 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSS 243
+ HRD+K N+L++ K+ADFG ++ + T +I + S
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 244 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ----------ENVSLAAFFVHSMRKNH 293
+ + D++S G + E++ G Q N + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 294 MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + + + K + +L + L L+ +R T ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-45
Identities = 59/292 (20%), Positives = 101/292 (34%), Gaps = 29/292 (9%)
Query: 68 KATNHFNVNRILGQGGQGTVYKG--MLEDGRIMAVKKFKLAVDDEEL-LKLEEFINEIVI 124
+A + +G+G G V+K + GR +A+K+ ++ +E + L + +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 125 LSQINHRNVVKLLGCCLETEVPLL-------------HLHDHHRNEEFPLTWEIRLRIAT 171
L H NVV+L C + + E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 172 EVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 231
++ L +LHS + HRD+K NIL+ + K+ADFG ++ + + T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VT 178
Query: 232 FGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291
Y PE S D++S G + E+ K + + Q L +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 292 NHMYDILDDQVVKLVKKNQIMAFA--------NLAERCLDLNGKKRPTMEEV 335
L Q I F +L +CL N KR +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 56/305 (18%)
Query: 71 NHFNVNRILGQGGQGTVYKGML--------EDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
+ + + LG+G G V +AVK K +++L + I+E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEM 69
Query: 123 VILSQI-NHRNVVKLLGCCLETEVPLL------------HLHDHHR-----------NEE 158
++ I H+N++ LLG C + + +L N E
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 159 FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218
L+ + + A +VA + YL S HRD+ + N+L+ E K+ADFG ++ I
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 219 MDQTHVTTK-IQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 277
+ T + ++ PE T +SDV+SFGV+L E+ T + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245
Query: 278 NVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337
++ +L + N + C +RPT +++
Sbjct: 246 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 338 ELNGI 342
+L+ I
Sbjct: 290 DLDRI 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 56/285 (19%), Positives = 106/285 (37%), Gaps = 28/285 (9%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH 130
+F +G+G G VYK G ++A+KK +L + E + I EI +L ++NH
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELNH 60
Query: 131 RNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
N+VKLL L + + + ++ L++ HS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ HRD+K N+L++ K+ADFG ++ + T ++ +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKP------------IFSTGNTSQENVSLAAFFVHSMR 290
+ D++S G + E++T + IF T T E V + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ D + ++ +L + L + KR + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDE--DGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 56/285 (19%), Positives = 108/285 (37%), Gaps = 26/285 (9%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ +G+G GTV+K E I+A+K+ +L DDE + + EI +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELK 59
Query: 130 HRNVVKLLGCC-------LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H+N+V+L L E L + + L EI ++ L + HS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ HRD+K N+L++ K+A+FG ++ + + ++ + +
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+ D++S G + EL +P+F GN + + + + + +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 303 VKLVKKNQIM------------AFANLAERCLDLNGKKRPTMEEV 335
K +L + L N +R + EE
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-44
Identities = 58/277 (20%), Positives = 95/277 (34%), Gaps = 21/277 (7%)
Query: 77 RILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEE-FINEIVILSQINHRNVV 134
LG+G TVYK +I+A+KK KL E + + EI +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 135 KLLGC-------CLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSP 187
LL L + L ++ LT L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HW 120
Query: 188 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTD 247
I HRD+K N+LLDE K+ADFG +K T ++ + +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 248 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF---------VHSMRKNHMYDIL 298
D+++ G +L ELL + + Q + S+ +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + +L + N R T +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 1e-43
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 35/276 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F + R LG G G V+ +GR A+K K + ++E +E ++LS +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 62
Query: 130 HRNVVKLLGCCLE-------TEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H ++++ G + + + + A EV AL YLHS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I +RD+K NILLD+ K+ DFG +K++ + GT Y+ PE +
Sbjct: 123 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVST 175
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
D +SFG+++ E+L G P F NT + + + ++ V
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMK------TYEKILNAELRFPPFFNEDV 228
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338
L+ R + + +R + E
Sbjct: 229 KDLLS------------RLITRDLSQRLGNLQNGTE 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 1e-43
Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 34/283 (12%)
Query: 64 KELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEI 122
K+ + + ++ +LG G V +++A+K + K NEI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEI 58
Query: 123 VILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVA 174
+L +I H N+V L L L D + T R+ +V
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVL 117
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
A+ YLH + LDE + ++DFG SK D V + GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGY 175
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294
+ PE + D +S GV+ LL G P F
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----------------FYDENDAKLF 218
Query: 295 YDILDDQVVKLVKKNQIM--AFANLAERCLDLNGKKRPTMEEV 335
IL + + + + ++ + +KR T E+
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-43
Identities = 55/292 (18%), Positives = 104/292 (35%), Gaps = 32/292 (10%)
Query: 70 TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI 128
+ +G+G G V + +A+KK + + EI IL +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC---QRTLREIKILLRF 63
Query: 129 NHRNVVKLLGCCLETEVP----------LLHLHDHHRNEEFPLTWEIRLRIATEVAGALS 178
H N++ + + L+ + + L+ + ++ L
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKIQGTFGYLE 236
Y+HSA + HRD+K +N+LL+ K+ DFG ++ D H T+ T Y
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 237 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP------------IFSTGNTSQENVSLAA 283
PE +S+ KS D++S G +L E+L+ + I + +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 284 FFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + + + N +L ++ L N KR +E+
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (368), Expect = 6e-42
Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 72 HFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLK-----LEEFINEIVIL 125
++ ILG+G V + + + AVK + + E + E+ IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 126 SQIN-HRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGA 176
+++ H N+++L L L D+ + L+ + +I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 122
Query: 177 LSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
+ LH I HRD+K NILLD+ K+ DFG S + D ++ GT YL
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLA 177
Query: 237 PEYHQSSQL------TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
PE + S + D++S GV++ LL G P + M
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----------LRMI 227
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ Y + +L R L + +KR T EE
Sbjct: 228 MSGNYQFGSPEWDDYSD-----TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-41
Identities = 58/272 (21%), Positives = 96/272 (35%), Gaps = 31/272 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
F ++++LG+G G V+ + + A+K K V + + + V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 130 HRNVVKLLGCCLETEVPLLHLH-------DHHRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H + + E + +H A E+ L +LHS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
I +RD+K NILLD+ K+ADFG K + T GT Y+ PE
Sbjct: 122 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+ D +SFGV+L E+L G+ P F + + F M L+ +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE------LFHSIRMDNPFYPRWLEKEA 230
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEE 334
L+ + +KR +
Sbjct: 231 KDLLV------------KLFVREPEKRLGVRG 250
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 46/280 (16%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKL--AVDDEELLKLEEFINEIVILSQ 127
+ + V +LG GG G+VY G+ + D +A+K + D EL E+V+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 128 IN--HRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGAL 177
++ V++LL + +L E L E+ +V A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 178 SYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
+ H+ + HRDIK NIL+D R K+ DFG+ + + V T GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSP 177
Query: 237 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295
PE+ + + +S V+S G++L +++ G P F H
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEIIRGQ 220
Query: 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+V +L CL L RPT EE+
Sbjct: 221 VFFRQRVSS--------ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 2e-41
Identities = 49/288 (17%), Positives = 91/288 (31%), Gaps = 38/288 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N + + R +G G G +Y G + G +A+K + + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQ 60
Query: 130 HRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
+ + C + L D + + L +A ++ + Y+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 182 SAASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV------TTKIQGTF 232
S HRD+K N L + + DFG +K +TH + GT
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 233 GYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN 292
Y H + + + D+ S G VL+ G P ++ +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----------QKYE 226
Query: 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340
+ + ++++ K FA C L +P +
Sbjct: 227 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 39/291 (13%)
Query: 60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFK--LAVDDEELLKLE 116
+F + +D ++++ LG G V K G A K K + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 117 EFINEIVILSQINHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLR 168
+ E+ IL +I H NV+ L +L L D +E LT E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATE 117
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAMDQTHV 224
++ + YLHS I H D+K NI+L +R R K+ DFG + I D +
Sbjct: 118 FLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNE 172
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAF 284
I GT ++ PE L ++D++S GV+ LL+G P G+T QE
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQE------- 223
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ Y+ D+ + R L + KKR T+++
Sbjct: 224 -TLANVSAVNYEFEDEYFSNTSA-----LAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-41
Identities = 59/291 (20%), Positives = 103/291 (35%), Gaps = 40/291 (13%)
Query: 73 FNVNRILGQGGQGTVYKGML-EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ +++G G G VY+ L + G ++A+KK E+ I+ +++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 73
Query: 132 NVVKLLGCCLETEVPL----------------LHLHDHHRNEEFPLTWEIRLRIATEVAG 175
N+V+L + + H+ + L ++
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 176 ALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 234
+L+Y+HS I HRDIK N+LLD + K+ DFG++K + + +V+ I +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYR 189
Query: 235 LEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ----------ENVSLAAF 284
++ T DV+S G VL ELL G+ Q
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 285 FVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + I K+ + L R L+ R T E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-41
Identities = 59/303 (19%), Positives = 105/303 (34%), Gaps = 36/303 (11%)
Query: 61 FSSKELDKAT----NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKL 115
F +E+ K + + +G G G V + G +A+KK E K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK- 62
Query: 116 EEFINEIVILSQINHRNVVKLLGCCLETEV-----------PLLHLHDHHRNEEFPLTWE 164
E+ +L + H NV+ LL E P + + L +
Sbjct: 63 -RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224
+ ++ L Y+H+A I HRD+K N+ ++E K+ DFG ++ + +
Sbjct: 122 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM 175
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP------------IFSTG 272
T + + + T D++S G ++ E++TGK I
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
T + L+ + + N NL E+ L L+ ++R T
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 333 EEV 335
E
Sbjct: 296 GEA 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 1e-39
Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 35/280 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKF--KLAVDDEELLKLEEFINEIVILSQ 127
N F+V+RI+G+GG G VY + G++ A+K K + + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 128 INHRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
+ +V + + LH H ++R A E+ L +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGLEH 122
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
+H+ + +RD+K NILLDE +++D G + + + H + GT GY+ PE
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEV 176
Query: 240 HQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298
Q D +D +S G +L +LL G P + + + + D
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELPDSF 232
Query: 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338
++ L++ L + +R +
Sbjct: 233 SPELRSLLE------------GLLQRDVNRRLGCLGRGAQ 260
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 59/300 (19%), Positives = 115/300 (38%), Gaps = 42/300 (14%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + +GQG G V+K + G+ +A+KK + + E + EI IL +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLLK 67
Query: 130 HRNVVKLLGCCLETEVPLLH---------------LHDHHRNEEFPLTWEIRLRIATEVA 174
H NVV L+ C P L N T R+ +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML- 126
Query: 175 GALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKIQGT 231
L+ L+ + I HRD+K+ N+L+ K+ADFG ++ ++ + + T T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 232 FGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
Y PE + D++ G ++ E+ T + GNT Q ++L + S+
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCGSIT 242
Query: 291 KNHMYDILDDQVVKLVKKNQIM---------------AFANLAERCLDLNGKKRPTMEEV 335
++ + ++ + ++ + +L ++ L L+ +R ++
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 61/276 (22%), Positives = 99/276 (35%), Gaps = 32/276 (11%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
N F+ ++LG+G G V GR A+K + V + ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63
Query: 130 HRNVVKLLGCCLETEVPLLHLHDH-------HRNEEFPLTWEIRLRIATEVAGALSYLHS 182
H + L + + H + E T E E+ AL YLHS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ +RDIK N++LD+ K+ DFG K D GT YL PE +
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
+ D + GVV+ E++ G+ P F + + F + M + L +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER------LFELILMEEIRFPRTLSPEA 232
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338
L+ L + K+R +
Sbjct: 233 KSLLA------------GLLKKDPKQRLGGGPSDAK 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (340), Expect = 8e-38
Identities = 42/285 (14%), Positives = 88/285 (30%), Gaps = 40/285 (14%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
H+ V R +G+G G +++G L + + +A+K D + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLA 58
Query: 130 HRNVVKLLGCCLETEVPLL--------HLHDHHRNEEFPLTWEIRLRIATEVAGALSYLH 181
+ + + + + L D + + A ++ + +H
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 182 SAASSPIYHRDIKSTNILLDERYR-----AKVADFGTSKFIAMDQTHV------TTKIQG 230
+ +RDIK N L+ V DFG KF T + G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 231 TFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290
T Y+ H + + + D+ + G V + L G P + + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----------QK 224
Query: 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + ++ + F +L P + +
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-37
Identities = 49/279 (17%), Positives = 93/279 (33%), Gaps = 43/279 (15%)
Query: 75 VNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRN 132
+++LG G G V + A+K + + E+ + + +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPH 66
Query: 133 VVKLLGCCLETE------------VPLLHLHDH-HRNEEFPLTWEIRLRIATEVAGALSY 179
+V+++ + L + T I + A+ Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 180 LHSAASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLE 236
LHS I HRD+K N+L + K+ DFG +K + T T Y+
Sbjct: 127 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181
Query: 237 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
PE + D++S GV++ LL G P +S + + + + Y+
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTRIRMGQYE 235
Query: 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + ++ + L L +R T+ E
Sbjct: 236 FPNPEWSEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 2e-36
Identities = 57/276 (20%), Positives = 97/276 (35%), Gaps = 35/276 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ F+ + LG G G V E G A+K +L ++E +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ-KVVKLKQIEHTLNEKRILQAVN 99
Query: 130 HRNVVKLLGCCLETEVPLLHLHDHHRNEEF-------PLTWEIRLRIATEVAGALSYLHS 182
+VKL + + + E F + A ++ YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 183 AASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQS 242
+ +RD+K N+L+D++ +V DFG +K + + GT L PE S
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILS 212
Query: 243 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302
D ++ GV++ E+ G P F Q + K +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP-FFADQPIQ------IYEKIVSGKVRFPSHFSSDL 265
Query: 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME 338
L++ L ++ KR + +
Sbjct: 266 KDLLR------------NLLQVDLTKRFGNLKNGVN 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 9e-36
Identities = 57/303 (18%), Positives = 100/303 (33%), Gaps = 36/303 (11%)
Query: 61 FSSKELDKA----TNHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKL 115
F +EL+K + +G G G+V + G +AVKK
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HA 61
Query: 116 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLH-----------DHHRNEEFPLTWE 164
+ E+ +L + H NV+ LL ++ + LT +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 165 IRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 224
+ ++ L Y+HSA I HRD+K +N+ ++E K+ DFG ++ +
Sbjct: 122 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EM 175
Query: 225 TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP------------IFSTG 272
T + + D++S G ++ ELLTG+ I
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 273 NTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTM 332
T + + + V +L E+ L L+ KR T
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 333 EEV 335
+
Sbjct: 296 AQA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-35
Identities = 69/284 (24%), Positives = 101/284 (35%), Gaps = 36/284 (12%)
Query: 71 NHFNVNRILGQGGQGTVYKGML----EDGRIMAVKKFKLAVDDEELLKLEEFINEIVILS 126
+F + ++LG G G V+ + G++ A+K K A ++ E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 127 QINHR-NVVKLLGCCLETEVPLLHLH-------DHHRNEEFPLTWEIRLRIATEVAGALS 178
I +V L L L H ++ T E+ AL
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 179 YLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPE 238
+LH I +RDIK NILLD + DFG SK D+T GT Y+ P+
Sbjct: 144 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 239 YHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296
+ D +S GV++ ELLTG P F KN +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEKNSQAE 243
Query: 297 ILDDQVVKLVKKNQIM--AFANLAERCLDLNGKKRPTMEEVTME 338
I + Q M +L +R L + KKR +
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 7e-35
Identities = 58/294 (19%), Positives = 109/294 (37%), Gaps = 41/294 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + + R LG+G V++ + + + + VK K K ++ EI IL +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLR 87
Query: 130 -HRNVVKLLGCCLETEVPLLHL-HDHHRNEEF-----PLTWEIRLRIATEVAGALSYLHS 182
N++ L + L +H N +F LT E+ AL Y HS
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 183 AASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQ 241
I HRD+K N+++D E + ++ D+G ++F Q + + + PE
Sbjct: 148 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 242 SSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF--------------- 285
Q+ D D++S G +L ++ K+P F + + V +A
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 286 ----VHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEV 335
+ + H + V + + ++ L + + R T E
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-34
Identities = 53/299 (17%), Positives = 110/299 (36%), Gaps = 41/299 (13%)
Query: 71 NHFNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129
+ + +G G QG V R +A+KK ++ + E+V++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVN 74
Query: 130 HRNVVKLLGCCLETE----------VPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSY 179
H+N++ LL + V L + + + L E + ++ + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 180 LHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEY 239
LHS + I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 189
Query: 240 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF---------VHSMR 290
+ D++S G ++ E++ K Q N + +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 291 KNHMYDILDDQVVKLVK--------------KNQIMAFANLAERCLDLNGKKRPTMEEV 335
+N++ + + K K + +L + L ++ KR ++++
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 6e-28
Identities = 50/322 (15%), Positives = 101/322 (31%), Gaps = 70/322 (21%)
Query: 73 FNVNRILGQGGQGTVYKGM-LEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHR 131
+ + R LG G TV+ + + +A+K + + + E +EI +L ++N
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDA 69
Query: 132 NVVKLLGCCLETEVPLLH-----------------------LHDHHRNEEFPLTWEIRLR 168
+ K + LL L + E + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 169 IATEVAGALSYLHSAASSPIYHRDIKSTNILLDER------YRAKVADFGTSKFIAMDQT 222
I+ ++ L Y+H I H DIK N+L++ + K+AD G + + T
Sbjct: 130 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP--------------- 267
+ T Y PE + +D++S ++ EL+TG
Sbjct: 188 NS----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 268 --------------IFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMA 313
+ G ++ + + + K++
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 314 FANLAERCLDLNGKKRPTMEEV 335
++ L L+ +KR +
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 4e-19
Identities = 25/153 (16%), Positives = 53/153 (34%), Gaps = 14/153 (9%)
Query: 75 VNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLK------LEEFINEIVILSQI 128
+ +++G+G + V+ E VK K+ + +K F + ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 129 NHRNVVKLLGCC----LETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAA 184
R + KL G E + + E + + E + + ++ +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR- 122
Query: 185 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217
I H D+ N+L+ E + DF S +
Sbjct: 123 --GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 366 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=381.76 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=194.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||+||+|.+.+++.||||+++..... .+.+.+|+.+++.++||||++++++|...+..+++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3679999999999999999999988889999999864433 24789999999999999999999999999999999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++...+ ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9987654 2346889999999999999999999999 9999999999999999999999999998775544
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+..... .............
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~-------- 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFR-------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCC--------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCC--------
Confidence 4444456789999999999999999999999999999999995444433221 0111111111111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
...+..+++++.+++..||+.||++|||++|+++.|+++..+
T Consensus 221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 112344566899999999999999999999999999988643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-54 Score=385.58 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=209.9
Q ss_pred HHHHhcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 66 LDKATNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
++...++|++.+.||+|+||+||+|.++ +++.||+|+++..... .+.+.+|+.+++.++|||||+++++|.+.+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-----HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 3445578999999999999999999976 5889999998765433 357899999999999999999999999999
Q ss_pred cceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 145 VPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 145 ~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..++++++...+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 999999987654 2347899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..............|++.|+|||++.+..++.++|||||||++|||++|..||...... . .........
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~-~~~~~i~~~--- 232 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------S-QVYELLEKD--- 232 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------H-HHHHHHHTT---
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------H-HHHHHHhcC---
Confidence 77655555555566899999999999999999999999999999999987776543211 0 011111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.....+..+++++.+|+..||+.||++|||++|+++.|+.+...
T Consensus 233 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 233 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11123445667899999999999999999999999999887543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=381.68 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=202.5
Q ss_pred HHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
...++|++.+.||+|+||.||+|.++++..||||+++..... .+.+.+|+.++++++|||||++++++.. +..+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 345789999999999999999999988889999999764433 3478999999999999999999998754 5568
Q ss_pred EEEeeccCCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 148 LHLHDHHRNEEF---------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 148 ~~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++...+... ++++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 888887665321 4899999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
...........||+.|+|||++.+..++.++|||||||++|||+||..|+...... .. .........
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~-~~~~i~~~~----- 227 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PE-VIQNLERGY----- 227 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTTC-----
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHhcC-----
Confidence 55444445567899999999999899999999999999999999966655433211 01 111111110
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
....+..+++++.+|+.+||+.||++|||++|+++.|+.+-
T Consensus 228 ----~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11123455678999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=376.46 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.++ +|+.||+|+++..... ...+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 57999999999999999999975 6899999999865433 2345788999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++.++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9987654 2336899999999999999999999999 99999999999999999999999999987654332
Q ss_pred -eeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 223 -HVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 223 -~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......... . ..........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~---~~~~~~~~~~----- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----Y---SDWKEKKTYL----- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH----H---HHHHTTCTTS-----
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH----H---HHHhcCCCCC-----
Confidence 23345679999999999988876 57899999999999999999999754421111 0 0011111100
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
......++++.+|+.+||+.||++|||++|+++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234567889999999999999999999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=371.81 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=206.0
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.++|++.+.||+|+||.||+|.+++++.||+|+++..... .+.+.+|+.+++.++||||++++++|.+....+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 4689999999999999999999988889999999875443 24789999999999999999999999999999999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++...+ ....+++..+..++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9887644 3346889999999999999999999999 9999999999999999999999999998766544
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccch
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDD 300 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (366)
........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... . . .........
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~------~-~~~~i~~~~------- 218 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--S------E-TAEHIAQGL------- 218 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--H------H-HHHHHHTTC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--H------H-HHHHHHhCC-------
Confidence 444445678999999999999999999999999999999998 8999976441 1 0 111111110
Q ss_pred HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 301 QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 301 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
....|..+++++.+|+..||+.||++|||++|+++.|.++
T Consensus 219 --~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1112344556899999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-53 Score=381.07 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=194.5
Q ss_pred hcCCcccceecccCceEEEEEEEcC-C---cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED-G---RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||+||+|.++. + ..||+|.+...... ...+.|.+|+.++++++|||||+++++|...+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3678999999999999999999753 3 35889988765544 345679999999999999999999999999999
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 99999987654 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCcee----eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcC
Q 037297 218 AMDQTHV----TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKN 292 (366)
Q Consensus 218 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (366)
....... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... . . ........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~------~-~~~~i~~~ 249 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--Q------D-VINAIEQD 249 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H------H-HHHHHHTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--H------H-HHHHHHcC
Confidence 5432221 122457899999999999999999999999999999998 8999976431 0 1 11111111
Q ss_pred ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 293 HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
. ....+..++..+.+|+.+||+.||++|||+.|+++.|+.+..+
T Consensus 250 ~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 Y---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 0 1112445667899999999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=373.45 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=200.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
.+|++.+.||+|+||+||+|.+. +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 47999999999999999999965 6999999999865433 245789999999999999999999999999999999
Q ss_pred EeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 150 LHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 150 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
++++.++. ...+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|....... .
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 99887653 236899999999999999999999999 9999999999999999999999999998765433 2
Q ss_pred eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 224 VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
.....+||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ............ +..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~-~~~------ 236 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT-PEL------ 236 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCS-CCC------
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCC-CCC------
Confidence 33456799999999999999999999999999999999999999965431 011111111111 111
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123345678999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=370.96 Aligned_cols=241 Identities=29% Similarity=0.364 Sum_probs=199.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999976 58899999987533221 12346788999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99887653 336899999999999999999999999 999999999999999999999999999765432
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ....
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~-~~~~-------- 221 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRIS-RVEF-------- 221 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCC--------
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHH-cCCC--------
Confidence 23446799999999999999999999999999999999999999965331 11111111 1110
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 123345668999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=375.26 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=197.7
Q ss_pred HhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
..++|++.+.||+|+||+||+|..+ ..||||+++...... ...+.+.+|+.++++++||||+++++++.. +..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3578999999999999999999864 359999997654433 345689999999999999999999998754 45678
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 88876543 3346899999999999999999999999 999999999999999999999999999876533
Q ss_pred Cc-eeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 221 QT-HVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 221 ~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .............
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--------~~~~~~~~~~~~p 229 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIFMVGRGYLSP 229 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHHHTSCCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcCCCCC
Confidence 22 23345679999999999864 358999999999999999999999997643111 0111111111000
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.....+..+++++.+|+.+||+.||++|||++|+++.|+.+..+
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 -----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 01123455677899999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=375.66 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=187.5
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC--Ccce
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPL 147 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 147 (366)
++|++.+.||+|+||+||+|.++ +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH--HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 57999999999999999999975 58999999998765443 3456789999999999999999999998653 4567
Q ss_pred EEEeeccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 148 LHLHDHHRNE-----------EFPLTWEIRLRIATEVAGALSYLHSAA--SSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 148 ~~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
+++++..+++ ...+++..++.++.|++.||.|||+++ .++|+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 8888876542 236899999999999999999999865 245999999999999999999999999999
Q ss_pred ccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 215 KFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 215 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . . ..........
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~------~-~~~~i~~~~~ 231 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--K------E-LAGKIREGKF 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--H------H-HHHHHHHTCC
T ss_pred eecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--H------H-HHHHHHcCCC
Confidence 8765332 233456799999999999999999999999999999999999999965331 1 1 1111111111
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .++..+++++.+|+.+||+.||++|||++|+++
T Consensus 232 ~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 123445678999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=373.62 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEEcCC-----cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDG-----RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
+.|++.+.||+|+||.||+|.++++ ..||||+++..... .....+.+|+.++++++|||||++++++...+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh---HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 5788999999999999999986532 36999999765544 234578999999999999999999999999999
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99998876553 3346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+..... . .... ......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~-----~~~~-~~i~~~--- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--N-----HEVM-KAINDG--- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--H-----HHHH-HHHHTT---
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--H-----HHHH-HHHhcc---
Confidence 433222 22335689999999999999999999999999999999997666543221 1 1111 111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.+...+..++.++.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11123444667899999999999999999999999999987654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=380.68 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=197.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||+||+|.+. +|+.||+|+++..... ...+.+.+|+.+++.++|||||+++++|.+.+..++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT---THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 468999999999999999999975 6899999999875443 234578899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSA-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++..++. ...+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|......
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999876542 33689999999999999999999974 8 999999999999999999999999999865422
Q ss_pred CceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHH---Hhh-------
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVH---SMR------- 290 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~------- 290 (366)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+................. ...
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2334689999999999999999999999999999999999999997644221100000000000 000
Q ss_pred ------cCccc-----cccchHHh----hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 ------KNHMY-----DILDDQVV----KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ------~~~~~-----~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... +..+.... .......+.++.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 00000000 0001124567999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=375.81 Aligned_cols=241 Identities=27% Similarity=0.418 Sum_probs=197.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
..|+.++.||+|+||+||+|.+. +++.||+|++........ ...+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 35999999999999999999965 688999999987544332 4456799999999999999999999999999999999
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++++.++ ...++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 9987654 2347899999999999999999999999 99999999999999999999999999976532
Q ss_pred eeeeeccccCCccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 223 HVTTKIQGTFGYLEPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .......... ..+..
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~-~~~~~-- 234 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQN-ESPAL-- 234 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-CCCCC--
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC-CCCCC--
Confidence 234579999999999864 4589999999999999999999999975431 1111111111 11111
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.+..+++++.+|+.+||+.||++|||++|+++
T Consensus 235 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 12335668999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=368.86 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCCcccce-ecccCceEEEEEEEc---CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRI-LGQGGQGTVYKGMLE---DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~-lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
++|.+.+. ||+|+||+||+|.++ ++..||||+++..... ...+.+.+|+.++++++|||||+++++|.. +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH---HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 45777774 999999999999864 3557999999865544 345689999999999999999999999865 457
Q ss_pred eEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
++++++..++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 8888876543 3346899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCcee--eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 219 MDQTHV--TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 219 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ... .......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----~~~----~~i~~~~-- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVM----AFIEQGK-- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HHH----HHHHTTC--
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-----HHH----HHHHcCC--
Confidence 443322 233468899999999999999999999999999999998 99999764311 011 1111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
+...+..+++++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11234556778999999999999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=368.88 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=196.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
+.|++++.||+|+||+||+|.++ +++.||+|+++..... ..+.+.+|+.+++.++|||||++++++.+.+..+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 46999999999999999999975 5899999999865433 345788999999999999999999999999999999
Q ss_pred EeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++.++. ..++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 99876542 346899999999999999999999999 999999999999999999999999999754321
Q ss_pred ceeeeeccccCCcccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 222 THVTTKIQGTFGYLEPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
........||+.|+|||++. +..++.++||||+||++|||++|+.||..... .+ .. ...... ....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~---~~---~~i~~~-~~~~ 234 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MR---VL---LKIAKS-EPPT 234 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GG---HH---HHHHHS-CCCC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HH---HH---HHHHcC-CCCC
Confidence 11223467999999999874 45689999999999999999999999976431 11 11 111111 1111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus 235 ~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 123345678999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=369.99 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=197.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.++ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 57999999999999999999975 68999999997533221 12346789999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC-
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ- 221 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~- 221 (366)
+++..+++ ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99876542 336899999999999999999999999 9999999999999999999999999998775433
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~-~~------- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKL-EY------- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTT-CC-------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcC-CC-------
Confidence 2233456799999999999999999999999999999999999999975331 1111111111 10
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.++...++++.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 123345667899999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=371.83 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=199.3
Q ss_pred HHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC
Q 037297 65 ELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 144 (366)
Q Consensus 65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (366)
+++...++|++++.||+|+||.||+|.++++..||+|+++..... .+.|.+|+.+++.++|||||+++++|.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 333445789999999999999999999988888999999765433 3578999999999999999999999854 5
Q ss_pred cceEEEeeccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 145 VPLLHLHDHHRNE---------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 145 ~~~~~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
..+++++++..+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhh
Confidence 5678888877653 225899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..............||+.|+|||.+.+..++.++|||||||++|||++|..|+...... .... .......
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~-~~i~~~~-- 231 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVL-DQVERGY-- 231 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHH-HHHHTTC--
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHH-HHHHhcC--
Confidence 76544444444567899999999999999999999999999999999976666543211 1111 1111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCC
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSN 346 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~ 346 (366)
....+..+++++.+++.+||+.||++|||++++++.|+..-.+.
T Consensus 232 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 -------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11234456678999999999999999999999999998876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=361.90 Aligned_cols=242 Identities=21% Similarity=0.331 Sum_probs=190.2
Q ss_pred CcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC----Ccce
Q 037297 73 FNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----EVPL 147 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~ 147 (366)
|++.+.||+|+||+||+|.+. +++.||+|.+....... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 467789999999999999976 58899999998754433 3456789999999999999999999998652 3467
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCeEEEeecCCcccccC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~-~~~~vkl~Dfg~a~~~~~ 219 (366)
+++++..++. ...+++..+..++.|++.||.|||+++ ++|+||||||+|||++ .++.+||+|||+|.....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 7888776653 236899999999999999999999975 4599999999999996 578999999999976432
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. .....+||+.|+|||++.+ .++.++||||+||++|||++|+.||...... ..... .......+
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~-~i~~~~~~---- 231 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYR-RVTSGVKP---- 231 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHH-HHTTTCCC----
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHH-HHHcCCCC----
Confidence 2 2345679999999998865 5999999999999999999999999653311 11111 11111110
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
...+...++++.+|+.+||+.||++|||++|+++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1122334557899999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=366.11 Aligned_cols=242 Identities=25% Similarity=0.373 Sum_probs=191.5
Q ss_pred ceecccCceEEEEEEEcC---CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEeec
Q 037297 77 RILGQGGQGTVYKGMLED---GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHDH 153 (366)
Q Consensus 77 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 153 (366)
+.||+|+||+||+|.+++ ++.||+|+++...... ...+.+.+|+.++++++|||||+++++|.. +..++++++.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C--HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH--HHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 479999999999998542 5689999997643322 345689999999999999999999999864 4567888887
Q ss_pred cCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee-
Q 037297 154 HRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT- 225 (366)
Q Consensus 154 ~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~- 225 (366)
..+. ..++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 6542 346899999999999999999999999 99999999999999999999999999987654433322
Q ss_pred -eeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHh
Q 037297 226 -TKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVV 303 (366)
Q Consensus 226 -~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (366)
....||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... . .......... +
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~-~~~~~i~~~~---------~ 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------S-EVTAMLEKGE---------R 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------H-HHHHHHHTTC---------C
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------H-HHHHHHHcCC---------C
Confidence 33568999999999999999999999999999999998 8999975431 0 1111111111 1
Q ss_pred hhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 304 KLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 304 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..+++++.+|+.+||+.||++|||++++++.|+..
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 123445677899999999999999999999999988765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-52 Score=370.80 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=184.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.+.|++.+.||+|+||+||+|.++ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999976 58999999998654432 23568899999999999999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCeEEEeecCCccccc
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~---~~~~vkl~Dfg~a~~~~ 218 (366)
+++++.+++ ...+++..+..++.|++.||.|||+++ |+||||||+|||+. .++.+||+|||+|+...
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999887653 347999999999999999999999999 99999999999995 57899999999998654
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ..............
T Consensus 162 ~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~--- 228 (307)
T d1a06a_ 162 PG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEYEF--- 228 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCCCC---
T ss_pred CC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCCCC---
Confidence 32 233446799999999999999999999999999999999999999975431 11111111111100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........++++.+|+.+||+.||++|||++|+++
T Consensus 229 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 ----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01122345668999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=365.06 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=190.2
Q ss_pred hcCCcccceecccCceEEEEEEEcC----CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLED----GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.++|++.+.||+|+||.||+|.+.. +..||+|.++..... ...+.+.+|+.+++.++||||+++++++. .+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4689999999999999999998642 346888888654443 34567999999999999999999999985 456
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++...+ ...++++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 78888876543 3446899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
............||+.|+|||++.+..++.++|||||||++|||++ |.+||...... ...... .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~~i----~~~~~-- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRI----ENGER-- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHH----HTTCC--
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHHHH----HcCCC--
Confidence 5544444455678999999999999999999999999999999998 89998764421 111111 11111
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
...+..+++++.+|+.+||+.||++|||++|+++.|+.+.
T Consensus 228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1234456778999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=375.45 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=198.8
Q ss_pred HHhcCCcccceecccCceEEEEEEEcC-C-----cEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEE
Q 037297 68 KATNHFNVNRILGQGGQGTVYKGMLED-G-----RIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 140 (366)
Q Consensus 68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (366)
...++|++.+.||+|+||+||+|.+.. + ..||+|.+...... .....+.+|+.++.++ +|||||++++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH---HHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 345789999999999999999998643 2 36899988764333 3345788999999998 899999999999
Q ss_pred eeCCcceEEEeeccCCC------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 037297 141 LETEVPLLHLHDHHRNE------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYH 190 (366)
Q Consensus 141 ~~~~~~~~~~~~~~~~~------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH 190 (366)
.+.+..++++++..+++ ...+++..++.++.|++.||.|||+++ |+|
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999876532 124789999999999999999999999 999
Q ss_pred CCCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 037297 191 RDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI 268 (366)
Q Consensus 191 ~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 268 (366)
|||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433 23344568999999999999999999999999999999998 89999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHh
Q 037297 269 FSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELN 340 (366)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~ 340 (366)
.+...... . ........ ....+..+++++.+|+.+||+.||++|||++||++.|.
T Consensus 268 ~~~~~~~~----~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDAN----F----YKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHH----H----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHH----H----HHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 76432110 1 11111110 11234456678999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-50 Score=366.21 Aligned_cols=244 Identities=19% Similarity=0.238 Sum_probs=199.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 468999999999999999999975 689999999976432 234678999999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCeEEEeecCCccccc
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--~~~~vkl~Dfg~a~~~~ 218 (366)
+++++.++ ....+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99987654 2346999999999999999999999999 99999999999996 46789999999998765
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......... .... .
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~-~~~~--~ 244 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKS-CDWN--M 244 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-TCCC--S
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCCC--C
Confidence 433 33446799999999999999999999999999999999999999965431 111111111 1100 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .......++++.+|+.+||+.||++|||++|+++
T Consensus 245 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 D----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp C----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1112345567899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=369.62 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=192.3
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc----EEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGR----IMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (366)
.+|++++.||+|+||+||+|.+. +|+ .||+|.++..... ...+.+.+|+.+++.++|||||+++++|.+...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTSTV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 46999999999999999999865 343 5888888654322 234678999999999999999999999987654
Q ss_pred ceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 PLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 ~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
+++++++..+ ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 86 -~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 -QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp -EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred -eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 4555555443 3447899999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCcee-eeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQTHV-TTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |..||..... .+ ..... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~---~~~~i----~~~--- 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SE---ISSIL----EKG--- 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GG---HHHHH----HHT---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HH---HHHHH----HcC---
Confidence 5443332 233568999999999999999999999999999999998 7888865431 11 11111 111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.+...+..+++++.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 230 ------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111224456678999999999999999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-50 Score=368.49 Aligned_cols=244 Identities=19% Similarity=0.258 Sum_probs=199.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++++.||+|+||.||+|.+. +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL----DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 357999999999999999999975 6999999999864322 34578899999999999999999999999999999
Q ss_pred EEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCeEEEeecCCccccc
Q 037297 149 HLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~--~~~~vkl~Dfg~a~~~~ 218 (366)
+++++.++. ..++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 999876542 336899999999999999999999999 99999999999998 67899999999998775
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......... ....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~-~~~~--- 246 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKR-CDWE--- 246 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHH-CCCC---
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCCC---
Confidence 433 33445789999999999999999999999999999999999999975431 111111111 1100
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.........++++.+|+.+||+.||.+|||++|+++
T Consensus 247 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 ---FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122345668899999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-51 Score=368.48 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=201.2
Q ss_pred HhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEee
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 142 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (366)
..++|++.+.||+|+||+||+|+.+ +++.||||+++..... ...+.+.+|+.+++.++||||++++++|..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh---HHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 4578999999999999999999864 3578999999865443 345678999999999999999999999999
Q ss_pred CCcceEEEeeccCCC-------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 037297 143 TEVPLLHLHDHHRNE-------------------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHR 191 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~-------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~ 191 (366)
....++++++...++ ...+++..++.++.|++.||.|||+++ ++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 998888888765432 124788999999999999999999999 9999
Q ss_pred CCCCCCEEecCCCeEEEeecCCcccccCCC-ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 037297 192 DIKSTNILLDERYRAKVADFGTSKFIAMDQ-THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIF 269 (366)
Q Consensus 192 dikp~Nill~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~ 269 (366)
||||+|||++.++.+||+|||+|+...... ........+|+.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999997654332 22234456889999999999999999999999999999999986 5665
Q ss_pred CCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 270 STGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.... . . ..........+ ..+..+++++.+|+..||+.||++|||+.|+++.|+++.
T Consensus 245 ~~~~--~------e-~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAH--E------E-VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCH--H------H-HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCH--H------H-HHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4331 1 1 11111122111 124455668999999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=363.64 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=200.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
-++|++++.||+|+||.||+|.++ +|+.||+|+++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 367999999999999999999975 68999999998643221 1235678899999999999999999999999999999
Q ss_pred EEeeccCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNEE-------FPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999877643 46899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
......+||+.|+|||++.+..|+.++|+||+||++|||++|+.||..... ........ ....
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~-~~~~------- 222 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL-MEEI------- 222 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCC-------
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHh-cCCC-------
Confidence 234456899999999999999999999999999999999999999976441 11111111 1111
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
.+|...++++.+|+..||+.||.+||+ ++|+++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 123445668899999999999999995 777764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-50 Score=359.71 Aligned_cols=240 Identities=26% Similarity=0.374 Sum_probs=198.4
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.++ +|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57999999999999999999975 5899999999764322 112356789999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99987653 336788899999999999999999999 999999999999999999999999999876432
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
....+||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ........... .
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-~-------- 218 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE-L-------- 218 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC-C--------
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCC-C--------
Confidence 2346799999999999999999999999999999999999999975431 11111111111 0
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..+...++++.+++.+||+.||.+|+ |++|+++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12334556799999999999999996 8999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=361.45 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=199.9
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH--HHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
.++|++++.||+|+||+||+|.++ +|+.||+|++........ ....+.+.+|+.+++.++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999975 689999999976443321 12346789999999999999999999999999999
Q ss_pred eEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----eEEEeecCCcc
Q 037297 147 LLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY----RAKVADFGTSK 215 (366)
Q Consensus 147 ~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~----~vkl~Dfg~a~ 215 (366)
+++++++.++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||+|.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999887653 236899999999999999999999999 99999999999998776 59999999998
Q ss_pred cccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .......... ..
T Consensus 166 ~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~-~~- 233 (293)
T d1jksa_ 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAV-NY- 233 (293)
T ss_dssp ECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTT-CC-
T ss_pred hcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhc-CC-
Confidence 76433 223445789999999999999999999999999999999999999975431 1111111111 00
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. . ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~-~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E-F----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-C----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-C----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 01122345668899999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.6e-50 Score=353.59 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=197.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|++.+.||+|+||+||+|.+. +|+.||+|+++...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 467999999999999999999975 68999999998654432 2345689999999999999999999999887653
Q ss_pred -ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 146 -PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 146 -~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
.++++++..++. ..++++..+..++.|++.||.|||++| |+||||||+|||++.++..+++|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 678888876542 336899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCc--eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 218 AMDQT--HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 218 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... ......+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ..............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPIP 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCCC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhcCCCC
Confidence 43322 233456799999999999999999999999999999999999999965331 11111112221111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHhhcc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRP-TMEEVTMELNGIR 343 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ell~~L~~~~ 343 (366)
........++++.+++.+||+.||++|| |++++++.|.++.
T Consensus 234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0112234566899999999999999999 8999999988765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=353.89 Aligned_cols=243 Identities=25% Similarity=0.379 Sum_probs=191.1
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC-CcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-EVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 148 (366)
.++|++.+.||+|+||.||+|..+ |..||+|+++.+.. .+.+.+|+.++++++||||++++++|.+. +..++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH------HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 467899999999999999999985 78899999976432 35788999999999999999999998654 45678
Q ss_pred EEeeccCCCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 149 HLHDHHRNEEF---------PLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 149 ~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
++++...+... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 88887665322 4799999999999999999999998 99999999999999999999999999976532
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
. .....+|..|+|||.+.+..++.++|||||||++|||+| |++||..... .+ .... ...
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~---~~~~----i~~------- 215 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KD---VVPR----VEK------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GG---HHHH----HTT-------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HH---HHHH----HHc-------
Confidence 2 233457889999999999999999999999999999998 6777754331 11 1111 111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
..+...+..+++++.+|+.+||+.||++|||+.|+++.|+.++.
T Consensus 216 --~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11122344556789999999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-50 Score=362.63 Aligned_cols=240 Identities=23% Similarity=0.269 Sum_probs=198.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||.||+|.++ +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++......+++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57999999999999999999975 6999999998753221 113346789999999999999999999999999999999
Q ss_pred EeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
+++..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99887653 236899999999999999999999999 999999999999999999999999999876432
Q ss_pred eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHH
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQV 302 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (366)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~-------- 255 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KV-------- 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC--------
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcC-CC--------
Confidence 2345799999999999999999999999999999999999999975331 1111111111 10
Q ss_pred hhhhcHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 037297 303 VKLVKKNQIMAFANLAERCLDLNGKKRP-----TMEEVTM 337 (366)
Q Consensus 303 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ell~ 337 (366)
..+...++++.+|+.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12334566899999999999999994 8999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=357.30 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=188.4
Q ss_pred cCCcccceecccCceEEEEEEEcC--C--cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLED--G--RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (366)
++|++.+.||+|+||.||+|.... + ..||+|+++....... ...+.+.+|+.+++.++||||++++++|.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 679999999999999999998532 2 3689999876543322 345689999999999999999999999965 456
Q ss_pred eEEEeeccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 147 LLHLHDHHRNE--------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 147 ~~~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+++++++..+. ..++++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 78888776543 236899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCce--eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccHHHHHHHHhhcCccc
Q 037297 219 MDQTH--VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAFFVHSMRKNHMY 295 (366)
Q Consensus 219 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (366)
..... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~~~- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGER- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCCCC-
Confidence 44332 2233457889999999999999999999999999999998 8999975431 1111111111111
Q ss_pred cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhc
Q 037297 296 DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGI 342 (366)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~ 342 (366)
...+..++.++.+|+.+||+.||++|||+.|+.+.|++.
T Consensus 234 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112344556899999999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=360.18 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=207.0
Q ss_pred ccccChHHHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CC
Q 037297 58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NH 130 (366)
Q Consensus 58 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 130 (366)
.+......++...++|++++.||+|+||.||+|.+. +++.||+|+++..... .....+.+|+.+++.+ +|
T Consensus 10 ~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNH 86 (311)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCC
T ss_pred ccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH---HHHHHHHHHHHHHHhccCC
Confidence 333333445555689999999999999999999852 3568999999875544 3455789999999999 79
Q ss_pred CceeeEeeEEeeCCcceEEEeeccCC-------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037297 131 RNVVKLLGCCLETEVPLLHLHDHHRN-------------------------EEFPLTWEIRLRIATEVAGALSYLHSAAS 185 (366)
Q Consensus 131 ~niv~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 185 (366)
||||+++++|......++++++...+ ....+++..+..++.||+.||.|||+++
T Consensus 87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~- 165 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN- 165 (311)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 99999999999999999999987543 2235889999999999999999999999
Q ss_pred CCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 037297 186 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTG 264 (366)
Q Consensus 186 ~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 264 (366)
++||||||+||+++.++.+|++|||.++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+
T Consensus 166 --ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~ 243 (311)
T d1t46a_ 166 --CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (311)
T ss_dssp --CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence 99999999999999999999999999987754433 333446789999999999999999999999999999999995
Q ss_pred -CCCCCCCCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 265 -KKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 265 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.+||..... ... .. ..... ......+..++.++.+|+.+||+.||++|||++|++++|+..-
T Consensus 244 g~p~~~~~~~-~~~----~~---~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 244 GSSPYPGMPV-DSK----FY---KMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp TCCSSTTCCS-SHH----HH---HHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCH-HHH----HH---HHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 554443321 110 00 01111 1111223345678999999999999999999999999998643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=361.11 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=211.0
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEe
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLL 137 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 137 (366)
++++...++|++.+.||+|+||+||+|.+. ++..||||+++..... .....+.+|+.++++++||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh---HHHHHHHHHHHHHHHcCCCCEeeee
Confidence 344555688999999999999999999863 2578999999865443 3445789999999999999999999
Q ss_pred eEEeeCCcceEEEeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 037297 138 GCCLETEVPLLHLHDHHRNE-----------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILL 200 (366)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill 200 (366)
++|...+..++++++...+. ...+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 99999999999998876542 224688899999999999999999998 9999999999999
Q ss_pred cCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccc
Q 037297 201 DERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFSTGNTSQEN 278 (366)
Q Consensus 201 ~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~ 278 (366)
+.++++||+|||+|+........ ......+|+.|+|||.+.+..++.++|||||||++|||+||. .||.....
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----- 241 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 241 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----
Confidence 99999999999999876543322 223346899999999999999999999999999999999985 66654321
Q ss_pred ccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCcccc
Q 037297 279 VSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKMI 352 (366)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 352 (366)
..... ....... ...+..++..+.+++..||+.||++|||++|+++.|+......+...+.
T Consensus 242 ---~~~~~-~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~ 302 (308)
T d1p4oa_ 242 ---EQVLR-FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302 (308)
T ss_dssp ---HHHHH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred ---HHHHH-HHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCC
Confidence 11111 1111111 1123455678999999999999999999999999999887766553333
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=356.10 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=195.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.+. +|+.||+|+++...... ...+.+.+|+.++++++||||+++++++.+....+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 57999999999999999999975 68999999997643322 2346789999999999999999999999999999999
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++.... ....+++..+..++.|++.||.|||+++ ||||||||+|||++.++.+||+|||.|.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9886543 3446899999999999999999999999 9999999999999999999999999998765332
Q ss_pred ceeeeeccccCCccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc---ccc-
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH---MYD- 296 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 296 (366)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...... + ...... ....... ...
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~--~~~~i~-~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--D--QLFRIF-RTLGTPDEVVWPGV 230 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H--HHHHHH-HHHCCCCTTTSTTG
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--H--HHHHHH-HhcCCCchhhcccc
Confidence 2334457999999999877665 578999999999999999999999754310 0 000000 0000000 000
Q ss_pred -----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 -----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 -----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..............+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000011122345578999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=355.09 Aligned_cols=254 Identities=24% Similarity=0.233 Sum_probs=189.6
Q ss_pred ccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH-HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEEee
Q 037297 75 VNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL-LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHLHD 152 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 152 (366)
.+++||+|+||+||+|.++ +|+.||+|+++........ ...+.+.+|+.+++.++||||+++++++...+..++++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 5899999999765433221 1234688999999999999999999999999999999988
Q ss_pred ccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCceee
Q 037297 153 HHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 225 (366)
Q Consensus 153 ~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 225 (366)
..+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 6543 3456888999999999999999999999 99999999999999999999999999976654332 23
Q ss_pred eeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc---Ccccc-----
Q 037297 226 TKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK---NHMYD----- 296 (366)
Q Consensus 226 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 296 (366)
...+||+.|+|||++.+ ..++.++||||+||++|||++|..||..... .+. .......... ..+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~---l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQ---LTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHHHCCCCTTTSSSTTSST
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHH---HHHHHHhcCCCChhhccchhccc
Confidence 34579999999998865 4679999999999999999999999965431 110 0011111100 00000
Q ss_pred ------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..............++++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000011122345678999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=355.80 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=198.3
Q ss_pred HhcCCcccceecccCceEEEEEEEcC--------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeE
Q 037297 69 ATNHFNVNRILGQGGQGTVYKGMLED--------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 139 (366)
Q Consensus 69 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (366)
..++|++++.||+|+||.||+|.... +..||+|+++..... .....+.+|...+.++ +||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh---HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 35789999999999999999998532 247999999876554 3345788898888888 89999999999
Q ss_pred EeeCCcceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 037297 140 CLETEVPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKST 196 (366)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~ 196 (366)
|.+....++++++...+. ...+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 999999999988876541 235899999999999999999999999 999999999
Q ss_pred CEEecCCCeEEEeecCCcccccCCCc-eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 037297 197 NILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 274 (366)
Q Consensus 197 Nill~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~ 274 (366)
|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999987754332 22344568999999999999999999999999999999998 6888764331
Q ss_pred CcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 275 SQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
. ........... ...+..+++++.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus 244 -~-------~~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -E-------ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -H-------HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -H-------HHHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 11111111111 11233456689999999999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-49 Score=353.93 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=196.7
Q ss_pred cCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLHL 150 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 150 (366)
++|++.+.||+|+||+||+|.+++|+.||+|+++...... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 5899999999999999999999889999999997654332 23467899999999999999999999999999999888
Q ss_pred eeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCce
Q 037297 151 HDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 223 (366)
Q Consensus 151 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 223 (366)
+..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||.+....... .
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 776543 3557999999999999999999999999 9999999999999999999999999998765332 2
Q ss_pred eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc---cc----
Q 037297 224 VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH---MY---- 295 (366)
Q Consensus 224 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---- 295 (366)
......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+... .+. ............ +.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQ---LMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHH---HHHHHHhhCCCChhhccchhh
Confidence 23344689999999988654 568999999999999999999999975431 110 011111111000 00
Q ss_pred --------cccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 296 --------DILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 296 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
....+..........++++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111112233445678999999999999999999999973
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=355.25 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=190.9
Q ss_pred HHHHHHhcCCcccceecccCceEEEEEEEc------CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeE
Q 037297 64 KELDKATNHFNVNRILGQGGQGTVYKGMLE------DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKL 136 (366)
Q Consensus 64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 136 (366)
++++...++|++.+.||+|+||.||+|.+. +++.||+|+++..... ...+.+.+|...+.++ +|+||+.+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH---HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc---HHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 334444578999999999999999999854 2468999998765444 3345677888888777 78999999
Q ss_pred eeEEeeCC-cceEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 037297 137 LGCCLETE-VPLLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRD 192 (366)
Q Consensus 137 ~~~~~~~~-~~~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d 192 (366)
++++...+ ..++++++...+. ...+++..+..++.|++.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99987665 4677777765432 224789999999999999999999999 99999
Q ss_pred CCCCCEEecCCCeEEEeecCCcccccCCCce-eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 037297 193 IKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFS 270 (366)
Q Consensus 193 ikp~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~ 270 (366)
|||+|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999866543322 234457999999999999999999999999999999999964 56654
Q ss_pred CCCCCcccccHHHHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 271 TGNTSQENVSLAAFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
..... ........... ...+..+++++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 240 ~~~~~--------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 240 VKIDE--------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CCCSH--------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHH--------HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 33111 01111111111 1123445668999999999999999999999999998774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-48 Score=342.24 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=198.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChH-----HHHHHHHHHHHHHHHhcCC-CCceeeEeeEEee
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDE-----ELLKLEEFINEIVILSQIN-HRNVVKLLGCCLE 142 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 142 (366)
.++|++.+.||+|+||+||+|++. +|+.+|+|+++...... .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 68999999997754321 1233457889999999996 9999999999999
Q ss_pred CCcceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 143 TEVPLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 143 ~~~~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.+..++++++..+++ ..++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 999999999987653 337899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeeeccccCCccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
..... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ........
T Consensus 159 ~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i~ 228 (277)
T d1phka_ 159 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMIM 228 (277)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred EccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHHH
Confidence 76532 23344679999999998753 3568899999999999999999999975431 11111111
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ... . ........++++.+|+.+||+.||++|||++|+++
T Consensus 229 ~~-~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SG-NYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HT-CCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hC-CCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 110 0 01112346678999999999999999999999853
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=351.40 Aligned_cols=254 Identities=29% Similarity=0.452 Sum_probs=198.4
Q ss_pred ccceecccCceEEEEEEEcCC----cEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC-cceEE
Q 037297 75 VNRILGQGGQGTVYKGMLEDG----RIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPLLH 149 (366)
Q Consensus 75 ~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 149 (366)
+.++||+|+||+||+|.+.++ ..||||.++..... ...+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 357899999999999996532 35899998754433 34578999999999999999999999987754 67778
Q ss_pred EeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 150 LHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 150 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
+++...+ .....++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 8876654 2335778889999999999999999999 9999999999999999999999999998764332
Q ss_pred ce---eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 222 TH---VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 222 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. ......||..|+|||.+.+..++.++||||||+++|||++|..||........ ..... .....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i---~~g~~----- 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---LQGRR----- 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHH---HTTCC-----
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHH---HcCCC-----
Confidence 21 22335689999999999999999999999999999999998888765332111 11111 11111
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccCCCCccc
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGSNFGHKM 351 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 351 (366)
...+..+++++.+|+.+||+.||++|||+.|+++.|+.+..+..+...
T Consensus 253 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 253 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred -----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 112334566899999999999999999999999999999877666543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-48 Score=357.31 Aligned_cols=245 Identities=22% Similarity=0.235 Sum_probs=192.2
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHH--HHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcce
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEEL--LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 147 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (366)
++|++.+.||+|+||.||+|.+. +|+.||+|++......... ........|+.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999976 5899999998753322111 11122334577888889999999999999999999
Q ss_pred EEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCC
Q 037297 148 LHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 220 (366)
Q Consensus 148 ~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~ 220 (366)
++++++.++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999887653 235789999999999999999999999 999999999999999999999999999876533
Q ss_pred CceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccc
Q 037297 221 QTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILD 299 (366)
Q Consensus 221 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (366)
. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ......
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~-~~~~~~------ 225 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDR-MTLTMA------ 225 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHH-HSSSCC------
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHH-hcccCC------
Confidence 2 234579999999999864 5789999999999999999999999976442111 11111 100100
Q ss_pred hHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 300 DQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 300 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
...+...++++.+|+.+||+.||++||| ++|+++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0123345667999999999999999999 577753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=350.35 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=197.5
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceE
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 148 (366)
.++|++++.||+|+||+||+|.++ +++.||+|+++.... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 367999999999999999999976 588999999986432 23467899999999999999999999999999999
Q ss_pred EEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CeEEEeecCCccccc
Q 037297 149 HLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIA 218 (366)
Q Consensus 149 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~--~~vkl~Dfg~a~~~~ 218 (366)
+++++.++ ...++++..+..++.||+.||.|||++| |+||||||+|||++.+ ..+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99987654 2336899999999999999999999999 9999999999999854 589999999998764
Q ss_pred CCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDIL 298 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (366)
.. .......+|+.|+|||...+..++.++||||+||++|+|++|..||..... .......... .. . .
T Consensus 156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~-~~-~-~ 222 (321)
T d1tkia_ 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNA-EY-T-F 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT-CC-C-C
T ss_pred cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CC-C-C
Confidence 33 233445789999999999999999999999999999999999999976431 1111111111 10 0 0
Q ss_pred chHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 299 DDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 299 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
+. ......++++.+|+..||+.||++|||++|+++
T Consensus 223 ~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ch----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 112234567899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=353.14 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=195.1
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHh-cCCCCceeeEeeEEeeCCcceE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILS-QINHRNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~ 148 (366)
++|++++.||+|+||+||+|.++ +|+.||+|+++....... ...+.+..|..++. .++||||+++++++.+.+..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 57999999999999999999976 589999999976332211 22345667776654 6899999999999999999999
Q ss_pred EEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCC
Q 037297 149 HLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 149 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~ 221 (366)
++++..++. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999887653 336899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCccccccchH
Q 037297 222 THVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYDILDDQ 301 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (366)
...+...||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... . . ..........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~------~-~~~~i~~~~~------- 220 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--E------E-LFHSIRMDNP------- 220 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H------H-HHHHHHHCCC-------
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--H------H-HHHHHHcCCC-------
Confidence 333446799999999999999999999999999999999999999975431 1 0 1111111110
Q ss_pred HhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 037297 302 VVKLVKKNQIMAFANLAERCLDLNGKKRPTME-EVT 336 (366)
Q Consensus 302 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ell 336 (366)
..+...++++.+|+.+||+.||++|||+. |++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 12334566799999999999999999996 664
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=355.08 Aligned_cols=237 Identities=27% Similarity=0.410 Sum_probs=190.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHH--HHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeCC
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEE--LLKLEEFINEIVILSQIN--HRNVVKLLGCCLETE 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 144 (366)
.++|++.+.||+|+||+||+|.+. +|+.||+|+++....... .....++.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999975 689999999876432210 011234668999999986 899999999999999
Q ss_pred cceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCeEEEeecCCcc
Q 037297 145 VPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-RYRAKVADFGTSK 215 (366)
Q Consensus 145 ~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-~~~vkl~Dfg~a~ 215 (366)
..+++++++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+|.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 999999887543 2336899999999999999999999999 999999999999985 5799999999997
Q ss_pred cccCCCceeeeeccccCCccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcc
Q 037297 216 FIAMDQTHVTTKIQGTFGYLEPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHM 294 (366)
Q Consensus 216 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (366)
..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ......
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~~- 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQV- 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCC-
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhccc-
Confidence 65322 3345679999999999887765 5678999999999999999999964210 011100
Q ss_pred ccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 295 YDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112234567899999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=353.45 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=195.6
Q ss_pred cCCcccceecccCceEEEEEEEc-CCc--EEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEeeCCcc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGR--IMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (366)
++|++.+.||+|+||.||+|.++ +|. .||||.++..... ...+.+.+|+.+++.+ +||||++++++|...+..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 68999999999999999999965 344 4677877644333 2346789999999999 799999999999999999
Q ss_pred eEEEeeccCCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 037297 147 LLHLHDHHRNE-----------------------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER 203 (366)
Q Consensus 147 ~~~~~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~ 203 (366)
++++++..++. ...+++..+..++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCC
Confidence 99999876532 246899999999999999999999999 9999999999999999
Q ss_pred CeEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCcccccHH
Q 037297 204 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-PIFSTGNTSQENVSLA 282 (366)
Q Consensus 204 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~~~ 282 (366)
+.+||+|||++....... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..
T Consensus 164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~ 233 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA 233 (309)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred CceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence 999999999997543221 1223468999999999999999999999999999999999764 564432 11
Q ss_pred HHHHHHhhcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcccC
Q 037297 283 AFFVHSMRKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRGS 345 (366)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~~ 345 (366)
.... ..... .....+..+++++.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 234 ~~~~-~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYE-KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHH-HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHH-HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 11111 11123445667899999999999999999999999999887643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=347.89 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=190.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-C-CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC---CCCceeeEeeEEeeC-
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-D-GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLET- 143 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~- 143 (366)
.++|++++.||+|+||+||+|.+. + ++.||+|+++....... ....+.+|+.+++.+ +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 478999999999999999999974 4 66799999976544321 112455677776665 799999999998643
Q ss_pred ----CcceEEEeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeec
Q 037297 144 ----EVPLLHLHDHHRN--------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADF 211 (366)
Q Consensus 144 ----~~~~~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Df 211 (366)
...++++++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2456666655432 3446899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 212 GTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 212 g~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
|++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+ ...........
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~---~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VD---QLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHHHHHCC
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HH---HHHHHHHhhCC
Confidence 998754322 233456799999999999999999999999999999999999999975431 11 01111111000
Q ss_pred C---cccc----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 292 N---HMYD----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 292 ~---~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .+.. ..............++.+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000 00001111233345668899999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=347.79 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=188.7
Q ss_pred hcCCcccc-eecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhc-CCCCceeeEeeEEee----
Q 037297 70 TNHFNVNR-ILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQ-INHRNVVKLLGCCLE---- 142 (366)
Q Consensus 70 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~---- 142 (366)
.++|.+.+ .||+|+||+||+|.+. +++.||+|+++.. +.+.+|+.++.+ .+||||+++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 35798875 6999999999999974 6899999998742 246679988655 589999999999865
Q ss_pred CCcceEEEeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEee
Q 037297 143 TEVPLLHLHDHHRN---------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVAD 210 (366)
Q Consensus 143 ~~~~~~~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~D 210 (366)
....+++++++.++ ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence 35678888887653 2346899999999999999999999999 999999999999985 56799999
Q ss_pred cCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhh
Q 037297 211 FGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMR 290 (366)
Q Consensus 211 fg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (366)
||+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......... ......
T Consensus 158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----~~~~i~ 230 (335)
T d2ozaa1 158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIR 230 (335)
T ss_dssp CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCC
T ss_pred cceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----HHHHHh
Confidence 99998765432 23446799999999999999999999999999999999999999976442111100 000000
Q ss_pred cCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 291 KNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
.. ...+. .......++++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~-~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MG-QYEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SC-SSSCC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cC-CCCCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 00010 1123356778999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=340.65 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=192.2
Q ss_pred hcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----c
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----V 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 145 (366)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.... .......|+..+..++||||++++++|...+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 35688999999999999999987 588999999875321 1112223455556789999999999998765 4
Q ss_pred ceEEEeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEecCCCeEEEeecCCc
Q 037297 146 PLLHLHDHHRNE------EFPLTWEIRLRIATEVAGALSYLHSAA-----SSPIYHRDIKSTNILLDERYRAKVADFGTS 214 (366)
Q Consensus 146 ~~~~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~iiH~dikp~Nill~~~~~vkl~Dfg~a 214 (366)
.++++++...+. ..++++..++.++.|++.||.|+|+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 577888776543 226899999999999999999999741 233999999999999999999999999999
Q ss_pred ccccCCCce---eeeeccccCCccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc------
Q 037297 215 KFIAMDQTH---VTTKIQGTFGYLEPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV------ 279 (366)
Q Consensus 215 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------ 279 (366)
......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877544332 223467999999999887653 56789999999999999999988754331111100
Q ss_pred cHHHHHHHHhhcCccccccchHH-hhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhccc
Q 037297 280 SLAAFFVHSMRKNHMYDILDDQV-VKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIRG 344 (366)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~~ 344 (366)
............... ++.. ....+......+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 011111111111111 1111 111233466779999999999999999999999999998864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-47 Score=338.73 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=193.4
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeE-eeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKL-LGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~ 147 (366)
+++|++++.||+|+||.||+|.+. +|+.||+|++...... +.+..|+++++.++|+|++.. .+++...+..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 467999999999999999999975 5899999998765332 356789999999987765554 55556666777
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCeEEEeecCCcccc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFI 217 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~---~~~vkl~Dfg~a~~~ 217 (366)
++++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++. +..++|+|||+|+..
T Consensus 80 ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 777765432 2446899999999999999999999999 999999999999863 557999999999877
Q ss_pred cCCCce------eeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhc
Q 037297 218 AMDQTH------VTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRK 291 (366)
Q Consensus 218 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (366)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............. ....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~-~~~~~~~-~ 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-RISEKKM-S 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH-HHHHHHH-H
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH-HhhcccC-C
Confidence 543321 2344679999999999999999999999999999999999999997654222111100 0000000 0
Q ss_pred CccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 292 NHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
. ........+++++.+++..||+.||++|||++++.+.|+++.
T Consensus 235 ~---------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 235 T---------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp S---------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred C---------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 011123345678999999999999999999999999988764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=342.34 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=188.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++++.||+|+||+||+|.+. +|+.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 478999999999999999999975 69999999987654332 23356789999999999999999999886543
Q ss_pred ----cceEEEeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCC
Q 037297 145 ----VPLLHLHDHHR-------NEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGT 213 (366)
Q Consensus 145 ----~~~~~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~ 213 (366)
..++++++... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45666666432 23456889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce---eeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 214 SKFIAMDQTH---VTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 214 a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
+......... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 9766533221 22335699999999988765 689999999999999999999999975331 11100110000000
Q ss_pred hcCccccc--------------cchHHhhh-hcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 290 RKNHMYDI--------------LDDQVVKL-VKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 290 ~~~~~~~~--------------~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
........ ........ .+...++++.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000 00000000 11223557889999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=347.60 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=188.7
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCc---
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 145 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 145 (366)
.++|++++.||+|+||+||+|.++ +|+.||+|+++..... ...+.+++|+.+++.++||||+++++++.....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh---HHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 467999999999999999999964 6999999999764433 345678999999999999999999999876542
Q ss_pred -ceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 -PLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 -~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..++ ....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 23444444432 2236899999999999999999999999 9999999999999999999999999997664
Q ss_pred CCCce--eeeeccccCCcccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc--
Q 037297 219 MDQTH--VTTKIQGTFGYLEPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH-- 293 (366)
Q Consensus 219 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (366)
..... .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||...... +. ............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~---~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQ---LNHILGILGSPSQE 235 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHHHHCSCCHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HH---HHHHhhhccCCChh
Confidence 33221 234456899999999874 456789999999999999999999999754311 00 000000000000
Q ss_pred ----------------cccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 294 ----------------MYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 294 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..... ........+..+.++.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00001122234567899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=342.33 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=191.6
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++++.||+|+||+||+|.++ +|+.||+|+++...... ...+.+.+|+.+++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh--HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 468999999999999999999975 59999999998654433 34568899999999999999999999997765
Q ss_pred --cceEEEeeccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 --VPLLHLHDHHRN-----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 --~~~~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..++++++.... ....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||+|...
T Consensus 95 ~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 357777776321 1236899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---- 292 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 292 (366)
... .+...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||...... .. ...........
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~---~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQ---LKEIMKVTGTPPAEF 242 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHHHHCCCCHHH
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HH---HHHHHhccCCCcHHH
Confidence 432 2345789999999988764 5689999999999999999999999764311 00 00000000000
Q ss_pred --------------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--Hhhcc
Q 037297 293 --------------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTME--LNGIR 343 (366)
Q Consensus 293 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~--L~~~~ 343 (366)
....... ..........++++.+|+.+||+.||.+|||++|+++- ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccc-cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000 00111223456678999999999999999999999863 55544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=335.00 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=197.9
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCCcceEE
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLH 149 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 149 (366)
++|++++.||+|+||+||+|.+. +++.||+|+++...... ...+++.+|+.+++.++||||+++++++......+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh--HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 57999999999999999999975 68899999997654432 3456889999999999999999999999999998888
Q ss_pred EeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccCCCc
Q 037297 150 LHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 222 (366)
Q Consensus 150 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 222 (366)
++...+. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 8776443 3446889999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeeeccccCCccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCc---ccc--
Q 037297 223 HVTTKIQGTFGYLEPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNH---MYD-- 296 (366)
Q Consensus 223 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 296 (366)
......++..|+|||.+.+.. ++.++||||+||++|||++|+.||......... ............ +..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH----HHHHHHHHCCCCTTTCTTGG
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH----HHHHHhhcCCCChhhhhhhh
Confidence 223345778899999887665 689999999999999999999998653321111 111111111100 000
Q ss_pred ----------ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 297 ----------ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 297 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
..............++.+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111233445668899999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=343.72 Aligned_cols=262 Identities=24% Similarity=0.275 Sum_probs=192.8
Q ss_pred CCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC------
Q 037297 72 HFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE------ 144 (366)
Q Consensus 72 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 144 (366)
+|+.+++||+|+||+||+|++. +|+.||+|++...... ..+|+.+++.++||||++++++|....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 6899999999999999999976 5899999999764322 346999999999999999999985432
Q ss_pred cceEEEeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-eEEEeecCC
Q 037297 145 VPLLHLHDHHRN----------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERY-RAKVADFGT 213 (366)
Q Consensus 145 ~~~~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~-~vkl~Dfg~ 213 (366)
..++++++...+ ....+++..+..++.|++.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence 356777776432 3446899999999999999999999999 99999999999999775 899999999
Q ss_pred cccccCCCceeeeeccccCCccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH-------HHHH
Q 037297 214 SKFIAMDQTHVTTKIQGTFGYLEPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------AAFF 285 (366)
Q Consensus 214 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------~~~~ 285 (366)
+....... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||............. ....
T Consensus 170 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 98764332 2334578999999998765 578999999999999999999999997543111000000 0000
Q ss_pred HHHh---hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcccCC
Q 037297 286 VHSM---RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIRGSN 346 (366)
Q Consensus 286 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~~~~ 346 (366)
.... .....................++++.+|+.+||+.||++|||+.|+++ .++++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 0000 000111111111112223345678999999999999999999999985 355555433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-45 Score=327.82 Aligned_cols=254 Identities=16% Similarity=0.194 Sum_probs=199.2
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC-CceeeEeeEEeeCCcce
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPL 147 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 147 (366)
.++|++++.||+|+||+||+|.+. +|+.||+|++...... +.+.+|++.++.++| +|++.+++++......+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 478999999999999999999975 5899999998764332 246678899999965 89999999999999999
Q ss_pred EEEeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----CCeEEEeecCCcc
Q 037297 148 LHLHDHHRN-------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSK 215 (366)
Q Consensus 148 ~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~-----~~~vkl~Dfg~a~ 215 (366)
+++++.... ....++..++..++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 988876432 2346899999999999999999999999 999999999999974 5789999999998
Q ss_pred cccCCCc------eeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHh
Q 037297 216 FIAMDQT------HVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSM 289 (366)
Q Consensus 216 ~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (366)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~~ 232 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKK 232 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhcc
Confidence 7653321 12334679999999999999999999999999999999999999997644222111 000000000
Q ss_pred hcCccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHhhcc
Q 037297 290 RKNHMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTMELNGIR 343 (366)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~~L~~~~ 343 (366)
.... ...+...+++++.+++..|+..+|++||+++.+.+.|+++-
T Consensus 233 ~~~~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 233 QSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCC---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0000 11123345568999999999999999999999998887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-46 Score=338.15 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=190.8
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEeeC--Ccc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLET--EVP 146 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~ 146 (366)
++|++++.||+|+||+||+|.+. +|+.||+|+++... .+.+.+|+.+++.+. ||||+++++++... ...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 67999999999999999999975 68999999987532 246788999999994 99999999998754 457
Q ss_pred eEEEeeccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CeEEEeecCCcccccCCC
Q 037297 147 LLHLHDHHRNE----EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ 221 (366)
Q Consensus 147 ~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~-~~vkl~Dfg~a~~~~~~~ 221 (366)
+++++++.... ...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|......
T Consensus 108 ~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 77788766543 336899999999999999999999999 9999999999999865 46999999999866433
Q ss_pred ceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHH-----HHHhhc---C
Q 037297 222 THVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFF-----VHSMRK---N 292 (366)
Q Consensus 222 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~---~ 292 (366)
.......+|..|+|||.+.+. .++.++||||+||++|+|++|+.||................. ...... .
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 223445789999999988765 579999999999999999999999976442111100000000 000000 0
Q ss_pred c---cccc--------cchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 037297 293 H---MYDI--------LDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM 337 (366)
Q Consensus 293 ~---~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~ 337 (366)
. .... .............++++.+|+.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 0000111122345668999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=335.39 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=188.0
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeC------
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET------ 143 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 143 (366)
++|++++.||+|+||+||+|.+. +|+.||+|+++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH--HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 67999999999999999999976 59999999998765443 3446789999999999999999999998654
Q ss_pred CcceEEEeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccccC
Q 037297 144 EVPLLHLHDHHRN----EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 219 (366)
Q Consensus 144 ~~~~~~~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~~ 219 (366)
...+++++++... -...+++..++.++.|++.||.|||++| |+||||||+|||++.++.++++|||++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence 4667888876543 1235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccH--------------HHHH
Q 037297 220 DQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL--------------AAFF 285 (366)
Q Consensus 220 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~--------------~~~~ 285 (366)
........+|+.|+|||++.+..+++++||||+||++|+|++|+.||...+......... ....
T Consensus 172 --~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 233345578999999999999999999999999999999999999996543110000000 0000
Q ss_pred HHHhhcC-cccc-----ccch---HHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 037297 286 VHSMRKN-HMYD-----ILDD---QVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVT 336 (366)
Q Consensus 286 ~~~~~~~-~~~~-----~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell 336 (366)
....... .... .... ..........++++.+|+.+||+.||++|||++|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000 0000 0000 001113345678899999999999999999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=341.15 Aligned_cols=249 Identities=27% Similarity=0.301 Sum_probs=195.8
Q ss_pred cCCcccceecccCceEEEEEEEc----CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCC-CceeeEeeEEeeCCc
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE----DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEV 145 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 145 (366)
++|++++.||+|+||+||+|... +|+.||+|+++......+....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 4789999998654322111223467889999999966 899999999999999
Q ss_pred ceEEEeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 146 PLLHLHDHHRNE-------EFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 146 ~~~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
.++++++..++. ...+++..+..++.|++.|+.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999998876653 235788999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeeeccccCCccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcCcccc
Q 037297 219 MDQTHVTTKIQGTFGYLEPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKNHMYD 296 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (366)
...........|++.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ...........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~---- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSE---- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCC----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccCC----
Confidence 5544445556799999999988654 4688999999999999999999999765422111 11111111110
Q ss_pred ccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 037297 297 ILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPT-----MEEVTM 337 (366)
Q Consensus 297 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ell~ 337 (366)
...+...++++.+|+.+||+.||++||| ++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1123456778999999999999999994 788764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=332.96 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=190.1
Q ss_pred hcCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCCCCceeeEeeEEeeCC----
Q 037297 70 TNHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 144 (366)
Q Consensus 70 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 144 (366)
.++|++++.||+|+||+||+|.+. +|+.||+|+++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 468999999999999999999975 69999999998654433 34457889999999999999999999986432
Q ss_pred -cceEEEeeccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCcccc
Q 037297 145 -VPLLHLHDHHRN------EEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 217 (366)
Q Consensus 145 -~~~~~~~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~ 217 (366)
..+++++++.++ ....+++..+..++.|++.||+|||++| |+||||||+|||++.++.+|++|||.+...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 334555555433 2346899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeeeccccCCccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 037297 218 AMDQTHVTTKIQGTFGYLEPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAFFVHSMRKN---- 292 (366)
Q Consensus 218 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 292 (366)
.. ......||..|+|||...+. .++.++||||+||++|+|++|+.||.+..... ............
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-----~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILRLVGTPGAEL 242 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCHHH
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCChHH
Confidence 32 22345688999999987665 46889999999999999999999997543110 000000000000
Q ss_pred --------------ccccccchHHhhhhcHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHhhcc
Q 037297 293 --------------HMYDILDDQVVKLVKKNQIMAFANLAERCLDLNGKKRPTMEEVTM--ELNGIR 343 (366)
Q Consensus 293 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ell~--~L~~~~ 343 (366)
......... ........++++.+|+.+||+.||.+|||++|+++ -++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCC-HHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhhhhhhcccCCCcc-hhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000 00112234567899999999999999999999987 455544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-41 Score=309.63 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=182.7
Q ss_pred cCCcccceecccCceEEEEEEEc-CCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-----------CCceeeEee
Q 037297 71 NHFNVNRILGQGGQGTVYKGMLE-DGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-----------HRNVVKLLG 138 (366)
Q Consensus 71 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~ 138 (366)
.+|++++.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.+. |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 46999999999999999999975 69999999998542 22346678888887774 578999998
Q ss_pred EEeeCC--cceEEEeeccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCC-
Q 037297 139 CCLETE--VPLLHLHDHHR----------NEEFPLTWEIRLRIATEVAGALSYLHS-AASSPIYHRDIKSTNILLDERY- 204 (366)
Q Consensus 139 ~~~~~~--~~~~~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~iiH~dikp~Nill~~~~- 204 (366)
++.... ....++..... .....+++..+..++.|++.|+.|||+ +| |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCc
Confidence 876543 33333333322 234468899999999999999999998 77 99999999999998654
Q ss_pred -----eEEEeecCCcccccCCCceeeeeccccCCccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 037297 205 -----RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLEPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 279 (366)
Q Consensus 205 -----~vkl~Dfg~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 279 (366)
.++++|||.+..... ......||+.|+|||++.+..++.++|+||+||++++|++|+.||...........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred ccccceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 499999999875432 22445789999999999999999999999999999999999999976532211110
Q ss_pred c-HHHHHHHHhhc------------------C----cccccc----ch--HHhhhhcHHHHHHHHHHHHHhhcCCCCCCC
Q 037297 280 S-LAAFFVHSMRK------------------N----HMYDIL----DD--QVVKLVKKNQIMAFANLAERCLDLNGKKRP 330 (366)
Q Consensus 280 ~-~~~~~~~~~~~------------------~----~~~~~~----~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 330 (366)
. ........+.. . ...... .. ..........++++.+|+.+||+.||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 0 00000000000 0 000000 00 011224567888999999999999999999
Q ss_pred CHHHHHH
Q 037297 331 TMEEVTM 337 (366)
Q Consensus 331 t~~ell~ 337 (366)
|++|+++
T Consensus 321 ta~e~L~ 327 (362)
T d1q8ya_ 321 DAGGLVN 327 (362)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.1e-25 Score=186.25 Aligned_cols=168 Identities=18% Similarity=0.171 Sum_probs=123.5
Q ss_pred CcccceecccCceEEEEEEEcCCcEEEEEEeecccCh--------------HHHHHHHHHHHHHHHHhcCCCCceeeEee
Q 037297 73 FNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDD--------------EELLKLEEFINEIVILSQINHRNVVKLLG 138 (366)
Q Consensus 73 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (366)
+.+++.||+|+||+||+|.+.+|+.||+|+++..... ...........|...+..+.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999888999999987643221 01122344567889999999999998876
Q ss_pred EEeeCCcceEEEeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCeEEEeecCCccccc
Q 037297 139 CCLETEVPLLHLHDHHRNEEFPLTWEIRLRIATEVAGALSYLHSAASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 218 (366)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~~~~ 218 (366)
+. ..+++++.........++......++.|++.++.|||++| |+||||||+|||++++ .++|+|||.|....
T Consensus 82 ~~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred ec----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 53 2356777766665556677778899999999999999999 9999999999999965 58999999987654
Q ss_pred CCCceeeeeccccCCcccc------ccccCCCCCchhhHHHHHHHH
Q 037297 219 MDQTHVTTKIQGTFGYLEP------EYHQSSQLTDKSDVYSFGVVL 258 (366)
Q Consensus 219 ~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~DiwslG~~l 258 (366)
.+.... |... +. -...|+.++|+||+.--+
T Consensus 154 ~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 154 EEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp STTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 332211 1111 11 135678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=6.6e-07 Score=75.57 Aligned_cols=148 Identities=16% Similarity=0.089 Sum_probs=98.8
Q ss_pred hHHHHHHhcCCcccceecccCceEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 037297 63 SKELDKATNHFNVNRILGQGGQGTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 141 (366)
Q Consensus 63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (366)
.+++......|++.+..+-++.+.||+... +++.+++|......... ...+.+|...+..+ .+-.+.+++.+..
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 355666667788777765566678998864 46667888776543321 12456788887776 3444677788777
Q ss_pred eCCcceEEEeeccCCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 037297 142 ETEVPLLHLHDHHRNEEF--PLTWEIRLRIATEVAGALSYLHSAA----------------------------------- 184 (366)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------- 184 (366)
..+..+++++...+.... ..+......++.+++..+..||+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred cCCceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 788888888776553211 1122223445667777777777531
Q ss_pred ---------------------CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 185 ---------------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 185 ---------------------~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137999999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=6.9e-06 Score=68.68 Aligned_cols=128 Identities=18% Similarity=0.142 Sum_probs=85.0
Q ss_pred eecccCc-eEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC--CCceeeEeeEEeeCCcceEEEeecc
Q 037297 78 ILGQGGQ-GTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETEVPLLHLHDHH 154 (366)
Q Consensus 78 ~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~~~ 154 (366)
.+..|.. +.||+....++..+++|........ .+..|...++.+. .-.+.+++.+..+.+..+++++...
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3445553 6899998877888999987654322 3556777777663 3346677877777777778877765
Q ss_pred CCCCCC--CCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 037297 155 RNEEFP--LTWEIRLRIATEVAGALSYLHSAA------------------------------------------------ 184 (366)
Q Consensus 155 ~~~~~~--l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------------ 184 (366)
+..... ... ...+.++...+.-||+..
T Consensus 90 G~~~~~~~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 90 GQDLLSSHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp SEETTTSCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ccccccccccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 432221 221 223445666666666421
Q ss_pred -------CCCeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 185 -------SSPIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 185 -------~~~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
...++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0137999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00047 Score=61.20 Aligned_cols=77 Identities=17% Similarity=0.184 Sum_probs=43.3
Q ss_pred cceecccCceEEEEEEEcC-CcEEEEEEeecccChHH---HHHHHHHHHHHHHHhcC-CC--CceeeEeeEEeeCCcceE
Q 037297 76 NRILGQGGQGTVYKGMLED-GRIMAVKKFKLAVDDEE---LLKLEEFINEIVILSQI-NH--RNVVKLLGCCLETEVPLL 148 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~---~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~ 148 (366)
.+.||.|..-.||++...+ ++.+++|.-........ .....+...|.+.++.+ .+ ..+++.+.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 67899996543211000 00122345677777666 22 345555543 4455566
Q ss_pred EEeecc
Q 037297 149 HLHDHH 154 (366)
Q Consensus 149 ~~~~~~ 154 (366)
++++..
T Consensus 109 vmE~L~ 114 (392)
T d2pula1 109 VMEDLS 114 (392)
T ss_dssp EECCCT
T ss_pred EEeccC
Confidence 666654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.24 E-value=0.0028 Score=54.02 Aligned_cols=29 Identities=17% Similarity=0.189 Sum_probs=26.2
Q ss_pred CeEeCCCCCCCEEecCCCeEEEeecCCcc
Q 037297 187 PIYHRDIKSTNILLDERYRAKVADFGTSK 215 (366)
Q Consensus 187 ~iiH~dikp~Nill~~~~~vkl~Dfg~a~ 215 (366)
.+||+|+.++||+++.+...-++||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 39999999999999998777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.0013 Score=56.63 Aligned_cols=40 Identities=23% Similarity=0.205 Sum_probs=30.1
Q ss_pred eEEEEEEEcCCcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC
Q 037297 85 GTVYKGMLEDGRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN 129 (366)
Q Consensus 85 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 129 (366)
=.||++...+|+.+++|+.+....+ .+++..|.+.+..|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s-----~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT-----ADQILEEHQFALQLV 75 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHH
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC-----HHHHHHHHHHHHHHH
Confidence 4799999888999999998865433 235667887777763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.019 Score=50.43 Aligned_cols=60 Identities=15% Similarity=0.170 Sum_probs=36.6
Q ss_pred cceecccCceEEEEEEEcC--------CcEEEEEEeecccChHHHHHHHHHHHHHHHHhcCC-CCceeeEeeEEe
Q 037297 76 NRILGQGGQGTVYKGMLED--------GRIMAVKKFKLAVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCL 141 (366)
Q Consensus 76 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 141 (366)
++.|+.|-.=.+|++...+ .+.+.+++.-. .... . ...+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~--i---dr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE--S---HLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH--H---HHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh--h---HHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 3568888888999998643 34577776653 2221 1 2346888888774 333345666553
|